{
"company_details": [
{
"company_id": "0001674930",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001674930.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001674930.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001674930.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001674930_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001674930_main_keyfigs.svg",
"name": "Fulgent Genetics Inc",
"rank": 1,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001674930.svg",
"report_text": "The relative strengths and weaknesses of Fulgent Genetics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Fulgent Genetics Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 94% points.The greatest weakness of Fulgent Genetics Inc is the variable Other Assets, reducing the Economic Capital Ratio by 13% points.
The company's Economic Capital Ratio, given in the ranking table, is 327%, being 159% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001674930_2022_Fulgent_Genetics_Inc.pdf",
"shrinked_graph_json": {
"2016": {
"Assets": "28.1",
"Liabilities": "67.7",
"Stockholders Equity": "137",
"ECR before LimitedLiability": "143",
"Assets, Non-Current": "34.5",
"Other Assets": "-4.20",
"Assets, Current": "10.3",
"Liabilities, Current": "43.6",
"Other Liabilities": "13.5",
"Long Term Liabilities": "21.4",
"Expenses": "26.5",
"Revenues": "4.50",
"Net Income": "6.19",
"General and Administrative Expense": "6.87",
"Labor Expense": "5.23",
"Other Expenses": "18.9",
"Research And Development Expense": "-4.08",
"Other Revenues": "4.50",
"Other Net Income": "-26.7",
"Comprehensive Net Income": "6.52",
"Economic Capital Ratio": "115"
},
"2017": {
"Other Assets": "7.71",
"Assets": "19.2",
"Stockholders Equity": "130",
"ECR before LimitedLiability": "152",
"Assets, Current": "12.2",
"Liabilities, Current": "42.7",
"Liabilities": "70.8",
"Other Liabilities": "9.39",
"Long Term Liabilities": "30.6",
"General and Administrative Expense": "5.92",
"Expenses": "18.3",
"Revenues": "12.8",
"Net Income": "13.5",
"Labor Expense": "5.74",
"Selling and Marketing Expense": "-6.26",
"Other Expenses": "24.9",
"Cost of Goods and Services Sold": "-11.6",
"Other Revenues": "12.8",
"Other Net Income": "-18.5",
"Comprehensive Net Income": "13.7",
"Economic Capital Ratio": "128"
},
"2018": {
"Other Assets": "2.42",
"Assets": "18.5",
"Liabilities": "68.8",
"Stockholders Equity": "116",
"ECR before LimitedLiability": "129",
"Intangible Assets": "-3.82",
"Assets, Current": "24.0",
"Other Liabilities": "8.78",
"Liabilities, Current": "41.2",
"Long Term Liabilities": "29.8",
"Selling and Marketing Expense": "-8.68",
"Expenses": "10.4",
"Net Income": "9.77",
"Operating Costs and Expenses": "3.78",
"Other Expenses": "18.1",
"General and Administrative Expense": "4.71",
"Research And Development Expense": "-9.19",
"Cost of Goods and Services Sold": "-8.10",
"Labor Expense": "7.61",
"Comprehensive Net Income": "10.0",
"Economic Capital Ratio": "109"
},
"2019": {
"Assets": "14.9",
"Liabilities": "65.8",
"Stockholders Equity": "112",
"ECR before LimitedLiability": "124",
"Other Assets": "19.2",
"Intangible Assets": "-3.13",
"Assets, Current": "4.35",
"Other Liabilities": "11.3",
"Long Term Liabilities": "32.8",
"Liabilities, Current": "32.9",
"Other Expenses": "10.9",
"Expenses": "17.8",
"Net Income": "16.5",
"General and Administrative Expense": "5.59",
"Cost of Goods and Services Sold": "-1.74",
"Research And Development Expense": "-4.18",
"Selling and Marketing Expense": "-5.42",
"Labor Expense": "6.03",
"Operating Costs and Expenses": "5.18",
"Comprehensive Net Income": "16.9",
"Economic Capital Ratio": "114"
},
"2020": {
"Assets": "8.41",
"Liabilities": "45.1",
"Stockholders Equity": "71.0",
"ECR before LimitedLiability": "126",
"Other Assets": "4.08",
"Intangible Assets": "-3.46",
"Assets, Current": "14.4",
"Assets, Non-Current": "-1.99",
"Liabilities, Current": "-6.49",
"Other Liabilities": "8.87",
"Long Term Liabilities": "43.1",
"Labor Expense": "5.68",
"Expenses": "29.5",
"Revenues": "24.9",
"Net Income": "53.3",
"General and Administrative Expense": "16.5",
"Operating Costs and Expenses": "4.52",
"Cost of Goods and Services Sold": "1.94",
"Other Revenues": "24.9",
"Comprehensive Net Income": "53.4",
"Economic Capital Ratio": "114"
},
"2021": {
"Other Assets": "-12.6",
"Assets": "-3.62",
"Stockholders Equity": "88.3",
"ECR before LimitedLiability": "165",
"Intangible Assets": "3.22",
"Liabilities, Current": "34.9",
"Liabilities": "94.1",
"Long Term Liabilities": "59.1",
"Other Liabilities": "20.4",
"General and Administrative Expense": "18.7",
"Expenses": "27.0",
"Revenues": "54.6",
"Net Income": "80.6",
"Operating Costs and Expenses": "7.06",
"Labor Expense": "6.12",
"Cost of Goods and Services Sold": "-5.96",
"Research And Development Expense": "3.39",
"Other Expenses": "-6.78",
"Other Revenues": "54.6",
"Comprehensive Net Income": "80.7",
"Economic Capital Ratio": "159"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001674930_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "26,138",
"Assets, Non-Current": "31,902",
"Cost of Goods and Services Sold": "6,722",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "4,609",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,316",
"Long Term Liabilities": "2.0",
"Operating Costs and Expenses": "0",
"Other Assets": "-6,234",
"Other Compr. Net Income": "-103",
"Other Expenses": "920",
"Other Liabilities": "243",
"Other Net Income": "-5,345",
"Other Revenues": "18,276",
"Property Plant and Equipment": "6,234",
"Research And Development Expense": "3,558",
"Selling and Marketing Expense": "2,469"
},
"output_variables": {
"Assets": "58,040",
"Liabilities": "3,561",
"Expenses": "18,278",
"Revenues": "18,276",
"Stockholders Equity": "54,479",
"Net Income": "-5,347",
"Comprehensive Net Income": "-5,450",
"BaseVar": "51,802",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "265%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "32,927",
"Assets, Non-Current": "1,976",
"Cost of Goods and Services Sold": "8,551",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,233",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,000",
"Long Term Liabilities": "6.0",
"Operating Costs and Expenses": "0",
"Other Assets": "15,009",
"Other Compr. Net Income": "59",
"Other Expenses": "-1,015",
"Other Liabilities": "0",
"Other Net Income": "-43",
"Other Revenues": "18,730",
"Property Plant and Equipment": "7,272",
"Research And Development Expense": "4,223",
"Selling and Marketing Expense": "4,205"
},
"output_variables": {
"Assets": "57,184",
"Liabilities": "3,006",
"Expenses": "21,197",
"Revenues": "18,730",
"Stockholders Equity": "54,178",
"Net Income": "-2,510",
"Comprehensive Net Income": "-2,451",
"BaseVar": "50,110",
"ECR before LimitedLiability": "253%",
"Economic Capital Ratio": "276%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "39,543",
"Assets, Non-Current": "1,529",
"Cost of Goods and Services Sold": "10,697",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,538",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,738",
"Long Term Liabilities": "14",
"Operating Costs and Expenses": "0",
"Other Assets": "6,386",
"Other Compr. Net Income": "9.0",
"Other Expenses": "36",
"Other Liabilities": "0",
"Other Net Income": "-501",
"Other Revenues": "21,351",
"Property Plant and Equipment": "6,446",
"Research And Development Expense": "5,534",
"Selling and Marketing Expense": "4,652"
},
"output_variables": {
"Assets": "53,904",
"Liabilities": "2,752",
"Expenses": "26,457",
"Revenues": "21,351",
"Stockholders Equity": "51,152",
"Net Income": "-5,607",
"Comprehensive Net Income": "-5,598",
"BaseVar": "52,487",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "268%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "37,079",
"Assets, Non-Current": "3,756",
"Cost of Goods and Services Sold": "14,107",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,414",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,723",
"Long Term Liabilities": "2,256",
"Operating Costs and Expenses": "0",
"Other Assets": "41,947",
"Other Compr. Net Income": "181",
"Other Expenses": "43",
"Other Liabilities": "0",
"Other Net Income": "-777",
"Other Revenues": "33,365",
"Property Plant and Equipment": "5,974",
"Research And Development Expense": "6,537",
"Selling and Marketing Expense": "5,898"
},
"output_variables": {
"Assets": "88,756",
"Liabilities": "5,979",
"Expenses": "32,999",
"Revenues": "33,365",
"Stockholders Equity": "82,777",
"Net Income": "-411",
"Comprehensive Net Income": "-230",
"BaseVar": "81,028",
"ECR before LimitedLiability": "253%",
"Economic Capital Ratio": "276%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "523,616",
"Assets, Non-Current": "4,144",
"Cost of Goods and Services Sold": "89,807",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "15,215",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "130,115",
"Long Term Liabilities": "582",
"Operating Costs and Expenses": "0",
"Other Assets": "132,502",
"Other Compr. Net Income": "292",
"Other Expenses": "76,886",
"Other Liabilities": "377",
"Other Net Income": "-488",
"Other Revenues": "423,238",
"Property Plant and Equipment": "40,199",
"Research And Development Expense": "11,580",
"Selling and Marketing Expense": "14,952"
},
"output_variables": {
"Assets": "700,461",
"Liabilities": "131,074",
"Expenses": "208,440",
"Revenues": "423,238",
"Stockholders Equity": "569,387",
"Net Income": "214,310",
"Comprehensive Net Income": "214,602",
"BaseVar": "731,996",
"ECR before LimitedLiability": "250%",
"Economic Capital Ratio": "274%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "611,960",
"Assets, Non-Current": "10,650",
"Cost of Goods and Services Sold": "215,533",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "50,732",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "50,897",
"Labor Expense": "0",
"Liabilities, Current": "105,310",
"Long Term Liabilities": "6,805",
"Operating Costs and Expenses": "0",
"Other Assets": "542,926",
"Other Compr. Net Income": "-72",
"Other Expenses": "176,503",
"Other Liabilities": "725",
"Other Net Income": "3,734",
"Other Revenues": "993,931",
"Property Plant and Equipment": "62,287",
"Research And Development Expense": "24,219",
"Selling and Marketing Expense": "24,439"
},
"output_variables": {
"Assets": "1,278,720",
"Liabilities": "112,840",
"Expenses": "491,426",
"Revenues": "993,931",
"Stockholders Equity": "1,165,880",
"Net Income": "506,239",
"Comprehensive Net Income": "506,167",
"BaseVar": "1,440,362",
"ECR before LimitedLiability": "316%",
"Economic Capital Ratio": "327%"
}
}
},
"top_rated": true,
"trend": 3.0,
"value": 3.2670255822266516,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001674930.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001674930.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001674930.svg"
},
{
"company_id": "0001138476",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001138476.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001138476.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001138476.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001138476_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001138476_main_keyfigs.svg",
"name": "Pacific Health CARE Organization INC",
"rank": 2,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001138476.svg",
"report_text": "The relative strengths and weaknesses of Pacific Health CARE Organization INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pacific Health CARE Organization INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 103% points.The greatest weakness of Pacific Health CARE Organization INC is the variable Labor Expense, reducing the Economic Capital Ratio by 33% points.
The company's Economic Capital Ratio, given in the ranking table, is 299%, being 131% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001138476_2022_Pacific_Health_CARE_Organization_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-27.7",
"Liabilities": "127",
"Stockholders Equity": "-59.4",
"ECR before LimitedLiability": "87.1",
"Property Plant and Equipment": "-16.9",
"Assets, Current": "12.6",
"Intangible Assets": "-20.1",
"Other Liabilities": "26.6",
"Long Term Liabilities": "78.1",
"Liabilities, Current": "46.1",
"Expenses": "-76.0",
"Revenues": "164",
"Net Income": "58.9",
"Research And Development Expense": "5.31",
"Operating Costs and Expenses": "-20.2",
"Labor Expense": "-103",
"Cost of Goods and Services Sold": "17.3",
"Other Revenues": "164",
"Other Net Income": "-71.4",
"Comprehensive Net Income": "59.4",
"Economic Capital Ratio": "80.4"
},
"2012": {
"Property Plant and Equipment": "-10.7",
"Assets": "-19.3",
"Stockholders Equity": "-42.9",
"ECR before LimitedLiability": "105",
"Intangible Assets": "-13.8",
"Liabilities, Current": "40.5",
"Liabilities": "113",
"Long Term Liabilities": "59.5",
"Other Liabilities": "39.1",
"Expenses": "-50.7",
"Revenues": "168",
"Net Income": "68.5",
"Other Expenses": "-18.0",
"General and Administrative Expense": "14.5",
"Operating Costs and Expenses": "-14.5",
"Cost of Goods and Services Sold": "16.0",
"Labor Expense": "-71.2",
"Other Revenues": "168",
"Other Net Income": "-62.1",
"Comprehensive Net Income": "69.2",
"Economic Capital Ratio": "90.9"
},
"2013": {
"Assets": "7.22",
"Stockholders Equity": "11.3",
"ECR before LimitedLiability": "171",
"Other Liabilities": "52.1",
"Liabilities": "175",
"Liabilities, Current": "109",
"Long Term Liabilities": "85.1",
"Expenses": "-62.4",
"Revenues": "188",
"Net Income": "99.0",
"Selling and Marketing Expense": "7.04",
"General and Administrative Expense": "29.4",
"Cost of Goods and Services Sold": "18.3",
"Labor Expense": "-78.7",
"Operating Costs and Expenses": "10.6",
"Other Expenses": "-74.8",
"Research And Development Expense": "10.6",
"Other Revenues": "188",
"Comprehensive Net Income": "99.6",
"Other Net Income": "-50.7",
"Economic Capital Ratio": "162"
},
"2014": {
"Other Liabilities": "35.9",
"Liabilities": "155",
"Stockholders Equity": "43.7",
"ECR before LimitedLiability": "175",
"Liabilities, Current": "89.6",
"Long Term Liabilities": "86.8",
"Expenses": "-35.5",
"Revenues": "157",
"Net Income": "89.2",
"Operating Costs and Expenses": "13.7",
"Labor Expense": "-46.4",
"Research And Development Expense": "10.4",
"Other Expenses": "-78.2",
"Selling and Marketing Expense": "9.93",
"Cost of Goods and Services Sold": "17.7",
"General and Administrative Expense": "26.3",
"Other Revenues": "157",
"Assets, Current": "-7.64",
"Comprehensive Net Income": "89.4",
"Other Net Income": "-51.6",
"Economic Capital Ratio": "162"
},
"2015": {
"Long Term Liabilities": "62.2",
"Liabilities": "141",
"Stockholders Equity": "68.2",
"ECR before LimitedLiability": "174",
"Other Liabilities": "34.2",
"Liabilities, Current": "93.0",
"Selling and Marketing Expense": "10.4",
"Expenses": "-20.2",
"Revenues": "126",
"Net Income": "81.4",
"Research And Development Expense": "8.38",
"Operating Costs and Expenses": "10.0",
"General and Administrative Expense": "20.2",
"Other Expenses": "-52.9",
"Labor Expense": "-44.5",
"Cost of Goods and Services Sold": "20.1",
"Other Revenues": "126",
"Assets, Current": "-12.5",
"Comprehensive Net Income": "82.0",
"Other Net Income": "-38.9",
"Economic Capital Ratio": "162"
},
"2016": {
"Assets": "3.40",
"Stockholders Equity": "104",
"ECR before LimitedLiability": "162",
"Assets, Current": "25.7",
"Liabilities, Current": "69.8",
"Liabilities": "104",
"Other Liabilities": "24.5",
"Long Term Liabilities": "34.8",
"Other Revenues": "61.4",
"Revenues": "61.4",
"Net Income": "41.5",
"Comprehensive Net Income": "42.3",
"Operating Costs and Expenses": "5.02",
"Selling and Marketing Expense": "8.06",
"General and Administrative Expense": "13.8",
"Labor Expense": "-47.2",
"Other Expenses": "-12.2",
"Cost of Goods and Services Sold": "19.4",
"Research And Development Expense": "7.16",
"Other Net Income": "-21.8",
"Economic Capital Ratio": "134"
},
"2017": {
"Liabilities, Current": "67.0",
"Liabilities": "105",
"Stockholders Equity": "96.1",
"ECR before LimitedLiability": "169",
"Other Liabilities": "15.3",
"Long Term Liabilities": "47.8",
"General and Administrative Expense": "16.9",
"Expenses": "2.79",
"Revenues": "70.5",
"Net Income": "48.3",
"Labor Expense": "-39.2",
"Operating Costs and Expenses": "3.38",
"Selling and Marketing Expense": "6.93",
"Research And Development Expense": "9.15",
"Other Expenses": "-14.1",
"Cost of Goods and Services Sold": "15.8",
"Other Revenues": "70.5",
"Assets, Current": "13.8",
"Other Net Income": "-29.8",
"Comprehensive Net Income": "48.5",
"Economic Capital Ratio": "145"
},
"2018": {
"Assets": "-2.81",
"Stockholders Equity": "141",
"ECR before LimitedLiability": "169",
"Assets, Current": "-6.78",
"Other Liabilities": "7.40",
"Liabilities": "56.5",
"Liabilities, Current": "30.5",
"Long Term Liabilities": "25.8",
"Expenses": "47.8",
"Revenues": "-44.6",
"Net Income": "41.4",
"Operating Costs and Expenses": "2.89",
"Other Expenses": "4.41",
"General and Administrative Expense": "14.4",
"Research And Development Expense": "4.07",
"Cost of Goods and Services Sold": "14.9",
"Labor Expense": "5.81",
"Other Revenues": "-44.6",
"Comprehensive Net Income": "41.6",
"Other Net Income": "34.0",
"Economic Capital Ratio": "148"
},
"2020": {
"Assets": "10.1",
"Stockholders Equity": "85.1",
"ECR before LimitedLiability": "118",
"Intangible Assets": "-4.70",
"Assets, Current": "40.1",
"Liabilities, Current": "24.2",
"Liabilities": "64.3",
"Other Liabilities": "9.47",
"Long Term Liabilities": "40.2",
"Labor Expense": "-29.7",
"Expenses": "8.05",
"Revenues": "16.8",
"Net Income": "25.4",
"General and Administrative Expense": "12.6",
"Research And Development Expense": "4.24",
"Other Expenses": "-8.69",
"Operating Costs and Expenses": "4.85",
"Cost of Goods and Services Sold": "19.0",
"Other Revenues": "16.8",
"Comprehensive Net Income": "25.4",
"Economic Capital Ratio": "106"
},
"2021": {
"Liabilities, Current": "39.2",
"Liabilities": "88.0",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "137",
"Long Term Liabilities": "51.1",
"Other Liabilities": "17.2",
"General and Administrative Expense": "13.1",
"Expenses": "8.66",
"Revenues": "16.5",
"Net Income": "35.4",
"Operating Costs and Expenses": "6.22",
"Labor Expense": "-33.0",
"Cost of Goods and Services Sold": "17.7",
"Research And Development Expense": "5.59",
"Other Expenses": "-9.16",
"Selling and Marketing Expense": "4.30",
"Other Revenues": "16.5",
"Assets, Current": "9.09",
"Comprehensive Net Income": "35.5",
"Other Net Income": "11.4",
"Economic Capital Ratio": "131"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001138476_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "980",
"Assets, Non-Current": "8.2",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "14",
"General and Administrative Expense": "392",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "1,132",
"Liabilities, Current": "257",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "359",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "735",
"Other Liabilities": "7.1",
"Other Net Income": "-1.5",
"Other Revenues": "2,832",
"Property Plant and Equipment": "71",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,059",
"Liabilities": "264",
"Expenses": "2,632",
"Revenues": "2,832",
"Stockholders Equity": "796",
"Net Income": "198",
"Comprehensive Net Income": "198",
"BaseVar": "3,394",
"ECR before LimitedLiability": "204%",
"Economic Capital Ratio": "241%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,873",
"Assets, Non-Current": "8.2",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "29",
"General and Administrative Expense": "491",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "1,655",
"Liabilities, Current": "520",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "487",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,454",
"Other Liabilities": "21",
"Other Net Income": "0.32",
"Other Revenues": "4,827",
"Property Plant and Equipment": "168",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,049",
"Liabilities": "542",
"Expenses": "4,116",
"Revenues": "4,827",
"Stockholders Equity": "1,507",
"Net Income": "711",
"Comprehensive Net Income": "711",
"BaseVar": "5,767",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "255%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "2,901",
"Assets, Non-Current": "8.2",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "44",
"General and Administrative Expense": "475",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,084",
"Liabilities, Current": "289",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,736",
"Other Liabilities": "8.2",
"Other Net Income": "-1.9",
"Other Revenues": "6,573",
"Property Plant and Equipment": "128",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,037",
"Liabilities": "297",
"Expenses": "5,339",
"Revenues": "6,573",
"Stockholders Equity": "2,740",
"Net Income": "1,233",
"Comprehensive Net Income": "1,233",
"BaseVar": "7,624",
"ECR before LimitedLiability": "312%",
"Economic Capital Ratio": "324%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "4,971",
"Assets, Non-Current": "8.2",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "49",
"General and Administrative Expense": "577",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,527",
"Liabilities, Current": "534",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4,346",
"Other Liabilities": "0",
"Other Net Income": "-1.1",
"Other Revenues": "9,463",
"Property Plant and Equipment": "179",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,159",
"Liabilities": "534",
"Expenses": "7,500",
"Revenues": "9,463",
"Stockholders Equity": "4,625",
"Net Income": "1,962",
"Comprehensive Net Income": "1,962",
"BaseVar": "11,328",
"ECR before LimitedLiability": "305%",
"Economic Capital Ratio": "317%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "5,222",
"Assets, Non-Current": "27",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "69",
"General and Administrative Expense": "638",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,325",
"Liabilities, Current": "385",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3,515",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "8,224",
"Property Plant and Equipment": "268",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,517",
"Liabilities": "385",
"Expenses": "6,547",
"Revenues": "8,224",
"Stockholders Equity": "5,132",
"Net Income": "1,677",
"Comprehensive Net Income": "1,677",
"BaseVar": "10,337",
"ECR before LimitedLiability": "309%",
"Economic Capital Ratio": "321%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "6,004",
"Assets, Non-Current": "27",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "85",
"General and Administrative Expense": "661",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,317",
"Liabilities, Current": "499",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,058",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "5,688",
"Property Plant and Equipment": "226",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,257",
"Liabilities": "499",
"Expenses": "5,121",
"Revenues": "5,688",
"Stockholders Equity": "5,758",
"Net Income": "567",
"Comprehensive Net Income": "567",
"BaseVar": "8,782",
"ECR before LimitedLiability": "264%",
"Economic Capital Ratio": "284%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "7,067",
"Assets, Non-Current": "27",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "76",
"General and Administrative Expense": "653",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,300",
"Liabilities, Current": "539",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,512",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "6,506",
"Property Plant and Equipment": "167",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,261",
"Liabilities": "539",
"Expenses": "5,541",
"Revenues": "6,506",
"Stockholders Equity": "6,722",
"Net Income": "964",
"Comprehensive Net Income": "964",
"BaseVar": "9,923",
"ECR before LimitedLiability": "275%",
"Economic Capital Ratio": "293%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "8,337",
"Assets, Non-Current": "27",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "424",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "530",
"Other Liabilities": "0",
"Other Net Income": "1,889",
"Other Revenues": "0",
"Property Plant and Equipment": "142",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,506",
"Liabilities": "424",
"Expenses": "530",
"Revenues": "0",
"Stockholders Equity": "8,082",
"Net Income": "1,360",
"Comprehensive Net Income": "1,360",
"BaseVar": "5,674",
"ECR before LimitedLiability": "293%",
"Economic Capital Ratio": "308%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "10,648",
"Assets, Non-Current": "336",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "55",
"General and Administrative Expense": "696",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,917",
"Liabilities, Current": "1,062",
"Long Term Liabilities": "216",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,825",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "6,043",
"Property Plant and Equipment": "123",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "11,107",
"Liabilities": "1,278",
"Expenses": "5,493",
"Revenues": "6,043",
"Stockholders Equity": "9,829",
"Net Income": "550",
"Comprehensive Net Income": "550",
"BaseVar": "11,960",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "266%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "11,143",
"Assets, Non-Current": "97",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "49",
"General and Administrative Expense": "658",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,741",
"Liabilities, Current": "508",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,640",
"Other Liabilities": "0",
"Other Net Income": "680",
"Other Revenues": "5,403",
"Property Plant and Equipment": "93",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "11,333",
"Liabilities": "508",
"Expenses": "5,088",
"Revenues": "5,403",
"Stockholders Equity": "10,824",
"Net Income": "995",
"Comprehensive Net Income": "995",
"BaseVar": "11,506",
"ECR before LimitedLiability": "282%",
"Economic Capital Ratio": "299%"
}
}
},
"top_rated": true,
"trend": 4.0,
"value": 2.986308803790388,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001138476.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001138476.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001138476.svg"
},
{
"company_id": "0001477449",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001477449.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001477449.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001477449.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001477449_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001477449_main_keyfigs.svg",
"name": "Teladoc Health Inc",
"rank": 3,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001477449.svg",
"report_text": "The relative strengths and weaknesses of Teladoc Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Teladoc Health Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 142% points.The greatest weakness of Teladoc Health Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 18% points.
The company's Economic Capital Ratio, given in the ranking table, is 293%, being 125% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001477449_2022_Teladoc_Health_Inc.pdf",
"shrinked_graph_json": {
"2015": {
"Assets, Current": "35.3",
"Assets": "29.6",
"Liabilities": "59.4",
"Stockholders Equity": "114",
"ECR before LimitedLiability": "91.9",
"Intangible Assets": "10.3",
"Property Plant and Equipment": "-6.84",
"Long Term Liabilities": "24.6",
"Other Liabilities": "12.8",
"Liabilities, Current": "29.9",
"Other Revenues": "4.87",
"Revenues": "4.87",
"Net Income": "-14.2",
"Comprehensive Net Income": "-13.9",
"Selling and Marketing Expense": "-6.73",
"Operating Costs and Expenses": "4.33",
"Other Net Income": "-17.7",
"General and Administrative Expense": "-13.8",
"Other Expenses": "11.5",
"Labor Expense": "10.1",
"Economic Capital Ratio": "79.4"
},
"2016": {
"Property Plant and Equipment": "-6.48",
"Assets": "28.6",
"Stockholders Equity": "128",
"ECR before LimitedLiability": "120",
"Intangible Assets": "58.8",
"Liabilities, Current": "45.1",
"Liabilities": "72.4",
"Other Liabilities": "15.4",
"Long Term Liabilities": "22.3",
"Expenses": "-3.92",
"Revenues": "8.90",
"Net Income": "-10.6",
"Operating Costs and Expenses": "3.43",
"Selling and Marketing Expense": "-9.33",
"Labor Expense": "5.81",
"Other Expenses": "2.96",
"Research And Development Expense": "-4.38",
"Other Revenues": "8.90",
"Other Net Income": "-15.9",
"Comprehensive Net Income": "-9.93",
"Economic Capital Ratio": "92.2"
},
"2017": {
"Assets": "25.6",
"Liabilities": "68.7",
"Stockholders Equity": "132",
"ECR before LimitedLiability": "142",
"Intangible Assets": "60.1",
"Assets, Current": "-2.16",
"Property Plant and Equipment": "-3.45",
"Liabilities, Current": "41.6",
"Other Liabilities": "8.91",
"Long Term Liabilities": "29.1",
"General and Administrative Expense": "5.01",
"Expenses": "15.0",
"Revenues": "6.41",
"Comprehensive Net Income": "2.16",
"Labor Expense": "5.59",
"Selling and Marketing Expense": "-5.60",
"Depreciation, Depletion, Amortization": "-2.16",
"Other Expenses": "10.5",
"Other Revenues": "6.41",
"Other Net Income": "-21.1",
"Economic Capital Ratio": "118"
},
"2018": {
"Assets": "21.5",
"Stockholders Equity": "130",
"ECR before LimitedLiability": "137",
"Intangible Assets": "28.7",
"Assets, Current": "2.71",
"Other Liabilities": "7.93",
"Liabilities": "64.0",
"Liabilities, Current": "38.4",
"Long Term Liabilities": "27.3",
"Selling and Marketing Expense": "-4.98",
"Expenses": "22.5",
"Revenues": "-9.79",
"Net Income": "12.2",
"Operating Costs and Expenses": "3.34",
"Other Expenses": "9.29",
"General and Administrative Expense": "5.77",
"Cost of Goods and Services Sold": "5.28",
"Labor Expense": "6.72",
"Other Revenues": "-9.79",
"Comprehensive Net Income": "10.8",
"Economic Capital Ratio": "117"
},
"2019": {
"Property Plant and Equipment": "-2.51",
"Assets": "17.7",
"Liabilities": "67.1",
"Stockholders Equity": "116",
"ECR before LimitedLiability": "120",
"Intangible Assets": "25.3",
"Assets, Current": "3.18",
"Other Liabilities": "11.0",
"Long Term Liabilities": "39.3",
"Liabilities, Current": "27.9",
"Other Expenses": "5.01",
"Expenses": "14.9",
"Revenues": "-4.29",
"Net Income": "8.52",
"Cost of Goods and Services Sold": "4.28",
"Selling and Marketing Expense": "-5.72",
"Labor Expense": "5.97",
"Operating Costs and Expenses": "5.13",
"Other Revenues": "-4.29",
"Comprehensive Net Income": "8.32",
"Economic Capital Ratio": "110"
},
"2020": {
"Assets": "16.4",
"Stockholders Equity": "154",
"ECR before LimitedLiability": "145",
"Intangible Assets": "57.1",
"Assets, Current": "-1.50",
"Liabilities, Current": "29.4",
"Liabilities": "60.3",
"Other Liabilities": "6.57",
"Long Term Liabilities": "32.8",
"Labor Expense": "3.92",
"Expenses": "32.3",
"Revenues": "-26.2",
"Net Income": "8.33",
"General and Administrative Expense": "9.03",
"Research And Development Expense": "1.29",
"Other Expenses": "6.92",
"Operating Costs and Expenses": "3.12",
"Cost of Goods and Services Sold": "8.98",
"Other Revenues": "-26.2",
"Comprehensive Net Income": "8.65",
"Economic Capital Ratio": "133"
},
"2021": {
"Assets": "12.8",
"Stockholders Equity": "142",
"ECR before LimitedLiability": "131",
"Intangible Assets": "42.1",
"Assets, Current": "-1.72",
"Liabilities, Current": "29.2",
"Liabilities": "64.0",
"Long Term Liabilities": "34.1",
"Other Liabilities": "11.0",
"General and Administrative Expense": "10.2",
"Expenses": "27.7",
"Revenues": "-18.4",
"Net Income": "11.0",
"Operating Costs and Expenses": "3.95",
"Labor Expense": "3.42",
"Cost of Goods and Services Sold": "5.75",
"Depreciation, Depletion, Amortization": "-1.03",
"Other Expenses": "5.51",
"Other Revenues": "-18.4",
"Comprehensive Net Income": "10.9",
"Economic Capital Ratio": "125"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001477449_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "151,578",
"Assets, Non-Current": "293",
"Cost of Goods and Services Sold": "21,041",
"Depreciation, Depletion, Amortization": "4,863",
"General and Administrative Expense": "54,843",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "71,607",
"Labor Expense": "0",
"Liabilities, Current": "17,986",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-42",
"Other Expenses": "18,012",
"Other Liabilities": "0",
"Other Net Income": "-2,199",
"Other Revenues": "77,384",
"Property Plant and Equipment": "6,259",
"Research And Development Expense": "14,210",
"Selling and Marketing Expense": "20,236"
},
"output_variables": {
"Assets": "229,737",
"Liabilities": "17,986",
"Expenses": "133,205",
"Revenues": "77,384",
"Stockholders Equity": "211,751",
"Net Income": "-58,020",
"Comprehensive Net Income": "-58,062",
"BaseVar": "230,276",
"ECR before LimitedLiability": "201%",
"Economic Capital Ratio": "239%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "82,717",
"Assets, Non-Current": "415",
"Cost of Goods and Services Sold": "31,971",
"Depreciation, Depletion, Amortization": "8,270",
"General and Administrative Expense": "48,568",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "213,059",
"Labor Expense": "0",
"Liabilities, Current": "21,073",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "41",
"Other Expenses": "49,441",
"Other Liabilities": "0",
"Other Net Income": "-2,588",
"Other Revenues": "123,157",
"Property Plant and Equipment": "7,479",
"Research And Development Expense": "21,815",
"Selling and Marketing Expense": "34,720"
},
"output_variables": {
"Assets": "303,670",
"Liabilities": "21,073",
"Expenses": "194,785",
"Revenues": "123,157",
"Stockholders Equity": "282,597",
"Net Income": "-74,216",
"Comprehensive Net Income": "-74,175",
"BaseVar": "322,657",
"ECR before LimitedLiability": "207%",
"Economic Capital Ratio": "243%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "156,239",
"Assets, Non-Current": "858",
"Cost of Goods and Services Sold": "61,623",
"Depreciation, Depletion, Amortization": "19,095",
"General and Administrative Expense": "79,781",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "658,331",
"Labor Expense": "0",
"Liabilities, Current": "40,330",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "4,090",
"Other Expenses": "69,949",
"Other Liabilities": "0",
"Other Net Income": "-17,491",
"Other Revenues": "233,279",
"Property Plant and Equipment": "8,963",
"Research And Development Expense": "34,459",
"Selling and Marketing Expense": "57,663"
},
"output_variables": {
"Assets": "824,391",
"Liabilities": "40,330",
"Expenses": "322,570",
"Revenues": "233,279",
"Stockholders Equity": "784,061",
"Net Income": "-106,782",
"Comprehensive Net Income": "-102,692",
"BaseVar": "721,076",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "266%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "532,736",
"Assets, Non-Current": "1,401",
"Cost of Goods and Services Sold": "128,735",
"Depreciation, Depletion, Amortization": "35,602",
"General and Administrative Expense": "116,916",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "984,591",
"Labor Expense": "0",
"Liabilities, Current": "62,439",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-17,159",
"Other Expenses": "73,644",
"Other Liabilities": "0",
"Other Net Income": "-20,612",
"Other Revenues": "417,907",
"Property Plant and Equipment": "10,148",
"Research And Development Expense": "54,373",
"Selling and Marketing Expense": "85,109"
},
"output_variables": {
"Assets": "1,528,876",
"Liabilities": "62,439",
"Expenses": "494,379",
"Revenues": "417,907",
"Stockholders Equity": "1,466,437",
"Net Income": "-97,084",
"Comprehensive Net Income": "-114,243",
"BaseVar": "1,270,686",
"ECR before LimitedLiability": "253%",
"Economic Capital Ratio": "276%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "588,002",
"Assets, Non-Current": "32,997",
"Cost of Goods and Services Sold": "184,465",
"Depreciation, Depletion, Amortization": "38,952",
"General and Administrative Expense": "157,694",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "971,532",
"Labor Expense": "0",
"Liabilities, Current": "90,181",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-4,169",
"Other Expenses": "67,706",
"Other Liabilities": "0",
"Other Net Income": "-29,013",
"Other Revenues": "553,307",
"Property Plant and Equipment": "10,296",
"Research And Development Expense": "64,644",
"Selling and Marketing Expense": "109,697"
},
"output_variables": {
"Assets": "1,602,827",
"Liabilities": "90,181",
"Expenses": "623,158",
"Revenues": "553,307",
"Stockholders Equity": "1,512,646",
"Net Income": "-98,864",
"Comprehensive Net Income": "-103,033",
"BaseVar": "1,451,328",
"ECR before LimitedLiability": "247%",
"Economic Capital Ratio": "272%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,059,607",
"Assets, Non-Current": "65,004",
"Cost of Goods and Services Sold": "390,829",
"Depreciation, Depletion, Amortization": "69,495",
"General and Administrative Expense": "497,808",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,602,119",
"Labor Expense": "0",
"Liabilities, Current": "332,649",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "35,757",
"Other Expenses": "160,307",
"Other Liabilities": "0",
"Other Net Income": "-69,572",
"Other Revenues": "1,093,962",
"Property Plant and Equipment": "28,551",
"Research And Development Expense": "164,941",
"Selling and Marketing Expense": "226,146"
},
"output_variables": {
"Assets": "17,755,281",
"Liabilities": "332,649",
"Expenses": "1,509,526",
"Revenues": "1,093,962",
"Stockholders Equity": "17,422,632",
"Net Income": "-485,136",
"Comprehensive Net Income": "-449,379",
"BaseVar": "10,398,374",
"ECR before LimitedLiability": "274%",
"Economic Capital Ratio": "293%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,225,439",
"Assets, Non-Current": "67,483",
"Cost of Goods and Services Sold": "650,258",
"Depreciation, Depletion, Amortization": "204,239",
"General and Administrative Expense": "438,007",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,414,452",
"Labor Expense": "0",
"Liabilities, Current": "331,013",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-24,803",
"Other Expenses": "321,361",
"Other Liabilities": "0",
"Other Net Income": "-119,025",
"Other Revenues": "2,032,707",
"Property Plant and Equipment": "27,234",
"Research And Development Expense": "311,884",
"Selling and Marketing Expense": "416,726"
},
"output_variables": {
"Assets": "17,734,608",
"Liabilities": "331,013",
"Expenses": "2,342,475",
"Revenues": "2,032,707",
"Stockholders Equity": "17,403,595",
"Net Income": "-428,793",
"Comprehensive Net Income": "-453,596",
"BaseVar": "11,292,316",
"ECR before LimitedLiability": "274%",
"Economic Capital Ratio": "293%"
}
}
},
"top_rated": true,
"trend": -2.0,
"value": 2.926090110460845,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001477449.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001477449.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001477449.svg"
},
{
"company_id": "0000096793",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000096793.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000096793.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000096793.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000096793_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000096793_main_keyfigs.svg",
"name": "Sunlink Health Systems INC",
"rank": 4,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000096793.svg",
"report_text": "The relative strengths and weaknesses of Sunlink Health Systems INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Sunlink Health Systems INC compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 109% points.The greatest weakness of Sunlink Health Systems INC is the variable Labor Expense, reducing the Economic Capital Ratio by 46% points.
The company's Economic Capital Ratio, given in the ranking table, is 283%, being 115% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000096793_2022_Sunlink_Health_Systems_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-58.7",
"Other Liabilities": "15.5",
"Stockholders Equity": "-79.0",
"ECR before LimitedLiability": "-41.0",
"Property Plant and Equipment": "-11.6",
"Assets, Current": "-13.2",
"Assets, Non-Current": "-10.9",
"Intangible Assets": "-45.3",
"Expenses": "-32.2",
"Revenues": "37.0",
"Net Income": "12.7",
"Other Expenses": "-10.6",
"Goodwill Impairment Loss": "-11.9",
"Operating Costs and Expenses": "-20.5",
"Labor Expense": "-46.3",
"General and Administrative Expense": "25.8",
"Cost of Goods and Services Sold": "14.2",
"Other Revenues": "37.0",
"Other Net Income": "-46.5",
"Comprehensive Net Income": "13.2",
"Economic Capital Ratio": "-47.7"
},
"2015": {
"Assets": "-18.9",
"Stockholders Equity": "-8.64",
"ECR before LimitedLiability": "38.7",
"Intangible Assets": "-17.0",
"Other Assets": "12.9",
"Long Term Liabilities": "-9.86",
"Liabilities": "40.5",
"Other Liabilities": "16.4",
"Liabilities, Current": "34.0",
"Expenses": "-15.3",
"Revenues": "76.1",
"Net Income": "29.0",
"Operating Costs and Expenses": "-12.1",
"General and Administrative Expense": "26.3",
"Other Expenses": "-13.4",
"Labor Expense": "-40.0",
"Cost of Goods and Services Sold": "13.6",
"Other Revenues": "76.1",
"Comprehensive Net Income": "29.5",
"Other Net Income": "-22.6",
"Economic Capital Ratio": "26.3"
},
"2016": {
"Assets": "-41.8",
"Liabilities": "38.2",
"Stockholders Equity": "-25.4",
"Economic Capital Ratio": "-24.8",
"Intangible Assets": "-29.3",
"Other Assets": "22.9",
"Assets, Current": "-21.0",
"Liabilities, Current": "14.0",
"Other Liabilities": "20.3",
"Long Term Liabilities": "12.0",
"Expenses": "-34.6",
"Operating Costs and Expenses": "-20.7",
"Selling and Marketing Expense": "10.8",
"General and Administrative Expense": "38.1",
"Labor Expense": "-57.7",
"Other Expenses": "-30.2",
"Cost of Goods and Services Sold": "27.4",
"Research And Development Expense": "9.57",
"Other Revenues": "42.0",
"Revenues": "42.0",
"Other Net Income": "-30.7"
},
"2017": {
"Assets": "-8.00",
"ECR before LimitedLiability": "137",
"Intangible Assets": "-6.88",
"Liabilities, Current": "20.0",
"Liabilities": "64.4",
"Other Liabilities": "15.0",
"Long Term Liabilities": "39.5",
"General and Administrative Expense": "31.3",
"Expenses": "17.9",
"Revenues": "93.4",
"Net Income": "103",
"Labor Expense": "-64.6",
"Operating Costs and Expenses": "-19.0",
"Selling and Marketing Expense": "7.37",
"Research And Development Expense": "9.74",
"Other Expenses": "30.8",
"Cost of Goods and Services Sold": "16.9",
"Other Revenues": "93.4",
"Other Net Income": "-8.85",
"Comprehensive Net Income": "104",
"Economic Capital Ratio": "113"
},
"2018": {
"Assets": "-27.9",
"Stockholders Equity": "-24.7",
"ECR before LimitedLiability": "63.5",
"Intangible Assets": "-15.1",
"Assets, Current": "-14.3",
"Other Liabilities": "12.3",
"Liabilities": "69.8",
"Liabilities, Current": "49.1",
"Long Term Liabilities": "13.1",
"Expenses": "-29.5",
"Revenues": "82.5",
"Net Income": "46.3",
"Operating Costs and Expenses": "-11.8",
"Other Expenses": "30.2",
"General and Administrative Expense": "33.9",
"Research And Development Expense": "9.24",
"Cost of Goods and Services Sold": "-35.7",
"Labor Expense": "-58.3",
"Other Revenues": "82.5",
"Comprehensive Net Income": "47.4",
"Economic Capital Ratio": "42.8"
},
"2019": {
"Assets": "-8.85",
"Stockholders Equity": "-28.5",
"ECR before LimitedLiability": "118",
"Intangible Assets": "-5.37",
"Other Liabilities": "19.4",
"Liabilities": "68.2",
"Long Term Liabilities": "57.3",
"Other Expenses": "16.9",
"Expenses": "11.9",
"Revenues": "95.1",
"Net Income": "109",
"General and Administrative Expense": "27.7",
"Cost of Goods and Services Sold": "35.9",
"Research And Development Expense": "11.2",
"Selling and Marketing Expense": "7.26",
"Labor Expense": "-81.2",
"Operating Costs and Expenses": "-13.4",
"Depreciation, Depletion, Amortization": "-4.25",
"Other Revenues": "95.1",
"Comprehensive Net Income": "109",
"Economic Capital Ratio": "108"
},
"2020": {
"Assets": "-16.1",
"Stockholders Equity": "-39.9",
"ECR before LimitedLiability": "85.5",
"Intangible Assets": "-9.89",
"Assets, Non-Current": "-5.18",
"Liabilities, Current": "-16.9",
"Liabilities": "34.9",
"Other Liabilities": "11.3",
"Long Term Liabilities": "37.9",
"Labor Expense": "-58.8",
"Expenses": "11.9",
"Revenues": "82.1",
"Net Income": "95.6",
"General and Administrative Expense": "27.3",
"Research And Development Expense": "5.61",
"Other Expenses": "14.2",
"Operating Costs and Expenses": "-8.30",
"Cost of Goods and Services Sold": "25.3",
"Other Revenues": "82.1",
"Comprehensive Net Income": "95.3",
"Economic Capital Ratio": "73.4"
},
"2021": {
"Liabilities, Current": "-18.3",
"Liabilities": "56.1",
"Stockholders Equity": "-12.9",
"ECR before LimitedLiability": "121",
"Long Term Liabilities": "52.7",
"Other Liabilities": "20.7",
"General and Administrative Expense": "27.3",
"Expenses": "22.5",
"Revenues": "69.6",
"Net Income": "108",
"Operating Costs and Expenses": "-10.5",
"Labor Expense": "-45.9",
"Cost of Goods and Services Sold": "22.4",
"Research And Development Expense": "7.08",
"Other Expenses": "14.3",
"Selling and Marketing Expense": "5.46",
"Other Revenues": "69.6",
"Intangible Assets": "-4.15",
"Comprehensive Net Income": "109",
"Other Net Income": "20.8",
"Economic Capital Ratio": "115"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000096793_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "43,365",
"Assets, Non-Current": "346",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "13,347",
"Intangible Assets": "4,869",
"Labor Expense": "63,846",
"Liabilities, Current": "31,332",
"Long Term Liabilities": "34,430",
"Operating Costs and Expenses": "30,754",
"Other Assets": "9,566",
"Other Compr. Net Income": "0",
"Other Expenses": "62,408",
"Other Liabilities": "0",
"Other Net Income": "-682",
"Other Revenues": "154,380",
"Property Plant and Equipment": "33,684",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "91,830",
"Liabilities": "65,762",
"Expenses": "170,355",
"Revenues": "154,380",
"Stockholders Equity": "26,068",
"Net Income": "-16,657",
"Comprehensive Net Income": "-16,657",
"BaseVar": "241,504",
"ECR before LimitedLiability": "27%",
"Economic Capital Ratio": "113%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "25,092",
"Assets, Non-Current": "1,520",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,837",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,298",
"Labor Expense": "33,620",
"Liabilities, Current": "10,764",
"Long Term Liabilities": "12,804",
"Operating Costs and Expenses": "11,259",
"Other Assets": "12,975",
"Other Compr. Net Income": "-40",
"Other Expenses": "27,593",
"Other Liabilities": "0",
"Other Net Income": "808",
"Other Revenues": "73,746",
"Property Plant and Equipment": "14,243",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "57,128",
"Liabilities": "23,568",
"Expenses": "74,309",
"Revenues": "73,746",
"Stockholders Equity": "33,560",
"Net Income": "245",
"Comprehensive Net Income": "205",
"BaseVar": "114,800",
"ECR before LimitedLiability": "121%",
"Economic Capital Ratio": "186%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "17,892",
"Assets, Non-Current": "732",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,878",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,156",
"Labor Expense": "30,783",
"Liabilities, Current": "20,051",
"Long Term Liabilities": "4,565",
"Operating Costs and Expenses": "11,357",
"Other Assets": "9,331",
"Other Compr. Net Income": "-46",
"Other Expenses": "31,332",
"Other Liabilities": "0",
"Other Net Income": "-2,166",
"Other Revenues": "63,433",
"Property Plant and Equipment": "12,994",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "44,105",
"Liabilities": "24,616",
"Expenses": "75,350",
"Revenues": "63,433",
"Stockholders Equity": "19,489",
"Net Income": "-14,083",
"Comprehensive Net Income": "-14,129",
"BaseVar": "104,858",
"ECR before LimitedLiability": "41%",
"Economic Capital Ratio": "126%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "22,621",
"Assets, Non-Current": "838",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,914",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,587",
"Labor Expense": "23,378",
"Liabilities, Current": "12,314",
"Long Term Liabilities": "1,329",
"Operating Costs and Expenses": "7,460",
"Other Assets": "0",
"Other Compr. Net Income": "93",
"Other Expenses": "2,549",
"Other Liabilities": "0",
"Other Net Income": "7,385",
"Other Revenues": "53,288",
"Property Plant and Equipment": "10,290",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "35,336",
"Liabilities": "13,643",
"Expenses": "35,301",
"Revenues": "53,288",
"Stockholders Equity": "21,693",
"Net Income": "25,372",
"Comprehensive Net Income": "25,465",
"BaseVar": "72,523",
"ECR before LimitedLiability": "232%",
"Economic Capital Ratio": "261%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "13,110",
"Assets, Non-Current": "885",
"Cost of Goods and Services Sold": "18,529",
"Depreciation, Depletion, Amortization": "1,531",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,470",
"Labor Expense": "18,610",
"Liabilities, Current": "4,851",
"Long Term Liabilities": "4,139",
"Operating Costs and Expenses": "4,895",
"Other Assets": "4,815",
"Other Compr. Net Income": "150",
"Other Expenses": "629",
"Other Liabilities": "0",
"Other Net Income": "-446",
"Other Revenues": "45,209",
"Property Plant and Equipment": "5,896",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "26,176",
"Liabilities": "8,990",
"Expenses": "44,194",
"Revenues": "45,209",
"Stockholders Equity": "17,186",
"Net Income": "569",
"Comprehensive Net Income": "719",
"BaseVar": "62,582",
"ECR before LimitedLiability": "146%",
"Economic Capital Ratio": "202%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "16,658",
"Assets, Non-Current": "1,165",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,486",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,353",
"Labor Expense": "19,191",
"Liabilities, Current": "8,410",
"Long Term Liabilities": "966",
"Operating Costs and Expenses": "5,136",
"Other Assets": "0",
"Other Compr. Net Income": "-76",
"Other Expenses": "656",
"Other Liabilities": "0",
"Other Net Income": "546",
"Other Revenues": "45,618",
"Property Plant and Equipment": "5,243",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "24,419",
"Liabilities": "9,376",
"Expenses": "26,469",
"Revenues": "45,618",
"Stockholders Equity": "15,043",
"Net Income": "19,695",
"Comprehensive Net Income": "19,619",
"BaseVar": "53,252",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "270%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "19,923",
"Assets, Non-Current": "1,470",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,450",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,254",
"Labor Expense": "19,563",
"Liabilities, Current": "11,416",
"Long Term Liabilities": "2,812",
"Operating Costs and Expenses": "4,581",
"Other Assets": "0",
"Other Compr. Net Income": "-86",
"Other Expenses": "897",
"Other Liabilities": "0",
"Other Net Income": "-515",
"Other Revenues": "47,813",
"Property Plant and Equipment": "5,324",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "27,971",
"Liabilities": "14,228",
"Expenses": "26,491",
"Revenues": "47,813",
"Stockholders Equity": "13,743",
"Net Income": "20,807",
"Comprehensive Net Income": "20,721",
"BaseVar": "58,552",
"ECR before LimitedLiability": "193%",
"Economic Capital Ratio": "233%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "21,941",
"Assets, Non-Current": "1,842",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,361",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,227",
"Labor Expense": "13,797",
"Liabilities, Current": "9,665",
"Long Term Liabilities": "1,089",
"Operating Costs and Expenses": "5,018",
"Other Assets": "0",
"Other Compr. Net Income": "177",
"Other Expenses": "616",
"Other Liabilities": "0",
"Other Net Income": "5,082",
"Other Revenues": "40,685",
"Property Plant and Equipment": "6,554",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "31,564",
"Liabilities": "10,754",
"Expenses": "20,792",
"Revenues": "40,685",
"Stockholders Equity": "20,810",
"Net Income": "24,975",
"Comprehensive Net Income": "25,152",
"BaseVar": "54,527",
"ECR before LimitedLiability": "261%",
"Economic Capital Ratio": "283%"
}
}
},
"top_rated": true,
"trend": 12.0,
"value": 2.8255570382512674,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000096793.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000096793.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000096793.svg"
},
{
"company_id": "0001022079",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001022079.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001022079.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001022079.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001022079_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001022079_main_keyfigs.svg",
"name": "Quest Diagnostics INC",
"rank": 5,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001022079.svg",
"report_text": "The relative strengths and weaknesses of Quest Diagnostics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Quest Diagnostics INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 77% points.The greatest weakness of Quest Diagnostics INC is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 47% points.
The company's Economic Capital Ratio, given in the ranking table, is 274%, being 106% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001022079_2022_Quest_Diagnostics_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "10.8",
"Stockholders Equity": "79.5",
"ECR before LimitedLiability": "71.5",
"Intangible Assets": "9.50",
"Liabilities, Current": "10.4",
"Liabilities": "52.4",
"Long Term Liabilities": "42.0",
"Other Liabilities": "4.28",
"Other Expenses": "16.3",
"Expenses": "7.55",
"Revenues": "36.8",
"Net Income": "1.97",
"General and Administrative Expense": "-16.0",
"Cost of Goods and Services Sold": "-12.9",
"Labor Expense": "5.30",
"Operating Costs and Expenses": "12.5",
"Depreciation, Depletion, Amortization": "1.15",
"Other Revenues": "36.8",
"Comprehensive Net Income": "1.97",
"Other Net Income": "-47.2",
"Economic Capital Ratio": "71.9"
},
"2010": {
"Other Liabilities": "21.1",
"Liabilities": "69.8",
"Assets, Current": "-2.44",
"Stockholders Equity": "52.8",
"ECR before LimitedLiability": "69.0",
"Liabilities, Current": "-4.04",
"Long Term Liabilities": "58.1",
"Other Expenses": "27.5",
"Expenses": "-16.4",
"Cost of Goods and Services Sold": "-53.7",
"General and Administrative Expense": "-19.4",
"Labor Expense": "10.5",
"Operating Costs and Expenses": "11.5",
"Depreciation, Depletion, Amortization": "1.89",
"Other Revenues": "63.7",
"Revenues": "63.7",
"Property Plant and Equipment": "-4.82",
"Intangible Assets": "13.5",
"Economic Capital Ratio": "70.8",
"Other Compr. Net Income": "1.23",
"Other Net Income": "-56.5"
},
"2011": {
"Assets": "6.63",
"Liabilities": "56.5",
"Stockholders Equity": "61.0",
"ECR before LimitedLiability": "95.1",
"Property Plant and Equipment": "-6.00",
"Assets, Current": "-5.90",
"Intangible Assets": "33.5",
"Other Liabilities": "14.1",
"Long Term Liabilities": "41.6",
"Liabilities, Current": "6.50",
"Expenses": "6.49",
"Revenues": "48.3",
"Net Income": "24.5",
"Other Expenses": "26.7",
"Operating Costs and Expenses": "8.11",
"Labor Expense": "12.7",
"Cost of Goods and Services Sold": "-52.2",
"Other Revenues": "48.3",
"Other Net Income": "-33.4",
"Comprehensive Net Income": "24.7",
"Economic Capital Ratio": "88.5"
},
"2012": {
"Property Plant and Equipment": "-3.63",
"Assets": "4.99",
"Liabilities": "74.4",
"Stockholders Equity": "75.7",
"ECR before LimitedLiability": "119",
"Intangible Assets": "23.3",
"Assets, Current": "-5.01",
"Liabilities, Current": "26.7",
"Long Term Liabilities": "37.4",
"Other Liabilities": "25.4",
"Expenses": "4.82",
"Revenues": "53.1",
"Net Income": "26.0",
"Other Expenses": "26.7",
"Operating Costs and Expenses": "6.90",
"Cost of Goods and Services Sold": "-57.7",
"Labor Expense": "14.3",
"Other Revenues": "53.1",
"Other Net Income": "-36.4",
"Comprehensive Net Income": "26.2",
"Economic Capital Ratio": "104"
},
"2013": {
"Assets": "4.12",
"Stockholders Equity": "74.9",
"ECR before LimitedLiability": "114",
"Assets, Current": "-6.30",
"Intangible Assets": "29.5",
"Other Liabilities": "22.6",
"Liabilities": "78.2",
"Liabilities, Current": "33.2",
"Long Term Liabilities": "38.7",
"Expenses": "4.07",
"Revenues": "50.2",
"Net Income": "33.3",
"Cost of Goods and Services Sold": "-59.5",
"Labor Expense": "14.0",
"Operating Costs and Expenses": "4.72",
"Other Expenses": "27.5",
"Research And Development Expense": "4.74",
"Other Revenues": "50.2",
"Comprehensive Net Income": "32.8",
"Other Net Income": "-23.6",
"Economic Capital Ratio": "105"
},
"2014": {
"Assets": "7.62",
"Liabilities": "62.7",
"Stockholders Equity": "68.9",
"ECR before LimitedLiability": "106",
"Intangible Assets": "39.2",
"Property Plant and Equipment": "-5.34",
"Assets, Current": "-6.50",
"Other Liabilities": "15.1",
"Liabilities, Current": "15.6",
"Long Term Liabilities": "40.5",
"Expenses": "6.40",
"Revenues": "43.3",
"Net Income": "26.2",
"Operating Costs and Expenses": "6.47",
"Labor Expense": "13.8",
"Other Expenses": "21.0",
"Cost of Goods and Services Sold": "-50.9",
"Other Revenues": "43.3",
"Comprehensive Net Income": "25.7",
"Other Net Income": "-25.5",
"Economic Capital Ratio": "92.5"
},
"2015": {
"Assets, Current": "-4.94",
"Assets": "6.97",
"Stockholders Equity": "82.8",
"ECR before LimitedLiability": "121",
"Intangible Assets": "27.5",
"Long Term Liabilities": "33.9",
"Liabilities": "73.8",
"Other Liabilities": "17.9",
"Liabilities, Current": "36.2",
"Selling and Marketing Expense": "5.92",
"Expenses": "9.61",
"Revenues": "46.3",
"Net Income": "32.5",
"Operating Costs and Expenses": "5.73",
"Other Expenses": "25.9",
"Labor Expense": "13.3",
"Cost of Goods and Services Sold": "-53.8",
"Other Revenues": "46.3",
"Comprehensive Net Income": "32.3",
"Other Net Income": "-25.9",
"Economic Capital Ratio": "108"
},
"2016": {
"Assets": "8.44",
"Stockholders Equity": "105",
"ECR before LimitedLiability": "151",
"Intangible Assets": "25.2",
"Liabilities, Current": "54.6",
"Liabilities": "86.9",
"Other Liabilities": "20.7",
"Long Term Liabilities": "29.7",
"Expenses": "8.95",
"Revenues": "44.5",
"Net Income": "34.3",
"Operating Costs and Expenses": "4.32",
"Selling and Marketing Expense": "6.93",
"Labor Expense": "7.29",
"Other Expenses": "24.4",
"Cost of Goods and Services Sold": "-48.4",
"Research And Development Expense": "6.15",
"Other Revenues": "44.5",
"Other Net Income": "-20.9",
"Comprehensive Net Income": "34.0",
"Economic Capital Ratio": "123"
},
"2017": {
"Assets": "6.34",
"Stockholders Equity": "93.3",
"ECR before LimitedLiability": "150",
"Intangible Assets": "25.4",
"Assets, Current": "-5.28",
"Liabilities, Current": "48.2",
"Liabilities": "83.8",
"Other Liabilities": "12.5",
"Long Term Liabilities": "39.7",
"Expenses": "9.10",
"Revenues": "50.7",
"Net Income": "36.0",
"Labor Expense": "7.75",
"Selling and Marketing Expense": "5.87",
"Research And Development Expense": "7.76",
"Other Expenses": "26.3",
"Cost of Goods and Services Sold": "-51.0",
"Other Revenues": "50.7",
"Other Net Income": "-26.6",
"Comprehensive Net Income": "35.8",
"Economic Capital Ratio": "126"
},
"2018": {
"Assets": "9.13",
"Stockholders Equity": "76.4",
"ECR before LimitedLiability": "123",
"Intangible Assets": "37.1",
"Assets, Current": "-7.59",
"Other Liabilities": "9.76",
"Liabilities": "61.0",
"Liabilities, Current": "27.4",
"Long Term Liabilities": "32.9",
"Expenses": "13.5",
"Revenues": "23.1",
"Net Income": "35.4",
"Operating Costs and Expenses": "4.30",
"Other Expenses": "17.7",
"General and Administrative Expense": "5.25",
"Research And Development Expense": "6.06",
"Cost of Goods and Services Sold": "-36.4",
"Labor Expense": "8.64",
"Other Revenues": "23.1",
"Comprehensive Net Income": "35.0",
"Economic Capital Ratio": "102"
},
"2019": {
"Assets": "10.7",
"Stockholders Equity": "72.6",
"ECR before LimitedLiability": "103",
"Intangible Assets": "27.5",
"Assets, Current": "-5.43",
"Other Liabilities": "11.6",
"Liabilities": "53.8",
"Long Term Liabilities": "41.1",
"Liabilities, Current": "6.22",
"Other Expenses": "9.65",
"Expenses": "12.5",
"Revenues": "15.4",
"Net Income": "26.9",
"Cost of Goods and Services Sold": "-26.7",
"Research And Development Expense": "6.80",
"Selling and Marketing Expense": "4.39",
"Labor Expense": "6.58",
"Operating Costs and Expenses": "5.66",
"Other Revenues": "15.4",
"Comprehensive Net Income": "26.8",
"Economic Capital Ratio": "93.0"
},
"2020": {
"Assets": "5.88",
"Stockholders Equity": "75.5",
"ECR before LimitedLiability": "121",
"Intangible Assets": "18.5",
"Assets, Current": "-4.96",
"Liabilities, Current": "20.3",
"Liabilities": "69.6",
"Other Liabilities": "10.4",
"Long Term Liabilities": "49.0",
"Labor Expense": "6.68",
"Expenses": "6.12",
"Revenues": "27.6",
"Net Income": "34.1",
"General and Administrative Expense": "8.46",
"Research And Development Expense": "4.65",
"Other Expenses": "8.89",
"Operating Costs and Expenses": "5.32",
"Cost of Goods and Services Sold": "-34.6",
"Other Revenues": "27.6",
"Comprehensive Net Income": "33.7",
"Economic Capital Ratio": "109"
},
"2021": {
"Liabilities, Current": "20.4",
"Liabilities": "77.3",
"Stockholders Equity": "56.6",
"Intangible Assets": "13.0",
"ECR before LimitedLiability": "112",
"Long Term Liabilities": "52.5",
"Other Liabilities": "17.9",
"Other Revenues": "40.4",
"Revenues": "40.4",
"Net Income": "43.9",
"Assets, Current": "-5.98",
"General and Administrative Expense": "7.84",
"Comprehensive Net Income": "43.3",
"Operating Costs and Expenses": "6.91",
"Labor Expense": "5.99",
"Cost of Goods and Services Sold": "-47.0",
"Other Net Income": "5.43",
"Research And Development Expense": "6.21",
"Other Expenses": "7.78",
"Selling and Marketing Expense": "4.78",
"Economic Capital Ratio": "106"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001022079_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "1,679,425",
"Assets, Non-Current": "150,663",
"Cost of Goods and Services Sold": "4,321,475",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,747,618",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,907,609",
"Labor Expense": "0",
"Liabilities, Current": "1,059,212",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "487,513",
"Other Liabilities": "0",
"Other Net Income": "-132,415",
"Other Revenues": "7,455,243",
"Property Plant and Equipment": "825,946",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,563,643",
"Liabilities": "1,059,212",
"Expenses": "6,556,606",
"Revenues": "7,455,243",
"Stockholders Equity": "7,504,431",
"Net Income": "766,222",
"Comprehensive Net Income": "766,222",
"BaseVar": "11,883,560",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "268%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,605,417",
"Assets, Non-Current": "189,494",
"Cost of Goods and Services Sold": "4,317,247",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,707,673",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,898,343",
"Labor Expense": "0",
"Liabilities, Current": "1,214,268",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "474,001",
"Other Liabilities": "0",
"Other Net Income": "-112,987",
"Other Revenues": "7,368,925",
"Property Plant and Equipment": "834,376",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,527,630",
"Liabilities": "1,214,268",
"Expenses": "6,498,921",
"Revenues": "7,368,925",
"Stockholders Equity": "7,313,362",
"Net Income": "757,017",
"Comprehensive Net Income": "757,017",
"BaseVar": "11,861,366",
"ECR before LimitedLiability": "233%",
"Economic Capital Ratio": "261%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,401,260",
"Assets, Non-Current": "280,971",
"Cost of Goods and Services Sold": "4,395,333",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,814,315",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "6,831,377",
"Labor Expense": "0",
"Liabilities, Current": "1,561,159",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "654,794",
"Other Liabilities": "0",
"Other Net Income": "-140,398",
"Other Revenues": "7,510,490",
"Property Plant and Equipment": "799,771",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,313,379",
"Liabilities": "1,561,159",
"Expenses": "6,864,442",
"Revenues": "7,510,490",
"Stockholders Equity": "7,752,220",
"Net Income": "505,650",
"Comprehensive Net Income": "505,650",
"BaseVar": "12,694,934",
"ECR before LimitedLiability": "216%",
"Economic Capital Ratio": "249%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,560,997",
"Assets, Non-Current": "204,631",
"Cost of Goods and Services Sold": "4,364,699",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,745,200",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "6,408,020",
"Labor Expense": "0",
"Liabilities, Current": "1,047,603",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "354,384",
"Other Compr. Net Income": "-14,026",
"Other Expenses": "473,763",
"Other Liabilities": "0",
"Other Net Income": "-206,766",
"Other Revenues": "7,382,562",
"Property Plant and Equipment": "755,831",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,283,863",
"Liabilities": "1,047,603",
"Expenses": "6,583,662",
"Revenues": "7,382,562",
"Stockholders Equity": "8,236,260",
"Net Income": "592,134",
"Comprehensive Net Income": "578,108",
"BaseVar": "12,259,241",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "268%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "1,383,000",
"Assets, Non-Current": "215,000",
"Cost of Goods and Services Sold": "4,326,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,704,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "6,545,000",
"Labor Expense": "0",
"Liabilities, Current": "1,132,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-56,000",
"Other Expenses": "141,000",
"Other Liabilities": "0",
"Other Net Income": "-92,000",
"Other Revenues": "7,146,000",
"Property Plant and Equipment": "805,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,948,000",
"Liabilities": "1,132,000",
"Expenses": "6,171,000",
"Revenues": "7,146,000",
"Stockholders Equity": "7,816,000",
"Net Income": "883,000",
"Comprehensive Net Income": "827,000",
"BaseVar": "11,772,500",
"ECR before LimitedLiability": "241%",
"Economic Capital Ratio": "267%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "1,603,000",
"Assets, Non-Current": "238,000",
"Cost of Goods and Services Sold": "4,637,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,728,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "7,103,000",
"Labor Expense": "0",
"Liabilities, Current": "1,709,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-55,000",
"Other Expenses": "349,000",
"Other Liabilities": "0",
"Other Net Income": "-129,000",
"Other Revenues": "7,435,000",
"Property Plant and Equipment": "933,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,877,000",
"Liabilities": "1,709,000",
"Expenses": "6,714,000",
"Revenues": "7,435,000",
"Stockholders Equity": "8,168,000",
"Net Income": "592,000",
"Comprehensive Net Income": "537,000",
"BaseVar": "12,959,500",
"ECR before LimitedLiability": "214%",
"Economic Capital Ratio": "248%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "1,501,000",
"Assets, Non-Current": "647,000",
"Cost of Goods and Services Sold": "4,657,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,679,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "6,889,000",
"Labor Expense": "0",
"Liabilities, Current": "1,173,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-55,000",
"Other Expenses": "131,000",
"Other Liabilities": "0",
"Other Net Income": "-273,000",
"Other Revenues": "7,493,000",
"Property Plant and Equipment": "925,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,962,000",
"Liabilities": "1,173,000",
"Expenses": "6,467,000",
"Revenues": "7,493,000",
"Stockholders Equity": "8,789,000",
"Net Income": "753,000",
"Comprehensive Net Income": "698,000",
"BaseVar": "12,711,500",
"ECR before LimitedLiability": "241%",
"Economic Capital Ratio": "267%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "1,531,000",
"Assets, Non-Current": "591,000",
"Cost of Goods and Services Sold": "4,616,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,681,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "6,949,000",
"Labor Expense": "0",
"Liabilities, Current": "981,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-85,000",
"Other Expenses": "370,000",
"Other Liabilities": "0",
"Other Net Income": "-152,000",
"Other Revenues": "7,515,000",
"Property Plant and Equipment": "1,029,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,100,000",
"Liabilities": "981,000",
"Expenses": "6,667,000",
"Revenues": "7,515,000",
"Stockholders Equity": "9,119,000",
"Net Income": "696,000",
"Comprehensive Net Income": "611,000",
"BaseVar": "12,750,000",
"ECR before LimitedLiability": "250%",
"Economic Capital Ratio": "274%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,306,000",
"Assets, Non-Current": "598,000",
"Cost of Goods and Services Sold": "4,719,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,750,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "7,454,000",
"Labor Expense": "0",
"Liabilities, Current": "1,057,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-28,000",
"Other Expenses": "316,000",
"Other Liabilities": "0",
"Other Net Income": "-100,000",
"Other Revenues": "7,709,000",
"Property Plant and Equipment": "1,145,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,503,000",
"Liabilities": "1,057,000",
"Expenses": "6,785,000",
"Revenues": "7,709,000",
"Stockholders Equity": "9,446,000",
"Net Income": "824,000",
"Comprehensive Net Income": "796,000",
"BaseVar": "13,091,000",
"ECR before LimitedLiability": "251%",
"Economic Capital Ratio": "274%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,390,000",
"Assets, Non-Current": "555,000",
"Cost of Goods and Services Sold": "4,926,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,424,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "7,770,000",
"Labor Expense": "0",
"Liabilities, Current": "1,485,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-61,000",
"Other Expenses": "262,000",
"Other Liabilities": "0",
"Other Net Income": "-131,000",
"Other Revenues": "7,531,000",
"Property Plant and Equipment": "1,288,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "11,003,000",
"Liabilities": "1,485,000",
"Expenses": "6,612,000",
"Revenues": "7,531,000",
"Stockholders Equity": "9,518,000",
"Net Income": "788,000",
"Comprehensive Net Income": "727,000",
"BaseVar": "13,411,500",
"ECR before LimitedLiability": "233%",
"Economic Capital Ratio": "261%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,490,000",
"Assets, Non-Current": "1,160,000",
"Cost of Goods and Services Sold": "5,037,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,457,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "7,740,000",
"Labor Expense": "0",
"Liabilities, Current": "1,990,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-28,000",
"Other Expenses": "248,000",
"Other Liabilities": "0",
"Other Net Income": "-78,000",
"Other Revenues": "7,726,000",
"Property Plant and Equipment": "1,453,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "12,843,000",
"Liabilities": "1,990,000",
"Expenses": "6,742,000",
"Revenues": "7,726,000",
"Stockholders Equity": "10,853,000",
"Net Income": "906,000",
"Comprehensive Net Income": "878,000",
"BaseVar": "14,703,500",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "255%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "3,058,000",
"Assets, Non-Current": "1,301,000",
"Cost of Goods and Services Sold": "5,804,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,550,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "8,040,000",
"Labor Expense": "0",
"Liabilities, Current": "1,776,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-50,000",
"Other Expenses": "572,000",
"Other Liabilities": "0",
"Other Net Income": "-12,000",
"Other Revenues": "9,437,000",
"Property Plant and Equipment": "1,627,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "14,026,000",
"Liabilities": "1,776,000",
"Expenses": "7,926,000",
"Revenues": "9,437,000",
"Stockholders Equity": "12,250,000",
"Net Income": "1,499,000",
"Comprehensive Net Income": "1,449,000",
"BaseVar": "16,613,500",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "269%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "2,741,000",
"Assets, Non-Current": "901,000",
"Cost of Goods and Services Sold": "6,579,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,727,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "8,262,000",
"Labor Expense": "0",
"Liabilities, Current": "1,753,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-78,000",
"Other Expenses": "698,000",
"Other Liabilities": "0",
"Other Net Income": "296,000",
"Other Revenues": "10,788,000",
"Property Plant and Equipment": "1,707,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "13,611,000",
"Liabilities": "1,753,000",
"Expenses": "9,004,000",
"Revenues": "10,788,000",
"Stockholders Equity": "11,858,000",
"Net Income": "2,080,000",
"Comprehensive Net Income": "2,002,000",
"BaseVar": "17,765,000",
"ECR before LimitedLiability": "250%",
"Economic Capital Ratio": "274%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.7372825069460034,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001022079.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001022079.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001022079.svg"
},
{
"company_id": "0000704415",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000704415.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000704415.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000704415.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000704415_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000704415_main_keyfigs.svg",
"name": "Tivity Health INC",
"rank": 6,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000704415.svg",
"report_text": "The relative strengths and weaknesses of Tivity Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Tivity Health INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 72% points.The greatest weakness of Tivity Health INC is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 44% points.
The company's Economic Capital Ratio, given in the ranking table, is 273%, being 106% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000704415_2022_Tivity_Health_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "77.8",
"Stockholders Equity": "109",
"ECR before LimitedLiability": "63.0",
"Property Plant and Equipment": "5.87",
"Intangible Assets": "55.2",
"Other Liabilities": "6.35",
"Liabilities": "9.26",
"Long Term Liabilities": "20.0",
"Liabilities, Current": "-19.8",
"Expenses": "43.7",
"Revenues": "-22.6",
"Net Income": "-16.4",
"Other Expenses": "14.8",
"Operating Costs and Expenses": "3.92",
"Labor Expense": "6.18",
"General and Administrative Expense": "10.1",
"Cost of Goods and Services Sold": "3.91",
"Other Revenues": "-22.6",
"Other Net Income": "-38.4",
"Comprehensive Net Income": "-16.3",
"Economic Capital Ratio": "56.4"
},
"2012": {
"Property Plant and Equipment": "6.15",
"Assets": "59.7",
"Stockholders Equity": "107",
"ECR before LimitedLiability": "93.5",
"Intangible Assets": "36.4",
"Liabilities, Current": "-26.7",
"Liabilities": "3.02",
"Long Term Liabilities": "15.4",
"Other Liabilities": "10.2",
"Expenses": "37.7",
"Revenues": "-20.3",
"Net Income": "8.65",
"Other Expenses": "12.7",
"General and Administrative Expense": "9.25",
"Operating Costs and Expenses": "2.80",
"Cost of Goods and Services Sold": "3.63",
"Labor Expense": "5.83",
"Other Revenues": "-20.3",
"Other Net Income": "-10.6",
"Comprehensive Net Income": "8.94",
"Economic Capital Ratio": "79.3"
},
"2018": {
"Other Liabilities": "13.8",
"Liabilities": "85.4",
"Stockholders Equity": "39.6",
"ECR before LimitedLiability": "129",
"Liabilities, Current": "43.7",
"Long Term Liabilities": "45.0",
"Selling and Marketing Expense": "5.70",
"Expenses": "-5.47",
"Revenues": "64.0",
"Net Income": "60.8",
"Operating Costs and Expenses": "6.06",
"Other Expenses": "19.9",
"General and Administrative Expense": "21.0",
"Research And Development Expense": "8.54",
"Cost of Goods and Services Sold": "-91.0",
"Labor Expense": "12.1",
"Other Revenues": "64.0",
"Intangible Assets": "28.5",
"Assets, Current": "-8.81",
"Comprehensive Net Income": "61.1",
"Economic Capital Ratio": "108"
},
"2019": {
"Property Plant and Equipment": "-5.12",
"Assets": "4.99",
"Liabilities": "79.5",
"Expenses": "-18.4",
"Stockholders Equity": "76.3",
"ECR before LimitedLiability": "92.1",
"Intangible Assets": "75.9",
"Assets, Current": "-12.4",
"Other Liabilities": "13.4",
"Long Term Liabilities": "46.9",
"Liabilities, Current": "31.6",
"Other Expenses": "-32.1",
"General and Administrative Expense": "12.0",
"Cost of Goods and Services Sold": "-26.7",
"Research And Development Expense": "8.15",
"Selling and Marketing Expense": "5.26",
"Labor Expense": "7.88",
"Operating Costs and Expenses": "6.78",
"Other Revenues": "17.9",
"Revenues": "17.9",
"Economic Capital Ratio": "82.0"
},
"2020": {
"Liabilities, Current": "24.2",
"Liabilities": "77.0",
"Stockholders Equity": "50.7",
"ECR before LimitedLiability": "56.4",
"Other Liabilities": "9.80",
"Long Term Liabilities": "49.2",
"Labor Expense": "7.62",
"Expenses": "15.1",
"Net Income": "-20.1",
"General and Administrative Expense": "17.7",
"Operating Costs and Expenses": "6.06",
"Cost of Goods and Services Sold": "-25.9",
"Other Revenues": "19.9",
"Revenues": "19.9",
"Property Plant and Equipment": "-7.22",
"Intangible Assets": "53.8",
"Assets, Current": "-16.9",
"Assets, Non-Current": "-7.48",
"Other Net Income": "-56.6",
"Comprehensive Net Income": "-21.2",
"Economic Capital Ratio": "44.4"
},
"2021": {
"Liabilities, Current": "14.4",
"Liabilities": "72.3",
"Stockholders Equity": "53.5",
"ECR before LimitedLiability": "112",
"Long Term Liabilities": "51.5",
"Other Liabilities": "17.6",
"General and Administrative Expense": "14.8",
"Expenses": "4.87",
"Revenues": "41.4",
"Net Income": "45.7",
"Operating Costs and Expenses": "6.76",
"Labor Expense": "5.86",
"Cost of Goods and Services Sold": "-43.6",
"Research And Development Expense": "6.07",
"Other Expenses": "4.67",
"Selling and Marketing Expense": "4.68",
"Other Revenues": "41.4",
"Intangible Assets": "13.0",
"Assets, Current": "-3.50",
"Comprehensive Net Income": "47.6",
"Economic Capital Ratio": "106"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000704415_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "127,531",
"Assets, Non-Current": "10,797",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "428,389",
"Labor Expense": "0",
"Liabilities, Current": "118,757",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "15,386",
"Other Liabilities": "0",
"Other Net Income": "-142,307",
"Other Revenues": "0",
"Property Plant and Equipment": "142,188",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "708,905",
"Liabilities": "118,757",
"Expenses": "15,386",
"Revenues": "0",
"Stockholders Equity": "590,148",
"Net Income": "-157,693",
"Comprehensive Net Income": "-157,693",
"BaseVar": "492,678",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "217%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "141,809",
"Assets, Non-Current": "21,042",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "428,923",
"Labor Expense": "0",
"Liabilities, Current": "128,258",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "860",
"Other Expenses": "6,722",
"Other Liabilities": "0",
"Other Net Income": "14,746",
"Other Revenues": "0",
"Property Plant and Equipment": "156,494",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "748,268",
"Liabilities": "128,258",
"Expenses": "6,722",
"Revenues": "0",
"Stockholders Equity": "620,010",
"Net Income": "8,024",
"Comprehensive Net Income": "8,884",
"BaseVar": "449,427",
"ECR before LimitedLiability": "207%",
"Economic Capital Ratio": "243%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "78,105",
"Assets, Non-Current": "23,904",
"Cost of Goods and Services Sold": "432,714",
"Depreciation, Depletion, Amortization": "4,667",
"General and Administrative Expense": "35,113",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "363,729",
"Labor Expense": "0",
"Liabilities, Current": "81,072",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "35,903",
"Other Liabilities": "0",
"Other Net Income": "901",
"Other Revenues": "606,299",
"Property Plant and Equipment": "16,341",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "482,079",
"Liabilities": "81,072",
"Expenses": "508,397",
"Revenues": "606,299",
"Stockholders Equity": "401,007",
"Net Income": "98,803",
"Comprehensive Net Income": "98,803",
"BaseVar": "839,374",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "268%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "161,737",
"Assets, Non-Current": "65,258",
"Cost of Goods and Services Sold": "678,057",
"Depreciation, Depletion, Amortization": "50,775",
"General and Administrative Expense": "110,038",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,344,321",
"Labor Expense": "0",
"Liabilities, Current": "146,358",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,680",
"Other Compr. Net Income": "-12,091",
"Other Expenses": "579,108",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "1,131,157",
"Property Plant and Equipment": "52,909",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,625,905",
"Liabilities": "146,358",
"Expenses": "1,417,978",
"Revenues": "1,131,157",
"Stockholders Equity": "1,479,547",
"Net Income": "-286,821",
"Comprehensive Net Income": "-298,912",
"BaseVar": "2,166,744",
"ECR before LimitedLiability": "208%",
"Economic Capital Ratio": "244%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "154,254",
"Assets, Non-Current": "18,301",
"Cost of Goods and Services Sold": "250,362",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "42,991",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "363,729",
"Labor Expense": "0",
"Liabilities, Current": "81,835",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "21,740",
"Other Compr. Net Income": "-5,298",
"Other Expenses": "87,492",
"Other Liabilities": "0",
"Other Net Income": "-280,500",
"Other Revenues": "437,714",
"Property Plant and Equipment": "20,959",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "578,983",
"Liabilities": "81,835",
"Expenses": "380,845",
"Revenues": "437,714",
"Stockholders Equity": "497,148",
"Net Income": "-223,631",
"Comprehensive Net Income": "-228,929",
"BaseVar": "882,588",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "204%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "195,901",
"Assets, Non-Current": "2,969",
"Cost of Goods and Services Sold": "278,252",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "41,991",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "363,729",
"Labor Expense": "0",
"Liabilities, Current": "87,423",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "10,695",
"Other Compr. Net Income": "9,138",
"Other Expenses": "44,172",
"Other Liabilities": "0",
"Other Net Income": "-11,923",
"Other Revenues": "481,252",
"Property Plant and Equipment": "25,247",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "598,541",
"Liabilities": "87,423",
"Expenses": "364,415",
"Revenues": "481,252",
"Stockholders Equity": "511,118",
"Net Income": "104,914",
"Comprehensive Net Income": "114,052",
"BaseVar": "776,346",
"ECR before LimitedLiability": "249%",
"Economic Capital Ratio": "273%"
}
}
},
"top_rated": true,
"trend": 19.0,
"value": 2.7331530021364117,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000704415.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000704415.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000704415.svg"
},
{
"company_id": "0001638833",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001638833.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001638833.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001638833.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001638833_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001638833_main_keyfigs.svg",
"name": "Surgery Partners Inc",
"rank": 7,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001638833.svg",
"report_text": "The relative strengths and weaknesses of Surgery Partners Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Surgery Partners Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 95% points.The greatest weakness of Surgery Partners Inc is the variable Operating Costs and Expenses, reducing the Economic Capital Ratio by 35% points.
The company's Economic Capital Ratio, given in the ranking table, is 268%, being 100% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001638833_2022_Surgery_Partners_Inc.pdf",
"shrinked_graph_json": {
"2015": {
"Assets": "16.6",
"Stockholders Equity": "108",
"ECR before LimitedLiability": "123",
"Intangible Assets": "32.2",
"Long Term Liabilities": "28.3",
"Liabilities": "64.1",
"Other Liabilities": "14.8",
"Liabilities, Current": "31.9",
"Selling and Marketing Expense": "4.80",
"Expenses": "25.4",
"Revenues": "21.1",
"Net Income": "23.4",
"Operating Costs and Expenses": "-14.9",
"General and Administrative Expense": "14.0",
"Other Expenses": "53.8",
"Labor Expense": "-6.06",
"Cost of Goods and Services Sold": "-35.7",
"Other Revenues": "21.1",
"Comprehensive Net Income": "19.4",
"Other Net Income": "-24.7",
"Economic Capital Ratio": "110"
},
"2016": {
"Assets": "16.7",
"Stockholders Equity": "121",
"ECR before LimitedLiability": "149",
"Intangible Assets": "31.4",
"Liabilities, Current": "46.3",
"Liabilities": "74.8",
"Other Liabilities": "17.3",
"Long Term Liabilities": "24.9",
"Expenses": "24.0",
"Revenues": "22.7",
"Net Income": "26.2",
"Operating Costs and Expenses": "-16.6",
"Selling and Marketing Expense": "5.75",
"General and Administrative Expense": "16.8",
"Labor Expense": "-15.7",
"Other Expenses": "59.3",
"Cost of Goods and Services Sold": "-36.9",
"Other Revenues": "22.7",
"Other Net Income": "-21.8",
"Comprehensive Net Income": "22.5",
"Economic Capital Ratio": "121"
},
"2018": {
"Assets": "20.0",
"Stockholders Equity": "111",
"ECR before LimitedLiability": "128",
"Intangible Assets": "45.6",
"Assets, Current": "-4.87",
"Other Liabilities": "8.26",
"Liabilities": "59.8",
"Liabilities, Current": "32.0",
"Long Term Liabilities": "28.3",
"Expenses": "23.7",
"Net Income": "19.8",
"Other Net Income": "-3.45",
"Operating Costs and Expenses": "-14.1",
"Other Expenses": "42.4",
"General and Administrative Expense": "15.0",
"Research And Development Expense": "5.03",
"Cost of Goods and Services Sold": "-21.8",
"Labor Expense": "-8.56",
"Comprehensive Net Income": "16.3",
"Other Compr. Net Income": "-3.69",
"Economic Capital Ratio": "108"
},
"2019": {
"Assets": "17.9",
"Stockholders Equity": "108",
"ECR before LimitedLiability": "117",
"Intangible Assets": "34.6",
"Assets, Current": "-4.71",
"Other Liabilities": "10.8",
"Liabilities": "60.8",
"Long Term Liabilities": "38.4",
"Liabilities, Current": "20.4",
"Other Expenses": "39.7",
"Expenses": "24.1",
"Net Income": "17.8",
"Other Net Income": "-4.74",
"General and Administrative Expense": "12.8",
"Cost of Goods and Services Sold": "-18.8",
"Research And Development Expense": "6.06",
"Labor Expense": "-9.28",
"Operating Costs and Expenses": "-12.0",
"Comprehensive Net Income": "14.1",
"Other Compr. Net Income": "-3.92",
"Economic Capital Ratio": "107"
},
"2020": {
"Assets": "19.9",
"Stockholders Equity": "100",
"ECR before LimitedLiability": "113",
"Intangible Assets": "35.4",
"Assets, Current": "-5.43",
"Liabilities, Current": "13.7",
"Liabilities": "53.9",
"Other Liabilities": "7.88",
"Long Term Liabilities": "38.3",
"Labor Expense": "-8.30",
"Expenses": "20.7",
"Other Net Income": "-4.15",
"Net Income": "16.2",
"General and Administrative Expense": "15.0",
"Research And Development Expense": "3.56",
"Other Expenses": "23.9",
"Operating Costs and Expenses": "-33.3",
"Cost of Goods and Services Sold": "16.0",
"Comprehensive Net Income": "13.3",
"Other Compr. Net Income": "-3.10",
"Economic Capital Ratio": "101"
},
"2021": {
"Assets": "14.2",
"Stockholders Equity": "95.3",
"ECR before LimitedLiability": "106",
"Intangible Assets": "25.4",
"Assets, Current": "-5.05",
"Liabilities, Current": "15.3",
"Liabilities": "59.1",
"Long Term Liabilities": "39.0",
"Other Liabilities": "12.8",
"General and Administrative Expense": "15.1",
"Expenses": "18.3",
"Revenues": "4.61",
"Net Income": "19.7",
"Operating Costs and Expenses": "-35.2",
"Labor Expense": "-10.2",
"Cost of Goods and Services Sold": "14.1",
"Research And Development Expense": "4.43",
"Other Expenses": "24.0",
"Other Revenues": "4.61",
"Comprehensive Net Income": "17.5",
"Economic Capital Ratio": "100"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001638833_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "310,957",
"Assets, Non-Current": "8,504",
"Cost of Goods and Services Sold": "669,326",
"Depreciation, Depletion, Amortization": "34,545",
"General and Administrative Expense": "55,992",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,461,495",
"Labor Expense": "261,685",
"Liabilities, Current": "181,314",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "296,210",
"Other Assets": "325,728",
"Other Compr. Net Income": "-71,416",
"Other Expenses": "-531,692",
"Other Liabilities": "0",
"Other Net Income": "-100,980",
"Other Revenues": "959,891",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,106,684",
"Liabilities": "181,314",
"Expenses": "786,066",
"Revenues": "959,891",
"Stockholders Equity": "1,925,370",
"Net Income": "72,845",
"Comprehensive Net Income": "1,429",
"BaseVar": "2,103,176",
"ECR before LimitedLiability": "244%",
"Economic Capital Ratio": "269%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "361,955",
"Assets, Non-Current": "16,435",
"Cost of Goods and Services Sold": "821,196",
"Depreciation, Depletion, Amortization": "39,551",
"General and Administrative Expense": "60,246",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,603,227",
"Labor Expense": "357,175",
"Liabilities, Current": "186,725",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "330,689",
"Other Assets": "323,341",
"Other Compr. Net Income": "-75,630",
"Other Expenses": "-649,073",
"Other Liabilities": "0",
"Other Net Income": "-100,571",
"Other Revenues": "1,145,438",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,304,958",
"Liabilities": "186,725",
"Expenses": "959,784",
"Revenues": "1,145,438",
"Stockholders Equity": "2,118,233",
"Net Income": "85,083",
"Comprehensive Net Income": "9,453",
"BaseVar": "2,386,553",
"ECR before LimitedLiability": "247%",
"Economic Capital Ratio": "272%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "588,322",
"Assets, Non-Current": "36,850",
"Cost of Goods and Services Sold": "1,361,431",
"Depreciation, Depletion, Amortization": "67,440",
"General and Administrative Expense": "93,558",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,437,139",
"Labor Expense": "534,740",
"Liabilities, Current": "349,299",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "594,557",
"Other Assets": "613,956",
"Other Compr. Net Income": "-132,526",
"Other Expenses": "-931,647",
"Other Liabilities": "0",
"Other Net Income": "-147,003",
"Other Revenues": "1,771,456",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,676,267",
"Liabilities": "349,299",
"Expenses": "1,720,079",
"Revenues": "1,771,456",
"Stockholders Equity": "4,326,968",
"Net Income": "-95,626",
"Comprehensive Net Income": "-228,152",
"BaseVar": "4,398,315",
"ECR before LimitedLiability": "241%",
"Economic Capital Ratio": "267%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "525,500",
"Assets, Non-Current": "328,500",
"Cost of Goods and Services Sold": "1,407,600",
"Depreciation, Depletion, Amortization": "76,500",
"General and Administrative Expense": "88,600",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,449,700",
"Labor Expense": "550,000",
"Liabilities, Current": "398,100",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "617,200",
"Other Assets": "715,200",
"Other Compr. Net Income": "-148,200",
"Other Expenses": "-1,132,500",
"Other Liabilities": "0",
"Other Net Income": "-178,900",
"Other Revenues": "1,831,400",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,018,900",
"Liabilities": "398,100",
"Expenses": "1,607,400",
"Revenues": "1,831,400",
"Stockholders Equity": "4,620,800",
"Net Income": "45,100",
"Comprehensive Net Income": "-103,100",
"BaseVar": "4,591,450",
"ECR before LimitedLiability": "244%",
"Economic Capital Ratio": "269%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "801,500",
"Assets, Non-Current": "337,100",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "94,800",
"General and Administrative Expense": "97,100",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,514,900",
"Labor Expense": "550,300",
"Liabilities, Current": "556,800",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "1,480,300",
"Other Assets": "215,100",
"Other Compr. Net Income": "-127,700",
"Other Expenses": "-565,500",
"Other Liabilities": "0",
"Other Net Income": "-201,800",
"Other Revenues": "1,860,100",
"Property Plant and Equipment": "544,600",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,413,200",
"Liabilities": "556,800",
"Expenses": "1,657,000",
"Revenues": "1,860,100",
"Stockholders Equity": "4,856,400",
"Net Income": "1,300",
"Comprehensive Net Income": "-126,400",
"BaseVar": "4,908,300",
"ECR before LimitedLiability": "232%",
"Economic Capital Ratio": "260%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "946,100",
"Assets, Non-Current": "383,200",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "98,800",
"General and Administrative Expense": "104,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,955,500",
"Labor Expense": "644,300",
"Liabilities, Current": "536,800",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "1,733,700",
"Other Assets": "203,100",
"Other Compr. Net Income": "-112,100",
"Other Expenses": "-647,400",
"Other Liabilities": "0",
"Other Net Income": "-221,000",
"Other Revenues": "2,225,100",
"Property Plant and Equipment": "629,700",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,117,600",
"Liabilities": "536,800",
"Expenses": "1,933,400",
"Revenues": "2,225,100",
"Stockholders Equity": "5,580,800",
"Net Income": "70,700",
"Comprehensive Net Income": "-41,400",
"BaseVar": "5,573,000",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "268%"
}
}
},
"top_rated": true,
"trend": 1.0,
"value": 2.678246896086665,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001638833.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001638833.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001638833.svg"
},
{
"company_id": "0001384101",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001384101.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001384101.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001384101.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001384101_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001384101_main_keyfigs.svg",
"name": "Veracyte INC",
"rank": 8,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001384101.svg",
"report_text": "The relative strengths and weaknesses of Veracyte INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Veracyte INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 111% points.The greatest weakness of Veracyte INC is the variable Other Revenues, reducing the Economic Capital Ratio by 12% points.
The company's Economic Capital Ratio, given in the ranking table, is 264%, being 96% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001384101_2022_Veracyte_INC.pdf",
"shrinked_graph_json": {
"2013": {
"Assets": "36.1",
"Liabilities": "13.2",
"Stockholders Equity": "59.6",
"ECR before LimitedLiability": "27.9",
"Property Plant and Equipment": "-10.4",
"Assets, Current": "99.7",
"Intangible Assets": "-13.9",
"Assets, Non-Current": "-3.15",
"Other Liabilities": "4.50",
"Long Term Liabilities": "9.26",
"Other Revenues": "-4.34",
"Revenues": "-4.34",
"Net Income": "-16.2",
"Comprehensive Net Income": "-16.0",
"Selling and Marketing Expense": "-14.4",
"Cost of Goods and Services Sold": "-11.2",
"Other Net Income": "-13.8",
"Labor Expense": "9.49",
"Other Expenses": "20.7",
"Research And Development Expense": "-7.19",
"Economic Capital Ratio": "18.7"
},
"2014": {
"Other Liabilities": "7.94",
"Liabilities": "27.7",
"Stockholders Equity": "29.7",
"Economic Capital Ratio": "-6.54",
"Long Term Liabilities": "21.0",
"Expenses": "-21.6",
"Revenues": "19.1",
"Net Income": "-27.6",
"Operating Costs and Expenses": "7.18",
"Labor Expense": "15.8",
"Research And Development Expense": "-11.5",
"Other Expenses": "29.8",
"Selling and Marketing Expense": "-31.2",
"Cost of Goods and Services Sold": "-19.1",
"General and Administrative Expense": "-10.3",
"Other Revenues": "19.1",
"Other Assets": "28.6",
"Intangible Assets": "-23.0",
"Property Plant and Equipment": "-20.1",
"Assets, Current": "54.0",
"Comprehensive Net Income": "-28.0",
"Other Net Income": "-23.8"
},
"2015": {
"Long Term Liabilities": "13.8",
"Liabilities": "33.5",
"Stockholders Equity": "31.8",
"ECR before LimitedLiability": "11.0",
"Liabilities, Current": "18.6",
"Selling and Marketing Expense": "-29.9",
"Expenses": "-24.6",
"Revenues": "23.5",
"Net Income": "-24.2",
"Research And Development Expense": "-13.8",
"General and Administrative Expense": "-10.7",
"Other Expenses": "30.1",
"Labor Expense": "14.4",
"Cost of Goods and Services Sold": "-19.3",
"Other Revenues": "23.5",
"Assets, Current": "37.4",
"Intangible Assets": "-21.4",
"Other Assets": "19.8",
"Property Plant and Equipment": "-11.9",
"Comprehensive Net Income": "-24.1",
"Other Net Income": "-21.1",
"Economic Capital Ratio": "-1.42"
},
"2016": {
"Property Plant and Equipment": "-11.4",
"Assets": "12.0",
"Liabilities": "20.4",
"Stockholders Equity": "33.8",
"ECR before LimitedLiability": "31.8",
"Intangible Assets": "-19.5",
"Other Assets": "13.0",
"Assets, Current": "62.2",
"Liabilities, Current": "41.3",
"Long Term Liabilities": "-28.5",
"Expenses": "-6.70",
"Revenues": "18.7",
"Net Income": "-5.66",
"Selling and Marketing Expense": "-22.3",
"Labor Expense": "6.94",
"Other Expenses": "28.7",
"Cost of Goods and Services Sold": "-10.7",
"Research And Development Expense": "-10.2",
"Other Revenues": "18.7",
"Other Net Income": "-16.3",
"Comprehensive Net Income": "-7.55",
"Economic Capital Ratio": "4.09"
},
"2017": {
"Other Assets": "16.1",
"Assets": "-24.9",
"Liabilities": "19.5",
"Stockholders Equity": "-16.2",
"Economic Capital Ratio": "-25.2",
"Intangible Assets": "-30.9",
"Assets, Non-Current": "-6.90",
"Assets, Current": "23.4",
"Property Plant and Equipment": "-16.2",
"Liabilities, Current": "35.7",
"Long Term Liabilities": "-24.4",
"Expenses": "-19.4",
"Revenues": "36.0",
"Comprehensive Net Income": "-10.4",
"Labor Expense": "9.97",
"Selling and Marketing Expense": "-36.0",
"Research And Development Expense": "-10.00",
"Other Expenses": "35.7",
"Cost of Goods and Services Sold": "-22.4",
"Other Revenues": "36.0",
"Other Net Income": "-28.4"
},
"2018": {
"Liabilities": "24.7",
"Stockholders Equity": "20.0",
"ECR before LimitedLiability": "42.7",
"Liabilities, Current": "34.1",
"Long Term Liabilities": "-12.0",
"Selling and Marketing Expense": "-30.1",
"Expenses": "-6.02",
"Revenues": "14.4",
"Net Income": "9.23",
"Operating Costs and Expenses": "4.35",
"Other Expenses": "20.9",
"Research And Development Expense": "-6.37",
"Cost of Goods and Services Sold": "-5.28",
"Labor Expense": "8.85",
"Other Revenues": "14.4",
"Property Plant and Equipment": "-7.10",
"Intangible Assets": "-14.6",
"Assets, Non-Current": "-6.40",
"Assets, Current": "42.5",
"Comprehensive Net Income": "8.83",
"Economic Capital Ratio": "22.0"
},
"2019": {
"Property Plant and Equipment": "-3.34",
"Assets": "17.9",
"Liabilities": "51.3",
"Stockholders Equity": "85.9",
"ECR before LimitedLiability": "96.8",
"Assets, Non-Current": "-2.80",
"Other Assets": "11.3",
"Intangible Assets": "-5.87",
"Assets, Current": "25.0",
"Other Liabilities": "3.86",
"Long Term Liabilities": "26.6",
"Liabilities, Current": "26.6",
"Other Expenses": "10.1",
"Expenses": "9.20",
"Net Income": "10.4",
"Cost of Goods and Services Sold": "4.34",
"Selling and Marketing Expense": "-20.8",
"Labor Expense": "5.98",
"Operating Costs and Expenses": "5.14",
"Comprehensive Net Income": "11.7",
"Economic Capital Ratio": "86.8"
},
"2020": {
"Assets": "24.3",
"Liabilities": "55.4",
"Stockholders Equity": "113",
"ECR before LimitedLiability": "114",
"Other Assets": "3.96",
"Intangible Assets": "-4.04",
"Assets, Current": "38.6",
"Liabilities, Current": "30.2",
"Long Term Liabilities": "30.4",
"Labor Expense": "4.84",
"Expenses": "12.8",
"Revenues": "-8.72",
"Net Income": "5.36",
"Selling and Marketing Expense": "-13.1",
"General and Administrative Expense": "5.83",
"Other Expenses": "-3.42",
"Operating Costs and Expenses": "3.85",
"Cost of Goods and Services Sold": "15.2",
"Other Revenues": "-8.72",
"Comprehensive Net Income": "5.36",
"Economic Capital Ratio": "102"
},
"2021": {
"Assets": "25.2",
"Liabilities": "49.3",
"Stockholders Equity": "111",
"ECR before LimitedLiability": "102",
"Intangible Assets": "48.7",
"Assets, Non-Current": "-1.63",
"Assets, Current": "-2.44",
"Liabilities, Current": "17.2",
"Long Term Liabilities": "29.2",
"Other Liabilities": "8.94",
"General and Administrative Expense": "3.05",
"Expenses": "16.9",
"Revenues": "-12.2",
"Net Income": "6.80",
"Operating Costs and Expenses": "4.09",
"Labor Expense": "3.55",
"Cost of Goods and Services Sold": "11.7",
"Selling and Marketing Expense": "-6.35",
"Other Revenues": "-12.2",
"Comprehensive Net Income": "6.88",
"Economic Capital Ratio": "96.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001384101_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "76,407",
"Assets, Non-Current": "153",
"Cost of Goods and Services Sold": "12,607",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "12,100",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "15,388",
"Long Term Liabilities": "4,899",
"Operating Costs and Expenses": "0",
"Other Assets": "118",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "2,900",
"Other Net Income": "0",
"Other Revenues": "21,884",
"Property Plant and Equipment": "2,952",
"Research And Development Expense": "7,810",
"Selling and Marketing Expense": "12,540"
},
"output_variables": {
"Assets": "79,630",
"Liabilities": "23,187",
"Expenses": "45,057",
"Revenues": "21,884",
"Stockholders Equity": "56,443",
"Net Income": "-23,173",
"Comprehensive Net Income": "-23,173",
"BaseVar": "84,879",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "181%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "43,348",
"Assets, Non-Current": "155",
"Cost of Goods and Services Sold": "16,606",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "18,854",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,057",
"Labor Expense": "0",
"Liabilities, Current": "17,145",
"Long Term Liabilities": "4,923",
"Operating Costs and Expenses": "0",
"Other Assets": "16,118",
"Other Compr. Net Income": "-367",
"Other Expenses": "0",
"Other Liabilities": "1,397",
"Other Net Income": "0",
"Other Revenues": "38,190",
"Property Plant and Equipment": "4,161",
"Research And Development Expense": "9,804",
"Selling and Marketing Expense": "21,932"
},
"output_variables": {
"Assets": "64,839",
"Liabilities": "23,465",
"Expenses": "67,196",
"Revenues": "38,190",
"Stockholders Equity": "41,374",
"Net Income": "-29,006",
"Comprehensive Net Income": "-29,373",
"BaseVar": "97,028",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "148%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "47,933",
"Assets, Non-Current": "178",
"Cost of Goods and Services Sold": "21,497",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "22,583",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,057",
"Labor Expense": "0",
"Liabilities, Current": "14,722",
"Long Term Liabilities": "5,028",
"Operating Costs and Expenses": "0",
"Other Assets": "15,803",
"Other Compr. Net Income": "-238",
"Other Expenses": "800",
"Other Liabilities": "4,283",
"Other Net Income": "0",
"Other Revenues": "49,503",
"Property Plant and Equipment": "10,314",
"Research And Development Expense": "12,796",
"Selling and Marketing Expense": "25,293"
},
"output_variables": {
"Assets": "75,285",
"Liabilities": "24,033",
"Expenses": "82,969",
"Revenues": "49,503",
"Stockholders Equity": "51,252",
"Net Income": "-33,466",
"Comprehensive Net Income": "-33,704",
"BaseVar": "116,014",
"ECR before LimitedLiability": "82%",
"Economic Capital Ratio": "158%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "73,627",
"Assets, Non-Current": "134",
"Cost of Goods and Services Sold": "25,462",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "23,787",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,057",
"Labor Expense": "0",
"Liabilities, Current": "11,534",
"Long Term Liabilities": "24,918",
"Operating Costs and Expenses": "0",
"Other Assets": "14,736",
"Other Compr. Net Income": "-2,555",
"Other Expenses": "1,067",
"Other Liabilities": "5,001",
"Other Net Income": "0",
"Other Revenues": "65,085",
"Property Plant and Equipment": "11,480",
"Research And Development Expense": "15,324",
"Selling and Marketing Expense": "28,248"
},
"output_variables": {
"Assets": "101,034",
"Liabilities": "41,453",
"Expenses": "93,888",
"Revenues": "65,085",
"Stockholders Equity": "59,581",
"Net Income": "-28,803",
"Comprehensive Net Income": "-31,358",
"BaseVar": "152,008",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "154%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "53,928",
"Assets, Non-Current": "326",
"Cost of Goods and Services Sold": "28,195",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "23,088",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,057",
"Labor Expense": "0",
"Liabilities, Current": "12,028",
"Long Term Liabilities": "24,938",
"Operating Costs and Expenses": "0",
"Other Assets": "13,670",
"Other Compr. Net Income": "-4,465",
"Other Expenses": "1,067",
"Other Liabilities": "4,478",
"Other Net Income": "0",
"Other Revenues": "71,953",
"Property Plant and Equipment": "9,688",
"Research And Development Expense": "13,881",
"Selling and Marketing Expense": "32,260"
},
"output_variables": {
"Assets": "78,669",
"Liabilities": "41,444",
"Expenses": "98,491",
"Revenues": "71,953",
"Stockholders Equity": "37,225",
"Net Income": "-26,538",
"Comprehensive Net Income": "-31,003",
"BaseVar": "147,511",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "123%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "96,952",
"Assets, Non-Current": "1,086",
"Cost of Goods and Services Sold": "33,078",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "23,963",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,057",
"Labor Expense": "0",
"Liabilities, Current": "13,059",
"Long Term Liabilities": "23,925",
"Operating Costs and Expenses": "0",
"Other Assets": "12,603",
"Other Compr. Net Income": "-766",
"Other Expenses": "1,067",
"Other Liabilities": "3,899",
"Other Net Income": "0",
"Other Revenues": "92,008",
"Property Plant and Equipment": "8,940",
"Research And Development Expense": "14,820",
"Selling and Marketing Expense": "41,313"
},
"output_variables": {
"Assets": "120,638",
"Liabilities": "40,883",
"Expenses": "114,241",
"Revenues": "92,008",
"Stockholders Equity": "79,755",
"Net Income": "-22,233",
"Comprehensive Net Income": "-22,999",
"BaseVar": "184,268",
"ECR before LimitedLiability": "115%",
"Economic Capital Ratio": "181%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "187,687",
"Assets, Non-Current": "10,245",
"Cost of Goods and Services Sold": "36,077",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "29,029",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,725",
"Labor Expense": "0",
"Liabilities, Current": "17,469",
"Long Term Liabilities": "12,200",
"Operating Costs and Expenses": "0",
"Other Assets": "65,622",
"Other Compr. Net Income": "2,528",
"Other Expenses": "1,847",
"Other Liabilities": "6,088",
"Other Net Income": "0",
"Other Revenues": "120,368",
"Property Plant and Equipment": "8,933",
"Research And Development Expense": "14,851",
"Selling and Marketing Expense": "53,691"
},
"output_variables": {
"Assets": "275,212",
"Liabilities": "35,757",
"Expenses": "135,495",
"Revenues": "120,368",
"Stockholders Equity": "239,455",
"Net Income": "-15,127",
"Comprehensive Net Income": "-12,599",
"BaseVar": "284,680",
"ECR before LimitedLiability": "215%",
"Economic Capital Ratio": "249%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "375,679",
"Assets, Non-Current": "9,242",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "36,729",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,725",
"Labor Expense": "0",
"Liabilities, Current": "16,781",
"Long Term Liabilities": "10,727",
"Operating Costs and Expenses": "0",
"Other Assets": "60,527",
"Other Compr. Net Income": "0",
"Other Expenses": "46,779",
"Other Liabilities": "8,423",
"Other Net Income": "709",
"Other Revenues": "117,483",
"Property Plant and Equipment": "8,990",
"Research And Development Expense": "17,204",
"Selling and Marketing Expense": "52,389"
},
"output_variables": {
"Assets": "457,163",
"Liabilities": "35,931",
"Expenses": "153,101",
"Revenues": "117,483",
"Stockholders Equity": "421,232",
"Net Income": "-34,909",
"Comprehensive Net Income": "-34,909",
"BaseVar": "382,194",
"ECR before LimitedLiability": "234%",
"Economic Capital Ratio": "262%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "243,102",
"Assets, Non-Current": "18,241",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "101,353",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "910,635",
"Labor Expense": "0",
"Liabilities, Current": "69,743",
"Long Term Liabilities": "15,503",
"Operating Costs and Expenses": "0",
"Other Assets": "749",
"Other Compr. Net Income": "0",
"Other Expenses": "84,295",
"Other Liabilities": "6,065",
"Other Net Income": "254",
"Other Revenues": "219,514",
"Property Plant and Equipment": "15,098",
"Research And Development Expense": "29,843",
"Selling and Marketing Expense": "79,840"
},
"output_variables": {
"Assets": "1,187,825",
"Liabilities": "91,311",
"Expenses": "295,331",
"Revenues": "219,514",
"Stockholders Equity": "1,096,514",
"Net Income": "-75,563",
"Comprehensive Net Income": "-75,563",
"BaseVar": "897,118",
"ECR before LimitedLiability": "237%",
"Economic Capital Ratio": "264%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.6400988262975504,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001384101.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001384101.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001384101.svg"
},
{
"company_id": "0000352915",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000352915.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000352915.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000352915.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000352915_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000352915_main_keyfigs.svg",
"name": "Universal Health Services Inc",
"rank": 9,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000352915.svg",
"report_text": "The relative strengths and weaknesses of Universal Health Services Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Universal Health Services Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 79% points.The greatest weakness of Universal Health Services Inc is the variable Labor Expense, reducing the Economic Capital Ratio by 56% points.
The company's Economic Capital Ratio, given in the ranking table, is 257%, being 89% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000352915_2022_Universal_Health_Services_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets": "3.86",
"Liabilities": "72.2",
"Stockholders Equity": "68.2",
"ECR before LimitedLiability": "73.3",
"Property Plant and Equipment": "8.34",
"Assets, Non-Current": "17.0",
"Other Assets": "-9.32",
"Other Liabilities": "20.5",
"Long Term Liabilities": "56.6",
"Other Expenses": "17.7",
"Expenses": "-16.1",
"Revenues": "-42.2",
"Net Income": "-6.14",
"Cost of Goods and Services Sold": "13.5",
"General and Administrative Expense": "6.28",
"Labor Expense": "-34.0",
"Operating Costs and Expenses": "-19.9",
"Other Revenues": "-42.2",
"Comprehensive Net Income": "-4.95",
"Other Net Income": "46.7",
"Economic Capital Ratio": "75.1"
},
"2011": {
"Other Liabilities": "18.0",
"Liabilities": "84.0",
"Stockholders Equity": "67.5",
"ECR before LimitedLiability": "115",
"Long Term Liabilities": "51.4",
"Liabilities, Current": "31.3",
"Expenses": "-6.31",
"Net Income": "29.5",
"Other Expenses": "23.2",
"Operating Costs and Expenses": "-29.6",
"Labor Expense": "-46.2",
"General and Administrative Expense": "24.9",
"Cost of Goods and Services Sold": "9.88",
"Other Revenues": "-61.7",
"Revenues": "-61.7",
"Other Assets": "-8.66",
"Property Plant and Equipment": "6.09",
"Assets, Non-Current": "15.1",
"Other Net Income": "86.3",
"Comprehensive Net Income": "29.8",
"Economic Capital Ratio": "108"
},
"2012": {
"Liabilities, Current": "30.3",
"Liabilities": "78.9",
"Property Plant and Equipment": "7.38",
"Stockholders Equity": "73.3",
"ECR before LimitedLiability": "119",
"Long Term Liabilities": "38.9",
"Other Liabilities": "26.4",
"Other Revenues": "57.8",
"Revenues": "57.8",
"Net Income": "26.4",
"Assets, Current": "-5.24",
"Other Assets": "-9.04",
"Assets, Non-Current": "16.5",
"Comprehensive Net Income": "26.2",
"Other Expenses": "26.2",
"General and Administrative Expense": "23.5",
"Other Net Income": "-34.7",
"Operating Costs and Expenses": "-29.3",
"Cost of Goods and Services Sold": "9.33",
"Labor Expense": "-43.3",
"Economic Capital Ratio": "105"
},
"2013": {
"Other Liabilities": "23.5",
"Liabilities": "82.7",
"Stockholders Equity": "69.0",
"Other Assets": "-10.6",
"ECR before LimitedLiability": "110",
"Liabilities, Current": "36.5",
"Long Term Liabilities": "40.1",
"Other Revenues": "55.6",
"Revenues": "55.6",
"Net Income": "30.5",
"Property Plant and Equipment": "8.52",
"Assets, Current": "-7.18",
"Assets, Non-Current": "18.5",
"Comprehensive Net Income": "30.5",
"General and Administrative Expense": "24.7",
"Cost of Goods and Services Sold": "8.66",
"Other Net Income": "-23.5",
"Labor Expense": "-43.5",
"Operating Costs and Expenses": "-32.0",
"Other Expenses": "23.9",
"Economic Capital Ratio": "101"
},
"2014": {
"Other Liabilities": "18.2",
"Liabilities": "83.8",
"Stockholders Equity": "72.7",
"Other Assets": "-7.47",
"ECR before LimitedLiability": "120",
"Liabilities, Current": "34.2",
"Long Term Liabilities": "47.8",
"Other Revenues": "58.8",
"Revenues": "58.8",
"Net Income": "30.7",
"Assets, Non-Current": "19.4",
"Property Plant and Equipment": "6.98",
"Assets, Current": "-9.96",
"Other Net Income": "-28.2",
"Comprehensive Net Income": "30.0",
"Operating Costs and Expenses": "-32.0",
"Labor Expense": "-40.6",
"Other Expenses": "21.6",
"Cost of Goods and Services Sold": "9.82",
"General and Administrative Expense": "23.5",
"Economic Capital Ratio": "106"
},
"2015": {
"Long Term Liabilities": "38.5",
"Liabilities": "86.4",
"Stockholders Equity": "73.5",
"Assets, Non-Current": "18.0",
"ECR before LimitedLiability": "122",
"Other Liabilities": "20.5",
"Liabilities, Current": "46.1",
"Other Revenues": "62.2",
"Revenues": "62.2",
"Net Income": "36.2",
"Other Assets": "-9.87",
"Property Plant and Equipment": "5.83",
"Comprehensive Net Income": "35.8",
"Selling and Marketing Expense": "6.81",
"Operating Costs and Expenses": "-38.0",
"Other Net Income": "-25.5",
"General and Administrative Expense": "24.7",
"Other Expenses": "24.0",
"Labor Expense": "-45.2",
"Cost of Goods and Services Sold": "13.2",
"Economic Capital Ratio": "109"
},
"2016": {
"Liabilities, Current": "55.0",
"Liabilities": "90.2",
"Stockholders Equity": "86.0",
"Property Plant and Equipment": "8.29",
"ECR before LimitedLiability": "141",
"Other Liabilities": "22.2",
"Long Term Liabilities": "31.6",
"Other Revenues": "58.1",
"Revenues": "58.1",
"Net Income": "37.0",
"Assets, Non-Current": "18.5",
"Other Assets": "-10.6",
"Comprehensive Net Income": "37.3",
"Operating Costs and Expenses": "-39.9",
"Selling and Marketing Expense": "7.66",
"General and Administrative Expense": "26.8",
"Labor Expense": "-53.1",
"Other Expenses": "24.8",
"Cost of Goods and Services Sold": "18.5",
"Other Net Income": "-20.8",
"Economic Capital Ratio": "113"
},
"2017": {
"Liabilities, Current": "37.7",
"Liabilities": "77.1",
"Other Assets": "-13.6",
"Stockholders Equity": "60.2",
"ECR before LimitedLiability": "126",
"Other Liabilities": "12.5",
"Long Term Liabilities": "39.8",
"Other Revenues": "63.7",
"Revenues": "63.7",
"Net Income": "36.2",
"Assets, Non-Current": "22.4",
"Assets, Current": "-9.79",
"Property Plant and Equipment": "11.7",
"General and Administrative Expense": "26.8",
"Comprehensive Net Income": "36.5",
"Labor Expense": "-50.6",
"Operating Costs and Expenses": "-39.2",
"Other Net Income": "-27.0",
"Other Expenses": "26.0",
"Cost of Goods and Services Sold": "14.4",
"Economic Capital Ratio": "102"
},
"2018": {
"Other Liabilities": "12.0",
"Liabilities": "79.5",
"Other Assets": "-10.8",
"Stockholders Equity": "62.2",
"ECR before LimitedLiability": "125",
"Liabilities, Current": "42.3",
"Long Term Liabilities": "39.8",
"Other Revenues": "42.7",
"Revenues": "42.7",
"Net Income": "41.4",
"Property Plant and Equipment": "12.5",
"Assets, Non-Current": "14.9",
"Assets, Current": "-8.08",
"Comprehensive Net Income": "41.4",
"Operating Costs and Expenses": "-40.3",
"Research And Development Expense": "7.47",
"Other Expenses": "19.9",
"General and Administrative Expense": "26.0",
"Cost of Goods and Services Sold": "27.0",
"Labor Expense": "-53.2",
"Economic Capital Ratio": "104"
},
"2019": {
"Other Liabilities": "15.9",
"Liabilities": "83.7",
"Stockholders Equity": "55.5",
"ECR before LimitedLiability": "110",
"Long Term Liabilities": "54.3",
"Liabilities, Current": "28.8",
"Other Expenses": "10.9",
"Expenses": "-10.2",
"Revenues": "42.6",
"Net Income": "33.8",
"General and Administrative Expense": "23.0",
"Cost of Goods and Services Sold": "29.9",
"Research And Development Expense": "9.28",
"Labor Expense": "-56.5",
"Operating Costs and Expenses": "-37.8",
"Other Revenues": "42.6",
"Property Plant and Equipment": "12.5",
"Assets, Non-Current": "11.8",
"Other Assets": "-10.4",
"Comprehensive Net Income": "34.2",
"Economic Capital Ratio": "100"
},
"2020": {
"Liabilities, Current": "11.9",
"Liabilities": "65.0",
"Stockholders Equity": "46.9",
"ECR before LimitedLiability": "98.7",
"Other Liabilities": "10.5",
"Long Term Liabilities": "49.5",
"Labor Expense": "-44.4",
"Expenses": "-6.66",
"Net Income": "30.5",
"General and Administrative Expense": "24.0",
"Other Expenses": "10.7",
"Operating Costs and Expenses": "-30.1",
"Cost of Goods and Services Sold": "22.3",
"Other Revenues": "35.7",
"Revenues": "35.7",
"Property Plant and Equipment": "16.2",
"Other Assets": "-12.6",
"Assets, Current": "-9.26",
"Assets, Non-Current": "13.3",
"Comprehensive Net Income": "30.6",
"Economic Capital Ratio": "86.6"
},
"2021": {
"Liabilities, Current": "20.1",
"Liabilities": "79.4",
"Stockholders Equity": "35.9",
"ECR before LimitedLiability": "95.0",
"Long Term Liabilities": "53.8",
"Other Liabilities": "18.4",
"General and Administrative Expense": "25.9",
"Expenses": "-18.0",
"Net Income": "36.1",
"Operating Costs and Expenses": "-36.7",
"Labor Expense": "-56.2",
"Cost of Goods and Services Sold": "21.2",
"Other Expenses": "10.8",
"Other Revenues": "49.6",
"Revenues": "49.6",
"Other Assets": "-10.6",
"Property Plant and Equipment": "18.3",
"Assets, Non-Current": "12.7",
"Assets, Current": "-11.4",
"Comprehensive Net Income": "36.1",
"Economic Capital Ratio": "88.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000352915_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "1,331,116",
"Assets, Non-Current": "2,943,853",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "223,915",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,589,914",
"Labor Expense": "2,423,102",
"Liabilities, Current": "826,299",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "1,738,381",
"Other Assets": "-2,589,914",
"Other Compr. Net Income": "0",
"Other Expenses": "906,992",
"Other Liabilities": "0",
"Other Net Income": "5,568,185",
"Other Revenues": "0",
"Property Plant and Equipment": "3,252,967",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,527,936",
"Liabilities": "826,299",
"Expenses": "5,292,390",
"Revenues": "0",
"Stockholders Equity": "6,701,637",
"Net Income": "275,795",
"Comprehensive Net Income": "275,795",
"BaseVar": "9,607,405",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "266%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,364,905",
"Assets, Non-Current": "3,012,360",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "295,228",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,627,602",
"Labor Expense": "3,394,967",
"Liabilities, Current": "836,933",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "2,207,491",
"Other Assets": "-2,627,602",
"Other Compr. Net Income": "0",
"Other Expenses": "1,153,642",
"Other Liabilities": "0",
"Other Net Income": "7,500,198",
"Other Revenues": "0",
"Property Plant and Equipment": "3,287,980",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,665,245",
"Liabilities": "836,933",
"Expenses": "7,051,328",
"Revenues": "0",
"Stockholders Equity": "6,828,312",
"Net Income": "448,870",
"Comprehensive Net Income": "448,870",
"BaseVar": "11,526,852",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "269%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,407,496",
"Assets, Non-Current": "3,411,112",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "302,426",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,036,765",
"Labor Expense": "3,440,917",
"Liabilities, Current": "894,058",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "2,175,743",
"Other Assets": "-3,036,765",
"Other Compr. Net Income": "-38,580",
"Other Expenses": "553,267",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "6,961,400",
"Property Plant and Equipment": "3,382,235",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,200,843",
"Liabilities": "894,058",
"Expenses": "6,472,353",
"Revenues": "6,961,400",
"Stockholders Equity": "7,306,785",
"Net Income": "489,047",
"Comprehensive Net Income": "450,467",
"BaseVar": "11,283,617",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "269%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "1,432,329",
"Assets, Non-Current": "3,437,225",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "337,172",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,049,016",
"Labor Expense": "3,604,620",
"Liabilities, Current": "1,059,888",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "2,289,833",
"Other Assets": "-3,049,016",
"Other Compr. Net Income": "-23,946",
"Other Expenses": "498,174",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "7,283,822",
"Property Plant and Equipment": "3,442,169",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,311,723",
"Liabilities": "1,059,888",
"Expenses": "6,729,799",
"Revenues": "7,283,822",
"Stockholders Equity": "7,251,835",
"Net Income": "554,023",
"Comprehensive Net Income": "530,077",
"BaseVar": "11,704,589",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "263%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "0",
"Assets, Non-Current": "3,679,616",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "375,624",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,291,213",
"Labor Expense": "3,845,461",
"Liabilities, Current": "1,182,827",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "2,678,674",
"Other Assets": "-1,676,075",
"Other Compr. Net Income": "-60,075",
"Other Expenses": "560,571",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "8,065,326",
"Property Plant and Equipment": "3,679,689",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,974,443",
"Liabilities": "1,182,827",
"Expenses": "7,460,330",
"Revenues": "8,065,326",
"Stockholders Equity": "7,791,616",
"Net Income": "604,996",
"Comprehensive Net Income": "544,921",
"BaseVar": "12,871,500",
"ECR before LimitedLiability": "233%",
"Economic Capital Ratio": "261%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "1,718,304",
"Assets, Non-Current": "4,079,831",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "398,618",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,596,114",
"Labor Expense": "4,212,387",
"Liabilities, Current": "1,100,406",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "3,093,893",
"Other Assets": "-3,596,114",
"Other Compr. Net Income": "-68,067",
"Other Expenses": "587,855",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "9,043,451",
"Property Plant and Equipment": "3,835,978",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,634,113",
"Liabilities": "1,100,406",
"Expenses": "8,292,753",
"Revenues": "9,043,451",
"Stockholders Equity": "8,533,707",
"Net Income": "750,698",
"Comprehensive Net Income": "682,631",
"BaseVar": "14,069,395",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "269%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "1,681,371",
"Assets, Non-Current": "4,305,475",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "416,608",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,784,106",
"Labor Expense": "4,585,530",
"Liabilities, Current": "1,317,373",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "3,390,676",
"Other Assets": "-3,784,106",
"Other Compr. Net Income": "-47,050",
"Other Expenses": "626,225",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "9,766,210",
"Property Plant and Equipment": "4,330,956",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,317,802",
"Liabilities": "1,317,373",
"Expenses": "9,019,039",
"Revenues": "9,766,210",
"Stockholders Equity": "9,000,429",
"Net Income": "747,171",
"Comprehensive Net Income": "700,121",
"BaseVar": "15,233,737",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "264%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "1,798,002",
"Assets, Non-Current": "4,391,989",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "447,765",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,825,157",
"Labor Expense": "4,980,637",
"Liabilities, Current": "1,848,034",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "3,598,158",
"Other Assets": "-3,825,157",
"Other Compr. Net Income": "13,585",
"Other Expenses": "611,993",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "10,409,865",
"Property Plant and Equipment": "4,571,837",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,761,828",
"Liabilities": "1,848,034",
"Expenses": "9,638,553",
"Revenues": "10,409,865",
"Stockholders Equity": "8,913,794",
"Net Income": "771,312",
"Comprehensive Net Income": "784,897",
"BaseVar": "16,335,932",
"ECR before LimitedLiability": "217%",
"Economic Capital Ratio": "250%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,937,802",
"Assets, Non-Current": "4,479,738",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "453,045",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,844,628",
"Labor Expense": "5,254,536",
"Liabilities, Current": "1,448,738",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "3,783,341",
"Other Assets": "-3,844,628",
"Other Compr. Net Income": "-22,664",
"Other Expenses": "497,692",
"Other Liabilities": "0",
"Other Net Income": "14,219",
"Other Revenues": "10,772,278",
"Property Plant and Equipment": "4,847,940",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "11,265,480",
"Liabilities": "1,448,738",
"Expenses": "9,988,614",
"Revenues": "10,772,278",
"Stockholders Equity": "9,816,742",
"Net Income": "797,883",
"Comprehensive Net Income": "775,219",
"BaseVar": "16,755,996",
"ECR before LimitedLiability": "236%",
"Economic Capital Ratio": "264%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,915,934",
"Assets, Non-Current": "4,735,618",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "490,392",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,869,760",
"Labor Expense": "5,588,893",
"Liabilities, Current": "1,563,390",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "3,975,257",
"Other Assets": "-3,869,760",
"Other Compr. Net Income": "14,962",
"Other Expenses": "509,336",
"Other Liabilities": "0",
"Other Net Income": "13,162",
"Other Revenues": "11,378,259",
"Property Plant and Equipment": "5,016,698",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "11,668,250",
"Liabilities": "1,563,390",
"Expenses": "10,563,878",
"Revenues": "11,378,259",
"Stockholders Equity": "10,104,860",
"Net Income": "827,543",
"Comprehensive Net Income": "842,505",
"BaseVar": "17,600,950",
"ECR before LimitedLiability": "234%",
"Economic Capital Ratio": "262%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "3,281,869",
"Assets, Non-Current": "4,821,886",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "510,493",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,882,715",
"Labor Expense": "5,613,097",
"Liabilities, Current": "2,481,039",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "3,960,894",
"Other Assets": "-3,882,715",
"Other Compr. Net Income": "7,390",
"Other Expenses": "521,637",
"Other Liabilities": "0",
"Other Net Income": "14",
"Other Revenues": "11,558,897",
"Property Plant and Equipment": "5,373,124",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "13,476,879",
"Liabilities": "2,481,039",
"Expenses": "10,606,121",
"Revenues": "11,558,897",
"Stockholders Equity": "10,995,840",
"Net Income": "952,790",
"Comprehensive Net Income": "960,180",
"BaseVar": "19,065,170",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "246%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "2,263,556",
"Assets, Non-Current": "4,955,712",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "533,213",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,962,624",
"Labor Expense": "6,163,944",
"Liabilities, Current": "1,984,109",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "4,463,003",
"Other Assets": "-3,962,624",
"Other Compr. Net Income": "-13,871",
"Other Expenses": "508,216",
"Other Liabilities": "0",
"Other Net Income": "13,891",
"Other Revenues": "12,642,117",
"Property Plant and Equipment": "5,874,275",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "13,093,543",
"Liabilities": "1,984,109",
"Expenses": "11,668,376",
"Revenues": "12,642,117",
"Stockholders Equity": "11,109,434",
"Net Income": "987,632",
"Comprehensive Net Income": "973,761",
"BaseVar": "19,707,954",
"ECR before LimitedLiability": "227%",
"Economic Capital Ratio": "257%"
}
}
},
"top_rated": true,
"trend": 4.0,
"value": 2.566319482366824,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000352915.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000352915.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000352915.svg"
},
{
"company_id": "0000744825",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000744825.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000744825.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000744825.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000744825_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000744825_main_keyfigs.svg",
"name": "American Shared Hospital Services",
"rank": 10,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000744825.svg",
"report_text": "The relative strengths and weaknesses of American Shared Hospital Services are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of American Shared Hospital Services compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 81% points.The greatest weakness of American Shared Hospital Services is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 17% points.
The company's Economic Capital Ratio, given in the ranking table, is 256%, being 88% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000744825_2022_American_Shared_Hospital_Services.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "29.9",
"Liabilities": "33.5",
"Stockholders Equity": "100",
"ECR before LimitedLiability": "102",
"Property Plant and Equipment": "43.9",
"Intangible Assets": "-5.98",
"Other Liabilities": "9.64",
"Long Term Liabilities": "29.3",
"Expenses": "26.5",
"Revenues": "-22.7",
"Net Income": "14.5",
"Other Expenses": "28.7",
"Depreciation, Depletion, Amortization": "-8.66",
"Operating Costs and Expenses": "5.36",
"Labor Expense": "8.41",
"General and Administrative Expense": "6.97",
"Cost of Goods and Services Sold": "-19.2",
"Other Revenues": "-22.7",
"Other Net Income": "9.22",
"Comprehensive Net Income": "14.7",
"Economic Capital Ratio": "95.0"
},
"2012": {
"Property Plant and Equipment": "51.1",
"Assets": "33.2",
"Stockholders Equity": "104",
"ECR before LimitedLiability": "106",
"Intangible Assets": "-5.32",
"Liabilities, Current": "-4.28",
"Liabilities": "31.1",
"Long Term Liabilities": "22.0",
"Other Liabilities": "14.6",
"Research And Development Expense": "2.00",
"Expenses": "27.4",
"Other Net Income": "-18.6",
"Net Income": "11.8",
"Depreciation, Depletion, Amortization": "-9.00",
"Other Expenses": "25.3",
"General and Administrative Expense": "6.22",
"Operating Costs and Expenses": "3.96",
"Cost of Goods and Services Sold": "-12.5",
"Labor Expense": "8.22",
"Comprehensive Net Income": "12.0",
"Economic Capital Ratio": "91.5"
},
"2014": {
"Assets": "42.4",
"Stockholders Equity": "79.9",
"ECR before LimitedLiability": "80.2",
"Intangible Assets": "-7.57",
"Property Plant and Equipment": "72.0",
"Other Liabilities": "8.41",
"Liabilities": "11.1",
"Liabilities, Current": "-25.4",
"Long Term Liabilities": "23.7",
"Expenses": "26.2",
"Net Income": "10.6",
"Other Net Income": "-14.3",
"Operating Costs and Expenses": "3.80",
"Depreciation, Depletion, Amortization": "-8.56",
"Labor Expense": "8.18",
"Research And Development Expense": "2.87",
"Other Expenses": "21.8",
"Cost of Goods and Services Sold": "-11.2",
"General and Administrative Expense": "6.29",
"Comprehensive Net Income": "10.8",
"Economic Capital Ratio": "67.1"
},
"2015": {
"Assets": "65.2",
"Stockholders Equity": "114",
"ECR before LimitedLiability": "94.5",
"Intangible Assets": "-4.31",
"Property Plant and Equipment": "122",
"Long Term Liabilities": "14.3",
"Liabilities": "7.78",
"Other Liabilities": "7.29",
"Liabilities, Current": "-15.7",
"Selling and Marketing Expense": "2.49",
"Expenses": "37.8",
"Revenues": "-21.6",
"Net Income": "8.69",
"General and Administrative Expense": "9.18",
"Other Expenses": "10.9",
"Labor Expense": "5.64",
"Cost of Goods and Services Sold": "4.87",
"Other Revenues": "-21.6",
"Comprehensive Net Income": "6.84",
"Other Net Income": "-9.35",
"Economic Capital Ratio": "82.1"
},
"2016": {
"Property Plant and Equipment": "92.4",
"Assets": "57.6",
"Stockholders Equity": "125",
"ECR before LimitedLiability": "129",
"Intangible Assets": "-3.56",
"Liabilities": "20.0",
"Other Liabilities": "9.06",
"Long Term Liabilities": "13.2",
"Expenses": "40.2",
"Revenues": "-25.0",
"Net Income": "16.0",
"Selling and Marketing Expense": "3.08",
"General and Administrative Expense": "10.9",
"Labor Expense": "3.24",
"Other Expenses": "11.3",
"Cost of Goods and Services Sold": "7.49",
"Research And Development Expense": "2.73",
"Other Revenues": "-25.0",
"Comprehensive Net Income": "13.7",
"Other Compr. Net Income": "-2.35",
"Economic Capital Ratio": "102"
},
"2019": {
"Property Plant and Equipment": "67.6",
"Assets": "21.9",
"Stockholders Equity": "85.7",
"ECR before LimitedLiability": "98.6",
"Intangible Assets": "-5.49",
"Assets, Current": "-3.48",
"Other Liabilities": "9.46",
"Liabilities": "39.7",
"Long Term Liabilities": "34.2",
"Other Expenses": "-7.84",
"Expenses": "19.4",
"Net Income": "18.5",
"General and Administrative Expense": "4.93",
"Cost of Goods and Services Sold": "18.2",
"Research And Development Expense": "5.58",
"Selling and Marketing Expense": "3.60",
"Labor Expense": "5.40",
"Operating Costs and Expenses": "4.64",
"Depreciation, Depletion, Amortization": "-15.9",
"Comprehensive Net Income": "18.6",
"Economic Capital Ratio": "88.6"
},
"2020": {
"Property Plant and Equipment": "107",
"Assets": "19.0",
"Liabilities": "19.5",
"Expenses": "20.3",
"Stockholders Equity": "46.3",
"ECR before LimitedLiability": "46.8",
"Other Assets": "-3.85",
"Intangible Assets": "-9.92",
"Assets, Current": "-10.1",
"Assets, Non-Current": "-5.68",
"Liabilities, Current": "-24.0",
"Other Liabilities": "6.43",
"Long Term Liabilities": "33.4",
"Labor Expense": "5.12",
"General and Administrative Expense": "6.58",
"Depreciation, Depletion, Amortization": "-15.0",
"Research And Development Expense": "3.55",
"Operating Costs and Expenses": "4.06",
"Cost of Goods and Services Sold": "16.5",
"Other Net Income": "-18.7",
"Economic Capital Ratio": "34.7"
},
"2021": {
"Other Assets": "48.5",
"Assets": "15.4",
"Stockholders Equity": "81.1",
"ECR before LimitedLiability": "94.6",
"Intangible Assets": "-5.76",
"Liabilities": "47.8",
"Long Term Liabilities": "36.9",
"Other Liabilities": "12.1",
"General and Administrative Expense": "4.45",
"Expenses": "13.6",
"Revenues": "5.78",
"Net Income": "19.5",
"Operating Costs and Expenses": "4.78",
"Labor Expense": "4.14",
"Cost of Goods and Services Sold": "-16.9",
"Research And Development Expense": "4.29",
"Other Expenses": "7.24",
"Selling and Marketing Expense": "3.30",
"Other Revenues": "5.78",
"Comprehensive Net Income": "19.6",
"Economic Capital Ratio": "88.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000744825_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "17,615",
"Assets, Non-Current": "997",
"Cost of Goods and Services Sold": "14,224",
"Depreciation, Depletion, Amortization": "6,127",
"General and Administrative Expense": "4,041",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "9,944",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "2,656",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,552",
"Other Liabilities": "0",
"Other Net Income": "17,237",
"Other Revenues": "5,092",
"Property Plant and Equipment": "53,267",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "74,535",
"Liabilities": "9,944",
"Expenses": "20,840",
"Revenues": "5,092",
"Stockholders Equity": "64,591",
"Net Income": "1,489",
"Comprehensive Net Income": "1,489",
"BaseVar": "63,824",
"ECR before LimitedLiability": "225%",
"Economic Capital Ratio": "256%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "15,956",
"Assets, Non-Current": "1,003",
"Cost of Goods and Services Sold": "10,118",
"Depreciation, Depletion, Amortization": "5,965",
"General and Administrative Expense": "4,045",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "9,653",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "2,687",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,703",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "17,238",
"Property Plant and Equipment": "53,677",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "73,323",
"Liabilities": "9,653",
"Expenses": "16,425",
"Revenues": "17,238",
"Stockholders Equity": "63,670",
"Net Income": "813",
"Comprehensive Net Income": "813",
"BaseVar": "58,320",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "255%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "14,247",
"Assets, Non-Current": "536",
"Cost of Goods and Services Sold": "10,138",
"Depreciation, Depletion, Amortization": "6,171",
"General and Administrative Expense": "3,630",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "16,251",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "2,709",
"Other Compr. Net Income": "52",
"Other Expenses": "-4,343",
"Other Liabilities": "0",
"Other Net Income": "-411",
"Other Revenues": "15,445",
"Property Plant and Equipment": "50,036",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "67,528",
"Liabilities": "16,251",
"Expenses": "15,596",
"Revenues": "15,445",
"Stockholders Equity": "51,277",
"Net Income": "-562",
"Comprehensive Net Income": "-510",
"BaseVar": "57,642",
"ECR before LimitedLiability": "176%",
"Economic Capital Ratio": "222%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "6,007",
"Assets, Non-Current": "984",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "8,698",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-946",
"Other Expenses": "434",
"Other Liabilities": "0",
"Other Net Income": "-142",
"Other Revenues": "0",
"Property Plant and Equipment": "47,123",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "54,114",
"Liabilities": "8,698",
"Expenses": "434",
"Revenues": "0",
"Stockholders Equity": "45,416",
"Net Income": "-576",
"Comprehensive Net Income": "-1,522",
"BaseVar": "32,167",
"ECR before LimitedLiability": "205%",
"Economic Capital Ratio": "241%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "8,388",
"Assets, Non-Current": "879",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "8,681",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-1,320",
"Other Expenses": "943",
"Other Liabilities": "0",
"Other Net Income": "3,193",
"Other Revenues": "0",
"Property Plant and Equipment": "51,331",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "60,598",
"Liabilities": "8,681",
"Expenses": "943",
"Revenues": "0",
"Stockholders Equity": "51,917",
"Net Income": "2,250",
"Comprehensive Net Income": "930",
"BaseVar": "37,368",
"ECR before LimitedLiability": "220%",
"Economic Capital Ratio": "252%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "10,742",
"Assets, Non-Current": "1,561",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "7,341",
"General and Administrative Expense": "4,060",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "8,214",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "7,790",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "20,621",
"Property Plant and Equipment": "41,480",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "53,783",
"Liabilities": "8,214",
"Expenses": "19,191",
"Revenues": "20,621",
"Stockholders Equity": "45,569",
"Net Income": "1,430",
"Comprehensive Net Income": "1,430",
"BaseVar": "50,904",
"ECR before LimitedLiability": "218%",
"Economic Capital Ratio": "250%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "10,850",
"Assets, Non-Current": "1,023",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "6,789",
"General and Administrative Expense": "4,608",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,343",
"Labor Expense": "0",
"Liabilities, Current": "12,380",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "19",
"Other Compr. Net Income": "0",
"Other Expenses": "5,902",
"Other Liabilities": "0",
"Other Net Income": "-8,264",
"Other Revenues": "17,847",
"Property Plant and Equipment": "30,418",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "43,653",
"Liabilities": "12,380",
"Expenses": "17,299",
"Revenues": "17,847",
"Stockholders Equity": "31,273",
"Net Income": "-7,716",
"Comprehensive Net Income": "-7,716",
"BaseVar": "49,722",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "194%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "15,087",
"Assets, Non-Current": "727",
"Cost of Goods and Services Sold": "10,902",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "4,531",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,343",
"Labor Expense": "0",
"Liabilities, Current": "5,891",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "28,273",
"Other Compr. Net Income": "0",
"Other Expenses": "1,008",
"Other Liabilities": "0",
"Other Net Income": "-509",
"Other Revenues": "17,628",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "45,430",
"Liabilities": "5,891",
"Expenses": "16,441",
"Revenues": "17,628",
"Stockholders Equity": "39,539",
"Net Income": "678",
"Comprehensive Net Income": "678",
"BaseVar": "42,950",
"ECR before LimitedLiability": "226%",
"Economic Capital Ratio": "256%"
}
}
},
"top_rated": true,
"trend": 16.0,
"value": 2.56254240137525,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000744825.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000744825.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000744825.svg"
},
{
"company_id": "0000860730",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000860730.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000860730.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000860730.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000860730_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000860730_main_keyfigs.svg",
"name": "HCA Healthcare Inc",
"rank": 11,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000860730.svg",
"report_text": "The relative strengths and weaknesses of HCA Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of HCA Healthcare Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 80% points.The greatest weakness of HCA Healthcare Inc is the variable Labor Expense, reducing the Economic Capital Ratio by 61% points.
The company's Economic Capital Ratio, given in the ranking table, is 253%, being 85% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000860730_2022_HCA_Healthcare_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "12.2",
"Assets": "48.2",
"Stockholders Equity": "92.0",
"ECR before LimitedLiability": "89.7",
"Property Plant and Equipment": "23.3",
"Assets, Current": "6.17",
"Intangible Assets": "-5.66",
"Expenses": "41.0",
"Net Income": "20.6",
"Other Expenses": "13.9",
"Operating Costs and Expenses": "3.90",
"Labor Expense": "6.13",
"General and Administrative Expense": "9.95",
"Cost of Goods and Services Sold": "3.89",
"Other Revenues": "-22.9",
"Revenues": "-22.9",
"Other Liabilities": "6.85",
"Long Term Liabilities": "21.3",
"Liabilities, Current": "-36.9",
"Comprehensive Net Income": "20.7",
"Economic Capital Ratio": "83.0"
},
"2012": {
"Property Plant and Equipment": "26.7",
"Assets": "52.6",
"Liabilities": "-3.43",
"Stockholders Equity": "88.5",
"ECR before LimitedLiability": "85.0",
"Intangible Assets": "-5.99",
"Assets, Current": "5.40",
"Other Assets": "14.1",
"Liabilities, Current": "-36.7",
"Long Term Liabilities": "16.1",
"Other Liabilities": "10.6",
"Expenses": "38.6",
"Revenues": "-21.8",
"Net Income": "15.7",
"Other Expenses": "11.3",
"General and Administrative Expense": "9.94",
"Cost of Goods and Services Sold": "3.90",
"Labor Expense": "6.26",
"Other Revenues": "-21.8",
"Comprehensive Net Income": "14.3",
"Economic Capital Ratio": "70.8"
},
"2013": {
"Other Assets": "12.4",
"Assets": "48.3",
"Liabilities": "7.02",
"Stockholders Equity": "95.9",
"ECR before LimitedLiability": "88.2",
"Property Plant and Equipment": "25.8",
"Assets, Current": "4.16",
"Intangible Assets": "-4.92",
"Other Liabilities": "9.90",
"Liabilities, Current": "-24.2",
"Long Term Liabilities": "17.6",
"Expenses": "37.3",
"Revenues": "-23.6",
"Net Income": "17.4",
"General and Administrative Expense": "10.7",
"Cost of Goods and Services Sold": "3.69",
"Labor Expense": "6.35",
"Other Expenses": "9.80",
"Other Revenues": "-23.6",
"Comprehensive Net Income": "16.6",
"Economic Capital Ratio": "79.0"
},
"2014": {
"Other Assets": "10.9",
"Assets": "47.5",
"Liabilities": "14.0",
"Stockholders Equity": "105",
"ECR before LimitedLiability": "105",
"Intangible Assets": "-4.54",
"Property Plant and Equipment": "21.8",
"Assets, Current": "6.10",
"Other Liabilities": "7.91",
"Liabilities, Current": "-19.1",
"Long Term Liabilities": "22.2",
"Expenses": "38.8",
"Revenues": "-23.5",
"Net Income": "18.7",
"Labor Expense": "7.10",
"Other Expenses": "8.79",
"Cost of Goods and Services Sold": "4.29",
"General and Administrative Expense": "10.4",
"Other Revenues": "-23.5",
"Comprehensive Net Income": "16.7",
"Economic Capital Ratio": "92.2"
},
"2015": {
"Assets, Current": "5.22",
"Assets": "46.3",
"Liabilities": "12.8",
"Stockholders Equity": "105",
"ECR before LimitedLiability": "104",
"Other Assets": "9.76",
"Property Plant and Equipment": "21.2",
"Long Term Liabilities": "16.7",
"Other Liabilities": "8.55",
"Liabilities, Current": "-14.1",
"Expenses": "39.5",
"Revenues": "-24.9",
"Net Income": "20.9",
"General and Administrative Expense": "10.5",
"Other Expenses": "8.99",
"Labor Expense": "6.46",
"Cost of Goods and Services Sold": "5.58",
"Other Revenues": "-24.9",
"Comprehensive Net Income": "19.3",
"Other Net Income": "4.29",
"Economic Capital Ratio": "91.1"
},
"2016": {
"Property Plant and Equipment": "23.6",
"Assets": "48.0",
"Liabilities": "18.1",
"Stockholders Equity": "112",
"ECR before LimitedLiability": "128",
"Intangible Assets": "-3.91",
"Other Assets": "9.55",
"Assets, Current": "4.65",
"Liabilities, Current": "-5.90",
"Other Liabilities": "9.76",
"Long Term Liabilities": "14.2",
"Expenses": "40.8",
"Revenues": "-27.2",
"Net Income": "24.2",
"General and Administrative Expense": "11.8",
"Other Expenses": "9.43",
"Cost of Goods and Services Sold": "8.11",
"Other Revenues": "-27.2",
"Other Net Income": "8.34",
"Comprehensive Net Income": "22.5",
"Economic Capital Ratio": "101"
},
"2017": {
"Other Assets": "9.69",
"Assets": "46.1",
"Liabilities": "16.9",
"Stockholders Equity": "107",
"ECR before LimitedLiability": "126",
"Intangible Assets": "-4.19",
"Property Plant and Equipment": "25.8",
"Liabilities, Current": "-8.86",
"Other Liabilities": "5.71",
"Long Term Liabilities": "19.2",
"General and Administrative Expense": "12.1",
"Expenses": "39.3",
"Revenues": "-22.6",
"Net Income": "21.4",
"Labor Expense": "3.70",
"Research And Development Expense": "3.71",
"Other Expenses": "9.43",
"Cost of Goods and Services Sold": "6.45",
"Other Revenues": "-22.6",
"Comprehensive Net Income": "20.0",
"Economic Capital Ratio": "102"
},
"2018": {
"Other Liabilities": "12.1",
"Liabilities": "74.1",
"Stockholders Equity": "33.4",
"ECR before LimitedLiability": "108",
"Liabilities, Current": "33.5",
"Long Term Liabilities": "40.2",
"Expenses": "-8.06",
"Revenues": "53.8",
"Net Income": "47.5",
"Operating Costs and Expenses": "-45.8",
"Other Expenses": "20.4",
"General and Administrative Expense": "27.6",
"Research And Development Expense": "7.90",
"Cost of Goods and Services Sold": "28.7",
"Labor Expense": "-56.7",
"Other Revenues": "53.8",
"Property Plant and Equipment": "19.6",
"Intangible Assets": "-8.70",
"Assets, Current": "-10.3",
"Comprehensive Net Income": "46.1",
"Economic Capital Ratio": "87.3"
},
"2019": {
"Other Liabilities": "16.1",
"Liabilities": "82.0",
"Stockholders Equity": "36.1",
"ECR before LimitedLiability": "98.7",
"Long Term Liabilities": "55.2",
"Liabilities, Current": "23.7",
"Other Expenses": "9.14",
"Expenses": "-15.0",
"Revenues": "50.4",
"Net Income": "37.0",
"General and Administrative Expense": "24.2",
"Cost of Goods and Services Sold": "31.4",
"Research And Development Expense": "9.73",
"Labor Expense": "-57.7",
"Operating Costs and Expenses": "-42.1",
"Other Revenues": "50.4",
"Property Plant and Equipment": "19.2",
"Intangible Assets": "-8.94",
"Assets, Current": "-9.28",
"Comprehensive Net Income": "35.5",
"Economic Capital Ratio": "88.6"
},
"2020": {
"Property Plant and Equipment": "21.6",
"Assets": "-6.28",
"Liabilities": "79.0",
"Stockholders Equity": "33.6",
"ECR before LimitedLiability": "99.7",
"Intangible Assets": "-9.18",
"Assets, Current": "-11.0",
"Liabilities, Current": "21.4",
"Other Liabilities": "12.1",
"Long Term Liabilities": "56.2",
"Labor Expense": "-55.0",
"Expenses": "-17.7",
"Revenues": "51.6",
"Net Income": "36.5",
"General and Administrative Expense": "27.8",
"Other Expenses": "10.5",
"Operating Costs and Expenses": "-39.4",
"Cost of Goods and Services Sold": "25.8",
"Other Revenues": "51.6",
"Comprehensive Net Income": "34.9",
"Economic Capital Ratio": "87.6"
},
"2021": {
"Assets": "-9.00",
"Liabilities": "80.1",
"Stockholders Equity": "16.1",
"ECR before LimitedLiability": "91.2",
"Intangible Assets": "-11.0",
"Property Plant and Equipment": "19.8",
"Assets, Current": "-11.2",
"Liabilities, Current": "16.1",
"Long Term Liabilities": "56.6",
"Other Liabilities": "19.4",
"General and Administrative Expense": "27.7",
"Expenses": "-20.5",
"Revenues": "62.0",
"Net Income": "46.2",
"Operating Costs and Expenses": "-39.8",
"Labor Expense": "-60.8",
"Cost of Goods and Services Sold": "22.7",
"Other Expenses": "12.2",
"Other Revenues": "62.0",
"Comprehensive Net Income": "44.9",
"Economic Capital Ratio": "85.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000860730_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "7,233,000",
"Assets, Non-Current": "742,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,554,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "6,089,000",
"Other Compr. Net Income": "0",
"Other Expenses": "719,000",
"Other Liabilities": "0",
"Other Net Income": "3,561,000",
"Other Revenues": "0",
"Property Plant and Equipment": "12,834,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "26,898,000",
"Liabilities": "5,554,000",
"Expenses": "719,000",
"Revenues": "0",
"Stockholders Equity": "21,344,000",
"Net Income": "2,842,000",
"Comprehensive Net Income": "2,842,000",
"BaseVar": "18,366,000",
"ECR before LimitedLiability": "208%",
"Economic Capital Ratio": "244%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "7,763,000",
"Assets, Non-Current": "783,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "6,172,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "6,344,000",
"Other Compr. Net Income": "-418,000",
"Other Expenses": "888,000",
"Other Liabilities": "0",
"Other Net Income": "2,894,000",
"Other Revenues": "0",
"Property Plant and Equipment": "13,185,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "28,075,000",
"Liabilities": "6,172,000",
"Expenses": "888,000",
"Revenues": "0",
"Stockholders Equity": "21,903,000",
"Net Income": "2,006,000",
"Comprehensive Net Income": "1,588,000",
"BaseVar": "19,223,500",
"ECR before LimitedLiability": "195%",
"Economic Capital Ratio": "234%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "8,037,000",
"Assets, Non-Current": "587,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,695,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "6,588,000",
"Other Compr. Net Income": "-240,000",
"Other Expenses": "950,000",
"Other Liabilities": "0",
"Other Net Income": "2,946,000",
"Other Revenues": "0",
"Property Plant and Equipment": "13,619,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "28,831,000",
"Liabilities": "5,695,000",
"Expenses": "950,000",
"Revenues": "0",
"Stockholders Equity": "23,136,000",
"Net Income": "1,996,000",
"Comprehensive Net Income": "1,756,000",
"BaseVar": "19,331,000",
"ECR before LimitedLiability": "205%",
"Economic Capital Ratio": "241%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "8,930,000",
"Assets, Non-Current": "785,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,480,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "7,129,000",
"Other Compr. Net Income": "-564,000",
"Other Expenses": "1,108,000",
"Other Liabilities": "0",
"Other Net Income": "3,481,000",
"Other Revenues": "0",
"Property Plant and Equipment": "14,355,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "31,199,000",
"Liabilities": "5,480,000",
"Expenses": "1,108,000",
"Revenues": "0",
"Stockholders Equity": "25,719,000",
"Net Income": "2,373,000",
"Comprehensive Net Income": "1,809,000",
"BaseVar": "20,916,000",
"ECR before LimitedLiability": "213%",
"Economic Capital Ratio": "247%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "9,232,000",
"Assets, Non-Current": "1,335,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,516,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "7,163,000",
"Other Compr. Net Income": "-509,000",
"Other Expenses": "1,261,000",
"Other Liabilities": "0",
"Other Net Income": "3,957,000",
"Other Revenues": "0",
"Property Plant and Equipment": "15,014,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "32,744,000",
"Liabilities": "5,516,000",
"Expenses": "1,261,000",
"Revenues": "0",
"Stockholders Equity": "27,228,000",
"Net Income": "2,696,000",
"Comprehensive Net Income": "2,187,000",
"BaseVar": "21,993,500",
"ECR before LimitedLiability": "218%",
"Economic Capital Ratio": "250%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "9,086,000",
"Assets, Non-Current": "1,280,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,834,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "7,040,000",
"Other Compr. Net Income": "-615,000",
"Other Expenses": "1,378,000",
"Other Liabilities": "0",
"Other Net Income": "4,810,000",
"Other Revenues": "0",
"Property Plant and Equipment": "16,352,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "33,758,000",
"Liabilities": "5,834,000",
"Expenses": "1,378,000",
"Revenues": "0",
"Stockholders Equity": "27,924,000",
"Net Income": "3,432,000",
"Comprehensive Net Income": "2,817,000",
"BaseVar": "23,197,500",
"ECR before LimitedLiability": "219%",
"Economic Capital Ratio": "251%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "9,977,000",
"Assets, Non-Current": "909,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "6,158,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "7,812,000",
"Other Compr. Net Income": "-467,000",
"Other Expenses": "1,638,000",
"Other Liabilities": "0",
"Other Net Income": "4,381,000",
"Other Revenues": "0",
"Property Plant and Equipment": "17,895,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "36,593,000",
"Liabilities": "6,158,000",
"Expenses": "1,638,000",
"Revenues": "0",
"Stockholders Equity": "30,435,000",
"Net Income": "2,743,000",
"Comprehensive Net Income": "2,276,000",
"BaseVar": "24,618,500",
"ECR before LimitedLiability": "217%",
"Economic Capital Ratio": "250%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "10,213,000",
"Assets, Non-Current": "922,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,278,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "21,425,000",
"Liabilities, Current": "7,569,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "16,332,000",
"Other Assets": "8,315,000",
"Other Compr. Net Income": "-610,000",
"Other Expenses": "2,253,000",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "46,677,000",
"Property Plant and Equipment": "19,757,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "39,207,000",
"Liabilities": "7,569,000",
"Expenses": "42,288,000",
"Revenues": "46,677,000",
"Stockholders Equity": "31,638,000",
"Net Income": "4,389,000",
"Comprehensive Net Income": "3,779,000",
"BaseVar": "68,175,500",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "247%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "11,196,000",
"Assets, Non-Current": "2,563,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,596,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "23,560,000",
"Liabilities, Current": "7,757,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "17,962,000",
"Other Assets": "8,584,000",
"Other Compr. Net Income": "-719,000",
"Other Expenses": "3,073,000",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "51,336,000",
"Property Plant and Equipment": "22,715,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "45,058,000",
"Liabilities": "7,757,000",
"Expenses": "47,191,000",
"Revenues": "51,336,000",
"Stockholders Equity": "37,301,000",
"Net Income": "4,145,000",
"Comprehensive Net Income": "3,426,000",
"BaseVar": "76,030,500",
"ECR before LimitedLiability": "218%",
"Economic Capital Ratio": "250%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "12,333,000",
"Assets, Non-Current": "2,992,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,721,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "23,874,000",
"Liabilities, Current": "8,704,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "17,676,000",
"Other Assets": "8,966,000",
"Other Compr. Net Income": "-675,000",
"Other Expenses": "2,875,000",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "51,533,000",
"Property Plant and Equipment": "23,199,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "47,490,000",
"Liabilities": "8,704,000",
"Expenses": "47,146,000",
"Revenues": "51,533,000",
"Stockholders Equity": "38,786,000",
"Net Income": "4,387,000",
"Comprehensive Net Income": "3,712,000",
"BaseVar": "77,774,000",
"ECR before LimitedLiability": "213%",
"Economic Capital Ratio": "247%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "13,542,000",
"Assets, Non-Current": "3,159,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,853,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "26,779,000",
"Liabilities, Current": "9,582,000",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "19,442,000",
"Other Assets": "9,978,000",
"Other Compr. Net Income": "-667,000",
"Other Expenses": "1,957,000",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "58,752,000",
"Property Plant and Equipment": "24,063,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "50,742,000",
"Liabilities": "9,582,000",
"Expenses": "51,031,000",
"Revenues": "58,752,000",
"Stockholders Equity": "41,160,000",
"Net Income": "7,721,000",
"Comprehensive Net Income": "7,054,000",
"BaseVar": "85,387,000",
"ECR before LimitedLiability": "221%",
"Economic Capital Ratio": "253%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.5282889214137985,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000860730.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000860730.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000860730.svg"
},
{
"company_id": "0001447362",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001447362.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001447362.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001447362.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001447362_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001447362_main_keyfigs.svg",
"name": "Castle Biosciences INC",
"rank": 12,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001447362.svg",
"report_text": "The relative strengths and weaknesses of Castle Biosciences INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Castle Biosciences INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 99% points.The greatest weakness of Castle Biosciences INC is the variable Other Revenues, reducing the Economic Capital Ratio by 11% points.
The company's Economic Capital Ratio, given in the ranking table, is 252%, being 84% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001447362_2022_Castle_Biosciences_INC.pdf",
"shrinked_graph_json": {
"2019": {
"Property Plant and Equipment": "-5.66",
"Assets": "20.9",
"Liabilities": "12.6",
"Stockholders Equity": "48.4",
"ECR before LimitedLiability": "64.0",
"Assets, Non-Current": "-6.07",
"Intangible Assets": "-8.88",
"Assets, Current": "90.4",
"Other Liabilities": "8.08",
"Long Term Liabilities": "-3.88",
"Liabilities, Current": "8.40",
"Other Expenses": "5.50",
"Expenses": "18.4",
"Net Income": "19.4",
"General and Administrative Expense": "-12.1",
"Cost of Goods and Services Sold": "11.4",
"Selling and Marketing Expense": "3.44",
"Labor Expense": "5.17",
"Operating Costs and Expenses": "4.44",
"Comprehensive Net Income": "19.6",
"Economic Capital Ratio": "54.0"
},
"2020": {
"Assets": "24.3",
"Stockholders Equity": "133",
"ECR before LimitedLiability": "131",
"Intangible Assets": "-2.26",
"Assets, Current": "58.0",
"Liabilities, Current": "22.2",
"Liabilities": "54.1",
"Other Liabilities": "4.48",
"Long Term Liabilities": "34.0",
"Labor Expense": "4.23",
"Expenses": "26.2",
"Revenues": "-17.6",
"Net Income": "10.2",
"Selling and Marketing Expense": "2.23",
"Research And Development Expense": "-1.41",
"Other Expenses": "8.69",
"Operating Costs and Expenses": "3.37",
"Cost of Goods and Services Sold": "10.2",
"Other Revenues": "-17.6",
"Comprehensive Net Income": "10.2",
"Economic Capital Ratio": "119"
},
"2021": {
"Other Assets": "9.01",
"Assets": "27.3",
"Liabilities": "40.8",
"Stockholders Equity": "98.7",
"ECR before LimitedLiability": "90.6",
"Intangible Assets": "-6.26",
"Assets, Current": "35.4",
"Liabilities, Current": "18.2",
"Long Term Liabilities": "27.6",
"General and Administrative Expense": "-9.61",
"Expenses": "15.5",
"Revenues": "-10.8",
"Net Income": "6.59",
"Operating Costs and Expenses": "4.03",
"Labor Expense": "3.50",
"Cost of Goods and Services Sold": "7.31",
"Research And Development Expense": "-4.56",
"Other Expenses": "10.3",
"Other Revenues": "-10.8",
"Comprehensive Net Income": "6.66",
"Economic Capital Ratio": "84.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001447362_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "116,681",
"Assets, Non-Current": "135",
"Cost of Goods and Services Sold": "7,310",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "29,842",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "15,289",
"Long Term Liabilities": "19,289",
"Operating Costs and Expenses": "0",
"Other Assets": "870",
"Other Compr. Net Income": "0",
"Other Expenses": "4,643",
"Other Liabilities": "55",
"Other Net Income": "2,592",
"Other Revenues": "51,865",
"Property Plant and Equipment": "2,060",
"Research And Development Expense": "7,385",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "119,746",
"Liabilities": "34,633",
"Expenses": "49,180",
"Revenues": "51,865",
"Stockholders Equity": "85,113",
"Net Income": "5,277",
"Comprehensive Net Income": "5,277",
"BaseVar": "129,008",
"ECR before LimitedLiability": "167%",
"Economic Capital Ratio": "216%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "429,594",
"Assets, Non-Current": "1,536",
"Cost of Goods and Services Sold": "9,685",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "48,132",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "20,876",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,096",
"Other Compr. Net Income": "0",
"Other Expenses": "836",
"Other Liabilities": "2,761",
"Other Net Income": "-1,024",
"Other Revenues": "62,649",
"Property Plant and Equipment": "7,102",
"Research And Development Expense": "13,256",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "439,328",
"Liabilities": "23,637",
"Expenses": "71,909",
"Revenues": "62,649",
"Stockholders Equity": "415,691",
"Net Income": "-10,284",
"Comprehensive Net Income": "-10,284",
"BaseVar": "299,274",
"ECR before LimitedLiability": "256%",
"Economic Capital Ratio": "278%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "353,743",
"Assets, Non-Current": "9,098",
"Cost of Goods and Services Sold": "15,822",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "86,738",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "25,521",
"Long Term Liabilities": "7,024",
"Operating Costs and Expenses": "0",
"Other Assets": "90,230",
"Other Compr. Net Income": "0",
"Other Expenses": "-6,761",
"Other Liabilities": "18,287",
"Other Net Income": "68",
"Other Revenues": "94,085",
"Property Plant and Equipment": "9,501",
"Research And Development Expense": "29,646",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "462,572",
"Liabilities": "50,832",
"Expenses": "125,445",
"Revenues": "94,085",
"Stockholders Equity": "411,740",
"Net Income": "-31,292",
"Comprehensive Net Income": "-31,292",
"BaseVar": "366,501",
"ECR before LimitedLiability": "220%",
"Economic Capital Ratio": "252%"
}
}
},
"top_rated": true,
"trend": -10.0,
"value": 2.522093830360737,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001447362.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001447362.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001447362.svg"
},
{
"company_id": "0001534969",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001534969.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001534969.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001534969_main_keyfigs.svg",
"name": "SERA Prognostics INC",
"rank": 13,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001534969.svg",
"report_text": "The relative strengths and weaknesses of SERA Prognostics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of SERA Prognostics INC compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 130% points.The greatest weakness of SERA Prognostics INC is the variable Other Revenues, reducing the Economic Capital Ratio by 33% points.
The company's Economic Capital Ratio, given in the ranking table, is 247%, being 79% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001534969_2022_SERA_Prognostics_INC.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "13.8",
"Assets": "47.3",
"Liabilities": "43.5",
"Stockholders Equity": "130",
"ECR before LimitedLiability": "85.5",
"Intangible Assets": "-6.02",
"Assets, Current": "47.8",
"Liabilities, Current": "12.2",
"Long Term Liabilities": "27.2",
"Other Liabilities": "8.53",
"Expenses": "10.5",
"Revenues": "-32.7",
"Net Income": "-18.8",
"Operating Costs and Expenses": "3.47",
"Cost of Goods and Services Sold": "9.96",
"Research And Development Expense": "-6.84",
"Other Expenses": "6.58",
"Selling and Marketing Expense": "-6.94",
"Other Revenues": "-32.7",
"Comprehensive Net Income": "-18.9",
"Economic Capital Ratio": "79.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001534969_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "110,251",
"Assets, Non-Current": "157",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "14,093",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "8,411",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "34,848",
"Other Compr. Net Income": "-183",
"Other Expenses": "783",
"Other Liabilities": "54",
"Other Net Income": "1,132",
"Other Revenues": "82",
"Property Plant and Equipment": "1,773",
"Research And Development Expense": "11,019",
"Selling and Marketing Expense": "10,328"
},
"output_variables": {
"Assets": "147,029",
"Liabilities": "8,465",
"Expenses": "36,223",
"Revenues": "82",
"Stockholders Equity": "138,564",
"Net Income": "-35,009",
"Comprehensive Net Income": "-35,192",
"BaseVar": "96,557",
"ECR before LimitedLiability": "213%",
"Economic Capital Ratio": "247%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.471288851504111,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001534969.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001534969.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001534969.svg"
},
{
"company_id": "0001729149",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001729149.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001729149.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001729149.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001729149_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001729149_main_keyfigs.svg",
"name": "Viemed Healthcare INC",
"rank": 14,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001729149.svg",
"report_text": "The relative strengths and weaknesses of Viemed Healthcare INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Viemed Healthcare INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 70% points.The greatest weakness of Viemed Healthcare INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 29% points.
The company's Economic Capital Ratio, given in the ranking table, is 244%, being 76% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001729149_2022_Viemed_Healthcare_INC.pdf",
"shrinked_graph_json": {
"2019": {
"Property Plant and Equipment": "65.4",
"Assets": "-9.54",
"Liabilities": "11.1",
"Stockholders Equity": "-9.57",
"ECR before LimitedLiability": "31.8",
"Assets, Non-Current": "68.6",
"Other Assets": "-37.5",
"Intangible Assets": "-16.2",
"Assets, Current": "-11.3",
"Other Liabilities": "15.2",
"Long Term Liabilities": "12.0",
"Liabilities, Current": "-17.4",
"Other Revenues": "27.5",
"Revenues": "27.5",
"Net Income": "31.8",
"Other Expenses": "8.12",
"Comprehensive Net Income": "31.8",
"General and Administrative Expense": "-26.9",
"Research And Development Expense": "6.53",
"Labor Expense": "7.25",
"Economic Capital Ratio": "21.8"
},
"2020": {
"Property Plant and Equipment": "20.1",
"Assets": "-8.11",
"Liabilities": "62.5",
"Stockholders Equity": "12.9",
"ECR before LimitedLiability": "96.5",
"Other Assets": "-17.7",
"Intangible Assets": "-9.44",
"Assets, Non-Current": "28.1",
"Liabilities, Current": "17.7",
"Other Liabilities": "11.6",
"Long Term Liabilities": "41.1",
"Other Revenues": "53.1",
"Revenues": "53.1",
"Net Income": "54.4",
"Other Net Income": "6.81",
"Comprehensive Net Income": "54.1",
"Labor Expense": "8.00",
"General and Administrative Expense": "-24.1",
"Other Expenses": "16.4",
"Cost of Goods and Services Sold": "-24.6",
"Economic Capital Ratio": "84.4"
},
"2021": {
"Other Assets": "-18.9",
"Assets": "-7.51",
"Liabilities": "69.8",
"Stockholders Equity": "22.2",
"ECR before LimitedLiability": "82.0",
"Intangible Assets": "-12.1",
"Property Plant and Equipment": "29.4",
"Assets, Non-Current": "35.5",
"Assets, Current": "-7.25",
"Liabilities, Current": "20.7",
"Long Term Liabilities": "42.2",
"Other Liabilities": "17.3",
"General and Administrative Expense": "-29.0",
"Expenses": "-17.8",
"Revenues": "47.3",
"Net Income": "35.3",
"Operating Costs and Expenses": "7.23",
"Cost of Goods and Services Sold": "-22.4",
"Other Revenues": "47.3",
"Comprehensive Net Income": "35.5",
"Economic Capital Ratio": "75.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001729149_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "27,811",
"Assets, Non-Current": "54,785",
"Cost of Goods and Services Sold": "24,250",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "41,381",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "28,229",
"Long Term Liabilities": "12,985",
"Operating Costs and Expenses": "0",
"Other Assets": "-54,772",
"Other Compr. Net Income": "-157",
"Other Expenses": "4,578",
"Other Liabilities": "-2,317",
"Other Net Income": "-674",
"Other Revenues": "80,256",
"Property Plant and Equipment": "54,772",
"Research And Development Expense": "848",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "82,596",
"Liabilities": "38,897",
"Expenses": "71,057",
"Revenues": "80,256",
"Stockholders Equity": "43,699",
"Net Income": "8,525",
"Comprehensive Net Income": "8,368",
"BaseVar": "136,818",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "184%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "47,175",
"Assets, Non-Current": "65,385",
"Cost of Goods and Services Sold": "51,198",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "52,829",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "23,017",
"Long Term Liabilities": "7,850",
"Operating Costs and Expenses": "0",
"Other Assets": "-55,056",
"Other Compr. Net Income": "-294",
"Other Expenses": "531",
"Other Liabilities": "0",
"Other Net Income": "5,862",
"Other Revenues": "131,309",
"Property Plant and Equipment": "55,056",
"Research And Development Expense": "1,083",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "112,560",
"Liabilities": "30,867",
"Expenses": "105,641",
"Revenues": "131,309",
"Stockholders Equity": "81,693",
"Net Income": "31,530",
"Comprehensive Net Income": "31,236",
"BaseVar": "193,266",
"ECR before LimitedLiability": "209%",
"Economic Capital Ratio": "244%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "47,310",
"Assets, Non-Current": "70,652",
"Cost of Goods and Services Sold": "43,652",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "54,893",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "17,811",
"Long Term Liabilities": "5,331",
"Operating Costs and Expenses": "0",
"Other Assets": "-62,846",
"Other Compr. Net Income": "173",
"Other Expenses": "9,378",
"Other Liabilities": "0",
"Other Net Income": "2,097",
"Other Revenues": "117,062",
"Property Plant and Equipment": "62,846",
"Research And Development Expense": "2,110",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "117,962",
"Liabilities": "23,142",
"Expenses": "110,033",
"Revenues": "117,062",
"Stockholders Equity": "94,820",
"Net Income": "9,126",
"Comprehensive Net Income": "9,299",
"BaseVar": "185,234",
"ECR before LimitedLiability": "208%",
"Economic Capital Ratio": "244%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.435793064184313,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001729149.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001729149.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001729149.svg"
},
{
"company_id": "0000320017",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000320017.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000320017.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000320017.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000320017_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000320017_main_keyfigs.svg",
"name": "Lisata Therapeutics INC",
"rank": 15,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000320017.svg",
"report_text": "The relative strengths and weaknesses of Lisata Therapeutics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Lisata Therapeutics INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 150% points.The greatest weakness of Lisata Therapeutics INC is the variable Other Revenues, reducing the Economic Capital Ratio by 33% points.
The company's Economic Capital Ratio, given in the ranking table, is 243%, being 75% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000320017_2022_Lisata_Therapeutics_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "17.3",
"Stockholders Equity": "12.2",
"ECR before LimitedLiability": "-13.7",
"Property Plant and Equipment": "10.7",
"Intangible Assets": "13.3",
"Other Liabilities": "9.47",
"Liabilities": "-8.98",
"Long Term Liabilities": "-10.5",
"Liabilities, Current": "-8.21",
"Other Revenues": "9.29",
"Revenues": "9.29",
"Net Income": "-21.7",
"Comprehensive Net Income": "-21.5",
"Other Net Income": "-27.4",
"Other Expenses": "35.9",
"Goodwill Impairment Loss": "-11.8",
"Operating Costs and Expenses": "7.75",
"Labor Expense": "12.3",
"General and Administrative Expense": "-9.88",
"Cost of Goods and Services Sold": "-30.1",
"Economic Capital Ratio": "-20.3"
},
"2017": {
"Assets": "11.1",
"Stockholders Equity": "78.1",
"ECR before LimitedLiability": "150",
"Intangible Assets": "-3.52",
"Assets, Current": "34.8",
"Liabilities, Current": "21.5",
"Liabilities": "40.7",
"Other Liabilities": "9.58",
"Long Term Liabilities": "14.1",
"Expenses": "40.2",
"Revenues": "-36.8",
"Net Income": "59.5",
"Labor Expense": "5.89",
"Selling and Marketing Expense": "4.46",
"Research And Development Expense": "-26.1",
"Other Expenses": "43.8",
"Cost of Goods and Services Sold": "10.2",
"Other Revenues": "-36.8",
"Other Net Income": "52.9",
"Comprehensive Net Income": "60.8",
"Economic Capital Ratio": "126"
},
"2018": {
"Assets": "76.5",
"Liabilities": "18.2",
"Stockholders Equity": "111",
"ECR before LimitedLiability": "64.6",
"Property Plant and Equipment": "-5.88",
"Intangible Assets": "-7.51",
"Assets, Current": "136",
"Other Liabilities": "4.76",
"Liabilities, Current": "4.71",
"Long Term Liabilities": "9.31",
"Expenses": "8.20",
"Revenues": "-36.6",
"Net Income": "-25.4",
"Other Expenses": "12.1",
"General and Administrative Expense": "-11.5",
"Research And Development Expense": "-15.9",
"Cost of Goods and Services Sold": "13.0",
"Labor Expense": "4.98",
"Other Revenues": "-36.6",
"Comprehensive Net Income": "-25.3",
"Economic Capital Ratio": "43.9"
},
"2019": {
"Property Plant and Equipment": "-13.3",
"Assets": "55.7",
"Liabilities": "17.4",
"Stockholders Equity": "56.9",
"ECR before LimitedLiability": "-8.94",
"Assets, Non-Current": "-7.90",
"Intangible Assets": "-18.3",
"Assets, Current": "102",
"Other Liabilities": "7.47",
"Long Term Liabilities": "24.3",
"Liabilities, Current": "-15.2",
"Other Expenses": "11.3",
"Expenses": "-22.8",
"Revenues": "-48.2",
"Net Income": "-65.1",
"General and Administrative Expense": "-26.3",
"Cost of Goods and Services Sold": "21.6",
"Research And Development Expense": "-40.8",
"Other Revenues": "-48.2",
"Comprehensive Net Income": "-64.9",
"Economic Capital Ratio": "-19.0"
},
"2020": {
"Property Plant and Equipment": "-3.17",
"Assets": "58.6",
"Liabilities": "30.8",
"Stockholders Equity": "123",
"ECR before LimitedLiability": "86.4",
"Intangible Assets": "-5.36",
"Assets, Current": "147",
"Liabilities, Current": "2.86",
"Other Liabilities": "5.10",
"Long Term Liabilities": "24.2",
"Labor Expense": "3.54",
"Expenses": "14.1",
"Revenues": "-32.8",
"Net Income": "-16.6",
"General and Administrative Expense": "-22.1",
"Research And Development Expense": "-30.1",
"Other Expenses": "43.7",
"Cost of Goods and Services Sold": "11.2",
"Other Revenues": "-32.8",
"Comprehensive Net Income": "-16.7",
"Economic Capital Ratio": "74.4"
},
"2021": {
"Assets": "49.3",
"Stockholders Equity": "132",
"ECR before LimitedLiability": "81.6",
"Intangible Assets": "-6.53",
"Assets, Current": "150",
"Liabilities, Current": "15.6",
"Liabilities": "45.4",
"Long Term Liabilities": "25.9",
"Other Liabilities": "8.67",
"General and Administrative Expense": "-2.87",
"Expenses": "6.41",
"Revenues": "-33.3",
"Net Income": "-24.8",
"Operating Costs and Expenses": "3.51",
"Labor Expense": "3.05",
"Cost of Goods and Services Sold": "10.1",
"Research And Development Expense": "-21.4",
"Other Expenses": "9.38",
"Other Revenues": "-33.3",
"Comprehensive Net Income": "-24.8",
"Economic Capital Ratio": "75.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000320017_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "38,610",
"Assets, Non-Current": "5,936",
"Cost of Goods and Services Sold": "55,974",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "41,845",
"Goodwill Impairment Loss": "19,433",
"Intangible Assets": "56,546",
"Labor Expense": "0",
"Liabilities, Current": "36,445",
"Long Term Liabilities": "33,938",
"Operating Costs and Expenses": "0",
"Other Assets": "4,872",
"Other Compr. Net Income": "0",
"Other Expenses": "393",
"Other Liabilities": "0",
"Other Net Income": "-1,653",
"Other Revenues": "73,718",
"Property Plant and Equipment": "49,363",
"Research And Development Expense": "11,003",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "155,328",
"Liabilities": "70,384",
"Expenses": "128,648",
"Revenues": "73,718",
"Stockholders Equity": "84,944",
"Net Income": "-56,583",
"Comprehensive Net Income": "-56,583",
"BaseVar": "214,865",
"ECR before LimitedLiability": "59%",
"Economic Capital Ratio": "140%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "61,110",
"Assets, Non-Current": "1,434",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "11,750",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "9,313",
"Long Term Liabilities": "3,873",
"Operating Costs and Expenses": "0",
"Other Assets": "575",
"Other Compr. Net Income": "723",
"Other Expenses": "-11,527",
"Other Liabilities": "0",
"Other Net Income": "38,295",
"Other Revenues": "0",
"Property Plant and Equipment": "257",
"Research And Development Expense": "15,843",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "63,376",
"Liabilities": "13,186",
"Expenses": "16,066",
"Revenues": "0",
"Stockholders Equity": "50,190",
"Net Income": "22,228",
"Comprehensive Net Income": "22,951",
"BaseVar": "65,823",
"ECR before LimitedLiability": "250%",
"Economic Capital Ratio": "274%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "44,106",
"Assets, Non-Current": "309",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "9,393",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,619",
"Long Term Liabilities": "1,507",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-3.0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "819",
"Other Revenues": "0",
"Property Plant and Equipment": "165",
"Research And Development Expense": "7,594",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "44,580",
"Liabilities": "7,126",
"Expenses": "16,987",
"Revenues": "0",
"Stockholders Equity": "37,454",
"Net Income": "-16,168",
"Comprehensive Net Income": "-16,171",
"BaseVar": "34,758",
"ECR before LimitedLiability": "148%",
"Economic Capital Ratio": "203%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "25,972",
"Assets, Non-Current": "1,081",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "9,295",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,976",
"Long Term Liabilities": "624",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "25",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "740",
"Other Revenues": "0",
"Property Plant and Equipment": "100",
"Research And Development Expense": "10,797",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "27,153",
"Liabilities": "6,600",
"Expenses": "20,092",
"Revenues": "0",
"Stockholders Equity": "20,553",
"Net Income": "-19,352",
"Comprehensive Net Income": "-19,327",
"BaseVar": "27,305",
"ECR before LimitedLiability": "62%",
"Economic Capital Ratio": "143%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "35,331",
"Assets, Non-Current": "614",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "9,892",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,506",
"Long Term Liabilities": "254",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-24",
"Other Expenses": "-10,872",
"Other Liabilities": "0",
"Other Net Income": "132",
"Other Revenues": "0",
"Property Plant and Equipment": "57",
"Research And Development Expense": "9,253",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "36,002",
"Liabilities": "3,760",
"Expenses": "8,273",
"Revenues": "0",
"Stockholders Equity": "32,242",
"Net Income": "-8,141",
"Comprehensive Net Income": "-8,165",
"BaseVar": "24,096",
"ECR before LimitedLiability": "194%",
"Economic Capital Ratio": "234%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "96,182",
"Assets, Non-Current": "764",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "11,370",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,523",
"Long Term Liabilities": "485",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-57",
"Other Expenses": "-1,508",
"Other Liabilities": "0",
"Other Net Income": "76",
"Other Revenues": "0",
"Property Plant and Equipment": "62",
"Research And Development Expense": "17,680",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "97,008",
"Liabilities": "5,008",
"Expenses": "27,542",
"Revenues": "0",
"Stockholders Equity": "92,000",
"Net Income": "-27,466",
"Comprehensive Net Income": "-27,523",
"BaseVar": "64,846",
"ECR before LimitedLiability": "208%",
"Economic Capital Ratio": "243%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.432422142867397,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000320017.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000320017.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000320017.svg"
},
{
"company_id": "0001418115",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001418115.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001418115.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001418115.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001418115_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001418115_main_keyfigs.svg",
"name": "Healthcare Solutions Management Group Inc",
"rank": 16,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001418115.svg",
"report_text": "The relative strengths and weaknesses of Healthcare Solutions Management Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Healthcare Solutions Management Group Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 102% points.The greatest weakness of Healthcare Solutions Management Group Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 30% points.
The company's Economic Capital Ratio, given in the ranking table, is 243%, being 75% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001418115_2022_Healthcare_Solutions_Management_Group_Inc.pdf",
"shrinked_graph_json": {
"2013": {
"Other Assets": "-4.26",
"Assets": "-37.8",
"Liabilities": "-11.8",
"Stockholders Equity": "-48.3",
"ECR before LimitedLiability": "-115",
"Property Plant and Equipment": "20.3",
"Assets, Current": "-29.7",
"Intangible Assets": "-23.4",
"Assets, Non-Current": "-5.16",
"Liabilities, Current": "-9.12",
"Goodwill Impairment Loss": "-32.3",
"Expenses": "-18.8",
"Revenues": "-6.54",
"Net Income": "-33.5",
"General and Administrative Expense": "8.56",
"Labor Expense": "5.19",
"Other Expenses": "-9.77",
"Other Revenues": "-6.54",
"Comprehensive Net Income": "-33.4",
"Other Net Income": "-8.28",
"Economic Capital Ratio": "-124"
},
"2021": {
"Assets": "42.5",
"Stockholders Equity": "97.0",
"ECR before LimitedLiability": "81.1",
"Intangible Assets": "-6.02",
"Assets, Current": "102",
"Liabilities, Current": "-18.8",
"Liabilities": "17.0",
"Long Term Liabilities": "24.8",
"Other Liabilities": "7.84",
"General and Administrative Expense": "11.2",
"Expenses": "26.7",
"Revenues": "-29.9",
"Net Income": "8.34",
"Operating Costs and Expenses": "3.17",
"Cost of Goods and Services Sold": "9.13",
"Research And Development Expense": "2.85",
"Other Expenses": "-5.44",
"Other Revenues": "-29.9",
"Comprehensive Net Income": "8.40",
"Other Net Income": "9.61",
"Economic Capital Ratio": "74.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001418115_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "974",
"Assets, Non-Current": "20",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "5,944",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,008",
"Long Term Liabilities": "2,442",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3,930",
"Other Liabilities": "0",
"Other Net Income": "10",
"Other Revenues": "2,411",
"Property Plant and Equipment": "3,454",
"Research And Development Expense": "36",
"Selling and Marketing Expense": "105"
},
"output_variables": {
"Assets": "4,448",
"Liabilities": "7,450",
"Expenses": "10,015",
"Revenues": "2,411",
"Stockholders Equity": "-3,003",
"Net Income": "-7,593",
"Comprehensive Net Income": "-7,593",
"BaseVar": "12,167",
"ECR before LimitedLiability": "-201%",
"Economic Capital Ratio": "38%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "91,308",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "14,475",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,821",
"Other Compr. Net Income": "0",
"Other Expenses": "9,439",
"Other Liabilities": "0",
"Other Net Income": "6,651",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "93,129",
"Liabilities": "14,475",
"Expenses": "9,439",
"Revenues": "0",
"Stockholders Equity": "78,655",
"Net Income": "-2,788",
"Comprehensive Net Income": "-2,788",
"BaseVar": "61,847",
"ECR before LimitedLiability": "207%",
"Economic Capital Ratio": "243%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.4270817220085292,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001418115.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001418115.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001418115.svg"
},
{
"company_id": "0001089815",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001089815.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001089815.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001089815.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001089815_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001089815_main_keyfigs.svg",
"name": "Elite Health Systems Inc",
"rank": 17,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001089815.svg",
"report_text": "The relative strengths and weaknesses of Elite Health Systems Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Elite Health Systems Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 92% points.The greatest weakness of Elite Health Systems Inc is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 20% points.
The company's Economic Capital Ratio, given in the ranking table, is 241%, being 74% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001089815_2022_Elite_Health_Systems_Inc.pdf",
"shrinked_graph_json": {
"2012": {
"Property Plant and Equipment": "-16.2",
"Assets": "15.7",
"Liabilities": "-39.9",
"Stockholders Equity": "-8.30",
"ECR before LimitedLiability": "12.6",
"Intangible Assets": "-18.2",
"Assets, Current": "76.9",
"Liabilities, Current": "-69.9",
"Long Term Liabilities": "20.1",
"Research And Development Expense": "2.37",
"Expenses": "29.5",
"Revenues": "-31.2",
"Net Income": "26.3",
"Other Expenses": "2.06",
"General and Administrative Expense": "-2.13",
"Operating Costs and Expenses": "4.72",
"Cost of Goods and Services Sold": "6.14",
"Labor Expense": "9.96",
"Other Revenues": "-31.2",
"Other Net Income": "32.2",
"Comprehensive Net Income": "26.6",
"Economic Capital Ratio": "-1.57"
},
"2013": {
"Assets": "81.0",
"Liabilities": "-11.1",
"Stockholders Equity": "70.4",
"ECR before LimitedLiability": "17.3",
"Property Plant and Equipment": "-11.4",
"Assets, Current": "89.0",
"Intangible Assets": "-12.1",
"Assets, Non-Current": "14.5",
"Other Liabilities": "9.08",
"Liabilities, Current": "-40.8",
"Long Term Liabilities": "16.4",
"Expenses": "15.4",
"Revenues": "-25.1",
"Net Income": "-22.3",
"General and Administrative Expense": "-36.8",
"Labor Expense": "7.37",
"Other Expenses": "35.8",
"Other Revenues": "-25.1",
"Comprehensive Net Income": "-22.1",
"Other Net Income": "-11.7",
"Economic Capital Ratio": "8.14"
},
"2014": {
"Other Assets": "-5.48",
"Assets": "28.7",
"Liabilities": "-58.0",
"Stockholders Equity": "-15.5",
"ECR before LimitedLiability": "-6.67",
"Intangible Assets": "-18.9",
"Property Plant and Equipment": "53.2",
"Assets, Current": "-9.84",
"Liabilities, Current": "10.8",
"Long Term Liabilities": "-66.0",
"Expenses": "38.0",
"Revenues": "-30.5",
"Net Income": "22.7",
"Operating Costs and Expenses": "4.83",
"Labor Expense": "10.5",
"Other Expenses": "4.73",
"Cost of Goods and Services Sold": "6.28",
"Other Revenues": "-30.5",
"Comprehensive Net Income": "22.8",
"Other Net Income": "20.2",
"Economic Capital Ratio": "-19.8"
},
"2015": {
"Assets, Current": "-7.32",
"Assets": "25.5",
"Liabilities": "-51.1",
"Stockholders Equity": "-11.6",
"ECR before LimitedLiability": "-4.56",
"Intangible Assets": "-17.9",
"Property Plant and Equipment": "56.2",
"Long Term Liabilities": "-52.7",
"Other Liabilities": "-8.40",
"Liabilities, Current": "9.44",
"Selling and Marketing Expense": "4.23",
"Expenses": "32.8",
"Revenues": "-32.8",
"Net Income": "23.1",
"Operating Costs and Expenses": "4.09",
"Labor Expense": "9.74",
"Cost of Goods and Services Sold": "8.37",
"Other Revenues": "-32.8",
"Comprehensive Net Income": "23.4",
"Other Net Income": "28.3",
"Economic Capital Ratio": "-17.0"
},
"2016": {
"Property Plant and Equipment": "61.2",
"Assets": "31.5",
"Liabilities": "-38.6",
"Stockholders Equity": "3.75",
"ECR before LimitedLiability": "26.0",
"Intangible Assets": "-16.2",
"Other Assets": "-3.56",
"Assets, Current": "5.00",
"Liabilities, Current": "16.0",
"Other Liabilities": "-79.9",
"Long Term Liabilities": "14.9",
"Expenses": "32.4",
"Revenues": "-34.7",
"Net Income": "25.6",
"Selling and Marketing Expense": "4.82",
"Labor Expense": "5.07",
"Cost of Goods and Services Sold": "12.0",
"Research And Development Expense": "4.27",
"Other Revenues": "-34.7",
"Other Net Income": "33.7",
"Comprehensive Net Income": "26.2",
"Economic Capital Ratio": "-1.72"
},
"2017": {
"Other Assets": "-4.04",
"Assets": "28.9",
"Liabilities": "-32.0",
"Stockholders Equity": "10.3",
"ECR before LimitedLiability": "39.0",
"Intangible Assets": "-14.6",
"Assets, Current": "17.8",
"Property Plant and Equipment": "39.9",
"Liabilities, Current": "6.91",
"Other Liabilities": "-68.0",
"Long Term Liabilities": "20.2",
"Expenses": "31.4",
"Revenues": "-28.0",
"Net Income": "24.8",
"Labor Expense": "5.02",
"Research And Development Expense": "5.03",
"Cost of Goods and Services Sold": "8.85",
"Other Revenues": "-28.0",
"Other Net Income": "24.7",
"Comprehensive Net Income": "24.9",
"Economic Capital Ratio": "14.9"
},
"2018": {
"Other Assets": "-6.66",
"Assets": "14.1",
"Liabilities": "-20.0",
"ECR before LimitedLiability": "21.0",
"Property Plant and Equipment": "-12.5",
"Intangible Assets": "-15.2",
"Assets, Non-Current": "35.6",
"Assets, Current": "30.4",
"Other Liabilities": "-34.6",
"Liabilities, Current": "-9.77",
"Long Term Liabilities": "21.9",
"Selling and Marketing Expense": "3.43",
"Expenses": "27.0",
"Net Income": "17.4",
"Operating Costs and Expenses": "3.65",
"Other Expenses": "-12.1",
"Research And Development Expense": "5.18",
"Cost of Goods and Services Sold": "19.8",
"Labor Expense": "7.44",
"Comprehensive Net Income": "17.7",
"Other Net Income": "-8.83",
"Economic Capital Ratio": "0.229"
},
"2019": {
"Property Plant and Equipment": "-7.62",
"Assets": "8.30",
"Liabilities": "10.3",
"Stockholders Equity": "22.2",
"ECR before LimitedLiability": "45.0",
"Assets, Non-Current": "34.0",
"Intangible Assets": "-12.3",
"Assets, Current": "11.9",
"Long Term Liabilities": "29.7",
"Liabilities, Current": "-29.0",
"Expenses": "38.8",
"Revenues": "9.48",
"Net Income": "20.3",
"General and Administrative Expense": "-8.22",
"Cost of Goods and Services Sold": "20.8",
"Research And Development Expense": "6.19",
"Labor Expense": "5.98",
"Other Revenues": "9.48",
"Comprehensive Net Income": "20.5",
"Other Net Income": "-26.4",
"Economic Capital Ratio": "35.0"
},
"2020": {
"Liabilities, Current": "33.7",
"Liabilities": "80.0",
"Stockholders Equity": "73.0",
"ECR before LimitedLiability": "128",
"Other Liabilities": "10.8",
"Long Term Liabilities": "50.2",
"Labor Expense": "7.37",
"Expenses": "26.2",
"Revenues": "37.2",
"Net Income": "39.1",
"General and Administrative Expense": "-13.6",
"Research And Development Expense": "5.14",
"Other Expenses": "-7.20",
"Operating Costs and Expenses": "5.87",
"Cost of Goods and Services Sold": "22.9",
"Other Revenues": "37.2",
"Assets, Current": "9.72",
"Assets, Non-Current": "5.07",
"Other Net Income": "-25.9",
"Comprehensive Net Income": "39.1",
"Economic Capital Ratio": "116"
},
"2021": {
"Other Assets": "-6.12",
"Assets": "21.6",
"Liabilities": "52.0",
"Stockholders Equity": "91.5",
"ECR before LimitedLiability": "79.9",
"Intangible Assets": "-5.02",
"Assets, Non-Current": "23.0",
"Assets, Current": "18.5",
"Liabilities, Current": "13.8",
"Long Term Liabilities": "33.4",
"Other Liabilities": "10.5",
"General and Administrative Expense": "-20.0",
"Expenses": "14.6",
"Revenues": "-5.90",
"Net Income": "-5.32",
"Operating Costs and Expenses": "4.66",
"Cost of Goods and Services Sold": "13.4",
"Other Revenues": "-5.90",
"Comprehensive Net Income": "-5.24",
"Other Net Income": "-14.5",
"Economic Capital Ratio": "73.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001089815_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "5,047",
"Assets, Non-Current": "246",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,034",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,863",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,236",
"Other Liabilities": "362",
"Other Net Income": "2,999",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,293",
"Liabilities": "3,225",
"Expenses": "2,270",
"Revenues": "0",
"Stockholders Equity": "2,068",
"Net Income": "729",
"Comprehensive Net Income": "729",
"BaseVar": "6,894",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "162%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "1,760",
"Assets, Non-Current": "320",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "994",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "679",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-347",
"Other Liabilities": "0",
"Other Net Income": "-20",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,080",
"Liabilities": "679",
"Expenses": "647",
"Revenues": "0",
"Stockholders Equity": "1,401",
"Net Income": "-667",
"Comprehensive Net Income": "-667",
"BaseVar": "1,713",
"ECR before LimitedLiability": "99%",
"Economic Capital Ratio": "170%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "1,525",
"Assets, Non-Current": "323",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,179",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,070",
"Long Term Liabilities": "3,838",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,118",
"Other Liabilities": "581",
"Other Net Income": "2,858",
"Other Revenues": "0",
"Property Plant and Equipment": "5,603",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,451",
"Liabilities": "5,489",
"Expenses": "2,297",
"Revenues": "0",
"Stockholders Equity": "1,962",
"Net Income": "561",
"Comprehensive Net Income": "561",
"BaseVar": "9,048",
"ECR before LimitedLiability": "53%",
"Economic Capital Ratio": "135%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "1,848",
"Assets, Non-Current": "364",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,232",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,299",
"Long Term Liabilities": "2,960",
"Operating Costs and Expenses": "0",
"Other Assets": "210",
"Other Compr. Net Income": "0",
"Other Expenses": "1,628",
"Other Liabilities": "769",
"Other Net Income": "3,256",
"Other Revenues": "0",
"Property Plant and Equipment": "4,964",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,386",
"Liabilities": "5,028",
"Expenses": "2,860",
"Revenues": "0",
"Stockholders Equity": "2,358",
"Net Income": "396",
"Comprehensive Net Income": "396",
"BaseVar": "9,265",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "142%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,943",
"Assets, Non-Current": "485",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,308",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,524",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,011",
"Other Liabilities": "3,826",
"Other Net Income": "3,855",
"Other Revenues": "0",
"Property Plant and Equipment": "4,816",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,244",
"Liabilities": "5,350",
"Expenses": "3,319",
"Revenues": "0",
"Stockholders Equity": "2,894",
"Net Income": "536",
"Comprehensive Net Income": "536",
"BaseVar": "10,384",
"ECR before LimitedLiability": "70%",
"Economic Capital Ratio": "149%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "3,986",
"Assets, Non-Current": "202",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,259",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,614",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,523",
"Other Liabilities": "2,869",
"Other Net Income": "3,320",
"Other Revenues": "0",
"Property Plant and Equipment": "3,727",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,915",
"Liabilities": "4,483",
"Expenses": "2,782",
"Revenues": "0",
"Stockholders Equity": "3,432",
"Net Income": "538",
"Comprehensive Net Income": "538",
"BaseVar": "9,250",
"ECR before LimitedLiability": "89%",
"Economic Capital Ratio": "163%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "4,061",
"Assets, Non-Current": "2,144",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,289",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,881",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,925",
"Other Liabilities": "1,313",
"Other Net Income": "-631",
"Other Revenues": "3,424",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,205",
"Liabilities": "3,194",
"Expenses": "3,214",
"Revenues": "3,424",
"Stockholders Equity": "3,011",
"Net Income": "-421",
"Comprehensive Net Income": "-421",
"BaseVar": "8,334",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "159%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,681",
"Assets, Non-Current": "2,316",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,230",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,638",
"Long Term Liabilities": "106",
"Operating Costs and Expenses": "0",
"Other Assets": "-128",
"Other Compr. Net Income": "0",
"Other Expenses": "450",
"Other Liabilities": "100",
"Other Net Income": "-1,380",
"Other Revenues": "3,202",
"Property Plant and Equipment": "128",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,997",
"Liabilities": "1,844",
"Expenses": "1,680",
"Revenues": "3,202",
"Stockholders Equity": "3,153",
"Net Income": "142",
"Comprehensive Net Income": "142",
"BaseVar": "6,552",
"ECR before LimitedLiability": "138%",
"Economic Capital Ratio": "197%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "3,007",
"Assets, Non-Current": "1,166",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,197",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "410",
"Long Term Liabilities": "66",
"Operating Costs and Expenses": "0",
"Other Assets": "-94",
"Other Compr. Net Income": "0",
"Other Expenses": "709",
"Other Liabilities": "11",
"Other Net Income": "-806",
"Other Revenues": "3,245",
"Property Plant and Equipment": "94",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,173",
"Liabilities": "487",
"Expenses": "1,906",
"Revenues": "3,245",
"Stockholders Equity": "3,686",
"Net Income": "533",
"Comprehensive Net Income": "533",
"BaseVar": "5,308",
"ECR before LimitedLiability": "252%",
"Economic Capital Ratio": "276%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "2,243",
"Assets, Non-Current": "1,445",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,064",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "315",
"Labor Expense": "0",
"Liabilities, Current": "327",
"Long Term Liabilities": "23",
"Operating Costs and Expenses": "0",
"Other Assets": "-374",
"Other Compr. Net Income": "0",
"Other Expenses": "209",
"Other Liabilities": "11",
"Other Net Income": "-470",
"Other Revenues": "1,069",
"Property Plant and Equipment": "59",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,688",
"Liabilities": "361",
"Expenses": "1,273",
"Revenues": "1,069",
"Stockholders Equity": "3,327",
"Net Income": "-674",
"Comprehensive Net Income": "-674",
"BaseVar": "3,430",
"ECR before LimitedLiability": "205%",
"Economic Capital Ratio": "241%"
}
}
},
"top_rated": true,
"trend": -14.0,
"value": 2.4146600355339976,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001089815.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001089815.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001089815.svg"
},
{
"company_id": "0001217234",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001217234.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001217234.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001217234.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001217234_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001217234_main_keyfigs.svg",
"name": "Caredx Inc",
"rank": 18,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001217234.svg",
"report_text": "The relative strengths and weaknesses of Caredx Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Caredx Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 55% points.The greatest weakness of Caredx Inc is the variable Selling and Marketing Expense, reducing the Economic Capital Ratio by 12% points.
The company's Economic Capital Ratio, given in the ranking table, is 233%, being 65% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001217234_2022_Caredx_Inc.pdf",
"shrinked_graph_json": {
"2014": {
"Other Assets": "-2.96",
"Assets": "25.6",
"Liabilities": "9.78",
"Stockholders Equity": "49.9",
"ECR before LimitedLiability": "62.8",
"Intangible Assets": "9.87",
"Property Plant and Equipment": "-9.72",
"Assets, Current": "39.5",
"Long Term Liabilities": "9.41",
"Expenses": "21.6",
"Revenues": "13.2",
"Net Income": "15.2",
"Operating Costs and Expenses": "4.57",
"Labor Expense": "9.88",
"Other Expenses": "8.61",
"Selling and Marketing Expense": "-7.23",
"Cost of Goods and Services Sold": "5.94",
"Other Revenues": "13.2",
"Comprehensive Net Income": "15.3",
"Other Net Income": "-19.4",
"Economic Capital Ratio": "49.6"
},
"2015": {
"Assets, Current": "40.8",
"Assets": "16.5",
"Liabilities": "-7.29",
"Stockholders Equity": "13.8",
"Economic Capital Ratio": "-9.50",
"Intangible Assets": "16.2",
"Other Assets": "-6.02",
"Property Plant and Equipment": "-17.4",
"Long Term Liabilities": "-22.1",
"Liabilities, Current": "13.2",
"Selling and Marketing Expense": "-10.4",
"Expenses": "5.53",
"Revenues": "10.7",
"Net Income": "-5.39",
"Research And Development Expense": "-13.1",
"Other Expenses": "5.16",
"Labor Expense": "11.8",
"Cost of Goods and Services Sold": "10.1",
"Other Revenues": "10.7",
"Comprehensive Net Income": "-5.01",
"Other Net Income": "-20.5"
},
"2016": {
"Liabilities, Current": "-5.40",
"Liabilities": "-6.95",
"Stockholders Equity": "-8.14",
"Property Plant and Equipment": "-12.9",
"Other Liabilities": "-0.794",
"Long Term Liabilities": "1.34",
"ECR before LimitedLiability": "-36.1",
"Assets, Non-Current": "-0.592",
"Intangible Assets": "17.4",
"Other Assets": "-0.508",
"Assets, Current": "-0.662",
"Net Income": "-8.87",
"Comprehensive Net Income": "-12.9",
"Selling and Marketing Expense": "-0.553",
"Labor Expense": "0.760",
"Other Expenses": "0.458",
"Cost of Goods and Services Sold": "2.13",
"Research And Development Expense": "-0.665",
"Goodwill Impairment Loss": "-0.835",
"Other Net Income": "-5.52",
"Economic Capital Ratio": "-63.8"
},
"2017": {
"Other Assets": "1.73",
"Assets": "-7.24",
"Liabilities": "-8.42",
"Stockholders Equity": "-29.6",
"ECR before LimitedLiability": "-45.8",
"Intangible Assets": "13.6",
"Assets, Non-Current": "-2.18",
"Assets, Current": "-7.00",
"Property Plant and Equipment": "-6.83",
"Liabilities, Current": "-2.59",
"Other Liabilities": "-6.16",
"General and Administrative Expense": "1.67",
"Expenses": "8.33",
"Other Net Income": "-9.06",
"Net Income": "-6.44",
"Labor Expense": "2.14",
"Selling and Marketing Expense": "-1.86",
"Other Expenses": "2.67",
"Cost of Goods and Services Sold": "3.86",
"Comprehensive Net Income": "-6.18",
"Economic Capital Ratio": "-69.9"
},
"2018": {
"Other Assets": "-6.67",
"Assets": "9.13",
"Liabilities": "33.0",
"Stockholders Equity": "42.1",
"ECR before LimitedLiability": "39.0",
"Property Plant and Equipment": "-10.2",
"Intangible Assets": "19.2",
"Assets, Non-Current": "-7.20",
"Assets, Current": "22.4",
"Other Liabilities": "-16.5",
"Liabilities, Current": "23.4",
"Long Term Liabilities": "25.3",
"Selling and Marketing Expense": "-13.8",
"Expenses": "8.63",
"Net Income": "-11.4",
"Other Net Income": "-20.8",
"Other Expenses": "-11.0",
"Cost of Goods and Services Sold": "23.2",
"Labor Expense": "8.71",
"Comprehensive Net Income": "-12.7",
"Economic Capital Ratio": "18.2"
},
"2019": {
"Property Plant and Equipment": "-10.7",
"Assets": "-7.06",
"Liabilities": "31.4",
"Stockholders Equity": "11.1",
"ECR before LimitedLiability": "31.7",
"Assets, Non-Current": "-9.22",
"Intangible Assets": "24.3",
"Other Liabilities": "-5.12",
"Long Term Liabilities": "35.7",
"Other Expenses": "15.4",
"Expenses": "-11.3",
"Revenues": "18.4",
"Net Income": "7.18",
"General and Administrative Expense": "-4.58",
"Research And Development Expense": "-12.4",
"Selling and Marketing Expense": "-20.4",
"Labor Expense": "7.60",
"Operating Costs and Expenses": "6.52",
"Other Revenues": "18.4",
"Comprehensive Net Income": "6.77",
"Economic Capital Ratio": "21.7"
},
"2020": {
"Property Plant and Equipment": "-4.48",
"Assets": "12.3",
"Liabilities": "31.6",
"Stockholders Equity": "48.6",
"ECR before LimitedLiability": "69.4",
"Assets, Current": "29.9",
"Assets, Non-Current": "-3.57",
"Other Liabilities": "4.79",
"Long Term Liabilities": "28.0",
"Other Revenues": "7.18",
"Revenues": "7.18",
"Net Income": "12.0",
"Comprehensive Net Income": "12.9",
"Labor Expense": "5.41",
"Selling and Marketing Expense": "-12.7",
"General and Administrative Expense": "4.52",
"Research And Development Expense": "-10.4",
"Other Expenses": "-6.33",
"Operating Costs and Expenses": "4.30",
"Cost of Goods and Services Sold": "17.2",
"Economic Capital Ratio": "57.3"
},
"2021": {
"Assets": "8.96",
"Stockholders Equity": "55.2",
"ECR before LimitedLiability": "71.3",
"Intangible Assets": "-4.03",
"Assets, Current": "27.0",
"Liabilities, Current": "7.87",
"Liabilities": "45.4",
"Long Term Liabilities": "31.2",
"Other Liabilities": "10.0",
"Other Revenues": "12.5",
"Revenues": "12.5",
"Net Income": "13.4",
"General and Administrative Expense": "3.51",
"Comprehensive Net Income": "13.0",
"Operating Costs and Expenses": "5.23",
"Labor Expense": "4.53",
"Cost of Goods and Services Sold": "15.0",
"Research And Development Expense": "-10.9",
"Other Expenses": "-8.44",
"Selling and Marketing Expense": "-12.2",
"Economic Capital Ratio": "65.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001217234_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "40,346",
"Assets, Non-Current": "25",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "8,436",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "18,655",
"Labor Expense": "0",
"Liabilities, Current": "11,135",
"Long Term Liabilities": "5,479",
"Operating Costs and Expenses": "0",
"Other Assets": "147",
"Other Compr. Net Income": "0",
"Other Expenses": "5,802",
"Other Liabilities": "3,229",
"Other Net Income": "-1,969",
"Other Revenues": "27,306",
"Property Plant and Equipment": "1,968",
"Research And Development Expense": "3,846",
"Selling and Marketing Expense": "6,472"
},
"output_variables": {
"Assets": "61,141",
"Liabilities": "19,843",
"Expenses": "24,556",
"Revenues": "27,306",
"Stockholders Equity": "41,298",
"Net Income": "781",
"Comprehensive Net Income": "781",
"BaseVar": "67,408",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "205%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "34,362",
"Assets, Non-Current": "49",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "12,247",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "18,655",
"Labor Expense": "0",
"Liabilities, Current": "10,152",
"Long Term Liabilities": "12,915",
"Operating Costs and Expenses": "0",
"Other Assets": "147",
"Other Compr. Net Income": "0",
"Other Expenses": "10,147",
"Other Liabilities": "3,077",
"Other Net Income": "-1,775",
"Other Revenues": "28,144",
"Property Plant and Equipment": "2,425",
"Research And Development Expense": "9,333",
"Selling and Marketing Expense": "8,349"
},
"output_variables": {
"Assets": "55,638",
"Liabilities": "26,144",
"Expenses": "40,076",
"Revenues": "28,144",
"Stockholders Equity": "29,494",
"Net Income": "-13,707",
"Comprehensive Net Income": "-13,707",
"BaseVar": "75,888",
"ECR before LimitedLiability": "71%",
"Economic Capital Ratio": "150%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "26,673",
"Assets, Non-Current": "20",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "20,725",
"Goodwill Impairment Loss": "13,021",
"Intangible Assets": "46,963",
"Labor Expense": "0",
"Liabilities, Current": "40,832",
"Long Term Liabilities": "2,320",
"Operating Costs and Expenses": "0",
"Other Assets": "143",
"Other Compr. Net Income": "-3,372",
"Other Expenses": "19,060",
"Other Liabilities": "13,817",
"Other Net Income": "-4,030",
"Other Revenues": "40,631",
"Property Plant and Equipment": "2,931",
"Research And Development Expense": "12,385",
"Selling and Marketing Expense": "11,166"
},
"output_variables": {
"Assets": "76,730",
"Liabilities": "56,969",
"Expenses": "76,357",
"Revenues": "40,631",
"Stockholders Equity": "19,761",
"Net Income": "-39,756",
"Comprehensive Net Income": "-43,128",
"BaseVar": "129,044",
"ECR before LimitedLiability": "-22%",
"Economic Capital Ratio": "87%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "26,767",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "18,913",
"Goodwill Impairment Loss": "1,958",
"Intangible Assets": "45,144",
"Labor Expense": "0",
"Liabilities, Current": "42,906",
"Long Term Liabilities": "19,653",
"Operating Costs and Expenses": "0",
"Other Assets": "9,579",
"Other Compr. Net Income": "1,405",
"Other Expenses": "20,842",
"Other Liabilities": "26,960",
"Other Net Income": "-36,975",
"Other Revenues": "48,324",
"Property Plant and Equipment": "2,075",
"Research And Development Expense": "12,388",
"Selling and Marketing Expense": "12,808"
},
"output_variables": {
"Assets": "83,565",
"Liabilities": "89,519",
"Expenses": "66,909",
"Revenues": "48,324",
"Stockholders Equity": "-5,954",
"Net Income": "-55,560",
"Comprehensive Net Income": "-54,155",
"BaseVar": "163,348",
"ECR before LimitedLiability": "-73%",
"Economic Capital Ratio": "78%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "81,114",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "21,959",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "45,257",
"Labor Expense": "0",
"Liabilities, Current": "19,504",
"Long Term Liabilities": "1,133",
"Operating Costs and Expenses": "0",
"Other Assets": "192",
"Other Compr. Net Income": "-1,908",
"Other Expenses": "38,350",
"Other Liabilities": "14,132",
"Other Net Income": "-26,857",
"Other Revenues": "76,569",
"Property Plant and Equipment": "4,134",
"Research And Development Expense": "14,514",
"Selling and Marketing Expense": "21,670"
},
"output_variables": {
"Assets": "130,697",
"Liabilities": "34,769",
"Expenses": "96,493",
"Revenues": "76,569",
"Stockholders Equity": "95,928",
"Net Income": "-46,781",
"Comprehensive Net Income": "-48,689",
"BaseVar": "183,646",
"ECR before LimitedLiability": "109%",
"Economic Capital Ratio": "177%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "71,922",
"Assets, Non-Current": "5,730",
"Cost of Goods and Services Sold": "45,455",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "36,540",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "69,398",
"Labor Expense": "0",
"Liabilities, Current": "36,801",
"Long Term Liabilities": "4,121",
"Operating Costs and Expenses": "0",
"Other Assets": "256",
"Other Compr. Net Income": "-927",
"Other Expenses": "-1,979",
"Other Liabilities": "11,814",
"Other Net Income": "585",
"Other Revenues": "127,068",
"Property Plant and Equipment": "4,430",
"Research And Development Expense": "30,711",
"Selling and Marketing Expense": "38,894"
},
"output_variables": {
"Assets": "151,736",
"Liabilities": "52,736",
"Expenses": "149,621",
"Revenues": "127,068",
"Stockholders Equity": "99,000",
"Net Income": "-21,968",
"Comprehensive Net Income": "-22,895",
"BaseVar": "241,336",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "183%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "273,097",
"Assets, Non-Current": "16,228",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "48,806",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "68,212",
"Labor Expense": "0",
"Liabilities, Current": "70,516",
"Long Term Liabilities": "16,309",
"Operating Costs and Expenses": "0",
"Other Assets": "270",
"Other Compr. Net Income": "3,109",
"Other Expenses": "62,081",
"Other Liabilities": "4,007",
"Other Net Income": "2,778",
"Other Revenues": "192,194",
"Property Plant and Equipment": "10,704",
"Research And Development Expense": "48,941",
"Selling and Marketing Expense": "53,858"
},
"output_variables": {
"Assets": "368,511",
"Liabilities": "90,832",
"Expenses": "213,686",
"Revenues": "192,194",
"Stockholders Equity": "277,679",
"Net Income": "-18,714",
"Comprehensive Net Income": "-15,605",
"BaseVar": "435,555",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "217%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "433,360",
"Assets, Non-Current": "23,828",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "74,964",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "87,178",
"Labor Expense": "0",
"Liabilities, Current": "77,716",
"Long Term Liabilities": "17,849",
"Operating Costs and Expenses": "0",
"Other Assets": "211",
"Other Compr. Net Income": "-2,574",
"Other Expenses": "95,963",
"Other Liabilities": "5,180",
"Other Net Income": "-2,362",
"Other Revenues": "296,397",
"Property Plant and Equipment": "22,044",
"Research And Development Expense": "76,525",
"Selling and Marketing Expense": "77,245"
},
"output_variables": {
"Assets": "566,621",
"Liabilities": "100,745",
"Expenses": "324,697",
"Revenues": "296,397",
"Stockholders Equity": "465,876",
"Net Income": "-30,662",
"Comprehensive Net Income": "-33,236",
"BaseVar": "646,698",
"ECR before LimitedLiability": "192%",
"Economic Capital Ratio": "233%"
}
}
},
"top_rated": true,
"trend": 0.0,
"value": 2.3293031537434365,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001217234.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001217234.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001217234.svg"
},
{
"company_id": "0001651944",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001651944.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001651944.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001651944.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001651944_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001651944_main_keyfigs.svg",
"name": "Dermtech Inc",
"rank": 19,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001651944.svg",
"report_text": "The relative strengths and weaknesses of Dermtech Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Dermtech Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 119% points.The greatest weakness of Dermtech Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 29% points.
The company's Economic Capital Ratio, given in the ranking table, is 232%, being 64% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001651944_2022_Dermtech_Inc.pdf",
"shrinked_graph_json": {
"2018": {
"Other Assets": "200",
"Assets": "24.5",
"Stockholders Equity": "156",
"ECR before LimitedLiability": "152",
"Other Liabilities": "-9.38",
"Liabilities": "44.6",
"Liabilities, Current": "36.1",
"Long Term Liabilities": "19.3",
"Selling and Marketing Expense": "2.07",
"Expenses": "43.2",
"Revenues": "-33.8",
"Net Income": "14.8",
"Operating Costs and Expenses": "2.20",
"Other Expenses": "10.3",
"General and Administrative Expense": "11.0",
"Research And Development Expense": "3.10",
"Cost of Goods and Services Sold": "11.4",
"Labor Expense": "4.43",
"Other Revenues": "-33.8",
"Comprehensive Net Income": "15.0",
"Economic Capital Ratio": "131"
},
"2019": {
"Property Plant and Equipment": "-6.85",
"Assets": "0.942",
"Liabilities": "2.27",
"Stockholders Equity": "4.79",
"Assets, Non-Current": "-14.0",
"Intangible Assets": "-26.1",
"Assets, Current": "54.1",
"Long Term Liabilities": "3.69",
"Liabilities, Current": "-10.4",
"Other Expenses": "1.45",
"Expenses": "-43.1",
"Revenues": "-42.5",
"Net Income": "-99.6",
"General and Administrative Expense": "-33.2",
"Selling and Marketing Expense": "-31.3",
"Labor Expense": "0.648",
"Other Revenues": "-42.5",
"ECR before LimitedLiability": "-64.6",
"Comprehensive Net Income": "-99.4",
"Other Net Income": "-4.18",
"Economic Capital Ratio": "-74.6"
},
"2020": {
"Assets": "51.6",
"Liabilities": "47.3",
"Stockholders Equity": "117",
"ECR before LimitedLiability": "56.8",
"Intangible Assets": "-9.86",
"Assets, Current": "124",
"Assets, Non-Current": "-5.87",
"Liabilities, Current": "16.0",
"Long Term Liabilities": "31.0",
"Labor Expense": "4.62",
"Expenses": "-16.2",
"Revenues": "-31.0",
"Net Income": "-47.2",
"Selling and Marketing Expense": "-25.6",
"General and Administrative Expense": "-8.12",
"Research And Development Expense": "-5.95",
"Other Expenses": "9.86",
"Cost of Goods and Services Sold": "4.30",
"Other Revenues": "-31.0",
"Comprehensive Net Income": "-47.2",
"Economic Capital Ratio": "44.7"
},
"2021": {
"Assets": "45.8",
"Liabilities": "43.0",
"Stockholders Equity": "119",
"ECR before LimitedLiability": "70.2",
"Intangible Assets": "-8.26",
"Property Plant and Equipment": "-2.22",
"Assets, Current": "117",
"Liabilities, Current": "16.7",
"Long Term Liabilities": "21.8",
"Other Liabilities": "8.56",
"Other Revenues": "-28.7",
"Revenues": "-28.7",
"Net Income": "-26.3",
"Comprehensive Net Income": "-26.3",
"Operating Costs and Expenses": "3.73",
"Labor Expense": "3.23",
"Cost of Goods and Services Sold": "5.47",
"Research And Development Expense": "-4.88",
"Other Expenses": "7.83",
"Selling and Marketing Expense": "-16.7",
"Economic Capital Ratio": "64.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001651944_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "543",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "42",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "146,350",
"Other Compr. Net Income": "0",
"Other Expenses": "306",
"Other Liabilities": "5,031",
"Other Net Income": "1,163",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "146,894",
"Liabilities": "5,073",
"Expenses": "306",
"Revenues": "0",
"Stockholders Equity": "141,820",
"Net Income": "856",
"Comprehensive Net Income": "856",
"BaseVar": "76,718",
"ECR before LimitedLiability": "272%",
"Economic Capital Ratio": "291%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "17,150",
"Assets, Non-Current": "84",
"Cost of Goods and Services Sold": "3,304",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "8,865",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,722",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-2,084",
"Other Revenues": "3,364",
"Property Plant and Equipment": "977",
"Research And Development Expense": "2,497",
"Selling and Marketing Expense": "6,303"
},
"output_variables": {
"Assets": "18,211",
"Liabilities": "5,722",
"Expenses": "20,969",
"Revenues": "3,364",
"Stockholders Equity": "12,489",
"Net Income": "-19,689",
"Comprehensive Net Income": "-19,689",
"BaseVar": "25,175",
"ECR before LimitedLiability": "-13%",
"Economic Capital Ratio": "87%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "66,882",
"Assets, Non-Current": "167",
"Cost of Goods and Services Sold": "5,981",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "13,823",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,425",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-1.0",
"Other Expenses": "0",
"Other Liabilities": "865",
"Other Net Income": "40",
"Other Revenues": "5,885",
"Property Plant and Equipment": "2,731",
"Research And Development Expense": "5,293",
"Selling and Marketing Expense": "16,077"
},
"output_variables": {
"Assets": "69,780",
"Liabilities": "6,290",
"Expenses": "41,174",
"Revenues": "5,885",
"Stockholders Equity": "63,490",
"Net Income": "-35,249",
"Comprehensive Net Income": "-35,250",
"BaseVar": "61,585",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "204%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "232,824",
"Assets, Non-Current": "7,911",
"Cost of Goods and Services Sold": "10,564",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "24,836",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "12,181",
"Long Term Liabilities": "6,148",
"Operating Costs and Expenses": "0",
"Other Assets": "3,025",
"Other Compr. Net Income": "-123",
"Other Expenses": "0",
"Other Liabilities": "282",
"Other Net Income": "-937",
"Other Revenues": "11,838",
"Property Plant and Equipment": "4,549",
"Research And Development Expense": "16,261",
"Selling and Marketing Expense": "37,575"
},
"output_variables": {
"Assets": "248,309",
"Liabilities": "18,611",
"Expenses": "89,236",
"Revenues": "11,838",
"Stockholders Equity": "229,698",
"Net Income": "-78,335",
"Comprehensive Net Income": "-78,458",
"BaseVar": "184,527",
"ECR before LimitedLiability": "191%",
"Economic Capital Ratio": "232%"
}
}
},
"top_rated": true,
"trend": 5.0,
"value": 2.3177474978207173,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001651944.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001651944.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001651944.svg"
},
{
"company_id": "0001551306",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001551306.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001551306.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001551306.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001551306_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001551306_main_keyfigs.svg",
"name": "Progyny Inc",
"rank": 20,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001551306.svg",
"report_text": "The relative strengths and weaknesses of Progyny Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Progyny Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 72% points.The greatest weakness of Progyny Inc is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 100% points.
The company's Economic Capital Ratio, given in the ranking table, is 228%, being 60% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001551306_2022_Progyny_Inc.pdf",
"shrinked_graph_json": {
"2019": {
"Property Plant and Equipment": "-11.6",
"Assets": "-23.0",
"Liabilities": "88.1",
"ECR before LimitedLiability": "65.2",
"Assets, Non-Current": "-11.6",
"Intangible Assets": "-13.1",
"Assets, Current": "18.0",
"Other Liabilities": "16.7",
"Long Term Liabilities": "59.6",
"Liabilities, Current": "20.9",
"Other Expenses": "19.9",
"Expenses": "-29.3",
"Net Income": "25.3",
"General and Administrative Expense": "11.4",
"Cost of Goods and Services Sold": "-104",
"Research And Development Expense": "11.2",
"Other Revenues": "69.7",
"Revenues": "69.7",
"Comprehensive Net Income": "25.6",
"Other Net Income": "-12.6",
"Economic Capital Ratio": "55.1"
},
"2020": {
"Property Plant and Equipment": "-8.29",
"Assets": "-17.4",
"Liabilities": "56.9",
"Stockholders Equity": "-9.87",
"ECR before LimitedLiability": "69.9",
"Intangible Assets": "-12.1",
"Assets, Non-Current": "-7.12",
"Other Liabilities": "11.0",
"Long Term Liabilities": "47.5",
"Labor Expense": "8.23",
"Expenses": "-17.4",
"Revenues": "62.5",
"Net Income": "45.2",
"General and Administrative Expense": "10.2",
"Research And Development Expense": "5.72",
"Other Expenses": "32.3",
"Operating Costs and Expenses": "6.54",
"Cost of Goods and Services Sold": "-88.4",
"Other Revenues": "62.5",
"Comprehensive Net Income": "45.2",
"Economic Capital Ratio": "57.8"
},
"2021": {
"Other Assets": "8.88",
"Assets": "-19.0",
"Liabilities": "66.9",
"Stockholders Equity": "-19.7",
"ECR before LimitedLiability": "66.7",
"Intangible Assets": "-15.5",
"Assets, Non-Current": "-6.47",
"Long Term Liabilities": "51.5",
"Other Liabilities": "18.4",
"General and Administrative Expense": "11.6",
"Expenses": "-25.6",
"Revenues": "72.5",
"Net Income": "49.2",
"Operating Costs and Expenses": "8.06",
"Labor Expense": "6.99",
"Cost of Goods and Services Sold": "-100",
"Research And Development Expense": "7.24",
"Other Expenses": "26.3",
"Other Revenues": "72.5",
"Comprehensive Net Income": "49.3",
"Economic Capital Ratio": "60.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001551306_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "132,444",
"Assets, Non-Current": "652",
"Cost of Goods and Services Sold": "184,178",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "23,927",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,880",
"Labor Expense": "0",
"Liabilities, Current": "36,163",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "2,375",
"Other Compr. Net Income": "0",
"Other Expenses": "12",
"Other Liabilities": "0",
"Other Net Income": "-18,234",
"Other Revenues": "229,683",
"Property Plant and Equipment": "3,083",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "11,901"
},
"output_variables": {
"Assets": "150,434",
"Liabilities": "36,163",
"Expenses": "220,018",
"Revenues": "229,683",
"Stockholders Equity": "114,271",
"Net Income": "-8,569",
"Comprehensive Net Income": "-8,569",
"BaseVar": "327,266",
"ECR before LimitedLiability": "168%",
"Economic Capital Ratio": "217%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "190,222",
"Assets, Non-Current": "9,241",
"Cost of Goods and Services Sold": "274,799",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "46,705",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,880",
"Labor Expense": "0",
"Liabilities, Current": "77,786",
"Long Term Liabilities": "9,194",
"Operating Costs and Expenses": "0",
"Other Assets": "39,184",
"Other Compr. Net Income": "1.0",
"Other Expenses": "-37,780",
"Other Liabilities": "0",
"Other Net Income": "331",
"Other Revenues": "344,858",
"Property Plant and Equipment": "3,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "15,006"
},
"output_variables": {
"Assets": "253,927",
"Liabilities": "86,980",
"Expenses": "298,730",
"Revenues": "344,858",
"Stockholders Equity": "166,947",
"Net Income": "46,459",
"Comprehensive Net Income": "46,460",
"BaseVar": "492,414",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "217%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "258,539",
"Assets, Non-Current": "10,746",
"Cost of Goods and Services Sold": "388,486",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "59,616",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,880",
"Labor Expense": "0",
"Liabilities, Current": "98,824",
"Long Term Liabilities": "7,419",
"Operating Costs and Expenses": "0",
"Other Assets": "71,873",
"Other Compr. Net Income": "-94",
"Other Expenses": "-33,334",
"Other Liabilities": "0",
"Other Net Income": "95",
"Other Revenues": "500,621",
"Property Plant and Equipment": "5,027",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "20,179"
},
"output_variables": {
"Assets": "358,065",
"Liabilities": "106,243",
"Expenses": "434,947",
"Revenues": "500,621",
"Stockholders Equity": "251,822",
"Net Income": "65,769",
"Comprehensive Net Income": "65,675",
"BaseVar": "700,032",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "228%"
}
}
},
"top_rated": true,
"trend": -3.0,
"value": 2.282804793467965,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001551306.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001551306.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001551306.svg"
},
{
"company_id": "0000731012",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000731012.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000731012.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000731012.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000731012_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000731012_main_keyfigs.svg",
"name": "Healthcare Services Group Inc",
"rank": 21,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000731012.svg",
"report_text": "The relative strengths and weaknesses of Healthcare Services Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Healthcare Services Group Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 137% points.The greatest weakness of Healthcare Services Group Inc is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 201% points.
The company's Economic Capital Ratio, given in the ranking table, is 228%, being 60% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000731012_2022_Healthcare_Services_Group_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "49.9",
"Assets": "29.0",
"Liabilities": "21.3",
"Stockholders Equity": "99.0",
"ECR before LimitedLiability": "72.3",
"Other Assets": "3.90",
"Intangible Assets": "-4.32",
"Other Liabilities": "11.4",
"Liabilities, Current": "-30.1",
"Long Term Liabilities": "33.3",
"Other Expenses": "9.01",
"Expenses": "30.9",
"Revenues": "-21.9",
"Net Income": "9.88",
"Cost of Goods and Services Sold": "7.28",
"General and Administrative Expense": "3.37",
"Labor Expense": "5.40",
"Operating Costs and Expenses": "5.94",
"Other Revenues": "-21.9",
"Comprehensive Net Income": "10.5",
"Economic Capital Ratio": "74.1"
},
"2011": {
"Other Assets": "3.65",
"Assets": "34.8",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "108",
"Assets, Current": "48.3",
"Other Liabilities": "8.19",
"Liabilities": "16.3",
"Long Term Liabilities": "25.2",
"Liabilities, Current": "-20.6",
"Expenses": "41.3",
"Revenues": "-26.3",
"Net Income": "25.8",
"Other Expenses": "11.0",
"Operating Costs and Expenses": "4.45",
"Labor Expense": "6.98",
"General and Administrative Expense": "11.3",
"Cost of Goods and Services Sold": "4.43",
"Other Revenues": "-26.3",
"Other Net Income": "8.56",
"Comprehensive Net Income": "26.0",
"Economic Capital Ratio": "101"
},
"2012": {
"Property Plant and Equipment": "-3.62",
"Assets": "38.0",
"Liabilities": "6.30",
"Stockholders Equity": "87.3",
"ECR before LimitedLiability": "98.0",
"Assets, Current": "52.4",
"Other Assets": "4.96",
"Liabilities, Current": "-30.6",
"Long Term Liabilities": "18.9",
"Other Liabilities": "12.5",
"Expenses": "38.4",
"Revenues": "-25.1",
"Net Income": "24.0",
"Other Expenses": "7.87",
"General and Administrative Expense": "11.3",
"Cost of Goods and Services Sold": "4.44",
"Labor Expense": "7.13",
"Other Revenues": "-25.1",
"Other Net Income": "8.88",
"Comprehensive Net Income": "24.1",
"Economic Capital Ratio": "83.8"
},
"2013": {
"Other Assets": "7.47",
"Assets": "44.1",
"Stockholders Equity": "84.0",
"ECR before LimitedLiability": "84.0",
"Property Plant and Equipment": "-3.90",
"Assets, Current": "43.5",
"Expenses": "37.5",
"Net Income": "21.9",
"General and Administrative Expense": "11.0",
"Cost of Goods and Services Sold": "3.80",
"Labor Expense": "6.54",
"Other Expenses": "8.98",
"Research And Development Expense": "2.19",
"Other Revenues": "-24.2",
"Revenues": "-24.2",
"Other Liabilities": "10.1",
"Liabilities, Current": "-32.1",
"Long Term Liabilities": "17.9",
"Comprehensive Net Income": "22.0",
"Other Net Income": "7.35",
"Economic Capital Ratio": "74.8"
},
"2014": {
"Other Assets": "8.88",
"Assets": "60.4",
"Liabilities": "-6.69",
"Stockholders Equity": "87.2",
"ECR before LimitedLiability": "83.4",
"Property Plant and Equipment": "-4.75",
"Assets, Current": "57.0",
"Other Liabilities": "6.68",
"Liabilities, Current": "-39.5",
"Long Term Liabilities": "19.0",
"Expenses": "37.4",
"Revenues": "-20.8",
"Net Income": "13.9",
"Labor Expense": "6.39",
"Other Expenses": "9.45",
"Cost of Goods and Services Sold": "3.85",
"General and Administrative Expense": "9.37",
"Other Revenues": "-20.8",
"Comprehensive Net Income": "13.9",
"Other Net Income": "-3.34",
"Economic Capital Ratio": "70.2"
},
"2015": {
"Assets, Current": "46.9",
"Assets": "41.2",
"Liabilities": "8.56",
"Stockholders Equity": "93.1",
"ECR before LimitedLiability": "101",
"Other Assets": "4.22",
"Property Plant and Equipment": "-3.76",
"Long Term Liabilities": "17.3",
"Other Liabilities": "8.86",
"Liabilities, Current": "-20.6",
"Expenses": "38.8",
"Revenues": "-26.1",
"Net Income": "25.4",
"General and Administrative Expense": "11.0",
"Other Expenses": "6.62",
"Labor Expense": "6.76",
"Cost of Goods and Services Sold": "5.84",
"Other Revenues": "-26.1",
"Comprehensive Net Income": "25.7",
"Other Net Income": "10.9",
"Economic Capital Ratio": "88.2"
},
"2016": {
"Assets": "39.8",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "130",
"Other Assets": "3.70",
"Assets, Current": "47.0",
"Liabilities, Current": "-7.09",
"Liabilities": "19.0",
"Other Liabilities": "10.6",
"Long Term Liabilities": "15.4",
"Expenses": "39.9",
"Revenues": "-29.5",
"Net Income": "30.1",
"Selling and Marketing Expense": "3.60",
"General and Administrative Expense": "12.8",
"Labor Expense": "3.79",
"Other Expenses": "5.90",
"Cost of Goods and Services Sold": "8.76",
"Other Revenues": "-29.5",
"Other Net Income": "17.3",
"Comprehensive Net Income": "30.3",
"Economic Capital Ratio": "103"
},
"2017": {
"Other Assets": "5.43",
"Assets": "45.0",
"Stockholders Equity": "76.5",
"ECR before LimitedLiability": "105",
"Assets, Current": "53.7",
"Property Plant and Equipment": "-4.26",
"General and Administrative Expense": "12.2",
"Expenses": "38.9",
"Net Income": "26.3",
"Labor Expense": "3.71",
"Research And Development Expense": "3.71",
"Other Expenses": "7.91",
"Cost of Goods and Services Sold": "6.47",
"Other Revenues": "-22.5",
"Revenues": "-22.5",
"Liabilities, Current": "-32.0",
"Other Liabilities": "5.38",
"Long Term Liabilities": "18.2",
"Other Net Income": "9.12",
"Comprehensive Net Income": "26.5",
"Economic Capital Ratio": "80.7"
},
"2018": {
"Assets": "-32.7",
"Liabilities": "145",
"Stockholders Equity": "-77.1",
"ECR before LimitedLiability": "98.6",
"Property Plant and Equipment": "-13.7",
"Intangible Assets": "-14.7",
"Assets, Current": "-13.5",
"Other Liabilities": "21.3",
"Liabilities, Current": "82.6",
"Long Term Liabilities": "67.6",
"Expenses": "-96.0",
"Revenues": "153",
"Net Income": "81.4",
"Other Expenses": "48.0",
"General and Administrative Expense": "31.0",
"Research And Development Expense": "14.8",
"Cost of Goods and Services Sold": "-294",
"Labor Expense": "21.0",
"Other Revenues": "153",
"Comprehensive Net Income": "82.0",
"Economic Capital Ratio": "77.9"
},
"2019": {
"Property Plant and Equipment": "-12.6",
"Assets": "-29.1",
"Stockholders Equity": "-61.1",
"ECR before LimitedLiability": "90.8",
"Intangible Assets": "-14.2",
"Other Liabilities": "26.6",
"Liabilities": "146",
"Long Term Liabilities": "87.2",
"Liabilities, Current": "61.0",
"Other Expenses": "26.3",
"Expenses": "-98.9",
"Revenues": "155",
"Net Income": "56.7",
"General and Administrative Expense": "19.7",
"Cost of Goods and Services Sold": "-252",
"Research And Development Expense": "17.0",
"Labor Expense": "16.5",
"Operating Costs and Expenses": "14.2",
"Other Revenues": "155",
"Comprehensive Net Income": "57.5",
"Economic Capital Ratio": "80.8"
},
"2020": {
"Property Plant and Equipment": "-9.23",
"Assets": "-25.1",
"Stockholders Equity": "-45.5",
"ECR before LimitedLiability": "98.8",
"Intangible Assets": "-12.3",
"Liabilities, Current": "55.9",
"Liabilities": "136",
"Other Liabilities": "19.6",
"Long Term Liabilities": "85.6",
"Labor Expense": "13.8",
"Expenses": "-88.9",
"Revenues": "141",
"Net Income": "57.1",
"General and Administrative Expense": "25.1",
"Research And Development Expense": "9.61",
"Other Expenses": "24.6",
"Operating Costs and Expenses": "11.0",
"Cost of Goods and Services Sold": "-218",
"Other Revenues": "141",
"Comprehensive Net Income": "57.5",
"Economic Capital Ratio": "86.7"
},
"2021": {
"Assets": "-33.3",
"Liabilities": "118",
"Stockholders Equity": "-68.0",
"ECR before LimitedLiability": "66.1",
"Intangible Assets": "-19.1",
"Assets, Non-Current": "-10.9",
"Assets, Current": "-13.5",
"Liabilities, Current": "33.8",
"Long Term Liabilities": "75.6",
"Other Liabilities": "25.8",
"General and Administrative Expense": "17.6",
"Expenses": "-84.6",
"Revenues": "137",
"Net Income": "50.2",
"Operating Costs and Expenses": "11.6",
"Cost of Goods and Services Sold": "-201",
"Research And Development Expense": "10.4",
"Other Expenses": "22.2",
"Other Revenues": "137",
"Comprehensive Net Income": "50.2",
"Economic Capital Ratio": "59.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000731012_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "221,775",
"Assets, Non-Current": "42",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,955",
"Labor Expense": "0",
"Liabilities, Current": "40,531",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "32,506",
"Other Compr. Net Income": "0",
"Other Expenses": "19,678",
"Other Liabilities": "0",
"Other Net Income": "54,119",
"Other Revenues": "0",
"Property Plant and Equipment": "6,656",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "277,934",
"Liabilities": "40,531",
"Expenses": "19,678",
"Revenues": "0",
"Stockholders Equity": "237,403",
"Net Income": "34,441",
"Comprehensive Net Income": "34,441",
"BaseVar": "196,131",
"ECR before LimitedLiability": "238%",
"Economic Capital Ratio": "265%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "232,121",
"Assets, Non-Current": "40",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,955",
"Labor Expense": "0",
"Liabilities, Current": "45,387",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "30,816",
"Other Compr. Net Income": "0",
"Other Expenses": "19,656",
"Other Liabilities": "0",
"Other Net Income": "57,812",
"Other Revenues": "0",
"Property Plant and Equipment": "9,763",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "289,695",
"Liabilities": "45,387",
"Expenses": "19,656",
"Revenues": "0",
"Stockholders Equity": "244,308",
"Net Income": "38,156",
"Comprehensive Net Income": "38,156",
"BaseVar": "206,275",
"ECR before LimitedLiability": "234%",
"Economic Capital Ratio": "262%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "267,846",
"Assets, Non-Current": "38",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,955",
"Labor Expense": "0",
"Liabilities, Current": "67,664",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "36,072",
"Other Compr. Net Income": "-216",
"Other Expenses": "26,050",
"Other Liabilities": "0",
"Other Net Income": "70,264",
"Other Revenues": "0",
"Property Plant and Equipment": "10,272",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "331,183",
"Liabilities": "67,664",
"Expenses": "26,050",
"Revenues": "0",
"Stockholders Equity": "263,519",
"Net Income": "44,214",
"Comprehensive Net Income": "43,998",
"BaseVar": "247,688",
"ECR before LimitedLiability": "214%",
"Economic Capital Ratio": "247%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "309,192",
"Assets, Non-Current": "38",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "40,183",
"Labor Expense": "0",
"Liabilities, Current": "99,103",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "64,625",
"Other Compr. Net Income": "-78",
"Other Expenses": "19,360",
"Other Liabilities": "0",
"Other Net Income": "66,489",
"Other Revenues": "0",
"Property Plant and Equipment": "11,304",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "425,342",
"Liabilities": "99,103",
"Expenses": "19,360",
"Revenues": "0",
"Stockholders Equity": "326,239",
"Net Income": "47,129",
"Comprehensive Net Income": "47,051",
"BaseVar": "305,186",
"ECR before LimitedLiability": "198%",
"Economic Capital Ratio": "237%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "334,828",
"Assets, Non-Current": "38",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "44,438",
"Labor Expense": "0",
"Liabilities, Current": "117,959",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "77,503",
"Other Compr. Net Income": "-24",
"Other Expenses": "9,858",
"Other Liabilities": "0",
"Other Net Income": "31,708",
"Other Revenues": "0",
"Property Plant and Equipment": "12,772",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "469,579",
"Liabilities": "117,959",
"Expenses": "9,858",
"Revenues": "0",
"Stockholders Equity": "351,620",
"Net Income": "21,850",
"Comprehensive Net Income": "21,826",
"BaseVar": "314,564",
"ECR before LimitedLiability": "181%",
"Economic Capital Ratio": "225%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "365,946",
"Assets, Non-Current": "45",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "44,438",
"Labor Expense": "0",
"Liabilities, Current": "96,065",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "57,434",
"Other Compr. Net Income": "518",
"Other Expenses": "31,740",
"Other Liabilities": "0",
"Other Net Income": "89,764",
"Other Revenues": "0",
"Property Plant and Equipment": "13,086",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "480,949",
"Liabilities": "96,065",
"Expenses": "31,740",
"Revenues": "0",
"Stockholders Equity": "384,884",
"Net Income": "58,024",
"Comprehensive Net Income": "58,542",
"BaseVar": "349,518",
"ECR before LimitedLiability": "214%",
"Economic Capital Ratio": "248%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "414,624",
"Assets, Non-Current": "48",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "44,438",
"Labor Expense": "0",
"Liabilities, Current": "100,871",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "55,881",
"Other Compr. Net Income": "-862",
"Other Expenses": "42,991",
"Other Liabilities": "0",
"Other Net Income": "120,387",
"Other Revenues": "0",
"Property Plant and Equipment": "13,455",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "528,446",
"Liabilities": "100,871",
"Expenses": "42,991",
"Revenues": "0",
"Stockholders Equity": "427,575",
"Net Income": "77,396",
"Comprehensive Net Income": "76,534",
"BaseVar": "396,778",
"ECR before LimitedLiability": "221%",
"Economic Capital Ratio": "253%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "527,406",
"Assets, Non-Current": "1,264",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "51,084",
"Labor Expense": "0",
"Liabilities, Current": "184,168",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "82,740",
"Other Compr. Net Income": "1,156",
"Other Expenses": "44,739",
"Other Liabilities": "0",
"Other Net Income": "132,965",
"Other Revenues": "0",
"Property Plant and Equipment": "13,509",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "676,003",
"Liabilities": "184,168",
"Expenses": "44,739",
"Revenues": "0",
"Stockholders Equity": "491,835",
"Net Income": "88,226",
"Comprehensive Net Income": "89,382",
"BaseVar": "519,516",
"ECR before LimitedLiability": "187%",
"Economic Capital Ratio": "229%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "508,136",
"Assets, Non-Current": "1,257",
"Cost of Goods and Services Sold": "1,771,981",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "136,603",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "51,084",
"Labor Expense": "0",
"Liabilities, Current": "163,391",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "119,226",
"Other Compr. Net Income": "-679",
"Other Expenses": "16,386",
"Other Liabilities": "0",
"Other Net Income": "-327",
"Other Revenues": "2,008,821",
"Property Plant and Equipment": "12,900",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "692,603",
"Liabilities": "163,391",
"Expenses": "1,924,970",
"Revenues": "2,008,821",
"Stockholders Equity": "529,212",
"Net Income": "83,524",
"Comprehensive Net Income": "82,845",
"BaseVar": "2,395,396",
"ECR before LimitedLiability": "199%",
"Economic Capital Ratio": "237%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "515,732",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "1,612,877",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "150,022",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "51,084",
"Labor Expense": "0",
"Liabilities, Current": "148,651",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "155,776",
"Other Compr. Net Income": "2,761",
"Other Expenses": "23,974",
"Other Liabilities": "0",
"Other Net Income": "10,676",
"Other Revenues": "1,840,778",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "722,592",
"Liabilities": "148,651",
"Expenses": "1,786,873",
"Revenues": "1,840,778",
"Stockholders Equity": "573,941",
"Net Income": "64,581",
"Comprehensive Net Income": "67,342",
"BaseVar": "2,256,166",
"ECR before LimitedLiability": "206%",
"Economic Capital Ratio": "243%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "572,403",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "1,492,317",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "150,778",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "51,084",
"Labor Expense": "0",
"Liabilities, Current": "162,260",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "161,544",
"Other Compr. Net Income": "2,644",
"Other Expenses": "30,504",
"Other Liabilities": "0",
"Other Net Income": "11,978",
"Other Revenues": "1,760,303",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "785,031",
"Liabilities": "162,260",
"Expenses": "1,673,599",
"Revenues": "1,760,303",
"Stockholders Equity": "622,771",
"Net Income": "98,682",
"Comprehensive Net Income": "101,326",
"BaseVar": "2,197,908",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "246%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "546,382",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "1,415,082",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "173,108",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "74,755",
"Labor Expense": "0",
"Liabilities, Current": "191,125",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "156,392",
"Other Compr. Net Income": "-1,563",
"Other Expenses": "15,960",
"Other Liabilities": "0",
"Other Net Income": "8,054",
"Other Revenues": "1,641,959",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "777,529",
"Liabilities": "191,125",
"Expenses": "1,604,150",
"Revenues": "1,641,959",
"Stockholders Equity": "586,404",
"Net Income": "45,863",
"Comprehensive Net Income": "44,300",
"BaseVar": "2,112,190",
"ECR before LimitedLiability": "185%",
"Economic Capital Ratio": "228%"
}
}
},
"top_rated": true,
"trend": -9.0,
"value": 2.276999208824154,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000731012.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000731012.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000731012.svg"
},
{
"company_id": "0001816233",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001816233.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001816233.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001816233_main_keyfigs.svg",
"name": "Sharecare Inc",
"rank": 22,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001816233.svg",
"report_text": "The relative strengths and weaknesses of Sharecare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Sharecare Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 52% points.The greatest weakness of Sharecare Inc is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 15% points.
The company's Economic Capital Ratio, given in the ranking table, is 227%, being 60% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001816233_2022_Sharecare_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "6.87",
"Liabilities": "48.5",
"Stockholders Equity": "52.3",
"ECR before LimitedLiability": "65.7",
"Intangible Assets": "16.1",
"Property Plant and Equipment": "-4.66",
"Assets, Non-Current": "-4.65",
"Assets, Current": "5.28",
"Liabilities, Current": "12.3",
"Long Term Liabilities": "32.0",
"Other Liabilities": "8.43",
"Expenses": "-7.29",
"Revenues": "13.0",
"Net Income": "7.63",
"Operating Costs and Expenses": "5.42",
"Labor Expense": "4.70",
"Cost of Goods and Services Sold": "-15.1",
"Research And Development Expense": "4.87",
"Other Revenues": "13.0",
"Comprehensive Net Income": "7.54",
"Economic Capital Ratio": "59.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001816233_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "390,966",
"Assets, Non-Current": "12,173",
"Cost of Goods and Services Sold": "203,218",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "136,594",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "347,528",
"Labor Expense": "0",
"Liabilities, Current": "95,060",
"Long Term Liabilities": "24,535",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-1,230",
"Other Expenses": "105,018",
"Other Liabilities": "12,565",
"Other Net Income": "-1,707",
"Other Revenues": "412,815",
"Property Plant and Equipment": "4,534",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "51,407"
},
"output_variables": {
"Assets": "755,201",
"Liabilities": "132,160",
"Expenses": "496,237",
"Revenues": "412,815",
"Stockholders Equity": "623,041",
"Net Income": "-85,129",
"Comprehensive Net Income": "-86,359",
"BaseVar": "899,675",
"ECR before LimitedLiability": "184%",
"Economic Capital Ratio": "227%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.273290861834365,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001816233.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001816233.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001816233.svg"
},
{
"company_id": "0001737523",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001737523.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001737523.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001737523.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001737523_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001737523_main_keyfigs.svg",
"name": "Bionexus Gene Lab Corp",
"rank": 23,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001737523.svg",
"report_text": "The relative strengths and weaknesses of Bionexus Gene Lab Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Bionexus Gene Lab Corp compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 79% points.The greatest weakness of Bionexus Gene Lab Corp is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 115% points.
The company's Economic Capital Ratio, given in the ranking table, is 226%, being 59% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001737523_2022_Bionexus_Gene_Lab_Corp.pdf",
"shrinked_graph_json": {
"2020": {
"Assets": "-15.4",
"Liabilities": "50.9",
"ECR before LimitedLiability": "64.5",
"Other Assets": "-13.7",
"Intangible Assets": "-14.3",
"Assets, Current": "11.7",
"Liabilities, Current": "-9.04",
"Other Liabilities": "10.3",
"Long Term Liabilities": "49.4",
"Labor Expense": "7.79",
"Expenses": "-13.7",
"Revenues": "51.6",
"Net Income": "36.5",
"General and Administrative Expense": "13.8",
"Research And Development Expense": "5.41",
"Other Expenses": "16.6",
"Operating Costs and Expenses": "6.19",
"Cost of Goods and Services Sold": "-74.0",
"Other Revenues": "51.6",
"Comprehensive Net Income": "38.0",
"Economic Capital Ratio": "52.4"
},
"2021": {
"Other Assets": "-11.1",
"Assets": "-21.0",
"Stockholders Equity": "-16.0",
"ECR before LimitedLiability": "64.7",
"Intangible Assets": "-17.8",
"Liabilities, Current": "11.7",
"Liabilities": "79.3",
"Long Term Liabilities": "56.6",
"Other Liabilities": "19.3",
"General and Administrative Expense": "16.9",
"Expenses": "-36.2",
"Revenues": "74.2",
"Net Income": "40.4",
"Operating Costs and Expenses": "8.53",
"Labor Expense": "7.39",
"Cost of Goods and Services Sold": "-115",
"Research And Development Expense": "7.66",
"Other Expenses": "14.7",
"Other Revenues": "74.2",
"Comprehensive Net Income": "37.9",
"Economic Capital Ratio": "58.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001737523_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "7,985",
"Assets, Non-Current": "2,130",
"Cost of Goods and Services Sold": "9,671",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,333",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,374",
"Long Term Liabilities": "80",
"Operating Costs and Expenses": "0",
"Other Assets": "-1,786",
"Other Compr. Net Income": "151",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-157",
"Other Revenues": "12,277",
"Property Plant and Equipment": "1,786",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,115",
"Liabilities": "3,453",
"Expenses": "11,004",
"Revenues": "12,277",
"Stockholders Equity": "6,662",
"Net Income": "1,117",
"Comprehensive Net Income": "1,268",
"BaseVar": "18,579",
"ECR before LimitedLiability": "161%",
"Economic Capital Ratio": "212%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "7,150",
"Assets, Non-Current": "2,425",
"Cost of Goods and Services Sold": "11,169",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,204",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,329",
"Long Term Liabilities": "66",
"Operating Costs and Expenses": "0",
"Other Assets": "-1,634",
"Other Compr. Net Income": "-234",
"Other Expenses": "291",
"Other Liabilities": "0",
"Other Net Income": "-13",
"Other Revenues": "13,429",
"Property Plant and Equipment": "1,634",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,574",
"Liabilities": "2,395",
"Expenses": "12,665",
"Revenues": "13,429",
"Stockholders Equity": "7,180",
"Net Income": "752",
"Comprehensive Net Income": "518",
"BaseVar": "19,155",
"ECR before LimitedLiability": "183%",
"Economic Capital Ratio": "226%"
}
}
},
"top_rated": true,
"trend": -1.0,
"value": 2.262977724901236,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001737523.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001737523.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001737523.svg"
},
{
"company_id": "0001822359",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001822359.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001822359.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001822359_main_keyfigs.svg",
"name": "Docgo Inc",
"rank": 24,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001822359.svg",
"report_text": "The relative strengths and weaknesses of Docgo Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Docgo Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 56% points.The greatest weakness of Docgo Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 62% points.
The company's Economic Capital Ratio, given in the ranking table, is 225%, being 57% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001822359_2022_Docgo_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "-11.9",
"Liabilities": "55.9",
"Stockholders Equity": "4.51",
"ECR before LimitedLiability": "63.0",
"Intangible Assets": "-13.1",
"Property Plant and Equipment": "-4.44",
"Assets, Non-Current": "-5.81",
"Assets, Current": "15.4",
"Liabilities, Current": "12.8",
"Long Term Liabilities": "45.6",
"Expenses": "-16.9",
"Revenues": "45.3",
"Net Income": "32.5",
"Operating Costs and Expenses": "6.95",
"Labor Expense": "6.02",
"Cost of Goods and Services Sold": "20.0",
"Research And Development Expense": "5.12",
"Other Expenses": "-62.1",
"Other Revenues": "45.3",
"Comprehensive Net Income": "34.2",
"Economic Capital Ratio": "56.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001822359_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "256,032",
"Assets, Non-Current": "8,596",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "7,512",
"General and Administrative Expense": "74,893",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "19,365",
"Labor Expense": "0",
"Liabilities, Current": "57,876",
"Long Term Liabilities": "4,284",
"Operating Costs and Expenses": "0",
"Other Assets": "12,876",
"Other Compr. Net Income": "4,580",
"Other Expenses": "213,494",
"Other Liabilities": "20,386",
"Other Net Income": "4,438",
"Other Revenues": "318,719",
"Property Plant and Equipment": "12,734",
"Research And Development Expense": "3,320",
"Selling and Marketing Expense": "4,758"
},
"output_variables": {
"Assets": "309,603",
"Liabilities": "82,546",
"Expenses": "303,977",
"Revenues": "318,719",
"Stockholders Equity": "227,057",
"Net Income": "19,179",
"Comprehensive Net Income": "23,760",
"BaseVar": "511,931",
"ECR before LimitedLiability": "180%",
"Economic Capital Ratio": "225%"
}
}
},
"top_rated": false,
"trend": null,
"value": 2.245767570683148,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001822359.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001822359.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001822359.svg"
},
{
"company_id": "0001590750",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001590750.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001590750.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001590750.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001590750_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001590750_main_keyfigs.svg",
"name": "Viridian Therapeutics Inc DE",
"rank": 25,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001590750.svg",
"report_text": "The relative strengths and weaknesses of Viridian Therapeutics Inc DE are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Viridian Therapeutics Inc DE compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 137% points.The greatest weakness of Viridian Therapeutics Inc DE is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 35% points.
The company's Economic Capital Ratio, given in the ranking table, is 221%, being 54% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001590750_2022_Viridian_Therapeutics_Inc_DE.pdf",
"shrinked_graph_json": {
"2015": {
"Assets, Current": "91.7",
"Assets": "46.6",
"Liabilities": "43.7",
"Stockholders Equity": "50.9",
"ECR before LimitedLiability": "-12.8",
"Intangible Assets": "-25.4",
"Property Plant and Equipment": "-15.9",
"Long Term Liabilities": "24.4",
"Other Liabilities": "12.3",
"Selling and Marketing Expense": "-20.4",
"Expenses": "-46.2",
"Revenues": "-22.1",
"Net Income": "-82.2",
"General and Administrative Expense": "-53.6",
"Other Expenses": "30.7",
"Labor Expense": "14.1",
"Cost of Goods and Services Sold": "-14.3",
"Other Revenues": "-22.1",
"Comprehensive Net Income": "-81.9",
"Other Net Income": "-20.5",
"Economic Capital Ratio": "-25.2"
},
"2016": {
"Property Plant and Equipment": "-29.3",
"Assets": "-54.8",
"Stockholders Equity": "-34.8",
"ECR before LimitedLiability": "-109",
"Assets, Non-Current": "-5.85",
"Intangible Assets": "-27.9",
"Other Assets": "-4.85",
"Assets, Current": "7.50",
"Expenses": "-51.4",
"Revenues": "-4.86",
"Net Income": "-67.3",
"Selling and Marketing Expense": "-4.76",
"General and Administrative Expense": "-35.8",
"Labor Expense": "2.19",
"Other Expenses": "-2.20",
"Cost of Goods and Services Sold": "-5.01",
"Research And Development Expense": "-1.54",
"Other Revenues": "-4.86",
"Other Net Income": "-6.67",
"Comprehensive Net Income": "-67.0",
"Economic Capital Ratio": "-137"
},
"2017": {
"Assets": "71.6",
"Liabilities": "13.2",
"Stockholders Equity": "75.4",
"ECR before LimitedLiability": "38.5",
"Intangible Assets": "-15.0",
"Assets, Current": "114",
"Property Plant and Equipment": "-12.3",
"Liabilities, Current": "26.7",
"Other Liabilities": "5.94",
"Long Term Liabilities": "-21.2",
"Other Revenues": "-20.6",
"Revenues": "-20.6",
"Net Income": "-38.0",
"General and Administrative Expense": "-6.88",
"Comprehensive Net Income": "-37.9",
"Labor Expense": "5.16",
"Other Net Income": "-14.6",
"Research And Development Expense": "-35.7",
"Other Expenses": "20.5",
"Cost of Goods and Services Sold": "9.11",
"Economic Capital Ratio": "14.4"
},
"2018": {
"Assets": "57.8",
"Liabilities": "17.8",
"Stockholders Equity": "84.0",
"ECR before LimitedLiability": "34.7",
"Property Plant and Equipment": "-9.18",
"Intangible Assets": "-12.3",
"Assets, Non-Current": "-5.60",
"Assets, Current": "111",
"Other Liabilities": "5.57",
"Liabilities, Current": "18.6",
"Long Term Liabilities": "-6.54",
"Expenses": "-6.37",
"Revenues": "-31.2",
"Net Income": "-34.5",
"Other Expenses": "14.5",
"Research And Development Expense": "-45.9",
"Cost of Goods and Services Sold": "17.2",
"Labor Expense": "6.51",
"Other Revenues": "-31.2",
"Comprehensive Net Income": "-34.3",
"Economic Capital Ratio": "14.0"
},
"2019": {
"Property Plant and Equipment": "-7.77",
"Assets": "-5.68",
"Stockholders Equity": "-3.15",
"Long Term Liabilities": "2.67",
"ECR before LimitedLiability": "-76.5",
"Assets, Non-Current": "-7.93",
"Other Assets": "-3.47",
"Intangible Assets": "-10.2",
"Assets, Current": "57.4",
"Other Expenses": "4.22",
"Expenses": "-18.9",
"Revenues": "-11.8",
"Net Income": "-75.7",
"General and Administrative Expense": "-5.96",
"Cost of Goods and Services Sold": "10.4",
"Research And Development Expense": "-65.8",
"Labor Expense": "2.83",
"Other Revenues": "-11.8",
"Liabilities, Current": "-3.34",
"Comprehensive Net Income": "-75.5",
"Economic Capital Ratio": "-86.5"
},
"2020": {
"Property Plant and Equipment": "-10.1",
"Assets": "68.2",
"Liabilities": "55.4",
"Stockholders Equity": "81.6",
"ECR before LimitedLiability": "15.5",
"Other Assets": "-5.49",
"Intangible Assets": "-16.5",
"Assets, Current": "130",
"Assets, Non-Current": "-9.14",
"Liabilities, Current": "18.4",
"Other Liabilities": "6.39",
"Long Term Liabilities": "33.0",
"Labor Expense": "5.69",
"Expenses": "-43.9",
"Revenues": "-45.8",
"Net Income": "-88.4",
"General and Administrative Expense": "5.86",
"Other Expenses": "-82.5",
"Cost of Goods and Services Sold": "18.6",
"Other Revenues": "-45.8",
"Comprehensive Net Income": "-88.4",
"Economic Capital Ratio": "3.43"
},
"2021": {
"Assets": "52.1",
"Liabilities": "41.3",
"Stockholders Equity": "121",
"ECR before LimitedLiability": "59.9",
"Intangible Assets": "-9.43",
"Property Plant and Equipment": "-3.62",
"Assets, Current": "137",
"Liabilities, Current": "11.7",
"Long Term Liabilities": "25.7",
"Other Liabilities": "7.02",
"Expenses": "-3.94",
"Revenues": "-32.6",
"Net Income": "-35.2",
"Operating Costs and Expenses": "3.70",
"Labor Expense": "3.20",
"Cost of Goods and Services Sold": "10.7",
"Research And Development Expense": "3.32",
"Other Expenses": "-27.2",
"Other Revenues": "-32.6",
"Comprehensive Net Income": "-35.2",
"Economic Capital Ratio": "53.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001590750_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "11,734",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "2,472",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "7,692",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,468",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "15",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "2,538",
"Property Plant and Equipment": "1,153",
"Research And Development Expense": "1,002",
"Selling and Marketing Expense": "2,559"
},
"output_variables": {
"Assets": "12,902",
"Liabilities": "2,468",
"Expenses": "13,725",
"Revenues": "2,538",
"Stockholders Equity": "10,434",
"Net Income": "-11,187",
"Comprehensive Net Income": "-11,187",
"BaseVar": "15,816",
"ECR before LimitedLiability": "51%",
"Economic Capital Ratio": "134%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "4,259",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "2,548",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "7,906",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,585",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3,000",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "3,337",
"Property Plant and Equipment": "0",
"Research And Development Expense": "888",
"Selling and Marketing Expense": "1,669"
},
"output_variables": {
"Assets": "4,259",
"Liabilities": "4,585",
"Expenses": "16,011",
"Revenues": "3,337",
"Stockholders Equity": "-326",
"Net Income": "-12,674",
"Comprehensive Net Income": "-12,674",
"BaseVar": "14,096",
"ECR before LimitedLiability": "-297%",
"Economic Capital Ratio": "14%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "51,868",
"Assets, Non-Current": "50",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "10,912",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,897",
"Long Term Liabilities": "10,074",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "383",
"Other Liabilities": "0",
"Other Net Income": "403",
"Other Revenues": "4,003",
"Property Plant and Equipment": "563",
"Research And Development Expense": "19,623",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "52,481",
"Liabilities": "13,971",
"Expenses": "30,918",
"Revenues": "4,003",
"Stockholders Equity": "38,510",
"Net Income": "-26,512",
"Comprehensive Net Income": "-26,512",
"BaseVar": "50,888",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "163%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "65,370",
"Assets, Non-Current": "50",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "11,049",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "6,733",
"Long Term Liabilities": "8,070",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-3.0",
"Other Expenses": "873",
"Other Liabilities": "0",
"Other Net Income": "1,254",
"Other Revenues": "8,386",
"Property Plant and Equipment": "727",
"Research And Development Expense": "30,421",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "66,147",
"Liabilities": "14,803",
"Expenses": "42,343",
"Revenues": "8,386",
"Stockholders Equity": "51,344",
"Net Income": "-32,703",
"Comprehensive Net Income": "-32,706",
"BaseVar": "66,468",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "173%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "29,739",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "11,646",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "10,180",
"Long Term Liabilities": "4,328",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "3.0",
"Other Expenses": "835",
"Other Liabilities": "0",
"Other Net Income": "941",
"Other Revenues": "4,461",
"Property Plant and Equipment": "523",
"Research And Development Expense": "34,794",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "30,262",
"Liabilities": "14,508",
"Expenses": "47,275",
"Revenues": "4,461",
"Stockholders Equity": "15,754",
"Net Income": "-41,873",
"Comprehensive Net Income": "-41,870",
"BaseVar": "48,725",
"ECR before LimitedLiability": "-85%",
"Economic Capital Ratio": "75%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "129,611",
"Assets, Non-Current": "1,335",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "13,265",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "10,674",
"Long Term Liabilities": "544",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-8.0",
"Other Expenses": "98,673",
"Other Liabilities": "0",
"Other Net Income": "173",
"Other Revenues": "1,050",
"Property Plant and Equipment": "309",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "131,255",
"Liabilities": "11,218",
"Expenses": "111,938",
"Revenues": "1,050",
"Stockholders Equity": "120,037",
"Net Income": "-110,715",
"Comprehensive Net Income": "-110,723",
"BaseVar": "127,821",
"ECR before LimitedLiability": "89%",
"Economic Capital Ratio": "163%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "200,163",
"Assets, Non-Current": "3,171",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "25,805",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "13,636",
"Long Term Liabilities": "1,208",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-149",
"Other Expenses": "56,889",
"Other Liabilities": "1,149",
"Other Net Income": "318",
"Other Revenues": "2,963",
"Property Plant and Equipment": "375",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "203,709",
"Liabilities": "15,993",
"Expenses": "82,694",
"Revenues": "2,963",
"Stockholders Equity": "187,716",
"Net Income": "-79,413",
"Comprehensive Net Income": "-79,562",
"BaseVar": "152,913",
"ECR before LimitedLiability": "175%",
"Economic Capital Ratio": "221%"
}
}
},
"top_rated": false,
"trend": 11.0,
"value": 2.2146709211778437,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001590750.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001590750.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001590750.svg"
},
{
"company_id": "0001803901",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001803901.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001803901.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001803901_main_keyfigs.svg",
"name": "Talkspace Inc",
"rank": 26,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001803901.svg",
"report_text": "The relative strengths and weaknesses of Talkspace Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Talkspace Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 67% points.The greatest weakness of Talkspace Inc is the variable Selling and Marketing Expense, reducing the Economic Capital Ratio by 51% points.
The company's Economic Capital Ratio, given in the ranking table, is 218%, being 50% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001803901_2022_Talkspace_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "6.30",
"Liabilities": "57.5",
"Stockholders Equity": "59.0",
"ECR before LimitedLiability": "56.0",
"Intangible Assets": "-12.1",
"Property Plant and Equipment": "-5.70",
"Assets, Non-Current": "-6.45",
"Assets, Current": "66.6",
"Liabilities, Current": "14.2",
"Long Term Liabilities": "39.6",
"Other Liabilities": "8.23",
"Expenses": "-21.4",
"Revenues": "7.79",
"Net Income": "-11.2",
"Labor Expense": "4.90",
"Cost of Goods and Services Sold": "-7.93",
"Other Expenses": "28.1",
"Selling and Marketing Expense": "-50.6",
"Other Revenues": "7.79",
"Comprehensive Net Income": "-11.1",
"Economic Capital Ratio": "49.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001803901_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "213,330",
"Assets, Non-Current": "82",
"Cost of Goods and Services Sold": "46,899",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "34,770",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "9,570",
"Labor Expense": "0",
"Liabilities, Current": "27,177",
"Long Term Liabilities": "86",
"Operating Costs and Expenses": "9,365",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-31,181",
"Other Liabilities": "4,070",
"Other Net Income": "0",
"Other Revenues": "113,671",
"Property Plant and Equipment": "624",
"Research And Development Expense": "15,919",
"Selling and Marketing Expense": "100,641"
},
"output_variables": {
"Assets": "223,606",
"Liabilities": "31,333",
"Expenses": "176,413",
"Revenues": "113,671",
"Stockholders Equity": "192,273",
"Net Income": "-62,742",
"Comprehensive Net Income": "-62,742",
"BaseVar": "272,512",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "218%"
}
}
},
"top_rated": false,
"trend": null,
"value": 2.175893723641178,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001803901.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001803901.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001803901.svg"
},
{
"company_id": "0001527753",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001527753.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001527753.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001527753.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001527753_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001527753_main_keyfigs.svg",
"name": "Personalis Inc",
"rank": 27,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001527753.svg",
"report_text": "The relative strengths and weaknesses of Personalis Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Personalis Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 66% points.The greatest weakness of Personalis Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 12% points.
The company's Economic Capital Ratio, given in the ranking table, is 211%, being 43% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001527753_2022_Personalis_Inc.pdf",
"shrinked_graph_json": {
"2019": {
"Assets": "21.6",
"Expenses": "7.09",
"Stockholders Equity": "40.6",
"ECR before LimitedLiability": "36.3",
"Assets, Non-Current": "-6.99",
"Other Assets": "-3.31",
"Intangible Assets": "-12.4",
"Assets, Current": "90.5",
"Other Liabilities": "7.99",
"Liabilities": "10.0",
"Long Term Liabilities": "29.8",
"Liabilities, Current": "-32.8",
"Other Expenses": "9.46",
"Cost of Goods and Services Sold": "-8.93",
"Research And Development Expense": "-8.72",
"Selling and Marketing Expense": "3.69",
"Labor Expense": "5.55",
"Operating Costs and Expenses": "4.76",
"Other Revenues": "-6.49",
"Revenues": "-6.49",
"Economic Capital Ratio": "26.2"
},
"2020": {
"Property Plant and Equipment": "-2.64",
"Assets": "26.1",
"Liabilities": "29.5",
"Stockholders Equity": "70.1",
"ECR before LimitedLiability": "66.3",
"Other Assets": "-2.97",
"Intangible Assets": "-9.19",
"Assets, Current": "76.5",
"Other Liabilities": "6.43",
"Long Term Liabilities": "24.8",
"Labor Expense": "4.78",
"Expenses": "3.16",
"Revenues": "-7.35",
"Net Income": "-3.05",
"Research And Development Expense": "-9.48",
"Other Expenses": "10.2",
"Operating Costs and Expenses": "3.80",
"Cost of Goods and Services Sold": "-11.0",
"Other Revenues": "-7.35",
"Comprehensive Net Income": "-3.03",
"Economic Capital Ratio": "54.2"
},
"2021": {
"Assets": "30.7",
"Liabilities": "18.0",
"Stockholders Equity": "65.9",
"ECR before LimitedLiability": "49.3",
"Intangible Assets": "-11.3",
"Assets, Non-Current": "5.49",
"Assets, Current": "56.6",
"Liabilities, Current": "12.4",
"Long Term Liabilities": "-2.96",
"Other Liabilities": "8.78",
"Expenses": "7.70",
"Revenues": "-12.2",
"Net Income": "-2.95",
"Operating Costs and Expenses": "3.94",
"Labor Expense": "3.41",
"Cost of Goods and Services Sold": "-3.28",
"Research And Development Expense": "-9.94",
"Other Expenses": "8.24",
"Other Revenues": "-12.2",
"Comprehensive Net Income": "-2.93",
"Economic Capital Ratio": "43.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001527753_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "139,578",
"Assets, Non-Current": "3,607",
"Cost of Goods and Services Sold": "43,127",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "22,080",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "49,962",
"Long Term Liabilities": "639",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "9.0",
"Other Expenses": "1,142",
"Other Liabilities": "0",
"Other Net Income": "-1,524",
"Other Revenues": "65,207",
"Property Plant and Equipment": "14,106",
"Research And Development Expense": "22,418",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "157,291",
"Liabilities": "50,601",
"Expenses": "88,767",
"Revenues": "65,207",
"Stockholders Equity": "106,690",
"Net Income": "-25,084",
"Comprehensive Net Income": "-25,075",
"BaseVar": "181,700",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "188%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "220,719",
"Assets, Non-Current": "12,289",
"Cost of Goods and Services Sold": "58,534",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "33,692",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "40,636",
"Long Term Liabilities": "9,261",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "28",
"Other Expenses": "59",
"Other Liabilities": "0",
"Other Net Income": "925",
"Other Revenues": "78,648",
"Property Plant and Equipment": "11,834",
"Research And Development Expense": "28,568",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "244,842",
"Liabilities": "49,897",
"Expenses": "120,853",
"Revenues": "78,648",
"Stockholders Equity": "194,945",
"Net Income": "-41,280",
"Comprehensive Net Income": "-41,252",
"BaseVar": "247,596",
"ECR before LimitedLiability": "164%",
"Economic Capital Ratio": "214%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "318,231",
"Assets, Non-Current": "58,647",
"Cost of Goods and Services Sold": "53,837",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "47,698",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "31,313",
"Long Term Liabilities": "54,914",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-188",
"Other Expenses": "198",
"Other Liabilities": "0",
"Other Net Income": "325",
"Other Revenues": "85,494",
"Property Plant and Equipment": "19,650",
"Research And Development Expense": "49,312",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "396,528",
"Liabilities": "86,227",
"Expenses": "151,045",
"Revenues": "85,494",
"Stockholders Equity": "310,301",
"Net Income": "-65,226",
"Comprehensive Net Income": "-65,414",
"BaseVar": "359,904",
"ECR before LimitedLiability": "159%",
"Economic Capital Ratio": "211%"
}
}
},
"top_rated": false,
"trend": -6.0,
"value": 2.1087186190855363,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001527753.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001527753.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001527753.svg"
},
{
"company_id": "0001828182",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001828182.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001828182.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001828182_main_keyfigs.svg",
"name": "Signify Health Inc",
"rank": 28,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001828182.svg",
"report_text": "The relative strengths and weaknesses of Signify Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Signify Health Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 41% points.The greatest weakness of Signify Health Inc is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 6.9% points.
The company's Economic Capital Ratio, given in the ranking table, is 210%, being 42% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001828182_2022_Signify_Health_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "19.9",
"Liabilities": "6.96",
"Stockholders Equity": "40.9",
"ECR before LimitedLiability": "48.1",
"Intangible Assets": "25.4",
"Property Plant and Equipment": "-4.09",
"Assets, Non-Current": "-4.94",
"Assets, Current": "7.33",
"Liabilities, Current": "13.3",
"Long Term Liabilities": "-5.09",
"General and Administrative Expense": "2.98",
"Expenses": "16.1",
"Net Income": "16.0",
"Operating Costs and Expenses": "4.11",
"Labor Expense": "3.56",
"Cost of Goods and Services Sold": "-6.86",
"Research And Development Expense": "3.69",
"Other Expenses": "4.08",
"Selling and Marketing Expense": "2.84",
"Comprehensive Net Income": "16.1",
"Economic Capital Ratio": "41.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001828182_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "1,000,600",
"Assets, Non-Current": "11,700",
"Cost of Goods and Services Sold": "393,500",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "244,500",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,052,400",
"Labor Expense": "0",
"Liabilities, Current": "183,100",
"Long Term Liabilities": "346,300",
"Operating Costs and Expenses": "0",
"Other Assets": "38,800",
"Other Compr. Net Income": "0",
"Other Expenses": "96,000",
"Other Liabilities": "104,900",
"Other Net Income": "-29,500",
"Other Revenues": "773,400",
"Property Plant and Equipment": "23,700",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,127,200",
"Liabilities": "634,300",
"Expenses": "734,000",
"Revenues": "773,400",
"Stockholders Equity": "1,492,900",
"Net Income": "9,900",
"Comprehensive Net Income": "9,900",
"BaseVar": "2,149,200",
"ECR before LimitedLiability": "157%",
"Economic Capital Ratio": "210%"
}
}
},
"top_rated": false,
"trend": null,
"value": 2.096816785236687,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001828182.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001828182.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001828182.svg"
},
{
"company_id": "0001047335",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001047335.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001047335.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001047335.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001047335_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001047335_main_keyfigs.svg",
"name": "National Healthcare CORP",
"rank": 29,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001047335.svg",
"report_text": "The relative strengths and weaknesses of National Healthcare CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of National Healthcare CORP compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 32% points.The greatest weakness of National Healthcare CORP is the variable Labor Expense, reducing the Economic Capital Ratio by 39% points.
The company's Economic Capital Ratio, given in the ranking table, is 207%, being 39% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001047335_2022_National_Healthcare_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Other Liabilities": "13.2",
"Liabilities": "42.3",
"Stockholders Equity": "36.3",
"ECR before LimitedLiability": "74.6",
"Long Term Liabilities": "39.5",
"Liabilities, Current": "-10.7",
"Expenses": "3.27",
"Net Income": "25.9",
"Other Expenses": "25.9",
"Operating Costs and Expenses": "-16.8",
"Labor Expense": "-42.5",
"General and Administrative Expense": "20.5",
"Cost of Goods and Services Sold": "7.99",
"Other Revenues": "-45.6",
"Revenues": "-45.6",
"Property Plant and Equipment": "16.0",
"Assets, Current": "5.30",
"Intangible Assets": "-12.5",
"Other Net Income": "66.7",
"Comprehensive Net Income": "26.2",
"Economic Capital Ratio": "67.9"
},
"2012": {
"Liabilities, Current": "-7.76",
"Liabilities": "42.7",
"Stockholders Equity": "37.9",
"ECR before LimitedLiability": "80.5",
"Long Term Liabilities": "31.1",
"Other Liabilities": "20.8",
"Expenses": "3.14",
"Net Income": "23.0",
"Other Expenses": "22.0",
"General and Administrative Expense": "20.4",
"Operating Costs and Expenses": "-17.4",
"Cost of Goods and Services Sold": "8.01",
"Labor Expense": "-38.8",
"Other Revenues": "-42.9",
"Revenues": "-42.9",
"Property Plant and Equipment": "15.2",
"Intangible Assets": "-11.4",
"Assets, Current": "3.73",
"Other Net Income": "60.8",
"Comprehensive Net Income": "25.0",
"Economic Capital Ratio": "66.3"
},
"2013": {
"Other Liabilities": "18.1",
"Liabilities": "47.0",
"Stockholders Equity": "39.6",
"Other Assets": "-3.13",
"ECR before LimitedLiability": "72.8",
"Long Term Liabilities": "31.7",
"Other Revenues": "-44.0",
"Revenues": "-44.0",
"Net Income": "26.0",
"Property Plant and Equipment": "17.7",
"Intangible Assets": "-10.6",
"Comprehensive Net Income": "25.8",
"Selling and Marketing Expense": "2.77",
"General and Administrative Expense": "21.1",
"Cost of Goods and Services Sold": "7.28",
"Other Net Income": "67.7",
"Labor Expense": "-38.1",
"Operating Costs and Expenses": "-17.2",
"Other Expenses": "18.5",
"Research And Development Expense": "4.20",
"Economic Capital Ratio": "63.6"
},
"2014": {
"Other Liabilities": "16.2",
"Liabilities": "69.1",
"Stockholders Equity": "65.0",
"Intangible Assets": "-7.87",
"ECR before LimitedLiability": "108",
"Liabilities, Current": "20.2",
"Long Term Liabilities": "43.2",
"Other Revenues": "-49.2",
"Revenues": "-49.2",
"Net Income": "26.4",
"Assets, Non-Current": "9.24",
"Property Plant and Equipment": "13.1",
"Other Net Income": "69.4",
"Comprehensive Net Income": "28.5",
"Operating Costs and Expenses": "-17.7",
"Labor Expense": "-44.6",
"Research And Development Expense": "5.24",
"Other Expenses": "18.9",
"Cost of Goods and Services Sold": "8.97",
"General and Administrative Expense": "21.6",
"Economic Capital Ratio": "94.6"
},
"2015": {
"Long Term Liabilities": "34.7",
"Liabilities": "73.8",
"Stockholders Equity": "66.7",
"Assets, Non-Current": "8.96",
"ECR before LimitedLiability": "108",
"Other Liabilities": "18.4",
"Liabilities, Current": "34.2",
"Other Revenues": "-55.1",
"Revenues": "-55.1",
"Net Income": "30.6",
"Intangible Assets": "-7.20",
"Property Plant and Equipment": "15.0",
"Comprehensive Net Income": "29.8",
"Selling and Marketing Expense": "6.28",
"Operating Costs and Expenses": "-21.6",
"Other Net Income": "80.8",
"General and Administrative Expense": "22.9",
"Other Expenses": "20.9",
"Labor Expense": "-52.8",
"Cost of Goods and Services Sold": "12.2",
"Economic Capital Ratio": "95.5"
},
"2016": {
"Liabilities, Current": "48.3",
"Liabilities": "82.7",
"Stockholders Equity": "85.4",
"Property Plant and Equipment": "15.4",
"ECR before LimitedLiability": "136",
"Other Liabilities": "20.7",
"Long Term Liabilities": "29.6",
"Other Revenues": "-59.1",
"Revenues": "-59.1",
"Net Income": "32.2",
"Assets, Non-Current": "7.57",
"Comprehensive Net Income": "34.4",
"Operating Costs and Expenses": "-23.5",
"Selling and Marketing Expense": "7.21",
"General and Administrative Expense": "25.3",
"Labor Expense": "-60.9",
"Other Expenses": "22.1",
"Cost of Goods and Services Sold": "17.4",
"Research And Development Expense": "6.41",
"Other Net Income": "83.4",
"Economic Capital Ratio": "108"
},
"2018": {
"Liabilities": "31.0",
"Stockholders Equity": "20.2",
"ECR before LimitedLiability": "71.0",
"Liabilities, Current": "29.3",
"Other Revenues": "27.2",
"Revenues": "27.2",
"Net Income": "33.8",
"Other Assets": "-6.23",
"Property Plant and Equipment": "29.7",
"Intangible Assets": "-10.6",
"Assets, Non-Current": "8.78",
"Assets, Current": "-10.7",
"Selling and Marketing Expense": "4.05",
"Comprehensive Net Income": "33.9",
"Operating Costs and Expenses": "-19.2",
"Research And Development Expense": "6.09",
"Other Expenses": "15.4",
"General and Administrative Expense": "21.9",
"Cost of Goods and Services Sold": "22.7",
"Labor Expense": "-46.4",
"Economic Capital Ratio": "50.2"
},
"2019": {
"Other Liabilities": "5.58",
"Liabilities": "15.4",
"Stockholders Equity": "9.62",
"ECR before LimitedLiability": "42.5",
"Liabilities, Current": "11.0",
"Other Expenses": "7.44",
"Expenses": "5.60",
"Revenues": "15.7",
"Net Income": "24.8",
"General and Administrative Expense": "17.6",
"Cost of Goods and Services Sold": "23.2",
"Research And Development Expense": "6.88",
"Labor Expense": "-37.2",
"Operating Costs and Expenses": "-14.1",
"Other Revenues": "15.7",
"Property Plant and Equipment": "24.4",
"Assets, Non-Current": "15.1",
"Intangible Assets": "-12.9",
"Assets, Current": "-11.7",
"Comprehensive Net Income": "25.4",
"Economic Capital Ratio": "32.5"
},
"2020": {
"Liabilities": "12.7",
"Stockholders Equity": "5.94",
"ECR before LimitedLiability": "40.5",
"Other Liabilities": "4.82",
"Long Term Liabilities": "5.10",
"Other Revenues": "19.3",
"Revenues": "19.3",
"Net Income": "22.8",
"Property Plant and Equipment": "25.4",
"Other Assets": "-5.88",
"Intangible Assets": "-13.5",
"Assets, Current": "-11.1",
"Assets, Non-Current": "14.1",
"Comprehensive Net Income": "23.0",
"Labor Expense": "-36.0",
"General and Administrative Expense": "21.0",
"Research And Development Expense": "4.16",
"Other Expenses": "9.14",
"Operating Costs and Expenses": "-15.1",
"Cost of Goods and Services Sold": "19.4",
"Economic Capital Ratio": "28.4"
},
"2021": {
"Other Assets": "-9.82",
"Assets": "-6.26",
"Liabilities": "25.0",
"ECR before LimitedLiability": "45.1",
"Intangible Assets": "-10.1",
"Property Plant and Equipment": "21.9",
"Assets, Non-Current": "16.1",
"Assets, Current": "-13.2",
"Long Term Liabilities": "11.0",
"Other Liabilities": "10.6",
"Other Revenues": "23.2",
"Revenues": "23.2",
"Net Income": "31.8",
"General and Administrative Expense": "20.5",
"Comprehensive Net Income": "31.6",
"Operating Costs and Expenses": "-15.3",
"Labor Expense": "-39.5",
"Cost of Goods and Services Sold": "16.6",
"Other Net Income": "8.99",
"Other Expenses": "7.83",
"Economic Capital Ratio": "39.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001047335_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "362,186",
"Assets, Non-Current": "73,835",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "28,901",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "20,320",
"Labor Expense": "428,672",
"Liabilities, Current": "215,907",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "198,439",
"Other Assets": "-20,320",
"Other Compr. Net Income": "0",
"Other Expenses": "73,986",
"Other Liabilities": "0",
"Other Net Income": "773,537",
"Other Revenues": "20,533",
"Property Plant and Equipment": "429,651",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "865,672",
"Liabilities": "215,907",
"Expenses": "729,998",
"Revenues": "20,533",
"Stockholders Equity": "649,765",
"Net Income": "64,072",
"Comprehensive Net Income": "64,072",
"BaseVar": "1,302,824",
"ECR before LimitedLiability": "186%",
"Economic Capital Ratio": "229%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "414,979",
"Assets, Non-Current": "84,295",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "29,792",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,600",
"Labor Expense": "426,934",
"Liabilities, Current": "226,495",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "198,691",
"Other Assets": "-17,600",
"Other Compr. Net Income": "14,106",
"Other Expenses": "73,133",
"Other Liabilities": "0",
"Other Net Income": "761,262",
"Other Revenues": "25,245",
"Property Plant and Equipment": "420,907",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "920,181",
"Liabilities": "226,495",
"Expenses": "728,550",
"Revenues": "25,245",
"Stockholders Equity": "693,686",
"Net Income": "57,957",
"Comprehensive Net Income": "72,063",
"BaseVar": "1,337,920",
"ECR before LimitedLiability": "188%",
"Economic Capital Ratio": "230%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "436,928",
"Assets, Non-Current": "86,999",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "28,547",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,600",
"Labor Expense": "453,560",
"Liabilities, Current": "250,359",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "194,989",
"Other Assets": "-17,600",
"Other Compr. Net Income": "-4,623",
"Other Expenses": "77,343",
"Other Liabilities": "0",
"Other Net Income": "788,957",
"Other Revenues": "30,095",
"Property Plant and Equipment": "456,798",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "980,725",
"Liabilities": "250,359",
"Expenses": "754,439",
"Revenues": "30,095",
"Stockholders Equity": "730,366",
"Net Income": "64,613",
"Comprehensive Net Income": "59,990",
"BaseVar": "1,404,599",
"ECR before LimitedLiability": "182%",
"Economic Capital Ratio": "226%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "322,525",
"Assets, Non-Current": "236,854",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "34,384",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,600",
"Labor Expense": "510,249",
"Liabilities, Current": "183,558",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "217,143",
"Other Assets": "-17,600",
"Other Compr. Net Income": "18,423",
"Other Expenses": "73,720",
"Other Liabilities": "0",
"Other Net Income": "871,683",
"Other Revenues": "17,182",
"Property Plant and Equipment": "514,744",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,074,123",
"Liabilities": "183,558",
"Expenses": "835,496",
"Revenues": "17,182",
"Stockholders Equity": "890,565",
"Net Income": "53,369",
"Comprehensive Net Income": "71,792",
"BaseVar": "1,500,232",
"ECR before LimitedLiability": "217%",
"Economic Capital Ratio": "250%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "278,942",
"Assets, Non-Current": "230,341",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "37,114",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,600",
"Labor Expense": "532,735",
"Liabilities, Current": "150,656",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "227,072",
"Other Assets": "-17,600",
"Other Compr. Net Income": "-11,244",
"Other Expenses": "74,706",
"Other Liabilities": "0",
"Other Net Income": "906,622",
"Other Revenues": "18,148",
"Property Plant and Equipment": "536,046",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,045,329",
"Liabilities": "150,656",
"Expenses": "871,627",
"Revenues": "18,148",
"Stockholders Equity": "894,673",
"Net Income": "53,143",
"Comprehensive Net Income": "41,899",
"BaseVar": "1,501,813",
"ECR before LimitedLiability": "224%",
"Economic Capital Ratio": "255%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "290,857",
"Assets, Non-Current": "236,966",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "39,023",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,600",
"Labor Expense": "548,007",
"Liabilities, Current": "150,928",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "233,833",
"Other Assets": "-17,600",
"Other Compr. Net Income": "12,704",
"Other Expenses": "74,902",
"Other Liabilities": "0",
"Other Net Income": "926,638",
"Other Revenues": "19,665",
"Property Plant and Equipment": "559,624",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,087,447",
"Liabilities": "150,928",
"Expenses": "895,765",
"Revenues": "19,665",
"Stockholders Equity": "936,519",
"Net Income": "50,538",
"Comprehensive Net Income": "63,242",
"BaseVar": "1,546,574",
"ECR before LimitedLiability": "230%",
"Economic Capital Ratio": "259%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "322,009",
"Assets, Non-Current": "224,289",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "41,894",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "20,995",
"Labor Expense": "582,721",
"Liabilities, Current": "157,924",
"Long Term Liabilities": "137,585",
"Operating Costs and Expenses": "254,038",
"Other Assets": "-20,995",
"Other Compr. Net Income": "-1,783",
"Other Expenses": "61,805",
"Other Liabilities": "50,982",
"Other Net Income": "18,808",
"Other Revenues": "980,349",
"Property Plant and Equipment": "534,650",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,080,948",
"Liabilities": "346,491",
"Expenses": "940,458",
"Revenues": "980,349",
"Stockholders Equity": "734,457",
"Net Income": "58,699",
"Comprehensive Net Income": "56,916",
"BaseVar": "1,684,418",
"ECR before LimitedLiability": "157%",
"Economic Capital Ratio": "209%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "341,053",
"Assets, Non-Current": "410,165",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "42,419",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "20,995",
"Labor Expense": "592,831",
"Liabilities, Current": "218,775",
"Long Term Liabilities": "261,215",
"Operating Costs and Expenses": "268,442",
"Other Assets": "-20,995",
"Other Compr. Net Income": "5,540",
"Other Expenses": "63,692",
"Other Liabilities": "27,589",
"Other Net Income": "38,977",
"Other Revenues": "996,383",
"Property Plant and Equipment": "535,430",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,286,648",
"Liabilities": "507,579",
"Expenses": "967,384",
"Revenues": "996,383",
"Stockholders Equity": "779,069",
"Net Income": "67,976",
"Comprehensive Net Income": "73,516",
"BaseVar": "1,901,256",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "194%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "456,755",
"Assets, Non-Current": "385,059",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "42,018",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "21,341",
"Labor Expense": "609,306",
"Liabilities, Current": "295,307",
"Long Term Liabilities": "250,563",
"Operating Costs and Expenses": "286,845",
"Other Assets": "-21,341",
"Other Compr. Net Income": "2,378",
"Other Expenses": "52,326",
"Other Liabilities": "18,002",
"Other Net Income": "4,268",
"Other Revenues": "1,028,217",
"Property Plant and Equipment": "520,318",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,362,132",
"Liabilities": "563,872",
"Expenses": "990,495",
"Revenues": "1,028,217",
"Stockholders Equity": "798,260",
"Net Income": "41,990",
"Comprehensive Net Income": "44,368",
"BaseVar": "1,975,681",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "188%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "426,638",
"Assets, Non-Current": "455,762",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "40,672",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "175,333",
"Labor Expense": "629,672",
"Liabilities, Current": "270,053",
"Long Term Liabilities": "212,027",
"Operating Costs and Expenses": "303,145",
"Other Assets": "-175,333",
"Other Compr. Net Income": "-3,949",
"Other Expenses": "60,839",
"Other Liabilities": "12,856",
"Other Net Income": "99,113",
"Other Revenues": "1,074,302",
"Property Plant and Equipment": "520,996",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,403,396",
"Liabilities": "494,936",
"Expenses": "1,034,328",
"Revenues": "1,074,302",
"Stockholders Equity": "908,460",
"Net Income": "139,087",
"Comprehensive Net Income": "135,138",
"BaseVar": "2,055,012",
"ECR before LimitedLiability": "153%",
"Economic Capital Ratio": "207%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 2.067376382378623,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001047335.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001047335.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001047335.svg"
},
{
"company_id": "0001773751",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001773751.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001773751.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001773751_main_keyfigs.svg",
"name": "Hims Hers Health Inc",
"rank": 30,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001773751.svg",
"report_text": "The relative strengths and weaknesses of Hims Hers Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Hims Hers Health Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 51% points.The greatest weakness of Hims Hers Health Inc is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 26% points.
The company's Economic Capital Ratio, given in the ranking table, is 204%, being 36% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001773751_2022_Hims_Hers_Health_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Liabilities": "51.5",
"Stockholders Equity": "34.0",
"ECR before LimitedLiability": "42.5",
"Long Term Liabilities": "39.0",
"Other Liabilities": "12.0",
"General and Administrative Expense": "-26.4",
"Expenses": "-23.8",
"Revenues": "16.3",
"Net Income": "-5.21",
"Operating Costs and Expenses": "6.06",
"Labor Expense": "5.24",
"Research And Development Expense": "5.43",
"Other Expenses": "-20.8",
"Selling and Marketing Expense": "4.18",
"Other Revenues": "16.3",
"Intangible Assets": "3.80",
"Property Plant and Equipment": "-7.25",
"Assets, Non-Current": "-5.96",
"Assets, Current": "12.0",
"Comprehensive Net Income": "-5.14",
"Economic Capital Ratio": "36.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001773751_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "269,905",
"Assets, Non-Current": "13,053",
"Cost of Goods and Services Sold": "67,384",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "183,634",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "136,771",
"Labor Expense": "0",
"Liabilities, Current": "79,221",
"Long Term Liabilities": "4,746",
"Operating Costs and Expenses": "0",
"Other Assets": "856",
"Other Compr. Net Income": "-126",
"Other Expenses": "128,964",
"Other Liabilities": "1,999",
"Other Net Income": "445",
"Other Revenues": "271,878",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "420,585",
"Liabilities": "85,966",
"Expenses": "379,982",
"Revenues": "271,878",
"Stockholders Equity": "334,619",
"Net Income": "-107,659",
"Comprehensive Net Income": "-107,785",
"BaseVar": "579,491",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "204%"
}
}
},
"top_rated": false,
"trend": null,
"value": 2.0410121972676327,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001773751.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001773751.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001773751.svg"
},
{
"company_id": "0001787640",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001787640.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001787640.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001787640_main_keyfigs.svg",
"name": "Convey Health Solutions Holdings Inc",
"rank": 31,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001787640.svg",
"report_text": "The relative strengths and weaknesses of Convey Health Solutions Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Convey Health Solutions Holdings Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 92% points.The greatest weakness of Convey Health Solutions Holdings Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 19% points.
The company's Economic Capital Ratio, given in the ranking table, is 196%, being 29% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001787640_2022_Convey_Health_Solutions_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "15.9",
"Stockholders Equity": "27.0",
"ECR before LimitedLiability": "34.7",
"Intangible Assets": "91.9",
"Property Plant and Equipment": "-4.03",
"Assets, Non-Current": "-6.13",
"Assets, Current": "-15.1",
"General and Administrative Expense": "4.14",
"Expenses": "14.9",
"Net Income": "15.1",
"Operating Costs and Expenses": "4.29",
"Labor Expense": "3.72",
"Cost of Goods and Services Sold": "12.5",
"Research And Development Expense": "3.85",
"Other Expenses": "-14.6",
"Selling and Marketing Expense": "2.96",
"Long Term Liabilities": "-18.5",
"Other Liabilities": "9.00",
"Liabilities, Current": "8.72",
"Comprehensive Net Income": "15.2",
"Economic Capital Ratio": "28.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001787640_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "132,253",
"Assets, Non-Current": "2,030",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "30,480",
"General and Administrative Expense": "94,093",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "675,220",
"Labor Expense": "0",
"Liabilities, Current": "96,388",
"Long Term Liabilities": "195,238",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-47",
"Other Expenses": "200,692",
"Other Liabilities": "528",
"Other Net Income": "-22,309",
"Other Revenues": "337,596",
"Property Plant and Equipment": "20,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "829,903",
"Liabilities": "292,154",
"Expenses": "325,265",
"Revenues": "337,596",
"Stockholders Equity": "537,749",
"Net Income": "-9,978",
"Comprehensive Net Income": "-10,025",
"BaseVar": "903,637",
"ECR before LimitedLiability": "137%",
"Economic Capital Ratio": "196%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.963020054687783,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001787640.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001787640.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001787640.svg"
},
{
"company_id": "0000885978",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000885978.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000885978.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000885978.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000885978_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000885978_main_keyfigs.svg",
"name": "U S Physical Therapy INC NV",
"rank": 32,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000885978.svg",
"report_text": "The relative strengths and weaknesses of U S Physical Therapy INC NV are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of U S Physical Therapy INC NV compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 48% points.The greatest weakness of U S Physical Therapy INC NV is the variable Labor Expense, reducing the Economic Capital Ratio by 31% points.
The company's Economic Capital Ratio, given in the ranking table, is 196%, being 28% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000885978_2022_U_S_Physical_Therapy_INC_NV.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-11.4",
"Stockholders Equity": "8.44",
"ECR before LimitedLiability": "84.8",
"Property Plant and Equipment": "-10.9",
"Intangible Assets": "13.7",
"Other Liabilities": "16.8",
"Liabilities": "70.2",
"Long Term Liabilities": "22.3",
"Liabilities, Current": "41.2",
"Expenses": "-14.3",
"Revenues": "96.8",
"Net Income": "43.7",
"Other Expenses": "-10.2",
"Operating Costs and Expenses": "10.9",
"Labor Expense": "-72.9",
"General and Administrative Expense": "27.6",
"Cost of Goods and Services Sold": "10.9",
"Other Revenues": "96.8",
"Other Net Income": "-38.7",
"Comprehensive Net Income": "44.0",
"Economic Capital Ratio": "78.1"
},
"2012": {
"Property Plant and Equipment": "-9.05",
"Assets": "-11.0",
"Liabilities": "82.3",
"Stockholders Equity": "14.0",
"ECR before LimitedLiability": "97.0",
"Intangible Assets": "16.8",
"Assets, Current": "-9.92",
"Liabilities, Current": "48.2",
"Long Term Liabilities": "18.9",
"Other Liabilities": "29.4",
"Expenses": "-22.0",
"Revenues": "103",
"Net Income": "40.1",
"Other Expenses": "-17.4",
"General and Administrative Expense": "29.3",
"Cost of Goods and Services Sold": "11.6",
"Labor Expense": "-77.2",
"Other Revenues": "103",
"Other Net Income": "-43.9",
"Comprehensive Net Income": "40.6",
"Economic Capital Ratio": "82.8"
},
"2013": {
"Assets": "-10.7",
"Liabilities": "55.7",
"Stockholders Equity": "12.7",
"ECR before LimitedLiability": "63.5",
"Property Plant and Equipment": "-10.9",
"Assets, Current": "-15.6",
"Intangible Assets": "38.2",
"Other Liabilities": "19.9",
"Liabilities, Current": "43.5",
"Long Term Liabilities": "-5.44",
"Expenses": "-8.51",
"Revenues": "68.6",
"Net Income": "32.5",
"General and Administrative Expense": "25.3",
"Cost of Goods and Services Sold": "8.64",
"Labor Expense": "-51.3",
"Other Expenses": "-11.4",
"Other Revenues": "68.6",
"Comprehensive Net Income": "32.8",
"Other Net Income": "-25.1",
"Economic Capital Ratio": "54.3"
},
"2014": {
"Assets": "-9.37",
"Liabilities": "64.8",
"Stockholders Equity": "21.0",
"ECR before LimitedLiability": "82.9",
"Intangible Assets": "34.2",
"Property Plant and Equipment": "-11.9",
"Assets, Current": "-11.1",
"Other Liabilities": "16.1",
"Liabilities, Current": "44.5",
"Long Term Liabilities": "10.4",
"Expenses": "-10.5",
"Revenues": "77.8",
"Net Income": "36.6",
"Labor Expense": "-55.6",
"Other Expenses": "-16.2",
"Cost of Goods and Services Sold": "10.2",
"General and Administrative Expense": "24.8",
"Other Revenues": "77.8",
"Comprehensive Net Income": "36.8",
"Other Net Income": "-28.8",
"Economic Capital Ratio": "69.8"
},
"2015": {
"Assets, Current": "-11.5",
"Assets": "-6.76",
"Liabilities": "56.9",
"Stockholders Equity": "22.4",
"ECR before LimitedLiability": "78.6",
"Intangible Assets": "39.0",
"Property Plant and Equipment": "-11.0",
"Other Liabilities": "9.06",
"Liabilities, Current": "53.4",
"Selling and Marketing Expense": "6.50",
"Expenses": "-7.35",
"Revenues": "70.1",
"Net Income": "37.7",
"Operating Costs and Expenses": "6.28",
"General and Administrative Expense": "12.6",
"Labor Expense": "-56.0",
"Cost of Goods and Services Sold": "12.7",
"Other Revenues": "70.1",
"Comprehensive Net Income": "38.3",
"Other Net Income": "-23.9",
"Economic Capital Ratio": "66.2"
},
"2016": {
"Liabilities, Current": "53.7",
"Liabilities": "22.6",
"Stockholders Equity": "13.5",
"Property Plant and Equipment": "-14.0",
"ECR before LimitedLiability": "59.9",
"Other Liabilities": "-34.0",
"Long Term Liabilities": "-4.56",
"Other Revenues": "48.1",
"Revenues": "48.1",
"Net Income": "33.2",
"Assets, Non-Current": "-4.18",
"Intangible Assets": "72.1",
"Assets, Current": "-15.9",
"Comprehensive Net Income": "34.0",
"Selling and Marketing Expense": "6.49",
"General and Administrative Expense": "14.8",
"Labor Expense": "-44.7",
"Cost of Goods and Services Sold": "16.1",
"Research And Development Expense": "5.75",
"Other Net Income": "-16.5",
"Economic Capital Ratio": "32.2"
},
"2017": {
"Liabilities, Current": "49.4",
"Liabilities": "56.1",
"Other Assets": "-3.40",
"Stockholders Equity": "38.0",
"ECR before LimitedLiability": "100",
"Other Liabilities": "3.27",
"Long Term Liabilities": "5.74",
"Other Revenues": "59.6",
"Revenues": "59.6",
"Net Income": "33.3",
"Intangible Assets": "51.8",
"Assets, Current": "-13.3",
"Property Plant and Equipment": "-8.50",
"General and Administrative Expense": "16.2",
"Comprehensive Net Income": "33.5",
"Labor Expense": "-55.3",
"Other Net Income": "-24.4",
"Research And Development Expense": "7.65",
"Selling and Marketing Expense": "5.78",
"Cost of Goods and Services Sold": "13.3",
"Economic Capital Ratio": "76.0"
},
"2018": {
"Other Liabilities": "3.97",
"Liabilities": "61.0",
"Stockholders Equity": "39.2",
"Property Plant and Equipment": "-5.12",
"ECR before LimitedLiability": "105",
"Liabilities, Current": "47.1",
"Long Term Liabilities": "15.5",
"Other Revenues": "42.0",
"Revenues": "42.0",
"Net Income": "43.4",
"Intangible Assets": "48.4",
"Assets, Non-Current": "-3.73",
"Assets, Current": "-11.7",
"Selling and Marketing Expense": "4.69",
"Comprehensive Net Income": "43.7",
"Operating Costs and Expenses": "4.99",
"Research And Development Expense": "7.03",
"General and Administrative Expense": "14.4",
"Cost of Goods and Services Sold": "25.6",
"Labor Expense": "-61.8",
"Economic Capital Ratio": "84.5"
},
"2019": {
"Other Liabilities": "10.8",
"Liabilities": "30.9",
"Stockholders Equity": "20.1",
"ECR before LimitedLiability": "62.0",
"Liabilities, Current": "21.1",
"Other Expenses": "-7.05",
"Expenses": "4.42",
"Revenues": "24.6",
"Net Income": "30.3",
"General and Administrative Expense": "10.1",
"Cost of Goods and Services Sold": "23.7",
"Research And Development Expense": "7.15",
"Selling and Marketing Expense": "4.60",
"Labor Expense": "-43.2",
"Operating Costs and Expenses": "5.94",
"Other Revenues": "24.6",
"Property Plant and Equipment": "-6.75",
"Intangible Assets": "42.8",
"Assets, Current": "-15.1",
"Comprehensive Net Income": "30.5",
"Economic Capital Ratio": "52.0"
},
"2020": {
"Liabilities, Current": "10.0",
"Liabilities": "28.4",
"Stockholders Equity": "27.1",
"ECR before LimitedLiability": "67.8",
"Other Liabilities": "7.88",
"Long Term Liabilities": "12.2",
"Labor Expense": "-35.0",
"Expenses": "4.83",
"Revenues": "19.6",
"Net Income": "27.9",
"General and Administrative Expense": "13.0",
"Research And Development Expense": "4.07",
"Other Expenses": "-5.41",
"Operating Costs and Expenses": "4.66",
"Cost of Goods and Services Sold": "18.6",
"Other Revenues": "19.6",
"Property Plant and Equipment": "-4.74",
"Intangible Assets": "47.9",
"Assets, Current": "-15.9",
"Comprehensive Net Income": "27.9",
"Economic Capital Ratio": "55.7"
},
"2021": {
"Liabilities, Current": "12.2",
"Liabilities": "7.05",
"Stockholders Equity": "5.60",
"ECR before LimitedLiability": "34.2",
"Long Term Liabilities": "-17.4",
"Other Liabilities": "10.7",
"General and Administrative Expense": "12.2",
"Expenses": "6.94",
"Revenues": "17.5",
"Net Income": "27.1",
"Operating Costs and Expenses": "5.06",
"Labor Expense": "-30.8",
"Cost of Goods and Services Sold": "14.8",
"Research And Development Expense": "4.54",
"Other Expenses": "-3.89",
"Other Revenues": "17.5",
"Intangible Assets": "48.0",
"Property Plant and Equipment": "-4.68",
"Assets, Current": "-20.6",
"Comprehensive Net Income": "27.2",
"Economic Capital Ratio": "28.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000885978_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "45,667",
"Assets, Non-Current": "2,043",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "102,353",
"Labor Expense": "125,117",
"Liabilities, Current": "16,324",
"Long Term Liabilities": "24,407",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "87,551",
"Other Liabilities": "941",
"Other Net Income": "5,445",
"Other Revenues": "237,006",
"Property Plant and Equipment": "13,189",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "163,252",
"Liabilities": "41,672",
"Expenses": "212,668",
"Revenues": "237,006",
"Stockholders Equity": "121,580",
"Net Income": "29,783",
"Comprehensive Net Income": "29,783",
"BaseVar": "330,022",
"ECR before LimitedLiability": "201%",
"Economic Capital Ratio": "239%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "45,322",
"Assets, Non-Current": "1,042",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "112,334",
"Labor Expense": "132,824",
"Liabilities, Current": "16,307",
"Long Term Liabilities": "19,854",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "93,052",
"Other Liabilities": "894",
"Other Net Income": "6.0",
"Other Revenues": "252,088",
"Property Plant and Equipment": "13,016",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "171,714",
"Liabilities": "37,055",
"Expenses": "225,876",
"Revenues": "252,088",
"Stockholders Equity": "134,659",
"Net Income": "26,218",
"Comprehensive Net Income": "26,218",
"BaseVar": "343,370",
"ECR before LimitedLiability": "212%",
"Economic Capital Ratio": "246%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "49,660",
"Assets, Non-Current": "1,081",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "158,434",
"Labor Expense": "141,840",
"Liabilities, Current": "23,172",
"Long Term Liabilities": "44,846",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "96,222",
"Other Liabilities": "996",
"Other Net Income": "-5,000",
"Other Revenues": "264,058",
"Property Plant and Equipment": "14,960",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "224,135",
"Liabilities": "69,014",
"Expenses": "238,062",
"Revenues": "264,058",
"Stockholders Equity": "155,121",
"Net Income": "20,996",
"Comprehensive Net Income": "20,996",
"BaseVar": "400,134",
"ECR before LimitedLiability": "168%",
"Economic Capital Ratio": "216%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "54,851",
"Assets, Non-Current": "1,115",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "172,821",
"Labor Expense": "163,417",
"Liabilities, Current": "25,504",
"Long Term Liabilities": "43,466",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "111,251",
"Other Liabilities": "991",
"Other Net Income": "0",
"Other Revenues": "305,092",
"Property Plant and Equipment": "15,764",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "244,551",
"Liabilities": "69,961",
"Expenses": "274,668",
"Revenues": "305,092",
"Stockholders Equity": "174,590",
"Net Income": "30,424",
"Comprehensive Net Income": "30,424",
"BaseVar": "447,136",
"ECR before LimitedLiability": "180%",
"Economic Capital Ratio": "225%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "60,182",
"Assets, Non-Current": "1,234",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "31,067",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "201,843",
"Labor Expense": "180,514",
"Liabilities, Current": "19,007",
"Long Term Liabilities": "48,335",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "88,111",
"Other Liabilities": "10,618",
"Other Net Income": "0",
"Other Revenues": "331,383",
"Property Plant and Equipment": "16,654",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "279,913",
"Liabilities": "77,960",
"Expenses": "299,692",
"Revenues": "331,383",
"Stockholders Equity": "201,953",
"Net Income": "31,691",
"Comprehensive Net Income": "31,691",
"BaseVar": "494,474",
"ECR before LimitedLiability": "181%",
"Economic Capital Ratio": "225%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "65,964",
"Assets, Non-Current": "1,228",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "32,479",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "264,866",
"Labor Expense": "198,495",
"Liabilities, Current": "24,617",
"Long Term Liabilities": "51,425",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "99,397",
"Other Liabilities": "86,501",
"Other Net Income": "0",
"Other Revenues": "356,639",
"Property Plant and Equipment": "19,173",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "351,231",
"Liabilities": "162,543",
"Expenses": "330,371",
"Revenues": "356,639",
"Stockholders Equity": "188,688",
"Net Income": "26,268",
"Comprehensive Net Income": "26,268",
"BaseVar": "600,392",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "183%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "77,081",
"Assets, Non-Current": "1,224",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "35,889",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "320,292",
"Labor Expense": "237,067",
"Liabilities, Current": "39,551",
"Long Term Liabilities": "57,471",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "113,459",
"Other Liabilities": "13,318",
"Other Net Income": "0",
"Other Revenues": "414,139",
"Property Plant and Equipment": "20,385",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "418,982",
"Liabilities": "110,340",
"Expenses": "386,415",
"Revenues": "414,139",
"Stockholders Equity": "308,642",
"Net Income": "27,724",
"Comprehensive Net Income": "27,724",
"BaseVar": "664,938",
"ECR before LimitedLiability": "180%",
"Economic Capital Ratio": "224%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "79,214",
"Assets, Non-Current": "1,430",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "41,349",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "342,353",
"Labor Expense": "259,228",
"Liabilities, Current": "41,946",
"Long Term Liabilities": "39,231",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "106,431",
"Other Liabilities": "11,171",
"Other Net Income": "1,846",
"Other Revenues": "454,004",
"Property Plant and Equipment": "20,169",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "443,166",
"Liabilities": "92,348",
"Expenses": "407,008",
"Revenues": "454,004",
"Stockholders Equity": "350,818",
"Net Income": "48,842",
"Comprehensive Net Income": "48,842",
"BaseVar": "699,186",
"ECR before LimitedLiability": "208%",
"Economic Capital Ratio": "244%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "85,386",
"Assets, Non-Current": "83,105",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "45,049",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "370,264",
"Labor Expense": "274,233",
"Liabilities, Current": "70,634",
"Long Term Liabilities": "110,760",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "110,988",
"Other Liabilities": "0",
"Other Net Income": "5,514",
"Other Revenues": "482,015",
"Property Plant and Equipment": "22,090",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "560,845",
"Liabilities": "181,394",
"Expenses": "430,270",
"Revenues": "482,015",
"Stockholders Equity": "379,451",
"Net Income": "57,259",
"Comprehensive Net Income": "57,259",
"BaseVar": "830,019",
"ECR before LimitedLiability": "164%",
"Economic Capital Ratio": "214%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "87,636",
"Assets, Non-Current": "83,134",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "42,037",
"Goodwill Impairment Loss": "1,859",
"Intangible Assets": "401,926",
"Labor Expense": "235,629",
"Liabilities, Current": "101,271",
"Long Term Liabilities": "83,120",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "105,687",
"Other Liabilities": "0",
"Other Net Income": "14,592",
"Other Revenues": "423,111",
"Property Plant and Equipment": "21,665",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "594,361",
"Liabilities": "184,391",
"Expenses": "385,212",
"Revenues": "423,111",
"Stockholders Equity": "409,970",
"Net Income": "52,491",
"Comprehensive Net Income": "52,491",
"BaseVar": "800,834",
"ECR before LimitedLiability": "166%",
"Economic Capital Ratio": "215%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "95,166",
"Assets, Non-Current": "98,005",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "46,533",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "521,061",
"Labor Expense": "278,469",
"Liabilities, Current": "97,866",
"Long Term Liabilities": "199,117",
"Operating Costs and Expenses": "0",
"Other Assets": "12,215",
"Other Compr. Net Income": "0",
"Other Expenses": "114,643",
"Other Liabilities": "0",
"Other Net Income": "2,547",
"Other Revenues": "495,022",
"Property Plant and Equipment": "22,979",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "749,426",
"Liabilities": "296,983",
"Expenses": "439,645",
"Revenues": "495,022",
"Stockholders Equity": "452,443",
"Net Income": "57,924",
"Comprehensive Net Income": "57,924",
"BaseVar": "991,812",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "196%"
}
}
},
"top_rated": false,
"trend": -13.0,
"value": 1.9581418502644874,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000885978.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000885978.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000885978.svg"
},
{
"company_id": "0001603454",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001603454.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001603454.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001603454.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001603454_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001603454_main_keyfigs.svg",
"name": "Celcuity Inc",
"rank": 33,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001603454.svg",
"report_text": "The relative strengths and weaknesses of Celcuity Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Celcuity Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 121% points.The greatest weakness of Celcuity Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 31% points.
The company's Economic Capital Ratio, given in the ranking table, is 195%, being 28% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001603454_2022_Celcuity_Inc.pdf",
"shrinked_graph_json": {
"2017": {
"Other Assets": "8.80",
"Assets": "50.1",
"Stockholders Equity": "166",
"ECR before LimitedLiability": "143",
"Assets, Current": "46.6",
"Liabilities, Current": "36.0",
"Liabilities": "56.8",
"Other Liabilities": "6.49",
"Long Term Liabilities": "21.7",
"General and Administrative Expense": "8.84",
"Expenses": "22.6",
"Revenues": "-24.7",
"Net Income": "-14.7",
"Labor Expense": "4.02",
"Research And Development Expense": "-19.1",
"Other Expenses": "15.9",
"Cost of Goods and Services Sold": "7.00",
"Other Revenues": "-24.7",
"Other Net Income": "-14.2",
"Comprehensive Net Income": "-14.6",
"Economic Capital Ratio": "119"
},
"2018": {
"Assets": "57.3",
"Stockholders Equity": "154",
"ECR before LimitedLiability": "113",
"Intangible Assets": "-3.94",
"Assets, Current": "148",
"Other Liabilities": "5.50",
"Liabilities": "50.8",
"Liabilities, Current": "30.9",
"Long Term Liabilities": "20.2",
"Expenses": "11.8",
"Revenues": "-40.1",
"Net Income": "-23.7",
"Other Expenses": "12.4",
"General and Administrative Expense": "4.48",
"Research And Development Expense": "-31.1",
"Cost of Goods and Services Sold": "13.3",
"Labor Expense": "5.17",
"Other Revenues": "-40.1",
"Comprehensive Net Income": "-23.5",
"Other Net Income": "3.01",
"Economic Capital Ratio": "92.1"
},
"2019": {
"Assets": "59.0",
"Liabilities": "48.2",
"Stockholders Equity": "143",
"ECR before LimitedLiability": "82.2",
"Assets, Non-Current": "-3.59",
"Intangible Assets": "-6.02",
"Assets, Current": "148",
"Other Liabilities": "7.19",
"Long Term Liabilities": "26.7",
"Liabilities, Current": "19.2",
"Other Revenues": "-41.0",
"Revenues": "-41.0",
"Net Income": "-35.7",
"Other Expenses": "8.02",
"Comprehensive Net Income": "-35.6",
"Cost of Goods and Services Sold": "14.9",
"Research And Development Expense": "-37.0",
"Other Net Income": "2.98",
"Labor Expense": "4.40",
"Operating Costs and Expenses": "3.78",
"Economic Capital Ratio": "72.2"
},
"2021": {
"Assets": "59.9",
"Liabilities": "11.8",
"Stockholders Equity": "86.8",
"ECR before LimitedLiability": "33.8",
"Intangible Assets": "-11.7",
"Property Plant and Equipment": "-4.36",
"Assets, Non-Current": "-4.92",
"Assets, Current": "121",
"Liabilities, Current": "18.7",
"Long Term Liabilities": "-15.7",
"Other Liabilities": "7.31",
"General and Administrative Expense": "8.91",
"Expenses": "6.08",
"Revenues": "-30.8",
"Net Income": "-25.0",
"Cost of Goods and Services Sold": "10.00",
"Research And Development Expense": "-29.9",
"Other Expenses": "7.26",
"Other Revenues": "-30.8",
"Comprehensive Net Income": "-25.0",
"Economic Capital Ratio": "27.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001603454_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "24,484",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "973",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "578",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "7,205",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-299",
"Other Revenues": "0",
"Property Plant and Equipment": "280",
"Research And Development Expense": "4,980",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "31,970",
"Liabilities": "578",
"Expenses": "5,953",
"Revenues": "0",
"Stockholders Equity": "31,391",
"Net Income": "-6,252",
"Comprehensive Net Income": "-6,252",
"BaseVar": "19,400",
"ECR before LimitedLiability": "241%",
"Economic Capital Ratio": "267%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "25,218",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,607",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "662",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "20",
"Other Net Income": "452",
"Other Revenues": "0",
"Property Plant and Equipment": "814",
"Research And Development Expense": "6,326",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "26,032",
"Liabilities": "682",
"Expenses": "7,933",
"Revenues": "0",
"Stockholders Equity": "25,350",
"Net Income": "-7,481",
"Comprehensive Net Income": "-7,481",
"BaseVar": "17,549",
"ECR before LimitedLiability": "219%",
"Economic Capital Ratio": "251%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "19,250",
"Assets, Non-Current": "197",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,536",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "911",
"Long Term Liabilities": "58",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "14",
"Other Net Income": "446",
"Other Revenues": "0",
"Property Plant and Equipment": "833",
"Research And Development Expense": "6,269",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "20,281",
"Liabilities": "983",
"Expenses": "7,805",
"Revenues": "0",
"Stockholders Equity": "19,298",
"Net Income": "-7,359",
"Comprehensive Net Income": "-7,359",
"BaseVar": "14,758",
"ECR before LimitedLiability": "194%",
"Economic Capital Ratio": "234%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "85,352",
"Assets, Non-Current": "242",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,598",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,506",
"Long Term Liabilities": "14,688",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "2.4",
"Other Net Income": "-1,249",
"Other Revenues": "0",
"Property Plant and Equipment": "312",
"Research And Development Expense": "25,758",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "85,906",
"Liabilities": "17,196",
"Expenses": "28,356",
"Revenues": "0",
"Stockholders Equity": "68,710",
"Net Income": "-29,605",
"Comprehensive Net Income": "-29,605",
"BaseVar": "66,354",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "195%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.9540025154447154,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001603454.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001603454.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001603454.svg"
},
{
"company_id": "0001834376",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001834376.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001834376.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001834376_main_keyfigs.svg",
"name": "Innovage Holding Corp",
"rank": 34,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001834376.svg",
"report_text": "The relative strengths and weaknesses of Innovage Holding Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Innovage Holding Corp compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 55% points.The greatest weakness of Innovage Holding Corp is the variable Other Expenses, reducing the Economic Capital Ratio by 79% points.
The company's Economic Capital Ratio, given in the ranking table, is 194%, being 27% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001834376_2022_Innovage_Holding_Corp.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "-30.3",
"Assets": "-25.2",
"Liabilities": "55.5",
"Stockholders Equity": "-19.8",
"ECR before LimitedLiability": "32.9",
"Intangible Assets": "-10.5",
"Property Plant and Equipment": "11.1",
"Assets, Non-Current": "42.4",
"Assets, Current": "-14.9",
"Liabilities, Current": "20.3",
"Long Term Liabilities": "25.1",
"Other Liabilities": "14.0",
"Expenses": "-29.0",
"Revenues": "55.3",
"Net Income": "20.8",
"Operating Costs and Expenses": "7.70",
"Cost of Goods and Services Sold": "22.7",
"Other Expenses": "-79.3",
"Other Revenues": "55.3",
"Comprehensive Net Income": "21.0",
"Economic Capital Ratio": "26.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001834376_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "250,932",
"Assets, Non-Current": "280,820",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "12,294",
"General and Administrative Expense": "132,333",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "124,217",
"Labor Expense": "0",
"Liabilities, Current": "94,265",
"Long Term Liabilities": "74,332",
"Operating Costs and Expenses": "0",
"Other Assets": "-266,932",
"Other Compr. Net Income": "0",
"Other Expenses": "493,045",
"Other Liabilities": "5,190",
"Other Net Income": "-22,632",
"Other Revenues": "637,800",
"Property Plant and Equipment": "142,715",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "22,236"
},
"output_variables": {
"Assets": "531,752",
"Liabilities": "173,787",
"Expenses": "659,908",
"Revenues": "637,800",
"Stockholders Equity": "357,965",
"Net Income": "-44,740",
"Comprehensive Net Income": "-44,740",
"BaseVar": "1,012,940",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "194%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.9448246043917314,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001834376.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001834376.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001834376.svg"
},
{
"company_id": "0001468328",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001468328.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001468328.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001468328.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001468328_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001468328_main_keyfigs.svg",
"name": "Addus Homecare Corp",
"rank": 35,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001468328.svg",
"report_text": "The relative strengths and weaknesses of Addus Homecare Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Addus Homecare Corp compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Addus Homecare Corp is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 42% points.
The company's Economic Capital Ratio, given in the ranking table, is 193%, being 26% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001468328_2022_Addus_Homecare_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "20.9",
"Liabilities": "-14.3",
"Stockholders Equity": "18.6",
"ECR before LimitedLiability": "24.4",
"Property Plant and Equipment": "-14.9",
"Assets, Current": "34.5",
"Intangible Assets": "13.1",
"Other Liabilities": "8.50",
"Liabilities, Current": "-21.2",
"Expenses": "18.5",
"Revenues": "-32.9",
"Net Income": "12.6",
"Other Expenses": "29.6",
"Goodwill Impairment Loss": "-8.44",
"Operating Costs and Expenses": "6.04",
"Labor Expense": "9.57",
"General and Administrative Expense": "-25.2",
"Other Revenues": "-32.9",
"Other Net Income": "29.9",
"Comprehensive Net Income": "12.8",
"Economic Capital Ratio": "17.8"
},
"2012": {
"Property Plant and Equipment": "-9.79",
"Assets": "29.1",
"Liabilities": "-10.2",
"Stockholders Equity": "37.6",
"ECR before LimitedLiability": "49.2",
"Intangible Assets": "15.8",
"Assets, Current": "28.8",
"Liabilities, Current": "-23.0",
"Other Liabilities": "12.8",
"Expenses": "24.3",
"Revenues": "-28.7",
"Net Income": "15.9",
"Other Expenses": "17.7",
"General and Administrative Expense": "-16.2",
"Operating Costs and Expenses": "4.09",
"Cost of Goods and Services Sold": "5.30",
"Labor Expense": "8.56",
"Other Revenues": "-28.7",
"Other Net Income": "21.0",
"Comprehensive Net Income": "16.2",
"Economic Capital Ratio": "35.0"
},
"2013": {
"Assets": "22.4",
"Liabilities": "10.1",
"Stockholders Equity": "50.3",
"ECR before LimitedLiability": "66.4",
"Property Plant and Equipment": "-7.74",
"Assets, Current": "17.9",
"Intangible Assets": "18.3",
"Other Liabilities": "8.18",
"Liabilities, Current": "-24.7",
"Long Term Liabilities": "22.6",
"Expenses": "23.7",
"Revenues": "-32.6",
"Net Income": "25.3",
"General and Administrative Expense": "-16.2",
"Cost of Goods and Services Sold": "5.12",
"Labor Expense": "8.83",
"Other Expenses": "16.5",
"Other Revenues": "-32.6",
"Comprehensive Net Income": "25.5",
"Other Net Income": "33.2",
"Economic Capital Ratio": "57.2"
},
"2014": {
"Assets": "24.4",
"Liabilities": "15.2",
"Stockholders Equity": "56.5",
"ECR before LimitedLiability": "75.6",
"Intangible Assets": "18.1",
"Property Plant and Equipment": "-7.86",
"Assets, Current": "21.4",
"Other Liabilities": "9.90",
"Liabilities, Current": "-12.9",
"Long Term Liabilities": "17.0",
"Expenses": "21.1",
"Revenues": "-32.2",
"Net Income": "20.8",
"Labor Expense": "9.84",
"Other Expenses": "14.9",
"Cost of Goods and Services Sold": "5.92",
"General and Administrative Expense": "-20.8",
"Other Revenues": "-32.2",
"Comprehensive Net Income": "20.9",
"Other Net Income": "31.0",
"Economic Capital Ratio": "62.4"
},
"2015": {
"Assets, Current": "18.8",
"Assets": "24.2",
"Liabilities": "17.4",
"Stockholders Equity": "60.1",
"ECR before LimitedLiability": "76.6",
"Intangible Assets": "17.8",
"Property Plant and Equipment": "-6.92",
"Long Term Liabilities": "11.4",
"Other Liabilities": "10.9",
"Liabilities, Current": "-4.81",
"Expenses": "20.5",
"Revenues": "-34.8",
"Net Income": "22.2",
"General and Administrative Expense": "-24.2",
"Other Expenses": "16.8",
"Labor Expense": "9.04",
"Cost of Goods and Services Sold": "7.80",
"Other Revenues": "-34.8",
"Comprehensive Net Income": "22.6",
"Other Net Income": "35.1",
"Economic Capital Ratio": "64.2"
},
"2016": {
"Property Plant and Equipment": "-7.99",
"Assets": "30.7",
"Liabilities": "13.8",
"Stockholders Equity": "62.4",
"ECR before LimitedLiability": "88.6",
"Intangible Assets": "18.3",
"Assets, Current": "25.3",
"Liabilities, Current": "6.64",
"Other Liabilities": "11.5",
"Expenses": "22.0",
"Revenues": "-35.4",
"Net Income": "22.2",
"Selling and Marketing Expense": "4.43",
"General and Administrative Expense": "-20.9",
"Labor Expense": "4.67",
"Other Expenses": "17.5",
"Cost of Goods and Services Sold": "10.9",
"Other Revenues": "-35.4",
"Other Net Income": "35.3",
"Comprehensive Net Income": "22.7",
"Economic Capital Ratio": "60.9"
},
"2017": {
"Assets": "28.8",
"Stockholders Equity": "49.0",
"ECR before LimitedLiability": "79.9",
"Intangible Assets": "20.1",
"Assets, Current": "22.2",
"Property Plant and Equipment": "-7.28",
"General and Administrative Expense": "-12.4",
"Expenses": "24.1",
"Net Income": "21.8",
"Labor Expense": "4.79",
"Research And Development Expense": "4.80",
"Other Expenses": "14.0",
"Cost of Goods and Services Sold": "8.40",
"Other Revenues": "-28.3",
"Revenues": "-28.3",
"Liabilities, Current": "5.64",
"Other Liabilities": "6.38",
"Long Term Liabilities": "-9.16",
"Other Net Income": "26.4",
"Comprehensive Net Income": "22.0",
"Economic Capital Ratio": "55.8"
},
"2018": {
"Assets": "-14.4",
"Stockholders Equity": "10.4",
"ECR before LimitedLiability": "93.8",
"Property Plant and Equipment": "-8.74",
"Intangible Assets": "11.6",
"Other Liabilities": "12.9",
"Liabilities": "80.6",
"Liabilities, Current": "46.4",
"Long Term Liabilities": "32.4",
"Selling and Marketing Expense": "5.85",
"Expenses": "-24.2",
"Revenues": "68.4",
"Net Income": "45.0",
"Operating Costs and Expenses": "6.23",
"Other Expenses": "28.6",
"Research And Development Expense": "8.78",
"Cost of Goods and Services Sold": "-96.0",
"Labor Expense": "12.5",
"Other Revenues": "68.4",
"Comprehensive Net Income": "45.4",
"Economic Capital Ratio": "73.1"
},
"2019": {
"Property Plant and Equipment": "-8.03",
"Assets": "-6.06",
"Liabilities": "55.5",
"Stockholders Equity": "23.9",
"ECR before LimitedLiability": "72.3",
"Assets, Non-Current": "-6.72",
"Intangible Assets": "21.5",
"Other Liabilities": "12.9",
"Long Term Liabilities": "23.5",
"Liabilities, Current": "25.2",
"Other Expenses": "13.5",
"Expenses": "-9.03",
"Revenues": "36.4",
"Net Income": "27.4",
"Cost of Goods and Services Sold": "-53.7",
"Research And Development Expense": "8.35",
"Labor Expense": "8.07",
"Operating Costs and Expenses": "6.93",
"Other Revenues": "36.4",
"Comprehensive Net Income": "27.6",
"Economic Capital Ratio": "62.3"
},
"2020": {
"Property Plant and Equipment": "-8.12",
"Assets": "-6.76",
"Liabilities": "17.6",
"ECR before LimitedLiability": "39.9",
"Other Assets": "-4.57",
"Intangible Assets": "43.4",
"Assets, Current": "-14.0",
"Assets, Non-Current": "-6.69",
"Liabilities, Current": "16.3",
"Other Liabilities": "7.80",
"Long Term Liabilities": "-6.67",
"Other Revenues": "25.8",
"Revenues": "25.8",
"Net Income": "24.8",
"Comprehensive Net Income": "24.8",
"Labor Expense": "6.39",
"Research And Development Expense": "4.43",
"Other Expenses": "12.8",
"Operating Costs and Expenses": "5.07",
"Cost of Goods and Services Sold": "-36.4",
"Economic Capital Ratio": "27.8"
},
"2021": {
"Assets": "-12.6",
"Liabilities": "23.5",
"Stockholders Equity": "-9.44",
"ECR before LimitedLiability": "31.9",
"Intangible Assets": "27.2",
"Property Plant and Equipment": "-6.84",
"Assets, Non-Current": "-6.49",
"Assets, Current": "-15.1",
"Liabilities, Current": "20.5",
"Long Term Liabilities": "-10.1",
"Other Liabilities": "12.7",
"Expenses": "-6.55",
"Revenues": "33.7",
"Net Income": "28.4",
"Operating Costs and Expenses": "6.10",
"Cost of Goods and Services Sold": "-42.2",
"Research And Development Expense": "5.47",
"Other Expenses": "11.4",
"Other Revenues": "33.7",
"Comprehensive Net Income": "28.5",
"Economic Capital Ratio": "25.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001468328_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "88,861",
"Assets, Non-Current": "513",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "3,554",
"General and Administrative Expense": "66,926",
"Goodwill Impairment Loss": "15,989",
"Intangible Assets": "58,739",
"Labor Expense": "0",
"Liabilities, Current": "43,293",
"Long Term Liabilities": "24,958",
"Operating Costs and Expenses": "0",
"Other Assets": "4,089",
"Other Compr. Net Income": "0",
"Other Expenses": "-2,954",
"Other Liabilities": "0",
"Other Net Income": "81,534",
"Other Revenues": "0",
"Property Plant and Equipment": "2,490",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "154,692",
"Liabilities": "68,251",
"Expenses": "83,515",
"Revenues": "0",
"Stockholders Equity": "86,441",
"Net Income": "-1,981",
"Comprehensive Net Income": "-1,981",
"BaseVar": "193,996",
"ECR before LimitedLiability": "111%",
"Economic Capital Ratio": "178%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "87,836",
"Assets, Non-Current": "298",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,521",
"General and Administrative Expense": "46,362",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "56,906",
"Labor Expense": "0",
"Liabilities, Current": "39,190",
"Long Term Liabilities": "16,250",
"Operating Costs and Expenses": "0",
"Other Assets": "2,328",
"Other Compr. Net Income": "0",
"Other Expenses": "4,312",
"Other Liabilities": "0",
"Other Net Income": "60,830",
"Other Revenues": "0",
"Property Plant and Equipment": "2,489",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "149,857",
"Liabilities": "55,440",
"Expenses": "53,195",
"Revenues": "0",
"Stockholders Equity": "94,417",
"Net Income": "7,635",
"Comprehensive Net Income": "7,635",
"BaseVar": "159,661",
"ECR before LimitedLiability": "141%",
"Economic Capital Ratio": "199%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "91,480",
"Assets, Non-Current": "132",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,160",
"General and Administrative Expense": "50,118",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "68,788",
"Labor Expense": "0",
"Liabilities, Current": "46,637",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "900",
"Other Compr. Net Income": "0",
"Other Expenses": "3,812",
"Other Liabilities": "3,441",
"Other Net Income": "75,235",
"Other Revenues": "0",
"Property Plant and Equipment": "2,634",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "163,934",
"Liabilities": "50,078",
"Expenses": "56,090",
"Revenues": "0",
"Stockholders Equity": "113,856",
"Net Income": "19,145",
"Comprehensive Net Income": "19,145",
"BaseVar": "172,668",
"ECR before LimitedLiability": "172%",
"Economic Capital Ratio": "219%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "97,372",
"Assets, Non-Current": "269",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "3,830",
"General and Administrative Expense": "61,834",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "74,567",
"Labor Expense": "0",
"Liabilities, Current": "43,205",
"Long Term Liabilities": "9,642",
"Operating Costs and Expenses": "0",
"Other Assets": "900",
"Other Compr. Net Income": "0",
"Other Expenses": "5,428",
"Other Liabilities": "0",
"Other Net Income": "83,335",
"Other Revenues": "0",
"Property Plant and Equipment": "7,695",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "180,803",
"Liabilities": "52,847",
"Expenses": "71,092",
"Revenues": "0",
"Stockholders Equity": "127,956",
"Net Income": "12,243",
"Comprehensive Net Income": "12,243",
"BaseVar": "194,038",
"ECR before LimitedLiability": "169%",
"Economic Capital Ratio": "217%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "102,561",
"Assets, Non-Current": "1,337",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "4,717",
"General and Administrative Expense": "70,452",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "79,195",
"Labor Expense": "0",
"Liabilities, Current": "42,189",
"Long Term Liabilities": "8,697",
"Operating Costs and Expenses": "0",
"Other Assets": "900",
"Other Compr. Net Income": "0",
"Other Expenses": "4,062",
"Other Liabilities": "0",
"Other Net Income": "90,854",
"Other Revenues": "0",
"Property Plant and Equipment": "8,619",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "192,612",
"Liabilities": "50,886",
"Expenses": "79,231",
"Revenues": "0",
"Stockholders Equity": "141,726",
"Net Income": "11,623",
"Comprehensive Net Income": "11,623",
"BaseVar": "206,792",
"ECR before LimitedLiability": "178%",
"Economic Capital Ratio": "223%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "131,010",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "6,647",
"General and Administrative Expense": "84,213",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "89,319",
"Labor Expense": "0",
"Liabilities, Current": "49,620",
"Long Term Liabilities": "22,482",
"Operating Costs and Expenses": "0",
"Other Assets": "4,053",
"Other Compr. Net Income": "0",
"Other Expenses": "3,994",
"Other Liabilities": "0",
"Other Net Income": "106,672",
"Other Revenues": "206",
"Property Plant and Equipment": "6,648",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "231,030",
"Liabilities": "72,102",
"Expenses": "94,854",
"Revenues": "206",
"Stockholders Equity": "158,928",
"Net Income": "12,024",
"Comprehensive Net Income": "12,024",
"BaseVar": "252,432",
"ECR before LimitedLiability": "160%",
"Economic Capital Ratio": "211%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "151,085",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "6,663",
"General and Administrative Expense": "76,902",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "106,935",
"Labor Expense": "0",
"Liabilities, Current": "52,170",
"Long Term Liabilities": "39,860",
"Operating Costs and Expenses": "0",
"Other Assets": "1,601",
"Other Compr. Net Income": "0",
"Other Expenses": "14,381",
"Other Liabilities": "0",
"Other Net Income": "111,337",
"Other Revenues": "217",
"Property Plant and Equipment": "7,489",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "267,110",
"Liabilities": "92,030",
"Expenses": "97,946",
"Revenues": "217",
"Stockholders Equity": "175,080",
"Net Income": "13,608",
"Comprehensive Net Income": "13,608",
"BaseVar": "284,320",
"ECR before LimitedLiability": "149%",
"Economic Capital Ratio": "204%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "185,504",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "379,843",
"Depreciation, Depletion, Amortization": "8,642",
"General and Administrative Expense": "105,025",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "159,226",
"Labor Expense": "0",
"Liabilities, Current": "61,504",
"Long Term Liabilities": "18,351",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4,808",
"Other Liabilities": "0",
"Other Net Income": "-2,298",
"Other Revenues": "518,119",
"Property Plant and Equipment": "10,658",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "355,388",
"Liabilities": "79,855",
"Expenses": "498,318",
"Revenues": "518,119",
"Stockholders Equity": "275,533",
"Net Income": "17,503",
"Comprehensive Net Income": "17,503",
"BaseVar": "726,989",
"ECR before LimitedLiability": "192%",
"Economic Capital Ratio": "232%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "269,387",
"Assets, Non-Current": "21,111",
"Cost of Goods and Services Sold": "469,553",
"Depreciation, Depletion, Amortization": "10,574",
"General and Administrative Expense": "133,569",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "332,447",
"Labor Expense": "0",
"Liabilities, Current": "87,528",
"Long Term Liabilities": "73,628",
"Operating Costs and Expenses": "0",
"Other Assets": "1,647",
"Other Compr. Net Income": "0",
"Other Expenses": "7,702",
"Other Liabilities": "0",
"Other Net Income": "-2,156",
"Other Revenues": "648,791",
"Property Plant and Equipment": "12,156",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "636,748",
"Liabilities": "161,156",
"Expenses": "621,398",
"Revenues": "648,791",
"Stockholders Equity": "475,592",
"Net Income": "25,237",
"Comprehensive Net Income": "25,237",
"BaseVar": "1,035,124",
"ECR before LimitedLiability": "179%",
"Economic Capital Ratio": "224%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "287,697",
"Assets, Non-Current": "37,991",
"Cost of Goods and Services Sold": "538,538",
"Depreciation, Depletion, Amortization": "12,051",
"General and Administrative Expense": "169,679",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "540,621",
"Labor Expense": "0",
"Liabilities, Current": "143,901",
"Long Term Liabilities": "230,005",
"Operating Costs and Expenses": "0",
"Other Assets": "6,524",
"Other Compr. Net Income": "0",
"Other Expenses": "8,809",
"Other Liabilities": "0",
"Other Net Income": "-2,565",
"Other Revenues": "764,775",
"Property Plant and Equipment": "19,749",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "892,582",
"Liabilities": "373,906",
"Expenses": "729,077",
"Revenues": "764,775",
"Stockholders Equity": "518,676",
"Net Income": "33,133",
"Comprehensive Net Income": "33,133",
"BaseVar": "1,381,452",
"ECR before LimitedLiability": "124%",
"Economic Capital Ratio": "188%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "324,341",
"Assets, Non-Current": "36,048",
"Cost of Goods and Services Sold": "594,651",
"Depreciation, Depletion, Amortization": "14,494",
"General and Administrative Expense": "189,418",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "568,713",
"Labor Expense": "0",
"Liabilities, Current": "117,689",
"Long Term Liabilities": "255,552",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "15,272",
"Other Liabilities": "0",
"Other Net Income": "-5,538",
"Other Revenues": "864,499",
"Property Plant and Equipment": "18,483",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "947,585",
"Liabilities": "373,241",
"Expenses": "813,835",
"Revenues": "864,499",
"Stockholders Equity": "574,344",
"Net Income": "45,126",
"Comprehensive Net Income": "45,126",
"BaseVar": "1,502,349",
"ECR before LimitedLiability": "133%",
"Economic Capital Ratio": "193%"
}
}
},
"top_rated": false,
"trend": -6.0,
"value": 1.9347416500151768,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001468328.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001468328.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001468328.svg"
},
{
"company_id": "0001404123",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001404123.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001404123.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001404123.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001404123_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001404123_main_keyfigs.svg",
"name": "1Life Healthcare Inc",
"rank": 36,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001404123.svg",
"report_text": "The relative strengths and weaknesses of 1Life Healthcare Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of 1Life Healthcare Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 46% points.The greatest weakness of 1Life Healthcare Inc is the variable Operating Costs and Expenses, reducing the Economic Capital Ratio by 29% points.
The company's Economic Capital Ratio, given in the ranking table, is 190%, being 22% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001404123_2022_1Life_Healthcare_Inc.pdf",
"shrinked_graph_json": {
"2019": {
"Other Liabilities": "5.84",
"Liabilities": "-4.00",
"ECR before LimitedLiability": "7.14",
"Long Term Liabilities": "-16.7",
"Liabilities, Current": "6.34",
"Other Revenues": "4.30",
"Revenues": "4.30",
"Net Income": "7.20",
"Other Expenses": "73.9",
"Comprehensive Net Income": "7.68",
"General and Administrative Expense": "-7.46",
"Cost of Goods and Services Sold": "-15.2",
"Research And Development Expense": "7.12",
"Selling and Marketing Expense": "-4.61",
"Labor Expense": "6.88",
"Operating Costs and Expenses": "-65.1",
"Property Plant and Equipment": "6.39",
"Economic Capital Ratio": "-2.89",
"Assets, Non-Current": "15.2",
"Other Assets": "-4.62",
"Intangible Assets": "-14.6"
},
"2020": {
"Assets": "23.1",
"Liabilities": "-21.1",
"Stockholders Equity": "12.3",
"ECR before LimitedLiability": "15.4",
"Other Assets": "-4.35",
"Intangible Assets": "-12.9",
"Assets, Current": "46.8",
"Assets, Non-Current": "3.68",
"Liabilities, Current": "13.2",
"Other Liabilities": "4.18",
"Long Term Liabilities": "-41.5",
"Labor Expense": "4.86",
"Expenses": "17.0",
"Revenues": "-7.97",
"Net Income": "7.47",
"Research And Development Expense": "3.37",
"Other Expenses": "58.2",
"Operating Costs and Expenses": "-35.3",
"Cost of Goods and Services Sold": "-6.04",
"Other Revenues": "-7.97",
"Comprehensive Net Income": "7.54",
"Economic Capital Ratio": "3.27"
},
"2021": {
"Assets": "29.9",
"Liabilities": "-6.32",
"Stockholders Equity": "38.3",
"ECR before LimitedLiability": "28.4",
"Intangible Assets": "45.6",
"Assets, Non-Current": "1.92",
"Assets, Current": "-8.63",
"Liabilities, Current": "7.06",
"Long Term Liabilities": "-20.4",
"Other Liabilities": "5.77",
"General and Administrative Expense": "1.36",
"Expenses": "15.0",
"Revenues": "-10.8",
"Net Income": "4.78",
"Operating Costs and Expenses": "-28.7",
"Labor Expense": "3.33",
"Research And Development Expense": "3.45",
"Other Expenses": "38.7",
"Other Revenues": "-10.8",
"Comprehensive Net Income": "4.84",
"Economic Capital Ratio": "22.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001404123_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "196,891",
"Assets, Non-Current": "116,295",
"Cost of Goods and Services Sold": "167,618",
"Depreciation, Depletion, Amortization": "14,268",
"General and Administrative Expense": "108,965",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "21,324",
"Labor Expense": "0",
"Liabilities, Current": "80,335",
"Long Term Liabilities": "121,136",
"Operating Costs and Expenses": "330,371",
"Other Assets": "1,922",
"Other Compr. Net Income": "1,193",
"Other Expenses": "-330,284",
"Other Liabilities": "7,220",
"Other Net Income": "505",
"Other Revenues": "276,258",
"Property Plant and Equipment": "90,716",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "39,520"
},
"output_variables": {
"Assets": "427,148",
"Liabilities": "208,691",
"Expenses": "330,458",
"Revenues": "276,258",
"Stockholders Equity": "218,457",
"Net Income": "-53,695",
"Comprehensive Net Income": "-52,502",
"BaseVar": "622,126",
"ECR before LimitedLiability": "83%",
"Economic Capital Ratio": "159%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "774,699",
"Assets, Non-Current": "144,386",
"Cost of Goods and Services Sold": "234,959",
"Depreciation, Depletion, Amortization": "22,374",
"General and Administrative Expense": "157,282",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "21,301",
"Labor Expense": "0",
"Liabilities, Current": "117,426",
"Long Term Liabilities": "397,465",
"Operating Costs and Expenses": "451,582",
"Other Assets": "4,567",
"Other Compr. Net Income": "674",
"Other Expenses": "-451,705",
"Other Liabilities": "7,624",
"Other Net Income": "-18,185",
"Other Revenues": "380,223",
"Property Plant and Equipment": "126,037",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "36,967"
},
"output_variables": {
"Assets": "1,070,990",
"Liabilities": "522,515",
"Expenses": "451,459",
"Revenues": "380,223",
"Stockholders Equity": "548,475",
"Net Income": "-89,421",
"Comprehensive Net Income": "-88,747",
"BaseVar": "1,222,023",
"ECR before LimitedLiability": "89%",
"Economic Capital Ratio": "163%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "613,027",
"Assets, Non-Current": "268,570",
"Cost of Goods and Services Sold": "318,639",
"Depreciation, Depletion, Amortization": "46,496",
"General and Administrative Expense": "323,127",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,499,622",
"Labor Expense": "0",
"Liabilities, Current": "275,984",
"Long Term Liabilities": "593,148",
"Operating Costs and Expenses": "866,799",
"Other Assets": "52,097",
"Other Compr. Net Income": "-201",
"Other Expenses": "-752,058",
"Other Liabilities": "29,317",
"Other Net Income": "-12,959",
"Other Revenues": "623,315",
"Property Plant and Equipment": "193,716",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "61,994"
},
"output_variables": {
"Assets": "2,627,032",
"Liabilities": "898,449",
"Expenses": "864,997",
"Revenues": "623,315",
"Stockholders Equity": "1,728,583",
"Net Income": "-254,641",
"Comprehensive Net Income": "-254,842",
"BaseVar": "2,513,476",
"ECR before LimitedLiability": "128%",
"Economic Capital Ratio": "190%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 1.9000452733001356,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001404123.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001404123.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001404123.svg"
},
{
"company_id": "0001303313",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001303313.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001303313.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001303313.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001303313_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001303313_main_keyfigs.svg",
"name": "LHC Group Inc",
"rank": 37,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001303313.svg",
"report_text": "The relative strengths and weaknesses of LHC Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of LHC Group Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 56% points.The greatest weakness of LHC Group Inc is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 27% points.
The company's Economic Capital Ratio, given in the ranking table, is 188%, being 20% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001303313_2022_LHC_Group_Inc.pdf",
"shrinked_graph_json": {
"2013": {
"Assets": "53.3",
"Stockholders Equity": "76.8",
"ECR before LimitedLiability": "69.4",
"Assets, Current": "6.14",
"Intangible Assets": "48.1",
"Other Liabilities": "-9.76",
"Liabilities": "-9.35",
"Liabilities, Current": "-3.53",
"Long Term Liabilities": "3.80",
"Expenses": "36.5",
"Revenues": "-22.4",
"Net Income": "16.5",
"General and Administrative Expense": "10.3",
"Cost of Goods and Services Sold": "3.55",
"Labor Expense": "6.11",
"Operating Costs and Expenses": "2.04",
"Other Expenses": "9.18",
"Research And Development Expense": "2.04",
"Other Revenues": "-22.4",
"Comprehensive Net Income": "16.6",
"Economic Capital Ratio": "60.2"
},
"2014": {
"Assets": "62.2",
"Liabilities": "-19.2",
"Stockholders Equity": "69.8",
"ECR before LimitedLiability": "67.7",
"Intangible Assets": "62.6",
"Property Plant and Equipment": "-3.31",
"Assets, Current": "6.96",
"Other Liabilities": "-10.6",
"Long Term Liabilities": "-8.28",
"Expenses": "37.9",
"Revenues": "-20.6",
"Net Income": "14.9",
"Operating Costs and Expenses": "2.99",
"Labor Expense": "6.44",
"Research And Development Expense": "2.25",
"Other Expenses": "8.85",
"Cost of Goods and Services Sold": "3.87",
"General and Administrative Expense": "9.46",
"Other Revenues": "-20.6",
"Comprehensive Net Income": "15.0",
"Economic Capital Ratio": "54.6"
},
"2015": {
"Assets, Current": "3.70",
"Assets": "61.0",
"Liabilities": "-25.7",
"Stockholders Equity": "62.3",
"ECR before LimitedLiability": "59.1",
"Intangible Assets": "72.3",
"Property Plant and Equipment": "-3.52",
"Long Term Liabilities": "-25.7",
"Other Liabilities": "-3.42",
"Liabilities, Current": "3.35",
"Selling and Marketing Expense": "2.60",
"Expenses": "38.7",
"Revenues": "-21.9",
"Net Income": "17.8",
"General and Administrative Expense": "9.67",
"Other Expenses": "8.51",
"Labor Expense": "5.91",
"Cost of Goods and Services Sold": "5.09",
"Other Revenues": "-21.9",
"Comprehensive Net Income": "18.0",
"Economic Capital Ratio": "46.7"
},
"2016": {
"Assets": "66.5",
"Stockholders Equity": "75.3",
"ECR before LimitedLiability": "87.8",
"Intangible Assets": "67.4",
"Assets, Current": "4.26",
"Liabilities, Current": "7.38",
"Liabilities": "-17.1",
"Other Liabilities": "-3.71",
"Long Term Liabilities": "-21.7",
"Expenses": "39.3",
"Revenues": "-23.4",
"Net Income": "18.7",
"Selling and Marketing Expense": "2.96",
"General and Administrative Expense": "10.6",
"Labor Expense": "3.11",
"Other Expenses": "9.20",
"Cost of Goods and Services Sold": "7.25",
"Other Revenues": "-23.4",
"Other Net Income": "3.31",
"Comprehensive Net Income": "19.1",
"Economic Capital Ratio": "60.2"
},
"2017": {
"Assets": "63.4",
"Liabilities": "-23.5",
"Stockholders Equity": "65.9",
"ECR before LimitedLiability": "82.3",
"Intangible Assets": "68.0",
"Assets, Current": "3.00",
"Property Plant and Equipment": "-2.51",
"Liabilities, Current": "4.74",
"Other Liabilities": "-3.06",
"Long Term Liabilities": "-25.6",
"General and Administrative Expense": "10.8",
"Expenses": "40.4",
"Revenues": "-19.3",
"Net Income": "18.9",
"Labor Expense": "3.25",
"Research And Development Expense": "3.26",
"Other Expenses": "11.7",
"Cost of Goods and Services Sold": "5.70",
"Other Revenues": "-19.3",
"Comprehensive Net Income": "18.9",
"Economic Capital Ratio": "58.2"
},
"2018": {
"Other Liabilities": "8.74",
"Liabilities": "45.8",
"Other Assets": "-4.43",
"Stockholders Equity": "32.1",
"ECR before LimitedLiability": "85.4",
"Liabilities, Current": "34.8",
"Long Term Liabilities": "5.14",
"Other Revenues": "32.3",
"Revenues": "32.3",
"Net Income": "33.5",
"Property Plant and Equipment": "-6.48",
"Intangible Assets": "59.6",
"Assets, Current": "-13.9",
"Comprehensive Net Income": "33.8",
"Operating Costs and Expenses": "4.54",
"Research And Development Expense": "6.41",
"Other Expenses": "20.1",
"General and Administrative Expense": "-6.66",
"Cost of Goods and Services Sold": "-41.6",
"Labor Expense": "9.15",
"Economic Capital Ratio": "64.7"
},
"2019": {
"Other Liabilities": "11.6",
"Liabilities": "45.0",
"Property Plant and Equipment": "-6.95",
"Stockholders Equity": "19.9",
"ECR before LimitedLiability": "65.1",
"Long Term Liabilities": "14.0",
"Liabilities, Current": "23.1",
"Other Revenues": "32.2",
"Revenues": "32.2",
"Net Income": "27.5",
"Assets, Non-Current": "-5.37",
"Intangible Assets": "48.7",
"Assets, Current": "-15.3",
"Other Expenses": "11.8",
"Comprehensive Net Income": "27.7",
"General and Administrative Expense": "-8.59",
"Cost of Goods and Services Sold": "-38.5",
"Research And Development Expense": "7.89",
"Labor Expense": "7.63",
"Operating Costs and Expenses": "6.55",
"Economic Capital Ratio": "55.1"
},
"2020": {
"Liabilities, Current": "-13.0",
"Liabilities": "28.9",
"Property Plant and Equipment": "-4.70",
"Stockholders Equity": "15.0",
"ECR before LimitedLiability": "57.3",
"Other Liabilities": "7.61",
"Long Term Liabilities": "32.8",
"Other Revenues": "26.4",
"Revenues": "26.4",
"Net Income": "26.0",
"Other Assets": "-4.20",
"Intangible Assets": "43.0",
"Assets, Current": "-14.1",
"Assets, Non-Current": "-5.07",
"Comprehensive Net Income": "26.0",
"Labor Expense": "6.26",
"Research And Development Expense": "4.35",
"Other Expenses": "11.7",
"Operating Costs and Expenses": "4.97",
"Cost of Goods and Services Sold": "-29.8",
"Economic Capital Ratio": "45.2"
},
"2021": {
"Assets": "-6.76",
"Liabilities": "9.70",
"Stockholders Equity": "-5.71",
"ECR before LimitedLiability": "26.2",
"Intangible Assets": "56.3",
"Property Plant and Equipment": "-4.09",
"Assets, Non-Current": "-4.81",
"Assets, Current": "-23.2",
"Liabilities, Current": "8.93",
"Long Term Liabilities": "-10.7",
"Other Liabilities": "10.9",
"Other Revenues": "23.5",
"Revenues": "23.5",
"Net Income": "26.4",
"Comprehensive Net Income": "26.5",
"Operating Costs and Expenses": "5.54",
"Labor Expense": "4.79",
"Cost of Goods and Services Sold": "-27.2",
"Research And Development Expense": "4.97",
"Other Expenses": "10.3",
"Economic Capital Ratio": "20.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001303313_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "129,555",
"Assets, Non-Current": "4,542",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "257,077",
"Labor Expense": "0",
"Liabilities, Current": "59,646",
"Long Term Liabilities": "22,963",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "15,859",
"Other Liabilities": "32,475",
"Other Net Income": "45,005",
"Other Revenues": "0",
"Property Plant and Equipment": "31,052",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "422,226",
"Liabilities": "115,084",
"Expenses": "15,859",
"Revenues": "0",
"Stockholders Equity": "307,142",
"Net Income": "29,146",
"Comprehensive Net Income": "29,146",
"BaseVar": "299,087",
"ECR before LimitedLiability": "177%",
"Economic Capital Ratio": "222%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "135,352",
"Assets, Non-Current": "1,896",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "319,704",
"Labor Expense": "0",
"Liabilities, Current": "60,842",
"Long Term Liabilities": "60,778",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "14,513",
"Other Liabilities": "37,007",
"Other Net Income": "43,265",
"Other Revenues": "0",
"Property Plant and Equipment": "34,787",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "491,739",
"Liabilities": "158,627",
"Expenses": "14,513",
"Revenues": "0",
"Stockholders Equity": "333,112",
"Net Income": "28,752",
"Comprehensive Net Income": "28,752",
"BaseVar": "354,072",
"ECR before LimitedLiability": "157%",
"Economic Capital Ratio": "210%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "138,830",
"Assets, Non-Current": "2,029",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "387,099",
"Labor Expense": "0",
"Liabilities, Current": "70,166",
"Long Term Liabilities": "98,543",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "22,848",
"Other Liabilities": "27,144",
"Other Net Income": "64,498",
"Other Revenues": "0",
"Property Plant and Equipment": "38,096",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "566,054",
"Liabilities": "195,853",
"Expenses": "22,848",
"Revenues": "0",
"Stockholders Equity": "370,201",
"Net Income": "41,650",
"Comprehensive Net Income": "41,650",
"BaseVar": "424,626",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "206%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "149,741",
"Assets, Non-Current": "11,756",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "409,323",
"Labor Expense": "0",
"Liabilities, Current": "80,467",
"Long Term Liabilities": "87,544",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "22,176",
"Other Liabilities": "31,941",
"Other Net Income": "68,118",
"Other Revenues": "0",
"Property Plant and Equipment": "43,251",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "614,071",
"Liabilities": "199,952",
"Expenses": "22,176",
"Revenues": "0",
"Stockholders Equity": "414,119",
"Net Income": "45,942",
"Comprehensive Net Income": "45,942",
"BaseVar": "452,158",
"ECR before LimitedLiability": "159%",
"Economic Capital Ratio": "211%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "200,965",
"Assets, Non-Current": "19,073",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "527,211",
"Labor Expense": "0",
"Liabilities, Current": "102,252",
"Long Term Liabilities": "144,000",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "10,944",
"Other Liabilities": "27,466",
"Other Net Income": "71,330",
"Other Revenues": "0",
"Property Plant and Equipment": "46,453",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "793,702",
"Liabilities": "273,718",
"Expenses": "10,944",
"Revenues": "0",
"Stockholders Equity": "519,984",
"Net Income": "60,386",
"Comprehensive Net Income": "60,386",
"BaseVar": "574,847",
"ECR before LimitedLiability": "153%",
"Economic Capital Ratio": "206%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "366,905",
"Assets, Non-Current": "20,301",
"Cost of Goods and Services Sold": "1,156,357",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "537,916",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,459,096",
"Labor Expense": "0",
"Liabilities, Current": "249,418",
"Long Term Liabilities": "235,930",
"Operating Costs and Expenses": "0",
"Other Assets": "2,850",
"Other Compr. Net Income": "0",
"Other Expenses": "36,767",
"Other Liabilities": "4,297",
"Other Net Income": "0",
"Other Revenues": "1,809,963",
"Property Plant and Equipment": "79,563",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,928,715",
"Liabilities": "489,645",
"Expenses": "1,731,040",
"Revenues": "1,809,963",
"Stockholders Equity": "1,439,070",
"Net Income": "78,923",
"Comprehensive Net Income": "78,923",
"BaseVar": "2,979,682",
"ECR before LimitedLiability": "179%",
"Economic Capital Ratio": "224%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "380,274",
"Assets, Non-Current": "134,085",
"Cost of Goods and Services Sold": "1,324,887",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "596,006",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,525,528",
"Labor Expense": "0",
"Liabilities, Current": "291,470",
"Long Term Liabilities": "322,556",
"Operating Costs and Expenses": "0",
"Other Assets": "2,500",
"Other Compr. Net Income": "0",
"Other Expenses": "45,496",
"Other Liabilities": "3,867",
"Other Net Income": "0",
"Other Revenues": "2,080,241",
"Property Plant and Equipment": "97,908",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,140,295",
"Liabilities": "617,893",
"Expenses": "1,966,389",
"Revenues": "2,080,241",
"Stockholders Equity": "1,522,402",
"Net Income": "113,852",
"Comprehensive Net Income": "113,852",
"BaseVar": "3,402,409",
"ECR before LimitedLiability": "168%",
"Economic Capital Ratio": "217%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "647,022",
"Assets, Non-Current": "121,564",
"Cost of Goods and Services Sold": "1,250,403",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "632,847",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,574,502",
"Labor Expense": "0",
"Liabilities, Current": "728,673",
"Long Term Liabilities": "116,203",
"Operating Costs and Expenses": "0",
"Other Assets": "1,900",
"Other Compr. Net Income": "0",
"Other Expenses": "42,021",
"Other Liabilities": "6,203",
"Other Net Income": "0",
"Other Revenues": "2,063,204",
"Property Plant and Equipment": "138,366",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,483,354",
"Liabilities": "851,079",
"Expenses": "1,925,271",
"Revenues": "2,063,204",
"Stockholders Equity": "1,632,275",
"Net Income": "137,933",
"Comprehensive Net Income": "137,933",
"BaseVar": "3,661,454",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "205%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "433,142",
"Assets, Non-Current": "160,092",
"Cost of Goods and Services Sold": "1,336,609",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "696,435",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,148,428",
"Labor Expense": "0",
"Liabilities, Current": "478,816",
"Long Term Liabilities": "739,885",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "42,962",
"Other Liabilities": "7,320",
"Other Net Income": "0",
"Other Revenues": "2,219,622",
"Property Plant and Equipment": "153,959",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,895,621",
"Liabilities": "1,226,021",
"Expenses": "2,076,006",
"Revenues": "2,219,622",
"Stockholders Equity": "1,669,600",
"Net Income": "143,616",
"Comprehensive Net Income": "143,616",
"BaseVar": "4,208,635",
"ECR before LimitedLiability": "124%",
"Economic Capital Ratio": "188%"
}
}
},
"top_rated": false,
"trend": -14.0,
"value": 1.8779862736082915,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001303313.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001303313.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001303313.svg"
},
{
"company_id": "0001520697",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001520697.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001520697.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001520697.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001520697_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001520697_main_keyfigs.svg",
"name": "Acadia Healthcare Company Inc",
"rank": 38,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001520697.svg",
"report_text": "The relative strengths and weaknesses of Acadia Healthcare Company Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Acadia Healthcare Company Inc compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Acadia Healthcare Company Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 187%, being 20% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001520697_2022_Acadia_Healthcare_Company_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "10.4",
"Liabilities": "-59.3",
"Stockholders Equity": "-35.9",
"ECR before LimitedLiability": "-39.3",
"Property Plant and Equipment": "-6.63",
"Assets, Current": "-5.93",
"Intangible Assets": "27.3",
"Other Liabilities": "8.41",
"Long Term Liabilities": "-91.9",
"Liabilities, Current": "16.5",
"Expenses": "24.6",
"Revenues": "-38.4",
"Net Income": "8.39",
"Other Expenses": "15.0",
"Labor Expense": "-25.4",
"General and Administrative Expense": "19.8",
"Cost of Goods and Services Sold": "7.48",
"Other Revenues": "-38.4",
"Other Net Income": "27.2",
"Comprehensive Net Income": "8.62",
"Economic Capital Ratio": "-46.0"
},
"2012": {
"Property Plant and Equipment": "5.48",
"Assets": "27.4",
"Liabilities": "-38.4",
"Stockholders Equity": "3.62",
"ECR before LimitedLiability": "10.4",
"Intangible Assets": "52.4",
"Assets, Current": "-14.5",
"Liabilities, Current": "17.8",
"Long Term Liabilities": "-80.4",
"Other Liabilities": "12.2",
"Expenses": "27.5",
"Revenues": "-29.5",
"Net Income": "14.1",
"Other Expenses": "13.0",
"General and Administrative Expense": "15.2",
"Cost of Goods and Services Sold": "5.81",
"Labor Expense": "-13.4",
"Other Revenues": "-29.5",
"Other Net Income": "19.7",
"Comprehensive Net Income": "14.4",
"Economic Capital Ratio": "-3.84"
},
"2013": {
"Other Assets": "-3.63",
"Assets": "8.79",
"Liabilities": "-27.4",
"Stockholders Equity": "-9.57",
"Economic Capital Ratio": "-9.22",
"Property Plant and Equipment": "10.5",
"Assets, Current": "-23.6",
"Intangible Assets": "47.6",
"Other Liabilities": "11.4",
"Liabilities, Current": "25.2",
"Long Term Liabilities": "-75.0",
"Expenses": "19.9",
"Revenues": "-35.7",
"Net Income": "20.5",
"General and Administrative Expense": "18.8",
"Cost of Goods and Services Sold": "6.28",
"Labor Expense": "-19.9",
"Other Expenses": "10.5",
"Other Revenues": "-35.7",
"Comprehensive Net Income": "20.8",
"Other Net Income": "42.5"
},
"2014": {
"Other Assets": "-4.65",
"Assets": "23.2",
"Liabilities": "-33.4",
"ECR before LimitedLiability": "9.00",
"Intangible Assets": "20.5",
"Property Plant and Equipment": "36.0",
"Assets, Current": "-16.6",
"Other Liabilities": "3.81",
"Liabilities, Current": "23.9",
"Long Term Liabilities": "-69.1",
"Expenses": "28.9",
"Net Income": "19.4",
"Labor Expense": "-13.5",
"Other Expenses": "11.2",
"Cost of Goods and Services Sold": "6.53",
"General and Administrative Expense": "16.3",
"Other Revenues": "-31.9",
"Revenues": "-31.9",
"Comprehensive Net Income": "16.4",
"Other Net Income": "27.0",
"Economic Capital Ratio": "-4.15"
},
"2015": {
"Assets, Current": "-20.7",
"Assets": "28.4",
"Liabilities": "-40.9",
"ECR before LimitedLiability": "4.89",
"Intangible Assets": "46.2",
"Property Plant and Equipment": "25.2",
"Long Term Liabilities": "-89.6",
"Other Liabilities": "7.95",
"Liabilities, Current": "26.3",
"Selling and Marketing Expense": "4.11",
"Expenses": "29.7",
"Net Income": "19.7",
"General and Administrative Expense": "15.6",
"Other Expenses": "9.98",
"Labor Expense": "-12.0",
"Cost of Goods and Services Sold": "8.12",
"Other Revenues": "-32.1",
"Revenues": "-32.1",
"Comprehensive Net Income": "19.2",
"Other Net Income": "26.7",
"Economic Capital Ratio": "-7.54"
},
"2017": {
"Other Assets": "-4.23",
"Assets": "23.7",
"Liabilities": "-32.4",
"ECR before LimitedLiability": "32.9",
"Intangible Assets": "31.2",
"Assets, Current": "-22.6",
"Property Plant and Equipment": "40.8",
"Liabilities, Current": "32.9",
"Long Term Liabilities": "-84.0",
"General and Administrative Expense": "18.2",
"Expenses": "29.6",
"Net Income": "22.3",
"Labor Expense": "-16.4",
"Research And Development Expense": "5.36",
"Other Expenses": "12.5",
"Cost of Goods and Services Sold": "9.45",
"Other Revenues": "-29.6",
"Revenues": "-29.6",
"Other Net Income": "26.1",
"Comprehensive Net Income": "25.2",
"Economic Capital Ratio": "8.81"
},
"2018": {
"Other Assets": "-6.19",
"Assets": "17.9",
"Liabilities": "-39.6",
"Stockholders Equity": "-10.3",
"ECR before LimitedLiability": "5.26",
"Property Plant and Equipment": "56.3",
"Intangible Assets": "32.1",
"Assets, Non-Current": "-6.61",
"Assets, Current": "-28.7",
"Liabilities, Current": "29.5",
"Long Term Liabilities": "-84.2",
"Expenses": "25.7",
"Revenues": "-4.89",
"Net Income": "21.2",
"General and Administrative Expense": "18.8",
"Research And Development Expense": "5.10",
"Cost of Goods and Services Sold": "19.5",
"Labor Expense": "-18.2",
"Other Revenues": "-4.89",
"Comprehensive Net Income": "19.9",
"Economic Capital Ratio": "-15.5"
},
"2019": {
"Property Plant and Equipment": "49.5",
"Assets": "16.3",
"Liabilities": "-41.2",
"Stockholders Equity": "-12.0",
"ECR before LimitedLiability": "-3.98",
"Assets, Non-Current": "-4.06",
"Other Assets": "-4.47",
"Intangible Assets": "23.1",
"Assets, Current": "-25.3",
"Long Term Liabilities": "-73.4",
"Liabilities, Current": "20.8",
"Expenses": "25.8",
"Revenues": "-6.70",
"Net Income": "18.5",
"General and Administrative Expense": "15.2",
"Cost of Goods and Services Sold": "20.1",
"Research And Development Expense": "5.90",
"Labor Expense": "-17.4",
"Other Revenues": "-6.70",
"Comprehensive Net Income": "19.4",
"Economic Capital Ratio": "-14.0"
},
"2020": {
"Property Plant and Equipment": "20.7",
"Assets": "19.3",
"Liabilities": "-52.6",
"Stockholders Equity": "-22.1",
"ECR before LimitedLiability": "-23.0",
"Other Assets": "-6.47",
"Intangible Assets": "22.5",
"Assets, Non-Current": "-9.32",
"Other Liabilities": "5.32",
"Long Term Liabilities": "-56.4",
"Labor Expense": "-12.3",
"Expenses": "36.4",
"Revenues": "-14.6",
"Net Income": "6.95",
"General and Administrative Expense": "19.2",
"Other Expenses": "6.10",
"Cost of Goods and Services Sold": "17.7",
"Other Revenues": "-14.6",
"Other Net Income": "-11.5",
"Comprehensive Net Income": "7.61",
"Economic Capital Ratio": "-35.1"
},
"2021": {
"Assets": "5.96",
"Liabilities": "-11.0",
"ECR before LimitedLiability": "25.8",
"Intangible Assets": "21.3",
"Property Plant and Equipment": "27.6",
"Assets, Non-Current": "-3.95",
"Assets, Current": "-21.2",
"Liabilities, Current": "14.6",
"Long Term Liabilities": "-40.1",
"Other Liabilities": "9.44",
"General and Administrative Expense": "16.6",
"Expenses": "16.2",
"Net Income": "21.6",
"Labor Expense": "-19.8",
"Cost of Goods and Services Sold": "13.4",
"Research And Development Expense": "4.11",
"Other Revenues": "3.65",
"Revenues": "3.65",
"Comprehensive Net Income": "29.4",
"Other Compr. Net Income": "7.23",
"Economic Capital Ratio": "19.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001520697_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "112,605",
"Assets, Non-Current": "16,366",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "4,288",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "195,047",
"Labor Expense": "156,561",
"Liabilities, Current": "40,668",
"Long Term Liabilities": "275,963",
"Operating Costs and Expenses": "20,472",
"Other Assets": "6,006",
"Other Compr. Net Income": "0",
"Other Expenses": "72,925",
"Other Liabilities": "0",
"Other Net Income": "219,354",
"Other Revenues": "0",
"Property Plant and Equipment": "82,972",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "412,996",
"Liabilities": "316,631",
"Expenses": "254,246",
"Revenues": "0",
"Stockholders Equity": "96,365",
"Net Income": "-34,892",
"Comprehensive Net Income": "-34,892",
"BaseVar": "601,614",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "115%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "140,981",
"Assets, Non-Current": "32,100",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "7,982",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "573,390",
"Labor Expense": "239,639",
"Liabilities, Current": "71,851",
"Long Term Liabilities": "478,014",
"Operating Costs and Expenses": "42,777",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "96,559",
"Other Liabilities": "998",
"Other Net Income": "407,360",
"Other Revenues": "0",
"Property Plant and Equipment": "236,942",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "983,413",
"Liabilities": "550,863",
"Expenses": "386,957",
"Revenues": "0",
"Stockholders Equity": "432,550",
"Net Income": "20,403",
"Comprehensive Net Income": "20,403",
"BaseVar": "1,164,296",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "160%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "145,126",
"Assets, Non-Current": "27,307",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "17,090",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "682,117",
"Labor Expense": "407,962",
"Liabilities, Current": "114,690",
"Long Term Liabilities": "621,288",
"Operating Costs and Expenses": "80,572",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "164,514",
"Other Liabilities": "7,971",
"Other Net Income": "712,717",
"Other Revenues": "0",
"Property Plant and Equipment": "370,109",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,224,659",
"Liabilities": "743,949",
"Expenses": "670,138",
"Revenues": "0",
"Stockholders Equity": "480,710",
"Net Income": "42,579",
"Comprehensive Net Income": "42,579",
"BaseVar": "1,675,732",
"ECR before LimitedLiability": "75%",
"Economic Capital Ratio": "153%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "274,143",
"Assets, Non-Current": "41,984",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "32,667",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "824,622",
"Labor Expense": "575,412",
"Liabilities, Current": "165,934",
"Long Term Liabilities": "1,112,811",
"Operating Costs and Expenses": "110,654",
"Other Assets": "13,141",
"Other Compr. Net Income": "-68,370",
"Other Expenses": "202,636",
"Other Liabilities": "63,880",
"Other Net Income": "1,004,409",
"Other Revenues": "0",
"Property Plant and Equipment": "1,069,700",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,223,590",
"Liabilities": "1,342,625",
"Expenses": "921,369",
"Revenues": "0",
"Stockholders Equity": "880,965",
"Net Income": "83,040",
"Comprehensive Net Income": "14,670",
"BaseVar": "2,780,182",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "151%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "294,736",
"Assets, Non-Current": "38,515",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "63,550",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,187,790",
"Labor Expense": "973,732",
"Liabilities, Current": "290,203",
"Long Term Liabilities": "2,273,986",
"Operating Costs and Expenses": "206,746",
"Other Assets": "49,114",
"Other Compr. Net Income": "-35,199",
"Other Expenses": "439,099",
"Other Liabilities": "23,936",
"Other Net Income": "1,794,603",
"Other Revenues": "0",
"Property Plant and Equipment": "1,709,053",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,279,208",
"Liabilities": "2,588,125",
"Expenses": "1,683,127",
"Revenues": "0",
"Stockholders Equity": "1,691,083",
"Net Income": "111,476",
"Comprehensive Net Income": "76,277",
"BaseVar": "5,190,131",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "152%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "471,550",
"Assets, Non-Current": "49,572",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "143,010",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,838,522",
"Labor Expense": "1,536,160",
"Liabilities, Current": "377,389",
"Long Term Liabilities": "3,371,492",
"Operating Costs and Expenses": "331,827",
"Other Assets": "16,728",
"Other Compr. Net Income": "175,698",
"Other Expenses": "625,730",
"Other Liabilities": "80,333",
"Other Net Income": "2,836,316",
"Other Revenues": "0",
"Property Plant and Equipment": "3,048,130",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,424,502",
"Liabilities": "3,829,214",
"Expenses": "2,636,727",
"Revenues": "0",
"Stockholders Equity": "2,595,288",
"Net Income": "199,589",
"Comprehensive Net Income": "375,287",
"BaseVar": "7,951,228",
"ECR before LimitedLiability": "81%",
"Economic Capital Ratio": "157%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "450,417",
"Assets, Non-Current": "64,927",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "158,832",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,485,402",
"Labor Expense": "1,659,348",
"Liabilities, Current": "416,377",
"Long Term Liabilities": "3,313,642",
"Operating Costs and Expenses": "473,812",
"Other Assets": "63,992",
"Other Compr. Net Income": "-88,523",
"Other Expenses": "895,936",
"Other Liabilities": "80,372",
"Other Net Income": "0",
"Other Revenues": "3,012,442",
"Property Plant and Equipment": "3,107,766",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,172,504",
"Liabilities": "3,810,391",
"Expenses": "3,187,928",
"Revenues": "3,012,442",
"Stockholders Equity": "2,362,113",
"Net Income": "-175,486",
"Comprehensive Net Income": "-264,009",
"BaseVar": "8,135,894",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "144%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "542,211",
"Assets, Non-Current": "570,070",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "164,044",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,539,488",
"Labor Expense": "1,717,180",
"Liabilities, Current": "463,576",
"Long Term Liabilities": "3,736,259",
"Operating Costs and Expenses": "498,494",
"Other Assets": "3,339",
"Other Compr. Net Income": "46,294",
"Other Expenses": "617,622",
"Other Liabilities": "140,775",
"Other Net Income": "0",
"Other Revenues": "3,107,462",
"Property Plant and Equipment": "3,224,034",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,879,142",
"Liabilities": "4,340,610",
"Expenses": "2,997,340",
"Revenues": "3,107,462",
"Stockholders Equity": "2,538,532",
"Net Income": "110,122",
"Comprehensive Net Income": "156,416",
"BaseVar": "8,685,424",
"ECR before LimitedLiability": "68%",
"Economic Capital Ratio": "148%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "2,523,395",
"Assets, Non-Current": "176,063",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "95,256",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,173,799",
"Labor Expense": "1,154,522",
"Liabilities, Current": "1,358,202",
"Long Term Liabilities": "3,186,389",
"Operating Costs and Expenses": "349,513",
"Other Assets": "3,209",
"Other Compr. Net Income": "40,586",
"Other Expenses": "347,447",
"Other Liabilities": "0",
"Other Net Income": "-812,390",
"Other Revenues": "2,089,929",
"Property Plant and Equipment": "1,622,896",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,499,362",
"Liabilities": "4,544,591",
"Expenses": "1,946,738",
"Revenues": "2,089,929",
"Stockholders Equity": "1,954,771",
"Net Income": "-669,199",
"Comprehensive Net Income": "-628,613",
"BaseVar": "7,966,798",
"ECR before LimitedLiability": "40%",
"Economic Capital Ratio": "125%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "495,031",
"Assets, Non-Current": "228,726",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "106,717",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,270,082",
"Labor Expense": "1,243,804",
"Liabilities, Current": "479,229",
"Long Term Liabilities": "1,705,972",
"Operating Costs and Expenses": "392,041",
"Other Assets": "3,080",
"Other Compr. Net Income": "366,438",
"Other Expenses": "363,629",
"Other Liabilities": "0",
"Other Net Income": "-12,641",
"Other Revenues": "2,314,394",
"Property Plant and Equipment": "1,771,159",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,768,078",
"Liabilities": "2,185,201",
"Expenses": "2,106,191",
"Revenues": "2,314,394",
"Stockholders Equity": "2,582,877",
"Net Income": "195,562",
"Comprehensive Net Income": "562,000",
"BaseVar": "5,876,472",
"ECR before LimitedLiability": "124%",
"Economic Capital Ratio": "187%"
}
}
},
"top_rated": false,
"trend": 12.0,
"value": 1.8742661755030623,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001520697.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001520697.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001520697.svg"
},
{
"company_id": "0001044378",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001044378.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001044378.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001044378.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001044378_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001044378_main_keyfigs.svg",
"name": "Biocept INC",
"rank": 39,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001044378.svg",
"report_text": "The relative strengths and weaknesses of Biocept INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biocept INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 40% points.The greatest weakness of Biocept INC is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 41% points.
The company's Economic Capital Ratio, given in the ranking table, is 187%, being 19% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001044378_2022_Biocept_INC.pdf",
"shrinked_graph_json": {
"2014": {
"Other Assets": "-6.55",
"Assets": "-30.7",
"Stockholders Equity": "-33.3",
"ECR before LimitedLiability": "-116",
"Intangible Assets": "-24.9",
"Assets, Non-Current": "-4.26",
"Property Plant and Equipment": "-19.7",
"Assets, Current": "19.1",
"Expenses": "-26.8",
"Revenues": "-18.4",
"Net Income": "-59.6",
"Labor Expense": "4.86",
"Research And Development Expense": "-18.1",
"Other Expenses": "8.41",
"Selling and Marketing Expense": "-7.07",
"Cost of Goods and Services Sold": "-5.66",
"General and Administrative Expense": "-14.3",
"Other Revenues": "-18.4",
"Comprehensive Net Income": "-59.6",
"Other Net Income": "-18.8",
"Economic Capital Ratio": "-129"
},
"2015": {
"Assets, Current": "48.0",
"Assets": "-6.20",
"Liabilities": "-4.01",
"Stockholders Equity": "-10.9",
"ECR before LimitedLiability": "-86.2",
"Intangible Assets": "-17.1",
"Other Assets": "-5.75",
"Property Plant and Equipment": "-13.1",
"Selling and Marketing Expense": "-11.7",
"Expenses": "-21.8",
"Revenues": "-16.2",
"Net Income": "-57.2",
"Research And Development Expense": "-8.65",
"General and Administrative Expense": "-12.0",
"Other Expenses": "11.8",
"Labor Expense": "5.56",
"Cost of Goods and Services Sold": "-12.1",
"Other Revenues": "-16.2",
"Comprehensive Net Income": "-56.7",
"Other Net Income": "-10.2",
"Economic Capital Ratio": "-98.7"
},
"2016": {
"Property Plant and Equipment": "-11.2",
"Assets": "-38.5",
"Stockholders Equity": "-27.6",
"ECR before LimitedLiability": "-96.5",
"Assets, Non-Current": "-6.48",
"Intangible Assets": "-27.0",
"Other Assets": "-5.42",
"Assets, Current": "8.45",
"Expenses": "-43.7",
"Revenues": "-12.1",
"Net Income": "-59.8",
"Selling and Marketing Expense": "-17.7",
"General and Administrative Expense": "-15.2",
"Labor Expense": "2.93",
"Other Expenses": "10.7",
"Cost of Goods and Services Sold": "-21.0",
"Research And Development Expense": "-7.83",
"Other Revenues": "-12.1",
"Other Net Income": "-9.67",
"Comprehensive Net Income": "-59.6",
"Economic Capital Ratio": "-124"
},
"2017": {
"Other Assets": "-7.32",
"Assets": "-59.3",
"Stockholders Equity": "-32.7",
"ECR before LimitedLiability": "-110",
"Intangible Assets": "-32.1",
"Assets, Non-Current": "-5.47",
"Assets, Current": "-20.9",
"General and Administrative Expense": "-12.5",
"Expenses": "-57.7",
"Revenues": "-2.98",
"Net Income": "-71.7",
"Labor Expense": "2.57",
"Operating Costs and Expenses": "0.985",
"Selling and Marketing Expense": "-20.1",
"Research And Development Expense": "-7.12",
"Other Expenses": "8.26",
"Cost of Goods and Services Sold": "-29.5",
"Other Revenues": "-2.98",
"Other Net Income": "-12.0",
"Comprehensive Net Income": "-71.6",
"Economic Capital Ratio": "-134"
},
"2018": {
"Other Assets": "-10.3",
"Assets": "-50.4",
"Stockholders Equity": "-26.7",
"ECR before LimitedLiability": "-121",
"Property Plant and Equipment": "2.78",
"Intangible Assets": "-26.4",
"Assets, Non-Current": "-10.9",
"Assets, Current": "-8.67",
"Selling and Marketing Expense": "-19.1",
"Expenses": "-58.9",
"Revenues": "-22.3",
"Net Income": "-74.7",
"Operating Costs and Expenses": "1.70",
"Other Expenses": "7.17",
"General and Administrative Expense": "-13.1",
"Research And Development Expense": "-11.9",
"Cost of Goods and Services Sold": "-25.4",
"Labor Expense": "3.30",
"Other Revenues": "-22.3",
"Comprehensive Net Income": "-74.2",
"Economic Capital Ratio": "-142"
},
"2019": {
"Property Plant and Equipment": "-4.85",
"Assets": "-7.17",
"ECR before LimitedLiability": "-73.5",
"Assets, Non-Current": "-5.96",
"Intangible Assets": "-8.71",
"Assets, Current": "28.1",
"Liabilities": "6.68",
"Long Term Liabilities": "8.49",
"Other Expenses": "5.65",
"Expenses": "-33.7",
"Revenues": "-8.82",
"Net Income": "-92.9",
"General and Administrative Expense": "-5.42",
"Cost of Goods and Services Sold": "-8.31",
"Research And Development Expense": "-5.38",
"Selling and Marketing Expense": "-7.40",
"Labor Expense": "2.96",
"Other Revenues": "-8.82",
"Comprehensive Net Income": "-92.7",
"Other Net Income": "-3.63",
"Economic Capital Ratio": "-83.6"
},
"2020": {
"Property Plant and Equipment": "-10.4",
"Assets": "-8.95",
"Liabilities, Current": "-3.88",
"Stockholders Equity": "-10.9",
"ECR before LimitedLiability": "-17.5",
"Other Assets": "-2.35",
"Intangible Assets": "-25.0",
"Assets, Current": "27.6",
"Assets, Non-Current": "12.5",
"Labor Expense": "7.45",
"Expenses": "-13.1",
"Other Net Income": "-4.37",
"Net Income": "-17.6",
"Selling and Marketing Expense": "-10.9",
"Research And Development Expense": "-7.08",
"Other Expenses": "16.2",
"Operating Costs and Expenses": "5.90",
"Cost of Goods and Services Sold": "-25.4",
"Long Term Liabilities": "2.46",
"Comprehensive Net Income": "-17.6",
"Economic Capital Ratio": "-29.6"
},
"2021": {
"Assets": "-19.6",
"Liabilities": "34.5",
"Stockholders Equity": "-16.0",
"ECR before LimitedLiability": "25.6",
"Intangible Assets": "-22.2",
"Property Plant and Equipment": "-6.69",
"Assets, Current": "11.2",
"Liabilities, Current": "11.2",
"Long Term Liabilities": "15.5",
"Other Liabilities": "9.32",
"Expenses": "-18.8",
"Revenues": "40.4",
"Net Income": "21.5",
"Operating Costs and Expenses": "6.81",
"Labor Expense": "5.89",
"Cost of Goods and Services Sold": "-40.7",
"Other Expenses": "14.3",
"Selling and Marketing Expense": "-8.69",
"Other Revenues": "40.4",
"Comprehensive Net Income": "21.7",
"Economic Capital Ratio": "19.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001044378_strength_weakness.svg",
"table_records": {
"2014": {
"input_variables": {
"Assets, Current": "5,903",
"Assets, Non-Current": "23",
"Cost of Goods and Services Sold": "2,171",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,202",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,431",
"Long Term Liabilities": "4,755",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1.5",
"Other Liabilities": "624",
"Other Net Income": "-1,991",
"Other Revenues": "133",
"Property Plant and Equipment": "662",
"Research And Development Expense": "4,498",
"Selling and Marketing Expense": "2,137"
},
"output_variables": {
"Assets": "6,588",
"Liabilities": "6,809",
"Expenses": "14,009",
"Revenues": "133",
"Stockholders Equity": "-221",
"Net Income": "-15,866",
"Comprehensive Net Income": "-15,866",
"BaseVar": "14,765",
"ECR before LimitedLiability": "-242%",
"Economic Capital Ratio": "26%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "9,641",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "4,596",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,686",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,341",
"Long Term Liabilities": "2,638",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1.6",
"Other Liabilities": "915",
"Other Net Income": "-537",
"Other Revenues": "610",
"Property Plant and Equipment": "946",
"Research And Development Expense": "2,858",
"Selling and Marketing Expense": "3,880"
},
"output_variables": {
"Assets": "10,587",
"Liabilities": "6,894",
"Expenses": "17,022",
"Revenues": "610",
"Stockholders Equity": "3,693",
"Net Income": "-16,950",
"Comprehensive Net Income": "-16,950",
"BaseVar": "17,825",
"ECR before LimitedLiability": "-133%",
"Economic Capital Ratio": "61%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "5,772",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "6,920",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,560",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,394",
"Long Term Liabilities": "1,123",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2.1",
"Other Liabilities": "1,403",
"Other Net Income": "-372",
"Other Revenues": "3,223",
"Property Plant and Equipment": "1,806",
"Research And Development Expense": "2,713",
"Selling and Marketing Expense": "5,054"
},
"output_variables": {
"Assets": "7,578",
"Liabilities": "6,920",
"Expenses": "21,250",
"Revenues": "3,223",
"Stockholders Equity": "659",
"Net Income": "-18,399",
"Comprehensive Net Income": "-18,399",
"BaseVar": "19,672",
"ECR before LimitedLiability": "-241%",
"Economic Capital Ratio": "26%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "4,255",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "9,345",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "7,190",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,661",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "7.6",
"Other Liabilities": "1,422",
"Other Net Income": "-431",
"Other Revenues": "5,069",
"Property Plant and Equipment": "3,124",
"Research And Development Expense": "3,365",
"Selling and Marketing Expense": "6,344"
},
"output_variables": {
"Assets": "7,379",
"Liabilities": "6,083",
"Expenses": "26,251",
"Revenues": "5,069",
"Stockholders Equity": "1,296",
"Net Income": "-21,614",
"Comprehensive Net Income": "-21,614",
"BaseVar": "22,606",
"ECR before LimitedLiability": "-293%",
"Economic Capital Ratio": "15%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "6,011",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "10,052",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "7,074",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,610",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1.9",
"Other Liabilities": "1,098",
"Other Net Income": "-311",
"Other Revenues": "3,250",
"Property Plant and Equipment": "2,739",
"Research And Development Expense": "4,469",
"Selling and Marketing Expense": "5,915"
},
"output_variables": {
"Assets": "8,750",
"Liabilities": "5,708",
"Expenses": "27,511",
"Revenues": "3,250",
"Stockholders Equity": "3,043",
"Net Income": "-24,572",
"Comprehensive Net Income": "-24,572",
"BaseVar": "22,765",
"ECR before LimitedLiability": "-279%",
"Economic Capital Ratio": "17%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "13,893",
"Assets, Non-Current": "729",
"Cost of Goods and Services Sold": "10,978",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,970",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,559",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,606",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "973",
"Other Net Income": "-2,081",
"Other Revenues": "5,529",
"Property Plant and Equipment": "1,504",
"Research And Development Expense": "4,697",
"Selling and Marketing Expense": "5,941"
},
"output_variables": {
"Assets": "17,733",
"Liabilities": "6,532",
"Expenses": "28,586",
"Revenues": "5,529",
"Stockholders Equity": "11,201",
"Net Income": "-25,138",
"Comprehensive Net Income": "-25,138",
"BaseVar": "30,230",
"ECR before LimitedLiability": "-73%",
"Economic Capital Ratio": "78%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "32,594",
"Assets, Non-Current": "10,202",
"Cost of Goods and Services Sold": "21,337",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "9,973",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "12,494",
"Long Term Liabilities": "9,805",
"Operating Costs and Expenses": "0",
"Other Assets": "2,338",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "1,460",
"Other Net Income": "-2,339",
"Other Revenues": "27,461",
"Property Plant and Equipment": "2,318",
"Research And Development Expense": "5,220",
"Selling and Marketing Expense": "6,400"
},
"output_variables": {
"Assets": "47,452",
"Liabilities": "23,759",
"Expenses": "42,930",
"Revenues": "27,461",
"Stockholders Equity": "23,692",
"Net Income": "-17,807",
"Comprehensive Net Income": "-17,807",
"BaseVar": "71,970",
"ECR before LimitedLiability": "46%",
"Economic Capital Ratio": "130%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "45,692",
"Assets, Non-Current": "9,482",
"Cost of Goods and Services Sold": "37,764",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "12,614",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "11,773",
"Long Term Liabilities": "9,736",
"Operating Costs and Expenses": "0",
"Other Assets": "2,842",
"Other Compr. Net Income": "0",
"Other Expenses": "125",
"Other Liabilities": "1,428",
"Other Net Income": "-290",
"Other Revenues": "61,249",
"Property Plant and Equipment": "2,401",
"Research And Development Expense": "4,960",
"Selling and Marketing Expense": "8,320"
},
"output_variables": {
"Assets": "60,417",
"Liabilities": "22,937",
"Expenses": "63,783",
"Revenues": "61,249",
"Stockholders Equity": "37,480",
"Net Income": "-2,824",
"Comprehensive Net Income": "-2,824",
"BaseVar": "104,338",
"ECR before LimitedLiability": "124%",
"Economic Capital Ratio": "187%"
}
}
},
"top_rated": false,
"trend": 10.0,
"value": 1.8724720304605649,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001044378.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001044378.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001044378.svg"
},
{
"company_id": "0001274737",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001274737.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001274737.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001274737.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001274737_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001274737_main_keyfigs.svg",
"name": "Exagen INC",
"rank": 40,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001274737.svg",
"report_text": "The relative strengths and weaknesses of Exagen INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Exagen INC compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 80% points.The greatest weakness of Exagen INC is the variable General and Administrative Expense, reducing the Economic Capital Ratio by 20% points.
The company's Economic Capital Ratio, given in the ranking table, is 184%, being 16% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001274737_2022_Exagen_INC.pdf",
"shrinked_graph_json": {
"2019": {
"Property Plant and Equipment": "-9.07",
"Assets": "17.2",
"Liabilities": "4.24",
"Expenses": "6.67",
"Revenues": "-4.77",
"Stockholders Equity": "28.5",
"ECR before LimitedLiability": "28.7",
"Assets, Non-Current": "-9.36",
"Other Assets": "-3.66",
"Intangible Assets": "-9.29",
"Assets, Current": "93.0",
"Other Liabilities": "8.08",
"Long Term Liabilities": "-29.7",
"Liabilities, Current": "22.5",
"Other Expenses": "6.56",
"General and Administrative Expense": "-17.2",
"Selling and Marketing Expense": "3.83",
"Labor Expense": "5.77",
"Operating Costs and Expenses": "4.94",
"Other Revenues": "-4.77",
"Economic Capital Ratio": "18.7"
},
"2020": {
"Property Plant and Equipment": "-9.47",
"Assets": "2.32",
"Stockholders Equity": "2.12",
"ECR before LimitedLiability": "6.39",
"Other Assets": "-6.35",
"Intangible Assets": "-13.1",
"Assets, Current": "66.7",
"Assets, Non-Current": "-11.6",
"Labor Expense": "6.25",
"Expenses": "-4.49",
"Other Net Income": "2.22",
"Net Income": "-2.02",
"Selling and Marketing Expense": "3.26",
"General and Administrative Expense": "-26.0",
"Other Expenses": "10.1",
"Operating Costs and Expenses": "4.95",
"Cost of Goods and Services Sold": "-2.11",
"Liabilities, Current": "19.8",
"Other Liabilities": "6.78",
"Long Term Liabilities": "-30.0",
"Economic Capital Ratio": "-5.70"
},
"2021": {
"Assets": "13.1",
"Liabilities": "13.4",
"Stockholders Equity": "30.8",
"ECR before LimitedLiability": "22.5",
"Intangible Assets": "-14.4",
"Property Plant and Equipment": "-4.00",
"Assets, Non-Current": "-7.52",
"Assets, Current": "80.3",
"Liabilities, Current": "18.4",
"Long Term Liabilities": "-16.1",
"Other Liabilities": "9.81",
"General and Administrative Expense": "-19.9",
"Expenses": "-3.39",
"Net Income": "-4.39",
"Operating Costs and Expenses": "4.82",
"Labor Expense": "4.17",
"Cost of Goods and Services Sold": "-3.34",
"Other Expenses": "7.83",
"Selling and Marketing Expense": "3.32",
"Comprehensive Net Income": "-4.31",
"Economic Capital Ratio": "16.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001274737_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "81,250",
"Assets, Non-Current": "174",
"Cost of Goods and Services Sold": "18,808",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "28,702",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,506",
"Labor Expense": "0",
"Liabilities, Current": "6,159",
"Long Term Liabilities": "26,492",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3,516",
"Other Liabilities": "0",
"Other Net Income": "777",
"Other Revenues": "40,387",
"Property Plant and Equipment": "1,380",
"Research And Development Expense": "2,176",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "88,310",
"Liabilities": "32,651",
"Expenses": "53,202",
"Revenues": "40,387",
"Stockholders Equity": "55,659",
"Net Income": "-12,038",
"Comprehensive Net Income": "-12,038",
"BaseVar": "107,664",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "180%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "70,517",
"Assets, Non-Current": "250",
"Cost of Goods and Services Sold": "16,559",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "37,033",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,506",
"Labor Expense": "0",
"Liabilities, Current": "8,929",
"Long Term Liabilities": "27,607",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,486",
"Other Liabilities": "0",
"Other Net Income": "984",
"Other Revenues": "41,975",
"Property Plant and Equipment": "2,102",
"Research And Development Expense": "3,568",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "78,375",
"Liabilities": "36,536",
"Expenses": "59,646",
"Revenues": "41,975",
"Stockholders Equity": "41,839",
"Net Income": "-16,687",
"Comprehensive Net Income": "-16,687",
"BaseVar": "108,758",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "154%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "112,734",
"Assets, Non-Current": "433",
"Cost of Goods and Services Sold": "20,588",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "44,541",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,506",
"Labor Expense": "0",
"Liabilities, Current": "9,624",
"Long Term Liabilities": "28,885",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,800",
"Other Liabilities": "0",
"Other Net Income": "16",
"Other Revenues": "48,299",
"Property Plant and Equipment": "4,772",
"Research And Development Expense": "7,237",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "123,445",
"Liabilities": "38,509",
"Expenses": "75,166",
"Revenues": "48,299",
"Stockholders Equity": "84,936",
"Net Income": "-26,851",
"Comprehensive Net Income": "-26,851",
"BaseVar": "142,718",
"ECR before LimitedLiability": "119%",
"Economic Capital Ratio": "184%"
}
}
},
"top_rated": false,
"trend": 0.0,
"value": 1.8408025482780181,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001274737.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001274737.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001274737.svg"
},
{
"company_id": "0000896262",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000896262.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000896262.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000896262.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000896262_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000896262_main_keyfigs.svg",
"name": "Amedisys INC",
"rank": 41,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000896262.svg",
"report_text": "The relative strengths and weaknesses of Amedisys INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Amedisys INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 101% points.The greatest weakness of Amedisys INC is the variable Other Revenues, reducing the Economic Capital Ratio by 62% points.
The company's Economic Capital Ratio, given in the ranking table, is 184%, being 16% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000896262_2022_Amedisys_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Current": "3.61",
"Liabilities": "11.3",
"Stockholders Equity": "6.14",
"ECR before LimitedLiability": "8.16",
"Long Term Liabilities": "9.40",
"Other Liabilities": "-1.69",
"Other Expenses": "-60.9",
"Expenses": "-3.17",
"Net Income": "1.31",
"General and Administrative Expense": "11.3",
"Cost of Goods and Services Sold": "57.3",
"Labor Expense": "-21.5",
"Operating Costs and Expenses": "12.9",
"Other Revenues": "-81.2",
"Revenues": "-81.2",
"Intangible Assets": "7.32",
"Assets, Current": "-4.89",
"Property Plant and Equipment": "-1.71",
"Comprehensive Net Income": "1.31",
"Other Net Income": "91.4",
"Economic Capital Ratio": "8.57"
},
"2010": {
"Assets, Current": "-7.22",
"Assets": "-16.2",
"Liabilities": "47.8",
"Stockholders Equity": "-9.62",
"ECR before LimitedLiability": "19.8",
"Property Plant and Equipment": "-12.4",
"Assets, Non-Current": "-2.37",
"Intangible Assets": "7.23",
"Other Liabilities": "11.5",
"Long Term Liabilities": "36.7",
"Other Expenses": "-50.4",
"Expenses": "-31.3",
"Revenues": "-45.4",
"Net Income": "-3.37",
"Cost of Goods and Services Sold": "15.2",
"General and Administrative Expense": "6.96",
"Labor Expense": "-16.3",
"Operating Costs and Expenses": "12.3",
"Other Revenues": "-45.4",
"Other Net Income": "76.5",
"Economic Capital Ratio": "21.7"
},
"2011": {
"Assets": "-52.4",
"Stockholders Equity": "-43.3",
"Economic Capital Ratio": "-17.8",
"Property Plant and Equipment": "-28.5",
"Assets, Current": "-30.1",
"Other Liabilities": "18.4",
"Liabilities": "55.7",
"Long Term Liabilities": "33.6",
"Liabilities, Current": "20.5",
"Expenses": "-62.9",
"Revenues": "-74.1",
"Net Income": "-16.2",
"Other Expenses": "-51.6",
"Goodwill Impairment Loss": "-65.1",
"Operating Costs and Expenses": "15.4",
"Labor Expense": "-19.8",
"General and Administrative Expense": "41.8",
"Cost of Goods and Services Sold": "15.3",
"Other Revenues": "-74.1",
"Other Net Income": "75.6",
"Comprehensive Net Income": "-15.8"
},
"2012": {
"Property Plant and Equipment": "-16.6",
"Assets": "-43.6",
"Stockholders Equity": "-49.5",
"ECR before LimitedLiability": "31.4",
"Assets, Current": "-29.3",
"Liabilities, Current": "26.0",
"Liabilities": "81.8",
"Long Term Liabilities": "30.7",
"Other Liabilities": "31.7",
"Expenses": "-56.4",
"Revenues": "-76.2",
"Net Income": "16.2",
"Other Expenses": "-91.8",
"General and Administrative Expense": "39.1",
"Goodwill Impairment Loss": "-17.7",
"Cost of Goods and Services Sold": "14.6",
"Labor Expense": "-22.6",
"Other Revenues": "-76.2",
"Other Net Income": "112",
"Comprehensive Net Income": "19.0",
"Economic Capital Ratio": "17.2"
},
"2013": {
"Other Assets": "6.06",
"Assets": "-45.7",
"Liabilities": "60.3",
"Stockholders Equity": "-46.2",
"Economic Capital Ratio": "-3.95",
"Property Plant and Equipment": "-14.8",
"Assets, Current": "-34.7",
"Intangible Assets": "-6.93",
"Other Liabilities": "24.5",
"Long Term Liabilities": "34.2",
"Expenses": "-43.2",
"Revenues": "-68.4",
"Net Income": "19.3",
"General and Administrative Expense": "38.4",
"Cost of Goods and Services Sold": "12.4",
"Labor Expense": "-19.8",
"Operating Costs and Expenses": "7.04",
"Other Expenses": "-88.9",
"Research And Development Expense": "7.07",
"Other Revenues": "-68.4",
"Comprehensive Net Income": "20.1",
"Other Net Income": "89.1"
},
"2014": {
"Assets": "-33.2",
"Stockholders Equity": "-25.3",
"ECR before LimitedLiability": "46.4",
"Property Plant and Equipment": "-14.8",
"Assets, Current": "-24.6",
"Other Liabilities": "19.2",
"Liabilities": "74.3",
"Liabilities, Current": "35.0",
"Long Term Liabilities": "25.9",
"Expenses": "-36.0",
"Revenues": "-68.0",
"Net Income": "33.5",
"Operating Costs and Expenses": "10.0",
"Labor Expense": "-20.1",
"Other Expenses": "-90.5",
"Cost of Goods and Services Sold": "13.0",
"General and Administrative Expense": "32.9",
"Other Revenues": "-68.0",
"Comprehensive Net Income": "33.7",
"Other Net Income": "111",
"Economic Capital Ratio": "33.3"
},
"2015": {
"Assets, Current": "-24.9",
"Assets": "-35.1",
"Stockholders Equity": "-32.5",
"ECR before LimitedLiability": "40.2",
"Property Plant and Equipment": "-22.4",
"Long Term Liabilities": "15.4",
"Liabilities": "72.5",
"Other Liabilities": "21.1",
"Liabilities, Current": "41.2",
"Selling and Marketing Expense": "8.88",
"Expenses": "-39.8",
"Revenues": "-74.3",
"Net Income": "37.1",
"General and Administrative Expense": "34.4",
"Other Expenses": "-103",
"Labor Expense": "-18.9",
"Cost of Goods and Services Sold": "17.6",
"Other Revenues": "-74.3",
"Comprehensive Net Income": "37.7",
"Other Net Income": "116",
"Economic Capital Ratio": "27.8"
},
"2016": {
"Property Plant and Equipment": "-19.7",
"Assets": "-29.3",
"ECR before LimitedLiability": "75.6",
"Assets, Current": "-20.2",
"Liabilities, Current": "61.6",
"Liabilities": "91.5",
"Other Liabilities": "24.6",
"Long Term Liabilities": "12.7",
"Expenses": "-39.0",
"Revenues": "-84.0",
"Net Income": "46.3",
"Selling and Marketing Expense": "10.3",
"General and Administrative Expense": "38.3",
"Labor Expense": "-29.5",
"Other Expenses": "-108",
"Cost of Goods and Services Sold": "25.7",
"Research And Development Expense": "9.13",
"Other Revenues": "-84.0",
"Other Net Income": "129",
"Comprehensive Net Income": "47.7",
"Economic Capital Ratio": "47.9"
},
"2017": {
"Assets": "-31.8",
"Stockholders Equity": "-20.7",
"ECR before LimitedLiability": "74.2",
"Assets, Current": "-20.5",
"Property Plant and Equipment": "-17.9",
"Liabilities, Current": "49.6",
"Liabilities": "86.9",
"Other Liabilities": "14.5",
"Long Term Liabilities": "30.4",
"General and Administrative Expense": "39.2",
"Expenses": "-37.9",
"Revenues": "-69.1",
"Net Income": "45.3",
"Labor Expense": "-25.0",
"Research And Development Expense": "11.5",
"Other Expenses": "-105",
"Cost of Goods and Services Sold": "20.2",
"Other Revenues": "-69.1",
"Other Net Income": "123",
"Comprehensive Net Income": "45.6",
"Economic Capital Ratio": "50.1"
},
"2018": {
"Assets": "-32.2",
"Liabilities": "98.5",
"Stockholders Equity": "-50.9",
"ECR before LimitedLiability": "80.8",
"Property Plant and Equipment": "-13.0",
"Intangible Assets": "9.53",
"Assets, Current": "-24.3",
"Other Liabilities": "15.8",
"Liabilities, Current": "45.8",
"Long Term Liabilities": "49.6",
"Expenses": "-49.1",
"Revenues": "-138",
"Net Income": "71.5",
"General and Administrative Expense": "40.8",
"Research And Development Expense": "11.3",
"Cost of Goods and Services Sold": "-109",
"Labor Expense": "-28.5",
"Other Revenues": "-138",
"Comprehensive Net Income": "72.0",
"Other Net Income": "175",
"Economic Capital Ratio": "60.1"
},
"2019": {
"Property Plant and Equipment": "-15.0",
"Assets": "-31.1",
"Liabilities": "38.9",
"Stockholders Equity": "-39.4",
"ECR before LimitedLiability": "27.8",
"Intangible Assets": "25.1",
"Assets, Current": "-24.8",
"Other Liabilities": "13.5",
"Long Term Liabilities": "12.2",
"Liabilities, Current": "15.0",
"Expenses": "-19.2",
"Revenues": "-84.4",
"Net Income": "40.0",
"General and Administrative Expense": "26.4",
"Cost of Goods and Services Sold": "-49.1",
"Research And Development Expense": "10.2",
"Labor Expense": "-18.6",
"Other Revenues": "-84.4",
"Comprehensive Net Income": "40.2",
"Other Net Income": "107",
"Economic Capital Ratio": "17.8"
},
"2020": {
"Property Plant and Equipment": "-11.3",
"Assets": "-25.7",
"Liabilities": "32.7",
"Stockholders Equity": "-31.1",
"ECR before LimitedLiability": "35.2",
"Intangible Assets": "38.0",
"Assets, Current": "-27.2",
"Assets, Non-Current": "-6.93",
"Other Liabilities": "9.67",
"Long Term Liabilities": "18.2",
"Labor Expense": "-18.0",
"Expenses": "-15.9",
"Revenues": "-68.2",
"Net Income": "39.2",
"General and Administrative Expense": "28.8",
"Operating Costs and Expenses": "6.43",
"Cost of Goods and Services Sold": "-42.8",
"Other Revenues": "-68.2",
"Other Net Income": "102",
"Comprehensive Net Income": "39.1",
"Economic Capital Ratio": "23.1"
},
"2021": {
"Assets": "-25.5",
"Liabilities": "25.7",
"Stockholders Equity": "-36.6",
"ECR before LimitedLiability": "22.3",
"Intangible Assets": "34.3",
"Property Plant and Equipment": "-9.36",
"Assets, Current": "-28.8",
"Liabilities, Current": "13.7",
"Other Liabilities": "14.2",
"General and Administrative Expense": "25.9",
"Expenses": "-14.2",
"Revenues": "-61.5",
"Net Income": "39.2",
"Operating Costs and Expenses": "7.06",
"Labor Expense": "-17.2",
"Cost of Goods and Services Sold": "-39.9",
"Research And Development Expense": "6.33",
"Other Revenues": "-61.5",
"Comprehensive Net Income": "39.3",
"Other Net Income": "101",
"Economic Capital Ratio": "16.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000896262_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "218,036",
"Assets, Non-Current": "17,865",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "28,312",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "844,531",
"Labor Expense": "327,738",
"Liabilities, Current": "229,306",
"Long Term Liabilities": "177,311",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,012,832",
"Other Liabilities": "29,399",
"Other Net Income": "1,505,105",
"Other Revenues": "0",
"Property Plant and Equipment": "91,919",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,172,351",
"Liabilities": "436,016",
"Expenses": "1,368,882",
"Revenues": "0",
"Stockholders Equity": "736,335",
"Net Income": "136,223",
"Comprehensive Net Income": "136,223",
"BaseVar": "2,241,177",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "205%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "293,930",
"Assets, Non-Current": "22,536",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "34,589",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "844,805",
"Labor Expense": "357,502",
"Liabilities, Current": "216,304",
"Long Term Liabilities": "151,520",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,121,027",
"Other Liabilities": "52,286",
"Other Net Income": "1,626,391",
"Other Revenues": "0",
"Property Plant and Equipment": "138,554",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,299,825",
"Liabilities": "420,110",
"Expenses": "1,513,118",
"Revenues": "0",
"Stockholders Equity": "879,715",
"Net Income": "113,273",
"Comprehensive Net Income": "113,273",
"BaseVar": "2,429,722",
"ECR before LimitedLiability": "162%",
"Economic Capital Ratio": "212%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "232,016",
"Assets, Non-Current": "24,322",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "579,955",
"Intangible Assets": "384,762",
"Labor Expense": "333,190",
"Liabilities, Current": "221,734",
"Long Term Liabilities": "116,403",
"Operating Costs and Expenses": "0",
"Other Assets": "68,649",
"Other Compr. Net Income": "0",
"Other Expenses": "924,653",
"Other Liabilities": "0",
"Other Net Income": "1,455,456",
"Other Revenues": "0",
"Property Plant and Equipment": "148,536",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "858,285",
"Liabilities": "338,137",
"Expenses": "1,837,798",
"Revenues": "0",
"Stockholders Equity": "520,148",
"Net Income": "-382,342",
"Comprehensive Net Income": "-382,342",
"BaseVar": "2,244,838",
"ECR before LimitedLiability": "62%",
"Economic Capital Ratio": "143%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "205,788",
"Assets, Non-Current": "18,650",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "162,103",
"Intangible Assets": "256,644",
"Labor Expense": "339,528",
"Liabilities, Current": "204,787",
"Long Term Liabilities": "71,575",
"Operating Costs and Expenses": "0",
"Other Assets": "92,804",
"Other Compr. Net Income": "14,997",
"Other Expenses": "1,077,082",
"Other Liabilities": "0",
"Other Net Income": "1,480,130",
"Other Revenues": "0",
"Property Plant and Equipment": "156,709",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "730,595",
"Liabilities": "276,362",
"Expenses": "1,578,713",
"Revenues": "0",
"Stockholders Equity": "454,233",
"Net Income": "-98,583",
"Comprehensive Net Income": "-83,586",
"BaseVar": "2,040,398",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "181%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "205,279",
"Assets, Non-Current": "26,283",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "9,492",
"Intangible Assets": "245,605",
"Labor Expense": "302,564",
"Liabilities, Current": "312,416",
"Long Term Liabilities": "41,511",
"Operating Costs and Expenses": "0",
"Other Assets": "90,214",
"Other Compr. Net Income": "1,597",
"Other Expenses": "1,033,486",
"Other Liabilities": "0",
"Other Net Income": "1,247,767",
"Other Revenues": "0",
"Property Plant and Equipment": "159,025",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "726,406",
"Liabilities": "353,927",
"Expenses": "1,345,542",
"Revenues": "0",
"Stockholders Equity": "372,479",
"Net Income": "-97,775",
"Comprehensive Net Income": "-96,178",
"BaseVar": "1,837,620",
"ECR before LimitedLiability": "82%",
"Economic Capital Ratio": "158%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "135,558",
"Assets, Non-Current": "33,161",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "3,107",
"Intangible Assets": "238,780",
"Labor Expense": "292,497",
"Liabilities, Current": "162,323",
"Long Term Liabilities": "109,657",
"Operating Costs and Expenses": "0",
"Other Assets": "124,788",
"Other Compr. Net Income": "-313",
"Other Expenses": "892,574",
"Other Liabilities": "0",
"Other Net Income": "1,201,267",
"Other Revenues": "0",
"Property Plant and Equipment": "137,455",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "669,742",
"Liabilities": "271,980",
"Expenses": "1,188,178",
"Revenues": "0",
"Stockholders Equity": "397,762",
"Net Income": "13,089",
"Comprehensive Net Income": "12,776",
"BaseVar": "1,665,740",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "188%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "175,263",
"Assets, Non-Current": "36,172",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "305,710",
"Labor Expense": "279,425",
"Liabilities, Current": "175,193",
"Long Term Liabilities": "99,456",
"Operating Costs and Expenses": "0",
"Other Assets": "125,245",
"Other Compr. Net Income": "-709",
"Other Expenses": "1,012,286",
"Other Liabilities": "0",
"Other Net Income": "1,289,399",
"Other Revenues": "0",
"Property Plant and Equipment": "42,695",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "685,085",
"Liabilities": "274,649",
"Expenses": "1,291,711",
"Revenues": "0",
"Stockholders Equity": "410,436",
"Net Income": "-2,312",
"Comprehensive Net Income": "-3,021",
"BaseVar": "1,770,776",
"ECR before LimitedLiability": "123%",
"Economic Capital Ratio": "187%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "214,910",
"Assets, Non-Current": "38,468",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "335,712",
"Labor Expense": "306,981",
"Liabilities, Current": "181,348",
"Long Term Liabilities": "91,539",
"Operating Costs and Expenses": "0",
"Other Assets": "107,940",
"Other Compr. Net Income": "-370",
"Other Expenses": "1,097,068",
"Other Liabilities": "0",
"Other Net Income": "1,441,680",
"Other Revenues": "0",
"Property Plant and Equipment": "36,999",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "734,029",
"Liabilities": "272,887",
"Expenses": "1,404,049",
"Revenues": "0",
"Stockholders Equity": "461,142",
"Net Income": "37,631",
"Comprehensive Net Income": "37,261",
"BaseVar": "1,926,508",
"ECR before LimitedLiability": "140%",
"Economic Capital Ratio": "198%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "311,156",
"Assets, Non-Current": "49,100",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "365,961",
"Labor Expense": "305,938",
"Liabilities, Current": "215,062",
"Long Term Liabilities": "82,003",
"Operating Costs and Expenses": "0",
"Other Assets": "56,143",
"Other Compr. Net Income": "-382",
"Other Expenses": "1,199,380",
"Other Liabilities": "-9.0",
"Other Net Income": "1,535,957",
"Other Revenues": "0",
"Property Plant and Equipment": "31,122",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "813,482",
"Liabilities": "297,056",
"Expenses": "1,505,318",
"Revenues": "0",
"Stockholders Equity": "516,426",
"Net Income": "30,639",
"Comprehensive Net Income": "30,257",
"BaseVar": "2,076,098",
"ECR before LimitedLiability": "140%",
"Economic Capital Ratio": "198%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "224,118",
"Assets, Non-Current": "54,145",
"Cost of Goods and Services Sold": "992,900",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "373,612",
"Labor Expense": "316,522",
"Liabilities, Current": "222,476",
"Long Term Liabilities": "12,000",
"Operating Costs and Expenses": "0",
"Other Assets": "35,843",
"Other Compr. Net Income": "-783",
"Other Expenses": "236,867",
"Other Liabilities": "9.0",
"Other Net Income": "1,666,440",
"Other Revenues": "0",
"Property Plant and Equipment": "29,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "717,118",
"Liabilities": "234,485",
"Expenses": "1,546,289",
"Revenues": "0",
"Stockholders Equity": "482,633",
"Net Income": "120,151",
"Comprehensive Net Income": "119,368",
"BaseVar": "2,082,558",
"ECR before LimitedLiability": "172%",
"Economic Capital Ratio": "219%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "350,554",
"Assets, Non-Current": "139,403",
"Cost of Goods and Services Sold": "1,150,337",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "723,248",
"Labor Expense": "394,452",
"Liabilities, Current": "326,943",
"Long Term Liabilities": "294,289",
"Operating Costs and Expenses": "0",
"Other Assets": "21,427",
"Other Compr. Net Income": "-1,074",
"Other Expenses": "275,875",
"Other Liabilities": "0",
"Other Net Income": "1,948,571",
"Other Revenues": "0",
"Property Plant and Equipment": "28,113",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,262,745",
"Liabilities": "621,232",
"Expenses": "1,820,664",
"Revenues": "0",
"Stockholders Equity": "641,513",
"Net Income": "127,907",
"Comprehensive Net Income": "126,833",
"BaseVar": "2,827,143",
"ECR before LimitedLiability": "112%",
"Economic Capital Ratio": "180%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "361,984",
"Assets, Non-Current": "126,640",
"Cost of Goods and Services Sold": "1,185,369",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,006,868",
"Labor Expense": "449,448",
"Liabilities, Current": "456,337",
"Long Term Liabilities": "300,120",
"Operating Costs and Expenses": "0",
"Other Assets": "47,987",
"Other Compr. Net Income": "-1,576",
"Other Expenses": "277,441",
"Other Liabilities": "0",
"Other Net Income": "2,063,070",
"Other Revenues": "34,372",
"Property Plant and Equipment": "23,719",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,567,198",
"Liabilities": "756,457",
"Expenses": "1,912,258",
"Revenues": "34,372",
"Stockholders Equity": "810,741",
"Net Income": "185,184",
"Comprehensive Net Income": "183,608",
"BaseVar": "3,167,466",
"ECR before LimitedLiability": "117%",
"Economic Capital Ratio": "183%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "356,684",
"Assets, Non-Current": "174,280",
"Cost of Goods and Services Sold": "1,233,356",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,307,280",
"Labor Expense": "474,718",
"Liabilities, Current": "374,282",
"Long Term Liabilities": "506,363",
"Operating Costs and Expenses": "0",
"Other Assets": "289",
"Other Compr. Net Income": "-1,094",
"Other Expenses": "337,488",
"Other Liabilities": "0",
"Other Net Income": "2,242,428",
"Other Revenues": "13,300",
"Property Plant and Equipment": "18,435",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,856,968",
"Liabilities": "880,645",
"Expenses": "2,045,562",
"Revenues": "13,300",
"Stockholders Equity": "976,323",
"Net Income": "210,166",
"Comprehensive Net Income": "209,072",
"BaseVar": "3,519,998",
"ECR before LimitedLiability": "119%",
"Economic Capital Ratio": "184%"
}
}
},
"top_rated": false,
"trend": -11.0,
"value": 1.8392255781147293,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000896262.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000896262.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000896262.svg"
},
{
"company_id": "0001501134",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001501134.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001501134.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001501134.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001501134_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001501134_main_keyfigs.svg",
"name": "Invitae Corp",
"rank": 42,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001501134.svg",
"report_text": "The relative strengths and weaknesses of Invitae Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Invitae Corp compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 89% points.The greatest weakness of Invitae Corp is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 49% points.
The company's Economic Capital Ratio, given in the ranking table, is 181%, being 14% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001501134_2022_Invitae_Corp.pdf",
"shrinked_graph_json": {
"2015": {
"Assets, Current": "110",
"Assets": "76.7",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "42.5",
"Intangible Assets": "-11.9",
"Long Term Liabilities": "10.00",
"Liabilities": "38.5",
"Other Liabilities": "7.03",
"Liabilities, Current": "23.2",
"Selling and Marketing Expense": "-13.3",
"Expenses": "-13.9",
"Revenues": "-25.3",
"Net Income": "-53.1",
"Research And Development Expense": "-29.3",
"Other Expenses": "18.5",
"Labor Expense": "8.75",
"Cost of Goods and Services Sold": "-5.15",
"Other Revenues": "-25.3",
"Comprehensive Net Income": "-52.8",
"Other Net Income": "-13.6",
"Economic Capital Ratio": "30.0"
},
"2016": {
"Assets": "48.9",
"Stockholders Equity": "53.2",
"ECR before LimitedLiability": "13.2",
"Intangible Assets": "-22.3",
"Assets, Current": "64.1",
"Liabilities, Current": "33.7",
"Liabilities": "36.8",
"Other Liabilities": "12.4",
"Long Term Liabilities": "-9.32",
"Expenses": "-33.2",
"Revenues": "-23.4",
"Net Income": "-67.1",
"Selling and Marketing Expense": "-21.4",
"Labor Expense": "6.82",
"Other Expenses": "28.9",
"Cost of Goods and Services Sold": "-12.1",
"Research And Development Expense": "-36.2",
"Other Revenues": "-23.4",
"Other Net Income": "-15.7",
"Comprehensive Net Income": "-66.5",
"Economic Capital Ratio": "-14.5"
},
"2017": {
"Other Assets": "32.6",
"Assets": "26.4",
"Liabilities": "5.20",
"Stockholders Equity": "32.4",
"Economic Capital Ratio": "-27.7",
"Assets, Non-Current": "-5.45",
"Assets, Current": "4.14",
"Property Plant and Equipment": "-5.14",
"Liabilities, Current": "23.0",
"Other Liabilities": "4.34",
"Long Term Liabilities": "-23.6",
"Expenses": "-17.3",
"Revenues": "-4.40",
"Net Income": "-41.8",
"Labor Expense": "7.62",
"Selling and Marketing Expense": "-24.1",
"Research And Development Expense": "-18.8",
"Cost of Goods and Services Sold": "13.5",
"Other Revenues": "-4.40",
"Other Net Income": "-22.3",
"Comprehensive Net Income": "-41.7"
},
"2018": {
"Other Assets": "7.49",
"Assets": "6.64",
"Stockholders Equity": "10.9",
"Other Liabilities": "6.18",
"Economic Capital Ratio": "-24.4",
"Property Plant and Equipment": "-7.04",
"Assets, Non-Current": "-9.05",
"Assets, Current": "20.9",
"Selling and Marketing Expense": "-24.4",
"Expenses": "-13.3",
"Revenues": "-8.65",
"Net Income": "-21.3",
"Operating Costs and Expenses": "4.72",
"Other Expenses": "22.2",
"Research And Development Expense": "-18.4",
"Cost of Goods and Services Sold": "-7.92",
"Labor Expense": "9.65",
"Other Revenues": "-8.65",
"Liabilities, Current": "27.4",
"Long Term Liabilities": "-32.7",
"Comprehensive Net Income": "-21.0"
},
"2019": {
"Property Plant and Equipment": "-9.24",
"Assets": "29.3",
"Liabilities": "-25.5",
"Stockholders Equity": "8.65",
"ECR before LimitedLiability": "-16.9",
"Assets, Non-Current": "-7.35",
"Intangible Assets": "22.3",
"Assets, Current": "33.7",
"Other Liabilities": "7.05",
"Long Term Liabilities": "-49.5",
"Liabilities, Current": "14.0",
"Other Expenses": "12.3",
"Expenses": "7.75",
"Revenues": "-22.2",
"Net Income": "-15.5",
"Research And Development Expense": "-13.0",
"Selling and Marketing Expense": "-12.6",
"Labor Expense": "6.14",
"Other Revenues": "-22.2",
"Comprehensive Net Income": "-15.4",
"Economic Capital Ratio": "-27.0"
},
"2020": {
"Property Plant and Equipment": "-5.42",
"Assets": "57.9",
"Liabilities": "-26.9",
"Stockholders Equity": "39.0",
"ECR before LimitedLiability": "18.2",
"Intangible Assets": "94.2",
"Assets, Current": "-14.6",
"Assets, Non-Current": "-5.59",
"Liabilities, Current": "17.0",
"Long Term Liabilities": "-45.8",
"Labor Expense": "3.87",
"Expenses": "21.9",
"Revenues": "-24.9",
"Net Income": "-5.28",
"General and Administrative Expense": "3.66",
"Research And Development Expense": "-4.37",
"Other Expenses": "10.8",
"Cost of Goods and Services Sold": "6.46",
"Other Revenues": "-24.9",
"Comprehensive Net Income": "-5.27",
"Economic Capital Ratio": "6.15"
},
"2021": {
"Assets": "47.5",
"Liabilities": "-25.9",
"Stockholders Equity": "37.9",
"ECR before LimitedLiability": "19.7",
"Intangible Assets": "88.8",
"Property Plant and Equipment": "-3.20",
"Assets, Non-Current": "-3.27",
"Assets, Current": "-5.35",
"Liabilities, Current": "15.7",
"Long Term Liabilities": "-48.8",
"General and Administrative Expense": "6.80",
"Expenses": "24.4",
"Revenues": "-20.0",
"Net Income": "4.84",
"Operating Costs and Expenses": "3.29",
"Labor Expense": "2.85",
"Research And Development Expense": "-5.30",
"Other Expenses": "14.7",
"Other Revenues": "-20.0",
"Comprehensive Net Income": "4.90",
"Economic Capital Ratio": "13.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001501134_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "131,310",
"Assets, Non-Current": "1,826",
"Cost of Goods and Services Sold": "16,523",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "16,047",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "10,877",
"Long Term Liabilities": "5,847",
"Operating Costs and Expenses": "0",
"Other Assets": "4,831",
"Other Compr. Net Income": "-15",
"Other Expenses": "211",
"Other Liabilities": "1,576",
"Other Net Income": "-94",
"Other Revenues": "8,378",
"Property Plant and Equipment": "18,709",
"Research And Development Expense": "42,806",
"Selling and Marketing Expense": "22,479"
},
"output_variables": {
"Assets": "156,676",
"Liabilities": "18,300",
"Expenses": "98,066",
"Revenues": "8,378",
"Stockholders Equity": "138,376",
"Net Income": "-89,782",
"Comprehensive Net Income": "-89,797",
"BaseVar": "140,764",
"ECR before LimitedLiability": "127%",
"Economic Capital Ratio": "189%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "101,800",
"Assets, Non-Current": "361",
"Cost of Goods and Services Sold": "27,878",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "24,085",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "14,753",
"Long Term Liabilities": "16,558",
"Operating Costs and Expenses": "0",
"Other Assets": "4,697",
"Other Compr. Net Income": "15",
"Other Expenses": "421",
"Other Liabilities": "266",
"Other Net Income": "348",
"Other Revenues": "25,048",
"Property Plant and Equipment": "23,793",
"Research And Development Expense": "44,630",
"Selling and Marketing Expense": "28,638"
},
"output_variables": {
"Assets": "130,651",
"Liabilities": "31,577",
"Expenses": "125,652",
"Revenues": "25,048",
"Stockholders Equity": "99,074",
"Net Income": "-100,256",
"Comprehensive Net Income": "-100,241",
"BaseVar": "156,646",
"ECR before LimitedLiability": "54%",
"Economic Capital Ratio": "136%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "86,681",
"Assets, Non-Current": "576",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "39,472",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "46,575",
"Labor Expense": "0",
"Liabilities, Current": "33,387",
"Long Term Liabilities": "52,524",
"Operating Costs and Expenses": "0",
"Other Assets": "46,905",
"Other Compr. Net Income": "-171",
"Other Expenses": "51,940",
"Other Liabilities": "3,373",
"Other Net Income": "-303",
"Other Revenues": "68,221",
"Property Plant and Equipment": "30,341",
"Research And Development Expense": "46,469",
"Selling and Marketing Expense": "53,417"
},
"output_variables": {
"Assets": "211,078",
"Liabilities": "89,284",
"Expenses": "191,298",
"Revenues": "68,221",
"Stockholders Equity": "121,794",
"Net Income": "-123,380",
"Comprehensive Net Income": "-123,551",
"BaseVar": "280,178",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "121%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "165,439",
"Assets, Non-Current": "3,064",
"Cost of Goods and Services Sold": "80,105",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "52,227",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "50,095",
"Labor Expense": "0",
"Liabilities, Current": "36,312",
"Long Term Liabilities": "83,433",
"Operating Costs and Expenses": "0",
"Other Assets": "36,475",
"Other Compr. Net Income": "166",
"Other Expenses": "4,230",
"Other Liabilities": "1,375",
"Other Net Income": "-2,568",
"Other Revenues": "147,699",
"Property Plant and Equipment": "27,886",
"Research And Development Expense": "63,496",
"Selling and Marketing Expense": "74,428"
},
"output_variables": {
"Assets": "282,959",
"Liabilities": "121,120",
"Expenses": "274,486",
"Revenues": "147,699",
"Stockholders Equity": "161,839",
"Net Income": "-129,355",
"Comprehensive Net Income": "-129,189",
"BaseVar": "414,499",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "135%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "442,398",
"Assets, Non-Current": "43,321",
"Cost of Goods and Services Sold": "118,103",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "79,070",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "251,952",
"Labor Expense": "0",
"Liabilities, Current": "81,860",
"Long Term Liabilities": "318,946",
"Operating Costs and Expenses": "0",
"Other Assets": "6,183",
"Other Compr. Net Income": "-4.0",
"Other Expenses": "-6,038",
"Other Liabilities": "1,155",
"Other Net Income": "-3,891",
"Other Revenues": "216,824",
"Property Plant and Equipment": "37,747",
"Research And Development Expense": "141,526",
"Selling and Marketing Expense": "122,237"
},
"output_variables": {
"Assets": "781,601",
"Liabilities": "401,961",
"Expenses": "454,898",
"Revenues": "216,824",
"Stockholders Equity": "379,640",
"Net Income": "-241,965",
"Comprehensive Net Income": "-241,969",
"BaseVar": "929,590",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "135%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "453,932",
"Assets, Non-Current": "58,297",
"Cost of Goods and Services Sold": "198,275",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "324,573",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,845,468",
"Labor Expense": "0",
"Liabilities, Current": "173,283",
"Long Term Liabilities": "1,173,337",
"Operating Costs and Expenses": "0",
"Other Assets": "6,686",
"Other Compr. Net Income": "10",
"Other Expenses": "-82,334",
"Other Liabilities": "107,572",
"Other Net Income": "-32,332",
"Other Revenues": "279,598",
"Property Plant and Equipment": "66,102",
"Research And Development Expense": "240,605",
"Selling and Marketing Expense": "168,317"
},
"output_variables": {
"Assets": "3,430,485",
"Liabilities": "1,454,192",
"Expenses": "849,436",
"Revenues": "279,598",
"Stockholders Equity": "1,976,293",
"Net Income": "-602,170",
"Comprehensive Net Income": "-602,160",
"BaseVar": "3,023,026",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "166%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,178,805",
"Assets, Non-Current": "144,720",
"Cost of Goods and Services Sold": "348,669",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "248,070",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,471,053",
"Labor Expense": "0",
"Liabilities, Current": "195,791",
"Long Term Liabilities": "1,626,304",
"Operating Costs and Expenses": "0",
"Other Assets": "10,275",
"Other Compr. Net Income": "-8.0",
"Other Expenses": "-373,603",
"Other Liabilities": "119,074",
"Other Net Income": "25,678",
"Other Revenues": "460,449",
"Property Plant and Equipment": "114,714",
"Research And Development Expense": "416,087",
"Selling and Marketing Expense": "225,910"
},
"output_variables": {
"Assets": "4,919,567",
"Liabilities": "1,941,169",
"Expenses": "865,133",
"Revenues": "460,449",
"Stockholders Equity": "2,978,398",
"Net Income": "-379,006",
"Comprehensive Net Income": "-379,014",
"BaseVar": "4,106,002",
"ECR before LimitedLiability": "115%",
"Economic Capital Ratio": "181%"
}
}
},
"top_rated": false,
"trend": -8.0,
"value": 1.8130395434021098,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001501134.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001501134.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001501134.svg"
},
{
"company_id": "0000019584",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000019584.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000019584.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000019584.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000019584_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000019584_main_keyfigs.svg",
"name": "Chemed CORP",
"rank": 43,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000019584.svg",
"report_text": "The relative strengths and weaknesses of Chemed CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Chemed CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 80% points.The greatest weakness of Chemed CORP is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 66% points.
The company's Economic Capital Ratio, given in the ranking table, is 181%, being 13% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000019584_2022_Chemed_CORP.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-12.0",
"Assets": "-30.2",
"Liabilities": "40.9",
"Stockholders Equity": "-43.3",
"ECR before LimitedLiability": "-3.98",
"Property Plant and Equipment": "-18.7",
"Assets, Non-Current": "-3.86",
"Other Liabilities": "8.86",
"Liabilities, Current": "5.35",
"Long Term Liabilities": "28.3",
"Other Expenses": "32.6",
"Expenses": "-39.6",
"Revenues": "102",
"Net Income": "-4.16",
"Cost of Goods and Services Sold": "-86.6",
"General and Administrative Expense": "-14.7",
"Labor Expense": "12.6",
"Operating Costs and Expenses": "13.9",
"Other Revenues": "102",
"Comprehensive Net Income": "-2.73",
"Other Net Income": "-58.7",
"Economic Capital Ratio": "-2.17"
},
"2011": {
"Assets": "-30.0",
"Liabilities": "38.7",
"Stockholders Equity": "-38.6",
"ECR before LimitedLiability": "28.4",
"Property Plant and Equipment": "-20.1",
"Assets, Current": "-21.3",
"Assets, Non-Current": "-4.98",
"Intangible Assets": "17.5",
"Long Term Liabilities": "11.4",
"Liabilities, Current": "26.5",
"Expenses": "-18.8",
"Revenues": "95.8",
"Net Income": "37.2",
"Other Expenses": "39.5",
"Operating Costs and Expenses": "11.2",
"Labor Expense": "17.8",
"Cost of Goods and Services Sold": "-103",
"Other Revenues": "95.8",
"Other Net Income": "-39.3",
"Comprehensive Net Income": "37.6",
"Economic Capital Ratio": "21.7"
},
"2012": {
"Property Plant and Equipment": "-17.5",
"Assets": "-30.4",
"Liabilities": "41.6",
"Stockholders Equity": "-38.5",
"ECR before LimitedLiability": "34.0",
"Intangible Assets": "16.9",
"Assets, Current": "-24.2",
"Liabilities, Current": "29.8",
"Other Liabilities": "12.4",
"Expenses": "-21.3",
"Revenues": "96.6",
"Net Income": "34.3",
"Other Expenses": "33.5",
"General and Administrative Expense": "6.27",
"Operating Costs and Expenses": "8.58",
"Cost of Goods and Services Sold": "-102",
"Labor Expense": "18.5",
"Other Revenues": "96.6",
"Other Net Income": "-37.7",
"Comprehensive Net Income": "34.9",
"Economic Capital Ratio": "19.8"
},
"2013": {
"Assets": "-32.1",
"Liabilities": "45.1",
"Stockholders Equity": "-35.6",
"ECR before LimitedLiability": "24.2",
"Property Plant and Equipment": "-17.0",
"Assets, Current": "-27.1",
"Intangible Assets": "21.7",
"Other Liabilities": "8.35",
"Long Term Liabilities": "37.0",
"Expenses": "-22.0",
"Revenues": "89.9",
"Net Income": "37.3",
"General and Administrative Expense": "7.83",
"Cost of Goods and Services Sold": "-92.8",
"Labor Expense": "18.1",
"Other Expenses": "29.4",
"Research And Development Expense": "5.91",
"Other Revenues": "89.9",
"Comprehensive Net Income": "37.8",
"Other Net Income": "-25.0",
"Economic Capital Ratio": "15.0"
},
"2014": {
"Assets": "-30.5",
"Liabilities": "55.0",
"Stockholders Equity": "-28.6",
"ECR before LimitedLiability": "42.2",
"Intangible Assets": "21.6",
"Property Plant and Equipment": "-18.4",
"Assets, Current": "-23.4",
"Liabilities, Current": "36.6",
"Long Term Liabilities": "19.7",
"Expenses": "-22.7",
"Revenues": "97.2",
"Net Income": "41.0",
"Operating Costs and Expenses": "9.21",
"Labor Expense": "20.2",
"Research And Development Expense": "6.92",
"Other Expenses": "25.7",
"Cost of Goods and Services Sold": "-101",
"Other Revenues": "97.2",
"Comprehensive Net Income": "41.2",
"Other Net Income": "-31.2",
"Economic Capital Ratio": "29.0"
},
"2015": {
"Assets, Current": "-23.6",
"Assets": "-27.9",
"Liabilities": "66.1",
"Stockholders Equity": "-25.9",
"ECR before LimitedLiability": "53.6",
"Intangible Assets": "20.6",
"Property Plant and Equipment": "-15.1",
"Long Term Liabilities": "19.2",
"Liabilities, Current": "46.3",
"Selling and Marketing Expense": "8.20",
"Expenses": "-28.0",
"Revenues": "113",
"Net Income": "47.5",
"Operating Costs and Expenses": "7.93",
"Other Expenses": "27.9",
"Labor Expense": "18.8",
"Cost of Goods and Services Sold": "-114",
"Other Revenues": "113",
"Comprehensive Net Income": "48.3",
"Other Net Income": "-29.4",
"Economic Capital Ratio": "41.1"
},
"2016": {
"Property Plant and Equipment": "-13.7",
"Assets": "-24.4",
"Liabilities": "74.8",
"ECR before LimitedLiability": "75.8",
"Intangible Assets": "21.9",
"Assets, Current": "-22.1",
"Liabilities, Current": "61.7",
"Other Liabilities": "7.86",
"Long Term Liabilities": "8.55",
"Expenses": "-25.4",
"Net Income": "49.8",
"Selling and Marketing Expense": "9.33",
"Labor Expense": "9.82",
"Other Expenses": "29.5",
"Cost of Goods and Services Sold": "-104",
"Research And Development Expense": "8.27",
"Other Revenues": "111",
"Revenues": "111",
"Other Net Income": "-23.9",
"Comprehensive Net Income": "51.1",
"Economic Capital Ratio": "48.1"
},
"2017": {
"Assets": "-30.2",
"Liabilities": "73.0",
"Stockholders Equity": "-23.2",
"ECR before LimitedLiability": "71.1",
"Intangible Assets": "17.0",
"Assets, Current": "-27.6",
"Property Plant and Equipment": "-11.3",
"Liabilities, Current": "54.2",
"Long Term Liabilities": "25.1",
"Expenses": "-27.9",
"Revenues": "109",
"Net Income": "50.3",
"Labor Expense": "10.8",
"Selling and Marketing Expense": "8.11",
"Research And Development Expense": "10.8",
"Other Expenses": "28.4",
"Cost of Goods and Services Sold": "-106",
"Other Revenues": "109",
"Other Net Income": "-32.2",
"Comprehensive Net Income": "50.6",
"Economic Capital Ratio": "47.0"
},
"2018": {
"Assets": "-26.0",
"Liabilities": "61.2",
"Stockholders Equity": "-32.5",
"ECR before LimitedLiability": "70.4",
"Intangible Assets": "22.3",
"Assets, Non-Current": "-7.28",
"Assets, Current": "-26.2",
"Other Liabilities": "-6.03",
"Liabilities, Current": "46.9",
"Long Term Liabilities": "22.7",
"Expenses": "-20.1",
"Revenues": "87.7",
"Net Income": "64.7",
"Operating Costs and Expenses": "6.22",
"Other Expenses": "23.7",
"Research And Development Expense": "8.97",
"Cost of Goods and Services Sold": "-93.5",
"Labor Expense": "12.8",
"Other Revenues": "87.7",
"Comprehensive Net Income": "65.1",
"Economic Capital Ratio": "49.7"
},
"2019": {
"Assets": "-24.7",
"Liabilities": "47.4",
"Stockholders Equity": "-28.5",
"ECR before LimitedLiability": "46.9",
"Assets, Non-Current": "-7.35",
"Intangible Assets": "20.2",
"Assets, Current": "-25.5",
"Long Term Liabilities": "26.9",
"Liabilities, Current": "20.6",
"Other Expenses": "9.94",
"Expenses": "-16.3",
"Revenues": "63.9",
"Net Income": "45.6",
"Cost of Goods and Services Sold": "-66.3",
"Research And Development Expense": "9.79",
"Selling and Marketing Expense": "6.29",
"Labor Expense": "9.46",
"Operating Costs and Expenses": "8.12",
"Other Revenues": "63.9",
"Comprehensive Net Income": "45.9",
"Economic Capital Ratio": "36.9"
},
"2020": {
"Assets": "-20.0",
"Liabilities": "55.7",
"Stockholders Equity": "-18.6",
"ECR before LimitedLiability": "67.2",
"Intangible Assets": "12.9",
"Assets, Current": "-21.0",
"Assets, Non-Current": "-4.71",
"Liabilities, Current": "20.8",
"Long Term Liabilities": "39.8",
"Labor Expense": "8.42",
"Expenses": "-17.9",
"Revenues": "67.7",
"Net Income": "49.8",
"General and Administrative Expense": "6.79",
"Research And Development Expense": "5.86",
"Other Expenses": "13.9",
"Operating Costs and Expenses": "6.70",
"Cost of Goods and Services Sold": "-70.2",
"Other Revenues": "67.7",
"Comprehensive Net Income": "49.8",
"Economic Capital Ratio": "55.1"
},
"2021": {
"Assets": "-36.9",
"Stockholders Equity": "-63.2",
"ECR before LimitedLiability": "18.9",
"Assets, Non-Current": "-6.47",
"Assets, Current": "-35.2",
"Liabilities, Current": "15.4",
"Liabilities": "34.4",
"Long Term Liabilities": "16.7",
"General and Administrative Expense": "4.55",
"Expenses": "-23.5",
"Revenues": "80.3",
"Net Income": "53.4",
"Operating Costs and Expenses": "8.20",
"Labor Expense": "7.09",
"Cost of Goods and Services Sold": "-65.9",
"Research And Development Expense": "7.35",
"Other Expenses": "7.63",
"Selling and Marketing Expense": "5.64",
"Other Revenues": "80.3",
"Comprehensive Net Income": "53.5",
"Economic Capital Ratio": "12.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000019584_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "196,797",
"Assets, Non-Current": "11,015",
"Cost of Goods and Services Sold": "906,016",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "201,964",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "514,753",
"Labor Expense": "0",
"Liabilities, Current": "149,342",
"Long Term Liabilities": "165,834",
"Operating Costs and Expenses": "0",
"Other Assets": "28,304",
"Other Compr. Net Income": "0",
"Other Expenses": "93,002",
"Other Liabilities": "52,936",
"Other Net Income": "2,268",
"Other Revenues": "1,280,545",
"Property Plant and Equipment": "79,292",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "830,161",
"Liabilities": "368,112",
"Expenses": "1,200,982",
"Revenues": "1,280,545",
"Stockholders Equity": "462,049",
"Net Income": "81,831",
"Comprehensive Net Income": "81,831",
"BaseVar": "1,841,034",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "188%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "150,753",
"Assets, Non-Current": "11,677",
"Cost of Goods and Services Sold": "970,484",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "202,260",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "518,895",
"Labor Expense": "0",
"Liabilities, Current": "145,400",
"Long Term Liabilities": "176,665",
"Operating Costs and Expenses": "0",
"Other Assets": "31,629",
"Other Compr. Net Income": "0",
"Other Expenses": "97,964",
"Other Liabilities": "60,156",
"Other Net Income": "717",
"Other Revenues": "1,355,970",
"Property Plant and Equipment": "82,951",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "795,905",
"Liabilities": "382,221",
"Expenses": "1,270,708",
"Revenues": "1,355,970",
"Stockholders Equity": "413,684",
"Net Income": "85,979",
"Comprehensive Net Income": "85,979",
"BaseVar": "1,902,760",
"ECR before LimitedLiability": "116%",
"Economic Capital Ratio": "182%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "197,671",
"Assets, Non-Current": "10,923",
"Cost of Goods and Services Sold": "1,033,321",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "208,656",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "523,009",
"Labor Expense": "0",
"Liabilities, Current": "156,822",
"Long Term Liabilities": "186,252",
"Operating Costs and Expenses": "1,126",
"Other Assets": "36,089",
"Other Compr. Net Income": "0",
"Other Expenses": "101,759",
"Other Liabilities": "63,261",
"Other Net Income": "4,123",
"Other Revenues": "1,430,043",
"Property Plant and Equipment": "91,934",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "859,626",
"Liabilities": "406,335",
"Expenses": "1,344,862",
"Revenues": "1,430,043",
"Stockholders Equity": "453,291",
"Net Income": "89,304",
"Comprehensive Net Income": "89,304",
"BaseVar": "2,022,494",
"ECR before LimitedLiability": "118%",
"Economic Capital Ratio": "183%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "224,656",
"Assets, Non-Current": "10,198",
"Cost of Goods and Services Sold": "1,008,808",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "212,518",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "523,427",
"Labor Expense": "0",
"Liabilities, Current": "363,986",
"Long Term Liabilities": "11,176",
"Operating Costs and Expenses": "26,221",
"Other Assets": "42,465",
"Other Compr. Net Income": "0",
"Other Expenses": "94,025",
"Other Liabilities": "69,649",
"Other Net Income": "5,470",
"Other Revenues": "1,413,329",
"Property Plant and Equipment": "92,955",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "893,701",
"Liabilities": "444,811",
"Expenses": "1,341,572",
"Revenues": "1,413,329",
"Stockholders Equity": "448,890",
"Net Income": "77,227",
"Comprehensive Net Income": "77,227",
"BaseVar": "2,049,442",
"ECR before LimitedLiability": "109%",
"Economic Capital Ratio": "177%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "174,564",
"Assets, Non-Current": "8,136",
"Cost of Goods and Services Sold": "1,034,673",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "220,118",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "522,749",
"Labor Expense": "0",
"Liabilities, Current": "175,554",
"Long Term Liabilities": "154,393",
"Operating Costs and Expenses": "0",
"Other Assets": "49,147",
"Other Compr. Net Income": "0",
"Other Expenses": "104,695",
"Other Liabilities": "78,629",
"Other Net Income": "2,521",
"Other Revenues": "1,456,282",
"Property Plant and Equipment": "105,336",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "859,932",
"Liabilities": "408,576",
"Expenses": "1,359,486",
"Revenues": "1,456,282",
"Stockholders Equity": "451,356",
"Net Income": "99,317",
"Comprehensive Net Income": "99,317",
"BaseVar": "2,043,398",
"ECR before LimitedLiability": "119%",
"Economic Capital Ratio": "184%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "150,808",
"Assets, Non-Current": "7,233",
"Cost of Goods and Services Sold": "1,087,610",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "237,821",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "527,433",
"Labor Expense": "0",
"Liabilities, Current": "171,336",
"Long Term Liabilities": "97,228",
"Operating Costs and Expenses": "0",
"Other Assets": "49,481",
"Other Compr. Net Income": "0",
"Other Expenses": "106,996",
"Other Liabilities": "70,508",
"Other Net Income": "-687",
"Other Revenues": "1,543,388",
"Property Plant and Equipment": "117,370",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "852,325",
"Liabilities": "339,072",
"Expenses": "1,432,427",
"Revenues": "1,543,388",
"Stockholders Equity": "513,253",
"Net Income": "110,274",
"Comprehensive Net Income": "110,274",
"BaseVar": "2,083,950",
"ECR before LimitedLiability": "143%",
"Economic Capital Ratio": "200%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "169,900",
"Assets, Non-Current": "7,037",
"Cost of Goods and Services Sold": "1,115,431",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "243,572",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "527,431",
"Labor Expense": "0",
"Liabilities, Current": "171,832",
"Long Term Liabilities": "115,549",
"Operating Costs and Expenses": "4,491",
"Other Assets": "54,389",
"Other Compr. Net Income": "0",
"Other Expenses": "106,664",
"Other Liabilities": "68,579",
"Other Net Income": "2,020",
"Other Revenues": "1,576,881",
"Property Plant and Equipment": "121,302",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "880,059",
"Liabilities": "355,960",
"Expenses": "1,470,158",
"Revenues": "1,576,881",
"Stockholders Equity": "524,099",
"Net Income": "108,743",
"Comprehensive Net Income": "108,743",
"BaseVar": "2,142,539",
"ECR before LimitedLiability": "141%",
"Economic Capital Ratio": "199%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "176,046",
"Assets, Non-Current": "7,127",
"Cost of Goods and Services Sold": "1,150,532",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "276,652",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "531,752",
"Labor Expense": "0",
"Liabilities, Current": "193,522",
"Long Term Liabilities": "107,710",
"Operating Costs and Expenses": "0",
"Other Assets": "62,067",
"Other Compr. Net Income": "0",
"Other Expenses": "149,517",
"Other Liabilities": "78,440",
"Other Net Income": "8,154",
"Other Revenues": "1,666,724",
"Property Plant and Equipment": "143,034",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "920,026",
"Liabilities": "379,672",
"Expenses": "1,576,701",
"Revenues": "1,666,724",
"Stockholders Equity": "540,354",
"Net Income": "98,177",
"Comprehensive Net Income": "98,177",
"BaseVar": "2,275,638",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "195%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "159,840",
"Assets, Non-Current": "9,209",
"Cost of Goods and Services Sold": "1,228,644",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "270,209",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "578,823",
"Labor Expense": "0",
"Liabilities, Current": "191,670",
"Long Term Liabilities": "106,311",
"Operating Costs and Expenses": "1,300",
"Other Assets": "65,624",
"Other Compr. Net Income": "0",
"Other Expenses": "77,909",
"Other Liabilities": "86,214",
"Other Net Income": "958",
"Other Revenues": "1,782,648",
"Property Plant and Equipment": "162,033",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "975,529",
"Liabilities": "384,195",
"Expenses": "1,578,062",
"Revenues": "1,782,648",
"Stockholders Equity": "591,334",
"Net Income": "205,544",
"Comprehensive Net Income": "205,544",
"BaseVar": "2,360,696",
"ECR before LimitedLiability": "156%",
"Economic Capital Ratio": "209%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "190,671",
"Assets, Non-Current": "120,700",
"Cost of Goods and Services Sold": "1,321,126",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "305,712",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "703,737",
"Labor Expense": "0",
"Liabilities, Current": "280,724",
"Long Term Liabilities": "184,539",
"Operating Costs and Expenses": "0",
"Other Assets": "77,446",
"Other Compr. Net Income": "0",
"Other Expenses": "100,558",
"Other Liabilities": "76,446",
"Other Net Income": "8,764",
"Other Revenues": "1,938,555",
"Property Plant and Equipment": "175,763",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,268,317",
"Liabilities": "541,709",
"Expenses": "1,727,396",
"Revenues": "1,938,555",
"Stockholders Equity": "726,608",
"Net Income": "219,923",
"Comprehensive Net Income": "219,923",
"BaseVar": "2,742,370",
"ECR before LimitedLiability": "141%",
"Economic Capital Ratio": "199%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "329,403",
"Assets, Non-Current": "132,207",
"Cost of Goods and Services Sold": "1,378,197",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "330,218",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "696,670",
"Labor Expense": "0",
"Liabilities, Current": "319,772",
"Long Term Liabilities": "125,483",
"Operating Costs and Expenses": "0",
"Other Assets": "88,811",
"Other Compr. Net Income": "0",
"Other Expenses": "60,367",
"Other Liabilities": "88,456",
"Other Net Income": "8,665",
"Other Revenues": "2,079,583",
"Property Plant and Equipment": "187,820",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,434,911",
"Liabilities": "533,711",
"Expenses": "1,768,782",
"Revenues": "2,079,583",
"Stockholders Equity": "901,200",
"Net Income": "319,466",
"Comprehensive Net Income": "319,466",
"BaseVar": "2,912,826",
"ECR before LimitedLiability": "165%",
"Economic Capital Ratio": "215%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "230,286",
"Assets, Non-Current": "133,186",
"Cost of Goods and Services Sold": "1,369,458",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "366,727",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "686,687",
"Labor Expense": "0",
"Liabilities, Current": "325,582",
"Long Term Liabilities": "295,271",
"Operating Costs and Expenses": "0",
"Other Assets": "98,884",
"Other Compr. Net Income": "0",
"Other Expenses": "143,670",
"Other Liabilities": "98,597",
"Other Net Income": "9,144",
"Other Revenues": "2,139,261",
"Property Plant and Equipment": "193,680",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,342,723",
"Liabilities": "719,450",
"Expenses": "1,879,855",
"Revenues": "2,139,261",
"Stockholders Equity": "623,273",
"Net Income": "268,550",
"Comprehensive Net Income": "268,550",
"BaseVar": "3,045,216",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "181%"
}
}
},
"top_rated": false,
"trend": -23.0,
"value": 1.8051746032714617,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000019584.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000019584.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000019584.svg"
},
{
"company_id": "0000920148",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000920148.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000920148.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000920148.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000920148_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000920148_main_keyfigs.svg",
"name": "Laboratory Corp OF America Holdings",
"rank": 44,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000920148.svg",
"report_text": "The relative strengths and weaknesses of Laboratory Corp OF America Holdings are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Laboratory Corp OF America Holdings compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 33% points.The greatest weakness of Laboratory Corp OF America Holdings is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 30% points.
The company's Economic Capital Ratio, given in the ranking table, is 180%, being 13% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000920148_2022_Laboratory_Corp_OF_America_Holdings.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "9.99",
"Stockholders Equity": "-10.7",
"ECR before LimitedLiability": "-28.7",
"Intangible Assets": "11.8",
"Assets, Current": "-3.40",
"Liabilities, Current": "-26.2",
"Liabilities": "-35.2",
"Long Term Liabilities": "-10.7",
"Other Liabilities": "2.65",
"Other Expenses": "13.2",
"Expenses": "15.1",
"Revenues": "25.4",
"Net Income": "2.19",
"General and Administrative Expense": "-8.43",
"Cost of Goods and Services Sold": "-5.80",
"Labor Expense": "4.56",
"Operating Costs and Expenses": "11.0",
"Other Revenues": "25.4",
"Comprehensive Net Income": "2.19",
"Other Net Income": "-34.9",
"Economic Capital Ratio": "-28.3"
},
"2010": {
"Assets, Current": "-9.24",
"Assets": "-8.24",
"Liabilities": "-22.2",
"Stockholders Equity": "-27.7",
"ECR before LimitedLiability": "-32.2",
"Property Plant and Equipment": "-15.0",
"Assets, Non-Current": "-2.71",
"Intangible Assets": "27.6",
"Other Liabilities": "13.1",
"Liabilities, Current": "-23.8",
"Long Term Liabilities": "-12.2",
"Other Revenues": "44.6",
"Revenues": "44.6",
"Operating Costs and Expenses": "9.70",
"Economic Capital Ratio": "-30.4",
"Other Expenses": "23.9",
"Cost of Goods and Services Sold": "-29.9",
"General and Administrative Expense": "-9.80",
"Labor Expense": "8.79",
"Other Net Income": "-39.2",
"Depreciation, Depletion, Amortization": "1.54"
},
"2011": {
"Assets": "-4.73",
"Liabilities": "-18.2",
"Stockholders Equity": "-19.9",
"ECR before LimitedLiability": "6.97",
"Property Plant and Equipment": "-15.7",
"Assets, Current": "-15.2",
"Assets, Non-Current": "-3.66",
"Intangible Assets": "52.3",
"Other Liabilities": "10.2",
"Long Term Liabilities": "-33.2",
"Liabilities, Current": "3.16",
"Expenses": "13.6",
"Revenues": "44.0",
"Net Income": "26.8",
"Other Expenses": "26.0",
"Operating Costs and Expenses": "7.74",
"Labor Expense": "12.3",
"Cost of Goods and Services Sold": "-38.9",
"Other Revenues": "44.0",
"Other Net Income": "-26.6",
"Comprehensive Net Income": "27.1",
"Economic Capital Ratio": "0.292"
},
"2012": {
"Liabilities": "-20.4",
"Stockholders Equity": "-19.8",
"ECR before LimitedLiability": "10.3",
"Long Term Liabilities": "-40.4",
"Other Liabilities": "16.1",
"Expenses": "14.2",
"Net Income": "24.7",
"Other Expenses": "22.2",
"General and Administrative Expense": "4.28",
"Operating Costs and Expenses": "5.89",
"Cost of Goods and Services Sold": "-36.5",
"Labor Expense": "12.5",
"Other Revenues": "39.1",
"Revenues": "39.1",
"Property Plant and Equipment": "-13.3",
"Intangible Assets": "53.7",
"Assets, Current": "-17.6",
"Assets, Non-Current": "-4.08",
"Other Net Income": "-25.1",
"Comprehensive Net Income": "25.4",
"Economic Capital Ratio": "-3.88"
},
"2013": {
"Assets": "-7.98",
"Liabilities": "-17.7",
"Stockholders Equity": "-24.0",
"Economic Capital Ratio": "-10.3",
"Property Plant and Equipment": "-12.8",
"Assets, Current": "-22.5",
"Intangible Assets": "60.0",
"Other Liabilities": "14.5",
"Liabilities, Current": "17.0",
"Long Term Liabilities": "-54.8",
"Expenses": "12.5",
"Revenues": "35.6",
"Net Income": "28.4",
"General and Administrative Expense": "6.07",
"Cost of Goods and Services Sold": "-37.7",
"Labor Expense": "12.8",
"Other Expenses": "20.3",
"Research And Development Expense": "4.18",
"Other Revenues": "35.6",
"Comprehensive Net Income": "28.7",
"Other Net Income": "-17.7"
},
"2014": {
"Other Liabilities": "11.0",
"Liabilities": "-12.6",
"Stockholders Equity": "-14.9",
"ECR before LimitedLiability": "12.7",
"Liabilities, Current": "12.2",
"Long Term Liabilities": "-38.6",
"Expenses": "13.4",
"Net Income": "27.0",
"Operating Costs and Expenses": "6.32",
"Labor Expense": "13.9",
"Research And Development Expense": "4.75",
"Other Expenses": "18.7",
"Cost of Goods and Services Sold": "-37.8",
"Other Revenues": "37.0",
"Revenues": "37.0",
"Other Assets": "-5.19",
"Intangible Assets": "53.2",
"Property Plant and Equipment": "-14.5",
"Assets, Current": "-14.3",
"Comprehensive Net Income": "26.0",
"Other Net Income": "-20.8",
"Economic Capital Ratio": "-0.454"
},
"2015": {
"Assets, Current": "-16.8",
"Assets": "10.9",
"Liabilities": "-36.1",
"Stockholders Equity": "-14.8",
"Economic Capital Ratio": "-16.1",
"Intangible Assets": "56.8",
"Other Assets": "-5.84",
"Property Plant and Equipment": "-10.7",
"Long Term Liabilities": "-59.9",
"Other Liabilities": "10.2",
"Liabilities, Current": "9.46",
"Expenses": "23.8",
"Revenues": "17.5",
"Net Income": "23.5",
"General and Administrative Expense": "7.04",
"Other Expenses": "18.0",
"Labor Expense": "11.2",
"Cost of Goods and Services Sold": "-26.7",
"Other Revenues": "17.5",
"Comprehensive Net Income": "21.8",
"Other Net Income": "-16.5"
},
"2016": {
"Property Plant and Equipment": "-9.17",
"Assets": "14.4",
"Liabilities": "-19.8",
"ECR before LimitedLiability": "28.9",
"Intangible Assets": "64.8",
"Assets, Current": "-16.3",
"Liabilities, Current": "18.9",
"Other Liabilities": "11.9",
"Long Term Liabilities": "-56.4",
"Expenses": "22.3",
"Revenues": "20.0",
"Net Income": "27.6",
"Selling and Marketing Expense": "5.62",
"General and Administrative Expense": "9.31",
"Labor Expense": "5.92",
"Other Expenses": "19.3",
"Cost of Goods and Services Sold": "-26.4",
"Research And Development Expense": "4.98",
"Other Revenues": "20.0",
"Other Net Income": "-14.0",
"Comprehensive Net Income": "26.1",
"Economic Capital Ratio": "1.26"
},
"2017": {
"Assets": "11.4",
"Liabilities": "-21.7",
"ECR before LimitedLiability": "37.6",
"Intangible Assets": "74.4",
"Assets, Current": "-18.6",
"Property Plant and Equipment": "-6.93",
"Liabilities, Current": "18.0",
"Other Liabilities": "6.73",
"Long Term Liabilities": "-51.6",
"General and Administrative Expense": "9.36",
"Expenses": "24.1",
"Net Income": "28.9",
"Labor Expense": "5.89",
"Research And Development Expense": "5.90",
"Other Expenses": "22.2",
"Cost of Goods and Services Sold": "-26.0",
"Other Revenues": "23.5",
"Revenues": "23.5",
"Other Net Income": "-17.5",
"Comprehensive Net Income": "30.6",
"Economic Capital Ratio": "13.5"
},
"2018": {
"Other Assets": "-6.61",
"Assets": "4.08",
"Liabilities": "-22.0",
"Stockholders Equity": "-10.5",
"ECR before LimitedLiability": "22.3",
"Intangible Assets": "73.6",
"Assets, Non-Current": "-6.13",
"Assets, Current": "-21.7",
"Other Liabilities": "6.38",
"Liabilities, Current": "17.1",
"Long Term Liabilities": "-50.2",
"Expenses": "19.3",
"Revenues": "9.36",
"Net Income": "31.8",
"Other Expenses": "13.8",
"General and Administrative Expense": "10.4",
"Research And Development Expense": "5.45",
"Cost of Goods and Services Sold": "-25.9",
"Labor Expense": "7.84",
"Other Revenues": "9.36",
"Comprehensive Net Income": "31.2",
"Economic Capital Ratio": "1.61"
},
"2019": {
"Other Liabilities": "7.27",
"Liabilities": "-23.1",
"Stockholders Equity": "-12.1",
"ECR before LimitedLiability": "7.50",
"Long Term Liabilities": "-34.5",
"Other Expenses": "7.19",
"Expenses": "17.2",
"Revenues": "5.24",
"Net Income": "23.2",
"General and Administrative Expense": "7.88",
"Cost of Goods and Services Sold": "-20.9",
"Research And Development Expense": "6.48",
"Selling and Marketing Expense": "4.15",
"Labor Expense": "6.26",
"Operating Costs and Expenses": "5.37",
"Other Revenues": "5.24",
"Assets, Non-Current": "-9.96",
"Other Assets": "-4.14",
"Intangible Assets": "71.3",
"Assets, Current": "-20.5",
"Comprehensive Net Income": "23.9",
"Economic Capital Ratio": "-2.54"
},
"2021": {
"Assets": "-8.62",
"Stockholders Equity": "-16.5",
"ECR before LimitedLiability": "18.7",
"Intangible Assets": "28.5",
"Assets, Non-Current": "-7.49",
"Assets, Current": "-18.8",
"General and Administrative Expense": "10.8",
"Expenses": "5.69",
"Revenues": "24.2",
"Net Income": "33.1",
"Operating Costs and Expenses": "5.50",
"Labor Expense": "4.76",
"Cost of Goods and Services Sold": "-30.5",
"Research And Development Expense": "4.93",
"Other Expenses": "5.37",
"Other Revenues": "24.2",
"Long Term Liabilities": "-21.5",
"Other Liabilities": "10.3",
"Liabilities, Current": "7.74",
"Comprehensive Net Income": "33.0",
"Economic Capital Ratio": "12.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000920148_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "935,600",
"Assets, Non-Current": "90,700",
"Cost of Goods and Services Sold": "2,723,800",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "958,900",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,239,300",
"Labor Expense": "0",
"Liabilities, Current": "1,596,100",
"Long Term Liabilities": "1,135,600",
"Operating Costs and Expenses": "0",
"Other Assets": "71,400",
"Other Compr. Net Income": "0",
"Other Expenses": "405,100",
"Other Liabilities": "0",
"Other Net Income": "-51,300",
"Other Revenues": "4,694,700",
"Property Plant and Equipment": "500,800",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,837,800",
"Liabilities": "2,731,700",
"Expenses": "4,087,800",
"Revenues": "4,694,700",
"Stockholders Equity": "2,106,100",
"Net Income": "555,600",
"Comprehensive Net Income": "555,600",
"BaseVar": "8,201,650",
"ECR before LimitedLiability": "95%",
"Economic Capital Ratio": "168%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,143,800",
"Assets, Non-Current": "103,200",
"Cost of Goods and Services Sold": "2,906,100",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,034,300",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,275,400",
"Labor Expense": "0",
"Liabilities, Current": "1,722,800",
"Long Term Liabilities": "1,978,100",
"Operating Costs and Expenses": "0",
"Other Assets": "78,500",
"Other Compr. Net Income": "0",
"Other Expenses": "416,700",
"Other Liabilities": "0",
"Other Net Income": "-51,200",
"Other Revenues": "5,003,900",
"Property Plant and Equipment": "586,900",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,187,800",
"Liabilities": "3,700,900",
"Expenses": "4,357,100",
"Revenues": "5,003,900",
"Stockholders Equity": "2,486,900",
"Net Income": "595,600",
"Comprehensive Net Income": "595,600",
"BaseVar": "9,650,450",
"ECR before LimitedLiability": "85%",
"Economic Capital Ratio": "160%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "1,084,800",
"Assets, Non-Current": "94,200",
"Cost of Goods and Services Sold": "3,267,600",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,159,600",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,302,500",
"Labor Expense": "0",
"Liabilities, Current": "1,300,100",
"Long Term Liabilities": "2,312,800",
"Operating Costs and Expenses": "0",
"Other Assets": "76,800",
"Other Compr. Net Income": "0",
"Other Expenses": "587,200",
"Other Liabilities": "0",
"Other Net Income": "5,200",
"Other Revenues": "5,542,300",
"Property Plant and Equipment": "578,300",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,136,600",
"Liabilities": "3,612,900",
"Expenses": "5,014,400",
"Revenues": "5,542,300",
"Stockholders Equity": "2,523,700",
"Net Income": "533,100",
"Comprehensive Net Income": "533,100",
"BaseVar": "10,155,700",
"ECR before LimitedLiability": "86%",
"Economic Capital Ratio": "161%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "1,391,800",
"Assets, Non-Current": "124,900",
"Cost of Goods and Services Sold": "3,421,700",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,114,600",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,569,400",
"Labor Expense": "0",
"Liabilities, Current": "1,574,500",
"Long Term Liabilities": "2,482,400",
"Operating Costs and Expenses": "0",
"Other Assets": "78,100",
"Other Compr. Net Income": "22,200",
"Other Expenses": "565,500",
"Other Liabilities": "0",
"Other Net Income": "15,200",
"Other Revenues": "5,671,400",
"Property Plant and Equipment": "630,800",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,795,000",
"Liabilities": "4,056,900",
"Expenses": "5,101,800",
"Revenues": "5,671,400",
"Stockholders Equity": "2,738,100",
"Net Income": "584,800",
"Comprehensive Net Income": "607,000",
"BaseVar": "10,831,250",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "160%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "1,432,100",
"Assets, Non-Current": "143,100",
"Cost of Goods and Services Sold": "3,585,100",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,128,800",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,594,800",
"Labor Expense": "0",
"Liabilities, Current": "1,299,600",
"Long Term Liabilities": "3,155,600",
"Operating Costs and Expenses": "0",
"Other Assets": "88,500",
"Other Compr. Net Income": "-4,800",
"Other Expenses": "540,200",
"Other Liabilities": "0",
"Other Net Income": "21,200",
"Other Revenues": "5,808,300",
"Property Plant and Equipment": "707,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,965,900",
"Liabilities": "4,455,200",
"Expenses": "5,254,100",
"Revenues": "5,808,300",
"Stockholders Equity": "2,510,700",
"Net Income": "575,400",
"Comprehensive Net Income": "570,600",
"BaseVar": "11,254,750",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "152%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "1,692,700",
"Assets, Non-Current": "154,800",
"Cost of Goods and Services Sold": "3,808,500",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,198,200",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,575,200",
"Labor Expense": "0",
"Liabilities, Current": "1,506,700",
"Long Term Liabilities": "2,956,900",
"Operating Costs and Expenses": "0",
"Other Assets": "92,600",
"Other Compr. Net Income": "-78,100",
"Other Expenses": "518,100",
"Other Liabilities": "0",
"Other Net Income": "25,800",
"Other Revenues": "6,011,600",
"Property Plant and Equipment": "786,500",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,301,800",
"Liabilities": "4,463,600",
"Expenses": "5,524,800",
"Revenues": "6,011,600",
"Stockholders Equity": "2,838,200",
"Net Income": "512,600",
"Comprehensive Net Income": "434,500",
"BaseVar": "11,702,850",
"ECR before LimitedLiability": "77%",
"Economic Capital Ratio": "155%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "2,663,000",
"Assets, Non-Current": "201,900",
"Cost of Goods and Services Sold": "5,602,400",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,622,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "9,551,200",
"Labor Expense": "0",
"Liabilities, Current": "2,947,200",
"Long Term Liabilities": "6,315,200",
"Operating Costs and Expenses": "0",
"Other Assets": "58,200",
"Other Compr. Net Income": "-277,600",
"Other Expenses": "847,400",
"Other Liabilities": "0",
"Other Net Income": "4,100",
"Other Revenues": "8,505,700",
"Property Plant and Equipment": "1,747,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "14,221,700",
"Liabilities": "9,262,400",
"Expenses": "8,071,800",
"Revenues": "8,505,700",
"Stockholders Equity": "4,959,300",
"Net Income": "438,000",
"Comprehensive Net Income": "160,400",
"BaseVar": "20,171,650",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "143%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,478,700",
"Assets, Non-Current": "165,100",
"Cost of Goods and Services Sold": "6,256,700",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,630,200",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "9,824,900",
"Labor Expense": "0",
"Liabilities, Current": "3,034,000",
"Long Term Liabilities": "5,692,000",
"Operating Costs and Expenses": "0",
"Other Assets": "59,700",
"Other Compr. Net Income": "-295,200",
"Other Expenses": "829,300",
"Other Liabilities": "0",
"Other Net Income": "12,200",
"Other Revenues": "9,437,200",
"Property Plant and Equipment": "1,718,600",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "14,247,000",
"Liabilities": "8,726,000",
"Expenses": "8,716,200",
"Revenues": "9,437,200",
"Stockholders Equity": "5,521,000",
"Net Income": "733,200",
"Comprehensive Net Income": "438,000",
"BaseVar": "20,716,900",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "152%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "2,682,600",
"Assets, Non-Current": "205,400",
"Cost of Goods and Services Sold": "6,741,900",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,812,400",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,870,800",
"Labor Expense": "0",
"Liabilities, Current": "2,994,400",
"Long Term Liabilities": "6,722,800",
"Operating Costs and Expenses": "0",
"Other Assets": "60,300",
"Other Compr. Net Income": "239,600",
"Other Expenses": "383,400",
"Other Liabilities": "0",
"Other Net Income": "5,800",
"Other Revenues": "10,205,900",
"Property Plant and Equipment": "1,748,900",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "16,568,000",
"Liabilities": "9,717,200",
"Expenses": "8,937,700",
"Revenues": "10,205,900",
"Stockholders Equity": "6,850,800",
"Net Income": "1,274,000",
"Comprehensive Net Income": "1,513,600",
"BaseVar": "22,837,100",
"ECR before LimitedLiability": "87%",
"Economic Capital Ratio": "162%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "2,835,400",
"Assets, Non-Current": "231,600",
"Cost of Goods and Services Sold": "8,157,000",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,570,900",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,271,400",
"Labor Expense": "0",
"Liabilities, Current": "2,818,900",
"Long Term Liabilities": "6,375,900",
"Operating Costs and Expenses": "0",
"Other Assets": "62,200",
"Other Compr. Net Income": "-129,600",
"Other Expenses": "908,400",
"Other Liabilities": "0",
"Other Net Income": "186,800",
"Other Revenues": "11,333,400",
"Property Plant and Equipment": "1,784,700",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "16,185,300",
"Liabilities": "9,194,800",
"Expenses": "10,636,300",
"Revenues": "11,333,400",
"Stockholders Equity": "6,990,500",
"Net Income": "883,900",
"Comprehensive Net Income": "754,300",
"BaseVar": "23,833,100",
"ECR before LimitedLiability": "86%",
"Economic Capital Ratio": "161%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,981,200",
"Assets, Non-Current": "435,400",
"Cost of Goods and Services Sold": "8,302,300",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,624,500",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,899,500",
"Labor Expense": "0",
"Liabilities, Current": "3,598,600",
"Long Term Liabilities": "6,769,600",
"Operating Costs and Expenses": "0",
"Other Assets": "93,700",
"Other Compr. Net Income": "89,600",
"Other Expenses": "818,500",
"Other Liabilities": "91,100",
"Other Net Income": "15,400",
"Other Revenues": "11,554,800",
"Property Plant and Equipment": "2,636,600",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "18,046,400",
"Liabilities": "10,459,300",
"Expenses": "10,745,300",
"Revenues": "11,554,800",
"Stockholders Equity": "7,587,100",
"Net Income": "824,900",
"Comprehensive Net Income": "914,500",
"BaseVar": "25,455,400",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "159%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "5,330,500",
"Assets, Non-Current": "462,600",
"Cost of Goods and Services Sold": "10,496,600",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,952,100",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,694,400",
"Labor Expense": "0",
"Liabilities, Current": "3,545,800",
"Long Term Liabilities": "6,461,000",
"Operating Costs and Expenses": "0",
"Other Assets": "82,500",
"Other Compr. Net Income": "-32,200",
"Other Expenses": "1,371,900",
"Other Liabilities": "84,600",
"Other Net Income": "79,200",
"Other Revenues": "16,120,900",
"Property Plant and Equipment": "2,815,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "20,385,400",
"Liabilities": "10,091,400",
"Expenses": "13,820,600",
"Revenues": "16,120,900",
"Stockholders Equity": "10,294,000",
"Net Income": "2,379,500",
"Comprehensive Net Income": "2,347,300",
"BaseVar": "30,264,850",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "180%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.802852684250792,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000920148.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000920148.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000920148.svg"
},
{
"company_id": "0001831097",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001831097.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001831097.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001831097_main_keyfigs.svg",
"name": "Agilon Health inc",
"rank": 45,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001831097.svg",
"report_text": "The relative strengths and weaknesses of Agilon Health inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Agilon Health inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 61% points.The greatest weakness of Agilon Health inc is the variable Other Expenses, reducing the Economic Capital Ratio by 100% points.
The company's Economic Capital Ratio, given in the ranking table, is 180%, being 12% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001831097_2022_Agilon_Health_inc.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "-30.5",
"Expenses": "-44.8",
"Stockholders Equity": "-20.4",
"ECR before LimitedLiability": "18.5",
"Intangible Assets": "-23.8",
"Property Plant and Equipment": "-11.4",
"Assets, Non-Current": "-7.61",
"Assets, Current": "16.3",
"Liabilities, Current": "11.9",
"Liabilities": "60.9",
"Long Term Liabilities": "36.1",
"Other Liabilities": "16.2",
"Operating Costs and Expenses": "8.23",
"Labor Expense": "7.11",
"Cost of Goods and Services Sold": "24.5",
"Research And Development Expense": "7.37",
"Other Expenses": "-99.5",
"Selling and Marketing Expense": "5.66",
"Other Revenues": "52.2",
"Revenues": "52.2",
"Economic Capital Ratio": "12.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001831097_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "1,367,195",
"Assets, Non-Current": "112,958",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "14,544",
"General and Administrative Expense": "455,821",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "96,938",
"Labor Expense": "0",
"Liabilities, Current": "356,960",
"Long Term Liabilities": "137,696",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,764,178",
"Other Liabilities": "0",
"Other Net Income": "-5,803",
"Other Revenues": "1,833,559",
"Property Plant and Equipment": "9,161",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,586,252",
"Liabilities": "494,656",
"Expenses": "2,234,543",
"Revenues": "1,833,559",
"Stockholders Equity": "1,091,596",
"Net Income": "-406,787",
"Comprehensive Net Income": "-406,787",
"BaseVar": "3,077,406",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "180%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.8006246416840788,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001831097.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001831097.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001831097.svg"
},
{
"company_id": "0000806517",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000806517.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000806517.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000806517.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000806517_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000806517_main_keyfigs.svg",
"name": "Psychemedics CORP",
"rank": 46,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000806517.svg",
"report_text": "The relative strengths and weaknesses of Psychemedics CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Psychemedics CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 50% points.The greatest weakness of Psychemedics CORP is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 43% points.
The company's Economic Capital Ratio, given in the ranking table, is 178%, being 11% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000806517_2022_Psychemedics_CORP.pdf",
"shrinked_graph_json": {
"2012": {
"Liabilities, Current": "21.7",
"Liabilities": "60.0",
"Stockholders Equity": "44.0",
"ECR before LimitedLiability": "107",
"Long Term Liabilities": "36.9",
"Other Liabilities": "9.72",
"Expenses": "6.16",
"Revenues": "-53.7",
"Net Income": "41.8",
"Other Expenses": "18.3",
"General and Administrative Expense": "-9.75",
"Selling and Marketing Expense": "-37.6",
"Operating Costs and Expenses": "7.04",
"Cost of Goods and Services Sold": "9.10",
"Labor Expense": "14.5",
"Other Revenues": "-53.7",
"Intangible Assets": "-8.52",
"Assets, Current": "13.4",
"Other Net Income": "82.7",
"Comprehensive Net Income": "42.2",
"Economic Capital Ratio": "92.7"
},
"2014": {
"Assets": "14.0",
"Liabilities": "-6.17",
"Stockholders Equity": "17.4",
"ECR before LimitedLiability": "45.3",
"Intangible Assets": "-13.8",
"Property Plant and Equipment": "31.2",
"Assets, Current": "10.1",
"Other Liabilities": "-12.4",
"Liabilities, Current": "13.9",
"Long Term Liabilities": "-8.58",
"Expenses": "21.7",
"Revenues": "-33.3",
"Net Income": "28.4",
"Labor Expense": "10.8",
"Other Expenses": "14.3",
"Selling and Marketing Expense": "-13.9",
"Cost of Goods and Services Sold": "6.46",
"Other Revenues": "-33.3",
"Comprehensive Net Income": "28.5",
"Other Net Income": "42.8",
"Economic Capital Ratio": "32.2"
},
"2015": {
"Assets, Current": "4.53",
"Assets": "18.4",
"Liabilities": "-14.8",
"Stockholders Equity": "15.4",
"ECR before LimitedLiability": "32.2",
"Intangible Assets": "-14.0",
"Property Plant and Equipment": "46.5",
"Long Term Liabilities": "-15.6",
"Other Liabilities": "-14.1",
"Liabilities, Current": "13.9",
"Selling and Marketing Expense": "-16.5",
"Expenses": "21.5",
"Revenues": "-34.0",
"Net Income": "24.0",
"Other Expenses": "21.4",
"Labor Expense": "9.62",
"Cost of Goods and Services Sold": "8.28",
"Other Revenues": "-34.0",
"Comprehensive Net Income": "24.4",
"Other Net Income": "40.2",
"Economic Capital Ratio": "19.8"
},
"2016": {
"Property Plant and Equipment": "24.3",
"Assets": "10.00",
"Liabilities": "22.0",
"Stockholders Equity": "36.7",
"ECR before LimitedLiability": "95.3",
"Intangible Assets": "-10.2",
"Assets, Current": "5.34",
"Liabilities, Current": "27.3",
"Other Liabilities": "-9.06",
"Expenses": "21.5",
"Revenues": "-44.5",
"Net Income": "47.0",
"Operating Costs and Expenses": "3.39",
"Selling and Marketing Expense": "-13.7",
"Labor Expense": "5.74",
"Other Expenses": "10.9",
"Cost of Goods and Services Sold": "13.3",
"Other Revenues": "-44.5",
"Other Net Income": "70.6",
"Comprehensive Net Income": "47.7",
"Economic Capital Ratio": "67.6"
},
"2017": {
"Assets": "9.97",
"Liabilities": "30.6",
"Stockholders Equity": "45.6",
"ECR before LimitedLiability": "108",
"Intangible Assets": "-8.89",
"Assets, Current": "8.65",
"Property Plant and Equipment": "17.5",
"Liabilities, Current": "24.7",
"Other Liabilities": "-2.60",
"Long Term Liabilities": "9.42",
"Expenses": "22.4",
"Revenues": "-37.9",
"Net Income": "44.5",
"Labor Expense": "6.11",
"Selling and Marketing Expense": "-13.9",
"Other Expenses": "16.4",
"Cost of Goods and Services Sold": "10.6",
"Other Revenues": "-37.9",
"Other Net Income": "58.2",
"Comprehensive Net Income": "43.7",
"Economic Capital Ratio": "83.8"
},
"2018": {
"Assets": "-18.0",
"Liabilities": "86.8",
"Stockholders Equity": "-5.67",
"ECR before LimitedLiability": "96.9",
"Property Plant and Equipment": "10.0",
"Intangible Assets": "-12.3",
"Assets, Current": "-6.66",
"Liabilities, Current": "55.7",
"Long Term Liabilities": "37.0",
"Selling and Marketing Expense": "-15.7",
"Expenses": "-23.5",
"Revenues": "85.7",
"Net Income": "63.1",
"Operating Costs and Expenses": "6.80",
"Other Expenses": "19.8",
"General and Administrative Expense": "6.50",
"Cost of Goods and Services Sold": "-65.5",
"Labor Expense": "13.7",
"Other Revenues": "85.7",
"Comprehensive Net Income": "58.4",
"Economic Capital Ratio": "76.2"
},
"2019": {
"Property Plant and Equipment": "15.6",
"Assets": "-22.7",
"Liabilities": "48.4",
"Stockholders Equity": "-17.9",
"ECR before LimitedLiability": "42.8",
"Intangible Assets": "-18.1",
"Assets, Current": "-9.74",
"Other Liabilities": "13.4",
"Long Term Liabilities": "22.4",
"Liabilities, Current": "15.6",
"Other Expenses": "11.6",
"Expenses": "-18.5",
"Revenues": "54.0",
"Net Income": "33.1",
"Cost of Goods and Services Sold": "-42.4",
"Selling and Marketing Expense": "-10.0",
"Labor Expense": "9.24",
"Operating Costs and Expenses": "7.92",
"Other Revenues": "54.0",
"Comprehensive Net Income": "32.5",
"Economic Capital Ratio": "32.7"
},
"2020": {
"Property Plant and Equipment": "31.8",
"Assets": "-18.4",
"Liabilities": "15.9",
"Stockholders Equity": "-16.8",
"ECR before LimitedLiability": "9.29",
"Other Assets": "-7.45",
"Intangible Assets": "-21.8",
"Assets, Current": "-16.6",
"Assets, Non-Current": "7.64",
"Liabilities, Current": "18.3",
"Other Liabilities": "8.25",
"Long Term Liabilities": "-11.0",
"Labor Expense": "7.56",
"Expenses": "-15.7",
"Revenues": "24.8",
"Net Income": "7.91",
"Selling and Marketing Expense": "-10.9",
"Other Expenses": "27.3",
"Cost of Goods and Services Sold": "-42.3",
"Other Revenues": "24.8",
"Comprehensive Net Income": "7.88",
"Economic Capital Ratio": "-2.80"
},
"2021": {
"Assets": "-27.1",
"Liabilities": "33.3",
"Stockholders Equity": "-31.8",
"ECR before LimitedLiability": "16.9",
"Intangible Assets": "-25.2",
"Property Plant and Equipment": "17.1",
"Assets, Non-Current": "4.42",
"Assets, Current": "-15.7",
"Long Term Liabilities": "18.8",
"Other Liabilities": "14.5",
"Expenses": "-18.7",
"Revenues": "49.9",
"Net Income": "25.5",
"Operating Costs and Expenses": "7.36",
"Labor Expense": "6.36",
"Cost of Goods and Services Sold": "-42.8",
"Other Expenses": "16.5",
"Selling and Marketing Expense": "-7.38",
"Other Revenues": "49.9",
"Comprehensive Net Income": "25.7",
"Economic Capital Ratio": "10.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000806517_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "9,574",
"Assets, Non-Current": "345",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,947",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,083",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,958",
"Other Liabilities": "815",
"Other Net Income": "14,254",
"Other Revenues": "0",
"Property Plant and Equipment": "4,201",
"Research And Development Expense": "826",
"Selling and Marketing Expense": "4,544"
},
"output_variables": {
"Assets": "14,121",
"Liabilities": "2,898",
"Expenses": "11,274",
"Revenues": "0",
"Stockholders Equity": "11,223",
"Net Income": "2,980",
"Comprehensive Net Income": "2,980",
"BaseVar": "21,273",
"ECR before LimitedLiability": "226%",
"Economic Capital Ratio": "256%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "10,577",
"Assets, Non-Current": "761",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "4,475",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,596",
"Long Term Liabilities": "4,848",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,427",
"Other Liabilities": "2,797",
"Other Net Income": "15,082",
"Other Revenues": "0",
"Property Plant and Equipment": "12,740",
"Research And Development Expense": "1,348",
"Selling and Marketing Expense": "4,625"
},
"output_variables": {
"Assets": "24,078",
"Liabilities": "11,241",
"Expenses": "11,876",
"Revenues": "0",
"Stockholders Equity": "12,837",
"Net Income": "3,206",
"Comprehensive Net Income": "3,206",
"BaseVar": "31,138",
"ECR before LimitedLiability": "124%",
"Economic Capital Ratio": "187%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "8,456",
"Assets, Non-Current": "774",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "4,561",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,565",
"Long Term Liabilities": "4,272",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-164",
"Other Liabilities": "2,853",
"Other Net Income": "12,592",
"Other Revenues": "0",
"Property Plant and Equipment": "13,132",
"Research And Development Expense": "1,632",
"Selling and Marketing Expense": "5,053"
},
"output_variables": {
"Assets": "22,363",
"Liabilities": "10,689",
"Expenses": "11,081",
"Revenues": "0",
"Stockholders Equity": "11,674",
"Net Income": "1,511",
"Comprehensive Net Income": "1,511",
"BaseVar": "28,363",
"ECR before LimitedLiability": "112%",
"Economic Capital Ratio": "179%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "10,854",
"Assets, Non-Current": "820",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "4,965",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,495",
"Long Term Liabilities": "2,237",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3,298",
"Other Liabilities": "2,693",
"Other Net Income": "21,316",
"Other Revenues": "0",
"Property Plant and Equipment": "13,358",
"Research And Development Expense": "1,415",
"Selling and Marketing Expense": "4,960"
},
"output_variables": {
"Assets": "25,032",
"Liabilities": "9,425",
"Expenses": "14,638",
"Revenues": "0",
"Stockholders Equity": "15,607",
"Net Income": "6,678",
"Comprehensive Net Income": "6,678",
"BaseVar": "35,206",
"ECR before LimitedLiability": "170%",
"Economic Capital Ratio": "218%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "13,865",
"Assets, Non-Current": "832",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,642",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,225",
"Long Term Liabilities": "2,420",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-238",
"Other Expenses": "2,056",
"Other Liabilities": "1,243",
"Other Net Income": "19,842",
"Other Revenues": "0",
"Property Plant and Equipment": "11,811",
"Research And Development Expense": "1,357",
"Selling and Marketing Expense": "4,666"
},
"output_variables": {
"Assets": "26,508",
"Liabilities": "7,888",
"Expenses": "13,721",
"Revenues": "0",
"Stockholders Equity": "18,620",
"Net Income": "6,121",
"Comprehensive Net Income": "5,883",
"BaseVar": "34,098",
"ECR before LimitedLiability": "191%",
"Economic Capital Ratio": "232%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "13,870",
"Assets, Non-Current": "927",
"Cost of Goods and Services Sold": "22,056",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,430",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,060",
"Long Term Liabilities": "1,212",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-1,161",
"Other Expenses": "3,069",
"Other Liabilities": "955",
"Other Net Income": "43",
"Other Revenues": "42,674",
"Property Plant and Equipment": "10,177",
"Research And Development Expense": "1,551",
"Selling and Marketing Expense": "5,027"
},
"output_variables": {
"Assets": "24,974",
"Liabilities": "6,227",
"Expenses": "38,133",
"Revenues": "42,674",
"Stockholders Equity": "18,747",
"Net Income": "4,584",
"Comprehensive Net Income": "3,423",
"BaseVar": "56,606",
"ECR before LimitedLiability": "196%",
"Economic Capital Ratio": "235%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "12,851",
"Assets, Non-Current": "3,818",
"Cost of Goods and Services Sold": "21,234",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "7,221",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "6,385",
"Long Term Liabilities": "4,326",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-225",
"Other Expenses": "1,514",
"Other Liabilities": "0",
"Other Net Income": "58",
"Other Revenues": "37,678",
"Property Plant and Equipment": "10,862",
"Research And Development Expense": "1,567",
"Selling and Marketing Expense": "4,658"
},
"output_variables": {
"Assets": "27,531",
"Liabilities": "10,711",
"Expenses": "36,194",
"Revenues": "37,678",
"Stockholders Equity": "16,820",
"Net Income": "1,542",
"Comprehensive Net Income": "1,317",
"BaseVar": "56,198",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "194%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "9,598",
"Assets, Non-Current": "5,174",
"Cost of Goods and Services Sold": "16,474",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,095",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,152",
"Long Term Liabilities": "7,339",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-10",
"Other Expenses": "-2,347",
"Other Liabilities": "0",
"Other Net Income": "-140",
"Other Revenues": "21,360",
"Property Plant and Equipment": "9,231",
"Research And Development Expense": "1,280",
"Selling and Marketing Expense": "3,577"
},
"output_variables": {
"Assets": "24,003",
"Liabilities": "11,491",
"Expenses": "25,079",
"Revenues": "21,360",
"Stockholders Equity": "12,512",
"Net Income": "-3,859",
"Comprehensive Net Income": "-3,869",
"BaseVar": "41,042",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "157%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "10,285",
"Assets, Non-Current": "4,416",
"Cost of Goods and Services Sold": "14,645",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,126",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,830",
"Long Term Liabilities": "3,479",
"Operating Costs and Expenses": "0",
"Other Assets": "160",
"Other Compr. Net Income": "0",
"Other Expenses": "-156",
"Other Liabilities": "0",
"Other Net Income": "-1,030",
"Other Revenues": "24,909",
"Property Plant and Equipment": "6,691",
"Research And Development Expense": "1,130",
"Selling and Marketing Expense": "2,799"
},
"output_variables": {
"Assets": "21,552",
"Liabilities": "9,309",
"Expenses": "24,544",
"Revenues": "24,909",
"Stockholders Equity": "12,243",
"Net Income": "-665",
"Comprehensive Net Income": "-665",
"BaseVar": "40,672",
"ECR before LimitedLiability": "111%",
"Economic Capital Ratio": "178%"
}
}
},
"top_rated": false,
"trend": -7.0,
"value": 1.7848930813877941,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000806517.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000806517.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000806517.svg"
},
{
"company_id": "0001791091",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001791091.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001791091.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001791091.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001791091_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001791091_main_keyfigs.svg",
"name": "SOC Telemed Inc",
"rank": 47,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001791091.svg",
"report_text": "The relative strengths and weaknesses of SOC Telemed Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of SOC Telemed Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 84% points.The greatest weakness of SOC Telemed Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 65% points.
The company's Economic Capital Ratio, given in the ranking table, is 171%, being 3.7% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001791091_2022_SOC_Telemed_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Property Plant and Equipment": "-12.5",
"Assets": "-20.3",
"ECR before LimitedLiability": "-12.7",
"Assets, Non-Current": "-17.9",
"Liabilities, Current": "15.6",
"Liabilities": "38.5",
"Other Liabilities": "-26.0",
"Long Term Liabilities": "46.7",
"Labor Expense": "8.85",
"Expenses": "-36.1",
"Revenues": "5.99",
"Net Income": "-39.7",
"General and Administrative Expense": "-51.8",
"Research And Development Expense": "6.11",
"Other Expenses": "19.2",
"Operating Costs and Expenses": "7.00",
"Cost of Goods and Services Sold": "-26.0",
"Other Revenues": "5.99",
"Other Net Income": "-9.90",
"Comprehensive Net Income": "-39.7",
"Economic Capital Ratio": "-24.8"
},
"2021": {
"Assets": "15.7",
"Liabilities": "-3.69",
"Stockholders Equity": "18.9",
"ECR before LimitedLiability": "9.83",
"Intangible Assets": "84.0",
"Property Plant and Equipment": "-6.53",
"Assets, Non-Current": "-8.33",
"Assets, Current": "-16.1",
"Liabilities, Current": "19.1",
"Long Term Liabilities": "29.9",
"Other Liabilities": "-65.2",
"Other Revenues": "-6.82",
"Revenues": "-6.82",
"General and Administrative Expense": "-15.1",
"Economic Capital Ratio": "3.65",
"Cost of Goods and Services Sold": "-10.1",
"Research And Development Expense": "4.19",
"Other Expenses": "11.2",
"Selling and Marketing Expense": "3.21",
"Operating Costs and Expenses": "4.67",
"Labor Expense": "4.04"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001791091_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "49,084",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "38,542",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "61,280",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "22,269",
"Labor Expense": "0",
"Liabilities, Current": "15,940",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "9,494",
"Other Compr. Net Income": "0",
"Other Expenses": "31",
"Other Liabilities": "13,933",
"Other Net Income": "-7,989",
"Other Revenues": "57,995",
"Property Plant and Equipment": "4,092",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "84,939",
"Liabilities": "29,873",
"Expenses": "99,853",
"Revenues": "57,995",
"Stockholders Equity": "55,066",
"Net Income": "-49,847",
"Comprehensive Net Income": "-49,847",
"BaseVar": "140,324",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "135%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "60,317",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "64,091",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "86,606",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "200,256",
"Labor Expense": "0",
"Liabilities, Current": "18,178",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "10,357",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,417",
"Other Liabilities": "88,922",
"Other Net Income": "2,296",
"Other Revenues": "94,442",
"Property Plant and Equipment": "3,295",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "274,225",
"Liabilities": "107,100",
"Expenses": "147,280",
"Revenues": "94,442",
"Stockholders Equity": "167,125",
"Net Income": "-50,542",
"Comprehensive Net Income": "-50,542",
"BaseVar": "312,672",
"ECR before LimitedLiability": "101%",
"Economic Capital Ratio": "171%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 1.7143470281128006,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001791091.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001791091.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001791091.svg"
},
{
"company_id": "0001759655",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001759655.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001759655.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001759655.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001759655_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001759655_main_keyfigs.svg",
"name": "Privia Health Group Inc",
"rank": 48,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001759655.svg",
"report_text": "The relative strengths and weaknesses of Privia Health Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Privia Health Group Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 74% points.The greatest weakness of Privia Health Group Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 112% points.
The company's Economic Capital Ratio, given in the ranking table, is 171%, being 3.4% points above the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001759655_2022_Privia_Health_Group_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "-20.6",
"Assets": "-42.3",
"Liabilities": "69.8",
"Stockholders Equity": "-41.8",
"ECR before LimitedLiability": "9.54",
"Intangible Assets": "-21.1",
"Property Plant and Equipment": "-13.8",
"Assets, Non-Current": "19.6",
"Assets, Current": "-14.0",
"Liabilities, Current": "9.28",
"Long Term Liabilities": "46.1",
"Other Liabilities": "18.0",
"Expenses": "-57.6",
"Revenues": "73.7",
"Comprehensive Net Income": "6.27",
"Operating Costs and Expenses": "9.49",
"Labor Expense": "8.20",
"Cost of Goods and Services Sold": "28.6",
"Research And Development Expense": "8.50",
"Other Expenses": "-112",
"Other Revenues": "73.7",
"Economic Capital Ratio": "3.36"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001759655_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "446,676",
"Assets, Non-Current": "239,697",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "2,464",
"General and Administrative Expense": "255,884",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "127,938",
"Labor Expense": "0",
"Liabilities, Current": "190,461",
"Long Term Liabilities": "45,731",
"Operating Costs and Expenses": "0",
"Other Assets": "-132,440",
"Other Compr. Net Income": "0",
"Other Expenses": "874,701",
"Other Liabilities": "0",
"Other Net Income": "-1,070",
"Other Revenues": "966,220",
"Property Plant and Equipment": "4,502",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "22,750"
},
"output_variables": {
"Assets": "686,373",
"Liabilities": "236,192",
"Expenses": "1,155,799",
"Revenues": "966,220",
"Stockholders Equity": "450,181",
"Net Income": "-190,649",
"Comprehensive Net Income": "-190,649",
"BaseVar": "1,522,827",
"ECR before LimitedLiability": "100%",
"Economic Capital Ratio": "171%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.7114559021068034,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001759655.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001759655.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001759655.svg"
},
{
"company_id": "0001799191",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001799191.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001799191.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001799191.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001799191_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001799191_main_keyfigs.svg",
"name": "Oncology Institute Inc",
"rank": 49,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001799191.svg",
"report_text": "The relative strengths and weaknesses of Oncology Institute Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Oncology Institute Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 66% points.The greatest weakness of Oncology Institute Inc is the variable Operating Costs and Expenses, reducing the Economic Capital Ratio by 105% points.
The company's Economic Capital Ratio, given in the ranking table, is 166%, being 2.1% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001799191_2022_Oncology_Institute_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Assets": "50.1",
"Liabilities": "24.1",
"Stockholders Equity": "124",
"ECR before LimitedLiability": "109",
"Other Assets": "224",
"Intangible Assets": "-3.24",
"Assets, Current": "-6.77",
"Liabilities, Current": "26.9",
"Other Liabilities": "-35.7",
"Long Term Liabilities": "24.9",
"Labor Expense": "3.18",
"Expenses": "36.5",
"Revenues": "-29.6",
"Net Income": "5.60",
"General and Administrative Expense": "10.8",
"Other Expenses": "6.74",
"Cost of Goods and Services Sold": "10.0",
"Other Revenues": "-29.6",
"Other Net Income": "-4.20",
"Comprehensive Net Income": "5.60",
"Economic Capital Ratio": "96.7"
},
"2021": {
"Assets": "-31.7",
"Liabilities": "25.5",
"Stockholders Equity": "-41.3",
"Economic Capital Ratio": "-2.05",
"Intangible Assets": "-14.2",
"Property Plant and Equipment": "-10.6",
"Assets, Non-Current": "-13.3",
"Liabilities, Current": "23.9",
"Long Term Liabilities": "41.0",
"Other Liabilities": "-46.4",
"General and Administrative Expense": "-12.6",
"Expenses": "-23.7",
"Revenues": "30.5",
"Net Income": "24.3",
"Operating Costs and Expenses": "-105",
"Labor Expense": "6.58",
"Cost of Goods and Services Sold": "22.8",
"Research And Development Expense": "6.82",
"Other Expenses": "65.8",
"Other Revenues": "30.5",
"Comprehensive Net Income": "24.4",
"Other Net Income": "19.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001799191_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "1,069",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "268",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "230,254",
"Other Compr. Net Income": "0",
"Other Expenses": "11",
"Other Liabilities": "25,091",
"Other Net Income": "-8,328",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "231,324",
"Liabilities": "25,359",
"Expenses": "11",
"Revenues": "0",
"Stockholders Equity": "205,965",
"Net Income": "-8,340",
"Comprehensive Net Income": "-8,340",
"BaseVar": "132,511",
"ECR before LimitedLiability": "226%",
"Economic Capital Ratio": "256%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "154,056",
"Assets, Non-Current": "320",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "3,341",
"General and Administrative Expense": "83,365",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "44,871",
"Labor Expense": "0",
"Liabilities, Current": "30,169",
"Long Term Liabilities": "6,900",
"Operating Costs and Expenses": "248,861",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-87,377",
"Other Liabilities": "62,211",
"Other Net Income": "34,260",
"Other Revenues": "203,003",
"Property Plant and Equipment": "4,192",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "203,439",
"Liabilities": "99,280",
"Expenses": "248,190",
"Revenues": "203,003",
"Stockholders Equity": "104,159",
"Net Income": "-10,927",
"Comprehensive Net Income": "-10,927",
"BaseVar": "394,086",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "166%"
}
}
},
"top_rated": false,
"trend": -40.0,
"value": 1.6573055362973315,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001799191.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001799191.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001799191.svg"
},
{
"company_id": "0001844392",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001844392.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001844392.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001844392_main_keyfigs.svg",
"name": "Marpai Inc",
"rank": 50,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001844392.svg",
"report_text": "The relative strengths and weaknesses of Marpai Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Marpai Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Marpai Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 28% points.
The company's Economic Capital Ratio, given in the ranking table, is 166%, being 2.2% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001844392_2022_Marpai_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "13.4",
"Assets": "14.6",
"Liabilities": "10.9",
"Stockholders Equity": "29.0",
"ECR before LimitedLiability": "3.95",
"Intangible Assets": "-5.83",
"Property Plant and Equipment": "-6.71",
"Assets, Non-Current": "-5.07",
"Assets, Current": "23.8",
"Liabilities, Current": "-27.7",
"Long Term Liabilities": "26.3",
"Other Liabilities": "9.78",
"Expenses": "-11.0",
"Revenues": "-10.8",
"Net Income": "-19.3",
"Operating Costs and Expenses": "5.13",
"Labor Expense": "4.44",
"Cost of Goods and Services Sold": "-10.3",
"Selling and Marketing Expense": "-8.52",
"Other Revenues": "-10.8",
"Comprehensive Net Income": "-19.3",
"Economic Capital Ratio": "-2.23"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001844392_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "26,992",
"Assets, Non-Current": "2,072",
"Cost of Goods and Services Sold": "10,290",
"Depreciation, Depletion, Amortization": "1,962",
"General and Administrative Expense": "8,056",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "7,891",
"Labor Expense": "0",
"Liabilities, Current": "13,146",
"Long Term Liabilities": "1,347",
"Operating Costs and Expenses": "0",
"Other Assets": "6,357",
"Other Compr. Net Income": "0",
"Other Expenses": "3,359",
"Other Liabilities": "0",
"Other Net Income": "154",
"Other Revenues": "14,227",
"Property Plant and Equipment": "890",
"Research And Development Expense": "1,734",
"Selling and Marketing Expense": "4,965"
},
"output_variables": {
"Assets": "44,202",
"Liabilities": "14,493",
"Expenses": "30,365",
"Revenues": "14,227",
"Stockholders Equity": "29,708",
"Net Income": "-15,985",
"Comprehensive Net Income": "-15,985",
"BaseVar": "51,720",
"ECR before LimitedLiability": "92%",
"Economic Capital Ratio": "166%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.655527749774157,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001844392.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001844392.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001844392.svg"
},
{
"company_id": "0001818331",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001818331.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001818331.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001818331_main_keyfigs.svg",
"name": "Genedx Holdings Corp",
"rank": 51,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001818331.svg",
"report_text": "The relative strengths and weaknesses of Genedx Holdings Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Genedx Holdings Corp compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 48% points.The greatest weakness of Genedx Holdings Corp is the variable Expenses, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 163%, being 5.2% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001818331_2022_Genedx_Holdings_Corp.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "-20.1",
"Economic Capital Ratio": "-5.25",
"Intangible Assets": "-28.1",
"Assets, Non-Current": "-12.2",
"Assets, Current": "44.6",
"Liabilities, Current": "11.0",
"Liabilities": "45.2",
"Long Term Liabilities": "39.7",
"General and Administrative Expense": "-15.3",
"Expenses": "-40.3",
"Revenues": "-21.7",
"Net Income": "-21.4",
"Operating Costs and Expenses": "7.37",
"Labor Expense": "6.37",
"Cost of Goods and Services Sold": "-24.1",
"Research And Development Expense": "-14.3",
"Other Expenses": "14.6",
"Selling and Marketing Expense": "-17.2",
"Other Revenues": "-21.7",
"Comprehensive Net Income": "-21.3",
"Other Net Income": "47.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001818331_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "483,544",
"Assets, Non-Current": "6,930",
"Cost of Goods and Services Sold": "228,797",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "205,988",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "101,284",
"Long Term Liabilities": "14,480",
"Operating Costs and Expenses": "0",
"Other Assets": "900",
"Other Compr. Net Income": "0",
"Other Expenses": "5,659",
"Other Liabilities": "50,226",
"Other Net Income": "200,759",
"Other Revenues": "212,195",
"Property Plant and Equipment": "62,719",
"Research And Development Expense": "105,162",
"Selling and Marketing Expense": "112,738"
},
"output_variables": {
"Assets": "554,093",
"Liabilities": "165,990",
"Expenses": "658,344",
"Revenues": "212,195",
"Stockholders Equity": "388,103",
"Net Income": "-245,390",
"Comprehensive Net Income": "-245,390",
"BaseVar": "895,690",
"ECR before LimitedLiability": "88%",
"Economic Capital Ratio": "163%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.6253825357833336,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001818331.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001818331.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001818331.svg"
},
{
"company_id": "0001124140",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001124140.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001124140.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001124140.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001124140_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001124140_main_keyfigs.svg",
"name": "Exact Sciences CORP",
"rank": 52,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001124140.svg",
"report_text": "The relative strengths and weaknesses of Exact Sciences CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Exact Sciences CORP compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 74% points.The greatest weakness of Exact Sciences CORP is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 56% points.
The company's Economic Capital Ratio, given in the ranking table, is 161%, being 6.5% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001124140_2022_Exact_Sciences_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "64.8",
"Liabilities": "34.9",
"Stockholders Equity": "133",
"ECR before LimitedLiability": "77.9",
"Property Plant and Equipment": "-5.73",
"Assets, Current": "163",
"Intangible Assets": "-7.84",
"Other Liabilities": "7.68",
"Long Term Liabilities": "23.8",
"Liabilities, Current": "5.75",
"Expenses": "10.5",
"Revenues": "-21.0",
"Net Income": "-27.5",
"Research And Development Expense": "-27.7",
"Other Expenses": "19.7",
"Operating Costs and Expenses": "4.55",
"Labor Expense": "7.14",
"Other Revenues": "-21.0",
"Other Net Income": "-17.1",
"Comprehensive Net Income": "-27.4",
"Economic Capital Ratio": "71.2"
},
"2012": {
"Property Plant and Equipment": "-7.56",
"Assets": "71.6",
"Liabilities": "35.1",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "56.3",
"Intangible Assets": "-10.9",
"Assets, Current": "149",
"Liabilities, Current": "5.39",
"Long Term Liabilities": "19.1",
"Other Liabilities": "12.6",
"Research And Development Expense": "-43.9",
"Expenses": "-4.91",
"Revenues": "-23.2",
"Net Income": "-46.9",
"Other Expenses": "19.5",
"Cost of Goods and Services Sold": "5.07",
"Labor Expense": "8.17",
"Other Revenues": "-23.2",
"Other Net Income": "-17.8",
"Comprehensive Net Income": "-46.3",
"Economic Capital Ratio": "42.1"
},
"2013": {
"Assets": "58.0",
"Stockholders Equity": "145",
"ECR before LimitedLiability": "85.5",
"Assets, Current": "137",
"Intangible Assets": "-6.09",
"Other Liabilities": "11.8",
"Liabilities": "48.7",
"Liabilities, Current": "22.0",
"Long Term Liabilities": "20.8",
"Expenses": "5.77",
"Revenues": "-24.6",
"Net Income": "-30.8",
"Selling and Marketing Expense": "-6.85",
"Cost of Goods and Services Sold": "4.45",
"Labor Expense": "7.64",
"Other Expenses": "16.3",
"Research And Development Expense": "-22.6",
"Other Revenues": "-24.6",
"Comprehensive Net Income": "-30.4",
"Other Net Income": "-11.7",
"Economic Capital Ratio": "76.4"
},
"2014": {
"Assets": "68.6",
"Stockholders Equity": "144",
"ECR before LimitedLiability": "89.9",
"Intangible Assets": "-6.44",
"Assets, Current": "149",
"Other Liabilities": "6.81",
"Liabilities": "42.2",
"Liabilities, Current": "18.6",
"Long Term Liabilities": "20.8",
"Expenses": "8.15",
"Revenues": "-25.3",
"Net Income": "-30.4",
"Operating Costs and Expenses": "3.68",
"Labor Expense": "7.90",
"Research And Development Expense": "-8.87",
"Other Expenses": "14.4",
"Selling and Marketing Expense": "-13.2",
"Other Revenues": "-25.3",
"Comprehensive Net Income": "-30.2",
"Other Net Income": "-13.2",
"Economic Capital Ratio": "76.7"
},
"2015": {
"Assets, Current": "126",
"Assets": "60.5",
"Stockholders Equity": "122",
"ECR before LimitedLiability": "62.6",
"Intangible Assets": "-9.57",
"Long Term Liabilities": "12.8",
"Liabilities": "41.4",
"Other Liabilities": "9.05",
"Liabilities, Current": "22.4",
"Selling and Marketing Expense": "-23.4",
"Expenses": "-5.59",
"Revenues": "-18.4",
"Net Income": "-38.0",
"Research And Development Expense": "-8.13",
"General and Administrative Expense": "-5.19",
"Other Expenses": "17.9",
"Labor Expense": "8.44",
"Other Revenues": "-18.4",
"Comprehensive Net Income": "-37.4",
"Other Net Income": "-13.3",
"Economic Capital Ratio": "50.2"
},
"2016": {
"Assets": "47.4",
"Stockholders Equity": "119",
"ECR before LimitedLiability": "83.6",
"Intangible Assets": "-10.8",
"Assets, Current": "120",
"Liabilities, Current": "36.1",
"Liabilities": "56.3",
"Other Liabilities": "12.3",
"Long Term Liabilities": "12.0",
"Expenses": "-13.1",
"Revenues": "-7.94",
"Net Income": "-34.6",
"Selling and Marketing Expense": "-30.8",
"General and Administrative Expense": "-6.19",
"Labor Expense": "5.28",
"Other Expenses": "21.9",
"Research And Development Expense": "-6.07",
"Other Revenues": "-7.94",
"Other Net Income": "-13.1",
"Comprehensive Net Income": "-33.4",
"Economic Capital Ratio": "55.9"
},
"2017": {
"Assets": "32.2",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "107",
"Intangible Assets": "-8.04",
"Assets, Current": "59.6",
"Liabilities, Current": "23.5",
"Liabilities": "48.0",
"Other Liabilities": "7.66",
"Long Term Liabilities": "21.7",
"General and Administrative Expense": "-4.00",
"Expenses": "6.05",
"Revenues": "-32.8",
"Net Income": "-4.23",
"Labor Expense": "5.33",
"Selling and Marketing Expense": "-27.4",
"Other Expenses": "21.2",
"Cost of Goods and Services Sold": "9.29",
"Other Revenues": "-32.8",
"Other Net Income": "21.0",
"Comprehensive Net Income": "-4.17",
"Economic Capital Ratio": "82.4"
},
"2018": {
"Assets": "37.9",
"Liabilities": "-39.8",
"Stockholders Equity": "7.92",
"ECR before LimitedLiability": "9.35",
"Property Plant and Equipment": "4.90",
"Intangible Assets": "-14.3",
"Assets, Non-Current": "-6.32",
"Assets, Current": "61.4",
"Liabilities, Current": "21.1",
"Long Term Liabilities": "-72.7",
"Selling and Marketing Expense": "-13.0",
"Expenses": "27.0",
"Revenues": "-15.9",
"Net Income": "8.94",
"Other Expenses": "15.9",
"General and Administrative Expense": "4.19",
"Cost of Goods and Services Sold": "8.86",
"Labor Expense": "6.42",
"Other Revenues": "-15.9",
"Comprehensive Net Income": "9.09",
"Economic Capital Ratio": "-11.4"
},
"2019": {
"Assets": "38.8",
"Liabilities": "-10.2",
"Stockholders Equity": "47.5",
"ECR before LimitedLiability": "44.4",
"Assets, Non-Current": "-3.56",
"Intangible Assets": "74.3",
"Assets, Current": "-8.37",
"Other Liabilities": "-49.1",
"Long Term Liabilities": "15.1",
"Liabilities, Current": "15.2",
"Other Expenses": "12.8",
"Expenses": "25.2",
"Revenues": "-13.5",
"Net Income": "10.2",
"Cost of Goods and Services Sold": "8.77",
"Selling and Marketing Expense": "-7.90",
"Labor Expense": "4.34",
"Operating Costs and Expenses": "3.72",
"Other Revenues": "-13.5",
"Comprehensive Net Income": "10.3",
"Economic Capital Ratio": "34.4"
},
"2020": {
"Assets": "27.2",
"Expenses": "11.4",
"Stockholders Equity": "24.4",
"ECR before LimitedLiability": "18.0",
"Other Assets": "-4.65",
"Intangible Assets": "34.0",
"Assets, Current": "7.29",
"Assets, Non-Current": "-5.40",
"Liabilities, Current": "11.4",
"Liabilities": "-11.8",
"Other Liabilities": "4.67",
"Long Term Liabilities": "-29.6",
"Labor Expense": "4.87",
"Selling and Marketing Expense": "-9.37",
"General and Administrative Expense": "6.77",
"Research And Development Expense": "-7.86",
"Other Expenses": "4.29",
"Cost of Goods and Services Sold": "8.21",
"Other Revenues": "-11.6",
"Revenues": "-11.6",
"Economic Capital Ratio": "5.95"
},
"2021": {
"Assets": "24.9",
"Liabilities": "-28.8",
"Stockholders Equity": "8.18",
"Economic Capital Ratio": "-6.48",
"Intangible Assets": "73.9",
"Assets, Non-Current": "-4.78",
"Assets, Current": "-15.1",
"Liabilities, Current": "13.9",
"Long Term Liabilities": "-56.0",
"Other Liabilities": "7.90",
"General and Administrative Expense": "3.07",
"Expenses": "17.4",
"Revenues": "-11.3",
"Net Income": "7.03",
"Operating Costs and Expenses": "4.19",
"Labor Expense": "3.62",
"Cost of Goods and Services Sold": "5.37",
"Other Expenses": "10.9",
"Selling and Marketing Expense": "-9.57",
"Other Revenues": "-11.3",
"Comprehensive Net Income": "7.07"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001124140_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "94,395",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "24",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "8,137",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "7,977",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "4,163",
"Property Plant and Equipment": "2,558",
"Research And Development Expense": "21,968",
"Selling and Marketing Expense": "2,857"
},
"output_variables": {
"Assets": "96,953",
"Liabilities": "7,977",
"Expenses": "32,986",
"Revenues": "4,163",
"Stockholders Equity": "88,976",
"Net Income": "-28,823",
"Comprehensive Net Income": "-28,823",
"BaseVar": "71,040",
"ECR before LimitedLiability": "191%",
"Economic Capital Ratio": "232%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "108,714",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "9,900",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "11,455",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "313",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "4,144",
"Property Plant and Equipment": "3,405",
"Research And Development Expense": "42,131",
"Selling and Marketing Expense": "4,755"
},
"output_variables": {
"Assets": "112,119",
"Liabilities": "11,455",
"Expenses": "56,786",
"Revenues": "4,144",
"Stockholders Equity": "100,664",
"Net Income": "-52,642",
"Comprehensive Net Income": "-52,329",
"BaseVar": "92,408",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "206%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "135,458",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "13,649",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "7,752",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "294",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "4,144",
"Property Plant and Equipment": "11,169",
"Research And Development Expense": "27,678",
"Selling and Marketing Expense": "9,578"
},
"output_variables": {
"Assets": "146,627",
"Liabilities": "7,752",
"Expenses": "50,905",
"Revenues": "4,144",
"Stockholders Equity": "138,875",
"Net Income": "-46,761",
"Comprehensive Net Income": "-46,467",
"BaseVar": "104,861",
"ECR before LimitedLiability": "201%",
"Economic Capital Ratio": "239%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "291,677",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "4,325",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "30,435",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "17,521",
"Long Term Liabilities": "3,399",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "251",
"Other Expenses": "0",
"Other Liabilities": "1,720",
"Other Net Income": "0",
"Other Revenues": "1,798",
"Property Plant and Equipment": "19,947",
"Research And Development Expense": "28,669",
"Selling and Marketing Expense": "38,908"
},
"output_variables": {
"Assets": "311,624",
"Liabilities": "22,640",
"Expenses": "102,337",
"Revenues": "1,798",
"Stockholders Equity": "288,984",
"Net Income": "-100,539",
"Comprehensive Net Income": "-100,288",
"BaseVar": "219,325",
"ECR before LimitedLiability": "191%",
"Economic Capital Ratio": "232%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "326,130",
"Assets, Non-Current": "4,070",
"Cost of Goods and Services Sold": "24,501",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "57,950",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "26,723",
"Long Term Liabilities": "9,656",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "947",
"Other Expenses": "0",
"Other Liabilities": "1,061",
"Other Net Income": "0",
"Other Revenues": "39,437",
"Property Plant and Equipment": "34,096",
"Research And Development Expense": "33,914",
"Selling and Marketing Expense": "82,140"
},
"output_variables": {
"Assets": "364,296",
"Liabilities": "37,440",
"Expenses": "198,505",
"Revenues": "39,437",
"Stockholders Equity": "326,856",
"Net Income": "-159,068",
"Comprehensive Net Income": "-158,121",
"BaseVar": "320,312",
"ECR before LimitedLiability": "157%",
"Economic Capital Ratio": "210%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "333,573",
"Assets, Non-Current": "5,325",
"Cost of Goods and Services Sold": "45,195",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "76,898",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "30,692",
"Long Term Liabilities": "10,367",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "1,820",
"Other Expenses": "0",
"Other Liabilities": "686",
"Other Net Income": "0",
"Other Revenues": "99,376",
"Property Plant and Equipment": "38,142",
"Research And Development Expense": "33,473",
"Selling and Marketing Expense": "112,826"
},
"output_variables": {
"Assets": "377,040",
"Liabilities": "41,745",
"Expenses": "268,392",
"Revenues": "99,376",
"Stockholders Equity": "335,295",
"Net Income": "-169,016",
"Comprehensive Net Income": "-167,196",
"BaseVar": "394,186",
"ECR before LimitedLiability": "152%",
"Economic Capital Ratio": "206%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "487,216",
"Assets, Non-Current": "9,198",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "109,040",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "68,124",
"Long Term Liabilities": "9,902",
"Operating Costs and Expenses": "0",
"Other Assets": "22,160",
"Other Compr. Net Income": "-332",
"Other Expenses": "-187",
"Other Liabilities": "116",
"Other Net Income": "190,519",
"Other Revenues": "0",
"Property Plant and Equipment": "79,986",
"Research And Development Expense": "42,139",
"Selling and Marketing Expense": "153,924"
},
"output_variables": {
"Assets": "598,560",
"Liabilities": "78,142",
"Expenses": "304,916",
"Revenues": "0",
"Stockholders Equity": "520,418",
"Net Income": "-114,397",
"Comprehensive Net Income": "-114,729",
"BaseVar": "586,234",
"ECR before LimitedLiability": "189%",
"Economic Capital Ratio": "231%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,228,067",
"Assets, Non-Current": "4,415",
"Cost of Goods and Services Sold": "117,982",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "178,293",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "136,590",
"Long Term Liabilities": "698,297",
"Operating Costs and Expenses": "0",
"Other Assets": "46,281",
"Other Compr. Net Income": "-672",
"Other Expenses": "92",
"Other Liabilities": "8,194",
"Other Net Income": "-15,586",
"Other Revenues": "454,462",
"Property Plant and Equipment": "245,259",
"Research And Development Expense": "68,210",
"Selling and Marketing Expense": "249,448"
},
"output_variables": {
"Assets": "1,524,022",
"Liabilities": "843,081",
"Expenses": "614,025",
"Revenues": "454,462",
"Stockholders Equity": "680,941",
"Net Income": "-175,149",
"Comprehensive Net Income": "-175,821",
"BaseVar": "1,725,924",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "148%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "556,959",
"Assets, Non-Current": "146,737",
"Cost of Goods and Services Sold": "216,717",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "352,453",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,346,747",
"Labor Expense": "0",
"Liabilities, Current": "236,494",
"Long Term Liabilities": "177,608",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "1,322",
"Other Expenses": "-168,823",
"Other Liabilities": "803,605",
"Other Net Income": "-35,069",
"Other Revenues": "876,293",
"Property Plant and Equipment": "455,325",
"Research And Development Expense": "139,694",
"Selling and Marketing Expense": "385,176"
},
"output_variables": {
"Assets": "3,505,768",
"Liabilities": "1,217,707",
"Expenses": "925,217",
"Revenues": "876,293",
"Stockholders Equity": "2,288,061",
"Net Income": "-83,993",
"Comprehensive Net Income": "-82,671",
"BaseVar": "3,280,688",
"ECR before LimitedLiability": "137%",
"Economic Capital Ratio": "196%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "2,198,594",
"Assets, Non-Current": "189,717",
"Cost of Goods and Services Sold": "354,324",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "481,716",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,086,098",
"Labor Expense": "0",
"Liabilities, Current": "575,844",
"Long Term Liabilities": "1,503,417",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "626",
"Other Expenses": "294,492",
"Other Liabilities": "22,342",
"Other Net Income": "-89,086",
"Other Revenues": "1,515,056",
"Property Plant and Equipment": "450,683",
"Research And Development Expense": "554,052",
"Selling and Marketing Expense": "589,919"
},
"output_variables": {
"Assets": "4,925,092",
"Liabilities": "2,101,603",
"Expenses": "2,274,503",
"Revenues": "1,515,056",
"Stockholders Equity": "2,823,489",
"Net Income": "-848,533",
"Comprehensive Net Income": "-847,907",
"BaseVar": "5,452,983",
"ECR before LimitedLiability": "92%",
"Economic Capital Ratio": "166%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,426,237",
"Assets, Non-Current": "248,816",
"Cost of Goods and Services Sold": "458,757",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "801,262",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,429,583",
"Labor Expense": "0",
"Liabilities, Current": "517,068",
"Long Term Liabilities": "2,780,180",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-1,969",
"Other Expenses": "-131,670",
"Other Liabilities": "0",
"Other Net Income": "13,172",
"Other Revenues": "1,767,087",
"Property Plant and Equipment": "580,248",
"Research And Development Expense": "385,646",
"Selling and Marketing Expense": "861,889"
},
"output_variables": {
"Assets": "6,684,884",
"Liabilities": "3,297,248",
"Expenses": "2,375,884",
"Revenues": "1,767,087",
"Stockholders Equity": "3,387,636",
"Net Income": "-595,625",
"Comprehensive Net Income": "-597,594",
"BaseVar": "7,070,122",
"ECR before LimitedLiability": "86%",
"Economic Capital Ratio": "161%"
}
}
},
"top_rated": false,
"trend": -17.0,
"value": 1.6129832911860245,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001124140.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001124140.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001124140.svg"
},
{
"company_id": "0001729944",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001729944.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001729944.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001729944.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001729944_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001729944_main_keyfigs.svg",
"name": "IMAC Holdings Inc",
"rank": 53,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001729944.svg",
"report_text": "The relative strengths and weaknesses of IMAC Holdings Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of IMAC Holdings Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 23% points.The greatest weakness of IMAC Holdings Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 45% points.
The company's Economic Capital Ratio, given in the ranking table, is 160%, being 7.6% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001729944_2022_IMAC_Holdings_Inc.pdf",
"shrinked_graph_json": {
"2019": {
"Assets": "-21.9",
"Stockholders Equity": "-35.1",
"ECR before LimitedLiability": "-37.9",
"Intangible Assets": "26.5",
"Assets, Current": "-41.8",
"Other Liabilities": "4.57",
"Liabilities": "-10.9",
"Long Term Liabilities": "-9.35",
"Liabilities, Current": "-6.20",
"Other Expenses": "-51.0",
"Expenses": "-11.2",
"Net Income": "-11.8",
"Other Net Income": "-3.87",
"General and Administrative Expense": "-4.15",
"Cost of Goods and Services Sold": "26.4",
"Research And Development Expense": "9.51",
"Labor Expense": "9.19",
"Operating Costs and Expenses": "7.87",
"Depreciation, Depletion, Amortization": "-6.51",
"Comprehensive Net Income": "-11.5",
"Economic Capital Ratio": "-48.0"
},
"2020": {
"Property Plant and Equipment": "-6.87",
"Assets": "-18.9",
"Liabilities": "-11.0",
"Stockholders Equity": "-32.0",
"ECR before LimitedLiability": "-26.0",
"Intangible Assets": "33.0",
"Assets, Current": "-33.8",
"Assets, Non-Current": "7.47",
"Liabilities, Current": "-6.96",
"Long Term Liabilities": "-7.01",
"Labor Expense": "7.83",
"Expenses": "-13.8",
"Other Net Income": "6.34",
"Net Income": "-5.62",
"Depreciation, Depletion, Amortization": "-7.82",
"Research And Development Expense": "5.41",
"Other Expenses": "-45.2",
"Operating Costs and Expenses": "6.20",
"Cost of Goods and Services Sold": "25.8",
"Comprehensive Net Income": "-5.60",
"Economic Capital Ratio": "-38.1"
},
"2021": {
"Assets": "-5.02",
"Liabilities": "22.5",
"Stockholders Equity": "10.9",
"Economic Capital Ratio": "-7.64",
"Intangible Assets": "12.9",
"Assets, Non-Current": "8.04",
"Assets, Current": "-17.0",
"Liabilities, Current": "4.46",
"Long Term Liabilities": "8.61",
"Other Liabilities": "9.94",
"General and Administrative Expense": "-4.02",
"Expenses": "-21.6",
"Revenues": "2.70",
"Net Income": "-18.7",
"Operating Costs and Expenses": "6.20",
"Labor Expense": "5.36",
"Cost of Goods and Services Sold": "18.4",
"Research And Development Expense": "5.56",
"Depreciation, Depletion, Amortization": "-5.40",
"Other Expenses": "-44.6",
"Other Revenues": "2.70",
"Comprehensive Net Income": "-18.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001729944_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "2,578",
"Assets, Non-Current": "3,719",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,553",
"General and Administrative Expense": "5,064",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "9,210",
"Labor Expense": "0",
"Liabilities, Current": "6,066",
"Long Term Liabilities": "5,770",
"Operating Costs and Expenses": "0",
"Other Assets": "1,219",
"Other Compr. Net Income": "0",
"Other Expenses": "13,456",
"Other Liabilities": "645",
"Other Net Income": "-766",
"Other Revenues": "15,126",
"Property Plant and Equipment": "3,692",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "1,238"
},
"output_variables": {
"Assets": "20,418",
"Liabilities": "12,481",
"Expenses": "21,312",
"Revenues": "15,126",
"Stockholders Equity": "7,937",
"Net Income": "-6,952",
"Comprehensive Net Income": "-6,952",
"BaseVar": "35,051",
"ECR before LimitedLiability": "28%",
"Economic Capital Ratio": "114%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,757",
"Assets, Non-Current": "3,816",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,722",
"General and Administrative Expense": "4,557",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "8,652",
"Labor Expense": "0",
"Liabilities, Current": "5,950",
"Long Term Liabilities": "5,465",
"Operating Costs and Expenses": "0",
"Other Assets": "743",
"Other Compr. Net Income": "0",
"Other Expenses": "12,095",
"Other Liabilities": "517",
"Other Net Income": "930",
"Other Revenues": "12,835",
"Property Plant and Equipment": "1,777",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "933"
},
"output_variables": {
"Assets": "19,746",
"Liabilities": "11,933",
"Expenses": "19,308",
"Revenues": "12,835",
"Stockholders Equity": "7,813",
"Net Income": "-5,542",
"Comprehensive Net Income": "-5,542",
"BaseVar": "32,376",
"ECR before LimitedLiability": "37%",
"Economic Capital Ratio": "122%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "9,068",
"Assets, Non-Current": "4,948",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "1,649",
"General and Administrative Expense": "6,423",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "10,459",
"Labor Expense": "0",
"Liabilities, Current": "4,934",
"Long Term Liabilities": "4,124",
"Operating Costs and Expenses": "0",
"Other Assets": "431",
"Other Compr. Net Income": "0",
"Other Expenses": "15,087",
"Other Liabilities": "219",
"Other Net Income": "-444",
"Other Revenues": "14,386",
"Property Plant and Equipment": "2,323",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "1,325"
},
"output_variables": {
"Assets": "27,229",
"Liabilities": "9,276",
"Expenses": "24,484",
"Revenues": "14,386",
"Stockholders Equity": "17,953",
"Net Income": "-10,542",
"Comprehensive Net Income": "-10,542",
"BaseVar": "37,910",
"ECR before LimitedLiability": "85%",
"Economic Capital Ratio": "160%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 1.6014016099031174,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001729944.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001729944.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001729944.svg"
},
{
"company_id": "0001014739",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001014739.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001014739.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001014739.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001014739_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001014739_main_keyfigs.svg",
"name": "Option Care Health Inc",
"rank": 54,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001014739.svg",
"report_text": "The relative strengths and weaknesses of Option Care Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Option Care Health Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 74% points.The greatest weakness of Option Care Health Inc is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 62% points.
The company's Economic Capital Ratio, given in the ranking table, is 160%, being 8.1% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001014739_2022_Option_Care_Health_Inc.pdf",
"shrinked_graph_json": {
"2009": {
"Other Assets": "4.70",
"Assets": "-57.7",
"Liabilities": "107",
"Stockholders Equity": "-159",
"Economic Capital Ratio": "-1.96",
"Intangible Assets": "-55.1",
"Property Plant and Equipment": "-14.2",
"Liabilities, Current": "25.4",
"Long Term Liabilities": "88.0",
"Other Liabilities": "7.32",
"Other Expenses": "31.8",
"Expenses": "-132",
"Revenues": "156",
"Net Income": "-8.53",
"General and Administrative Expense": "30.6",
"Cost of Goods and Services Sold": "-288",
"Labor Expense": "14.2",
"Operating Costs and Expenses": "35.0",
"Depreciation, Depletion, Amortization": "3.03",
"Other Revenues": "156",
"Comprehensive Net Income": "-8.53",
"Other Net Income": "-120"
},
"2011": {
"Assets": "-70.2",
"Liabilities": "50.7",
"Stockholders Equity": "-106",
"ECR before LimitedLiability": "-15.9",
"Property Plant and Equipment": "-43.5",
"Assets, Current": "-29.7",
"Intangible Assets": "-16.6",
"Other Liabilities": "18.2",
"Liabilities, Current": "26.3",
"Expenses": "-54.1",
"Revenues": "81.4",
"Net Income": "43.5",
"Other Expenses": "33.4",
"Operating Costs and Expenses": "17.6",
"Labor Expense": "28.4",
"General and Administrative Expense": "48.2",
"Cost of Goods and Services Sold": "-175",
"Other Revenues": "81.4",
"Other Net Income": "-55.5",
"Comprehensive Net Income": "44.1",
"Economic Capital Ratio": "-22.6"
},
"2018": {
"Assets": "-37.3",
"Liabilities": "-38.6",
"Stockholders Equity": "-86.1",
"Property Plant and Equipment": "-6.19",
"Intangible Assets": "9.90",
"Assets, Current": "-29.7",
"Liabilities, Current": "3.48",
"Long Term Liabilities": "-92.9",
"Expenses": "1.32",
"Revenues": "3.12",
"Net Income": "3.95",
"Operating Costs and Expenses": "-0.763",
"Other Expenses": "3.56",
"General and Administrative Expense": "2.64",
"Research And Development Expense": "0.773",
"Cost of Goods and Services Sold": "-23.6",
"Labor Expense": "1.19",
"Other Revenues": "3.12",
"ECR before LimitedLiability": "-51.8",
"Comprehensive Net Income": "4.01",
"Economic Capital Ratio": "-72.6"
},
"2019": {
"Property Plant and Equipment": "-13.3",
"Assets": "-18.1",
"Liabilities": "-16.3",
"Stockholders Equity": "-36.5",
"ECR before LimitedLiability": "-12.5",
"Assets, Non-Current": "62.9",
"Other Assets": "-48.4",
"Intangible Assets": "45.3",
"Assets, Current": "-27.4",
"Other Liabilities": "9.85",
"Long Term Liabilities": "-53.4",
"Liabilities, Current": "22.5",
"Other Revenues": "17.6",
"Revenues": "17.6",
"Net Income": "21.0",
"Other Expenses": "15.1",
"Comprehensive Net Income": "20.9",
"Cost of Goods and Services Sold": "-37.4",
"Research And Development Expense": "8.36",
"Labor Expense": "8.08",
"Economic Capital Ratio": "-22.5"
},
"2020": {
"Property Plant and Equipment": "-11.9",
"Assets": "-30.7",
"Liabilities, Current": "24.6",
"Stockholders Equity": "-44.5",
"Economic Capital Ratio": "-12.0",
"Other Assets": "-46.1",
"Intangible Assets": "34.1",
"Assets, Current": "-33.0",
"Assets, Non-Current": "65.9",
"Labor Expense": "8.26",
"Expenses": "-8.85",
"Revenues": "41.4",
"Net Income": "27.4",
"General and Administrative Expense": "9.89",
"Other Expenses": "17.9",
"Operating Costs and Expenses": "6.54",
"Cost of Goods and Services Sold": "-53.7",
"Other Revenues": "41.4",
"Other Liabilities": "8.90",
"Long Term Liabilities": "-30.4",
"Comprehensive Net Income": "27.3"
},
"2021": {
"Other Assets": "-40.2",
"Assets": "-34.4",
"Liabilities": "12.5",
"Stockholders Equity": "-53.7",
"Economic Capital Ratio": "-8.11",
"Intangible Assets": "13.5",
"Property Plant and Equipment": "-9.53",
"Assets, Non-Current": "74.5",
"Assets, Current": "-33.1",
"Liabilities, Current": "21.4",
"Long Term Liabilities": "-24.7",
"Other Liabilities": "14.0",
"General and Administrative Expense": "9.22",
"Expenses": "-14.5",
"Revenues": "53.2",
"Net Income": "35.4",
"Operating Costs and Expenses": "7.59",
"Cost of Goods and Services Sold": "-61.9",
"Other Expenses": "17.1",
"Other Revenues": "53.2",
"Comprehensive Net Income": "36.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001014739_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "219,281",
"Assets, Non-Current": "1,194",
"Cost of Goods and Services Sold": "1,171,703",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "24,498",
"Labor Expense": "0",
"Liabilities, Current": "128,203",
"Long Term Liabilities": "787",
"Operating Costs and Expenses": "0",
"Other Assets": "26,793",
"Other Compr. Net Income": "0",
"Other Expenses": "103,723",
"Other Liabilities": "2,437",
"Other Net Income": "0",
"Other Revenues": "1,329,525",
"Property Plant and Equipment": "15,454",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "287,220",
"Liabilities": "131,427",
"Expenses": "1,275,426",
"Revenues": "1,329,525",
"Stockholders Equity": "155,793",
"Net Income": "54,099",
"Comprehensive Net Income": "54,099",
"BaseVar": "1,511,799",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "194%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "292,469",
"Assets, Non-Current": "1,830",
"Cost of Goods and Services Sold": "1,505,723",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "349,367",
"Labor Expense": "0",
"Liabilities, Current": "220,774",
"Long Term Liabilities": "230,754",
"Operating Costs and Expenses": "0",
"Other Assets": "3,992",
"Other Compr. Net Income": "0",
"Other Expenses": "304,431",
"Other Liabilities": "10,295",
"Other Net Income": "0",
"Other Revenues": "1,818,026",
"Property Plant and Equipment": "29,444",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "677,102",
"Liabilities": "461,823",
"Expenses": "1,810,154",
"Revenues": "1,818,026",
"Stockholders Equity": "215,279",
"Net Income": "7,872",
"Comprehensive Net Income": "7,872",
"BaseVar": "2,383,552",
"ECR before LimitedLiability": "56%",
"Economic Capital Ratio": "138%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "174,705",
"Assets, Non-Current": "1,745",
"Cost of Goods and Services Sold": "465,865",
"Depreciation, Depletion, Amortization": "23,601",
"General and Administrative Expense": "47,264",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "367,198",
"Labor Expense": "0",
"Liabilities, Current": "107,316",
"Long Term Liabilities": "527,337",
"Operating Costs and Expenses": "154,813",
"Other Assets": "11,502",
"Other Compr. Net Income": "0",
"Other Expenses": "7,025",
"Other Liabilities": "0",
"Other Net Income": "-62,028",
"Other Revenues": "708,903",
"Property Plant and Equipment": "28,788",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "583,938",
"Liabilities": "634,653",
"Expenses": "698,568",
"Revenues": "708,903",
"Stockholders Equity": "-50,715",
"Net Income": "-51,693",
"Comprehensive Net Income": "-51,693",
"BaseVar": "1,344,045",
"ECR before LimitedLiability": "-21%",
"Economic Capital Ratio": "87%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "558,654",
"Assets, Non-Current": "2,030,893",
"Cost of Goods and Services Sold": "1,797,418",
"Depreciation, Depletion, Amortization": "53,690",
"General and Administrative Expense": "459,628",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,425,542",
"Labor Expense": "0",
"Liabilities, Current": "332,147",
"Long Term Liabilities": "1,352,716",
"Operating Costs and Expenses": "0",
"Other Assets": "-1,558,740",
"Other Compr. Net Income": "-8,039",
"Other Expenses": "-2,274",
"Other Liabilities": "-2,143",
"Other Net Income": "-77,875",
"Other Revenues": "2,310,417",
"Property Plant and Equipment": "133,198",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,589,547",
"Liabilities": "1,682,720",
"Expenses": "2,308,462",
"Revenues": "2,310,417",
"Stockholders Equity": "906,827",
"Net Income": "-75,920",
"Comprehensive Net Income": "-83,959",
"BaseVar": "4,488,530",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "657,012",
"Assets, Non-Current": "1,990,427",
"Cost of Goods and Services Sold": "2,350,346",
"Depreciation, Depletion, Amortization": "71,310",
"General and Administrative Expense": "500,199",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,428,610",
"Labor Expense": "0",
"Liabilities, Current": "437,362",
"Long Term Liabilities": "1,197,692",
"Operating Costs and Expenses": "0",
"Other Assets": "-1,549,759",
"Other Compr. Net Income": "-3,977",
"Other Expenses": "2,833",
"Other Liabilities": "-3,339",
"Other Net Income": "-115,998",
"Other Revenues": "3,032,610",
"Property Plant and Equipment": "121,149",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,647,439",
"Liabilities": "1,631,715",
"Expenses": "2,924,688",
"Revenues": "3,032,610",
"Stockholders Equity": "1,015,724",
"Net Income": "-8,076",
"Comprehensive Net Income": "-12,053",
"BaseVar": "5,178,214",
"ECR before LimitedLiability": "68%",
"Economic Capital Ratio": "148%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "710,256",
"Assets, Non-Current": "2,080,662",
"Cost of Goods and Services Sold": "2,659,034",
"Depreciation, Depletion, Amortization": "63,058",
"General and Administrative Expense": "525,707",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,477,564",
"Labor Expense": "0",
"Liabilities, Current": "459,695",
"Long Term Liabilities": "1,155,337",
"Operating Costs and Expenses": "0",
"Other Assets": "-1,589,099",
"Other Compr. Net Income": "10,721",
"Other Expenses": "-23,404",
"Other Liabilities": "0",
"Other Net Income": "-74,347",
"Other Revenues": "3,438,640",
"Property Plant and Equipment": "111,535",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,790,918",
"Liabilities": "1,615,032",
"Expenses": "3,224,395",
"Revenues": "3,438,640",
"Stockholders Equity": "1,175,886",
"Net Income": "139,898",
"Comprehensive Net Income": "150,619",
"BaseVar": "5,577,026",
"ECR before LimitedLiability": "84%",
"Economic Capital Ratio": "160%"
}
}
},
"top_rated": false,
"trend": -12.0,
"value": 1.5967823217325314,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001014739.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001014739.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001014739.svg"
},
{
"company_id": "0001870940",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001870940.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001870940.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001870940_main_keyfigs.svg",
"name": "Airsculpt Technologies Inc",
"rank": 55,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001870940.svg",
"report_text": "The relative strengths and weaknesses of Airsculpt Technologies Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Airsculpt Technologies Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 29% points.The greatest weakness of Airsculpt Technologies Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 55% points.
The company's Economic Capital Ratio, given in the ranking table, is 159%, being 9.1% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001870940_2022_Airsculpt_Technologies_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "28.9",
"Assets": "-6.84",
"Liabilities": "-21.1",
"Stockholders Equity": "-24.8",
"Economic Capital Ratio": "-9.07",
"Intangible Assets": "12.8",
"Assets, Current": "-27.9",
"Liabilities, Current": "17.8",
"Long Term Liabilities": "-54.8",
"Other Liabilities": "10.1",
"General and Administrative Expense": "-11.3",
"Expenses": "9.56",
"Revenues": "14.2",
"Net Income": "26.5",
"Operating Costs and Expenses": "5.41",
"Labor Expense": "4.68",
"Cost of Goods and Services Sold": "-5.16",
"Research And Development Expense": "4.85",
"Other Expenses": "8.69",
"Other Revenues": "14.2",
"Comprehensive Net Income": "26.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001870940_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "29,440",
"Assets, Non-Current": "19,901",
"Cost of Goods and Services Sold": "44,536",
"Depreciation, Depletion, Amortization": "6,597",
"General and Administrative Expense": "65,732",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "81,734",
"Labor Expense": "0",
"Liabilities, Current": "20,766",
"Long Term Liabilities": "96,260",
"Operating Costs and Expenses": "0",
"Other Assets": "55,852",
"Other Compr. Net Income": "0",
"Other Expenses": "5,899",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "133,315",
"Property Plant and Equipment": "13,627",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "200,554",
"Liabilities": "117,026",
"Expenses": "122,764",
"Revenues": "133,315",
"Stockholders Equity": "83,528",
"Net Income": "10,551",
"Comprehensive Net Income": "10,551",
"BaseVar": "286,830",
"ECR before LimitedLiability": "83%",
"Economic Capital Ratio": "159%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.5870893022153358,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001870940.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001870940.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001870940.svg"
},
{
"company_id": "0001159281",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001159281.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001159281.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001159281.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001159281_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001159281_main_keyfigs.svg",
"name": "Alerislife Inc",
"rank": 56,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001159281.svg",
"report_text": "The relative strengths and weaknesses of Alerislife Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Alerislife Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 84% points.The greatest weakness of Alerislife Inc is the variable Other Expenses, reducing the Economic Capital Ratio by 200% points.
The company's Economic Capital Ratio, given in the ranking table, is 158%, being 10% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001159281_2022_Alerislife_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-43.7",
"Stockholders Equity": "-65.5",
"ECR before LimitedLiability": "21.9",
"Assets, Current": "-25.4",
"Intangible Assets": "-33.2",
"Other Liabilities": "18.3",
"Liabilities": "55.5",
"Long Term Liabilities": "26.0",
"Liabilities, Current": "14.1",
"Expenses": "-35.3",
"Revenues": "97.8",
"Net Income": "44.5",
"Other Expenses": "-34.9",
"Operating Costs and Expenses": "13.6",
"Labor Expense": "-60.7",
"General and Administrative Expense": "26.3",
"Cost of Goods and Services Sold": "13.5",
"Other Revenues": "97.8",
"Other Net Income": "-46.0",
"Comprehensive Net Income": "44.9",
"Economic Capital Ratio": "15.2"
},
"2012": {
"Assets": "-48.6",
"Liabilities": "78.9",
"Stockholders Equity": "-72.9",
"ECR before LimitedLiability": "30.2",
"Intangible Assets": "-32.8",
"Assets, Current": "-33.7",
"Other Assets": "12.1",
"Liabilities, Current": "25.3",
"Long Term Liabilities": "26.6",
"Other Liabilities": "33.1",
"Expenses": "-54.3",
"Revenues": "106",
"Net Income": "34.9",
"Other Expenses": "-57.2",
"General and Administrative Expense": "29.7",
"Cost of Goods and Services Sold": "15.3",
"Labor Expense": "-64.2",
"Other Revenues": "106",
"Other Net Income": "-50.1",
"Comprehensive Net Income": "37.9",
"Economic Capital Ratio": "16.0"
},
"2013": {
"Assets": "-49.7",
"Liabilities": "82.6",
"Stockholders Equity": "-61.8",
"ECR before LimitedLiability": "20.1",
"Property Plant and Equipment": "13.3",
"Assets, Current": "-37.0",
"Intangible Assets": "-30.7",
"Other Liabilities": "28.2",
"Liabilities, Current": "33.5",
"Long Term Liabilities": "27.3",
"Expenses": "-52.8",
"Revenues": "95.8",
"Net Income": "38.8",
"General and Administrative Expense": "30.6",
"Cost of Goods and Services Sold": "13.7",
"Labor Expense": "-58.7",
"Other Expenses": "-56.7",
"Other Revenues": "95.8",
"Comprehensive Net Income": "38.3",
"Other Net Income": "-33.3",
"Economic Capital Ratio": "11.0"
},
"2014": {
"Assets": "-70.0",
"Liabilities": "53.8",
"Stockholders Equity": "-80.5",
"Economic Capital Ratio": "-15.6",
"Intangible Assets": "-43.4",
"Property Plant and Equipment": "12.3",
"Assets, Current": "-46.6",
"Other Liabilities": "23.5",
"Liabilities, Current": "30.8",
"Long Term Liabilities": "39.4",
"Expenses": "-68.0",
"Revenues": "79.8",
"Net Income": "30.1",
"Operating Costs and Expenses": "14.7",
"Labor Expense": "-62.8",
"Other Expenses": "-79.0",
"Cost of Goods and Services Sold": "19.3",
"General and Administrative Expense": "33.8",
"Other Revenues": "79.8",
"Comprehensive Net Income": "29.2",
"Other Net Income": "-45.6"
},
"2015": {
"Assets, Current": "-51.1",
"Assets": "-72.0",
"Liabilities": "47.0",
"Stockholders Equity": "-94.3",
"ECR before LimitedLiability": "-13.1",
"Intangible Assets": "-43.5",
"Property Plant and Equipment": "22.9",
"Long Term Liabilities": "17.5",
"Other Liabilities": "24.4",
"Liabilities, Current": "29.7",
"Expenses": "-61.5",
"Revenues": "74.2",
"Net Income": "45.3",
"General and Administrative Expense": "34.3",
"Other Expenses": "-70.0",
"Labor Expense": "-64.5",
"Cost of Goods and Services Sold": "25.2",
"Other Revenues": "74.2",
"Comprehensive Net Income": "45.8",
"Other Net Income": "-39.5",
"Economic Capital Ratio": "-25.6"
},
"2016": {
"Property Plant and Equipment": "21.3",
"Assets": "-69.6",
"Liabilities": "48.2",
"Stockholders Equity": "-73.4",
"Economic Capital Ratio": "-16.8",
"Intangible Assets": "-42.0",
"Assets, Current": "-48.3",
"Liabilities, Current": "47.1",
"Other Liabilities": "27.8",
"Long Term Liabilities": "-14.1",
"Expenses": "-60.4",
"Revenues": "74.5",
"Net Income": "46.3",
"Selling and Marketing Expense": "14.7",
"General and Administrative Expense": "40.0",
"Labor Expense": "-77.9",
"Other Expenses": "-71.4",
"Cost of Goods and Services Sold": "37.7",
"Other Revenues": "74.5",
"Other Net Income": "-34.0",
"Comprehensive Net Income": "46.4"
},
"2017": {
"Assets": "-80.3",
"Stockholders Equity": "-104",
"Economic Capital Ratio": "-17.7",
"Intangible Assets": "-47.0",
"Assets, Current": "-52.4",
"Liabilities, Current": "43.3",
"Liabilities": "46.0",
"Other Liabilities": "17.6",
"Long Term Liabilities": "24.2",
"General and Administrative Expense": "43.2",
"Expenses": "-68.7",
"Revenues": "85.2",
"Net Income": "43.8",
"Labor Expense": "-82.8",
"Selling and Marketing Expense": "13.4",
"Research And Development Expense": "18.0",
"Other Expenses": "-75.0",
"Cost of Goods and Services Sold": "32.4",
"Other Revenues": "85.2",
"Other Net Income": "-47.8",
"Comprehensive Net Income": "43.9"
},
"2018": {
"Other Assets": "-26.9",
"Assets": "-110",
"Liabilities": "13.7",
"Stockholders Equity": "-160",
"Property Plant and Equipment": "8.09",
"Intangible Assets": "-57.9",
"Assets, Non-Current": "-26.9",
"Assets, Current": "-82.5",
"ECR before LimitedLiability": "-43.4",
"Liabilities, Current": "9.22",
"Long Term Liabilities": "8.09",
"Expenses": "-90.6",
"Revenues": "47.0",
"Net Income": "13.8",
"Other Expenses": "-224",
"General and Administrative Expense": "10.4",
"Cost of Goods and Services Sold": "14.6",
"Labor Expense": "8.35",
"Other Revenues": "47.0",
"Comprehensive Net Income": "14.0",
"Economic Capital Ratio": "-64.1"
},
"2019": {
"Assets": "-97.2",
"Liabilities": "57.6",
"Stockholders Equity": "-185",
"Economic Capital Ratio": "-25.3",
"Assets, Non-Current": "-35.0",
"Intangible Assets": "-52.4",
"Assets, Current": "-66.3",
"Other Liabilities": "27.2",
"Long Term Liabilities": "50.1",
"Liabilities, Current": "45.1",
"Other Expenses": "-334",
"Expenses": "-121",
"Revenues": "96.0",
"Net Income": "49.7",
"General and Administrative Expense": "37.9",
"Cost of Goods and Services Sold": "52.2",
"Research And Development Expense": "25.1",
"Labor Expense": "24.2",
"Operating Costs and Expenses": "20.6",
"Other Revenues": "96.0",
"Comprehensive Net Income": "49.8"
},
"2020": {
"Assets": "-65.0",
"Liabilities": "73.6",
"Stockholders Equity": "-102",
"ECR before LimitedLiability": "13.0",
"Other Assets": "-11.0",
"Intangible Assets": "-34.4",
"Assets, Current": "-37.8",
"Assets, Non-Current": "-19.6",
"Liabilities, Current": "24.9",
"Other Liabilities": "15.3",
"Long Term Liabilities": "56.3",
"Labor Expense": "14.2",
"Expenses": "-71.3",
"Revenues": "84.5",
"Net Income": "47.5",
"General and Administrative Expense": "31.0",
"Other Expenses": "-194",
"Operating Costs and Expenses": "11.2",
"Cost of Goods and Services Sold": "48.7",
"Other Revenues": "84.5",
"Comprehensive Net Income": "47.6",
"Economic Capital Ratio": "0.884"
},
"2021": {
"Assets": "-69.9",
"Liabilities": "70.9",
"Stockholders Equity": "-122",
"Economic Capital Ratio": "-10.0",
"Intangible Assets": "-43.8",
"Property Plant and Equipment": "21.8",
"Assets, Non-Current": "-18.6",
"Assets, Current": "-45.8",
"Liabilities, Current": "19.0",
"Long Term Liabilities": "53.5",
"Other Liabilities": "23.8",
"General and Administrative Expense": "25.2",
"Expenses": "-83.4",
"Revenues": "84.1",
"Net Income": "45.3",
"Operating Costs and Expenses": "13.3",
"Labor Expense": "11.5",
"Cost of Goods and Services Sold": "41.0",
"Research And Development Expense": "11.9",
"Other Expenses": "-200",
"Other Revenues": "84.1",
"Comprehensive Net Income": "45.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001159281_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "141,516",
"Assets, Non-Current": "56,419",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "21,127",
"General and Administrative Expense": "57,540",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "536,386",
"Liabilities, Current": "189,331",
"Long Term Liabilities": "113,952",
"Operating Costs and Expenses": "0",
"Other Assets": "32,477",
"Other Compr. Net Income": "0",
"Other Expenses": "603,985",
"Other Liabilities": "0",
"Other Net Income": "5,551",
"Other Revenues": "1,281,764",
"Property Plant and Equipment": "353,065",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "583,477",
"Liabilities": "303,283",
"Expenses": "1,219,038",
"Revenues": "1,281,764",
"Stockholders Equity": "280,194",
"Net Income": "68,277",
"Comprehensive Net Income": "68,277",
"BaseVar": "1,696,556",
"ECR before LimitedLiability": "107%",
"Economic Capital Ratio": "176%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "137,314",
"Assets, Non-Current": "9,797",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "25,064",
"General and Administrative Expense": "61,599",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "548,164",
"Liabilities, Current": "183,960",
"Long Term Liabilities": "80,591",
"Operating Costs and Expenses": "0",
"Other Assets": "88,633",
"Other Compr. Net Income": "11,916",
"Other Expenses": "707,211",
"Other Liabilities": "0",
"Other Net Income": "4,588",
"Other Revenues": "1,350,878",
"Property Plant and Equipment": "335,612",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "571,356",
"Liabilities": "264,551",
"Expenses": "1,342,038",
"Revenues": "1,350,878",
"Stockholders Equity": "306,805",
"Net Income": "13,428",
"Comprehensive Net Income": "25,344",
"BaseVar": "1,772,664",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "180%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "150,884",
"Assets, Non-Current": "9,086",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "27,022",
"General and Administrative Expense": "63,509",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "525,733",
"Liabilities, Current": "198,528",
"Long Term Liabilities": "81,277",
"Operating Costs and Expenses": "0",
"Other Assets": "89,937",
"Other Compr. Net Income": "-5,834",
"Other Expenses": "677,585",
"Other Liabilities": "0",
"Other Net Income": "511",
"Other Revenues": "1,296,787",
"Property Plant and Equipment": "340,276",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "590,183",
"Liabilities": "279,805",
"Expenses": "1,293,849",
"Revenues": "1,296,787",
"Stockholders Equity": "310,378",
"Net Income": "3,449",
"Comprehensive Net Income": "-2,385",
"BaseVar": "1,733,484",
"ECR before LimitedLiability": "103%",
"Economic Capital Ratio": "173%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "121,781",
"Assets, Non-Current": "8,097",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "31,834",
"General and Administrative Expense": "72,385",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "533,549",
"Liabilities, Current": "215,392",
"Long Term Liabilities": "92,799",
"Operating Costs and Expenses": "0",
"Other Assets": "47,909",
"Other Compr. Net Income": "-5,684",
"Other Expenses": "771,003",
"Other Liabilities": "0",
"Other Net Income": "1,346",
"Other Revenues": "1,328,075",
"Property Plant and Equipment": "357,186",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "534,973",
"Liabilities": "308,191",
"Expenses": "1,408,771",
"Revenues": "1,328,075",
"Stockholders Equity": "226,782",
"Net Income": "-79,350",
"Comprehensive Net Income": "-85,034",
"BaseVar": "1,793,520",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "112,069",
"Assets, Non-Current": "7,922",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "33,815",
"General and Administrative Expense": "70,757",
"Goodwill Impairment Loss": "25,344",
"Intangible Assets": "0",
"Labor Expense": "539,086",
"Liabilities, Current": "243,920",
"Long Term Liabilities": "103,398",
"Operating Costs and Expenses": "0",
"Other Assets": "27,921",
"Other Compr. Net Income": "-3,099",
"Other Expenses": "739,021",
"Other Liabilities": "0",
"Other Net Income": "1,854",
"Other Revenues": "1,365,410",
"Property Plant and Equipment": "383,858",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "531,770",
"Liabilities": "347,318",
"Expenses": "1,408,023",
"Revenues": "1,365,410",
"Stockholders Equity": "184,452",
"Net Income": "-40,759",
"Comprehensive Net Income": "-43,858",
"BaseVar": "1,828,737",
"ECR before LimitedLiability": "51%",
"Economic Capital Ratio": "134%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "129,387",
"Assets, Non-Current": "9,920",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "38,052",
"General and Administrative Expense": "73,516",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "545,603",
"Liabilities, Current": "172,993",
"Long Term Liabilities": "172,475",
"Operating Costs and Expenses": "0",
"Other Assets": "18,498",
"Other Compr. Net Income": "713",
"Other Expenses": "744,172",
"Other Liabilities": "0",
"Other Net Income": "1,228",
"Other Revenues": "1,378,108",
"Property Plant and Equipment": "351,929",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "509,734",
"Liabilities": "345,468",
"Expenses": "1,401,343",
"Revenues": "1,378,108",
"Stockholders Equity": "164,266",
"Net Income": "-22,007",
"Comprehensive Net Income": "-21,294",
"BaseVar": "1,818,297",
"ECR before LimitedLiability": "51%",
"Economic Capital Ratio": "134%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "197,185",
"Assets, Non-Current": "14,985",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "38,192",
"General and Administrative Expense": "75,212",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "551,102",
"Liabilities, Current": "218,642",
"Long Term Liabilities": "112,272",
"Operating Costs and Expenses": "0",
"Other Assets": "12,234",
"Other Compr. Net Income": "602",
"Other Expenses": "754,426",
"Other Liabilities": "0",
"Other Net Income": "1,924",
"Other Revenues": "1,396,106",
"Property Plant and Equipment": "251,504",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "475,908",
"Liabilities": "330,914",
"Expenses": "1,418,932",
"Revenues": "1,396,106",
"Stockholders Equity": "144,994",
"Net Income": "-20,902",
"Comprehensive Net Income": "-20,300",
"BaseVar": "1,812,193",
"ECR before LimitedLiability": "47%",
"Economic Capital Ratio": "131%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "138,053",
"Assets, Non-Current": "14,702",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "35,939",
"General and Administrative Expense": "78,189",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "229,693",
"Long Term Liabilities": "104,762",
"Operating Costs and Expenses": "0",
"Other Assets": "8,996",
"Other Compr. Net Income": "-347",
"Other Expenses": "1,351,092",
"Other Liabilities": "0",
"Other Net Income": "743",
"Other Revenues": "1,390,394",
"Property Plant and Equipment": "243,873",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "405,624",
"Liabilities": "334,455",
"Expenses": "1,465,220",
"Revenues": "1,390,394",
"Stockholders Equity": "71,169",
"Net Income": "-74,083",
"Comprehensive Net Income": "-74,430",
"BaseVar": "1,798,392",
"ECR before LimitedLiability": "7.8%",
"Economic Capital Ratio": "95%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "143,368",
"Assets, Non-Current": "26,829",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "16,640",
"General and Administrative Expense": "87,884",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "164,300",
"Long Term Liabilities": "61,512",
"Operating Costs and Expenses": "0",
"Other Assets": "8,349",
"Other Compr. Net Income": "921",
"Other Expenses": "1,333,565",
"Other Liabilities": "0",
"Other Net Income": "2,950",
"Other Revenues": "1,415,144",
"Property Plant and Equipment": "167,247",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "345,793",
"Liabilities": "225,812",
"Expenses": "1,438,089",
"Revenues": "1,415,144",
"Stockholders Equity": "119,981",
"Net Income": "-19,995",
"Comprehensive Net Income": "-19,074",
"BaseVar": "1,714,354",
"ECR before LimitedLiability": "54%",
"Economic Capital Ratio": "136%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "262,308",
"Assets, Non-Current": "21,997",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "10,997",
"General and Administrative Expense": "87,168",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "177,908",
"Long Term Liabilities": "65,766",
"Operating Costs and Expenses": "0",
"Other Assets": "10,650",
"Other Compr. Net Income": "347",
"Other Expenses": "1,055,364",
"Other Liabilities": "0",
"Other Net Income": "-21,237",
"Other Revenues": "1,167,177",
"Property Plant and Equipment": "159,251",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "454,206",
"Liabilities": "243,674",
"Expenses": "1,153,529",
"Revenues": "1,167,177",
"Stockholders Equity": "210,532",
"Net Income": "-7,589",
"Comprehensive Net Income": "-7,242",
"BaseVar": "1,520,085",
"ECR before LimitedLiability": "85%",
"Economic Capital Ratio": "161%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "186,833",
"Assets, Non-Current": "21,279",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "11,873",
"General and Administrative Expense": "85,718",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "140,907",
"Long Term Liabilities": "53,780",
"Operating Costs and Expenses": "0",
"Other Assets": "8,322",
"Other Compr. Net Income": "-287",
"Other Expenses": "872,573",
"Other Liabilities": "0",
"Other Net Income": "-2,149",
"Other Revenues": "942,388",
"Property Plant and Equipment": "159,843",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "376,277",
"Liabilities": "194,687",
"Expenses": "970,164",
"Revenues": "942,388",
"Stockholders Equity": "181,590",
"Net Income": "-29,925",
"Comprehensive Net Income": "-30,212",
"BaseVar": "1,242,976",
"ECR before LimitedLiability": "82%",
"Economic Capital Ratio": "158%"
}
}
},
"top_rated": false,
"trend": -18.0,
"value": 1.5776961156447684,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001159281.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001159281.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001159281.svg"
},
{
"company_id": "0001725255",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001725255.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001725255.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001725255.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001725255_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001725255_main_keyfigs.svg",
"name": "Adapthealth Corp",
"rank": 57,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001725255.svg",
"report_text": "The relative strengths and weaknesses of Adapthealth Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Adapthealth Corp compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 65% points.The greatest weakness of Adapthealth Corp is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 64% points.
The company's Economic Capital Ratio, given in the ranking table, is 153%, being 15% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001725255_2022_Adapthealth_Corp.pdf",
"shrinked_graph_json": {
"2019": {
"Property Plant and Equipment": "-3.63",
"Assets": "-34.1",
"Liabilities": "-53.8",
"Stockholders Equity": "-84.3",
"Assets, Non-Current": "-14.5",
"Intangible Assets": "2.87",
"Assets, Current": "-24.1",
"Other Liabilities": "0.454",
"Long Term Liabilities": "-70.8",
"Other Expenses": "0.470",
"Expenses": "0.603",
"Revenues": "0.795",
"Net Income": "1.90",
"General and Administrative Expense": "0.843",
"Cost of Goods and Services Sold": "-35.0",
"Research And Development Expense": "0.500",
"Labor Expense": "0.479",
"Other Revenues": "0.795",
"ECR before LimitedLiability": "-64.4",
"Comprehensive Net Income": "1.94",
"Economic Capital Ratio": "-74.5"
},
"2020": {
"Property Plant and Equipment": "-8.49",
"Assets": "-7.32",
"Liabilities": "-48.7",
"Stockholders Equity": "-45.1",
"ECR before LimitedLiability": "-31.1",
"Other Assets": "6.58",
"Intangible Assets": "32.3",
"Assets, Current": "-32.0",
"Assets, Non-Current": "-14.2",
"Long Term Liabilities": "-54.0",
"Labor Expense": "6.58",
"Expenses": "15.9",
"Net Income": "18.3",
"Selling and Marketing Expense": "3.43",
"General and Administrative Expense": "18.0",
"Research And Development Expense": "4.55",
"Other Expenses": "6.21",
"Operating Costs and Expenses": "5.21",
"Cost of Goods and Services Sold": "-27.2",
"Comprehensive Net Income": "17.4",
"Economic Capital Ratio": "-43.1"
},
"2021": {
"Assets": "5.93",
"Liabilities": "-36.0",
"Stockholders Equity": "-18.5",
"ECR before LimitedLiability": "-8.89",
"Intangible Assets": "65.4",
"Assets, Non-Current": "-6.94",
"Assets, Current": "-26.5",
"Liabilities, Current": "14.8",
"Long Term Liabilities": "-63.6",
"Other Liabilities": "6.91",
"General and Administrative Expense": "14.4",
"Expenses": "18.7",
"Net Income": "21.8",
"Operating Costs and Expenses": "4.80",
"Labor Expense": "4.15",
"Cost of Goods and Services Sold": "-21.4",
"Research And Development Expense": "4.31",
"Other Expenses": "8.21",
"Selling and Marketing Expense": "3.30",
"Comprehensive Net Income": "21.9",
"Economic Capital Ratio": "-15.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001725255_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "181,415",
"Assets, Non-Current": "6,852",
"Cost of Goods and Services Sold": "440,386",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "56,493",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "266,791",
"Labor Expense": "0",
"Liabilities, Current": "150,894",
"Long Term Liabilities": "424,243",
"Operating Costs and Expenses": "0",
"Other Assets": "27,505",
"Other Compr. Net Income": "426",
"Other Expenses": "43,529",
"Other Liabilities": "233",
"Other Net Income": "-2,121",
"Other Revenues": "529,644",
"Property Plant and Equipment": "63,559",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "546,122",
"Liabilities": "575,370",
"Expenses": "540,408",
"Revenues": "529,644",
"Stockholders Equity": "-29,248",
"Net Income": "-12,885",
"Comprehensive Net Income": "-12,459",
"BaseVar": "1,097,046",
"ECR before LimitedLiability": "-9.8%",
"Economic Capital Ratio": "87%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "363,251",
"Assets, Non-Current": "16,483",
"Cost of Goods and Services Sold": "898,601",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "89,346",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,114,871",
"Labor Expense": "0",
"Liabilities, Current": "422,053",
"Long Term Liabilities": "963,038",
"Operating Costs and Expenses": "0",
"Other Assets": "208,399",
"Other Compr. Net Income": "-16,430",
"Other Expenses": "139,565",
"Other Liabilities": "33,631",
"Other Net Income": "12,405",
"Other Revenues": "1,056,389",
"Property Plant and Equipment": "110,468",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,813,472",
"Liabilities": "1,418,722",
"Expenses": "1,127,512",
"Revenues": "1,056,389",
"Stockholders Equity": "394,750",
"Net Income": "-58,718",
"Comprehensive Net Income": "-75,148",
"BaseVar": "2,722,465",
"ECR before LimitedLiability": "31%",
"Economic Capital Ratio": "117%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "670,058",
"Assets, Non-Current": "162,858",
"Cost of Goods and Services Sold": "2,008,925",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "167,505",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,714,798",
"Labor Expense": "0",
"Liabilities, Current": "499,812",
"Long Term Liabilities": "2,626,219",
"Operating Costs and Expenses": "0",
"Other Assets": "304,193",
"Other Compr. Net Income": "3,798",
"Other Expenses": "108,526",
"Other Liabilities": "57,764",
"Other Net Income": "-11,426",
"Other Revenues": "2,454,535",
"Property Plant and Equipment": "398,577",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,250,484",
"Liabilities": "3,183,795",
"Expenses": "2,284,956",
"Revenues": "2,454,535",
"Stockholders Equity": "2,066,689",
"Net Income": "158,153",
"Comprehensive Net Income": "161,951",
"BaseVar": "6,594,497",
"ECR before LimitedLiability": "75%",
"Economic Capital Ratio": "153%"
}
}
},
"top_rated": false,
"trend": -1.0,
"value": 1.5271307561123113,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001725255.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001725255.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001725255.svg"
},
{
"company_id": "0001125376",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001125376.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001125376.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001125376.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001125376_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001125376_main_keyfigs.svg",
"name": "Ensign Group INC",
"rank": 58,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001125376.svg",
"report_text": "The relative strengths and weaknesses of Ensign Group INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ensign Group INC compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Ensign Group INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 46% points.
The company's Economic Capital Ratio, given in the ranking table, is 150%, being 17% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001125376_2022_Ensign_Group_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Other Liabilities": "18.5",
"Liabilities": "80.9",
"Stockholders Equity": "36.8",
"ECR before LimitedLiability": "97.8",
"Long Term Liabilities": "53.0",
"Liabilities, Current": "22.8",
"Expenses": "-15.7",
"Net Income": "33.1",
"Other Expenses": "-93.7",
"Operating Costs and Expenses": "10.7",
"Labor Expense": "16.7",
"General and Administrative Expense": "21.3",
"Cost of Goods and Services Sold": "10.7",
"Other Revenues": "-67.3",
"Revenues": "-67.3",
"Property Plant and Equipment": "22.0",
"Assets, Current": "-5.94",
"Intangible Assets": "-10.9",
"Other Net Income": "109",
"Comprehensive Net Income": "33.1",
"Economic Capital Ratio": "91.1"
},
"2013": {
"Assets": "-21.7",
"Liabilities": "18.9",
"Stockholders Equity": "-23.7",
"ECR before LimitedLiability": "13.3",
"Property Plant and Equipment": "44.3",
"Assets, Current": "-21.9",
"Intangible Assets": "-21.0",
"Assets, Non-Current": "-5.79",
"Other Liabilities": "17.0",
"Liabilities, Current": "33.5",
"Long Term Liabilities": "-35.9",
"Expenses": "-8.05",
"Revenues": "-50.2",
"Net Income": "27.3",
"General and Administrative Expense": "21.2",
"Cost of Goods and Services Sold": "8.80",
"Labor Expense": "15.4",
"Other Expenses": "-61.6",
"Other Revenues": "-50.2",
"Comprehensive Net Income": "27.7",
"Other Net Income": "80.3",
"Economic Capital Ratio": "4.14"
},
"2014": {
"Assets": "-41.2",
"Liabilities": "74.5",
"Stockholders Equity": "-44.8",
"ECR before LimitedLiability": "37.9",
"Intangible Assets": "-24.4",
"Property Plant and Equipment": "-12.3",
"Assets, Current": "-17.2",
"Other Liabilities": "19.1",
"Liabilities, Current": "37.7",
"Long Term Liabilities": "22.9",
"Expenses": "-39.7",
"Revenues": "-71.7",
"Net Income": "41.8",
"Labor Expense": "24.0",
"Other Expenses": "-131",
"Cost of Goods and Services Sold": "14.2",
"General and Administrative Expense": "24.1",
"Other Revenues": "-71.7",
"Comprehensive Net Income": "42.8",
"Other Net Income": "112",
"Economic Capital Ratio": "24.7"
},
"2015": {
"Assets, Current": "-15.6",
"Assets": "-31.3",
"Liabilities": "61.1",
"Stockholders Equity": "-30.6",
"ECR before LimitedLiability": "42.2",
"Intangible Assets": "-20.1",
"Other Liabilities": "18.9",
"Liabilities, Current": "39.3",
"Selling and Marketing Expense": "8.27",
"Expenses": "-29.4",
"Revenues": "-69.4",
"Net Income": "42.7",
"Operating Costs and Expenses": "8.00",
"General and Administrative Expense": "23.1",
"Other Expenses": "-117",
"Labor Expense": "19.1",
"Cost of Goods and Services Sold": "16.4",
"Other Revenues": "-69.4",
"Comprehensive Net Income": "43.3",
"Other Net Income": "113",
"Economic Capital Ratio": "29.7"
},
"2016": {
"Property Plant and Equipment": "12.9",
"Assets": "-29.8",
"Liabilities": "47.1",
"Stockholders Equity": "-20.2",
"ECR before LimitedLiability": "43.4",
"Intangible Assets": "-20.7",
"Assets, Current": "-19.5",
"Liabilities, Current": "53.5",
"Other Liabilities": "18.4",
"Long Term Liabilities": "-27.9",
"Expenses": "-19.7",
"Revenues": "-66.0",
"Net Income": "42.8",
"General and Administrative Expense": "27.4",
"Labor Expense": "9.67",
"Other Expenses": "-94.3",
"Cost of Goods and Services Sold": "23.1",
"Other Revenues": "-66.0",
"Other Net Income": "91.7",
"Comprehensive Net Income": "43.8",
"Economic Capital Ratio": "15.7"
},
"2017": {
"Assets": "-36.5",
"Liabilities": "45.4",
"Stockholders Equity": "-37.1",
"ECR before LimitedLiability": "39.6",
"Intangible Assets": "-22.5",
"Assets, Current": "-26.6",
"Property Plant and Equipment": "17.7",
"Liabilities, Current": "49.6",
"Long Term Liabilities": "-13.7",
"General and Administrative Expense": "29.3",
"Expenses": "-22.0",
"Revenues": "-57.2",
"Net Income": "43.3",
"Labor Expense": "10.6",
"Research And Development Expense": "10.6",
"Other Expenses": "-94.0",
"Cost of Goods and Services Sold": "18.9",
"Other Revenues": "-57.2",
"Other Net Income": "87.5",
"Comprehensive Net Income": "43.6",
"Economic Capital Ratio": "15.5"
},
"2018": {
"Assets": "-33.9",
"Liabilities": "42.8",
"Stockholders Equity": "-43.3",
"ECR before LimitedLiability": "39.2",
"Property Plant and Equipment": "28.9",
"Intangible Assets": "-17.3",
"Assets, Non-Current": "-10.2",
"Assets, Current": "-28.3",
"Other Liabilities": "7.55",
"Liabilities, Current": "38.9",
"Expenses": "-20.2",
"Revenues": "79.1",
"Net Income": "52.6",
"Other Expenses": "18.6",
"General and Administrative Expense": "24.7",
"Research And Development Expense": "8.95",
"Cost of Goods and Services Sold": "-93.8",
"Labor Expense": "12.9",
"Other Revenues": "79.1",
"Comprehensive Net Income": "53.0",
"Economic Capital Ratio": "18.5"
},
"2020": {
"Property Plant and Equipment": "18.8",
"Assets": "-20.9",
"Liabilities": "-16.8",
"Stockholders Equity": "-41.7",
"Economic Capital Ratio": "-15.7",
"Intangible Assets": "-21.0",
"Assets, Current": "-30.0",
"Assets, Non-Current": "33.9",
"Liabilities, Current": "9.68",
"Long Term Liabilities": "-24.8",
"Other Revenues": "27.1",
"Revenues": "27.1",
"Net Income": "31.3",
"Comprehensive Net Income": "31.3",
"Labor Expense": "7.21",
"Selling and Marketing Expense": "3.75",
"General and Administrative Expense": "20.5",
"Research And Development Expense": "4.99",
"Other Expenses": "8.80",
"Operating Costs and Expenses": "5.71",
"Cost of Goods and Services Sold": "-42.3"
},
"2021": {
"Assets": "-23.5",
"Liabilities": "-14.5",
"Stockholders Equity": "-45.7",
"ECR before LimitedLiability": "-11.3",
"Intangible Assets": "-26.0",
"Property Plant and Equipment": "22.3",
"Assets, Non-Current": "33.6",
"Assets, Current": "-30.8",
"Liabilities, Current": "10.9",
"Long Term Liabilities": "-27.7",
"Other Revenues": "30.3",
"Revenues": "30.3",
"Net Income": "32.8",
"General and Administrative Expense": "18.5",
"Comprehensive Net Income": "33.0",
"Operating Costs and Expenses": "6.48",
"Labor Expense": "5.60",
"Cost of Goods and Services Sold": "-43.8",
"Research And Development Expense": "5.81",
"Other Expenses": "7.04",
"Economic Capital Ratio": "-17.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001125376_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "140,639",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "23,286",
"General and Administrative Expense": "29,766",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,177",
"Labor Expense": "0",
"Liabilities, Current": "100,387",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "34,661",
"Other Compr. Net Income": "-1,308",
"Other Expenses": "644,021",
"Other Liabilities": "0",
"Other Net Income": "744,748",
"Other Revenues": "0",
"Property Plant and Equipment": "403,862",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "596,339",
"Liabilities": "100,387",
"Expenses": "697,073",
"Revenues": "0",
"Stockholders Equity": "495,952",
"Net Income": "47,675",
"Comprehensive Net Income": "46,367",
"BaseVar": "1,069,928",
"ECR before LimitedLiability": "220%",
"Economic Capital Ratio": "252%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "210,996",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "33,909",
"General and Administrative Expense": "40,103",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "23,935",
"Labor Expense": "0",
"Liabilities, Current": "112,456",
"Long Term Liabilities": "285,537",
"Operating Costs and Expenses": "0",
"Other Assets": "45,614",
"Other Compr. Net Income": "819",
"Other Expenses": "792,605",
"Other Liabilities": "5,065",
"Other Net Income": "890,471",
"Other Revenues": "0",
"Property Plant and Equipment": "479,770",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "760,315",
"Liabilities": "403,058",
"Expenses": "866,617",
"Revenues": "0",
"Stockholders Equity": "357,257",
"Net Income": "23,854",
"Comprehensive Net Income": "24,673",
"BaseVar": "1,460,640",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "166%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "213,642",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "26,430",
"General and Administrative Expense": "56,895",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "30,269",
"Labor Expense": "0",
"Liabilities, Current": "130,433",
"Long Term Liabilities": "102,445",
"Operating Costs and Expenses": "0",
"Other Assets": "100,297",
"Other Compr. Net Income": "3,321",
"Other Expenses": "897,958",
"Other Liabilities": "3,235",
"Other Net Income": "1,015,024",
"Other Revenues": "0",
"Property Plant and Equipment": "149,708",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "493,916",
"Liabilities": "236,113",
"Expenses": "981,283",
"Revenues": "0",
"Stockholders Equity": "257,803",
"Net Income": "33,741",
"Comprehensive Net Income": "37,062",
"BaseVar": "1,364,828",
"ECR before LimitedLiability": "113%",
"Economic Capital Ratio": "180%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "294,970",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "28,111",
"General and Administrative Expense": "64,163",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "40,886",
"Labor Expense": "0",
"Liabilities, Current": "179,866",
"Long Term Liabilities": "136,932",
"Operating Costs and Expenses": "0",
"Other Assets": "112,270",
"Other Compr. Net Income": "-485",
"Other Expenses": "1,191,652",
"Other Liabilities": "3,976",
"Other Net Income": "1,339,843",
"Other Revenues": "0",
"Property Plant and Equipment": "299,633",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "747,759",
"Liabilities": "320,774",
"Expenses": "1,283,926",
"Revenues": "0",
"Stockholders Equity": "426,985",
"Net Income": "55,917",
"Comprehensive Net Income": "55,432",
"BaseVar": "1,846,394",
"ECR before LimitedLiability": "126%",
"Economic Capital Ratio": "189%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "333,862",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "38,682",
"General and Administrative Expense": "69,165",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "67,100",
"Labor Expense": "0",
"Liabilities, Current": "211,928",
"Long Term Liabilities": "319,478",
"Operating Costs and Expenses": "0",
"Other Assets": "115,565",
"Other Compr. Net Income": "-2,853",
"Other Expenses": "1,488,145",
"Other Liabilities": "9,124",
"Other Net Income": "1,648,835",
"Other Revenues": "0",
"Property Plant and Equipment": "484,498",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,001,025",
"Liabilities": "540,530",
"Expenses": "1,595,992",
"Revenues": "0",
"Stockholders Equity": "460,495",
"Net Income": "52,843",
"Comprehensive Net Income": "49,990",
"BaseVar": "2,394,618",
"ECR before LimitedLiability": "93%",
"Economic Capital Ratio": "166%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "368,076",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "44,472",
"General and Administrative Expense": "80,617",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "81,062",
"Labor Expense": "0",
"Liabilities, Current": "225,821",
"Long Term Liabilities": "353,210",
"Operating Costs and Expenses": "0",
"Other Assets": "116,211",
"Other Compr. Net Income": "0",
"Other Expenses": "1,671,388",
"Other Liabilities": "23,343",
"Other Net Income": "1,837,310",
"Other Revenues": "0",
"Property Plant and Equipment": "537,084",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,102,433",
"Liabilities": "602,374",
"Expenses": "1,796,477",
"Revenues": "0",
"Stockholders Equity": "500,059",
"Net Income": "40,833",
"Comprehensive Net Income": "40,833",
"BaseVar": "2,669,297",
"ECR before LimitedLiability": "90%",
"Economic Capital Ratio": "164%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "348,072",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "1,627,672",
"Depreciation, Depletion, Amortization": "47,344",
"General and Administrative Expense": "100,307",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "80,477",
"Labor Expense": "0",
"Liabilities, Current": "269,227",
"Long Term Liabilities": "287,740",
"Operating Costs and Expenses": "0",
"Other Assets": "134,535",
"Other Compr. Net Income": "0",
"Other Expenses": "159,689",
"Other Liabilities": "22,651",
"Other Net Income": "-13,119",
"Other Revenues": "2,040,659",
"Property Plant and Equipment": "618,874",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,181,958",
"Liabilities": "579,618",
"Expenses": "1,935,012",
"Revenues": "2,040,659",
"Stockholders Equity": "602,340",
"Net Income": "92,528",
"Comprehensive Net Income": "92,528",
"BaseVar": "2,875,183",
"ECR before LimitedLiability": "110%",
"Economic Capital Ratio": "178%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "582,956",
"Assets, Non-Current": "1,025,510",
"Cost of Goods and Services Sold": "1,865,201",
"Depreciation, Depletion, Amortization": "54,571",
"General and Administrative Expense": "129,743",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "54,469",
"Labor Expense": "0",
"Liabilities, Current": "562,399",
"Long Term Liabilities": "1,012,722",
"Operating Costs and Expenses": "0",
"Other Assets": "104,399",
"Other Compr. Net Income": "0",
"Other Expenses": "176,168",
"Other Liabilities": "152,230",
"Other Net Income": "-5,549",
"Other Revenues": "2,402,596",
"Property Plant and Equipment": "778,244",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,545,578",
"Liabilities": "1,727,351",
"Expenses": "2,225,683",
"Revenues": "2,402,596",
"Stockholders Equity": "818,227",
"Net Income": "171,364",
"Comprehensive Net Income": "171,364",
"BaseVar": "4,453,378",
"ECR before LimitedLiability": "64%",
"Economic Capital Ratio": "144%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "639,709",
"Assets, Non-Current": "1,138,872",
"Cost of Goods and Services Sold": "2,019,879",
"Depreciation, Depletion, Amortization": "55,985",
"General and Administrative Expense": "151,761",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "60,469",
"Labor Expense": "0",
"Liabilities, Current": "523,068",
"Long Term Liabilities": "1,125,823",
"Operating Costs and Expenses": "0",
"Other Assets": "123,139",
"Other Compr. Net Income": "0",
"Other Expenses": "199,650",
"Other Liabilities": "180,018",
"Other Net Income": "-2,461",
"Other Revenues": "2,627,461",
"Property Plant and Equipment": "888,434",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,850,623",
"Liabilities": "1,828,909",
"Expenses": "2,427,275",
"Revenues": "2,627,461",
"Stockholders Equity": "1,021,714",
"Net Income": "197,725",
"Comprehensive Net Income": "197,725",
"BaseVar": "4,868,364",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "150%"
}
}
},
"top_rated": false,
"trend": -14.0,
"value": 1.5032854822820831,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001125376.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001125376.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001125376.svg"
},
{
"company_id": "0001713210",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001713210.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001713210.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001713210.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001713210_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001713210_main_keyfigs.svg",
"name": "Agape ATP Corp",
"rank": 59,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001713210.svg",
"report_text": "The relative strengths and weaknesses of Agape ATP Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Agape ATP Corp compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 64% points.The greatest weakness of Agape ATP Corp is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 41% points.
The company's Economic Capital Ratio, given in the ranking table, is 150%, being 18% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001713210_2022_Agape_ATP_Corp.pdf",
"shrinked_graph_json": {
"2018": {
"Assets": "9.31",
"Stockholders Equity": "158",
"ECR before LimitedLiability": "160",
"Assets, Non-Current": "1.94",
"Assets, Current": "7.89",
"Other Liabilities": "7.08",
"Liabilities": "66.1",
"Liabilities, Current": "43.7",
"Long Term Liabilities": "24.7",
"Selling and Marketing Expense": "2.65",
"Expenses": "34.9",
"Revenues": "-22.7",
"Net Income": "13.9",
"Operating Costs and Expenses": "2.82",
"Other Expenses": "13.4",
"General and Administrative Expense": "5.53",
"Research And Development Expense": "3.98",
"Labor Expense": "5.67",
"Other Revenues": "-22.7",
"Comprehensive Net Income": "14.1",
"Economic Capital Ratio": "139"
},
"2020": {
"Assets": "9.98",
"Stockholders Equity": "64.5",
"ECR before LimitedLiability": "101",
"Intangible Assets": "-6.66",
"Assets, Current": "26.0",
"Liabilities, Current": "11.2",
"Liabilities": "49.5",
"Other Liabilities": "8.93",
"Long Term Liabilities": "34.4",
"Labor Expense": "5.86",
"Expenses": "8.28",
"Revenues": "4.48",
"Net Income": "24.2",
"General and Administrative Expense": "-6.65",
"Other Expenses": "-10.1",
"Operating Costs and Expenses": "4.67",
"Cost of Goods and Services Sold": "5.93",
"Other Revenues": "4.48",
"Other Net Income": "11.8",
"Comprehensive Net Income": "26.9",
"Economic Capital Ratio": "88.5"
},
"2021": {
"Other Assets": "5.91",
"Assets": "21.6",
"Liabilities": "15.3",
"Stockholders Equity": "40.3",
"ECR before LimitedLiability": "-11.5",
"Intangible Assets": "-23.9",
"Assets, Current": "64.2",
"Liabilities, Current": "-25.5",
"Long Term Liabilities": "28.3",
"Other Liabilities": "10.5",
"General and Administrative Expense": "-23.2",
"Expenses": "-8.02",
"Revenues": "-22.3",
"Net Income": "-39.5",
"Operating Costs and Expenses": "5.47",
"Cost of Goods and Services Sold": "8.37",
"Other Expenses": "-12.5",
"Other Revenues": "-22.3",
"Comprehensive Net Income": "-41.4",
"Other Net Income": "-11.0",
"Economic Capital Ratio": "-17.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001713210_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "3,796",
"Assets, Non-Current": "1,332",
"Cost of Goods and Services Sold": "441",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "280",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "30",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-1.3",
"Other Expenses": "5.3",
"Other Liabilities": "0",
"Other Net Income": "-30",
"Other Revenues": "626",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,129",
"Liabilities": "30",
"Expenses": "726",
"Revenues": "626",
"Stockholders Equity": "5,099",
"Net Income": "-130",
"Comprehensive Net Income": "-132",
"BaseVar": "3,271",
"ECR before LimitedLiability": "282%",
"Economic Capital Ratio": "298%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "5,684",
"Assets, Non-Current": "394",
"Cost of Goods and Services Sold": "776",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,628",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5.8",
"Labor Expense": "0",
"Liabilities, Current": "1,044",
"Long Term Liabilities": "247",
"Operating Costs and Expenses": "0",
"Other Assets": "828",
"Other Compr. Net Income": "171",
"Other Expenses": "1,369",
"Other Liabilities": "-5.7",
"Other Net Income": "674",
"Other Revenues": "3,453",
"Property Plant and Equipment": "298",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,211",
"Liabilities": "1,286",
"Expenses": "3,772",
"Revenues": "3,453",
"Stockholders Equity": "5,925",
"Net Income": "355",
"Comprehensive Net Income": "526",
"BaseVar": "8,284",
"ECR before LimitedLiability": "215%",
"Economic Capital Ratio": "248%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,912",
"Assets, Non-Current": "238",
"Cost of Goods and Services Sold": "297",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,746",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3.7",
"Labor Expense": "0",
"Liabilities, Current": "1,328",
"Long Term Liabilities": "99",
"Operating Costs and Expenses": "0",
"Other Assets": "355",
"Other Compr. Net Income": "-87",
"Other Expenses": "970",
"Other Liabilities": "-16",
"Other Net Income": "-529",
"Other Revenues": "1,017",
"Property Plant and Equipment": "216",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,725",
"Liabilities": "1,412",
"Expenses": "3,013",
"Revenues": "1,017",
"Stockholders Equity": "3,313",
"Net Income": "-2,525",
"Comprehensive Net Income": "-2,612",
"BaseVar": "5,391",
"ECR before LimitedLiability": "71%",
"Economic Capital Ratio": "150%"
}
}
},
"top_rated": false,
"trend": -49.0,
"value": 1.5006531656514208,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001713210.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001713210.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001713210.svg"
},
{
"company_id": "0000785161",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000785161.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000785161.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000785161.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000785161_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000785161_main_keyfigs.svg",
"name": "Encompass Health Corp",
"rank": 60,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000785161.svg",
"report_text": "The relative strengths and weaknesses of Encompass Health Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Encompass Health Corp compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 35% points.The greatest weakness of Encompass Health Corp is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 59% points.
The company's Economic Capital Ratio, given in the ranking table, is 148%, being 20% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000785161_2022_Encompass_Health_Corp.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-10.5",
"Assets": "-8.75",
"Liabilities": "-60.9",
"Stockholders Equity": "-51.3",
"ECR before LimitedLiability": "-45.9",
"Other Assets": "33.0",
"Intangible Assets": "-20.3",
"Other Liabilities": "3.47",
"Long Term Liabilities": "-64.7",
"Other Expenses": "10.6",
"Expenses": "24.6",
"Revenues": "-29.4",
"Net Income": "26.5",
"Cost of Goods and Services Sold": "11.1",
"Labor Expense": "8.14",
"Operating Costs and Expenses": "-5.68",
"Depreciation, Depletion, Amortization": "-1.30",
"Other Revenues": "-29.4",
"Comprehensive Net Income": "25.9",
"Other Net Income": "35.6",
"Economic Capital Ratio": "-44.1"
},
"2011": {
"Other Assets": "35.7",
"Assets": "-10.1",
"Liabilities": "-39.6",
"Stockholders Equity": "-41.1",
"ECR before LimitedLiability": "-17.9",
"Assets, Current": "-19.6",
"Intangible Assets": "-12.6",
"Other Liabilities": "9.91",
"Long Term Liabilities": "-72.2",
"Liabilities, Current": "16.2",
"Expenses": "20.8",
"Revenues": "-41.9",
"Net Income": "31.0",
"Other Expenses": "-14.4",
"Labor Expense": "13.1",
"General and Administrative Expense": "16.9",
"Cost of Goods and Services Sold": "8.22",
"Other Revenues": "-41.9",
"Other Net Income": "49.0",
"Comprehensive Net Income": "29.0",
"Economic Capital Ratio": "-24.6"
},
"2020": {
"Property Plant and Equipment": "27.7",
"Assets": "-9.22",
"Liabilities": "-30.7",
"Stockholders Equity": "-34.2",
"ECR before LimitedLiability": "-7.61",
"Other Assets": "-7.07",
"Intangible Assets": "26.3",
"Assets, Current": "-31.8",
"Liabilities, Current": "20.6",
"Long Term Liabilities": "-63.7",
"Labor Expense": "-31.0",
"Expenses": "13.0",
"Revenues": "12.4",
"Net Income": "27.5",
"General and Administrative Expense": "20.4",
"Other Expenses": "8.18",
"Operating Costs and Expenses": "-7.14",
"Cost of Goods and Services Sold": "21.1",
"Other Revenues": "12.4",
"Comprehensive Net Income": "26.1",
"Economic Capital Ratio": "-19.7"
},
"2021": {
"Assets": "-14.7",
"Liabilities": "-25.7",
"Stockholders Equity": "-38.7",
"ECR before LimitedLiability": "-13.7",
"Intangible Assets": "11.7",
"Property Plant and Equipment": "35.3",
"Assets, Current": "-33.1",
"Liabilities, Current": "17.0",
"Long Term Liabilities": "-58.7",
"Other Liabilities": "10.5",
"General and Administrative Expense": "18.7",
"Expenses": "9.19",
"Revenues": "18.3",
"Net Income": "31.0",
"Operating Costs and Expenses": "-6.32",
"Labor Expense": "-32.2",
"Cost of Goods and Services Sold": "17.5",
"Other Expenses": "7.09",
"Other Revenues": "18.3",
"Comprehensive Net Income": "29.5",
"Economic Capital Ratio": "-19.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000785161_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "406,200",
"Assets, Non-Current": "90,400",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "76,400",
"General and Administrative Expense": "106,200",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "480,100",
"Labor Expense": "0",
"Liabilities, Current": "359,300",
"Long Term Liabilities": "1,496,800",
"Operating Costs and Expenses": "407,700",
"Other Assets": "710,000",
"Other Compr. Net Income": "-40,300",
"Other Expenses": "457,600",
"Other Liabilities": "130,800",
"Other Net Income": "1,987,700",
"Other Revenues": "0",
"Property Plant and Equipment": "685,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,372,100",
"Liabilities": "1,986,900",
"Expenses": "1,047,900",
"Revenues": "0",
"Stockholders Equity": "385,200",
"Net Income": "939,800",
"Comprehensive Net Income": "899,500",
"BaseVar": "3,717,450",
"ECR before LimitedLiability": "67%",
"Economic Capital Ratio": "147%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "391,000",
"Assets, Non-Current": "99,300",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "78,800",
"General and Administrative Expense": "110,500",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "479,400",
"Labor Expense": "0",
"Liabilities, Current": "313,200",
"Long Term Liabilities": "1,369,000",
"Operating Costs and Expenses": "386,800",
"Other Assets": "637,100",
"Other Compr. Net Income": "-46,600",
"Other Expenses": "1,220,900",
"Other Liabilities": "0",
"Other Net Income": "2,051,600",
"Other Revenues": "0",
"Property Plant and Equipment": "664,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,271,200",
"Liabilities": "1,682,200",
"Expenses": "1,797,000",
"Revenues": "0",
"Stockholders Equity": "589,000",
"Net Income": "254,600",
"Comprehensive Net Income": "208,000",
"BaseVar": "3,924,300",
"ECR before LimitedLiability": "54%",
"Economic Capital Ratio": "136%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "948,600",
"Assets, Non-Current": "540,700",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "243,000",
"General and Administrative Expense": "155,500",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,750,000",
"Labor Expense": "2,682,000",
"Liabilities, Current": "769,100",
"Long Term Liabilities": "3,675,200",
"Operating Costs and Expenses": "834,900",
"Other Assets": "0",
"Other Compr. Net Income": "-84,600",
"Other Expenses": "372,000",
"Other Liabilities": "0",
"Other Net Income": "11,800",
"Other Revenues": "4,644,400",
"Property Plant and Equipment": "2,206,600",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,445,900",
"Liabilities": "4,444,300",
"Expenses": "4,287,400",
"Revenues": "4,644,400",
"Stockholders Equity": "2,001,600",
"Net Income": "368,800",
"Comprehensive Net Income": "284,200",
"BaseVar": "9,959,200",
"ECR before LimitedLiability": "59%",
"Economic Capital Ratio": "140%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "921,400",
"Assets, Non-Current": "496,500",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "256,600",
"General and Administrative Expense": "197,300",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,845,400",
"Labor Expense": "2,886,500",
"Liabilities, Current": "835,500",
"Long Term Liabilities": "3,630,200",
"Operating Costs and Expenses": "894,500",
"Other Assets": "0",
"Other Compr. Net Income": "-105,000",
"Other Expenses": "384,400",
"Other Liabilities": "0",
"Other Net Income": "14,900",
"Other Revenues": "5,121,600",
"Property Plant and Equipment": "2,601,600",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,864,900",
"Liabilities": "4,465,700",
"Expenses": "4,619,300",
"Revenues": "5,121,600",
"Stockholders Equity": "2,399,200",
"Net Income": "517,200",
"Comprehensive Net Income": "412,200",
"BaseVar": "10,595,700",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "148%"
}
}
},
"top_rated": false,
"trend": -15.0,
"value": 1.4795414842404306,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000785161.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000785161.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000785161.svg"
},
{
"company_id": "0000893949",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000893949.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000893949.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000893949.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000893949_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000893949_main_keyfigs.svg",
"name": "Pediatrix Medical Group Inc",
"rank": 61,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000893949.svg",
"report_text": "The relative strengths and weaknesses of Pediatrix Medical Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pediatrix Medical Group Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Pediatrix Medical Group Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 40% points.
The company's Economic Capital Ratio, given in the ranking table, is 143%, being 24% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000893949_2022_Pediatrix_Medical_Group_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-5.23",
"Assets": "6.34",
"Liabilities": "22.2",
"Stockholders Equity": "29.7",
"ECR before LimitedLiability": "28.9",
"Property Plant and Equipment": "-10.7",
"Intangible Assets": "35.6",
"Other Liabilities": "6.46",
"Liabilities, Current": "-9.19",
"Long Term Liabilities": "24.1",
"Other Revenues": "-32.1",
"Revenues": "-32.1",
"Net Income": "1.69",
"Other Expenses": "-26.8",
"Comprehensive Net Income": "2.60",
"Cost of Goods and Services Sold": "10.7",
"General and Administrative Expense": "-2.85",
"Labor Expense": "7.92",
"Operating Costs and Expenses": "8.72",
"Other Net Income": "32.9",
"Economic Capital Ratio": "30.7"
},
"2011": {
"Assets": "11.8",
"Stockholders Equity": "51.0",
"ECR before LimitedLiability": "79.9",
"Property Plant and Equipment": "-8.91",
"Intangible Assets": "46.4",
"Other Liabilities": "-12.2",
"Liabilities": "31.7",
"Long Term Liabilities": "27.2",
"Liabilities, Current": "16.1",
"Expenses": "14.5",
"Revenues": "-41.5",
"Net Income": "25.8",
"Other Expenses": "20.3",
"Operating Costs and Expenses": "6.90",
"Labor Expense": "-37.5",
"General and Administrative Expense": "9.57",
"Cost of Goods and Services Sold": "6.88",
"Other Revenues": "-41.5",
"Other Net Income": "50.0",
"Comprehensive Net Income": "26.0",
"Economic Capital Ratio": "73.2"
},
"2012": {
"Property Plant and Equipment": "-8.71",
"Assets": "12.2",
"Liabilities": "26.8",
"Stockholders Equity": "46.5",
"ECR before LimitedLiability": "77.9",
"Intangible Assets": "57.0",
"Assets, Current": "-9.83",
"Liabilities, Current": "20.6",
"Long Term Liabilities": "10.5",
"Expenses": "13.8",
"Revenues": "-38.6",
"Net Income": "23.0",
"Other Expenses": "17.3",
"General and Administrative Expense": "9.92",
"Operating Costs and Expenses": "5.23",
"Cost of Goods and Services Sold": "6.78",
"Labor Expense": "-33.9",
"Other Revenues": "-38.6",
"Other Net Income": "46.0",
"Comprehensive Net Income": "23.3",
"Economic Capital Ratio": "63.7"
},
"2013": {
"Assets": "8.30",
"Liabilities": "43.7",
"Stockholders Equity": "52.5",
"ECR before LimitedLiability": "82.3",
"Property Plant and Equipment": "-7.95",
"Assets, Current": "-10.8",
"Intangible Assets": "55.5",
"Other Liabilities": "-7.33",
"Liabilities, Current": "29.0",
"Long Term Liabilities": "23.8",
"Expenses": "9.25",
"Revenues": "-44.2",
"Net Income": "27.4",
"General and Administrative Expense": "11.7",
"Cost of Goods and Services Sold": "6.72",
"Labor Expense": "-39.5",
"Other Expenses": "15.6",
"Other Revenues": "-44.2",
"Comprehensive Net Income": "27.7",
"Other Net Income": "59.4",
"Economic Capital Ratio": "73.1"
},
"2014": {
"Assets": "11.3",
"Liabilities": "14.1",
"Stockholders Equity": "30.8",
"ECR before LimitedLiability": "59.9",
"Intangible Assets": "71.5",
"Property Plant and Equipment": "-12.4",
"Assets, Current": "-11.9",
"Other Liabilities": "-6.85",
"Liabilities, Current": "22.3",
"Expenses": "14.5",
"Revenues": "-36.4",
"Net Income": "24.9",
"Operating Costs and Expenses": "5.28",
"Labor Expense": "-29.9",
"Other Expenses": "13.4",
"Cost of Goods and Services Sold": "6.86",
"General and Administrative Expense": "10.2",
"Other Revenues": "-36.4",
"Comprehensive Net Income": "25.0",
"Other Net Income": "48.6",
"Economic Capital Ratio": "46.8"
},
"2015": {
"Assets, Current": "-15.1",
"Assets": "15.5",
"Liabilities": "-10.0",
"Stockholders Equity": "15.8",
"ECR before LimitedLiability": "35.4",
"Intangible Assets": "95.3",
"Property Plant and Equipment": "-13.5",
"Long Term Liabilities": "-36.8",
"Other Liabilities": "-4.64",
"Liabilities, Current": "26.5",
"Expenses": "19.6",
"Revenues": "-35.1",
"Net Income": "25.1",
"General and Administrative Expense": "9.80",
"Other Expenses": "-21.1",
"Labor Expense": "9.88",
"Cost of Goods and Services Sold": "8.51",
"Other Revenues": "-35.1",
"Comprehensive Net Income": "25.5",
"Other Net Income": "44.5",
"Economic Capital Ratio": "23.0"
},
"2016": {
"Property Plant and Equipment": "-12.9",
"Assets": "22.7",
"Liabilities": "-6.94",
"Stockholders Equity": "26.0",
"ECR before LimitedLiability": "54.8",
"Intangible Assets": "82.7",
"Other Assets": "9.49",
"Assets, Current": "-15.1",
"Liabilities, Current": "36.0",
"Long Term Liabilities": "-49.0",
"Expenses": "21.4",
"Revenues": "-36.8",
"Net Income": "25.3",
"General and Administrative Expense": "11.2",
"Labor Expense": "5.18",
"Other Expenses": "-19.2",
"Cost of Goods and Services Sold": "12.2",
"Other Revenues": "-36.8",
"Other Net Income": "45.5",
"Comprehensive Net Income": "25.9",
"Economic Capital Ratio": "27.1"
},
"2017": {
"Other Assets": "6.86",
"Assets": "16.4",
"Liabilities": "-7.81",
"Stockholders Equity": "17.7",
"ECR before LimitedLiability": "53.8",
"Intangible Assets": "82.0",
"Assets, Current": "-18.5",
"Property Plant and Equipment": "-11.4",
"Liabilities, Current": "31.4",
"Long Term Liabilities": "-40.4",
"General and Administrative Expense": "11.8",
"Expenses": "20.7",
"Revenues": "-31.5",
"Net Income": "25.3",
"Research And Development Expense": "5.57",
"Other Expenses": "-18.0",
"Cost of Goods and Services Sold": "9.80",
"Other Revenues": "-31.5",
"Other Net Income": "39.5",
"Comprehensive Net Income": "25.4",
"Economic Capital Ratio": "29.7"
},
"2018": {
"Assets": "12.7",
"Liabilities": "-14.4",
"Stockholders Equity": "8.00",
"ECR before LimitedLiability": "38.1",
"Property Plant and Equipment": "-9.07",
"Intangible Assets": "89.3",
"Assets, Non-Current": "-4.63",
"Assets, Current": "-20.7",
"Liabilities, Current": "28.9",
"Long Term Liabilities": "-45.0",
"Expenses": "21.1",
"Revenues": "6.63",
"Net Income": "27.9",
"Other Expenses": "-25.8",
"General and Administrative Expense": "10.8",
"Research And Development Expense": "4.92",
"Cost of Goods and Services Sold": "18.7",
"Labor Expense": "7.06",
"Other Revenues": "6.63",
"Comprehensive Net Income": "28.1",
"Economic Capital Ratio": "17.4"
},
"2020": {
"Property Plant and Equipment": "-15.3",
"Assets": "-10.9",
"Liabilities": "-47.2",
"Stockholders Equity": "-49.3",
"Intangible Assets": "11.1",
"Assets, Current": "-8.34",
"Assets, Non-Current": "-14.0",
"Liabilities, Current": "9.55",
"Other Liabilities": "-6.46",
"Long Term Liabilities": "-57.2",
"Labor Expense": "7.26",
"Expenses": "10.5",
"ECR before LimitedLiability": "-50.6",
"General and Administrative Expense": "9.60",
"Other Expenses": "-27.7",
"Operating Costs and Expenses": "5.76",
"Cost of Goods and Services Sold": "9.86",
"Other Revenues": "-7.23",
"Revenues": "-7.23",
"Other Net Income": "-26.0",
"Economic Capital Ratio": "-62.7"
},
"2021": {
"Assets": "-13.2",
"Liabilities": "-30.9",
"Stockholders Equity": "-39.7",
"ECR before LimitedLiability": "-18.1",
"Intangible Assets": "33.6",
"Property Plant and Equipment": "-8.65",
"Assets, Non-Current": "-7.73",
"Assets, Current": "-21.8",
"Liabilities, Current": "8.01",
"Long Term Liabilities": "-32.9",
"Other Liabilities": "-6.29",
"General and Administrative Expense": "11.6",
"Expenses": "11.3",
"Revenues": "15.1",
"Net Income": "27.8",
"Operating Costs and Expenses": "5.81",
"Cost of Goods and Services Sold": "17.3",
"Other Expenses": "-35.2",
"Other Revenues": "15.1",
"Comprehensive Net Income": "27.9",
"Economic Capital Ratio": "-24.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000893949_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "296,009",
"Assets, Non-Current": "70,151",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "154,267",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,601,319",
"Labor Expense": "0",
"Liabilities, Current": "320,847",
"Long Term Liabilities": "195,223",
"Operating Costs and Expenses": "0",
"Other Assets": "27,393",
"Other Compr. Net Income": "0",
"Other Expenses": "1,046,035",
"Other Liabilities": "74,122",
"Other Net Income": "1,402,993",
"Other Revenues": "0",
"Property Plant and Equipment": "42,774",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,037,646",
"Liabilities": "590,192",
"Expenses": "1,200,302",
"Revenues": "0",
"Stockholders Equity": "1,447,454",
"Net Income": "202,691",
"Comprehensive Net Income": "202,691",
"BaseVar": "2,615,566",
"ECR before LimitedLiability": "175%",
"Economic Capital Ratio": "221%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "337,273",
"Assets, Non-Current": "83,092",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "25,292",
"General and Administrative Expense": "170,356",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,746,762",
"Labor Expense": "970,396",
"Liabilities, Current": "254,301",
"Long Term Liabilities": "83,544",
"Operating Costs and Expenses": "0",
"Other Assets": "44,991",
"Other Compr. Net Income": "0",
"Other Expenses": "205,702",
"Other Liabilities": "203,787",
"Other Net Income": "1,589,743",
"Other Revenues": "0",
"Property Plant and Equipment": "60,530",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,272,648",
"Liabilities": "541,632",
"Expenses": "1,371,746",
"Revenues": "0",
"Stockholders Equity": "1,731,016",
"Net Income": "217,997",
"Comprehensive Net Income": "217,997",
"BaseVar": "2,887,884",
"ECR before LimitedLiability": "194%",
"Economic Capital Ratio": "234%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "359,044",
"Assets, Non-Current": "118,290",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "30,816",
"General and Administrative Expense": "193,540",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,165,672",
"Labor Expense": "1,130,913",
"Liabilities, Current": "268,338",
"Long Term Liabilities": "200,951",
"Operating Costs and Expenses": "0",
"Other Assets": "47,593",
"Other Compr. Net Income": "0",
"Other Expenses": "222,332",
"Other Liabilities": "245,680",
"Other Net Income": "1,818,508",
"Other Revenues": "0",
"Property Plant and Equipment": "59,738",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,750,337",
"Liabilities": "714,969",
"Expenses": "1,577,601",
"Revenues": "0",
"Stockholders Equity": "2,035,368",
"Net Income": "240,907",
"Comprehensive Net Income": "240,907",
"BaseVar": "3,430,708",
"ECR before LimitedLiability": "184%",
"Economic Capital Ratio": "227%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "408,839",
"Assets, Non-Current": "129,438",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "39,966",
"General and Administrative Expense": "218,209",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,393,731",
"Labor Expense": "1,361,318",
"Liabilities, Current": "326,792",
"Long Term Liabilities": "87,985",
"Operating Costs and Expenses": "0",
"Other Assets": "57,511",
"Other Compr. Net Income": "0",
"Other Expenses": "255,698",
"Other Liabilities": "291,665",
"Other Net Income": "2,155,708",
"Other Revenues": "0",
"Property Plant and Equipment": "59,911",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,049,430",
"Liabilities": "706,442",
"Expenses": "1,875,191",
"Revenues": "0",
"Stockholders Equity": "2,342,988",
"Net Income": "280,517",
"Comprehensive Net Income": "280,517",
"BaseVar": "3,893,386",
"ECR before LimitedLiability": "196%",
"Economic Capital Ratio": "235%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "467,052",
"Assets, Non-Current": "235,425",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "45,990",
"General and Administrative Expense": "247,527",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,776,188",
"Labor Expense": "1,543,395",
"Liabilities, Current": "416,273",
"Long Term Liabilities": "617,818",
"Operating Costs and Expenses": "0",
"Other Assets": "64,082",
"Other Compr. Net Income": "0",
"Other Expenses": "280,415",
"Other Liabilities": "309,138",
"Other Net Income": "2,434,530",
"Other Revenues": "0",
"Property Plant and Equipment": "66,048",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,608,795",
"Liabilities": "1,343,229",
"Expenses": "2,117,327",
"Revenues": "0",
"Stockholders Equity": "2,265,566",
"Net Income": "317,203",
"Comprehensive Net Income": "317,203",
"BaseVar": "4,751,940",
"ECR before LimitedLiability": "145%",
"Economic Capital Ratio": "202%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "527,769",
"Assets, Non-Current": "82,154",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "64,228",
"General and Administrative Expense": "305,915",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,790,369",
"Labor Expense": "0",
"Liabilities, Current": "428,771",
"Long Term Liabilities": "1,315,109",
"Operating Costs and Expenses": "0",
"Other Assets": "63,288",
"Other Compr. Net Income": "0",
"Other Expenses": "2,056,023",
"Other Liabilities": "365,488",
"Other Net Income": "2,761,857",
"Other Revenues": "0",
"Property Plant and Equipment": "83,634",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,547,214",
"Liabilities": "2,109,368",
"Expenses": "2,426,166",
"Revenues": "0",
"Stockholders Equity": "2,437,846",
"Net Income": "335,691",
"Comprehensive Net Income": "335,691",
"BaseVar": "5,922,302",
"ECR before LimitedLiability": "116%",
"Economic Capital Ratio": "182%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "587,128",
"Assets, Non-Current": "56,543",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "89,264",
"General and Administrative Expense": "372,572",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,845,157",
"Labor Expense": "0",
"Liabilities, Current": "448,949",
"Long Term Liabilities": "1,728,802",
"Operating Costs and Expenses": "0",
"Other Assets": "747,504",
"Other Compr. Net Income": "0",
"Other Expenses": "2,338,839",
"Other Liabilities": "400,882",
"Other Net Income": "3,125,271",
"Other Revenues": "0",
"Property Plant and Equipment": "103,068",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,339,400",
"Liabilities": "2,578,633",
"Expenses": "2,800,675",
"Revenues": "0",
"Stockholders Equity": "2,760,767",
"Net Income": "324,596",
"Comprehensive Net Income": "324,596",
"BaseVar": "6,921,990",
"ECR before LimitedLiability": "109%",
"Economic Capital Ratio": "178%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "627,235",
"Assets, Non-Current": "91,934",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "102,879",
"General and Administrative Expense": "417,105",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,283,963",
"Labor Expense": "0",
"Liabilities, Current": "531,425",
"Long Term Liabilities": "1,909,328",
"Operating Costs and Expenses": "0",
"Other Assets": "740,610",
"Other Compr. Net Income": "0",
"Other Expenses": "2,548,302",
"Other Liabilities": "360,071",
"Other Net Income": "3,388,658",
"Other Revenues": "0",
"Property Plant and Equipment": "123,536",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,867,278",
"Liabilities": "2,800,824",
"Expenses": "3,068,286",
"Revenues": "0",
"Stockholders Equity": "3,066,454",
"Net Income": "320,372",
"Comprehensive Net Income": "320,372",
"BaseVar": "7,562,523",
"ECR before LimitedLiability": "110%",
"Economic Capital Ratio": "178%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "657,409",
"Assets, Non-Current": "103,459",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "111,281",
"General and Administrative Expense": "432,378",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,382,995",
"Labor Expense": "0",
"Liabilities, Current": "500,193",
"Long Term Liabilities": "2,006,534",
"Operating Costs and Expenses": "0",
"Other Assets": "658,011",
"Other Compr. Net Income": "0",
"Other Expenses": "2,757,826",
"Other Liabilities": "340,300",
"Other Net Income": "-77,009",
"Other Revenues": "3,647,123",
"Property Plant and Equipment": "133,037",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,934,911",
"Liabilities": "2,847,027",
"Expenses": "3,301,485",
"Revenues": "3,647,123",
"Stockholders Equity": "3,087,884",
"Net Income": "268,629",
"Comprehensive Net Income": "268,629",
"BaseVar": "7,903,778",
"ECR before LimitedLiability": "108%",
"Economic Capital Ratio": "177%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,549,348",
"Assets, Non-Current": "107,355",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "28,441",
"General and Administrative Expense": "248,947",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,477,968",
"Labor Expense": "0",
"Liabilities, Current": "506,081",
"Long Term Liabilities": "1,828,876",
"Operating Costs and Expenses": "0",
"Other Assets": "137,086",
"Other Compr. Net Income": "0",
"Other Expenses": "1,375,159",
"Other Liabilities": "265,274",
"Other Net Income": "-877,892",
"Other Revenues": "1,733,951",
"Property Plant and Equipment": "76,191",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,347,948",
"Liabilities": "2,600,231",
"Expenses": "1,652,547",
"Revenues": "1,733,951",
"Stockholders Equity": "747,717",
"Net Income": "-796,488",
"Comprehensive Net Income": "-796,488",
"BaseVar": "5,106,284",
"ECR before LimitedLiability": "9.7%",
"Economic Capital Ratio": "97%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "840,564",
"Assets, Non-Current": "131,028",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "32,147",
"General and Administrative Expense": "263,357",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,505,430",
"Labor Expense": "0",
"Liabilities, Current": "468,775",
"Long Term Liabilities": "1,085,986",
"Operating Costs and Expenses": "0",
"Other Assets": "175,370",
"Other Compr. Net Income": "0",
"Other Expenses": "1,440,010",
"Other Liabilities": "271,093",
"Other Net Income": "-44,740",
"Other Revenues": "1,911,191",
"Property Plant and Equipment": "70,154",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,722,546",
"Liabilities": "1,825,854",
"Expenses": "1,735,514",
"Revenues": "1,911,191",
"Stockholders Equity": "896,692",
"Net Income": "130,937",
"Comprehensive Net Income": "130,937",
"BaseVar": "4,119,922",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "143%"
}
}
},
"top_rated": false,
"trend": 1.0,
"value": 1.4346052367643236,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000893949.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000893949.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000893949.svg"
},
{
"company_id": "0001800682",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001800682.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001800682.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001800682_main_keyfigs.svg",
"name": "Cano Health Inc",
"rank": 62,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001800682.svg",
"report_text": "The relative strengths and weaknesses of Cano Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Cano Health Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 53% points.The greatest weakness of Cano Health Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 128% points.
The company's Economic Capital Ratio, given in the ranking table, is 141%, being 27% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001800682_2022_Cano_Health_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "53.4",
"Assets": "-19.5",
"Liabilities": "-18.5",
"Stockholders Equity": "-40.3",
"ECR before LimitedLiability": "-20.7",
"Property Plant and Equipment": "-8.34",
"Assets, Non-Current": "-6.85",
"Assets, Current": "-36.1",
"Liabilities, Current": "38.1",
"Long Term Liabilities": "36.4",
"Other Liabilities": "-128",
"Other Revenues": "17.5",
"Revenues": "17.5",
"Net Income": "19.2",
"General and Administrative Expense": "11.2",
"Comprehensive Net Income": "19.3",
"Operating Costs and Expenses": "6.39",
"Cost of Goods and Services Sold": "19.0",
"Research And Development Expense": "5.73",
"Other Expenses": "-47.8",
"Economic Capital Ratio": "-26.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001800682_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "317,235",
"Assets, Non-Current": "145,755",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "49,441",
"General and Administrative Expense": "252,133",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "769,667",
"Labor Expense": "0",
"Liabilities, Current": "0",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "825,621",
"Other Compr. Net Income": "0",
"Other Expenses": "1,442,996",
"Other Liabilities": "1,344,971",
"Other Net Income": "18,464",
"Other Revenues": "1,609,369",
"Property Plant and Equipment": "85,261",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,143,539",
"Liabilities": "1,344,971",
"Expenses": "1,744,570",
"Revenues": "1,609,369",
"Stockholders Equity": "798,568",
"Net Income": "-116,737",
"Comprehensive Net Income": "-116,737",
"BaseVar": "3,430,456",
"ECR before LimitedLiability": "60%",
"Economic Capital Ratio": "141%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.4089147409745904,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001800682.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001800682.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001800682.svg"
},
{
"company_id": "0001604821",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001604821.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001604821.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001604821.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001604821_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001604821_main_keyfigs.svg",
"name": "Natera Inc",
"rank": 63,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001604821.svg",
"report_text": "The relative strengths and weaknesses of Natera Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Natera Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 48% points.The greatest weakness of Natera Inc is the variable Intangible Assets, reducing the Economic Capital Ratio by 30% points.
The company's Economic Capital Ratio, given in the ranking table, is 134%, being 33% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001604821_2022_Natera_Inc.pdf",
"shrinked_graph_json": {
"2015": {
"Long Term Liabilities": "26.4",
"Liabilities": "34.3",
"Stockholders Equity": "33.9",
"ECR before LimitedLiability": "33.5",
"Other Liabilities": "13.3",
"Selling and Marketing Expense": "5.63",
"Expenses": "-10.8",
"Revenues": "29.8",
"Comprehensive Net Income": "-5.42",
"Research And Development Expense": "-6.41",
"Operating Costs and Expenses": "5.45",
"General and Administrative Expense": "-22.1",
"Other Expenses": "-18.9",
"Labor Expense": "13.0",
"Cost of Goods and Services Sold": "11.1",
"Other Revenues": "29.8",
"Assets, Current": "93.6",
"Intangible Assets": "-17.9",
"Property Plant and Equipment": "-15.5",
"Other Net Income": "-22.2",
"Economic Capital Ratio": "21.1"
},
"2016": {
"Property Plant and Equipment": "-18.9",
"Assets": "-25.4",
"Economic Capital Ratio": "-27.8",
"Intangible Assets": "-32.8",
"Other Assets": "-7.66",
"Assets, Current": "37.2",
"Liabilities": "35.1",
"Other Liabilities": "11.3",
"Long Term Liabilities": "26.5",
"Expenses": "-35.7",
"Revenues": "35.5",
"Net Income": "-16.2",
"Selling and Marketing Expense": "9.65",
"General and Administrative Expense": "-37.7",
"Labor Expense": "10.2",
"Other Expenses": "-31.8",
"Cost of Goods and Services Sold": "24.4",
"Research And Development Expense": "-14.2",
"Other Revenues": "35.5",
"Other Net Income": "-22.6",
"Comprehensive Net Income": "-14.8"
},
"2017": {
"Other Assets": "-4.06",
"Assets": "-21.5",
"Liabilities": "-4.61",
"Stockholders Equity": "-47.3",
"ECR before LimitedLiability": "-48.2",
"Intangible Assets": "-10.6",
"Assets, Current": "2.77",
"Property Plant and Equipment": "-6.72",
"Long Term Liabilities": "-3.98",
"General and Administrative Expense": "-9.13",
"Expenses": "-9.03",
"Revenues": "13.9",
"Net Income": "-7.33",
"Labor Expense": "3.17",
"Research And Development Expense": "-3.76",
"Other Expenses": "-6.98",
"Cost of Goods and Services Sold": "5.71",
"Other Revenues": "13.9",
"Other Net Income": "-7.48",
"Comprehensive Net Income": "-7.29",
"Economic Capital Ratio": "-72.3"
},
"2018": {
"Other Assets": "-1.51",
"Assets": "-24.4",
"Liabilities": "-5.40",
"Stockholders Equity": "-58.6",
"Property Plant and Equipment": "-1.65",
"Intangible Assets": "-10.9",
"Assets, Non-Current": "-1.47",
"Assets, Current": "8.65",
"Other Liabilities": "-1.55",
"ECR before LimitedLiability": "-52.9",
"Long Term Liabilities": "-1.03",
"Expenses": "-1.59",
"Revenues": "1.19",
"Net Income": "-0.981",
"Other Expenses": "3.60",
"General and Administrative Expense": "-1.86",
"Research And Development Expense": "-1.09",
"Cost of Goods and Services Sold": "-1.86",
"Labor Expense": "1.74",
"Other Revenues": "1.19",
"Economic Capital Ratio": "-73.7"
},
"2019": {
"Property Plant and Equipment": "-11.4",
"Assets": "5.64",
"Liabilities": "-13.8",
"Stockholders Equity": "-4.19",
"Net Income": "-2.60",
"ECR before LimitedLiability": "-7.94",
"Assets, Non-Current": "-8.09",
"Other Assets": "-5.53",
"Intangible Assets": "-20.2",
"Assets, Current": "59.3",
"Long Term Liabilities": "2.79",
"Liabilities, Current": "-17.9",
"Other Revenues": "-6.08",
"Revenues": "-6.08",
"Other Expenses": "-17.8",
"General and Administrative Expense": "-18.2",
"Cost of Goods and Services Sold": "24.5",
"Selling and Marketing Expense": "4.57",
"Labor Expense": "6.89",
"Operating Costs and Expenses": "5.90",
"Economic Capital Ratio": "-18.0"
},
"2020": {
"Property Plant and Equipment": "-8.16",
"Assets": "11.7",
"Liabilities": "-10.0",
"Stockholders Equity": "6.17",
"Economic Capital Ratio": "-11.1",
"Other Assets": "-6.19",
"Intangible Assets": "-18.6",
"Assets, Current": "63.8",
"Assets, Non-Current": "-7.79",
"Long Term Liabilities": "-10.3",
"Other Revenues": "-7.59",
"Revenues": "-7.59",
"Net Income": "-6.93",
"Labor Expense": "5.88",
"Comprehensive Net Income": "-6.56",
"Selling and Marketing Expense": "3.06",
"General and Administrative Expense": "-13.7",
"Research And Development Expense": "-7.06",
"Other Expenses": "-11.8",
"Operating Costs and Expenses": "4.66",
"Cost of Goods and Services Sold": "19.2"
},
"2021": {
"Other Assets": "-5.09",
"Assets": "-10.1",
"Stockholders Equity": "-13.2",
"ECR before LimitedLiability": "-27.3",
"Intangible Assets": "-30.2",
"Property Plant and Equipment": "-6.81",
"Assets, Non-Current": "-7.05",
"Assets, Current": "48.0",
"General and Administrative Expense": "-22.1",
"Expenses": "-18.7",
"Net Income": "-17.6",
"Operating Costs and Expenses": "6.55",
"Labor Expense": "5.66",
"Cost of Goods and Services Sold": "19.5",
"Research And Development Expense": "-17.4",
"Other Expenses": "-15.4",
"Long Term Liabilities": "-15.0",
"Other Liabilities": "7.91",
"Liabilities, Current": "6.23",
"Comprehensive Net Income": "-18.0",
"Economic Capital Ratio": "-33.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001604821_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "250,726",
"Assets, Non-Current": "1,121",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "109,637",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "80,475",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "683",
"Other Compr. Net Income": "-1,416",
"Other Expenses": "116,350",
"Other Liabilities": "0",
"Other Net Income": "-6,932",
"Other Revenues": "190,355",
"Property Plant and Equipment": "12,710",
"Research And Development Expense": "27,711",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "265,240",
"Liabilities": "80,475",
"Expenses": "253,698",
"Revenues": "190,355",
"Stockholders Equity": "184,765",
"Net Income": "-70,275",
"Comprehensive Net Income": "-71,691",
"BaseVar": "399,058",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "180%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "174,115",
"Assets, Non-Current": "3,934",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "136,126",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "96,415",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "342",
"Other Compr. Net Income": "691",
"Other Expenses": "136,249",
"Other Liabilities": "7,789",
"Other Net Income": "1,398",
"Other Revenues": "217,074",
"Property Plant and Equipment": "32,289",
"Research And Development Expense": "41,862",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "210,680",
"Liabilities": "104,204",
"Expenses": "314,237",
"Revenues": "217,074",
"Stockholders Equity": "106,476",
"Net Income": "-95,765",
"Comprehensive Net Income": "-95,074",
"BaseVar": "424,142",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "123%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "144,788",
"Assets, Non-Current": "3,979",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "155,306",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "105,511",
"Long Term Liabilities": "74,394",
"Operating Costs and Expenses": "0",
"Other Assets": "342",
"Other Compr. Net Income": "-41",
"Other Expenses": "144,263",
"Other Liabilities": "9,241",
"Other Net Income": "2,380",
"Other Revenues": "210,939",
"Property Plant and Equipment": "29,667",
"Research And Development Expense": "50,064",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "178,776",
"Liabilities": "189,146",
"Expenses": "349,633",
"Revenues": "210,939",
"Stockholders Equity": "-10,370",
"Net Income": "-136,314",
"Comprehensive Net Income": "-136,355",
"BaseVar": "465,458",
"ECR before LimitedLiability": "-82%",
"Economic Capital Ratio": "76%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "240,518",
"Assets, Non-Current": "3,317",
"Cost of Goods and Services Sold": "158,081",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "154,872",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "113,981",
"Long Term Liabilities": "73,357",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "214",
"Other Expenses": "18,771",
"Other Liabilities": "48,671",
"Other Net Income": "-2,729",
"Other Revenues": "257,654",
"Property Plant and Equipment": "24,336",
"Research And Development Expense": "51,355",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "268,171",
"Liabilities": "236,009",
"Expenses": "383,079",
"Revenues": "257,654",
"Stockholders Equity": "32,162",
"Net Income": "-128,154",
"Comprehensive Net Income": "-127,940",
"BaseVar": "573,928",
"ECR before LimitedLiability": "-32%",
"Economic Capital Ratio": "86%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "523,167",
"Assets, Non-Current": "36,206",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "206,176",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "179,874",
"Long Term Liabilities": "100,263",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "1,471",
"Other Expenses": "173,774",
"Other Liabilities": "23,808",
"Other Net Income": "4,152",
"Other Revenues": "302,328",
"Property Plant and Equipment": "23,283",
"Research And Development Expense": "51,357",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "582,656",
"Liabilities": "303,945",
"Expenses": "431,307",
"Revenues": "302,328",
"Stockholders Equity": "278,711",
"Net Income": "-124,827",
"Comprehensive Net Income": "-123,356",
"BaseVar": "812,930",
"ECR before LimitedLiability": "63%",
"Economic Capital Ratio": "144%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "862,663",
"Assets, Non-Current": "36,142",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "303,627",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "199,053",
"Long Term Liabilities": "224,059",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "3,340",
"Other Expenses": "218,800",
"Other Liabilities": "22,805",
"Other Net Income": "1,714",
"Other Revenues": "391,005",
"Property Plant and Equipment": "33,348",
"Research And Development Expense": "100,035",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "932,153",
"Liabilities": "445,917",
"Expenses": "622,462",
"Revenues": "391,005",
"Stockholders Equity": "486,236",
"Net Income": "-229,743",
"Comprehensive Net Income": "-226,403",
"BaseVar": "1,198,296",
"ECR before LimitedLiability": "69%",
"Economic Capital Ratio": "149%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,093,138",
"Assets, Non-Current": "77,833",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "511,034",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "218,956",
"Long Term Liabilities": "342,909",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-6,546",
"Other Expenses": "327,341",
"Other Liabilities": "21,318",
"Other Net Income": "5,381",
"Other Revenues": "625,486",
"Property Plant and Equipment": "65,516",
"Research And Development Expense": "264,208",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,236,487",
"Liabilities": "583,183",
"Expenses": "1,102,583",
"Revenues": "625,486",
"Stockholders Equity": "653,304",
"Net Income": "-471,716",
"Comprehensive Net Income": "-478,262",
"BaseVar": "1,779,833",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "134%"
}
}
},
"top_rated": false,
"trend": -22.0,
"value": 1.3429510908362896,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001604821.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001604821.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001604821.svg"
},
{
"company_id": "0001293818",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001293818.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001293818.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001293818.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001293818_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001293818_main_keyfigs.svg",
"name": "Capforce Inc",
"rank": 64,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001293818.svg",
"report_text": "The relative strengths and weaknesses of Capforce Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Capforce Inc compared to the market average is the variable Assets, increasing the Economic Capital Ratio by 41% points.The greatest weakness of Capforce Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 39% points.
The company's Economic Capital Ratio, given in the ranking table, is 129%, being 39% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001293818_2022_Capforce_Inc.pdf",
"shrinked_graph_json": {
"2015": {
"Selling and Marketing Expense": "-5.74",
"Expenses": "-7.21",
"Revenues": "-5.54",
"Net Income": "-74.5",
"Research And Development Expense": "-7.09",
"Operating Costs and Expenses": "1.69",
"General and Administrative Expense": "-5.09",
"Other Expenses": "4.20",
"Labor Expense": "4.19",
"Cost of Goods and Services Sold": "3.57",
"Other Revenues": "-5.54",
"Comprehensive Net Income": "-74.0",
"Other Net Income": "-7.01",
"ECR before LimitedLiability": "-66.7",
"Economic Capital Ratio": "-79.2",
"Intangible Assets": "-6.42",
"Assets, Current": "29.2",
"Long Term Liabilities": "2.23",
"Other Assets": "4.27",
"Liabilities, Current": "-1.96",
"Property Plant and Equipment": "-6.10"
},
"2016": {
"Property Plant and Equipment": "-22.4",
"Assets": "-31.8",
"Stockholders Equity": "-14.6",
"ECR before LimitedLiability": "-83.7",
"Assets, Non-Current": "-4.46",
"Intangible Assets": "-22.9",
"Other Assets": "10.8",
"Assets, Current": "5.33",
"Expenses": "-44.2",
"Revenues": "-11.8",
"Net Income": "-66.3",
"Selling and Marketing Expense": "-21.3",
"General and Administrative Expense": "-16.1",
"Labor Expense": "3.79",
"Other Expenses": "5.79",
"Cost of Goods and Services Sold": "8.55",
"Research And Development Expense": "-34.7",
"Other Revenues": "-11.8",
"Other Net Income": "-10.6",
"Comprehensive Net Income": "-65.0",
"Economic Capital Ratio": "-111"
},
"2017": {
"Other Assets": "8.45",
"Assets": "-43.9",
"Stockholders Equity": "-30.1",
"Long Term Liabilities": "2.21",
"ECR before LimitedLiability": "-94.1",
"Intangible Assets": "-23.9",
"Assets, Current": "-17.1",
"Property Plant and Equipment": "-17.5",
"General and Administrative Expense": "-22.4",
"Expenses": "-47.2",
"Revenues": "-6.82",
"Net Income": "-57.2",
"Labor Expense": "3.58",
"Selling and Marketing Expense": "-11.3",
"Research And Development Expense": "-33.7",
"Other Expenses": "4.46",
"Cost of Goods and Services Sold": "6.09",
"Other Revenues": "-6.82",
"Other Net Income": "-13.4",
"Comprehensive Net Income": "-57.2",
"Economic Capital Ratio": "-118"
},
"2018": {
"Assets": "-14.1",
"Stockholders Equity": "-14.1",
"ECR before LimitedLiability": "-72.8",
"Property Plant and Equipment": "-4.56",
"Intangible Assets": "-11.6",
"Assets, Non-Current": "-5.64",
"Assets, Current": "5.28",
"Selling and Marketing Expense": "-4.64",
"Expenses": "-20.0",
"Revenues": "-14.9",
"Net Income": "-45.1",
"Operating Costs and Expenses": "2.09",
"General and Administrative Expense": "-16.8",
"Research And Development Expense": "-17.6",
"Cost of Goods and Services Sold": "11.3",
"Labor Expense": "4.26",
"Other Revenues": "-14.9",
"Liabilities, Current": "-4.91",
"Long Term Liabilities": "3.31",
"Comprehensive Net Income": "-44.5",
"Economic Capital Ratio": "-93.6"
},
"2019": {
"Property Plant and Equipment": "-6.85",
"Assets": "-7.14",
"Stockholders Equity": "-7.39",
"ECR before LimitedLiability": "-74.0",
"Other Assets": "7.39",
"Intangible Assets": "-7.47",
"Assets, Current": "8.38",
"Other Expenses": "-3.70",
"Expenses": "-9.69",
"Revenues": "-8.37",
"Net Income": "-51.7",
"General and Administrative Expense": "-8.46",
"Cost of Goods and Services Sold": "9.81",
"Research And Development Expense": "-8.68",
"Selling and Marketing Expense": "-2.50",
"Labor Expense": "2.61",
"Other Revenues": "-8.37",
"Long Term Liabilities": "4.84",
"Liabilities, Current": "-6.49",
"Comprehensive Net Income": "-51.5",
"Economic Capital Ratio": "-84.0"
},
"2020": {
"Property Plant and Equipment": "-5.51",
"Assets": "18.0",
"Liabilities": "-36.4",
"ECR before LimitedLiability": "-42.6",
"Other Assets": "22.4",
"Assets, Current": "-8.66",
"Assets, Non-Current": "-6.62",
"Liabilities, Current": "6.82",
"Other Liabilities": "4.94",
"Long Term Liabilities": "-49.7",
"Labor Expense": "6.04",
"Expenses": "6.71",
"Net Income": "-39.7",
"Research And Development Expense": "-18.9",
"Cost of Goods and Services Sold": "17.5",
"Other Revenues": "-39.3",
"Revenues": "-39.3",
"Other Net Income": "-7.03",
"Other Compr. Net Income": "6.21",
"Comprehensive Net Income": "-34.5",
"Economic Capital Ratio": "-54.7"
},
"2021": {
"Other Assets": "41.4",
"Assets": "41.4",
"Liabilities": "-18.1",
"Stockholders Equity": "24.8",
"ECR before LimitedLiability": "-32.7",
"Intangible Assets": "-13.6",
"Assets, Non-Current": "-7.14",
"Assets, Current": "31.5",
"Liabilities, Current": "-26.2",
"Other Liabilities": "7.66",
"Expenses": "15.6",
"Revenues": "-34.2",
"Net Income": "-36.0",
"Operating Costs and Expenses": "4.94",
"Cost of Goods and Services Sold": "14.6",
"Research And Development Expense": "-13.2",
"Other Expenses": "5.30",
"Other Revenues": "-34.2",
"Comprehensive Net Income": "-38.7",
"Other Net Income": "-16.5",
"Economic Capital Ratio": "-38.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001293818_strength_weakness.svg",
"table_records": {
"2015": {
"input_variables": {
"Assets, Current": "9,891",
"Assets, Non-Current": "270",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,835",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "638",
"Labor Expense": "0",
"Liabilities, Current": "4,894",
"Long Term Liabilities": "1,000",
"Operating Costs and Expenses": "0",
"Other Assets": "1,889",
"Other Compr. Net Income": "-1.1",
"Other Expenses": "1,945",
"Other Liabilities": "378",
"Other Net Income": "-2,422",
"Other Revenues": "3,158",
"Property Plant and Equipment": "1,075",
"Research And Development Expense": "6,003",
"Selling and Marketing Expense": "4,305"
},
"output_variables": {
"Assets": "13,763",
"Liabilities": "6,272",
"Expenses": "18,088",
"Revenues": "3,158",
"Stockholders Equity": "7,491",
"Net Income": "-17,352",
"Comprehensive Net Income": "-17,353",
"BaseVar": "21,852",
"ECR before LimitedLiability": "-65%",
"Economic Capital Ratio": "80%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "5,682",
"Assets, Non-Current": "280",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,603",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "601",
"Labor Expense": "0",
"Liabilities, Current": "5,272",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,621",
"Other Compr. Net Income": "7.2",
"Other Expenses": "2,290",
"Other Liabilities": "545",
"Other Net Income": "-157",
"Other Revenues": "4,026",
"Property Plant and Equipment": "801",
"Research And Development Expense": "8,613",
"Selling and Marketing Expense": "5,529"
},
"output_variables": {
"Assets": "8,984",
"Liabilities": "5,817",
"Expenses": "23,035",
"Revenues": "4,026",
"Stockholders Equity": "3,167",
"Net Income": "-19,167",
"Comprehensive Net Income": "-19,160",
"BaseVar": "21,013",
"ECR before LimitedLiability": "-197%",
"Economic Capital Ratio": "39%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "3,502",
"Assets, Non-Current": "329",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,693",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "601",
"Labor Expense": "0",
"Liabilities, Current": "4,790",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,353",
"Other Compr. Net Income": "-32",
"Other Expenses": "2,133",
"Other Liabilities": "429",
"Other Net Income": "-154",
"Other Revenues": "3,211",
"Property Plant and Equipment": "836",
"Research And Development Expense": "6,883",
"Selling and Marketing Expense": "2,768"
},
"output_variables": {
"Assets": "6,620",
"Liabilities": "5,219",
"Expenses": "18,477",
"Revenues": "3,211",
"Stockholders Equity": "1,401",
"Net Income": "-15,419",
"Comprehensive Net Income": "-15,451",
"BaseVar": "16,856",
"ECR before LimitedLiability": "-227%",
"Economic Capital Ratio": "30%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "5,783",
"Assets, Non-Current": "259",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "7,069",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "601",
"Labor Expense": "0",
"Liabilities, Current": "4,381",
"Long Term Liabilities": "660",
"Operating Costs and Expenses": "0",
"Other Assets": "1,085",
"Other Compr. Net Income": "13",
"Other Expenses": "1,848",
"Other Liabilities": "600",
"Other Net Income": "-188",
"Other Revenues": "2,946",
"Property Plant and Equipment": "1,222",
"Research And Development Expense": "5,677",
"Selling and Marketing Expense": "1,532"
},
"output_variables": {
"Assets": "8,950",
"Liabilities": "5,642",
"Expenses": "16,127",
"Revenues": "2,946",
"Stockholders Equity": "3,309",
"Net Income": "-13,368",
"Comprehensive Net Income": "-13,355",
"BaseVar": "16,933",
"ECR before LimitedLiability": "-117%",
"Economic Capital Ratio": "66%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "6,667",
"Assets, Non-Current": "1,247",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,252",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "601",
"Labor Expense": "0",
"Liabilities, Current": "4,939",
"Long Term Liabilities": "877",
"Operating Costs and Expenses": "0",
"Other Assets": "1,776",
"Other Compr. Net Income": "-4.2",
"Other Expenses": "2,932",
"Other Liabilities": "313",
"Other Net Income": "-175",
"Other Revenues": "3,499",
"Property Plant and Equipment": "131",
"Research And Development Expense": "5,121",
"Selling and Marketing Expense": "1,465"
},
"output_variables": {
"Assets": "10,422",
"Liabilities": "6,128",
"Expenses": "15,770",
"Revenues": "3,499",
"Stockholders Equity": "4,293",
"Net Income": "-12,446",
"Comprehensive Net Income": "-12,451",
"BaseVar": "17,999",
"ECR before LimitedLiability": "-75%",
"Economic Capital Ratio": "78%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "16,888",
"Assets, Non-Current": "2,862",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "8,802",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "8,025",
"Labor Expense": "0",
"Liabilities, Current": "7,372",
"Long Term Liabilities": "21,028",
"Operating Costs and Expenses": "0",
"Other Assets": "18,717",
"Other Compr. Net Income": "2,564",
"Other Expenses": "5,205",
"Other Liabilities": "160",
"Other Net Income": "-3,360",
"Other Revenues": "4,214",
"Property Plant and Equipment": "3,259",
"Research And Development Expense": "9,965",
"Selling and Marketing Expense": "3,094"
},
"output_variables": {
"Assets": "49,751",
"Liabilities": "28,560",
"Expenses": "27,065",
"Revenues": "4,214",
"Stockholders Equity": "21,191",
"Net Income": "-26,211",
"Comprehensive Net Income": "-23,646",
"BaseVar": "57,758",
"ECR before LimitedLiability": "18%",
"Economic Capital Ratio": "105%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "39,743",
"Assets, Non-Current": "2,366",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "9,936",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "7,453",
"Labor Expense": "0",
"Liabilities, Current": "19,917",
"Long Term Liabilities": "10,300",
"Operating Costs and Expenses": "0",
"Other Assets": "18,093",
"Other Compr. Net Income": "-1,962",
"Other Expenses": "3,063",
"Other Liabilities": "232",
"Other Net Income": "-11,489",
"Other Revenues": "4,306",
"Property Plant and Equipment": "4,012",
"Research And Development Expense": "10,911",
"Selling and Marketing Expense": "3,713"
},
"output_variables": {
"Assets": "71,667",
"Liabilities": "30,449",
"Expenses": "27,623",
"Revenues": "4,306",
"Stockholders Equity": "41,217",
"Net Income": "-34,806",
"Comprehensive Net Income": "-36,767",
"BaseVar": "73,748",
"ECR before LimitedLiability": "45%",
"Economic Capital Ratio": "129%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 1.2887586292475603,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001293818.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001293818.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001293818.svg"
},
{
"company_id": "0001835567",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001835567.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001835567.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001835567_main_keyfigs.svg",
"name": "Pear Therapeutics Inc",
"rank": 65,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001835567.svg",
"report_text": "The relative strengths and weaknesses of Pear Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pear Therapeutics Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 51% points.The greatest weakness of Pear Therapeutics Inc is the variable Other Liabilities, reducing the Economic Capital Ratio by 48% points.
The company's Economic Capital Ratio, given in the ranking table, is 128%, being 40% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001835567_2022_Pear_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "19.4",
"Liabilities": "-30.9",
"Stockholders Equity": "-5.70",
"ECR before LimitedLiability": "-34.1",
"Intangible Assets": "-26.0",
"Property Plant and Equipment": "-7.03",
"Assets, Non-Current": "-8.82",
"Assets, Current": "51.0",
"Liabilities, Current": "-13.0",
"Long Term Liabilities": "26.9",
"Other Liabilities": "-47.8",
"Other Revenues": "-40.1",
"Revenues": "-40.1",
"Net Income": "-16.4",
"General and Administrative Expense": "-18.7",
"Comprehensive Net Income": "-16.3",
"Cost of Goods and Services Sold": "12.3",
"Other Net Income": "25.9",
"Research And Development Expense": "-15.5",
"Other Expenses": "11.1",
"Economic Capital Ratio": "-40.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001835567_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "185,241",
"Assets, Non-Current": "5,253",
"Cost of Goods and Services Sold": "5,233",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "67,619",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "47,166",
"Long Term Liabilities": "1,994",
"Operating Costs and Expenses": "0",
"Other Assets": "411",
"Other Compr. Net Income": "-1.0",
"Other Expenses": "0",
"Other Liabilities": "57,566",
"Other Net Income": "40,543",
"Other Revenues": "4,208",
"Property Plant and Equipment": "6,255",
"Research And Development Expense": "37,041",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "197,160",
"Liabilities": "106,726",
"Expenses": "109,893",
"Revenues": "4,208",
"Stockholders Equity": "90,434",
"Net Income": "-65,142",
"Comprehensive Net Income": "-65,143",
"BaseVar": "229,266",
"ECR before LimitedLiability": "43%",
"Economic Capital Ratio": "128%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.2751171046113168,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001835567.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001835567.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001835567.svg"
},
{
"company_id": "0001136174",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001136174.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001136174.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001136174.jpg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001136174_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001136174_main_keyfigs.svg",
"name": "Ontrak Inc",
"rank": 66,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001136174.svg",
"report_text": "The relative strengths and weaknesses of Ontrak Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ontrak Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 31% points.The greatest weakness of Ontrak Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 45% points.
The company's Economic Capital Ratio, given in the ranking table, is 125%, being 43% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001136174_2022_Ontrak_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "-1.74",
"Assets": "-33.3",
"Liabilities": "-8.09",
"Stockholders Equity": "-59.0",
"ECR before LimitedLiability": "-130",
"Property Plant and Equipment": "-20.0",
"Assets, Current": "-10.3",
"Other Liabilities": "-5.71",
"Liabilities, Current": "-2.18",
"Expenses": "-11.7",
"Revenues": "-12.5",
"Net Income": "-37.4",
"Other Expenses": "16.0",
"Operating Costs and Expenses": "2.08",
"Labor Expense": "3.22",
"General and Administrative Expense": "-52.4",
"Cost of Goods and Services Sold": "2.07",
"Other Revenues": "-12.5",
"Other Net Income": "-8.86",
"Comprehensive Net Income": "-37.3",
"Economic Capital Ratio": "-137"
},
"2012": {
"Property Plant and Equipment": "-15.7",
"Assets": "-38.0",
"Liabilities": "-6.92",
"Stockholders Equity": "-66.9",
"ECR before LimitedLiability": "-130",
"Intangible Assets": "-12.5",
"Assets, Current": "-6.56",
"Other Assets": "-0.751",
"Assets, Non-Current": "-2.72",
"Other Liabilities": "-7.48",
"Expenses": "-3.79",
"Revenues": "-9.60",
"Net Income": "-23.1",
"General and Administrative Expense": "-13.0",
"Operating Costs and Expenses": "1.31",
"Cost of Goods and Services Sold": "1.69",
"Labor Expense": "2.67",
"Other Revenues": "-9.60",
"Other Net Income": "-6.71",
"Comprehensive Net Income": "-23.0",
"Economic Capital Ratio": "-144"
},
"2013": {
"Other Assets": "-2.20",
"Assets": "-41.0",
"Liabilities": "-13.7",
"Stockholders Equity": "-89.2",
"ECR before LimitedLiability": "-133",
"Property Plant and Equipment": "-10.7",
"Assets, Current": "-15.7",
"Intangible Assets": "-13.1",
"Other Liabilities": "-13.8",
"Expenses": "4.50",
"Revenues": "-7.36",
"Net Income": "-5.81",
"General and Administrative Expense": "-8.67",
"Cost of Goods and Services Sold": "1.35",
"Labor Expense": "2.29",
"Other Expenses": "5.68",
"Research And Development Expense": "0.786",
"Other Revenues": "-7.36",
"Comprehensive Net Income": "-5.74",
"Other Net Income": "-3.79",
"Economic Capital Ratio": "-142"
},
"2015": {
"Assets, Current": "-6.17",
"Assets": "-36.6",
"Liabilities": "-4.51",
"Stockholders Equity": "-67.7",
"ECR before LimitedLiability": "-129",
"Intangible Assets": "-14.9",
"Other Assets": "-3.91",
"Property Plant and Equipment": "-11.9",
"Other Liabilities": "-2.63",
"Selling and Marketing Expense": "1.09",
"Expenses": "8.51",
"Revenues": "-10.7",
"Net Income": "-21.0",
"General and Administrative Expense": "-29.9",
"Other Expenses": "14.6",
"Labor Expense": "2.41",
"Cost of Goods and Services Sold": "2.09",
"Other Revenues": "-10.7",
"Comprehensive Net Income": "-20.9",
"Other Net Income": "-23.1",
"Economic Capital Ratio": "-141"
},
"2016": {
"Property Plant and Equipment": "-8.73",
"Assets": "-39.7",
"Liabilities": "5.71",
"Stockholders Equity": "-74.9",
"ECR before LimitedLiability": "-116",
"Assets, Non-Current": "-1.01",
"Intangible Assets": "-9.50",
"Other Assets": "-1.55",
"Assets, Current": "-10.3",
"Liabilities, Current": "4.81",
"Other Liabilities": "0.869",
"Expenses": "-1.90",
"Revenues": "-6.69",
"Net Income": "-14.9",
"General and Administrative Expense": "-4.14",
"Other Expenses": "-2.69",
"Cost of Goods and Services Sold": "1.48",
"Other Revenues": "-6.69",
"Other Net Income": "-2.81",
"Comprehensive Net Income": "-14.7",
"Economic Capital Ratio": "-143"
},
"2017": {
"Other Assets": "-9.23",
"Assets": "-46.4",
"Stockholders Equity": "-38.3",
"ECR before LimitedLiability": "-86.1",
"Intangible Assets": "-31.7",
"Property Plant and Equipment": "-22.9",
"General and Administrative Expense": "-43.9",
"Expenses": "-44.2",
"Revenues": "-27.8",
"Net Income": "-47.9",
"Labor Expense": "4.47",
"Selling and Marketing Expense": "3.40",
"Research And Development Expense": "4.48",
"Other Expenses": "-24.2",
"Cost of Goods and Services Sold": "7.65",
"Other Revenues": "-27.8",
"Liabilities, Current": "-4.34",
"Long Term Liabilities": "3.85",
"Other Net Income": "16.2",
"Comprehensive Net Income": "-47.8",
"Economic Capital Ratio": "-110"
},
"2018": {
"Other Assets": "-8.47",
"Assets": "-62.7",
"Liabilities": "-3.09",
"Stockholders Equity": "-85.9",
"ECR before LimitedLiability": "-115",
"Property Plant and Equipment": "-20.5",
"Intangible Assets": "-27.2",
"Assets, Non-Current": "-10.8",
"Assets, Current": "-29.9",
"Long Term Liabilities": "-2.46",
"Expenses": "-28.8",
"Revenues": "3.60",
"Net Income": "-22.8",
"Other Expenses": "7.74",
"General and Administrative Expense": "-36.9",
"Research And Development Expense": "2.83",
"Cost of Goods and Services Sold": "-16.8",
"Labor Expense": "3.97",
"Other Revenues": "3.60",
"Comprehensive Net Income": "-22.6",
"Economic Capital Ratio": "-136"
},
"2019": {
"Property Plant and Equipment": "-16.7",
"Assets": "-38.1",
"Liabilities": "-16.9",
"Stockholders Equity": "-85.8",
"ECR before LimitedLiability": "-103",
"Assets, Non-Current": "-15.8",
"Intangible Assets": "-22.1",
"Assets, Current": "-9.68",
"Long Term Liabilities": "-16.3",
"Other Expenses": "-27.3",
"Expenses": "-11.7",
"Net Income": "-13.6",
"Other Net Income": "-2.29",
"General and Administrative Expense": "9.50",
"Cost of Goods and Services Sold": "-6.63",
"Research And Development Expense": "3.83",
"Selling and Marketing Expense": "2.47",
"Labor Expense": "3.70",
"Operating Costs and Expenses": "3.18",
"Comprehensive Net Income": "-13.5",
"Economic Capital Ratio": "-113"
},
"2020": {
"Liabilities, Current": "-3.73",
"Liabilities": "-18.7",
"Stockholders Equity": "-17.0",
"ECR before LimitedLiability": "-8.69",
"Other Liabilities": "6.12",
"Long Term Liabilities": "-21.3",
"Labor Expense": "6.45",
"Expenses": "2.41",
"Revenues": "1.98",
"Net Income": "4.50",
"General and Administrative Expense": "-4.05",
"Research And Development Expense": "-4.64",
"Other Expenses": "9.09",
"Operating Costs and Expenses": "5.11",
"Cost of Goods and Services Sold": "-10.3",
"Other Revenues": "1.98",
"Property Plant and Equipment": "-11.8",
"Intangible Assets": "-15.5",
"Assets, Current": "51.7",
"Assets, Non-Current": "-11.7",
"Comprehensive Net Income": "4.51",
"Economic Capital Ratio": "-20.8"
},
"2021": {
"Assets": "-40.2",
"Liabilities": "16.6",
"Stockholders Equity": "-44.9",
"ECR before LimitedLiability": "-36.4",
"Intangible Assets": "-31.7",
"Property Plant and Equipment": "-12.5",
"Assets, Non-Current": "-17.5",
"Assets, Current": "30.6",
"Liabilities, Current": "28.8",
"Long Term Liabilities": "-27.9",
"Other Liabilities": "13.7",
"General and Administrative Expense": "-21.8",
"Expenses": "-37.5",
"Revenues": "27.3",
"Net Income": "-12.8",
"Operating Costs and Expenses": "8.58",
"Cost of Goods and Services Sold": "-13.0",
"Research And Development Expense": "-14.1",
"Other Revenues": "27.3",
"Comprehensive Net Income": "-12.7",
"Economic Capital Ratio": "-42.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001136174_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "1,359",
"Assets, Non-Current": "212",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "349",
"General and Administrative Expense": "11,145",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,920",
"Labor Expense": "0",
"Liabilities, Current": "3,530",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-3,145",
"Other Liabilities": "4,546",
"Other Net Income": "-41",
"Other Revenues": "271",
"Property Plant and Equipment": "89",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,580",
"Liabilities": "8,076",
"Expenses": "8,349",
"Revenues": "271",
"Stockholders Equity": "-4,496",
"Net Income": "-8,119",
"Comprehensive Net Income": "-8,119",
"BaseVar": "10,158",
"ECR before LimitedLiability": "-251%",
"Economic Capital Ratio": "24%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "3,622",
"Assets, Non-Current": "205",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "289",
"General and Administrative Expense": "8,341",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,048",
"Labor Expense": "0",
"Liabilities, Current": "3,998",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "3,554",
"Other Liabilities": "14,694",
"Other Net Income": "0",
"Other Revenues": "541",
"Property Plant and Equipment": "59",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,934",
"Liabilities": "18,692",
"Expenses": "12,184",
"Revenues": "541",
"Stockholders Equity": "-13,758",
"Net Income": "-11,643",
"Comprehensive Net Income": "-11,643",
"BaseVar": "18,176",
"ECR before LimitedLiability": "-267%",
"Economic Capital Ratio": "20%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "1,699",
"Assets, Non-Current": "440",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "170",
"General and Administrative Expense": "6,115",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "118",
"Labor Expense": "0",
"Liabilities, Current": "4,133",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-634",
"Other Liabilities": "16,533",
"Other Net Income": "0",
"Other Revenues": "972",
"Property Plant and Equipment": "366",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,623",
"Liabilities": "20,666",
"Expenses": "5,651",
"Revenues": "972",
"Stockholders Equity": "-18,043",
"Net Income": "-4,679",
"Comprehensive Net Income": "-4,679",
"BaseVar": "14,956",
"ECR before LimitedLiability": "-265%",
"Economic Capital Ratio": "20%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "2,081",
"Assets, Non-Current": "387",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "122",
"General and Administrative Expense": "9,049",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,821",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-6,633",
"Other Liabilities": "6,783",
"Other Net Income": "-4,749",
"Other Revenues": "64",
"Property Plant and Equipment": "412",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,880",
"Liabilities": "11,604",
"Expenses": "2,538",
"Revenues": "64",
"Stockholders Equity": "-8,724",
"Net Income": "-7,223",
"Comprehensive Net Income": "-7,223",
"BaseVar": "10,918",
"ECR before LimitedLiability": "-274%",
"Economic Capital Ratio": "18%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "2,323",
"Assets, Non-Current": "371",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "141",
"General and Administrative Expense": "8,838",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "22,977",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "7,940",
"Other Liabilities": "5,455",
"Other Net Income": "-1,123",
"Other Revenues": "106",
"Property Plant and Equipment": "410",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,104",
"Liabilities": "28,432",
"Expenses": "16,919",
"Revenues": "106",
"Stockholders Equity": "-25,328",
"Net Income": "-17,936",
"Comprehensive Net Income": "-17,936",
"BaseVar": "24,842",
"ECR before LimitedLiability": "-347%",
"Economic Capital Ratio": "7.2%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "5,656",
"Assets, Non-Current": "336",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "246",
"General and Administrative Expense": "11,811",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,649",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "8,028",
"Other Liabilities": "57",
"Other Net Income": "6,348",
"Other Revenues": "132",
"Property Plant and Equipment": "612",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,604",
"Liabilities": "5,706",
"Expenses": "20,085",
"Revenues": "132",
"Stockholders Equity": "898",
"Net Income": "-13,605",
"Comprehensive Net Income": "-13,605",
"BaseVar": "19,438",
"ECR before LimitedLiability": "-200%",
"Economic Capital Ratio": "38%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "5,486",
"Assets, Non-Current": "166",
"Cost of Goods and Services Sold": "11,119",
"Depreciation, Depletion, Amortization": "288",
"General and Administrative Expense": "17,395",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "7,730",
"Long Term Liabilities": "7,472",
"Operating Costs and Expenses": "0",
"Other Assets": "408",
"Other Compr. Net Income": "0",
"Other Expenses": "627",
"Other Liabilities": "86",
"Other Net Income": "0",
"Other Revenues": "15,217",
"Property Plant and Equipment": "263",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,323",
"Liabilities": "15,288",
"Expenses": "29,429",
"Revenues": "15,217",
"Stockholders Equity": "-8,965",
"Net Income": "-14,212",
"Comprehensive Net Income": "-14,212",
"BaseVar": "33,128",
"ECR before LimitedLiability": "-252%",
"Economic Capital Ratio": "23%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "20,392",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "20,408",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "14,098",
"Long Term Liabilities": "31,597",
"Operating Costs and Expenses": "0",
"Other Assets": "3,313",
"Other Compr. Net Income": "0",
"Other Expenses": "37,808",
"Other Liabilities": "2,069",
"Other Net Income": "-2,538",
"Other Revenues": "35,095",
"Property Plant and Equipment": "150",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "23,855",
"Liabilities": "47,764",
"Expenses": "58,216",
"Revenues": "35,095",
"Stockholders Equity": "-23,909",
"Net Income": "-25,659",
"Comprehensive Net Income": "-25,659",
"BaseVar": "83,734",
"ECR before LimitedLiability": "-168%",
"Economic Capital Ratio": "48%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "123,638",
"Assets, Non-Current": "2,326",
"Cost of Goods and Services Sold": "43,603",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "36,709",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "9,288",
"Labor Expense": "0",
"Liabilities, Current": "36,410",
"Long Term Liabilities": "47,122",
"Operating Costs and Expenses": "0",
"Other Assets": "7,176",
"Other Compr. Net Income": "0",
"Other Expenses": "6,574",
"Other Liabilities": "418",
"Other Net Income": "-1,213",
"Other Revenues": "82,837",
"Property Plant and Equipment": "2,273",
"Research And Development Expense": "12,923",
"Selling and Marketing Expense": "4,525"
},
"output_variables": {
"Assets": "144,701",
"Liabilities": "83,950",
"Expenses": "104,334",
"Revenues": "82,837",
"Stockholders Equity": "60,751",
"Net Income": "-22,710",
"Comprehensive Net Income": "-22,710",
"BaseVar": "208,518",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "139%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "80,332",
"Assets, Non-Current": "1,100",
"Cost of Goods and Services Sold": "31,214",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "43,774",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "8,059",
"Labor Expense": "0",
"Liabilities, Current": "10,333",
"Long Term Liabilities": "37,658",
"Operating Costs and Expenses": "0",
"Other Assets": "406",
"Other Compr. Net Income": "0",
"Other Expenses": "17,102",
"Other Liabilities": "136",
"Other Net Income": "-1,013",
"Other Revenues": "84,133",
"Property Plant and Equipment": "3,785",
"Research And Development Expense": "18,279",
"Selling and Marketing Expense": "9,895"
},
"output_variables": {
"Assets": "93,682",
"Liabilities": "48,127",
"Expenses": "120,264",
"Revenues": "84,133",
"Stockholders Equity": "45,555",
"Net Income": "-37,144",
"Comprehensive Net Income": "-37,144",
"BaseVar": "173,610",
"ECR before LimitedLiability": "41%",
"Economic Capital Ratio": "125%"
}
}
},
"top_rated": false,
"trend": -19.0,
"value": 1.2524958305998517,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001136174.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001136174.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001136174.svg"
},
{
"company_id": "0001822479",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001822479.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001822479.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001822479_main_keyfigs.svg",
"name": "Sotera Health Co",
"rank": 67,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001822479.svg",
"report_text": "The relative strengths and weaknesses of Sotera Health Co are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Sotera Health Co compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 38% points.The greatest weakness of Sotera Health Co is the variable Other Liabilities, reducing the Economic Capital Ratio by 123% points.
The company's Economic Capital Ratio, given in the ranking table, is 124%, being 44% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001822479_2022_Sotera_Health_Co.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "11.8",
"Liabilities": "-69.3",
"Stockholders Equity": "-39.0",
"ECR before LimitedLiability": "-37.8",
"Intangible Assets": "37.7",
"Property Plant and Equipment": "19.7",
"Assets, Non-Current": "-8.80",
"Assets, Current": "-30.5",
"Liabilities, Current": "11.0",
"Long Term Liabilities": "23.2",
"Other Liabilities": "-123",
"General and Administrative Expense": "10.0",
"Expenses": "35.2",
"Revenues": "-9.78",
"Net Income": "22.7",
"Operating Costs and Expenses": "4.72",
"Research And Development Expense": "4.24",
"Other Expenses": "5.69",
"Other Revenues": "-9.78",
"Comprehensive Net Income": "23.2",
"Economic Capital Ratio": "-43.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001822479_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "345,961",
"Assets, Non-Current": "62,217",
"Cost of Goods and Services Sold": "412,806",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "198,158",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,719,164",
"Labor Expense": "0",
"Liabilities, Current": "295,662",
"Long Term Liabilities": "49,291",
"Operating Costs and Expenses": "0",
"Other Assets": "11,363",
"Other Compr. Net Income": "10,037",
"Other Expenses": "122,376",
"Other Liabilities": "1,858,453",
"Other Net Income": "-81,017",
"Other Revenues": "931,478",
"Property Plant and Equipment": "650,797",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,789,502",
"Liabilities": "2,203,406",
"Expenses": "733,340",
"Revenues": "931,478",
"Stockholders Equity": "586,096",
"Net Income": "117,121",
"Comprehensive Net Income": "127,158",
"BaseVar": "3,374,390",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "124%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.2384131601689052,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001822479.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001822479.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001822479.svg"
},
{
"company_id": "0001320414",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001320414.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001320414.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001320414.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001320414_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001320414_main_keyfigs.svg",
"name": "Select Medical Holdings Corp",
"rank": 68,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001320414.svg",
"report_text": "The relative strengths and weaknesses of Select Medical Holdings Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Select Medical Holdings Corp compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Select Medical Holdings Corp is the variable Stockholders Equity, reducing the Economic Capital Ratio by 67% points.
The company's Economic Capital Ratio, given in the ranking table, is 121%, being 47% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001320414_2022_Select_Medical_Holdings_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-15.7",
"Liabilities": "-26.4",
"Stockholders Equity": "-40.0",
"ECR before LimitedLiability": "-14.7",
"Property Plant and Equipment": "-13.3",
"Assets, Current": "-21.0",
"Intangible Assets": "36.6",
"Long Term Liabilities": "-55.2",
"Liabilities, Current": "18.6",
"Expenses": "9.70",
"Revenues": "-44.8",
"Net Income": "25.0",
"Other Expenses": "-44.3",
"Operating Costs and Expenses": "8.86",
"Labor Expense": "14.1",
"General and Administrative Expense": "21.1",
"Cost of Goods and Services Sold": "8.82",
"Other Revenues": "-44.8",
"Other Net Income": "52.7",
"Comprehensive Net Income": "25.3",
"Economic Capital Ratio": "-21.4"
},
"2012": {
"Property Plant and Equipment": "-12.2",
"Assets": "-22.8",
"Liabilities": "-25.1",
"Stockholders Equity": "-48.6",
"ECR before LimitedLiability": "-14.6",
"Intangible Assets": "40.4",
"Assets, Current": "-30.1",
"Liabilities, Current": "22.7",
"Long Term Liabilities": "-68.1",
"Other Liabilities": "13.1",
"Other Revenues": "-45.7",
"Revenues": "-45.7",
"Net Income": "25.8",
"Comprehensive Net Income": "26.0",
"Other Expenses": "-50.4",
"General and Administrative Expense": "22.7",
"Other Net Income": "49.2",
"Operating Costs and Expenses": "7.30",
"Cost of Goods and Services Sold": "9.52",
"Labor Expense": "15.5",
"Economic Capital Ratio": "-28.8"
},
"2019": {
"Assets": "-10.2",
"Liabilities": "-38.9",
"Stockholders Equity": "-41.0",
"ECR before LimitedLiability": "-21.7",
"Other Assets": "-6.33",
"Intangible Assets": "42.5",
"Assets, Current": "-29.3",
"Other Liabilities": "8.58",
"Long Term Liabilities": "-68.6",
"Liabilities, Current": "15.8",
"Other Expenses": "10.0",
"Expenses": "16.2",
"Revenues": "7.84",
"Net Income": "24.8",
"General and Administrative Expense": "17.9",
"Cost of Goods and Services Sold": "-33.5",
"Research And Development Expense": "7.61",
"Labor Expense": "7.36",
"Other Revenues": "7.84",
"Comprehensive Net Income": "25.0",
"Economic Capital Ratio": "-31.8"
},
"2020": {
"Assets": "-15.2",
"Liabilities": "-41.9",
"Stockholders Equity": "-48.9",
"ECR before LimitedLiability": "-24.0",
"Other Assets": "-8.17",
"Intangible Assets": "36.1",
"Assets, Current": "-32.5",
"Liabilities, Current": "8.39",
"Other Liabilities": "6.67",
"Long Term Liabilities": "-59.6",
"Labor Expense": "6.86",
"Expenses": "13.9",
"Revenues": "10.2",
"Net Income": "27.7",
"General and Administrative Expense": "22.5",
"Other Expenses": "11.3",
"Operating Costs and Expenses": "5.44",
"Cost of Goods and Services Sold": "-35.1",
"Other Revenues": "10.2",
"Comprehensive Net Income": "26.5",
"Economic Capital Ratio": "-36.1"
},
"2021": {
"Assets": "-30.5",
"Liabilities": "-40.4",
"Stockholders Equity": "-67.2",
"ECR before LimitedLiability": "-40.6",
"Intangible Assets": "23.6",
"Assets, Non-Current": "6.49",
"Assets, Current": "-42.5",
"Liabilities, Current": "9.69",
"Long Term Liabilities": "-65.0",
"Other Liabilities": "11.1",
"General and Administrative Expense": "23.2",
"Expenses": "6.82",
"Revenues": "21.2",
"Net Income": "33.6",
"Operating Costs and Expenses": "6.85",
"Cost of Goods and Services Sold": "-44.8",
"Research And Development Expense": "6.14",
"Other Expenses": "11.1",
"Other Revenues": "21.2",
"Comprehensive Net Income": "33.2",
"Economic Capital Ratio": "-46.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001320414_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "483,410",
"Assets, Non-Current": "72,128",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "71,517",
"General and Administrative Expense": "62,354",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,703,839",
"Labor Expense": "0",
"Liabilities, Current": "383,938",
"Long Term Liabilities": "1,450,855",
"Operating Costs and Expenses": "0",
"Other Assets": "2,742",
"Other Compr. Net Income": "0",
"Other Expenses": "2,530,101",
"Other Liabilities": "82,028",
"Other Net Income": "2,776,734",
"Other Revenues": "0",
"Property Plant and Equipment": "510,028",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,772,147",
"Liabilities": "1,916,821",
"Expenses": "2,663,972",
"Revenues": "0",
"Stockholders Equity": "855,326",
"Net Income": "112,762",
"Comprehensive Net Income": "112,762",
"BaseVar": "5,064,837",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "453,663",
"Assets, Non-Current": "91,125",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "63,311",
"General and Administrative Expense": "66,194",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,712,279",
"Labor Expense": "0",
"Liabilities, Current": "388,463",
"Long Term Liabilities": "1,527,099",
"Operating Costs and Expenses": "0",
"Other Assets": "2,742",
"Other Compr. Net Income": "-5,663",
"Other Expenses": "2,667,212",
"Other Liabilities": "89,510",
"Other Net Income": "2,950,610",
"Other Revenues": "0",
"Property Plant and Equipment": "501,552",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,761,361",
"Liabilities": "2,005,072",
"Expenses": "2,796,717",
"Revenues": "0",
"Stockholders Equity": "756,289",
"Net Income": "153,893",
"Comprehensive Net Income": "148,230",
"BaseVar": "5,259,712",
"ECR before LimitedLiability": "52%",
"Economic Capital Ratio": "135%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,212,992",
"Assets, Non-Current": "1,327,867",
"Cost of Goods and Services Sold": "4,641,002",
"Depreciation, Depletion, Amortization": "212,576",
"General and Administrative Expense": "128,463",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,801,023",
"Labor Expense": "0",
"Liabilities, Current": "1,062,538",
"Long Term Liabilities": "4,374,174",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "264,288",
"Other Liabilities": "0",
"Other Net Income": "-6,562",
"Other Revenues": "5,453,922",
"Property Plant and Equipment": "998,406",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,340,288",
"Liabilities": "5,436,712",
"Expenses": "5,246,329",
"Revenues": "5,453,922",
"Stockholders Equity": "1,903,576",
"Net Income": "201,031",
"Comprehensive Net Income": "201,031",
"BaseVar": "11,741,906",
"ECR before LimitedLiability": "46%",
"Economic Capital Ratio": "130%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,594,000",
"Assets, Non-Current": "1,351,424",
"Cost of Goods and Services Sold": "4,710,372",
"Depreciation, Depletion, Amortization": "205,659",
"General and Administrative Expense": "138,037",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,766,555",
"Labor Expense": "0",
"Liabilities, Current": "1,570,787",
"Long Term Liabilities": "4,433,468",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-87,638",
"Other Expenses": "264,878",
"Other Liabilities": "0",
"Other Net Income": "131,839",
"Other Revenues": "5,531,713",
"Property Plant and Equipment": "943,420",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,655,399",
"Liabilities": "6,004,255",
"Expenses": "5,318,946",
"Revenues": "5,531,713",
"Stockholders Equity": "1,651,144",
"Net Income": "344,606",
"Comprehensive Net Income": "256,968",
"BaseVar": "12,364,895",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "124%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,139,439",
"Assets, Non-Current": "1,435,474",
"Cost of Goods and Services Sold": "5,285,149",
"Depreciation, Depletion, Amortization": "202,645",
"General and Administrative Expense": "146,975",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,823,791",
"Labor Expense": "0",
"Liabilities, Current": "1,415,869",
"Long Term Liabilities": "4,579,367",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-83,415",
"Other Expenses": "260,408",
"Other Liabilities": "0",
"Other Net Income": "190,611",
"Other Revenues": "6,204,515",
"Property Plant and Equipment": "961,467",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,360,171",
"Liabilities": "5,995,236",
"Expenses": "5,895,177",
"Revenues": "6,204,515",
"Stockholders Equity": "1,364,935",
"Net Income": "499,949",
"Comprehensive Net Income": "416,534",
"BaseVar": "12,864,562",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "121%"
}
}
},
"top_rated": false,
"trend": -17.0,
"value": 1.2101398314076148,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001320414.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001320414.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001320414.svg"
},
{
"company_id": "0001832415",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001832415.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001832415.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001832415_main_keyfigs.svg",
"name": "Better Therapeutics Inc",
"rank": 69,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001832415.svg",
"report_text": "The relative strengths and weaknesses of Better Therapeutics Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Better Therapeutics Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 59% points.The greatest weakness of Better Therapeutics Inc is the variable Net Income, reducing the Economic Capital Ratio by 76% points.
The company's Economic Capital Ratio, given in the ranking table, is 121%, being 47% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001832415_2022_Better_Therapeutics_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "13.4",
"Assets": "33.8",
"Liabilities": "13.7",
"Stockholders Equity": "34.6",
"ECR before LimitedLiability": "-40.8",
"Intangible Assets": "-29.5",
"Property Plant and Equipment": "-12.1",
"Assets, Non-Current": "-12.1",
"Assets, Current": "59.3",
"Liabilities, Current": "13.1",
"Other Liabilities": "9.45",
"Expenses": "-12.1",
"Revenues": "-46.6",
"Net Income": "-76.4",
"Cost of Goods and Services Sold": "17.3",
"Research And Development Expense": "-42.6",
"Other Expenses": "10.5",
"Other Revenues": "-46.6",
"Comprehensive Net Income": "-76.3",
"Other Net Income": "-24.4",
"Economic Capital Ratio": "-47.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001832415_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "45,251",
"Assets, Non-Current": "548",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "8,788",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,733",
"Long Term Liabilities": "9,505",
"Operating Costs and Expenses": "0",
"Other Assets": "5,077",
"Other Compr. Net Income": "0",
"Other Expenses": "679",
"Other Liabilities": "0",
"Other Net Income": "-10,390",
"Other Revenues": "0",
"Property Plant and Equipment": "82",
"Research And Development Expense": "19,436",
"Selling and Marketing Expense": "2,336"
},
"output_variables": {
"Assets": "50,958",
"Liabilities": "14,238",
"Expenses": "31,239",
"Revenues": "0",
"Stockholders Equity": "36,720",
"Net Income": "-41,629",
"Comprehensive Net Income": "-41,629",
"BaseVar": "53,412",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "121%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.2080008946958634,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001832415.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001832415.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001832415.svg"
},
{
"company_id": "0001766400",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001766400.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001766400.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001766400.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001766400_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001766400_main_keyfigs.svg",
"name": "Pennant Group Inc",
"rank": 70,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001766400.svg",
"report_text": "The relative strengths and weaknesses of Pennant Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pennant Group Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 37% points.The greatest weakness of Pennant Group Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 64% points.
The company's Economic Capital Ratio, given in the ranking table, is 121%, being 47% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001766400_2022_Pennant_Group_Inc.pdf",
"shrinked_graph_json": {
"2019": {
"Property Plant and Equipment": "-16.7",
"Assets": "-16.8",
"Liabilities": "-50.7",
"Stockholders Equity": "-56.5",
"ECR before LimitedLiability": "-39.7",
"Assets, Non-Current": "36.8",
"Intangible Assets": "-17.6",
"Assets, Current": "-40.3",
"Long Term Liabilities": "-80.3",
"Liabilities, Current": "21.4",
"Expenses": "17.3",
"Revenues": "6.24",
"Net Income": "24.2",
"General and Administrative Expense": "21.1",
"Cost of Goods and Services Sold": "-28.6",
"Research And Development Expense": "8.15",
"Labor Expense": "7.88",
"Operating Costs and Expenses": "6.74",
"Other Revenues": "6.24",
"Comprehensive Net Income": "24.4",
"Economic Capital Ratio": "-49.7"
},
"2020": {
"Property Plant and Equipment": "-12.3",
"Assets": "-18.3",
"Liabilities": "-42.1",
"Stockholders Equity": "-52.6",
"ECR before LimitedLiability": "-26.8",
"Intangible Assets": "-12.8",
"Assets, Current": "-40.4",
"Assets, Non-Current": "38.3",
"Liabilities, Current": "13.9",
"Long Term Liabilities": "-63.6",
"Labor Expense": "7.06",
"Expenses": "11.7",
"Revenues": "13.5",
"Net Income": "26.8",
"General and Administrative Expense": "25.1",
"Research And Development Expense": "4.88",
"Operating Costs and Expenses": "5.59",
"Cost of Goods and Services Sold": "-32.3",
"Other Revenues": "13.5",
"Comprehensive Net Income": "26.8",
"Economic Capital Ratio": "-38.9"
},
"2021": {
"Other Assets": "9.31",
"Assets": "-29.3",
"Liabilities": "-37.4",
"Stockholders Equity": "-63.7",
"ECR before LimitedLiability": "-41.0",
"Intangible Assets": "-22.0",
"Property Plant and Equipment": "-11.1",
"Assets, Non-Current": "36.7",
"Assets, Current": "-43.2",
"Liabilities, Current": "18.0",
"Long Term Liabilities": "-53.7",
"Other Revenues": "21.2",
"Revenues": "21.2",
"Net Income": "27.4",
"General and Administrative Expense": "25.4",
"Comprehensive Net Income": "27.5",
"Operating Costs and Expenses": "6.86",
"Labor Expense": "5.93",
"Cost of Goods and Services Sold": "-41.6",
"Research And Development Expense": "6.15",
"Economic Capital Ratio": "-47.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001766400_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "38,683",
"Assets, Non-Current": "316,328",
"Cost of Goods and Services Sold": "258,941",
"Depreciation, Depletion, Amortization": "3,810",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "41,233",
"Labor Expense": "0",
"Liabilities, Current": "51,192",
"Long Term Liabilities": "306,921",
"Operating Costs and Expenses": "0",
"Other Assets": "36,862",
"Other Compr. Net Income": "0",
"Other Expenses": "72,195",
"Other Liabilities": "18,526",
"Other Net Income": "-410",
"Other Revenues": "338,531",
"Property Plant and Equipment": "14,644",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "447,750",
"Liabilities": "376,639",
"Expenses": "334,946",
"Revenues": "338,531",
"Stockholders Equity": "71,111",
"Net Income": "3,175",
"Comprehensive Net Income": "3,175",
"BaseVar": "749,138",
"ECR before LimitedLiability": "26%",
"Economic Capital Ratio": "112%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "59,599",
"Assets, Non-Current": "308,650",
"Cost of Goods and Services Sold": "296,874",
"Depreciation, Depletion, Amortization": "4,675",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "66,444",
"Labor Expense": "0",
"Liabilities, Current": "89,015",
"Long Term Liabilities": "308,512",
"Operating Costs and Expenses": "0",
"Other Assets": "54,399",
"Other Compr. Net Income": "0",
"Other Expenses": "72,837",
"Other Liabilities": "8,277",
"Other Net Income": "-1,014",
"Other Revenues": "390,953",
"Property Plant and Equipment": "17,884",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "506,976",
"Liabilities": "405,804",
"Expenses": "374,386",
"Revenues": "390,953",
"Stockholders Equity": "101,172",
"Net Income": "15,553",
"Comprehensive Net Income": "15,553",
"BaseVar": "839,566",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "121%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "75,841",
"Assets, Non-Current": "300,997",
"Cost of Goods and Services Sold": "353,093",
"Depreciation, Depletion, Amortization": "4,784",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "74,265",
"Labor Expense": "0",
"Liabilities, Current": "71,635",
"Long Term Liabilities": "293,046",
"Operating Costs and Expenses": "0",
"Other Assets": "62,406",
"Other Compr. Net Income": "0",
"Other Expenses": "77,704",
"Other Liabilities": "51,372",
"Other Net Income": "-1,965",
"Other Revenues": "439,694",
"Property Plant and Equipment": "16,788",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "530,297",
"Liabilities": "416,053",
"Expenses": "435,581",
"Revenues": "439,694",
"Stockholders Equity": "114,244",
"Net Income": "2,148",
"Comprehensive Net Income": "2,148",
"BaseVar": "911,795",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "121%"
}
}
},
"top_rated": false,
"trend": -17.0,
"value": 1.2065319860358739,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001766400.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001766400.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001766400.svg"
},
{
"company_id": "0001770141",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001770141.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001770141.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001770141_main_keyfigs.svg",
"name": "Uphealth Inc",
"rank": 71,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001770141.svg",
"report_text": "The relative strengths and weaknesses of Uphealth Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Uphealth Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 44% points.The greatest weakness of Uphealth Inc is the variable Goodwill Impairment Loss, reducing the Economic Capital Ratio by 56% points.
The company's Economic Capital Ratio, given in the ranking table, is 120%, being 48% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001770141_2022_Uphealth_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "-5.43",
"Assets": "4.75",
"Stockholders Equity": "6.72",
"Other Liabilities": "7.58",
"ECR before LimitedLiability": "-41.7",
"Intangible Assets": "43.7",
"Assets, Non-Current": "-13.6",
"Assets, Current": "-34.7",
"General and Administrative Expense": "10.5",
"Expenses": "-27.7",
"Revenues": "-29.0",
"Net Income": "-45.2",
"Operating Costs and Expenses": "6.52",
"Labor Expense": "5.64",
"Goodwill Impairment Loss": "-56.1",
"Other Expenses": "5.81",
"Other Revenues": "-29.0",
"Liabilities, Current": "-6.32",
"Comprehensive Net Income": "-45.8",
"Other Net Income": "10.6",
"Economic Capital Ratio": "-47.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001770141_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "106,747",
"Assets, Non-Current": "6,907",
"Cost of Goods and Services Sold": "80,208",
"Depreciation, Depletion, Amortization": "13,044",
"General and Administrative Expense": "57,763",
"Goodwill Impairment Loss": "297,930",
"Intangible Assets": "399,581",
"Labor Expense": "0",
"Liabilities, Current": "124,985",
"Long Term Liabilities": "101,919",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-3,928",
"Other Expenses": "35,815",
"Other Liabilities": "8,560",
"Other Net Income": "36,645",
"Other Revenues": "123,795",
"Property Plant and Equipment": "56,072",
"Research And Development Expense": "7,302",
"Selling and Marketing Expense": "9,275"
},
"output_variables": {
"Assets": "569,307",
"Liabilities": "235,464",
"Expenses": "501,337",
"Revenues": "123,795",
"Stockholders Equity": "333,843",
"Net Income": "-340,897",
"Comprehensive Net Income": "-344,825",
"BaseVar": "735,238",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "120%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.1990230113788367,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001770141.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001770141.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001770141.svg"
},
{
"company_id": "0000070318",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000070318.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000070318.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000070318.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000070318_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000070318_main_keyfigs.svg",
"name": "Tenet Healthcare CORP",
"rank": 72,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000070318.svg",
"report_text": "The relative strengths and weaknesses of Tenet Healthcare CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Tenet Healthcare CORP compared to the market average is the variable Comprehensive Net Income, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Tenet Healthcare CORP is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 71% points.
The company's Economic Capital Ratio, given in the ranking table, is 116%, being 52% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000070318_2022_Tenet_Healthcare_CORP.pdf",
"shrinked_graph_json": {
"2018": {
"Other Assets": "-10.0",
"Assets": "-18.4",
"Liabilities": "-60.2",
"Stockholders Equity": "-64.5",
"ECR before LimitedLiability": "-35.1",
"Property Plant and Equipment": "16.0",
"Intangible Assets": "16.2",
"Assets, Current": "-36.0",
"Liabilities, Current": "16.1",
"Long Term Liabilities": "-94.1",
"Expenses": "16.1",
"Revenues": "9.39",
"Net Income": "16.6",
"Operating Costs and Expenses": "-25.7",
"Other Expenses": "16.0",
"General and Administrative Expense": "16.2",
"Cost of Goods and Services Sold": "16.2",
"Labor Expense": "-26.7",
"Other Revenues": "9.39",
"Comprehensive Net Income": "16.7",
"Economic Capital Ratio": "-55.8"
},
"2019": {
"Property Plant and Equipment": "13.3",
"Assets": "-23.0",
"Liabilities": "-57.8",
"Stockholders Equity": "-68.0",
"ECR before LimitedLiability": "-51.0",
"Assets, Non-Current": "-8.89",
"Other Assets": "-7.15",
"Intangible Assets": "13.3",
"Assets, Current": "-33.7",
"Long Term Liabilities": "-79.9",
"Liabilities, Current": "12.7",
"Other Expenses": "9.43",
"Expenses": "13.3",
"Net Income": "13.5",
"General and Administrative Expense": "13.4",
"Cost of Goods and Services Sold": "13.7",
"Research And Development Expense": "8.56",
"Labor Expense": "-27.3",
"Operating Costs and Expenses": "-22.7",
"Comprehensive Net Income": "13.5",
"Economic Capital Ratio": "-61.0"
},
"2020": {
"Property Plant and Equipment": "15.6",
"Assets": "-16.3",
"Liabilities": "-59.3",
"Stockholders Equity": "-61.6",
"ECR before LimitedLiability": "-41.5",
"Other Assets": "-7.48",
"Intangible Assets": "18.7",
"Assets, Current": "-30.8",
"Assets, Non-Current": "-5.83",
"Liabilities, Current": "11.6",
"Long Term Liabilities": "-71.7",
"Labor Expense": "-22.6",
"Expenses": "18.6",
"Net Income": "18.7",
"General and Administrative Expense": "18.7",
"Research And Development Expense": "4.80",
"Other Expenses": "10.5",
"Operating Costs and Expenses": "-19.5",
"Cost of Goods and Services Sold": "18.7",
"Comprehensive Net Income": "18.7",
"Economic Capital Ratio": "-53.6"
},
"2021": {
"Assets": "-23.8",
"Liabilities": "-52.2",
"Stockholders Equity": "-65.3",
"ECR before LimitedLiability": "-45.7",
"Intangible Assets": "8.19",
"Property Plant and Equipment": "15.5",
"Assets, Current": "-33.4",
"Liabilities, Current": "7.78",
"Long Term Liabilities": "-71.2",
"Other Liabilities": "7.81",
"General and Administrative Expense": "23.6",
"Expenses": "13.2",
"Revenues": "11.7",
"Net Income": "28.4",
"Operating Costs and Expenses": "-19.3",
"Labor Expense": "-24.3",
"Cost of Goods and Services Sold": "19.0",
"Other Expenses": "8.48",
"Other Revenues": "11.7",
"Comprehensive Net Income": "28.4",
"Economic Capital Ratio": "-51.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000070318_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "4,636,000",
"Assets, Non-Current": "1,456,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "802,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "9,012,000",
"Labor Expense": "8,634,000",
"Liabilities, Current": "3,893,000",
"Long Term Liabilities": "15,888,000",
"Operating Costs and Expenses": "7,263,000",
"Other Assets": "312,000",
"Other Compr. Net Income": "0",
"Other Expenses": "1,394,000",
"Other Liabilities": "521,000",
"Other Net Income": "246,000",
"Other Revenues": "18,313,000",
"Property Plant and Equipment": "6,993,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "22,409,000",
"Liabilities": "20,302,000",
"Expenses": "18,093,000",
"Revenues": "18,313,000",
"Stockholders Equity": "2,107,000",
"Net Income": "466,000",
"Comprehensive Net Income": "466,000",
"BaseVar": "39,681,500",
"ECR before LimitedLiability": "16%",
"Economic Capital Ratio": "103%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "5,081,000",
"Assets, Non-Current": "2,369,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "850,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "8,854,000",
"Labor Expense": "8,704,000",
"Liabilities, Current": "4,232,000",
"Long Term Liabilities": "16,570,000",
"Operating Costs and Expenses": "7,246,000",
"Other Assets": "169,000",
"Other Compr. Net Income": "0",
"Other Expenses": "1,328,000",
"Other Liabilities": "560,000",
"Other Net Income": "-197,000",
"Other Revenues": "18,479,000",
"Property Plant and Equipment": "6,878,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "23,351,000",
"Liabilities": "21,362,000",
"Expenses": "18,128,000",
"Revenues": "18,479,000",
"Stockholders Equity": "1,989,000",
"Net Income": "154,000",
"Comprehensive Net Income": "154,000",
"BaseVar": "40,758,500",
"ECR before LimitedLiability": "14%",
"Economic Capital Ratio": "101%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "7,147,000",
"Assets, Non-Current": "2,534,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "857,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "10,408,000",
"Labor Expense": "8,418,000",
"Liabilities, Current": "4,876,000",
"Long Term Liabilities": "17,926,000",
"Operating Costs and Expenses": "7,107,000",
"Other Assets": "325,000",
"Other Compr. Net Income": "0",
"Other Expenses": "1,196,000",
"Other Liabilities": "1,415,000",
"Other Net Income": "706,000",
"Other Revenues": "17,640,000",
"Property Plant and Equipment": "6,692,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "27,106,000",
"Liabilities": "24,217,000",
"Expenses": "17,578,000",
"Revenues": "17,640,000",
"Stockholders Equity": "2,889,000",
"Net Income": "768,000",
"Comprehensive Net Income": "768,000",
"BaseVar": "43,623,500",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "106%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "7,075,000",
"Assets, Non-Current": "3,254,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "855,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "10,758,000",
"Labor Expense": "8,878,000",
"Liabilities, Current": "5,145,000",
"Long Term Liabilities": "17,741,000",
"Operating Costs and Expenses": "7,534,000",
"Other Assets": "65,000",
"Other Compr. Net Income": "0",
"Other Expenses": "1,419,000",
"Other Liabilities": "436,000",
"Other Net Income": "677,000",
"Other Revenues": "19,485,000",
"Property Plant and Equipment": "6,427,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "27,579,000",
"Liabilities": "23,322,000",
"Expenses": "18,686,000",
"Revenues": "19,485,000",
"Stockholders Equity": "4,257,000",
"Net Income": "1,476,000",
"Comprehensive Net Income": "1,476,000",
"BaseVar": "44,874,500",
"ECR before LimitedLiability": "30%",
"Economic Capital Ratio": "116%"
}
}
},
"top_rated": false,
"trend": -14.0,
"value": 1.158740148270108,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000070318.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000070318.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000070318.svg"
},
{
"company_id": "0001576280",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001576280.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001576280.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001576280.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001576280_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001576280_main_keyfigs.svg",
"name": "Guardant Health Inc",
"rank": 73,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001576280.svg",
"report_text": "The relative strengths and weaknesses of Guardant Health Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Guardant Health Inc compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 27% points.The greatest weakness of Guardant Health Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 88% points.
The company's Economic Capital Ratio, given in the ranking table, is 114%, being 54% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001576280_2022_Guardant_Health_Inc.pdf",
"shrinked_graph_json": {
"2018": {
"Other Assets": "5.80",
"Assets": "42.1",
"Expenses": "18.2",
"Stockholders Equity": "114",
"ECR before LimitedLiability": "105",
"Intangible Assets": "-4.86",
"Assets, Current": "54.4",
"Liabilities": "36.5",
"Liabilities, Current": "19.7",
"Long Term Liabilities": "21.0",
"Selling and Marketing Expense": "-8.89",
"Operating Costs and Expenses": "2.76",
"Other Expenses": "4.04",
"General and Administrative Expense": "6.21",
"Research And Development Expense": "-6.96",
"Cost of Goods and Services Sold": "14.3",
"Labor Expense": "5.56",
"Other Revenues": "-22.1",
"Revenues": "-22.1",
"Economic Capital Ratio": "84.5",
"Other Net Income": "2.80"
},
"2019": {
"Assets": "31.7",
"Liabilities": "39.9",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "96.3",
"Other Assets": "15.5",
"Intangible Assets": "-4.75",
"Assets, Current": "25.4",
"Other Liabilities": "6.40",
"Long Term Liabilities": "21.9",
"Liabilities, Current": "15.4",
"Expenses": "18.4",
"Revenues": "-15.8",
"Net Income": "5.30",
"General and Administrative Expense": "4.81",
"Cost of Goods and Services Sold": "16.5",
"Research And Development Expense": "-6.19",
"Selling and Marketing Expense": "-6.98",
"Labor Expense": "4.88",
"Other Revenues": "-15.8",
"Comprehensive Net Income": "4.58",
"Economic Capital Ratio": "86.3"
},
"2020": {
"Property Plant and Equipment": "-4.29",
"Assets": "50.3",
"Liabilities": "-22.5",
"Expenses": "22.5",
"Revenues": "-20.7",
"Stockholders Equity": "40.8",
"ECR before LimitedLiability": "28.7",
"Other Assets": "6.64",
"Intangible Assets": "-10.00",
"Assets, Current": "88.8",
"Assets, Non-Current": "-4.55",
"Liabilities, Current": "21.3",
"Other Liabilities": "4.53",
"Long Term Liabilities": "-56.1",
"Labor Expense": "3.82",
"General and Administrative Expense": "4.67",
"Research And Development Expense": "-3.85",
"Other Expenses": "3.87",
"Cost of Goods and Services Sold": "12.3",
"Other Revenues": "-20.7",
"Economic Capital Ratio": "16.6"
},
"2021": {
"Other Assets": "27.5",
"Assets": "23.9",
"Liabilities": "-61.7",
"Expenses": "22.7",
"Stockholders Equity": "-27.1",
"ECR before LimitedLiability": "-47.8",
"Intangible Assets": "-25.5",
"Assets, Current": "13.8",
"Liabilities, Current": "12.6",
"Long Term Liabilities": "-88.0",
"Other Liabilities": "7.70",
"General and Administrative Expense": "7.25",
"Operating Costs and Expenses": "4.83",
"Labor Expense": "4.18",
"Cost of Goods and Services Sold": "14.3",
"Research And Development Expense": "-8.16",
"Other Expenses": "4.09",
"Selling and Marketing Expense": "-5.81",
"Other Revenues": "-23.9",
"Revenues": "-23.9",
"Economic Capital Ratio": "-54.0"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001576280_strength_weakness.svg",
"table_records": {
"2018": {
"input_variables": {
"Assets, Current": "468,991",
"Assets, Non-Current": "2,046",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "36,192",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "46,944",
"Long Term Liabilities": "206",
"Operating Costs and Expenses": "0",
"Other Assets": "85,363",
"Other Compr. Net Income": "-351",
"Other Expenses": "44,499",
"Other Liabilities": "15,301",
"Other Net Income": "9,968",
"Other Revenues": "90,639",
"Property Plant and Equipment": "31,003",
"Research And Development Expense": "50,714",
"Selling and Marketing Expense": "53,465"
},
"output_variables": {
"Assets": "587,403",
"Liabilities": "62,451",
"Expenses": "184,870",
"Revenues": "90,639",
"Stockholders Equity": "524,952",
"Net Income": "-84,263",
"Comprehensive Net Income": "-84,614",
"BaseVar": "467,841",
"ECR before LimitedLiability": "208%",
"Economic Capital Ratio": "244%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "597,358",
"Assets, Non-Current": "34,022",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "61,399",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,814",
"Labor Expense": "0",
"Liabilities, Current": "72,734",
"Long Term Liabilities": "34,928",
"Operating Costs and Expenses": "0",
"Other Assets": "275,673",
"Other Compr. Net Income": "-6,606",
"Other Expenses": "70,029",
"Other Liabilities": "6,880",
"Other Net Income": "13,829",
"Other Revenues": "214,375",
"Property Plant and Equipment": "43,668",
"Research And Development Expense": "86,292",
"Selling and Marketing Expense": "78,335"
},
"output_variables": {
"Assets": "962,535",
"Liabilities": "114,542",
"Expenses": "296,055",
"Revenues": "214,375",
"Stockholders Equity": "847,993",
"Net Income": "-67,851",
"Comprehensive Net Income": "-74,457",
"BaseVar": "803,971",
"ECR before LimitedLiability": "214%",
"Economic Capital Ratio": "248%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,888,361",
"Assets, Non-Current": "54,551",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "192,770",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "19,445",
"Labor Expense": "0",
"Liabilities, Current": "66,809",
"Long Term Liabilities": "849,377",
"Operating Costs and Expenses": "0",
"Other Assets": "246,642",
"Other Compr. Net Income": "-5,914",
"Other Expenses": "97,680",
"Other Liabilities": "0",
"Other Net Income": "13,812",
"Other Revenues": "286,730",
"Property Plant and Equipment": "62,782",
"Research And Development Expense": "149,862",
"Selling and Marketing Expense": "106,513"
},
"output_variables": {
"Assets": "2,271,781",
"Liabilities": "916,186",
"Expenses": "546,825",
"Revenues": "286,730",
"Stockholders Equity": "1,355,595",
"Net Income": "-246,283",
"Comprehensive Net Income": "-252,197",
"BaseVar": "2,020,624",
"ECR before LimitedLiability": "107%",
"Economic Capital Ratio": "176%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,114,126",
"Assets, Non-Current": "250,381",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "206,640",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,497",
"Labor Expense": "0",
"Liabilities, Current": "194,687",
"Long Term Liabilities": "1,364,807",
"Operating Costs and Expenses": "0",
"Other Assets": "698,034",
"Other Compr. Net Income": "-28,361",
"Other Expenses": "125,789",
"Other Liabilities": "0",
"Other Net Income": "29,108",
"Other Revenues": "373,653",
"Property Plant and Equipment": "124,461",
"Research And Development Expense": "263,221",
"Selling and Marketing Expense": "191,881"
},
"output_variables": {
"Assets": "2,204,499",
"Liabilities": "1,559,494",
"Expenses": "787,531",
"Revenues": "373,653",
"Stockholders Equity": "645,005",
"Net Income": "-384,770",
"Comprehensive Net Income": "-413,131",
"BaseVar": "2,491,323",
"ECR before LimitedLiability": "28%",
"Economic Capital Ratio": "114%"
}
}
},
"top_rated": false,
"trend": -42.0,
"value": 1.1380295341928393,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001576280.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001576280.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001576280.svg"
},
{
"company_id": "0000927066",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000927066.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000927066.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000927066.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000927066_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000927066_main_keyfigs.svg",
"name": "Davita INC",
"rank": 74,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000927066.svg",
"report_text": "The relative strengths and weaknesses of Davita INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Davita INC compared to the market average is the variable Net Income, increasing the Economic Capital Ratio by 26% points.The greatest weakness of Davita INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 78% points.
The company's Economic Capital Ratio, given in the ranking table, is 113%, being 54% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000927066_2022_Davita_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "17.8",
"Stockholders Equity": "-20.5",
"ECR before LimitedLiability": "-50.7",
"Assets, Current": "9.43",
"Property Plant and Equipment": "6.46",
"Liabilities, Current": "6.74",
"Liabilities": "-56.3",
"Long Term Liabilities": "-57.8",
"Other Liabilities": "-5.71",
"Other Expenses": "12.6",
"Expenses": "20.6",
"Revenues": "-56.5",
"Net Income": "-2.14",
"General and Administrative Expense": "2.71",
"Cost of Goods and Services Sold": "49.5",
"Labor Expense": "4.46",
"Operating Costs and Expenses": "-38.9",
"Other Revenues": "-56.5",
"Comprehensive Net Income": "-2.14",
"Other Net Income": "45.1",
"Economic Capital Ratio": "-50.3"
},
"2010": {
"Assets, Current": "2.37",
"Assets": "-13.2",
"Liabilities": "-36.4",
"Stockholders Equity": "-43.0",
"ECR before LimitedLiability": "-53.1",
"Property Plant and Equipment": "-14.1",
"Assets, Non-Current": "-4.65",
"Intangible Assets": "6.02",
"Other Liabilities": "4.18",
"Liabilities, Current": "6.13",
"Long Term Liabilities": "-48.4",
"Other Revenues": "-33.4",
"Revenues": "-33.4",
"Net Income": "-4.20",
"Other Expenses": "24.1",
"Comprehensive Net Income": "-3.16",
"Cost of Goods and Services Sold": "12.8",
"Labor Expense": "9.39",
"Operating Costs and Expenses": "-38.6",
"Other Net Income": "33.7",
"Economic Capital Ratio": "-51.3"
},
"2011": {
"Liabilities": "-38.6",
"Stockholders Equity": "-30.3",
"ECR before LimitedLiability": "-12.4",
"Long Term Liabilities": "-58.4",
"Liabilities, Current": "15.0",
"Expenses": "20.4",
"Net Income": "24.5",
"Other Expenses": "26.7",
"Operating Costs and Expenses": "-38.7",
"Labor Expense": "12.2",
"General and Administrative Expense": "12.3",
"Cost of Goods and Services Sold": "7.62",
"Other Revenues": "-39.2",
"Revenues": "-39.2",
"Property Plant and Equipment": "-11.5",
"Assets, Current": "-9.38",
"Assets, Non-Current": "-5.16",
"Intangible Assets": "36.5",
"Other Net Income": "51.7",
"Comprehensive Net Income": "24.7",
"Economic Capital Ratio": "-19.1"
},
"2012": {
"Property Plant and Equipment": "-10.2",
"Assets": "14.9",
"Liabilities": "-54.8",
"Stockholders Equity": "-25.1",
"ECR before LimitedLiability": "-15.3",
"Intangible Assets": "48.7",
"Assets, Current": "-17.9",
"Liabilities, Current": "12.2",
"Long Term Liabilities": "-78.6",
"Expenses": "30.0",
"Revenues": "-33.5",
"Net Income": "18.2",
"Other Expenses": "22.2",
"General and Administrative Expense": "12.1",
"Operating Costs and Expenses": "-26.6",
"Cost of Goods and Services Sold": "6.77",
"Labor Expense": "11.0",
"Other Revenues": "-33.5",
"Other Net Income": "27.1",
"Comprehensive Net Income": "17.9",
"Economic Capital Ratio": "-29.5"
},
"2013": {
"Assets": "12.3",
"Liabilities": "-57.9",
"Stockholders Equity": "-11.7",
"ECR before LimitedLiability": "42.7",
"Property Plant and Equipment": "-3.28",
"Assets, Current": "-8.77",
"Intangible Assets": "40.1",
"Other Liabilities": "-113",
"Liabilities, Current": "12.1",
"Long Term Liabilities": "15.9",
"Expenses": "54.5",
"Revenues": "-28.3",
"Net Income": "71.6",
"General and Administrative Expense": "13.6",
"Cost of Goods and Services Sold": "4.62",
"Labor Expense": "7.99",
"Other Expenses": "15.3",
"Other Revenues": "-28.3",
"Comprehensive Net Income": "75.7",
"Other Net Income": "44.6",
"Economic Capital Ratio": "33.5"
},
"2014": {
"Liabilities": "-25.0",
"Stockholders Equity": "-17.4",
"Economic Capital Ratio": "-9.79",
"Liabilities, Current": "24.1",
"Long Term Liabilities": "-56.3",
"Expenses": "18.3",
"Revenues": "-38.0",
"Net Income": "24.0",
"Operating Costs and Expenses": "-38.9",
"Labor Expense": "13.3",
"Research And Development Expense": "4.57",
"Other Expenses": "19.4",
"Cost of Goods and Services Sold": "7.92",
"General and Administrative Expense": "12.7",
"Other Revenues": "-38.0",
"Other Assets": "-5.62",
"Intangible Assets": "57.8",
"Property Plant and Equipment": "-11.8",
"Assets, Current": "-14.9",
"Comprehensive Net Income": "23.2",
"Other Net Income": "51.8"
},
"2015": {
"Long Term Liabilities": "-69.9",
"Liabilities": "-31.3",
"Stockholders Equity": "-24.9",
"ECR before LimitedLiability": "-8.12",
"Liabilities, Current": "26.4",
"Selling and Marketing Expense": "5.43",
"Expenses": "17.2",
"Revenues": "-41.3",
"Net Income": "25.1",
"Operating Costs and Expenses": "-41.8",
"General and Administrative Expense": "12.7",
"Other Expenses": "20.2",
"Labor Expense": "12.5",
"Cost of Goods and Services Sold": "10.8",
"Other Revenues": "-41.3",
"Assets, Current": "-15.9",
"Intangible Assets": "37.2",
"Property Plant and Equipment": "-10.8",
"Comprehensive Net Income": "24.5",
"Other Net Income": "51.4",
"Economic Capital Ratio": "-20.5"
},
"2016": {
"Liabilities, Current": "34.3",
"Liabilities": "-23.1",
"Stockholders Equity": "-13.7",
"ECR before LimitedLiability": "17.4",
"Long Term Liabilities": "-72.7",
"Expenses": "19.2",
"Revenues": "-44.0",
"Net Income": "30.7",
"Operating Costs and Expenses": "-45.5",
"Selling and Marketing Expense": "6.26",
"General and Administrative Expense": "14.6",
"Labor Expense": "6.60",
"Other Expenses": "25.8",
"Cost of Goods and Services Sold": "15.7",
"Other Revenues": "-44.0",
"Property Plant and Equipment": "-7.39",
"Intangible Assets": "52.7",
"Assets, Current": "-17.5",
"Other Net Income": "53.0",
"Comprehensive Net Income": "30.5",
"Economic Capital Ratio": "-10.3"
},
"2017": {
"Assets": "12.8",
"Stockholders Equity": "-15.2",
"ECR before LimitedLiability": "15.6",
"Intangible Assets": "17.8",
"Assets, Current": "6.90",
"Liabilities, Current": "16.7",
"Liabilities": "-38.5",
"Other Liabilities": "6.47",
"Long Term Liabilities": "-67.2",
"General and Administrative Expense": "15.2",
"Expenses": "27.8",
"Revenues": "-33.2",
"Net Income": "26.6",
"Operating Costs and Expenses": "-33.6",
"Research And Development Expense": "6.14",
"Other Expenses": "22.8",
"Cost of Goods and Services Sold": "10.8",
"Other Revenues": "-33.2",
"Other Net Income": "37.6",
"Comprehensive Net Income": "26.4",
"Economic Capital Ratio": "-8.55"
},
"2018": {
"Other Assets": "-7.15",
"Assets": "5.99",
"Liabilities": "-51.0",
"Stockholders Equity": "-32.0",
"ECR before LimitedLiability": "-9.92",
"Property Plant and Equipment": "3.04",
"Intangible Assets": "24.5",
"Assets, Non-Current": "-8.71",
"Liabilities, Current": "2.67",
"Long Term Liabilities": "-55.6",
"Selling and Marketing Expense": "3.74",
"Expenses": "30.5",
"Net Income": "28.9",
"Operating Costs and Expenses": "-34.9",
"Other Expenses": "16.3",
"General and Administrative Expense": "14.6",
"Research And Development Expense": "5.64",
"Cost of Goods and Services Sold": "21.7",
"Labor Expense": "8.12",
"Comprehensive Net Income": "27.9",
"Economic Capital Ratio": "-30.6"
},
"2019": {
"Property Plant and Equipment": "4.82",
"Assets": "-6.28",
"Liabilities": "-51.4",
"Stockholders Equity": "-45.1",
"ECR before LimitedLiability": "-29.1",
"Other Assets": "-4.51",
"Intangible Assets": "24.8",
"Assets, Current": "-25.1",
"Long Term Liabilities": "-74.0",
"Liabilities, Current": "15.3",
"Other Expenses": "8.80",
"Expenses": "24.2",
"Net Income": "27.3",
"General and Administrative Expense": "12.4",
"Cost of Goods and Services Sold": "25.2",
"Research And Development Expense": "7.33",
"Selling and Marketing Expense": "4.70",
"Labor Expense": "7.09",
"Operating Costs and Expenses": "-35.2",
"Comprehensive Net Income": "26.2",
"Economic Capital Ratio": "-39.1"
},
"2020": {
"Property Plant and Equipment": "9.39",
"Assets": "-12.6",
"Liabilities": "-51.5",
"Stockholders Equity": "-52.3",
"ECR before LimitedLiability": "-30.1",
"Intangible Assets": "27.3",
"Assets, Current": "-34.1",
"Liabilities, Current": "8.99",
"Other Liabilities": "6.37",
"Long Term Liabilities": "-70.2",
"Labor Expense": "6.69",
"Expenses": "19.3",
"Revenues": "7.50",
"Net Income": "28.5",
"General and Administrative Expense": "16.0",
"Other Expenses": "10.3",
"Operating Costs and Expenses": "-37.1",
"Cost of Goods and Services Sold": "21.9",
"Other Revenues": "7.50",
"Comprehensive Net Income": "27.0",
"Economic Capital Ratio": "-42.2"
},
"2021": {
"Assets": "-21.0",
"Liabilities": "-57.2",
"Stockholders Equity": "-65.1",
"ECR before LimitedLiability": "-48.2",
"Intangible Assets": "14.2",
"Property Plant and Equipment": "11.7",
"Assets, Current": "-38.0",
"Liabilities, Current": "6.45",
"Long Term Liabilities": "-77.5",
"Other Liabilities": "9.86",
"General and Administrative Expense": "15.7",
"Expenses": "18.2",
"Revenues": "10.5",
"Net Income": "26.0",
"Operating Costs and Expenses": "-36.0",
"Cost of Goods and Services Sold": "18.5",
"Research And Development Expense": "5.59",
"Other Expenses": "9.98",
"Other Revenues": "10.5",
"Comprehensive Net Income": "25.9",
"Economic Capital Ratio": "-54.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000927066_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "2,302,521",
"Assets, Non-Current": "32,615",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "228,986",
"General and Administrative Expense": "531,531",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,087,928",
"Labor Expense": "0",
"Liabilities, Current": "1,046,941",
"Long Term Liabilities": "3,619,909",
"Operating Costs and Expenses": "4,248,668",
"Other Assets": "30,247",
"Other Compr. Net Income": "0",
"Other Expenses": "623,564",
"Other Liabilities": "365,502",
"Other Net Income": "6,108,800",
"Other Revenues": "3,708",
"Property Plant and Equipment": "1,104,925",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,558,236",
"Liabilities": "5,032,352",
"Expenses": "5,632,749",
"Revenues": "3,708",
"Stockholders Equity": "2,525,884",
"Net Income": "479,759",
"Comprehensive Net Income": "479,759",
"BaseVar": "12,167,922",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "146%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "2,622,854",
"Assets, Non-Current": "32,054",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "234,378",
"General and Administrative Expense": "579,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,253,942",
"Labor Expense": "0",
"Liabilities, Current": "924,345",
"Long Term Liabilities": "4,323,140",
"Operating Costs and Expenses": "4,474,735",
"Other Assets": "34,766",
"Other Compr. Net Income": "0",
"Other Expenses": "678,479",
"Other Liabilities": "446,753",
"Other Net Income": "6,447,391",
"Other Revenues": "3,420",
"Property Plant and Equipment": "1,170,808",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,114,424",
"Liabilities": "5,694,238",
"Expenses": "5,966,592",
"Revenues": "3,420",
"Stockholders Equity": "2,420,186",
"Net Income": "484,219",
"Comprehensive Net Income": "484,219",
"BaseVar": "13,113,032",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "2,281,608",
"Assets, Non-Current": "34,231",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "266,628",
"General and Administrative Expense": "691,243",
"Goodwill Impairment Loss": "24,000",
"Intangible Assets": "5,106,467",
"Labor Expense": "0",
"Liabilities, Current": "1,153,116",
"Long Term Liabilities": "4,549,630",
"Operating Costs and Expenses": "4,680,772",
"Other Assets": "37,215",
"Other Compr. Net Income": "0",
"Other Expenses": "745,623",
"Other Liabilities": "443,085",
"Other Net Income": "6,978,679",
"Other Revenues": "2,982",
"Property Plant and Equipment": "1,432,651",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,892,172",
"Liabilities": "6,145,831",
"Expenses": "6,408,266",
"Revenues": "2,982",
"Stockholders Equity": "2,746,341",
"Net Income": "573,395",
"Comprehensive Net Income": "573,395",
"BaseVar": "14,213,965",
"ECR before LimitedLiability": "61%",
"Economic Capital Ratio": "142%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,878,794",
"Assets, Non-Current": "80,194",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "341,969",
"General and Administrative Expense": "894,575",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,092,747",
"Labor Expense": "0",
"Liabilities, Current": "2,018,174",
"Long Term Liabilities": "8,770,277",
"Operating Costs and Expenses": "5,578,853",
"Other Assets": "94,491",
"Other Compr. Net Income": "-101,033",
"Other Expenses": "733,161",
"Other Liabilities": "721,405",
"Other Net Income": "8,186,058",
"Other Revenues": "3,737",
"Property Plant and Equipment": "1,872,370",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "16,018,596",
"Liabilities": "11,509,856",
"Expenses": "7,548,558",
"Revenues": "3,737",
"Stockholders Equity": "4,508,740",
"Net Income": "641,237",
"Comprehensive Net Income": "540,204",
"BaseVar": "21,683,919",
"ECR before LimitedLiability": "51%",
"Economic Capital Ratio": "134%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "3,472,278",
"Assets, Non-Current": "79,598",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,237,347",
"Labor Expense": "0",
"Liabilities, Current": "2,462,049",
"Long Term Liabilities": "371,010",
"Operating Costs and Expenses": "0",
"Other Assets": "120,243",
"Other Compr. Net Income": "646,098",
"Other Expenses": "429,943",
"Other Liabilities": "8,962,977",
"Other Net Income": "11,768,837",
"Other Revenues": "0",
"Property Plant and Equipment": "2,189,411",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "17,098,877",
"Liabilities": "11,796,036",
"Expenses": "429,943",
"Revenues": "0",
"Stockholders Equity": "5,302,841",
"Net Income": "11,338,894",
"Comprehensive Net Income": "11,984,992",
"BaseVar": "20,869,896",
"ECR before LimitedLiability": "136%",
"Economic Capital Ratio": "196%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "3,876,797",
"Assets, Non-Current": "77,000",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "590,935",
"General and Administrative Expense": "1,261,506",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "11,364,793",
"Labor Expense": "0",
"Liabilities, Current": "2,088,652",
"Long Term Liabilities": "8,773,086",
"Operating Costs and Expenses": "9,119,305",
"Other Assets": "155,026",
"Other Compr. Net Income": "-162,588",
"Other Expenses": "962,404",
"Other Liabilities": "890,701",
"Other Net Income": "12,797,480",
"Other Revenues": "0",
"Property Plant and Equipment": "2,469,099",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "17,942,715",
"Liabilities": "11,752,439",
"Expenses": "11,934,150",
"Revenues": "0",
"Stockholders Equity": "6,190,276",
"Net Income": "863,330",
"Comprehensive Net Income": "700,742",
"BaseVar": "27,294,686",
"ECR before LimitedLiability": "65%",
"Economic Capital Ratio": "145%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "4,503,280",
"Assets, Non-Current": "73,560",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "638,024",
"General and Administrative Expense": "1,452,135",
"Goodwill Impairment Loss": "210,234",
"Intangible Assets": "9,294,479",
"Labor Expense": "0",
"Liabilities, Current": "2,399,138",
"Long Term Liabilities": "9,440,537",
"Operating Costs and Expenses": "9,824,834",
"Other Assets": "1,854,816",
"Other Compr. Net Income": "-192,487",
"Other Expenses": "1,238,093",
"Other Liabilities": "726,962",
"Other Net Income": "13,790,730",
"Other Revenues": "0",
"Property Plant and Equipment": "2,788,740",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "18,514,875",
"Liabilities": "12,566,637",
"Expenses": "13,363,320",
"Revenues": "0",
"Stockholders Equity": "5,948,238",
"Net Income": "427,410",
"Comprehensive Net Income": "234,923",
"BaseVar": "29,214,024",
"ECR before LimitedLiability": "57%",
"Economic Capital Ratio": "139%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "3,980,228",
"Assets, Non-Current": "44,510",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "720,252",
"General and Administrative Expense": "1,592,698",
"Goodwill Impairment Loss": "296,408",
"Intangible Assets": "10,935,084",
"Labor Expense": "0",
"Liabilities, Current": "2,696,445",
"Long Term Liabilities": "9,412,685",
"Operating Costs and Expenses": "10,646,736",
"Other Assets": "606,068",
"Other Compr. Net Income": "-183,025",
"Other Expenses": "464,663",
"Other Liabilities": "809,128",
"Other Net Income": "14,753,839",
"Other Revenues": "0",
"Property Plant and Equipment": "3,175,367",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "18,741,257",
"Liabilities": "12,918,258",
"Expenses": "13,720,757",
"Revenues": "0",
"Stockholders Equity": "5,822,999",
"Net Income": "1,033,082",
"Comprehensive Net Income": "850,057",
"BaseVar": "30,158,568",
"ECR before LimitedLiability": "59%",
"Economic Capital Ratio": "140%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "8,744,358",
"Assets, Non-Current": "47,287",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "559,911",
"General and Administrative Expense": "1,064,026",
"Goodwill Impairment Loss": "36,196",
"Intangible Assets": "6,724,106",
"Labor Expense": "0",
"Liabilities, Current": "3,527,424",
"Long Term Liabilities": "9,523,343",
"Operating Costs and Expenses": "7,640,005",
"Other Assets": "283,229",
"Other Compr. Net Income": "-64,059",
"Other Expenses": "518,234",
"Other Liabilities": "0",
"Other Net Income": "10,648,927",
"Other Revenues": "0",
"Property Plant and Equipment": "3,149,213",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "18,948,193",
"Liabilities": "13,050,767",
"Expenses": "9,818,372",
"Revenues": "0",
"Stockholders Equity": "5,897,426",
"Net Income": "830,555",
"Comprehensive Net Income": "766,496",
"BaseVar": "26,265,159",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "140%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "8,424,159",
"Assets, Non-Current": "71,583",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "591,035",
"General and Administrative Expense": "1,135,454",
"Goodwill Impairment Loss": "3,106",
"Intangible Assets": "6,960,806",
"Labor Expense": "0",
"Liabilities, Current": "4,891,161",
"Long Term Liabilities": "8,623,516",
"Operating Costs and Expenses": "8,195,513",
"Other Assets": "260,035",
"Other Compr. Net Income": "-213,437",
"Other Expenses": "699,754",
"Other Liabilities": "562,536",
"Other Net Income": "-446,949",
"Other Revenues": "11,404,851",
"Property Plant and Equipment": "3,393,669",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "19,110,252",
"Liabilities": "14,077,213",
"Expenses": "10,624,862",
"Revenues": "11,404,851",
"Stockholders Equity": "5,033,039",
"Net Income": "333,040",
"Comprehensive Net Income": "119,603",
"BaseVar": "27,938,782",
"ECR before LimitedLiability": "45%",
"Economic Capital Ratio": "129%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "3,690,170",
"Assets, Non-Current": "2,946,019",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "615,152",
"General and Administrative Expense": "1,103,312",
"Goodwill Impairment Loss": "124,892",
"Intangible Assets": "6,923,319",
"Labor Expense": "0",
"Liabilities, Current": "2,372,098",
"Long Term Liabilities": "10,862,135",
"Operating Costs and Expenses": "7,914,485",
"Other Assets": "278,502",
"Other Compr. Net Income": "-222,887",
"Other Expenses": "744,175",
"Other Liabilities": "577,543",
"Other Net Income": "134,831",
"Other Revenues": "11,388,479",
"Property Plant and Equipment": "3,473,384",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "17,311,394",
"Liabilities": "13,811,776",
"Expenses": "10,502,016",
"Revenues": "11,388,479",
"Stockholders Equity": "3,499,618",
"Net Income": "1,021,294",
"Comprehensive Net Income": "798,407",
"BaseVar": "26,685,692",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "123%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "3,148,724",
"Assets, Non-Current": "2,942,590",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "630,435",
"General and Administrative Expense": "1,247,584",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "7,085,694",
"Labor Expense": "0",
"Liabilities, Current": "3,285,743",
"Long Term Liabilities": "10,805,993",
"Operating Costs and Expenses": "7,988,613",
"Other Assets": "289,684",
"Other Compr. Net Income": "-239,691",
"Other Expenses": "696,401",
"Other Liabilities": "0",
"Other Net Income": "7,106",
"Other Revenues": "11,550,604",
"Property Plant and Equipment": "3,521,824",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "16,988,516",
"Liabilities": "14,091,736",
"Expenses": "10,563,033",
"Revenues": "11,550,604",
"Stockholders Equity": "2,896,780",
"Net Income": "994,677",
"Comprehensive Net Income": "754,986",
"BaseVar": "26,720,343",
"ECR before LimitedLiability": "32%",
"Economic Capital Ratio": "118%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,167,723",
"Assets, Non-Current": "2,961,464",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "680,615",
"General and Administrative Expense": "1,195,335",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "7,223,934",
"Labor Expense": "0",
"Liabilities, Current": "3,229,487",
"Long Term Liabilities": "11,521,021",
"Operating Costs and Expenses": "7,972,414",
"Other Assets": "288,395",
"Other Compr. Net Income": "-306,405",
"Other Expenses": "565,049",
"Other Liabilities": "0",
"Other Net Income": "6,378",
"Other Revenues": "11,618,797",
"Property Plant and Equipment": "3,479,972",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "17,121,488",
"Liabilities": "14,750,508",
"Expenses": "10,413,413",
"Revenues": "11,618,797",
"Stockholders Equity": "2,370,980",
"Net Income": "1,211,762",
"Comprehensive Net Income": "905,357",
"BaseVar": "27,108,494",
"ECR before LimitedLiability": "27%",
"Economic Capital Ratio": "113%"
}
}
},
"top_rated": false,
"trend": -19.0,
"value": 1.1336240413402296,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000927066.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000927066.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000927066.svg"
},
{
"company_id": "0001776197",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001776197.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001776197.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001776197_main_keyfigs.svg",
"name": "Akumin INC",
"rank": 75,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001776197.svg",
"report_text": "The relative strengths and weaknesses of Akumin INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Akumin INC compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Akumin INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 107% points.
The company's Economic Capital Ratio, given in the ranking table, is 110%, being 57% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001776197_2022_Akumin_INC.pdf",
"shrinked_graph_json": {
"2021": {
"Assets": "20.6",
"Liabilities": "-80.3",
"Stockholders Equity": "-42.2",
"ECR before LimitedLiability": "-51.2",
"Intangible Assets": "28.4",
"Property Plant and Equipment": "6.91",
"Assets, Current": "-33.8",
"Liabilities, Current": "12.6",
"Long Term Liabilities": "-107",
"Other Liabilities": "6.02",
"General and Administrative Expense": "16.9",
"Expenses": "23.5",
"Revenues": "-18.7",
"Net Income": "16.0",
"Operating Costs and Expenses": "-13.7",
"Cost of Goods and Services Sold": "13.7",
"Research And Development Expense": "4.16",
"Other Expenses": "11.3",
"Other Revenues": "-18.7",
"Comprehensive Net Income": "15.6",
"Economic Capital Ratio": "-57.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001776197_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "185,165",
"Assets, Non-Current": "220,040",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "44,895",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,254,499",
"Labor Expense": "0",
"Liabilities, Current": "164,182",
"Long Term Liabilities": "1,417,545",
"Operating Costs and Expenses": "359,735",
"Other Assets": "0",
"Other Compr. Net Income": "-8,459",
"Other Expenses": "-27,016",
"Other Liabilities": "15,951",
"Other Net Income": "-78,279",
"Other Revenues": "421,079",
"Property Plant and Equipment": "259,122",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,918,826",
"Liabilities": "1,597,678",
"Expenses": "377,614",
"Revenues": "421,079",
"Stockholders Equity": "321,148",
"Net Income": "-34,814",
"Comprehensive Net Income": "-43,273",
"BaseVar": "2,200,968",
"ECR before LimitedLiability": "24%",
"Economic Capital Ratio": "110%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.1042870608433688,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001776197.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001776197.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001776197.svg"
},
{
"company_id": "0000722723",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000722723.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000722723.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000722723.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000722723_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000722723_main_keyfigs.svg",
"name": "Hanger INC",
"rank": 76,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000722723.svg",
"report_text": "The relative strengths and weaknesses of Hanger INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Hanger INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 22% points.The greatest weakness of Hanger INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 89% points.
The company's Economic Capital Ratio, given in the ranking table, is 109%, being 59% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000722723_2022_Hanger_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Liabilities": "-26.5",
"Stockholders Equity": "-21.6",
"Economic Capital Ratio": "-8.49",
"Long Term Liabilities": "-53.2",
"Liabilities, Current": "23.3",
"Expenses": "15.9",
"Revenues": "36.7",
"Net Income": "22.7",
"Research And Development Expense": "2.28",
"Other Expenses": "5.43",
"Operating Costs and Expenses": "-7.21",
"Labor Expense": "-14.6",
"General and Administrative Expense": "20.1",
"Cost of Goods and Services Sold": "7.59",
"Other Revenues": "36.7",
"Property Plant and Equipment": "-16.2",
"Assets, Current": "-5.31",
"Assets, Non-Current": "-4.51",
"Intangible Assets": "36.7",
"Other Net Income": "-26.1",
"Comprehensive Net Income": "23.0"
},
"2012": {
"Liabilities, Current": "24.6",
"Liabilities": "-21.3",
"Stockholders Equity": "-18.4",
"ECR before LimitedLiability": "7.38",
"Long Term Liabilities": "-58.1",
"Other Liabilities": "5.41",
"Expenses": "13.5",
"Net Income": "21.2",
"General and Administrative Expense": "20.2",
"Operating Costs and Expenses": "-8.31",
"Cost of Goods and Services Sold": "7.66",
"Labor Expense": "-12.9",
"Other Revenues": "36.3",
"Revenues": "36.3",
"Property Plant and Equipment": "-13.5",
"Intangible Assets": "41.9",
"Assets, Current": "-11.2",
"Assets, Non-Current": "-4.97",
"Other Net Income": "-25.2",
"Comprehensive Net Income": "21.5",
"Economic Capital Ratio": "-6.82"
},
"2013": {
"Assets": "-4.81",
"Liabilities": "-3.87",
"Stockholders Equity": "-10.1",
"ECR before LimitedLiability": "12.6",
"Property Plant and Equipment": "-11.4",
"Assets, Current": "-13.4",
"Intangible Assets": "41.8",
"Other Liabilities": "4.38",
"Liabilities, Current": "32.2",
"Long Term Liabilities": "-46.8",
"Expenses": "8.78",
"Revenues": "35.9",
"Net Income": "24.4",
"General and Administrative Expense": "21.4",
"Cost of Goods and Services Sold": "7.13",
"Labor Expense": "-14.6",
"Operating Costs and Expenses": "-9.45",
"Research And Development Expense": "4.08",
"Other Revenues": "35.9",
"Comprehensive Net Income": "24.8",
"Other Net Income": "-18.1",
"Economic Capital Ratio": "3.42"
},
"2018": {
"Assets": "-57.9",
"Liabilities": "-35.8",
"Stockholders Equity": "-100",
"Property Plant and Equipment": "-13.1",
"Intangible Assets": "-1.13",
"Assets, Non-Current": "-12.5",
"Assets, Current": "-32.2",
"Liabilities, Current": "1.94",
"Long Term Liabilities": "-85.1",
"Other Revenues": "4.53",
"Revenues": "4.53",
"Net Income": "4.23",
"ECR before LimitedLiability": "-51.1",
"Comprehensive Net Income": "4.24",
"Operating Costs and Expenses": "-5.56",
"Other Net Income": "-1.07",
"Other Expenses": "-16.7",
"General and Administrative Expense": "1.02",
"Cost of Goods and Services Sold": "2.94",
"Labor Expense": "-30.4",
"Economic Capital Ratio": "-71.8"
},
"2019": {
"Property Plant and Equipment": "-18.0",
"Assets": "-55.3",
"Liabilities": "-39.4",
"Stockholders Equity": "-95.7",
"Assets, Non-Current": "-10.4",
"Intangible Assets": "-7.88",
"Assets, Current": "-35.5",
"Long Term Liabilities": "-69.6",
"Liabilities, Current": "4.14",
"Other Revenues": "5.77",
"Revenues": "5.77",
"Net Income": "5.62",
"ECR before LimitedLiability": "-60.3",
"Other Expenses": "-27.3",
"Comprehensive Net Income": "5.55",
"General and Administrative Expense": "4.13",
"Cost of Goods and Services Sold": "5.90",
"Research And Development Expense": "4.04",
"Labor Expense": "-31.1",
"Operating Costs and Expenses": "-6.66",
"Economic Capital Ratio": "-70.4"
},
"2020": {
"Property Plant and Equipment": "-11.0",
"Assets": "-43.1",
"Stockholders Equity": "-83.2",
"Assets, Current": "-32.5",
"Liabilities, Current": "9.29",
"Liabilities": "-44.3",
"Other Liabilities": "7.72",
"Long Term Liabilities": "-64.2",
"Labor Expense": "-26.3",
"Expenses": "5.96",
"Revenues": "11.6",
"Net Income": "11.9",
"Selling and Marketing Expense": "4.53",
"General and Administrative Expense": "11.1",
"Research And Development Expense": "6.02",
"Other Expenses": "-18.4",
"Cost of Goods and Services Sold": "11.6",
"Other Revenues": "11.6",
"ECR before LimitedLiability": "-49.1",
"Comprehensive Net Income": "11.8",
"Economic Capital Ratio": "-61.2"
},
"2021": {
"Assets": "-49.1",
"Liabilities": "-35.1",
"Stockholders Equity": "-88.8",
"ECR before LimitedLiability": "-52.7",
"Intangible Assets": "-6.19",
"Property Plant and Equipment": "-8.57",
"Assets, Current": "-41.7",
"Liabilities, Current": "10.8",
"Long Term Liabilities": "-62.2",
"Other Liabilities": "12.6",
"Other Revenues": "22.0",
"Revenues": "22.0",
"Net Income": "21.9",
"General and Administrative Expense": "16.6",
"Comprehensive Net Income": "21.9",
"Labor Expense": "-29.8",
"Cost of Goods and Services Sold": "21.5",
"Research And Development Expense": "7.30",
"Other Expenses": "-20.1",
"Selling and Marketing Expense": "5.59",
"Economic Capital Ratio": "-58.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000722723_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "333,471",
"Assets, Non-Current": "8,394",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "30,969",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "664,378",
"Labor Expense": "322,765",
"Liabilities, Current": "91,742",
"Long Term Liabilities": "532,786",
"Operating Costs and Expenses": "178,335",
"Other Assets": "17,485",
"Other Compr. Net Income": "0",
"Other Expenses": "331,451",
"Other Liabilities": "74,309",
"Other Net Income": "0",
"Other Revenues": "918,539",
"Property Plant and Equipment": "104,772",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,128,500",
"Liabilities": "698,837",
"Expenses": "863,520",
"Revenues": "918,539",
"Stockholders Equity": "429,663",
"Net Income": "55,019",
"Comprehensive Net Income": "55,019",
"BaseVar": "1,804,698",
"ECR before LimitedLiability": "74%",
"Economic Capital Ratio": "152%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "358,652",
"Assets, Non-Current": "11,126",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "34,652",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "739,055",
"Labor Expense": "335,328",
"Liabilities, Current": "107,187",
"Long Term Liabilities": "549,316",
"Operating Costs and Expenses": "188,868",
"Other Assets": "14,033",
"Other Compr. Net Income": "-734",
"Other Expenses": "363,010",
"Other Liabilities": "77,730",
"Other Net Income": "0",
"Other Revenues": "985,550",
"Property Plant and Equipment": "114,461",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,237,327",
"Liabilities": "734,233",
"Expenses": "921,858",
"Revenues": "985,550",
"Stockholders Equity": "503,094",
"Net Income": "63,692",
"Comprehensive Net Income": "62,958",
"BaseVar": "1,939,851",
"ECR before LimitedLiability": "80%",
"Economic Capital Ratio": "157%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "382,964",
"Assets, Non-Current": "13,766",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "37,486",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "739,568",
"Labor Expense": "369,738",
"Liabilities, Current": "115,879",
"Long Term Liabilities": "499,016",
"Operating Costs and Expenses": "186,304",
"Other Assets": "8,564",
"Other Compr. Net Income": "899",
"Other Expenses": "382,681",
"Other Liabilities": "76,545",
"Other Net Income": "-6,645",
"Other Revenues": "1,046,438",
"Property Plant and Equipment": "126,798",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,271,660",
"Liabilities": "691,440",
"Expenses": "976,209",
"Revenues": "1,046,438",
"Stockholders Equity": "580,220",
"Net Income": "63,584",
"Comprehensive Net Income": "64,483",
"BaseVar": "1,996,646",
"ECR before LimitedLiability": "92%",
"Economic Capital Ratio": "166%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "325,900",
"Assets, Non-Current": "7,766",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "109,552",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "198,742",
"Labor Expense": "364,089",
"Liabilities, Current": "171,274",
"Long Term Liabilities": "553,660",
"Operating Costs and Expenses": "123,902",
"Other Assets": "81,113",
"Other Compr. Net Income": "-2,482",
"Other Expenses": "397,511",
"Other Liabilities": "0",
"Other Net Income": "-54,564",
"Other Revenues": "1,048,760",
"Property Plant and Equipment": "89,489",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "703,010",
"Liabilities": "724,934",
"Expenses": "995,054",
"Revenues": "1,048,760",
"Stockholders Equity": "-21,924",
"Net Income": "-858",
"Comprehensive Net Income": "-3,340",
"BaseVar": "1,764,402",
"ECR before LimitedLiability": "-4.9%",
"Economic Capital Ratio": "87%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "315,655",
"Assets, Non-Current": "121,864",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "118,065",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "232,244",
"Labor Expense": "372,225",
"Liabilities, Current": "208,406",
"Long Term Liabilities": "624,343",
"Operating Costs and Expenses": "134,943",
"Other Assets": "88,433",
"Other Compr. Net Income": "-8,020",
"Other Expenses": "411,030",
"Other Liabilities": "0",
"Other Net Income": "-34,258",
"Other Revenues": "1,098,046",
"Property Plant and Equipment": "84,057",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "842,253",
"Liabilities": "832,749",
"Expenses": "1,036,263",
"Revenues": "1,098,046",
"Stockholders Equity": "9,504",
"Net Income": "27,525",
"Comprehensive Net Income": "19,505",
"BaseVar": "1,925,794",
"ECR before LimitedLiability": "4.0%",
"Economic Capital Ratio": "91%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "374,872",
"Assets, Non-Current": "140,475",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "118,764",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "277,223",
"Labor Expense": "351,191",
"Liabilities, Current": "245,580",
"Long Term Liabilities": "654,194",
"Operating Costs and Expenses": "99,854",
"Other Assets": "73,308",
"Other Compr. Net Income": "-7,664",
"Other Expenses": "360,704",
"Other Liabilities": "0",
"Other Net Income": "-32,445",
"Other Revenues": "1,001,150",
"Property Plant and Equipment": "84,873",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "950,751",
"Liabilities": "899,774",
"Expenses": "930,513",
"Revenues": "1,001,150",
"Stockholders Equity": "50,977",
"Net Income": "38,192",
"Comprehensive Net Income": "30,528",
"BaseVar": "1,911,148",
"ECR before LimitedLiability": "11%",
"Economic Capital Ratio": "99%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "318,329",
"Assets, Non-Current": "162,436",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "127,752",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "363,554",
"Labor Expense": "397,574",
"Liabilities, Current": "226,805",
"Long Term Liabilities": "661,163",
"Operating Costs and Expenses": "135,630",
"Other Assets": "71,386",
"Other Compr. Net Income": "9,065",
"Other Expenses": "388,686",
"Other Liabilities": "0",
"Other Net Income": "-28,864",
"Other Revenues": "1,120,488",
"Property Plant and Equipment": "82,434",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "998,139",
"Liabilities": "887,968",
"Expenses": "1,049,642",
"Revenues": "1,120,488",
"Stockholders Equity": "110,171",
"Net Income": "41,982",
"Comprehensive Net Income": "51,047",
"BaseVar": "2,047,083",
"ECR before LimitedLiability": "22%",
"Economic Capital Ratio": "109%"
}
}
},
"top_rated": false,
"trend": -15.0,
"value": 1.0889717353797819,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000722723.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000722723.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000722723.svg"
},
{
"company_id": "0001349929",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001349929.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001349929.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001349929.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001349929_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001349929_main_keyfigs.svg",
"name": "Vyant Bio Inc",
"rank": 77,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001349929.svg",
"report_text": "The relative strengths and weaknesses of Vyant Bio Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Vyant Bio Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 27% points.The greatest weakness of Vyant Bio Inc is the variable Comprehensive Net Income, reducing the Economic Capital Ratio by 115% points.
The company's Economic Capital Ratio, given in the ranking table, is 107%, being 61% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001349929_2022_Vyant_Bio_Inc.pdf",
"shrinked_graph_json": {
"2013": {
"Assets": "52.3",
"Liabilities": "22.9",
"Stockholders Equity": "98.5",
"ECR before LimitedLiability": "61.8",
"Property Plant and Equipment": "-6.52",
"Assets, Current": "128",
"Intangible Assets": "-8.38",
"Other Liabilities": "6.21",
"Liabilities, Current": "-2.39",
"Long Term Liabilities": "19.4",
"Expenses": "21.1",
"Revenues": "-13.9",
"Net Income": "-13.6",
"Cost of Goods and Services Sold": "-5.61",
"Labor Expense": "7.61",
"Operating Costs and Expenses": "2.53",
"Other Expenses": "17.7",
"Other Revenues": "-13.9",
"Comprehensive Net Income": "-13.4",
"Other Net Income": "-21.0",
"Economic Capital Ratio": "52.6"
},
"2014": {
"Other Assets": "-9.38",
"Assets": "47.0",
"Liabilities": "16.9",
"Stockholders Equity": "74.5",
"ECR before LimitedLiability": "37.6",
"Intangible Assets": "-9.02",
"Assets, Non-Current": "24.0",
"Property Plant and Equipment": "-7.31",
"Assets, Current": "69.2",
"Liabilities, Current": "18.2",
"Other Revenues": "-8.33",
"Revenues": "-8.33",
"Net Income": "-23.5",
"Other Net Income": "-15.7",
"Comprehensive Net Income": "-23.4",
"Labor Expense": "10.2",
"Research And Development Expense": "-7.05",
"Other Expenses": "24.8",
"Cost of Goods and Services Sold": "-13.2",
"General and Administrative Expense": "-13.5",
"Economic Capital Ratio": "24.5"
},
"2015": {
"Assets, Current": "39.6",
"Assets": "29.7",
"Liabilities": "13.7",
"Stockholders Equity": "49.0",
"ECR before LimitedLiability": "13.8",
"Assets, Non-Current": "41.6",
"Intangible Assets": "6.65",
"Other Assets": "-26.3",
"Property Plant and Equipment": "-8.05",
"Long Term Liabilities": "21.7",
"Other Liabilities": "-14.8",
"Selling and Marketing Expense": "-6.98",
"Expenses": "-8.79",
"Net Income": "-25.0",
"Other Net Income": "-16.8",
"Research And Development Expense": "-8.36",
"General and Administrative Expense": "-14.6",
"Other Expenses": "27.5",
"Labor Expense": "11.3",
"Cost of Goods and Services Sold": "-21.5",
"Comprehensive Net Income": "-24.7",
"Economic Capital Ratio": "1.34"
},
"2016": {
"Property Plant and Equipment": "-12.8",
"Assets": "9.29",
"Liabilities": "25.8",
"Stockholders Equity": "35.6",
"ECR before LimitedLiability": "27.9",
"Assets, Non-Current": "47.3",
"Other Assets": "-29.8",
"Assets, Current": "24.7",
"Liabilities, Current": "16.6",
"Other Liabilities": "-12.4",
"Long Term Liabilities": "21.3",
"Expenses": "-15.2",
"Revenues": "17.0",
"Net Income": "-14.4",
"General and Administrative Expense": "-16.3",
"Other Expenses": "31.7",
"Cost of Goods and Services Sold": "-26.0",
"Research And Development Expense": "-9.15",
"Other Revenues": "17.0",
"Other Net Income": "-15.0",
"Comprehensive Net Income": "-13.6",
"Economic Capital Ratio": "0.170"
},
"2017": {
"Other Assets": "-39.8",
"Assets": "4.39",
"Stockholders Equity": "8.63",
"Liabilities, Current": "-12.1",
"ECR before LimitedLiability": "5.82",
"Intangible Assets": "17.6",
"Assets, Non-Current": "46.1",
"Property Plant and Equipment": "-11.9",
"Other Revenues": "17.7",
"Revenues": "17.7",
"Net Income": "-17.4",
"Other Liabilities": "-13.2",
"Long Term Liabilities": "27.8",
"General and Administrative Expense": "-16.6",
"Comprehensive Net Income": "-17.1",
"Labor Expense": "7.92",
"Other Net Income": "-31.2",
"Selling and Marketing Expense": "-4.85",
"Other Expenses": "38.8",
"Cost of Goods and Services Sold": "-24.1",
"Economic Capital Ratio": "-18.3"
},
"2018": {
"Other Assets": "-44.9",
"Assets": "-16.0",
"Liabilities": "-1.94",
"Stockholders Equity": "-46.1",
"Property Plant and Equipment": "-1.44",
"Intangible Assets": "8.75",
"Assets, Non-Current": "34.0",
"Assets, Current": "-21.6",
"ECR before LimitedLiability": "-53.0",
"Liabilities, Current": "-38.4",
"Long Term Liabilities": "3.76",
"Selling and Marketing Expense": "-1.05",
"Expenses": "-1.83",
"Net Income": "-1.79",
"Other Net Income": "0.837",
"Other Expenses": "2.71",
"General and Administrative Expense": "-1.91",
"Cost of Goods and Services Sold": "-1.86",
"Labor Expense": "1.72",
"Comprehensive Net Income": "-1.78",
"Economic Capital Ratio": "-73.7"
},
"2019": {
"Liabilities": "-6.39",
"ECR before LimitedLiability": "-31.1",
"Long Term Liabilities": "33.1",
"Liabilities, Current": "-49.1",
"Other Revenues": "-13.4",
"Revenues": "-13.4",
"Net Income": "-27.4",
"Other Expenses": "18.7",
"Comprehensive Net Income": "-27.5",
"General and Administrative Expense": "-18.6",
"Research And Development Expense": "8.45",
"Other Net Income": "-11.3",
"Labor Expense": "8.16",
"Operating Costs and Expenses": "6.99",
"Goodwill Impairment Loss": "-21.2",
"Property Plant and Equipment": "-15.5",
"Economic Capital Ratio": "-41.2",
"Assets, Current": "6.35",
"Assets, Non-Current": "35.8",
"Other Assets": "-46.4",
"Intangible Assets": "33.1"
},
"2020": {
"Property Plant and Equipment": "-2.29",
"Assets": "-29.1",
"Liabilities": "3.28",
"Stockholders Equity": "-13.0",
"Other Assets": "-35.7",
"Intangible Assets": "2.45",
"Assets, Current": "-2.69",
"Assets, Non-Current": "18.2",
"Liabilities, Current": "-2.72",
"ECR before LimitedLiability": "-62.8",
"Long Term Liabilities": "7.70",
"Labor Expense": "1.74",
"Expenses": "-45.6",
"Net Income": "-49.0",
"Selling and Marketing Expense": "-1.57",
"General and Administrative Expense": "-27.9",
"Other Expenses": "-2.02",
"Operating Costs and Expenses": "1.35",
"Cost of Goods and Services Sold": "-1.87",
"Comprehensive Net Income": "-52.2",
"Economic Capital Ratio": "-74.9"
},
"2021": {
"Other Assets": "-11.7",
"Assets": "19.8",
"Liabilities": "20.8",
"Stockholders Equity": "26.5",
"ECR before LimitedLiability": "-54.7",
"Intangible Assets": "-38.3",
"Property Plant and Equipment": "-11.7",
"Assets, Non-Current": "27.4",
"Assets, Current": "21.4",
"Long Term Liabilities": "19.8",
"General and Administrative Expense": "19.6",
"Expenses": "19.4",
"Revenues": "-54.6",
"Net Income": "-115",
"Cost of Goods and Services Sold": "19.5",
"Research And Development Expense": "-11.1",
"Selling and Marketing Expense": "-28.6",
"Other Revenues": "-54.6",
"Comprehensive Net Income": "-115",
"Other Net Income": "-85.7",
"Economic Capital Ratio": "-60.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001349929_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "51,891",
"Assets, Non-Current": "2,001",
"Cost of Goods and Services Sold": "4,925",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,115",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "8,619",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-664",
"Other Liabilities": "1,075",
"Other Net Income": "-4,575",
"Other Revenues": "6,610",
"Property Plant and Equipment": "1,265",
"Research And Development Expense": "2,190",
"Selling and Marketing Expense": "1,842"
},
"output_variables": {
"Assets": "55,157",
"Liabilities": "9,694",
"Expenses": "14,408",
"Revenues": "6,610",
"Stockholders Equity": "45,463",
"Net Income": "-12,373",
"Comprehensive Net Income": "-12,373",
"BaseVar": "45,222",
"ECR before LimitedLiability": "165%",
"Economic Capital Ratio": "215%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "31,774",
"Assets, Non-Current": "10,885",
"Cost of Goods and Services Sold": "8,454",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "12,369",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,994",
"Labor Expense": "0",
"Liabilities, Current": "4,366",
"Long Term Liabilities": "6,560",
"Operating Costs and Expenses": "0",
"Other Assets": "-2,994",
"Other Compr. Net Income": "0",
"Other Expenses": "-2,350",
"Other Liabilities": "1,625",
"Other Net Income": "216",
"Other Revenues": "10,199",
"Property Plant and Equipment": "4,447",
"Research And Development Expense": "4,623",
"Selling and Marketing Expense": "3,964"
},
"output_variables": {
"Assets": "47,105",
"Liabilities": "12,551",
"Expenses": "27,058",
"Revenues": "10,199",
"Stockholders Equity": "34,554",
"Net Income": "-16,643",
"Comprehensive Net Income": "-16,643",
"BaseVar": "48,565",
"ECR before LimitedLiability": "112%",
"Economic Capital Ratio": "179%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "28,198",
"Assets, Non-Current": "14,617",
"Cost of Goods and Services Sold": "14,098",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "14,567",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "12,029",
"Labor Expense": "0",
"Liabilities, Current": "9,865",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "-12,029",
"Other Compr. Net Income": "0",
"Other Expenses": "-1,184",
"Other Liabilities": "6,002",
"Other Net Income": "9.0",
"Other Revenues": "18,040",
"Property Plant and Equipment": "6,069",
"Research And Development Expense": "5,483",
"Selling and Marketing Expense": "5,269"
},
"output_variables": {
"Assets": "48,884",
"Liabilities": "15,867",
"Expenses": "38,233",
"Revenues": "18,040",
"Stockholders Equity": "33,017",
"Net Income": "-20,184",
"Comprehensive Net Income": "-20,184",
"BaseVar": "60,516",
"ECR before LimitedLiability": "86%",
"Economic Capital Ratio": "161%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "23,424",
"Assets, Non-Current": "14,272",
"Cost of Goods and Services Sold": "17,104",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "16,034",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "12,029",
"Labor Expense": "0",
"Liabilities, Current": "11,046",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "-12,029",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "5,764",
"Other Net Income": "921",
"Other Revenues": "27,049",
"Property Plant and Equipment": "4,738",
"Research And Development Expense": "5,967",
"Selling and Marketing Expense": "4,668"
},
"output_variables": {
"Assets": "42,434",
"Liabilities": "16,810",
"Expenses": "43,773",
"Revenues": "27,049",
"Stockholders Equity": "25,624",
"Net Income": "-15,803",
"Comprehensive Net Income": "-15,803",
"BaseVar": "65,494",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "151%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "23,206",
"Assets, Non-Current": "23,465",
"Cost of Goods and Services Sold": "18,070",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "19,894",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,992",
"Labor Expense": "0",
"Liabilities, Current": "19,640",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "-17,992",
"Other Compr. Net Income": "69",
"Other Expenses": "-2,079",
"Other Liabilities": "5,816",
"Other Net Income": "-4,337",
"Other Revenues": "29,121",
"Property Plant and Equipment": "5,550",
"Research And Development Expense": "4,789",
"Selling and Marketing Expense": "4,990"
},
"output_variables": {
"Assets": "52,221",
"Liabilities": "25,456",
"Expenses": "45,664",
"Revenues": "29,121",
"Stockholders Equity": "26,765",
"Net Income": "-20,880",
"Comprehensive Net Income": "-20,811",
"BaseVar": "78,434",
"ECR before LimitedLiability": "46%",
"Economic Capital Ratio": "130%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "9,347",
"Assets, Non-Current": "22,003",
"Cost of Goods and Services Sold": "18,724",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "19,184",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "17,257",
"Labor Expense": "0",
"Liabilities, Current": "27,293",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "-17,257",
"Other Compr. Net Income": "-9.0",
"Other Expenses": "3,784",
"Other Liabilities": "1,311",
"Other Net Income": "1,605",
"Other Revenues": "27,470",
"Property Plant and Equipment": "4,056",
"Research And Development Expense": "2,488",
"Selling and Marketing Expense": "5,268"
},
"output_variables": {
"Assets": "35,406",
"Liabilities": "28,604",
"Expenses": "49,448",
"Revenues": "27,470",
"Stockholders Equity": "6,802",
"Net Income": "-20,373",
"Comprehensive Net Income": "-20,382",
"BaseVar": "71,271",
"ECR before LimitedLiability": "-33%",
"Economic Capital Ratio": "86%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "7,178",
"Assets, Non-Current": "7,168",
"Cost of Goods and Services Sold": "3,701",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,171",
"Goodwill Impairment Loss": "2,900",
"Intangible Assets": "5,985",
"Labor Expense": "0",
"Liabilities, Current": "6,972",
"Long Term Liabilities": "10",
"Operating Costs and Expenses": "0",
"Other Assets": "-5,985",
"Other Compr. Net Income": "-34",
"Other Expenses": "-422",
"Other Liabilities": "537",
"Other Net Income": "-1,517",
"Other Revenues": "7,305",
"Property Plant and Equipment": "558",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "1,146"
},
"output_variables": {
"Assets": "14,904",
"Liabilities": "7,519",
"Expenses": "12,496",
"Revenues": "7,305",
"Stockholders Equity": "7,385",
"Net Income": "-6,708",
"Comprehensive Net Income": "-6,742",
"BaseVar": "21,888",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "121%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,107",
"Assets, Non-Current": "3,793",
"Cost of Goods and Services Sold": "3,353",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,595",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,977",
"Labor Expense": "0",
"Liabilities, Current": "4,263",
"Long Term Liabilities": "32",
"Operating Costs and Expenses": "0",
"Other Assets": "-2,977",
"Other Compr. Net Income": "-249",
"Other Expenses": "2,740",
"Other Liabilities": "73",
"Other Net Income": "182",
"Other Revenues": "5,751",
"Property Plant and Equipment": "448",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "1,246"
},
"output_variables": {
"Assets": "8,348",
"Liabilities": "4,368",
"Expenses": "13,934",
"Revenues": "5,751",
"Stockholders Equity": "3,980",
"Net Income": "-8,001",
"Comprehensive Net Income": "-8,250",
"BaseVar": "16,416",
"ECR before LimitedLiability": "-39%",
"Economic Capital Ratio": "85%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "23,214",
"Assets, Non-Current": "14,422",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,431",
"Long Term Liabilities": "516",
"Operating Costs and Expenses": "0",
"Other Assets": "-1,020",
"Other Compr. Net Income": "-74",
"Other Expenses": "4,157",
"Other Liabilities": "399",
"Other Net Income": "-25,153",
"Other Revenues": "1,148",
"Property Plant and Equipment": "1,020",
"Research And Development Expense": "4,273",
"Selling and Marketing Expense": "8,424"
},
"output_variables": {
"Assets": "37,636",
"Liabilities": "6,346",
"Expenses": "16,854",
"Revenues": "1,148",
"Stockholders Equity": "31,290",
"Net Income": "-40,859",
"Comprehensive Net Income": "-40,933",
"BaseVar": "43,606",
"ECR before LimitedLiability": "20%",
"Economic Capital Ratio": "107%"
}
}
},
"top_rated": false,
"trend": -9.0,
"value": 1.0689017146178437,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001349929.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001349929.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001349929.svg"
},
{
"company_id": "0001735803",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001735803.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001735803.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001735803_main_keyfigs.svg",
"name": "Apria Inc",
"rank": 78,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001735803.svg",
"report_text": "The relative strengths and weaknesses of Apria Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Apria Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 19% points.The greatest weakness of Apria Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 109% points.
The company's Economic Capital Ratio, given in the ranking table, is 103%, being 65% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001735803_2022_Apria_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "16.5",
"Assets": "-65.7",
"Liabilities": "-24.7",
"Stockholders Equity": "-109",
"ECR before LimitedLiability": "-58.4",
"Intangible Assets": "-36.8",
"Property Plant and Equipment": "-17.9",
"Assets, Non-Current": "-10.0",
"Assets, Current": "-44.2",
"Long Term Liabilities": "-32.0",
"Other Liabilities": "14.4",
"General and Administrative Expense": "16.4",
"Expenses": "-18.1",
"Revenues": "19.5",
"Net Income": "17.3",
"Operating Costs and Expenses": "9.54",
"Cost of Goods and Services Sold": "-15.0",
"Other Expenses": "-63.3",
"Other Revenues": "19.5",
"Comprehensive Net Income": "17.4",
"Economic Capital Ratio": "-64.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001735803_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "333,277",
"Assets, Non-Current": "91,777",
"Cost of Goods and Services Sold": "341,288",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "100,636",
"Labor Expense": "0",
"Liabilities, Current": "314,141",
"Long Term Liabilities": "421,555",
"Operating Costs and Expenses": "0",
"Other Assets": "228,458",
"Other Compr. Net Income": "0",
"Other Expenses": "742,567",
"Other Liabilities": "0",
"Other Net Income": "3,457",
"Other Revenues": "1,145,275",
"Property Plant and Equipment": "21,281",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "775,429",
"Liabilities": "735,696",
"Expenses": "1,083,855",
"Revenues": "1,145,275",
"Stockholders Equity": "39,733",
"Net Income": "64,877",
"Comprehensive Net Income": "64,877",
"BaseVar": "1,871,856",
"ECR before LimitedLiability": "16%",
"Economic Capital Ratio": "103%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.031841094531299,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001735803.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001735803.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001735803.svg"
},
{
"company_id": "0001043000",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001043000.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001043000.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001043000.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001043000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001043000_main_keyfigs.svg",
"name": "Sonida Senior Living INC",
"rank": 79,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001043000.svg",
"report_text": "The relative strengths and weaknesses of Sonida Senior Living INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Sonida Senior Living INC compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 46% points.The greatest weakness of Sonida Senior Living INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 106% points.
The company's Economic Capital Ratio, given in the ranking table, is 103%, being 65% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001043000_2022_Sonida_Senior_Living_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "12.3",
"Stockholders Equity": "97.2",
"ECR before LimitedLiability": "116",
"Property Plant and Equipment": "38.9",
"Intangible Assets": "-5.62",
"Other Liabilities": "13.9",
"Liabilities": "66.4",
"Long Term Liabilities": "40.8",
"Liabilities, Current": "22.5",
"Expenses": "11.1",
"Revenues": "33.4",
"Net Income": "17.7",
"Other Expenses": "-36.0",
"Operating Costs and Expenses": "7.52",
"Labor Expense": "11.8",
"General and Administrative Expense": "15.3",
"Cost of Goods and Services Sold": "7.49",
"Other Revenues": "33.4",
"Other Net Income": "-29.2",
"Comprehensive Net Income": "17.9",
"Economic Capital Ratio": "109"
},
"2012": {
"Property Plant and Equipment": "55.0",
"Assets": "15.6",
"Liabilities": "59.5",
"Stockholders Equity": "97.1",
"ECR before LimitedLiability": "115",
"Intangible Assets": "-5.67",
"Assets, Current": "-5.66",
"Liabilities, Current": "18.7",
"Long Term Liabilities": "30.1",
"Other Liabilities": "20.3",
"Expenses": "12.3",
"Revenues": "25.5",
"Net Income": "13.7",
"Other Expenses": "-28.9",
"General and Administrative Expense": "14.6",
"Cost of Goods and Services Sold": "7.07",
"Labor Expense": "11.3",
"Other Revenues": "25.5",
"Other Net Income": "-25.9",
"Comprehensive Net Income": "14.0",
"Economic Capital Ratio": "101"
},
"2013": {
"Assets": "13.8",
"Stockholders Equity": "106",
"ECR before LimitedLiability": "116",
"Property Plant and Equipment": "63.3",
"Assets, Current": "-6.18",
"Other Liabilities": "18.8",
"Liabilities": "71.2",
"Liabilities, Current": "33.4",
"Long Term Liabilities": "32.5",
"Expenses": "8.96",
"Revenues": "22.2",
"Net Income": "14.5",
"General and Administrative Expense": "15.7",
"Cost of Goods and Services Sold": "6.70",
"Depreciation, Depletion, Amortization": "-5.99",
"Labor Expense": "11.5",
"Other Expenses": "-32.7",
"Other Revenues": "22.2",
"Comprehensive Net Income": "14.8",
"Other Net Income": "-17.6",
"Economic Capital Ratio": "107"
},
"2014": {
"Assets": "20.3",
"Stockholders Equity": "102",
"ECR before LimitedLiability": "115",
"Intangible Assets": "-5.79",
"Property Plant and Equipment": "62.8",
"Other Liabilities": "12.9",
"Liabilities": "58.5",
"Liabilities, Current": "19.0",
"Long Term Liabilities": "34.9",
"Expenses": "12.9",
"Revenues": "17.9",
"Net Income": "12.6",
"Depreciation, Depletion, Amortization": "-5.34",
"Labor Expense": "11.4",
"Other Expenses": "-29.0",
"Cost of Goods and Services Sold": "6.91",
"General and Administrative Expense": "13.9",
"Other Revenues": "17.9",
"Comprehensive Net Income": "12.7",
"Other Net Income": "-19.1",
"Economic Capital Ratio": "102"
},
"2015": {
"Assets": "17.0",
"Stockholders Equity": "116",
"ECR before LimitedLiability": "127",
"Property Plant and Equipment": "57.7",
"Long Term Liabilities": "28.1",
"Liabilities": "66.6",
"Other Liabilities": "14.7",
"Liabilities, Current": "35.5",
"Selling and Marketing Expense": "4.71",
"Expenses": "15.8",
"Revenues": "16.6",
"Net Income": "16.7",
"General and Administrative Expense": "14.5",
"Other Expenses": "-27.9",
"Labor Expense": "10.6",
"Cost of Goods and Services Sold": "9.17",
"Depreciation, Depletion, Amortization": "-5.86",
"Other Revenues": "16.6",
"Comprehensive Net Income": "17.0",
"Other Net Income": "-16.5",
"Economic Capital Ratio": "114"
},
"2016": {
"Property Plant and Equipment": "72.4",
"Assets": "21.4",
"Stockholders Equity": "130",
"ECR before LimitedLiability": "149",
"Liabilities, Current": "43.5",
"Liabilities": "70.3",
"Other Liabilities": "15.9",
"Long Term Liabilities": "23.0",
"Depreciation, Depletion, Amortization": "-6.21",
"Expenses": "17.0",
"Revenues": "12.9",
"Net Income": "16.3",
"Selling and Marketing Expense": "5.26",
"General and Administrative Expense": "15.8",
"Labor Expense": "5.54",
"Other Expenses": "-25.7",
"Cost of Goods and Services Sold": "12.7",
"Other Revenues": "12.9",
"Other Net Income": "-14.0",
"Comprehensive Net Income": "16.9",
"Economic Capital Ratio": "121"
},
"2017": {
"Assets": "19.0",
"Stockholders Equity": "118",
"ECR before LimitedLiability": "145",
"Property Plant and Equipment": "94.3",
"Liabilities, Current": "39.0",
"Liabilities": "68.5",
"Other Liabilities": "9.59",
"Long Term Liabilities": "31.2",
"General and Administrative Expense": "16.8",
"Expenses": "15.1",
"Revenues": "-37.4",
"Net Income": "15.4",
"Labor Expense": "5.98",
"Research And Development Expense": "5.98",
"Depreciation, Depletion, Amortization": "-6.63",
"Other Expenses": "-25.9",
"Cost of Goods and Services Sold": "10.4",
"Other Revenues": "-37.4",
"Other Net Income": "34.2",
"Comprehensive Net Income": "15.5",
"Economic Capital Ratio": "121"
},
"2018": {
"Assets": "18.7",
"Liabilities": "61.5",
"Stockholders Equity": "110",
"ECR before LimitedLiability": "129",
"Property Plant and Equipment": "108",
"Intangible Assets": "-3.75",
"Assets, Current": "-6.46",
"Other Liabilities": "8.46",
"Liabilities, Current": "33.4",
"Long Term Liabilities": "28.9",
"Expenses": "15.0",
"Net Income": "16.9",
"Operating Costs and Expenses": "3.65",
"Depreciation, Depletion, Amortization": "-6.43",
"Other Expenses": "-34.4",
"General and Administrative Expense": "15.0",
"Research And Development Expense": "5.15",
"Cost of Goods and Services Sold": "18.7",
"Labor Expense": "7.34",
"Comprehensive Net Income": "17.1",
"Economic Capital Ratio": "108"
},
"2019": {
"Property Plant and Equipment": "60.6",
"Assets": "19.5",
"Stockholders Equity": "99.5",
"ECR before LimitedLiability": "108",
"Assets, Current": "-7.53",
"Other Liabilities": "10.4",
"Liabilities": "54.9",
"Long Term Liabilities": "37.2",
"Liabilities, Current": "13.9",
"Other Expenses": "-35.4",
"Expenses": "14.1",
"Revenues": "-5.26",
"Net Income": "12.9",
"General and Administrative Expense": "12.2",
"Cost of Goods and Services Sold": "19.5",
"Research And Development Expense": "5.99",
"Labor Expense": "5.79",
"Depreciation, Depletion, Amortization": "-5.46",
"Other Revenues": "-5.26",
"Comprehensive Net Income": "13.0",
"Economic Capital Ratio": "98.2"
},
"2020": {
"Property Plant and Equipment": "94.7",
"Assets": "-10.1",
"Liabilities, Current": "-57.8",
"Stockholders Equity": "-16.2",
"ECR before LimitedLiability": "-28.2",
"Other Assets": "-9.26",
"Intangible Assets": "-27.1",
"Assets, Current": "-46.6",
"Assets, Non-Current": "-16.5",
"Labor Expense": "7.69",
"Expenses": "11.4",
"Other Net Income": "-28.8",
"Net Income": "-22.7",
"General and Administrative Expense": "22.4",
"Depreciation, Depletion, Amortization": "-8.22",
"Other Expenses": "-44.0",
"Cost of Goods and Services Sold": "25.3",
"Other Liabilities": "7.34",
"Long Term Liabilities": "32.0",
"Comprehensive Net Income": "-22.7",
"Economic Capital Ratio": "-40.3"
},
"2021": {
"Assets": "-16.5",
"Liabilities": "-82.3",
"Stockholders Equity": "-75.3",
"ECR before LimitedLiability": "-58.6",
"Intangible Assets": "-31.9",
"Property Plant and Equipment": "46.2",
"Assets, Non-Current": "-14.1",
"Assets, Current": "-40.4",
"Liabilities, Current": "7.98",
"Long Term Liabilities": "-106",
"Other Liabilities": "8.79",
"General and Administrative Expense": "15.6",
"Expenses": "16.1",
"Revenues": "-20.4",
"Net Income": "16.6",
"Operating Costs and Expenses": "-14.1",
"Cost of Goods and Services Sold": "15.6",
"Other Revenues": "-20.4",
"Comprehensive Net Income": "16.7",
"Other Net Income": "16.0",
"Economic Capital Ratio": "-64.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001043000_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "60,999",
"Assets, Non-Current": "29,016",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "18,299",
"General and Administrative Expense": "13,198",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "40,213",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "6,852",
"Other Compr. Net Income": "0",
"Other Expenses": "228,493",
"Other Liabilities": "0",
"Other Net Income": "-487",
"Other Revenues": "263,502",
"Property Plant and Equipment": "365,459",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "462,326",
"Liabilities": "40,213",
"Expenses": "259,990",
"Revenues": "263,502",
"Stockholders Equity": "422,113",
"Net Income": "3,025",
"Comprehensive Net Income": "3,025",
"BaseVar": "513,259",
"ECR before LimitedLiability": "245%",
"Economic Capital Ratio": "270%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "56,442",
"Assets, Non-Current": "42,917",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "35,130",
"General and Administrative Expense": "16,114",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "62,154",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "10,424",
"Other Compr. Net Income": "0",
"Other Expenses": "262,628",
"Other Liabilities": "0",
"Other Net Income": "217",
"Other Revenues": "310,536",
"Property Plant and Equipment": "527,159",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "636,942",
"Liabilities": "62,154",
"Expenses": "313,872",
"Revenues": "310,536",
"Stockholders Equity": "574,788",
"Net Income": "-3,119",
"Comprehensive Net Income": "-3,119",
"BaseVar": "661,860",
"ECR before LimitedLiability": "238%",
"Economic Capital Ratio": "265%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "52,813",
"Assets, Non-Current": "42,769",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "43,238",
"General and Administrative Expense": "20,238",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "58,705",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "305,162",
"Other Liabilities": "0",
"Other Net Income": "1,772",
"Other Revenues": "350,362",
"Property Plant and Equipment": "649,967",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "745,549",
"Liabilities": "58,705",
"Expenses": "368,638",
"Revenues": "350,362",
"Stockholders Equity": "686,844",
"Net Income": "-16,504",
"Comprehensive Net Income": "-16,504",
"BaseVar": "762,513",
"ECR before LimitedLiability": "244%",
"Economic Capital Ratio": "269%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "112,574",
"Assets, Non-Current": "37,884",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "49,487",
"General and Administrative Expense": "19,622",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "100,816",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "341,425",
"Other Liabilities": "0",
"Other Net Income": "2,483",
"Other Revenues": "383,925",
"Property Plant and Equipment": "747,243",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "897,701",
"Liabilities": "100,816",
"Expenses": "410,534",
"Revenues": "383,925",
"Stockholders Equity": "796,885",
"Net Income": "-24,126",
"Comprehensive Net Income": "-24,126",
"BaseVar": "897,730",
"ECR before LimitedLiability": "227%",
"Economic Capital Ratio": "257%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "97,268",
"Assets, Non-Current": "31,193",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "53,017",
"General and Administrative Expense": "20,351",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "70,542",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "359,372",
"Other Liabilities": "0",
"Other Net Income": "6,279",
"Other Revenues": "412,177",
"Property Plant and Equipment": "890,572",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,019,033",
"Liabilities": "70,542",
"Expenses": "432,740",
"Revenues": "412,177",
"Stockholders Equity": "948,491",
"Net Income": "-14,284",
"Comprehensive Net Income": "-14,284",
"BaseVar": "970,386",
"ECR before LimitedLiability": "250%",
"Economic Capital Ratio": "274%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "82,028",
"Assets, Non-Current": "31,323",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "60,398",
"General and Administrative Expense": "23,671",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "81,390",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "391,631",
"Other Liabilities": "0",
"Other Net Income": "235",
"Other Revenues": "447,448",
"Property Plant and Equipment": "1,032,430",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,145,781",
"Liabilities": "81,390",
"Expenses": "475,700",
"Revenues": "447,448",
"Stockholders Equity": "1,064,391",
"Net Income": "-28,017",
"Comprehensive Net Income": "-28,017",
"BaseVar": "1,075,277",
"ECR before LimitedLiability": "247%",
"Economic Capital Ratio": "272%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "64,049",
"Assets, Non-Current": "18,836",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "66,199",
"General and Administrative Expense": "23,574",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "87,003",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "421,349",
"Other Liabilities": "0",
"Other Net Income": "466,954",
"Other Revenues": "0",
"Property Plant and Equipment": "1,099,786",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,182,671",
"Liabilities": "87,003",
"Expenses": "511,122",
"Revenues": "0",
"Stockholders Equity": "1,095,668",
"Net Income": "-44,168",
"Comprehensive Net Income": "-44,168",
"BaseVar": "1,123,875",
"ECR before LimitedLiability": "243%",
"Economic Capital Ratio": "269%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "73,458",
"Assets, Non-Current": "16,485",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "62,824",
"General and Administrative Expense": "26,961",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "85,030",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "152",
"Other Compr. Net Income": "0",
"Other Expenses": "424,025",
"Other Liabilities": "0",
"Other Net Income": "196",
"Other Revenues": "460,018",
"Property Plant and Equipment": "1,059,049",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,149,144",
"Liabilities": "85,030",
"Expenses": "513,810",
"Revenues": "460,018",
"Stockholders Equity": "1,064,114",
"Net Income": "-53,596",
"Comprehensive Net Income": "-53,596",
"BaseVar": "1,104,099",
"ECR before LimitedLiability": "241%",
"Economic Capital Ratio": "267%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "63,213",
"Assets, Non-Current": "235,196",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "64,190",
"General and Administrative Expense": "27,518",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "129,025",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "76",
"Other Compr. Net Income": "0",
"Other Expenses": "428,178",
"Other Liabilities": "0",
"Other Net Income": "36,756",
"Other Revenues": "447,100",
"Property Plant and Equipment": "969,211",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,267,696",
"Liabilities": "129,025",
"Expenses": "519,886",
"Revenues": "447,100",
"Stockholders Equity": "1,138,671",
"Net Income": "-36,030",
"Comprehensive Net Income": "-36,030",
"BaseVar": "1,200,232",
"ECR before LimitedLiability": "231%",
"Economic Capital Ratio": "260%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "43,428",
"Assets, Non-Current": "3,674",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "60,302",
"General and Administrative Expense": "27,904",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "373,122",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "396,201",
"Other Liabilities": "0",
"Other Net Income": "-194,825",
"Other Revenues": "383,864",
"Property Plant and Equipment": "655,731",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "702,833",
"Liabilities": "373,122",
"Expenses": "484,407",
"Revenues": "383,864",
"Stockholders Equity": "329,711",
"Net Income": "-295,368",
"Comprehensive Net Income": "-295,368",
"BaseVar": "1,069,526",
"ECR before LimitedLiability": "34%",
"Economic Capital Ratio": "119%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "103,550",
"Assets, Non-Current": "3,803",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "37,870",
"General and Administrative Expense": "29,521",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "120,482",
"Long Term Liabilities": "613,342",
"Operating Costs and Expenses": "157,269",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "88,028",
"Other Liabilities": "288",
"Other Net Income": "203,577",
"Other Revenues": "234,718",
"Property Plant and Equipment": "621,199",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "728,552",
"Liabilities": "734,112",
"Expenses": "312,688",
"Revenues": "234,718",
"Stockholders Equity": "-5,560",
"Net Income": "125,607",
"Comprehensive Net Income": "125,607",
"BaseVar": "1,106,824",
"ECR before LimitedLiability": "16%",
"Economic Capital Ratio": "103%"
}
}
},
"top_rated": false,
"trend": -25.0,
"value": 1.0305321801722167,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001043000.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001043000.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001043000.svg"
},
{
"company_id": "0001332349",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001332349.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001332349.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001332349.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001332349_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001332349_main_keyfigs.svg",
"name": "Brookdale Senior Living Inc",
"rank": 80,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001332349.svg",
"report_text": "The relative strengths and weaknesses of Brookdale Senior Living Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Brookdale Senior Living Inc compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 41% points.The greatest weakness of Brookdale Senior Living Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 88% points.
The company's Economic Capital Ratio, given in the ranking table, is 102%, being 66% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001332349_2022_Brookdale_Senior_Living_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Liabilities": "-60.8",
"Stockholders Equity": "-40.8",
"ECR before LimitedLiability": "-70.3",
"Long Term Liabilities": "-58.8",
"Other Expenses": "-29.0",
"Expenses": "13.3",
"Revenues": "16.7",
"Net Income": "-9.61",
"Cost of Goods and Services Sold": "11.3",
"General and Administrative Expense": "8.07",
"Labor Expense": "8.30",
"Operating Costs and Expenses": "9.17",
"Depreciation, Depletion, Amortization": "7.93",
"Other Revenues": "16.7",
"Assets, Current": "-19.9",
"Property Plant and Equipment": "47.3",
"Other Assets": "4.64",
"Intangible Assets": "-35.7",
"Comprehensive Net Income": "-8.71",
"Other Net Income": "-35.9",
"Economic Capital Ratio": "-68.5"
},
"2011": {
"Assets": "11.2",
"Liabilities": "-59.9",
"Stockholders Equity": "-34.3",
"ECR before LimitedLiability": "-32.4",
"Property Plant and Equipment": "46.7",
"Assets, Current": "-26.1",
"Intangible Assets": "-26.3",
"Long Term Liabilities": "-67.0",
"Liabilities, Current": "9.76",
"Expenses": "28.8",
"Revenues": "14.4",
"Net Income": "15.1",
"Other Expenses": "-14.5",
"Operating Costs and Expenses": "7.21",
"Labor Expense": "11.5",
"General and Administrative Expense": "15.5",
"Cost of Goods and Services Sold": "7.19",
"Other Revenues": "14.4",
"Other Net Income": "-25.0",
"Comprehensive Net Income": "15.4",
"Economic Capital Ratio": "-39.1"
},
"2012": {
"Liabilities": "-57.4",
"Stockholders Equity": "-40.1",
"ECR before LimitedLiability": "-30.6",
"Long Term Liabilities": "-57.8",
"Expenses": "24.5",
"Net Income": "14.6",
"Other Expenses": "-20.9",
"General and Administrative Expense": "16.2",
"Operating Costs and Expenses": "5.93",
"Cost of Goods and Services Sold": "7.71",
"Labor Expense": "12.5",
"Other Revenues": "18.2",
"Revenues": "18.2",
"Property Plant and Equipment": "46.4",
"Intangible Assets": "-25.9",
"Assets, Current": "-32.8",
"Other Assets": "5.60",
"Assets, Non-Current": "-4.28",
"Other Net Income": "-25.1",
"Comprehensive Net Income": "15.0",
"Economic Capital Ratio": "-44.8"
},
"2013": {
"Liabilities": "-48.4",
"Stockholders Equity": "-38.4",
"ECR before LimitedLiability": "-32.8",
"Liabilities, Current": "13.4",
"Long Term Liabilities": "-67.2",
"Expenses": "21.8",
"Revenues": "16.7",
"Net Income": "19.4",
"General and Administrative Expense": "17.5",
"Cost of Goods and Services Sold": "7.21",
"Labor Expense": "12.6",
"Operating Costs and Expenses": "4.11",
"Other Expenses": "-23.2",
"Research And Development Expense": "4.12",
"Other Revenues": "16.7",
"Property Plant and Equipment": "47.1",
"Assets, Current": "-36.5",
"Intangible Assets": "-23.3",
"Comprehensive Net Income": "19.8",
"Other Net Income": "-17.6",
"Economic Capital Ratio": "-41.9"
},
"2014": {
"Assets": "28.7",
"Liabilities": "-55.0",
"Stockholders Equity": "-15.4",
"ECR before LimitedLiability": "-13.5",
"Intangible Assets": "-14.0",
"Property Plant and Equipment": "52.3",
"Assets, Current": "-24.5",
"Other Liabilities": "-41.3",
"Liabilities, Current": "20.9",
"Long Term Liabilities": "-35.0",
"Expenses": "32.8",
"Net Income": "14.3",
"Other Net Income": "-17.1",
"Operating Costs and Expenses": "5.09",
"Labor Expense": "11.1",
"Research And Development Expense": "3.83",
"Other Expenses": "-9.36",
"Cost of Goods and Services Sold": "6.63",
"General and Administrative Expense": "13.8",
"Comprehensive Net Income": "14.5",
"Economic Capital Ratio": "-26.7"
},
"2015": {
"Assets, Current": "-31.1",
"Assets": "15.0",
"Liabilities": "-54.8",
"Stockholders Equity": "-28.0",
"ECR before LimitedLiability": "-26.4",
"Intangible Assets": "-16.1",
"Property Plant and Equipment": "46.1",
"Long Term Liabilities": "-47.5",
"Other Liabilities": "-36.5",
"Liabilities, Current": "27.5",
"Expenses": "26.4",
"Revenues": "7.99",
"Net Income": "15.8",
"General and Administrative Expense": "15.1",
"Other Expenses": "-18.5",
"Labor Expense": "11.5",
"Cost of Goods and Services Sold": "9.86",
"Other Revenues": "7.99",
"Comprehensive Net Income": "16.2",
"Other Net Income": "-16.9",
"Economic Capital Ratio": "-38.8"
},
"2016": {
"Property Plant and Equipment": "44.9",
"Assets": "18.5",
"Liabilities": "-47.1",
"Stockholders Equity": "-20.4",
"Economic Capital Ratio": "-32.9",
"Intangible Assets": "-15.2",
"Assets, Current": "-30.1",
"Liabilities, Current": "30.2",
"Other Liabilities": "-38.9",
"Long Term Liabilities": "-50.1",
"Expenses": "26.3",
"Revenues": "8.25",
"Net Income": "18.6",
"Selling and Marketing Expense": "5.94",
"General and Administrative Expense": "18.3",
"Labor Expense": "6.26",
"Other Expenses": "-22.9",
"Cost of Goods and Services Sold": "14.8",
"Other Revenues": "8.25",
"Other Net Income": "-14.6",
"Comprehensive Net Income": "19.3"
},
"2017": {
"Liabilities, Current": "22.9",
"Liabilities": "-46.4",
"Stockholders Equity": "-37.7",
"ECR before LimitedLiability": "-13.9",
"Other Liabilities": "-24.0",
"Long Term Liabilities": "-53.0",
"General and Administrative Expense": "21.5",
"Expenses": "20.9",
"Net Income": "18.2",
"Labor Expense": "7.37",
"Research And Development Expense": "7.38",
"Other Expenses": "-29.6",
"Cost of Goods and Services Sold": "13.0",
"Other Revenues": "20.9",
"Revenues": "20.9",
"Intangible Assets": "-20.4",
"Assets, Current": "-35.2",
"Property Plant and Equipment": "37.6",
"Other Net Income": "-21.4",
"Comprehensive Net Income": "18.4",
"Economic Capital Ratio": "-38.0"
},
"2018": {
"Other Assets": "-9.75",
"Assets": "-14.4",
"Liabilities": "-54.3",
"Stockholders Equity": "-56.9",
"ECR before LimitedLiability": "-35.6",
"Property Plant and Equipment": "41.1",
"Intangible Assets": "-23.8",
"Assets, Non-Current": "-9.35",
"Assets, Current": "-42.7",
"Other Liabilities": "-21.4",
"Liabilities, Current": "15.8",
"Long Term Liabilities": "-66.6",
"Expenses": "15.5",
"Net Income": "15.6",
"Other Expenses": "-45.2",
"General and Administrative Expense": "15.5",
"Research And Development Expense": "6.95",
"Cost of Goods and Services Sold": "15.7",
"Labor Expense": "10.00",
"Comprehensive Net Income": "15.6",
"Economic Capital Ratio": "-56.3"
},
"2019": {
"Property Plant and Equipment": "27.7",
"Assets": "-6.89",
"Liabilities": "-68.3",
"Stockholders Equity": "-59.3",
"Intangible Assets": "-24.6",
"Assets, Current": "-40.7",
"Other Liabilities": "-8.74",
"Long Term Liabilities": "-74.0",
"Liabilities, Current": "10.7",
"Other Expenses": "-36.3",
"Expenses": "11.0",
"Revenues": "-7.29",
"Net Income": "10.8",
"General and Administrative Expense": "10.7",
"Cost of Goods and Services Sold": "11.1",
"Research And Development Expense": "7.65",
"Labor Expense": "7.39",
"Other Revenues": "-7.29",
"ECR before LimitedLiability": "-53.6",
"Comprehensive Net Income": "10.8",
"Economic Capital Ratio": "-63.6"
},
"2020": {
"Property Plant and Equipment": "37.5",
"Assets": "-7.98",
"Liabilities": "-64.1",
"Stockholders Equity": "-56.5",
"ECR before LimitedLiability": "-41.6",
"Other Assets": "-7.35",
"Intangible Assets": "-23.0",
"Assets, Current": "-40.5",
"Liabilities, Current": "18.5",
"Long Term Liabilities": "-83.2",
"Labor Expense": "6.52",
"Expenses": "18.5",
"Revenues": "-6.35",
"Net Income": "18.5",
"General and Administrative Expense": "18.5",
"Other Expenses": "-31.2",
"Cost of Goods and Services Sold": "18.5",
"Other Revenues": "-6.35",
"Other Net Income": "6.68",
"Comprehensive Net Income": "18.5",
"Economic Capital Ratio": "-53.7"
},
"2021": {
"Assets": "-9.82",
"Liabilities": "-71.2",
"Stockholders Equity": "-63.0",
"ECR before LimitedLiability": "-59.5",
"Intangible Assets": "-31.7",
"Property Plant and Equipment": "41.3",
"Assets, Current": "-42.6",
"Liabilities, Current": "14.7",
"Long Term Liabilities": "-87.9",
"General and Administrative Expense": "14.7",
"Expenses": "14.8",
"Revenues": "-8.60",
"Net Income": "14.8",
"Operating Costs and Expenses": "5.81",
"Cost of Goods and Services Sold": "14.7",
"Research And Development Expense": "5.21",
"Other Expenses": "-27.4",
"Other Revenues": "-8.60",
"Comprehensive Net Income": "14.8",
"Other Net Income": "6.96",
"Economic Capital Ratio": "-65.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001332349_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "328,109",
"Assets, Non-Current": "98,973",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "-292,341",
"General and Administrative Expense": "-131,709",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "109,693",
"Labor Expense": "0",
"Liabilities, Current": "606,358",
"Long Term Liabilities": "2,527,885",
"Operating Costs and Expenses": "0",
"Other Assets": "256,853",
"Other Compr. Net Income": "0",
"Other Expenses": "2,681,492",
"Other Liabilities": "336,230",
"Other Net Income": "-4,723",
"Other Revenues": "2,213,264",
"Property Plant and Equipment": "3,736,842",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,530,470",
"Liabilities": "3,470,473",
"Expenses": "2,257,442",
"Revenues": "2,213,264",
"Stockholders Equity": "1,059,997",
"Net Income": "-48,901",
"Comprehensive Net Income": "-48,901",
"BaseVar": "6,238,186",
"ECR before LimitedLiability": "37%",
"Economic Capital Ratio": "122%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "280,875",
"Assets, Non-Current": "109,934",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "268,506",
"General and Administrative Expense": "148,327",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "109,553",
"Labor Expense": "0",
"Liabilities, Current": "620,950",
"Long Term Liabilities": "2,458,497",
"Operating Costs and Expenses": "0",
"Other Assets": "271,635",
"Other Compr. Net Income": "0",
"Other Expenses": "2,091,545",
"Other Liabilities": "346,406",
"Other Net Income": "-17,715",
"Other Revenues": "2,457,918",
"Property Plant and Equipment": "3,694,064",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,466,061",
"Liabilities": "3,425,853",
"Expenses": "2,508,378",
"Revenues": "2,457,918",
"Stockholders Equity": "1,040,208",
"Net Income": "-68,175",
"Comprehensive Net Income": "-68,175",
"BaseVar": "6,437,962",
"ECR before LimitedLiability": "36%",
"Economic Capital Ratio": "122%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "309,038",
"Assets, Non-Current": "113,315",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "252,281",
"General and Administrative Expense": "178,829",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "109,553",
"Labor Expense": "0",
"Liabilities, Current": "1,121,503",
"Long Term Liabilities": "2,212,109",
"Operating Costs and Expenses": "0",
"Other Assets": "254,095",
"Other Compr. Net Income": "1,015",
"Other Expenses": "2,405,152",
"Other Liabilities": "329,649",
"Other Net Income": "532",
"Other Revenues": "2,770,085",
"Property Plant and Equipment": "3,879,977",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,665,978",
"Liabilities": "3,663,261",
"Expenses": "2,836,262",
"Revenues": "2,770,085",
"Stockholders Equity": "1,002,717",
"Net Income": "-65,645",
"Comprehensive Net Income": "-64,630",
"BaseVar": "6,968,566",
"ECR before LimitedLiability": "33%",
"Economic Capital Ratio": "119%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "294,862",
"Assets, Non-Current": "177,396",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "268,757",
"General and Administrative Expense": "184,548",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "109,553",
"Labor Expense": "0",
"Liabilities, Current": "870,844",
"Long Term Liabilities": "2,522,945",
"Operating Costs and Expenses": "0",
"Other Assets": "260,471",
"Other Compr. Net Income": "0",
"Other Expenses": "2,447,508",
"Other Liabilities": "323,031",
"Other Net Income": "5,263",
"Other Revenues": "2,891,966",
"Property Plant and Equipment": "3,895,475",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,737,757",
"Liabilities": "3,716,820",
"Expenses": "2,900,813",
"Revenues": "2,891,966",
"Stockholders Equity": "1,020,937",
"Net Income": "-3,584",
"Comprehensive Net Income": "-3,584",
"BaseVar": "7,126,310",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "120%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "614,789",
"Assets, Non-Current": "256,190",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "537,035",
"General and Administrative Expense": "280,267",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "736,805",
"Labor Expense": "0",
"Liabilities, Current": "877,762",
"Long Term Liabilities": "3,724,657",
"Operating Costs and Expenses": "0",
"Other Assets": "524,074",
"Other Compr. Net Income": "436",
"Other Expenses": "3,163,481",
"Other Liabilities": "3,036,703",
"Other Net Income": "-349",
"Other Revenues": "3,831,706",
"Property Plant and Equipment": "8,389,505",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,521,363",
"Liabilities": "7,639,122",
"Expenses": "3,980,783",
"Revenues": "3,831,706",
"Stockholders Equity": "2,882,241",
"Net Income": "-149,426",
"Comprehensive Net Income": "-148,990",
"BaseVar": "12,986,880",
"ECR before LimitedLiability": "44%",
"Economic Capital Ratio": "128%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "497,943",
"Assets, Non-Current": "259,342",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "733,165",
"General and Administrative Expense": "370,579",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "725,696",
"Labor Expense": "0",
"Liabilities, Current": "840,148",
"Long Term Liabilities": "3,986,663",
"Operating Costs and Expenses": "0",
"Other Assets": "534,207",
"Other Compr. Net Income": "0",
"Other Expenses": "4,317,828",
"Other Liabilities": "2,763,026",
"Other Net Income": "2,809",
"Other Revenues": "4,960,608",
"Property Plant and Equipment": "8,031,376",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,048,564",
"Liabilities": "7,589,837",
"Expenses": "5,421,572",
"Revenues": "4,960,608",
"Stockholders Equity": "2,458,727",
"Net Income": "-458,155",
"Comprehensive Net Income": "-458,155",
"BaseVar": "14,011,695",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "120%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "619,504",
"Assets, Non-Current": "234,508",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "520,402",
"General and Administrative Expense": "313,409",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "705,476",
"Labor Expense": "0",
"Liabilities, Current": "731,142",
"Long Term Liabilities": "3,644,889",
"Operating Costs and Expenses": "0",
"Other Assets": "278,894",
"Other Compr. Net Income": "0",
"Other Expenses": "4,565,069",
"Other Liabilities": "2,763,924",
"Other Net Income": "17,264",
"Other Revenues": "4,976,980",
"Property Plant and Equipment": "7,379,305",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "9,217,687",
"Liabilities": "7,139,955",
"Expenses": "5,398,880",
"Revenues": "4,976,980",
"Stockholders Equity": "2,077,732",
"Net Income": "-404,636",
"Comprehensive Net Income": "-404,636",
"BaseVar": "13,375,383",
"ECR before LimitedLiability": "32%",
"Economic Capital Ratio": "118%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "901,872",
"Assets, Non-Current": "195,168",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "482,077",
"General and Administrative Expense": "255,446",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "505,783",
"Labor Expense": "0",
"Liabilities, Current": "1,095,776",
"Long Term Liabilities": "3,589,968",
"Operating Costs and Expenses": "0",
"Other Assets": "220,481",
"Other Compr. Net Income": "0",
"Other Expenses": "4,589,103",
"Other Liabilities": "1,459,414",
"Other Net Income": "7,904",
"Other Revenues": "4,747,116",
"Property Plant and Equipment": "5,852,145",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,675,449",
"Liabilities": "6,145,158",
"Expenses": "5,326,626",
"Revenues": "4,747,116",
"Stockholders Equity": "1,530,291",
"Net Income": "-571,606",
"Comprehensive Net Income": "-571,606",
"BaseVar": "11,951,126",
"ECR before LimitedLiability": "24%",
"Economic Capital Ratio": "110%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "774,016",
"Assets, Non-Current": "160,418",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "447,455",
"General and Administrative Expense": "250,495",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "154,131",
"Labor Expense": "0",
"Liabilities, Current": "773,331",
"Long Term Liabilities": "3,543,043",
"Operating Costs and Expenses": "0",
"Other Assets": "103,268",
"Other Compr. Net Income": "0",
"Other Expenses": "4,658,135",
"Other Liabilities": "1,132,473",
"Other Net Income": "296,307",
"Other Revenues": "4,531,426",
"Property Plant and Equipment": "5,275,427",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,467,260",
"Liabilities": "5,448,847",
"Expenses": "5,356,085",
"Revenues": "4,531,426",
"Stockholders Equity": "1,018,413",
"Net Income": "-528,352",
"Comprehensive Net Income": "-528,352",
"BaseVar": "11,049,962",
"ECR before LimitedLiability": "16%",
"Economic Capital Ratio": "103%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "596,175",
"Assets, Non-Current": "1,243,271",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "379,433",
"General and Administrative Expense": "219,289",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "154,131",
"Labor Expense": "0",
"Liabilities, Current": "1,062,369",
"Long Term Liabilities": "4,654,336",
"Operating Costs and Expenses": "0",
"Other Assets": "91,022",
"Other Compr. Net Income": "0",
"Other Expenses": "3,748,723",
"Other Liabilities": "779,003",
"Other Net Income": "21,865",
"Other Revenues": "4,057,088",
"Property Plant and Equipment": "5,109,834",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,194,433",
"Liabilities": "6,495,708",
"Expenses": "4,347,445",
"Revenues": "4,057,088",
"Stockholders Equity": "698,725",
"Net Income": "-268,492",
"Comprehensive Net Income": "-268,492",
"BaseVar": "11,058,270",
"ECR before LimitedLiability": "11%",
"Economic Capital Ratio": "98%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "773,603",
"Assets, Non-Current": "844,397",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "359,226",
"General and Administrative Expense": "206,575",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "154,131",
"Labor Expense": "0",
"Liabilities, Current": "700,290",
"Long Term Liabilities": "4,854,975",
"Operating Costs and Expenses": "0",
"Other Assets": "61,567",
"Other Compr. Net Income": "0",
"Other Expenses": "3,286,217",
"Other Liabilities": "543,764",
"Other Net Income": "393,768",
"Other Revenues": "3,540,195",
"Property Plant and Equipment": "5,068,060",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,901,758",
"Liabilities": "6,099,029",
"Expenses": "3,852,018",
"Revenues": "3,540,195",
"Stockholders Equity": "802,729",
"Net Income": "81,945",
"Comprehensive Net Income": "81,945",
"BaseVar": "10,393,384",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "106%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "698,994",
"Assets, Non-Current": "647,719",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "337,613",
"General and Administrative Expense": "184,916",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "27,321",
"Labor Expense": "0",
"Liabilities, Current": "631,954",
"Long Term Liabilities": "4,546,754",
"Operating Costs and Expenses": "0",
"Other Assets": "132,141",
"Other Compr. Net Income": "0",
"Other Expenses": "2,639,643",
"Other Liabilities": "532,136",
"Other Net Income": "304,549",
"Other Revenues": "2,758,259",
"Property Plant and Equipment": "4,904,292",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,410,467",
"Liabilities": "5,710,844",
"Expenses": "3,162,172",
"Revenues": "2,758,259",
"Stockholders Equity": "699,623",
"Net Income": "-99,364",
"Comprehensive Net Income": "-99,364",
"BaseVar": "9,173,146",
"ECR before LimitedLiability": "15%",
"Economic Capital Ratio": "102%"
}
}
},
"top_rated": false,
"trend": -21.0,
"value": 1.0213431187997581,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001332349.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001332349.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001332349.svg"
},
{
"company_id": "0000862692",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000862692.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000862692.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000862692.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000862692_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000862692_main_keyfigs.svg",
"name": "CRYO CELL International INC",
"rank": 81,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000862692.svg",
"report_text": "The relative strengths and weaknesses of CRYO CELL International INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of CRYO CELL International INC compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 30% points.The greatest weakness of CRYO CELL International INC is the variable Liabilities, reducing the Economic Capital Ratio by 77% points.
The company's Economic Capital Ratio, given in the ranking table, is 101%, being 67% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000862692_2022_CRYO_CELL_International_INC.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-10.8",
"Other Liabilities": "11.1",
"Stockholders Equity": "-19.2",
"Economic Capital Ratio": "-10.2",
"Property Plant and Equipment": "-20.3",
"Assets, Current": "52.8",
"Assets, Non-Current": "17.3",
"Intangible Assets": "-28.4",
"Expenses": "7.05",
"Revenues": "46.8",
"Net Income": "9.19",
"Other Expenses": "10.7",
"Operating Costs and Expenses": "8.82",
"Labor Expense": "14.1",
"General and Administrative Expense": "-38.1",
"Cost of Goods and Services Sold": "8.79",
"Other Revenues": "46.8",
"Long Term Liabilities": "35.5",
"Liabilities, Current": "-60.4",
"Other Net Income": "-37.3",
"Comprehensive Net Income": "9.46"
},
"2012": {
"Property Plant and Equipment": "-14.6",
"Assets": "-53.2",
"Liabilities": "-0.951",
"Stockholders Equity": "-77.7",
"Intangible Assets": "-32.5",
"Assets, Current": "1.27",
"Liabilities, Current": "-49.7",
"ECR before LimitedLiability": "-64.1",
"Long Term Liabilities": "5.04",
"Other Liabilities": "3.09",
"Expenses": "-1.98",
"Revenues": "17.7",
"Net Income": "-1.92",
"General and Administrative Expense": "-51.1",
"Operating Costs and Expenses": "1.56",
"Cost of Goods and Services Sold": "2.11",
"Labor Expense": "3.72",
"Other Revenues": "17.7",
"Other Net Income": "-39.9",
"Comprehensive Net Income": "-1.90",
"Economic Capital Ratio": "-78.3"
},
"2013": {
"Other Assets": "-8.70",
"Assets": "-60.4",
"Other Liabilities": "20.9",
"Stockholders Equity": "-86.5",
"ECR before LimitedLiability": "-43.2",
"Property Plant and Equipment": "-30.4",
"Assets, Current": "7.38",
"Intangible Assets": "-41.0",
"Expenses": "-10.3",
"Revenues": "31.4",
"Net Income": "22.6",
"General and Administrative Expense": "-54.8",
"Cost of Goods and Services Sold": "12.6",
"Labor Expense": "22.1",
"Operating Costs and Expenses": "7.13",
"Other Revenues": "31.4",
"Liabilities, Current": "-66.2",
"Long Term Liabilities": "22.7",
"Comprehensive Net Income": "22.6",
"Other Net Income": "-40.8",
"Economic Capital Ratio": "-52.4"
},
"2014": {
"Other Assets": "-14.4",
"Assets": "-67.3",
"Other Liabilities": "17.4",
"Stockholders Equity": "-92.5",
"ECR before LimitedLiability": "-33.3",
"Intangible Assets": "-44.1",
"Property Plant and Equipment": "-39.5",
"Assets, Current": "17.1",
"Expenses": "-16.2",
"Revenues": "37.2",
"Net Income": "22.0",
"Operating Costs and Expenses": "12.0",
"Labor Expense": "21.1",
"Cost of Goods and Services Sold": "15.7",
"General and Administrative Expense": "-68.3",
"Other Revenues": "37.2",
"Liabilities, Current": "-64.7",
"Long Term Liabilities": "22.4",
"Comprehensive Net Income": "22.0",
"Other Net Income": "-48.3",
"Economic Capital Ratio": "-46.5"
},
"2015": {
"Expenses": "32.6",
"Net Income": "60.3",
"General and Administrative Expense": "-36.3",
"Other Expenses": "31.6",
"Labor Expense": "11.5",
"Cost of Goods and Services Sold": "9.87",
"Other Revenues": "54.4",
"Revenues": "54.4",
"Long Term Liabilities": "24.9",
"Stockholders Equity": "-8.36",
"ECR before LimitedLiability": "53.5",
"Comprehensive Net Income": "61.7",
"Assets, Current": "7.38",
"Other Liabilities": "12.7",
"Assets, Non-Current": "33.2",
"Intangible Assets": "-7.84",
"Other Assets": "-10.5",
"Liabilities, Current": "-50.9",
"Property Plant and Equipment": "-12.2",
"Other Net Income": "-26.7",
"Economic Capital Ratio": "41.0"
},
"2016": {
"Property Plant and Equipment": "-9.04",
"Assets": "-11.9",
"Liabilities": "-20.2",
"Stockholders Equity": "-70.1",
"ECR before LimitedLiability": "-48.1",
"Assets, Non-Current": "20.1",
"Intangible Assets": "-9.37",
"Other Assets": "-2.96",
"Assets, Current": "-5.68",
"Other Liabilities": "2.46",
"Long Term Liabilities": "-26.5",
"Expenses": "8.59",
"Revenues": "7.55",
"Net Income": "7.05",
"General and Administrative Expense": "-6.42",
"Other Expenses": "4.55",
"Cost of Goods and Services Sold": "5.38",
"Other Revenues": "7.55",
"Other Net Income": "-7.15",
"Comprehensive Net Income": "7.17",
"Economic Capital Ratio": "-75.8"
},
"2017": {
"Other Assets": "-2.03",
"Assets": "-6.00",
"Liabilities": "-49.3",
"Stockholders Equity": "-79.8",
"ECR before LimitedLiability": "-41.6",
"Intangible Assets": "-4.61",
"Assets, Non-Current": "14.6",
"Assets, Current": "-2.53",
"Property Plant and Equipment": "-4.17",
"Liabilities, Current": "-1.75",
"Long Term Liabilities": "-42.4",
"General and Administrative Expense": "-2.65",
"Expenses": "7.01",
"Revenues": "8.09",
"Net Income": "8.37",
"Labor Expense": "1.59",
"Cost of Goods and Services Sold": "2.92",
"Other Revenues": "8.09",
"Other Net Income": "-3.97",
"Comprehensive Net Income": "8.43",
"Economic Capital Ratio": "-65.7"
},
"2018": {
"Other Assets": "-1.43",
"Assets": "-1.44",
"Liabilities": "-72.5",
"Stockholders Equity": "-71.4",
"ECR before LimitedLiability": "-52.6",
"Property Plant and Equipment": "-1.37",
"Intangible Assets": "-1.39",
"Assets, Non-Current": "3.81",
"Assets, Current": "2.95",
"Other Liabilities": "0.584",
"Long Term Liabilities": "-75.7",
"Expenses": "5.44",
"Net Income": "4.08",
"Operating Costs and Expenses": "0.503",
"Other Expenses": "1.71",
"General and Administrative Expense": "-0.884",
"Research And Development Expense": "0.706",
"Cost of Goods and Services Sold": "0.624",
"Labor Expense": "1.09",
"Comprehensive Net Income": "4.25",
"Economic Capital Ratio": "-73.3"
},
"2019": {
"Property Plant and Equipment": "-3.11",
"Assets": "-12.7",
"Liabilities": "-73.1",
"Stockholders Equity": "-78.7",
"Assets, Non-Current": "13.5",
"Other Assets": "-2.08",
"Intangible Assets": "-8.12",
"Assets, Current": "-7.19",
"Other Liabilities": "0.547",
"Long Term Liabilities": "-68.8",
"Liabilities, Current": "-0.455",
"Other Expenses": "0.644",
"Expenses": "3.56",
"Net Income": "2.98",
"General and Administrative Expense": "-0.466",
"Research And Development Expense": "0.601",
"Labor Expense": "0.583",
"Operating Costs and Expenses": "0.487",
"ECR before LimitedLiability": "-64.8",
"Comprehensive Net Income": "3.01",
"Economic Capital Ratio": "-74.8"
},
"2020": {
"Property Plant and Equipment": "-13.7",
"Assets": "-21.3",
"Liabilities": "-79.4",
"Stockholders Equity": "-80.3",
"Other Assets": "-17.5",
"Intangible Assets": "-21.6",
"Assets, Current": "-20.4",
"Assets, Non-Current": "9.62",
"Liabilities, Current": "-12.3",
"Other Liabilities": "0.0766",
"Long Term Liabilities": "-71.4",
"Labor Expense": "0.102",
"Expenses": "1.81",
"Other Net Income": "-3.94",
"Net Income": "1.69",
"General and Administrative Expense": "-5.54",
"Other Expenses": "0.346",
"Operating Costs and Expenses": "0.0664",
"ECR before LimitedLiability": "-60.1",
"Comprehensive Net Income": "1.69",
"Economic Capital Ratio": "-72.2"
},
"2021": {
"Other Assets": "-12.2",
"Assets": "-9.12",
"Liabilities": "-77.4",
"Stockholders Equity": "-66.2",
"ECR before LimitedLiability": "-60.6",
"Intangible Assets": "-26.4",
"Property Plant and Equipment": "-6.83",
"Assets, Non-Current": "30.4",
"Assets, Current": "-29.3",
"Liabilities, Current": "-21.5",
"Long Term Liabilities": "-62.6",
"Other Liabilities": "8.63",
"Expenses": "14.0",
"Net Income": "13.8",
"Operating Costs and Expenses": "5.69",
"Labor Expense": "4.92",
"Research And Development Expense": "5.01",
"Other Expenses": "10.6",
"Selling and Marketing Expense": "3.91",
"Comprehensive Net Income": "13.8",
"Economic Capital Ratio": "-66.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000862692_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "14,053",
"Assets, Non-Current": "3,873",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "361",
"General and Administrative Expense": "12,413",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "10,563",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5,409",
"Other Liabilities": "0",
"Other Net Income": "-1,647",
"Other Revenues": "17,918",
"Property Plant and Equipment": "1,540",
"Research And Development Expense": "184",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "19,467",
"Liabilities": "10,563",
"Expenses": "18,367",
"Revenues": "17,918",
"Stockholders Equity": "8,903",
"Net Income": "-2,096",
"Comprehensive Net Income": "-2,096",
"BaseVar": "33,981",
"ECR before LimitedLiability": "72%",
"Economic Capital Ratio": "151%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "9,315",
"Assets, Non-Current": "1,735",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "204",
"General and Administrative Expense": "14,426",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "10,664",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,829",
"Other Liabilities": "0",
"Other Net Income": "-2,709",
"Other Revenues": "17,970",
"Property Plant and Equipment": "1,281",
"Research And Development Expense": "110",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "12,331",
"Liabilities": "10,664",
"Expenses": "21,569",
"Revenues": "17,970",
"Stockholders Equity": "1,667",
"Net Income": "-6,308",
"Comprehensive Net Income": "-6,308",
"BaseVar": "32,621",
"ECR before LimitedLiability": "-34%",
"Economic Capital Ratio": "85%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "9,425",
"Assets, Non-Current": "868",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "188",
"General and Administrative Expense": "11,366",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "9,810",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5,871",
"Other Liabilities": "0",
"Other Net Income": "-1,506",
"Other Revenues": "18,995",
"Property Plant and Equipment": "1,207",
"Research And Development Expense": "36",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "11,501",
"Liabilities": "9,810",
"Expenses": "17,461",
"Revenues": "18,995",
"Stockholders Equity": "1,690",
"Net Income": "27",
"Comprehensive Net Income": "27",
"BaseVar": "29,637",
"ECR before LimitedLiability": "23%",
"Economic Capital Ratio": "110%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "8,492",
"Assets, Non-Current": "764",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "171",
"General and Administrative Expense": "12,252",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "9,127",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5,781",
"Other Liabilities": "0",
"Other Net Income": "-1,304",
"Other Revenues": "20,127",
"Property Plant and Equipment": "953",
"Research And Development Expense": "64",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,210",
"Liabilities": "9,127",
"Expenses": "18,269",
"Revenues": "20,127",
"Stockholders Equity": "1,082",
"Net Income": "554",
"Comprehensive Net Income": "554",
"BaseVar": "29,518",
"ECR before LimitedLiability": "22%",
"Economic Capital Ratio": "109%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "10,353",
"Assets, Non-Current": "8,266",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "92",
"General and Administrative Expense": "12,389",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,294",
"Labor Expense": "0",
"Liabilities, Current": "10,424",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "-2,294",
"Other Compr. Net Income": "170",
"Other Expenses": "-1,526",
"Other Liabilities": "0",
"Other Net Income": "-1,984",
"Other Revenues": "21,091",
"Property Plant and Equipment": "879",
"Research And Development Expense": "46",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "19,498",
"Liabilities": "10,424",
"Expenses": "11,001",
"Revenues": "21,091",
"Stockholders Equity": "9,074",
"Net Income": "8,106",
"Comprehensive Net Income": "8,276",
"BaseVar": "32,084",
"ECR before LimitedLiability": "143%",
"Economic Capital Ratio": "200%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "9,012",
"Assets, Non-Current": "9,547",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "155",
"General and Administrative Expense": "14,723",
"Goodwill Impairment Loss": "1,989",
"Intangible Assets": "261",
"Labor Expense": "0",
"Liabilities, Current": "13,112",
"Long Term Liabilities": "21,841",
"Operating Costs and Expenses": "0",
"Other Assets": "-261",
"Other Compr. Net Income": "-136",
"Other Expenses": "4,615",
"Other Liabilities": "0",
"Other Net Income": "-2,914",
"Other Revenues": "23,128",
"Property Plant and Equipment": "979",
"Research And Development Expense": "53",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "19,538",
"Liabilities": "34,953",
"Expenses": "21,535",
"Revenues": "23,128",
"Stockholders Equity": "-15,414",
"Net Income": "-1,321",
"Comprehensive Net Income": "-1,456",
"BaseVar": "51,102",
"ECR before LimitedLiability": "-87%",
"Economic Capital Ratio": "75%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "12,737",
"Assets, Non-Current": "10,291",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "132",
"General and Administrative Expense": "13,481",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "226",
"Labor Expense": "0",
"Liabilities, Current": "13,940",
"Long Term Liabilities": "22,473",
"Operating Costs and Expenses": "0",
"Other Assets": "-226",
"Other Compr. Net Income": "6.5",
"Other Expenses": "8,033",
"Other Liabilities": "0",
"Other Net Income": "-1,383",
"Other Revenues": "25,384",
"Property Plant and Equipment": "882",
"Research And Development Expense": "41",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "23,910",
"Liabilities": "36,413",
"Expenses": "21,687",
"Revenues": "25,384",
"Stockholders Equity": "-12,503",
"Net Income": "2,315",
"Comprehensive Net Income": "2,322",
"BaseVar": "54,391",
"ECR before LimitedLiability": "-52%",
"Economic Capital Ratio": "83%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "29,535",
"Assets, Non-Current": "11,362",
"Cost of Goods and Services Sold": "8,540",
"Depreciation, Depletion, Amortization": "180",
"General and Administrative Expense": "15,633",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,283",
"Labor Expense": "0",
"Liabilities, Current": "15,430",
"Long Term Liabilities": "35,869",
"Operating Costs and Expenses": "0",
"Other Assets": "-3,283",
"Other Compr. Net Income": "300",
"Other Expenses": "4,057",
"Other Liabilities": "0",
"Other Net Income": "-1,572",
"Other Revenues": "29,218",
"Property Plant and Equipment": "1,493",
"Research And Development Expense": "92",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "42,390",
"Liabilities": "51,298",
"Expenses": "28,502",
"Revenues": "29,218",
"Stockholders Equity": "-8,908",
"Net Income": "-855",
"Comprehensive Net Income": "-555",
"BaseVar": "76,640",
"ECR before LimitedLiability": "-29%",
"Economic Capital Ratio": "86%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "15,388",
"Assets, Non-Current": "25,652",
"Cost of Goods and Services Sold": "10,036",
"Depreciation, Depletion, Amortization": "206",
"General and Administrative Expense": "14,891",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,191",
"Labor Expense": "0",
"Liabilities, Current": "15,429",
"Long Term Liabilities": "34,410",
"Operating Costs and Expenses": "0",
"Other Assets": "-3,191",
"Other Compr. Net Income": "0",
"Other Expenses": "2,690",
"Other Liabilities": "0",
"Other Net Income": "-1,671",
"Other Revenues": "31,817",
"Property Plant and Equipment": "1,846",
"Research And Development Expense": "30",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "42,886",
"Liabilities": "49,839",
"Expenses": "27,855",
"Revenues": "31,817",
"Stockholders Equity": "-6,953",
"Net Income": "2,291",
"Comprehensive Net Income": "2,291",
"BaseVar": "77,034",
"ECR before LimitedLiability": "-17%",
"Economic Capital Ratio": "87%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "18,556",
"Assets, Non-Current": "26,003",
"Cost of Goods and Services Sold": "9,657",
"Depreciation, Depletion, Amortization": "166",
"General and Administrative Expense": "14,294",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,123",
"Labor Expense": "0",
"Liabilities, Current": "16,415",
"Long Term Liabilities": "32,451",
"Operating Costs and Expenses": "0",
"Other Assets": "-3,123",
"Other Compr. Net Income": "0",
"Other Expenses": "759",
"Other Liabilities": "0",
"Other Net Income": "-2,622",
"Other Revenues": "31,148",
"Property Plant and Equipment": "1,641",
"Research And Development Expense": "24",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "46,200",
"Liabilities": "48,865",
"Expenses": "24,901",
"Revenues": "31,148",
"Stockholders Equity": "-2,665",
"Net Income": "3,625",
"Comprehensive Net Income": "3,625",
"BaseVar": "76,868",
"ECR before LimitedLiability": "-0.50%",
"Economic Capital Ratio": "87%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "15,783",
"Assets, Non-Current": "41,649",
"Cost of Goods and Services Sold": "8,990",
"Depreciation, Depletion, Amortization": "835",
"General and Administrative Expense": "14,625",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,501",
"Labor Expense": "0",
"Liabilities, Current": "21,074",
"Long Term Liabilities": "35,404",
"Operating Costs and Expenses": "0",
"Other Assets": "-3,501",
"Other Compr. Net Income": "0",
"Other Expenses": "910",
"Other Liabilities": "0",
"Other Net Income": "-1,392",
"Other Revenues": "28,885",
"Property Plant and Equipment": "3,230",
"Research And Development Expense": "50",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "60,662",
"Liabilities": "56,478",
"Expenses": "25,409",
"Revenues": "28,885",
"Stockholders Equity": "4,184",
"Net Income": "2,084",
"Comprehensive Net Income": "2,084",
"BaseVar": "86,413",
"ECR before LimitedLiability": "14%",
"Economic Capital Ratio": "101%"
}
}
},
"top_rated": false,
"trend": -16.0,
"value": 1.0101395118046952,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000862692.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000862692.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000862692.svg"
},
{
"company_id": "0001680139",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001680139.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001680139.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001680139.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001680139_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001680139_main_keyfigs.svg",
"name": "Healthlynked Corp",
"rank": 82,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001680139.svg",
"report_text": "The relative strengths and weaknesses of Healthlynked Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Healthlynked Corp compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 35% points.The greatest weakness of Healthlynked Corp is the variable Net Income, reducing the Economic Capital Ratio by 84% points.
The company's Economic Capital Ratio, given in the ranking table, is 88%, being 80% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001680139_2022_Healthlynked_Corp.pdf",
"shrinked_graph_json": {
"2017": {
"Other Assets": "-2.73",
"Assets": "-68.6",
"Liabilities": "2.65",
"Stockholders Equity": "-78.2",
"ECR before LimitedLiability": "-120",
"Intangible Assets": "-16.7",
"Assets, Non-Current": "-2.15",
"Assets, Current": "-23.7",
"Property Plant and Equipment": "-11.8",
"Liabilities, Current": "3.79",
"General and Administrative Expense": "-9.89",
"Expenses": "-14.3",
"Revenues": "-8.40",
"Net Income": "-20.1",
"Labor Expense": "-18.5",
"Other Expenses": "2.54",
"Cost of Goods and Services Sold": "1.34",
"Other Revenues": "-8.40",
"Other Net Income": "2.50",
"Comprehensive Net Income": "-20.1",
"Economic Capital Ratio": "-144"
},
"2018": {
"Other Assets": "-0.840",
"Assets": "-70.5",
"Liabilities": "0.236",
"Stockholders Equity": "-65.1",
"ECR before LimitedLiability": "-138",
"Property Plant and Equipment": "-2.71",
"Intangible Assets": "-4.73",
"Assets, Non-Current": "-0.969",
"Assets, Current": "-19.8",
"Liabilities, Current": "0.252",
"Long Term Liabilities": "-0.284",
"Expenses": "-0.625",
"Revenues": "-0.256",
"Net Income": "-14.7",
"General and Administrative Expense": "-1.53",
"Cost of Goods and Services Sold": "0.180",
"Labor Expense": "-1.74",
"Other Revenues": "-0.256",
"Comprehensive Net Income": "-14.6",
"Other Net Income": "-3.81",
"Economic Capital Ratio": "-159"
},
"2019": {
"Property Plant and Equipment": "-11.0",
"Assets": "-58.7",
"Liabilities": "-4.09",
"Stockholders Equity": "-65.2",
"ECR before LimitedLiability": "-126",
"Assets, Non-Current": "-18.6",
"Other Assets": "18.0",
"Intangible Assets": "-27.5",
"Assets, Current": "-44.5",
"Liabilities, Current": "-11.5",
"Other Expenses": "5.59",
"Expenses": "-9.50",
"Net Income": "-32.4",
"Other Net Income": "-17.3",
"General and Administrative Expense": "-11.6",
"Cost of Goods and Services Sold": "9.74",
"Research And Development Expense": "3.27",
"Labor Expense": "-13.9",
"Operating Costs and Expenses": "-10.1",
"Comprehensive Net Income": "-32.3",
"Economic Capital Ratio": "-136"
},
"2021": {
"Other Assets": "34.8",
"Assets": "-69.4",
"Liabilities": "6.25",
"Stockholders Equity": "-36.9",
"Intangible Assets": "-48.1",
"Property Plant and Equipment": "-22.3",
"Assets, Non-Current": "-30.3",
"Assets, Current": "-58.6",
"Long Term Liabilities": "4.36",
"Other Liabilities": "-9.35",
"General and Administrative Expense": "-24.9",
"Expenses": "-45.3",
"Net Income": "-84.1",
"Other Net Income": "-62.4",
"Operating Costs and Expenses": "-49.6",
"Labor Expense": "-31.3",
"Cost of Goods and Services Sold": "2.64",
"Depreciation, Depletion, Amortization": "-9.17",
"ECR before LimitedLiability": "-73.7",
"Comprehensive Net Income": "-84.0",
"Economic Capital Ratio": "-79.9"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001680139_strength_weakness.svg",
"table_records": {
"2017": {
"input_variables": {
"Assets, Current": "367",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "24",
"General and Administrative Expense": "1,849",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,022",
"Liabilities, Current": "2,470",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "9.5",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "21",
"Other Net Income": "1,314",
"Other Revenues": "0",
"Property Plant and Equipment": "63",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "440",
"Liabilities": "2,491",
"Expenses": "3,895",
"Revenues": "0",
"Stockholders Equity": "-2,051",
"Net Income": "-2,581",
"Comprehensive Net Income": "-2,581",
"BaseVar": "4,070",
"ECR before LimitedLiability": "-379%",
"Economic Capital Ratio": "4.4%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "375",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "24",
"General and Administrative Expense": "2,841",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,367",
"Liabilities, Current": "3,359",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "9.5",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "3.1",
"Other Net Income": "-2,819",
"Other Revenues": "2,259",
"Property Plant and Equipment": "43",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "427",
"Liabilities": "3,362",
"Expenses": "5,231",
"Revenues": "2,259",
"Stockholders Equity": "-2,935",
"Net Income": "-5,791",
"Comprehensive Net Income": "-5,791",
"BaseVar": "7,049",
"ECR before LimitedLiability": "-530%",
"Economic Capital Ratio": "0.25%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "403",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "73",
"General and Administrative Expense": "2,915",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "2,394",
"Liabilities, Current": "5,309",
"Long Term Liabilities": "81",
"Operating Costs and Expenses": "1,845",
"Other Assets": "1,630",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-2,320",
"Other Revenues": "4,019",
"Property Plant and Equipment": "514",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,547",
"Liabilities": "5,389",
"Expenses": "7,228",
"Revenues": "4,019",
"Stockholders Equity": "-2,843",
"Net Income": "-5,529",
"Comprehensive Net Income": "-5,529",
"BaseVar": "10,751",
"ECR before LimitedLiability": "-243%",
"Economic Capital Ratio": "26%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,650",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "828",
"General and Administrative Expense": "4,930",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,148",
"Labor Expense": "3,115",
"Liabilities, Current": "1,918",
"Long Term Liabilities": "239",
"Operating Costs and Expenses": "4,762",
"Other Assets": "5,545",
"Other Compr. Net Income": "0",
"Other Expenses": "607",
"Other Liabilities": "1,333",
"Other Net Income": "-5,369",
"Other Revenues": "9,198",
"Property Plant and Equipment": "350",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,695",
"Liabilities": "3,491",
"Expenses": "14,241",
"Revenues": "9,198",
"Stockholders Equity": "7,204",
"Net Income": "-10,413",
"Comprehensive Net Income": "-10,413",
"BaseVar": "21,497",
"ECR before LimitedLiability": "0.47%",
"Economic Capital Ratio": "88%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.8791516958203601,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001680139.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001680139.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001680139.svg"
},
{
"company_id": "0001780097",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001780097.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001780097.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001780097.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001780097_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001780097_main_keyfigs.svg",
"name": "Baudax Bio Inc",
"rank": 83,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001780097.svg",
"report_text": "The relative strengths and weaknesses of Baudax Bio Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Baudax Bio Inc compared to the market average is the variable Other Expenses, increasing the Economic Capital Ratio by 9.2% points.The greatest weakness of Baudax Bio Inc is the variable Liabilities, reducing the Economic Capital Ratio by 70% points.
The company's Economic Capital Ratio, given in the ranking table, is 87%, being 80% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001780097_2022_Baudax_Bio_Inc.pdf",
"shrinked_graph_json": {
"2019": {
"Other Liabilities": "-92.7",
"Liabilities": "-36.4",
"Stockholders Equity": "-27.7",
"ECR before LimitedLiability": "-78.1",
"Long Term Liabilities": "4.36",
"Liabilities, Current": "1.90",
"Other Expenses": "10.5",
"Expenses": "5.04",
"Net Income": "-8.29",
"General and Administrative Expense": "-6.83",
"Cost of Goods and Services Sold": "6.01",
"Research And Development Expense": "-6.46",
"Other Revenues": "-11.1",
"Revenues": "-11.1",
"Property Plant and Equipment": "-2.75",
"Assets, Non-Current": "-5.13",
"Other Assets": "28.9",
"Intangible Assets": "-6.59",
"Assets, Current": "-2.78",
"Comprehensive Net Income": "-8.26",
"Economic Capital Ratio": "-88.1"
},
"2020": {
"Property Plant and Equipment": "-4.25",
"Assets": "-9.74",
"Liabilities": "-19.2",
"Stockholders Equity": "-24.7",
"ECR before LimitedLiability": "-85.4",
"Other Assets": "-4.37",
"Intangible Assets": "9.41",
"Assets, Non-Current": "-7.68",
"Other Liabilities": "-22.4",
"Long Term Liabilities": "2.66",
"Labor Expense": "2.18",
"Expenses": "-7.28",
"Revenues": "-16.6",
"Net Income": "-21.0",
"General and Administrative Expense": "-10.7",
"Research And Development Expense": "-2.43",
"Other Expenses": "-5.06",
"Cost of Goods and Services Sold": "6.21",
"Other Revenues": "-16.6",
"Comprehensive Net Income": "-21.0",
"Economic Capital Ratio": "-97.5"
},
"2021": {
"Other Assets": "-3.71",
"Assets": "1.79",
"Liabilities": "-70.0",
"Stockholders Equity": "-33.6",
"Intangible Assets": "3.41",
"Assets, Non-Current": "-10.3",
"Assets, Current": "0.0897",
"Liabilities, Current": "-21.3",
"Other Liabilities": "-48.9",
"General and Administrative Expense": "-67.4",
"Expenses": "0.489",
"Revenues": "-39.1",
"Net Income": "-21.1",
"Cost of Goods and Services Sold": "0.207",
"Research And Development Expense": "-0.864",
"Other Expenses": "9.19",
"Other Revenues": "-39.1",
"ECR before LimitedLiability": "-74.2",
"Comprehensive Net Income": "-21.0",
"Other Net Income": "0.0726",
"Economic Capital Ratio": "-80.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001780097_strength_weakness.svg",
"table_records": {
"2019": {
"input_variables": {
"Assets, Current": "20,135",
"Assets, Non-Current": "730",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "27,012",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,127",
"Labor Expense": "0",
"Liabilities, Current": "7,713",
"Long Term Liabilities": "455",
"Operating Costs and Expenses": "0",
"Other Assets": "26,400",
"Other Compr. Net Income": "0",
"Other Expenses": "-14,554",
"Other Liabilities": "62,766",
"Other Net Income": "-38",
"Other Revenues": "0",
"Property Plant and Equipment": "4,821",
"Research And Development Expense": "20,061",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "54,213",
"Liabilities": "70,934",
"Expenses": "32,519",
"Revenues": "0",
"Stockholders Equity": "-16,721",
"Net Income": "-32,557",
"Comprehensive Net Income": "-32,557",
"BaseVar": "78,852",
"ECR before LimitedLiability": "-91%",
"Economic Capital Ratio": "74%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "36,717",
"Assets, Non-Current": "583",
"Cost of Goods and Services Sold": "1,732",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "43,335",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "26,381",
"Labor Expense": "0",
"Liabilities, Current": "18,129",
"Long Term Liabilities": "8,762",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "22,484",
"Other Liabilities": "56,641",
"Other Net Income": "45",
"Other Revenues": "493",
"Property Plant and Equipment": "5,052",
"Research And Development Expense": "9,087",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "68,733",
"Liabilities": "83,532",
"Expenses": "76,638",
"Revenues": "493",
"Stockholders Equity": "-14,799",
"Net Income": "-76,100",
"Comprehensive Net Income": "-76,100",
"BaseVar": "114,720",
"ECR before LimitedLiability": "-128%",
"Economic Capital Ratio": "62%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "23,494",
"Assets, Non-Current": "963",
"Cost of Goods and Services Sold": "2,445",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "45,310",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "23,805",
"Labor Expense": "0",
"Liabilities, Current": "15,646",
"Long Term Liabilities": "6,959",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "-28,491",
"Other Liabilities": "17,446",
"Other Net Income": "1,540",
"Other Revenues": "1,080",
"Property Plant and Equipment": "5,015",
"Research And Development Expense": "3,125",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "53,277",
"Liabilities": "40,051",
"Expenses": "22,389",
"Revenues": "1,080",
"Stockholders Equity": "13,226",
"Net Income": "-19,769",
"Comprehensive Net Income": "-19,769",
"BaseVar": "59,168",
"ECR before LimitedLiability": "-1.3%",
"Economic Capital Ratio": "87%"
}
}
},
"top_rated": false,
"trend": -13.0,
"value": 0.8744646326330346,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001780097.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001780097.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001780097.svg"
},
{
"company_id": "0001815849",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001815849.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001815849.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001815849_main_keyfigs.svg",
"name": "ATI Physical Therapy Inc",
"rank": 84,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001815849.svg",
"report_text": "The relative strengths and weaknesses of ATI Physical Therapy Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of ATI Physical Therapy Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 10% points.The greatest weakness of ATI Physical Therapy Inc is the variable Goodwill Impairment Loss, reducing the Economic Capital Ratio by 61% points.
The company's Economic Capital Ratio, given in the ranking table, is 87%, being 80% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001815849_2022_ATI_Physical_Therapy_Inc.pdf",
"shrinked_graph_json": {
"2021": {
"Other Assets": "-4.66",
"Assets": "-24.0",
"Liabilities": "-26.9",
"Stockholders Equity": "-50.4",
"Intangible Assets": "10.1",
"Property Plant and Equipment": "-1.92",
"Assets, Current": "-55.8",
"Long Term Liabilities": "-52.2",
"General and Administrative Expense": "0.771",
"Expenses": "-20.1",
"Revenues": "-16.4",
"Net Income": "-27.4",
"Operating Costs and Expenses": "-29.0",
"Labor Expense": "-16.1",
"Goodwill Impairment Loss": "-61.1",
"Cost of Goods and Services Sold": "1.06",
"Other Expenses": "4.52",
"Other Revenues": "-16.4",
"ECR before LimitedLiability": "-74.2",
"Comprehensive Net Income": "-26.9",
"Economic Capital Ratio": "-80.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001815849_strength_weakness.svg",
"table_records": {
"2021": {
"input_variables": {
"Assets, Current": "143,578",
"Assets, Non-Current": "258,879",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "111,809",
"Goodwill Impairment Loss": "962,303",
"Intangible Assets": "1,020,507",
"Labor Expense": "336,496",
"Liabilities, Current": "204,789",
"Long Term Liabilities": "796,697",
"Operating Costs and Expenses": "533,797",
"Other Assets": "0",
"Other Compr. Net Income": "5,635",
"Other Expenses": "-419,964",
"Other Liabilities": "49,701",
"Other Net Income": "114,542",
"Other Revenues": "627,871",
"Property Plant and Equipment": "139,730",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,562,694",
"Liabilities": "1,051,187",
"Expenses": "1,524,441",
"Revenues": "627,871",
"Stockholders Equity": "511,507",
"Net Income": "-782,028",
"Comprehensive Net Income": "-776,393",
"BaseVar": "2,443,185",
"ECR before LimitedLiability": "-2.7%",
"Economic Capital Ratio": "87%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.8743655105819951,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001815849.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001815849.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001815849.svg"
},
{
"company_id": "0001108109",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001108109.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001108109.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001108109.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001108109_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001108109_main_keyfigs.svg",
"name": "Community Health System Inc",
"rank": 85,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001108109.svg",
"report_text": "The relative strengths and weaknesses of Community Health System Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Community Health System Inc compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 3.3% points.The greatest weakness of Community Health System Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 97% points.
The company's Economic Capital Ratio, given in the ranking table, is 87%, being 80% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001108109_2022_Community_Health_System_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-15.7",
"Assets": "-26.4",
"Liabilities": "-46.3",
"Stockholders Equity": "-65.0",
"ECR before LimitedLiability": "-75.6",
"Property Plant and Equipment": "17.0",
"Intangible Assets": "-24.9",
"Other Liabilities": "7.40",
"Liabilities, Current": "8.63",
"Long Term Liabilities": "-65.4",
"Other Expenses": "5.75",
"Expenses": "-4.46",
"Revenues": "-37.7",
"Net Income": "-8.79",
"Cost of Goods and Services Sold": "14.6",
"General and Administrative Expense": "6.62",
"Labor Expense": "-23.1",
"Other Revenues": "-37.7",
"Comprehensive Net Income": "-7.62",
"Other Net Income": "29.6",
"Economic Capital Ratio": "-73.8"
},
"2011": {
"Assets": "-15.5",
"Liabilities": "-48.0",
"Stockholders Equity": "-53.2",
"ECR before LimitedLiability": "-36.3",
"Property Plant and Equipment": "20.0",
"Assets, Current": "-22.1",
"Intangible Assets": "-8.06",
"Long Term Liabilities": "-74.8",
"Liabilities, Current": "18.9",
"Expenses": "16.7",
"Revenues": "-44.7",
"Net Income": "22.7",
"Other Expenses": "9.44",
"Operating Costs and Expenses": "-7.31",
"Labor Expense": "-21.1",
"General and Administrative Expense": "23.6",
"Cost of Goods and Services Sold": "8.87",
"Other Revenues": "-44.7",
"Other Net Income": "31.9",
"Comprehensive Net Income": "23.0",
"Economic Capital Ratio": "-43.0"
},
"2018": {
"Other Assets": "-0.845",
"Assets": "-21.1",
"Liabilities": "-60.5",
"Stockholders Equity": "-77.0",
"Property Plant and Equipment": "2.97",
"Assets, Current": "-32.0",
"Liabilities, Current": "2.41",
"Long Term Liabilities": "-110",
"Expenses": "2.24",
"Revenues": "0.608",
"Net Income": "2.95",
"Operating Costs and Expenses": "-3.22",
"Other Expenses": "1.61",
"General and Administrative Expense": "2.51",
"Research And Development Expense": "0.454",
"Cost of Goods and Services Sold": "0.931",
"Labor Expense": "-15.1",
"Other Revenues": "0.608",
"ECR before LimitedLiability": "-51.4",
"Comprehensive Net Income": "2.93",
"Economic Capital Ratio": "-72.1"
},
"2019": {
"Property Plant and Equipment": "2.75",
"Assets": "-21.2",
"Liabilities": "-57.2",
"Stockholders Equity": "-78.5",
"Other Assets": "-0.469",
"Assets, Current": "-25.5",
"Other Liabilities": "0.654",
"Long Term Liabilities": "-93.4",
"Liabilities, Current": "1.56",
"Other Expenses": "0.990",
"Expenses": "2.41",
"Net Income": "2.19",
"General and Administrative Expense": "2.37",
"Cost of Goods and Services Sold": "1.55",
"Research And Development Expense": "0.733",
"Selling and Marketing Expense": "0.441",
"Labor Expense": "-9.54",
"Operating Costs and Expenses": "-0.564",
"ECR before LimitedLiability": "-64.9",
"Comprehensive Net Income": "2.16",
"Economic Capital Ratio": "-74.9"
},
"2020": {
"Property Plant and Equipment": "2.07",
"Assets": "-23.4",
"Liabilities": "-69.9",
"Stockholders Equity": "-80.3",
"Other Assets": "-4.05",
"Assets, Current": "-31.3",
"Liabilities, Current": "0.631",
"Other Liabilities": "0.208",
"Long Term Liabilities": "-97.1",
"Labor Expense": "-18.6",
"Expenses": "1.61",
"Revenues": "0.206",
"Net Income": "1.95",
"General and Administrative Expense": "1.70",
"Other Expenses": "0.999",
"Operating Costs and Expenses": "-5.88",
"Cost of Goods and Services Sold": "0.494",
"Other Revenues": "0.206",
"ECR before LimitedLiability": "-60.2",
"Comprehensive Net Income": "1.88",
"Economic Capital Ratio": "-72.3"
},
"2021": {
"Other Assets": "-0.632",
"Assets": "-37.1",
"Liabilities": "-65.3",
"Stockholders Equity": "-91.7",
"Intangible Assets": "-6.66",
"Property Plant and Equipment": "3.27",
"Assets, Current": "-42.6",
"Liabilities, Current": "0.598",
"Long Term Liabilities": "-97.2",
"Other Liabilities": "0.403",
"General and Administrative Expense": "1.73",
"Expenses": "0.969",
"Revenues": "0.707",
"Net Income": "2.18",
"Operating Costs and Expenses": "-5.72",
"Labor Expense": "-20.5",
"Other Expenses": "0.596",
"Other Revenues": "0.707",
"ECR before LimitedLiability": "-74.2",
"Comprehensive Net Income": "2.09",
"Economic Capital Ratio": "-80.4"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001108109_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "2,871,193",
"Assets, Non-Current": "1,169,559",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "609,839",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,199,905",
"Labor Expense": "5,237,971",
"Liabilities, Current": "1,642,040",
"Long Term Liabilities": "9,810,057",
"Operating Costs and Expenses": "2,406,596",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4,429,085",
"Other Liabilities": "608,177",
"Other Net Income": "13,031,932",
"Other Revenues": "0",
"Property Plant and Equipment": "6,457,466",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "14,698,123",
"Liabilities": "12,060,274",
"Expenses": "12,683,491",
"Revenues": "0",
"Stockholders Equity": "2,637,849",
"Net Income": "348,441",
"Comprehensive Net Income": "348,441",
"BaseVar": "26,236,910",
"ECR before LimitedLiability": "31%",
"Economic Capital Ratio": "117%"
}
},
"2011": {
"input_variables": {
"Assets, Current": "2,846,089",
"Assets, Non-Current": "1,241,930",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "652,674",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,264,845",
"Labor Expense": "5,577,925",
"Liabilities, Current": "1,911,139",
"Long Term Liabilities": "9,732,788",
"Operating Costs and Expenses": "2,515,638",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4,527,509",
"Other Liabilities": "704,725",
"Other Net Income": "13,551,369",
"Other Revenues": "0",
"Property Plant and Equipment": "6,855,976",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "15,208,840",
"Liabilities": "12,348,652",
"Expenses": "13,273,746",
"Revenues": "0",
"Stockholders Equity": "2,860,188",
"Net Income": "277,623",
"Comprehensive Net Income": "277,623",
"BaseVar": "27,191,304",
"ECR before LimitedLiability": "32%",
"Economic Capital Ratio": "118%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "3,549,000",
"Assets, Non-Current": "1,543,000",
"Cost of Goods and Services Sold": "2,355,000",
"Depreciation, Depletion, Amortization": "700,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,559,000",
"Labor Expense": "6,384,000",
"Liabilities, Current": "2,392,000",
"Long Term Liabilities": "14,400,000",
"Operating Costs and Expenses": "3,496,000",
"Other Assets": "69,000",
"Other Compr. Net Income": "-67,000",
"Other Expenses": "1,001,000",
"Other Liabilities": "26,000",
"Other Net Income": "-923,000",
"Other Revenues": "14,155,000",
"Property Plant and Equipment": "6,139,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "15,859,000",
"Liabilities": "16,818,000",
"Expenses": "13,936,000",
"Revenues": "14,155,000",
"Stockholders Equity": "-959,000",
"Net Income": "-704,000",
"Comprehensive Net Income": "-771,000",
"BaseVar": "30,879,000",
"ECR before LimitedLiability": "-13%",
"Economic Capital Ratio": "87%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "3,427,000",
"Assets, Non-Current": "2,208,000",
"Cost of Goods and Services Sold": "2,151,000",
"Depreciation, Depletion, Amortization": "608,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,328,000",
"Labor Expense": "5,947,000",
"Liabilities, Current": "2,482,000",
"Long Term Liabilities": "14,766,000",
"Operating Costs and Expenses": "3,303,000",
"Other Assets": "38,000",
"Other Compr. Net Income": "-84,000",
"Other Expenses": "711,000",
"Other Liabilities": "0",
"Other Net Income": "-1,080,000",
"Other Revenues": "13,210,000",
"Property Plant and Equipment": "5,608,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "15,609,000",
"Liabilities": "17,248,000",
"Expenses": "12,720,000",
"Revenues": "13,210,000",
"Stockholders Equity": "-1,639,000",
"Net Income": "-590,000",
"Comprehensive Net Income": "-674,000",
"BaseVar": "29,975,500",
"ECR before LimitedLiability": "-19%",
"Economic Capital Ratio": "87%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "4,510,000",
"Assets, Non-Current": "1,896,000",
"Cost of Goods and Services Sold": "1,963,000",
"Depreciation, Depletion, Amortization": "558,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,219,000",
"Labor Expense": "5,411,000",
"Liabilities, Current": "2,844,000",
"Long Term Liabilities": "14,216,000",
"Operating Costs and Expenses": "2,957,000",
"Other Assets": "59,000",
"Other Compr. Net Income": "-100,000",
"Other Expenses": "-411,000",
"Other Liabilities": "0",
"Other Net Income": "-704,000",
"Other Revenues": "11,789,000",
"Property Plant and Equipment": "5,322,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "16,006,000",
"Liabilities": "17,060,000",
"Expenses": "10,478,000",
"Revenues": "11,789,000",
"Stockholders Equity": "-1,054,000",
"Net Income": "607,000",
"Comprehensive Net Income": "507,000",
"BaseVar": "28,068,500",
"ECR before LimitedLiability": "-6.2%",
"Economic Capital Ratio": "87%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,479,000",
"Assets, Non-Current": "1,913,000",
"Cost of Goods and Services Sold": "2,042,000",
"Depreciation, Depletion, Amortization": "540,000",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,219,000",
"Labor Expense": "5,242,000",
"Liabilities, Current": "2,556,000",
"Long Term Liabilities": "13,471,000",
"Operating Costs and Expenses": "2,958,000",
"Other Assets": "53,000",
"Other Compr. Net Income": "-140,000",
"Other Expenses": "315,000",
"Other Liabilities": "0",
"Other Net Income": "-903,000",
"Other Revenues": "12,368,000",
"Property Plant and Equipment": "5,553,000",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "15,217,000",
"Liabilities": "16,027,000",
"Expenses": "11,097,000",
"Revenues": "12,368,000",
"Stockholders Equity": "-810,000",
"Net Income": "368,000",
"Comprehensive Net Income": "228,000",
"BaseVar": "27,876,000",
"ECR before LimitedLiability": "-6.1%",
"Economic Capital Ratio": "87%"
}
}
},
"top_rated": false,
"trend": -19.0,
"value": 0.8738260252181319,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001108109.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001108109.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001108109.svg"
},
{
"company_id": "0001439725",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001439725.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001439725.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001439725.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001439725_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001439725_main_keyfigs.svg",
"name": "Biodesix INC",
"rank": 86,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001439725.svg",
"report_text": "The relative strengths and weaknesses of Biodesix INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biodesix INC compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 10% points.The greatest weakness of Biodesix INC is the variable Stockholders Equity, reducing the Economic Capital Ratio by 60% points.
The company's Economic Capital Ratio, given in the ranking table, is 87%, being 81% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001439725_2022_Biodesix_INC.pdf",
"shrinked_graph_json": {
"2020": {
"Property Plant and Equipment": "-11.8",
"Assets": "8.59",
"Liabilities": "-39.5",
"Stockholders Equity": "-23.9",
"ECR before LimitedLiability": "-33.4",
"Other Assets": "-35.0",
"Assets, Current": "27.5",
"Assets, Non-Current": "26.8",
"Liabilities, Current": "-8.99",
"Long Term Liabilities": "-36.3",
"Labor Expense": "6.34",
"Expenses": "13.9",
"Revenues": "-14.3",
"Net Income": "-7.77",
"General and Administrative Expense": "-9.54",
"Other Expenses": "-6.97",
"Cost of Goods and Services Sold": "20.7",
"Other Revenues": "-14.3",
"Other Net Income": "-6.51",
"Comprehensive Net Income": "-7.76",
"Economic Capital Ratio": "-45.4"
},
"2021": {
"Other Assets": "-40.5",
"Assets": "-35.5",
"Liabilities": "-0.874",
"Stockholders Equity": "-60.4",
"Property Plant and Equipment": "-0.768",
"Assets, Non-Current": "10.0",
"Assets, Current": "-0.855",
"Liabilities, Current": "-0.841",
"ECR before LimitedLiability": "-75.0",
"Long Term Liabilities": "-0.815",
"Other Liabilities": "1.12",
"General and Administrative Expense": "-23.5",
"Expenses": "-15.5",
"Net Income": "-11.4",
"Operating Costs and Expenses": "0.813",
"Labor Expense": "0.689",
"Cost of Goods and Services Sold": "3.04",
"Research And Development Expense": "-0.678",
"Other Expenses": "-9.13",
"Comprehensive Net Income": "-11.2",
"Economic Capital Ratio": "-81.2"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001439725_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "86,140",
"Assets, Non-Current": "34,930",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "34,857",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "28,291",
"Labor Expense": "0",
"Liabilities, Current": "32,125",
"Long Term Liabilities": "47,779",
"Operating Costs and Expenses": "0",
"Other Assets": "-31,469",
"Other Compr. Net Income": "0",
"Other Expenses": "22,816",
"Other Liabilities": "0",
"Other Net Income": "-8,416",
"Other Revenues": "45,557",
"Property Plant and Equipment": "3,178",
"Research And Development Expense": "10,818",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "121,070",
"Liabilities": "79,904",
"Expenses": "68,491",
"Revenues": "45,557",
"Stockholders Equity": "41,166",
"Net Income": "-31,350",
"Comprehensive Net Income": "-31,350",
"BaseVar": "161,719",
"ECR before LimitedLiability": "28%",
"Economic Capital Ratio": "114%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "43,613",
"Assets, Non-Current": "32,484",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "50,517",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "26,648",
"Labor Expense": "0",
"Liabilities, Current": "28,960",
"Long Term Liabilities": "27,410",
"Operating Costs and Expenses": "0",
"Other Assets": "-30,827",
"Other Compr. Net Income": "0",
"Other Expenses": "32,140",
"Other Liabilities": "0",
"Other Net Income": "-2,219",
"Other Revenues": "54,506",
"Property Plant and Equipment": "4,179",
"Research And Development Expense": "12,789",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "76,097",
"Liabilities": "56,370",
"Expenses": "95,446",
"Revenues": "54,506",
"Stockholders Equity": "19,727",
"Net Income": "-43,159",
"Comprehensive Net Income": "-43,159",
"BaseVar": "142,319",
"ECR before LimitedLiability": "-22%",
"Economic Capital Ratio": "87%"
}
}
},
"top_rated": false,
"trend": -29.0,
"value": 0.8657491946214491,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001439725.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001439725.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001439725.svg"
},
{
"company_id": "0000802257",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000802257.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000802257.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000802257.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000802257_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000802257_main_keyfigs.svg",
"name": "Mitesco Inc",
"rank": 87,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000802257.svg",
"report_text": "The relative strengths and weaknesses of Mitesco Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Mitesco Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 15% points.The greatest weakness of Mitesco Inc is the variable Liabilities, reducing the Economic Capital Ratio by 17% points.
The company's Economic Capital Ratio, given in the ranking table, is 81%, being 87% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000802257_2022_Mitesco_Inc.pdf",
"shrinked_graph_json": {
"2013": {
"Other Assets": "23.9",
"Assets": "-31.1",
"Liabilities": "-6.29",
"Stockholders Equity": "-40.9",
"ECR before LimitedLiability": "-119",
"Property Plant and Equipment": "-20.5",
"Assets, Current": "-10.1",
"Intangible Assets": "-23.5",
"Assets, Non-Current": "-5.32",
"Liabilities, Current": "-14.2",
"Expenses": "-28.3",
"Revenues": "-16.5",
"Net Income": "-48.7",
"General and Administrative Expense": "-31.8",
"Labor Expense": "4.90",
"Other Expenses": "3.03",
"Research And Development Expense": "-13.1",
"Other Revenues": "-16.5",
"Comprehensive Net Income": "-48.5",
"Other Net Income": "-8.01",
"Economic Capital Ratio": "-128"
},
"2014": {
"Other Assets": "7.16",
"Assets": "-46.5",
"Liabilities": "3.35",
"Stockholders Equity": "-66.1",
"ECR before LimitedLiability": "-133",
"Intangible Assets": "-15.8",
"Assets, Non-Current": "-2.29",
"Property Plant and Equipment": "-16.9",
"Assets, Current": "-22.5",
"Liabilities, Current": "5.39",
"Expenses": "-13.6",
"Revenues": "-6.97",
"Net Income": "-35.7",
"Labor Expense": "1.91",
"Research And Development Expense": "-5.15",
"Cost of Goods and Services Sold": "1.20",
"General and Administrative Expense": "-14.1",
"Other Revenues": "-6.97",
"Comprehensive Net Income": "-35.4",
"Other Net Income": "-4.11",
"Economic Capital Ratio": "-147"
},
"2015": {
"Assets, Current": "-10.7",
"Assets": "-46.5",
"Liabilities": "4.71",
"Stockholders Equity": "-79.0",
"ECR before LimitedLiability": "-142",
"Assets, Non-Current": "-1.14",
"Intangible Assets": "-9.40",
"Other Assets": "-2.06",
"Property Plant and Equipment": "-10.0",
"Liabilities, Current": "4.97",
"Expenses": "3.59",
"Revenues": "-5.34",
"Net Income": "-15.7",
"Other Expenses": "1.83",
"Labor Expense": "0.965",
"Cost of Goods and Services Sold": "0.843",
"Other Revenues": "-5.34",
"Comprehensive Net Income": "-13.8",
"Other Net Income": "-21.7",
"Other Compr. Net Income": "0.627",
"Economic Capital Ratio": "-154"
},
"2020": {
"Property Plant and Equipment": "-7.09",
"Assets": "-46.6",
"Liabilities": "3.62",
"Stockholders Equity": "-72.7",
"ECR before LimitedLiability": "-137",
"Other Assets": "4.77",
"Intangible Assets": "-13.1",
"Assets, Current": "-31.5",
"Liabilities, Current": "4.57",
"Labor Expense": "1.01",
"Expenses": "-5.95",
"Revenues": "-12.6",
"Net Income": "-26.6",
"General and Administrative Expense": "-21.3",
"Other Expenses": "2.07",
"Operating Costs and Expenses": "0.810",
"Cost of Goods and Services Sold": "2.96",
"Other Revenues": "-12.6",
"Other Net Income": "-2.27",
"Comprehensive Net Income": "-26.6",
"Economic Capital Ratio": "-149"
},
"2021": {
"Liabilities, Current": "-6.40",
"Liabilities": "-17.4",
"Stockholders Equity": "-14.8",
"Other Assets": "7.49",
"ECR before LimitedLiability": "-81.0",
"Long Term Liabilities": "-4.30",
"Other Liabilities": "1.39",
"Other Revenues": "-6.51",
"Revenues": "-6.51",
"Net Income": "-6.75",
"Intangible Assets": "-6.17",
"Property Plant and Equipment": "12.8",
"Assets, Non-Current": "14.9",
"Assets, Current": "-6.74",
"General and Administrative Expense": "-5.89",
"Comprehensive Net Income": "-6.75",
"Operating Costs and Expenses": "1.22",
"Cost of Goods and Services Sold": "2.66",
"Other Net Income": "-2.48",
"Other Expenses": "2.68",
"Economic Capital Ratio": "-87.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000802257_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "856",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,268",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,981",
"Long Term Liabilities": "2.5",
"Operating Costs and Expenses": "0",
"Other Assets": "748",
"Other Compr. Net Income": "12",
"Other Expenses": "471",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "176",
"Property Plant and Equipment": "46",
"Research And Development Expense": "839",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,651",
"Liabilities": "1,984",
"Expenses": "3,578",
"Revenues": "176",
"Stockholders Equity": "-333",
"Net Income": "-3,402",
"Comprehensive Net Income": "-3,390",
"BaseVar": "3,700",
"ECR before LimitedLiability": "-213%",
"Economic Capital Ratio": "34%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "125",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,235",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,229",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "840",
"Other Compr. Net Income": "14",
"Other Expenses": "865",
"Other Liabilities": "0",
"Other Net Income": "-5.7",
"Other Revenues": "228",
"Property Plant and Equipment": "0",
"Research And Development Expense": "892",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "965",
"Liabilities": "3,229",
"Expenses": "3,992",
"Revenues": "228",
"Stockholders Equity": "-2,264",
"Net Income": "-3,770",
"Comprehensive Net Income": "-3,756",
"BaseVar": "4,217",
"ECR before LimitedLiability": "-336%",
"Economic Capital Ratio": "8.4%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "45",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "65",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "565",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "25",
"Other Expenses": "0.90",
"Other Liabilities": "0",
"Other Net Income": "-337",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "45",
"Liabilities": "565",
"Expenses": "66",
"Revenues": "0",
"Stockholders Equity": "-520",
"Net Income": "-403",
"Comprehensive Net Income": "-378",
"BaseVar": "519",
"ECR before LimitedLiability": "-371%",
"Economic Capital Ratio": "5.0%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "65",
"Assets, Non-Current": "310",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,534",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,029",
"Long Term Liabilities": "312",
"Operating Costs and Expenses": "0",
"Other Assets": "417",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-327",
"Other Revenues": "0",
"Property Plant and Equipment": "6.3",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "799",
"Liabilities": "3,341",
"Expenses": "2,534",
"Revenues": "0",
"Stockholders Equity": "-2,542",
"Net Income": "-2,861",
"Comprehensive Net Income": "-2,861",
"BaseVar": "3,500",
"ECR before LimitedLiability": "-316%",
"Economic Capital Ratio": "11%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,307",
"Assets, Non-Current": "3,887",
"Cost of Goods and Services Sold": "456",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,059",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,559",
"Long Term Liabilities": "3,973",
"Operating Costs and Expenses": "0",
"Other Assets": "1,985",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-1,524",
"Other Revenues": "116",
"Property Plant and Equipment": "3,476",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,655",
"Liabilities": "9,532",
"Expenses": "6,515",
"Revenues": "116",
"Stockholders Equity": "1,123",
"Net Income": "-7,923",
"Comprehensive Net Income": "-7,923",
"BaseVar": "14,171",
"ECR before LimitedLiability": "-62%",
"Economic Capital Ratio": "81%"
}
}
},
"top_rated": false,
"trend": -13.0,
"value": 0.8065030184557712,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000802257.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000802257.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000802257.svg"
},
{
"company_id": "0000948320",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000948320.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000948320.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000948320.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000948320_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000948320_main_keyfigs.svg",
"name": "Lifemd Inc",
"rank": 88,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000948320.svg",
"report_text": "The relative strengths and weaknesses of Lifemd Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Lifemd Inc compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 28% points.The greatest weakness of Lifemd Inc is the variable Selling and Marketing Expense, reducing the Economic Capital Ratio by 122% points.
The company's Economic Capital Ratio, given in the ranking table, is 80%, being 88% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000948320_2022_Lifemd_Inc.pdf",
"shrinked_graph_json": {
"2013": {
"Other Assets": "-11.1",
"Assets": "-72.7",
"Liabilities": "4.77",
"Stockholders Equity": "-75.0",
"Property Plant and Equipment": "-29.1",
"Intangible Assets": "-50.9",
"Assets, Non-Current": "-13.9",
"ECR before LimitedLiability": "-62.2",
"Liabilities, Current": "-24.7",
"Long Term Liabilities": "5.60",
"Expenses": "-60.1",
"Revenues": "15.3",
"Net Income": "-19.0",
"General and Administrative Expense": "-39.5",
"Cost of Goods and Services Sold": "-23.7",
"Labor Expense": "4.23",
"Other Expenses": "-50.4",
"Other Revenues": "15.3",
"Comprehensive Net Income": "-18.5",
"Other Net Income": "-35.3",
"Economic Capital Ratio": "-71.3"
},
"2014": {
"Other Assets": "-13.4",
"Assets": "-104",
"Stockholders Equity": "-100",
"ECR before LimitedLiability": "-123",
"Intangible Assets": "-48.2",
"Assets, Non-Current": "-9.08",
"Property Plant and Equipment": "-41.7",
"Assets, Current": "-42.4",
"Expenses": "-61.8",
"Revenues": "17.1",
"Net Income": "-37.6",
"Operating Costs and Expenses": "4.04",
"Labor Expense": "7.90",
"Research And Development Expense": "3.11",
"Other Expenses": "-54.5",
"Cost of Goods and Services Sold": "-11.0",
"General and Administrative Expense": "-24.6",
"Other Revenues": "17.1",
"Comprehensive Net Income": "-37.4",
"Other Net Income": "-19.5",
"Economic Capital Ratio": "-136"
},
"2015": {
"Assets": "-94.8",
"Liabilities": "34.6",
"Stockholders Equity": "-116",
"ECR before LimitedLiability": "-32.1",
"Intangible Assets": "-57.1",
"Other Assets": "-21.4",
"Property Plant and Equipment": "-59.0",
"Long Term Liabilities": "28.8",
"Other Liabilities": "27.3",
"Liabilities, Current": "24.9",
"Expenses": "-101",
"Revenues": "64.6",
"Net Income": "24.9",
"General and Administrative Expense": "-23.1",
"Other Expenses": "-121",
"Labor Expense": "27.6",
"Cost of Goods and Services Sold": "-29.1",
"Other Revenues": "64.6",
"Comprehensive Net Income": "26.3",
"Other Net Income": "-23.5",
"Economic Capital Ratio": "-44.5"
},
"2018": {
"Other Assets": "-28.3",
"Assets": "-120",
"Liabilities": "14.2",
"Stockholders Equity": "-161",
"Property Plant and Equipment": "-52.7",
"Intangible Assets": "-62.0",
"Assets, Current": "-76.2",
"Other Liabilities": "-12.7",
"Liabilities, Current": "6.78",
"Long Term Liabilities": "7.29",
"Expenses": "-120",
"Revenues": "36.1",
"Net Income": "3.44",
"Other Expenses": "-148",
"General and Administrative Expense": "2.10",
"Labor Expense": "-24.2",
"Other Revenues": "36.1",
"ECR before LimitedLiability": "-51.2",
"Comprehensive Net Income": "3.59",
"Other Net Income": "4.95",
"Economic Capital Ratio": "-71.9"
},
"2019": {
"Property Plant and Equipment": "-21.5",
"Assets": "-104",
"Liabilities": "7.48",
"Stockholders Equity": "-144",
"ECR before LimitedLiability": "-89.8",
"Assets, Non-Current": "-14.8",
"Other Assets": "-9.78",
"Intangible Assets": "-24.5",
"Assets, Current": "-24.6",
"Long Term Liabilities": "12.8",
"Liabilities, Current": "-8.86",
"Expenses": "-45.4",
"Revenues": "38.4",
"Net Income": "-8.38",
"Research And Development Expense": "7.47",
"Selling and Marketing Expense": "-79.8",
"Labor Expense": "7.22",
"Operating Costs and Expenses": "6.19",
"Other Revenues": "38.4",
"Comprehensive Net Income": "-8.20",
"Economic Capital Ratio": "-99.8"
},
"2020": {
"Property Plant and Equipment": "-11.8",
"Assets": "-92.6",
"Liabilities": "-1.84",
"Stockholders Equity": "-62.8",
"ECR before LimitedLiability": "-146",
"Other Assets": "-3.90",
"Intangible Assets": "-28.4",
"Assets, Current": "-42.1",
"Assets, Non-Current": "-9.01",
"Long Term Liabilities": "-1.67",
"Labor Expense": "0.441",
"Expenses": "-79.6",
"Revenues": "0.665",
"Net Income": "-72.0",
"Selling and Marketing Expense": "-49.4",
"General and Administrative Expense": "-26.9",
"Other Expenses": "0.577",
"Other Revenues": "0.665",
"Other Net Income": "-0.367",
"Comprehensive Net Income": "-72.0",
"Economic Capital Ratio": "-159"
},
"2021": {
"Other Assets": "-3.88",
"Assets": "-96.9",
"Liabilities": "17.6",
"Stockholders Equity": "-92.2",
"ECR before LimitedLiability": "-81.4",
"Intangible Assets": "-47.3",
"Property Plant and Equipment": "-6.78",
"Assets, Non-Current": "-5.74",
"Assets, Current": "-7.12",
"Long Term Liabilities": "13.7",
"Other Liabilities": "4.35",
"General and Administrative Expense": "-6.57",
"Expenses": "-108",
"Revenues": "28.3",
"Net Income": "-40.6",
"Operating Costs and Expenses": "4.14",
"Research And Development Expense": "3.69",
"Selling and Marketing Expense": "-122",
"Other Revenues": "28.3",
"Comprehensive Net Income": "-40.3",
"Economic Capital Ratio": "-87.6"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000948320_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "451",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "181",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "393",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "326",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "506",
"Other Liabilities": "30",
"Other Net Income": "0",
"Other Revenues": "813",
"Property Plant and Equipment": "101",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "551",
"Liabilities": "356",
"Expenses": "1,081",
"Revenues": "813",
"Stockholders Equity": "195",
"Net Income": "-268",
"Comprehensive Net Income": "-268",
"BaseVar": "1,401",
"ECR before LimitedLiability": "3.3%",
"Economic Capital Ratio": "91%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "131",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "173",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "374",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "302",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "636",
"Other Liabilities": "13",
"Other Net Income": "0",
"Other Revenues": "722",
"Property Plant and Equipment": "44",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "175",
"Liabilities": "315",
"Expenses": "1,183",
"Revenues": "722",
"Stockholders Equity": "-139",
"Net Income": "-460",
"Comprehensive Net Income": "-460",
"BaseVar": "1,197",
"ECR before LimitedLiability": "-271%",
"Economic Capital Ratio": "19%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "448",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "248",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "331",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "267",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "902",
"Other Liabilities": "0",
"Other Net Income": "127",
"Other Revenues": "1,219",
"Property Plant and Equipment": "0",
"Research And Development Expense": "24",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "448",
"Liabilities": "267",
"Expenses": "1,505",
"Revenues": "1,219",
"Stockholders Equity": "181",
"Net Income": "-159",
"Comprehensive Net Income": "-159",
"BaseVar": "1,784",
"ECR before LimitedLiability": "29%",
"Economic Capital Ratio": "115%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "1,605",
"Assets, Non-Current": "1,011",
"Cost of Goods and Services Sold": "1,969",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,099",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "1,410",
"Liabilities, Current": "1,192",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "6,132",
"Other Liabilities": "604",
"Other Net Income": "926",
"Other Revenues": "8,324",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,616",
"Liabilities": "1,796",
"Expenses": "10,610",
"Revenues": "8,324",
"Stockholders Equity": "820",
"Net Income": "-1,360",
"Comprehensive Net Income": "-1,360",
"BaseVar": "12,136",
"ECR before LimitedLiability": "-7.8%",
"Economic Capital Ratio": "87%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "2,747",
"Assets, Non-Current": "699",
"Cost of Goods and Services Sold": "3,271",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,399",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,975",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,157",
"Other Liabilities": "600",
"Other Net Income": "0",
"Other Revenues": "12,469",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "8,171"
},
"output_variables": {
"Assets": "3,446",
"Liabilities": "4,575",
"Expenses": "15,997",
"Revenues": "12,469",
"Stockholders Equity": "-1,129",
"Net Income": "-3,528",
"Comprehensive Net Income": "-3,528",
"BaseVar": "18,244",
"ECR before LimitedLiability": "-129%",
"Economic Capital Ratio": "62%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "12,063",
"Assets, Non-Current": "990",
"Cost of Goods and Services Sold": "8,907",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "42,207",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "13,490",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "2,452",
"Other Liabilities": "385",
"Other Net Income": "-2,582",
"Other Revenues": "37,294",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "41,669"
},
"output_variables": {
"Assets": "13,054",
"Liabilities": "13,875",
"Expenses": "95,236",
"Revenues": "37,294",
"Stockholders Equity": "-822",
"Net Income": "-60,524",
"Comprehensive Net Income": "-60,524",
"BaseVar": "81,021",
"ECR before LimitedLiability": "-458%",
"Economic Capital Ratio": "1.1%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "44,921",
"Assets, Non-Current": "5,002",
"Cost of Goods and Services Sold": "17,995",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "39,570",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "22,826",
"Long Term Liabilities": "1,179",
"Operating Costs and Expenses": "0",
"Other Assets": "-234",
"Other Compr. Net Income": "0",
"Other Expenses": "10,097",
"Other Liabilities": "100",
"Other Net Income": "-3,996",
"Other Revenues": "92,876",
"Property Plant and Equipment": "234",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "82,542"
},
"output_variables": {
"Assets": "49,923",
"Liabilities": "24,104",
"Expenses": "150,204",
"Revenues": "92,876",
"Stockholders Equity": "25,819",
"Net Income": "-61,324",
"Comprehensive Net Income": "-61,324",
"BaseVar": "160,552",
"ECR before LimitedLiability": "-65%",
"Economic Capital Ratio": "80%"
}
}
},
"top_rated": false,
"trend": -13.0,
"value": 0.8018910597121117,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000948320.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000948320.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000948320.svg"
},
{
"company_id": "0000895665",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000895665.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000895665.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000895665.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000895665_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000895665_main_keyfigs.svg",
"name": "Clearday Inc",
"rank": 89,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000895665.svg",
"report_text": "The relative strengths and weaknesses of Clearday Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Clearday Inc compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 37% points.The greatest weakness of Clearday Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 64% points.
The company's Economic Capital Ratio, given in the ranking table, is 75%, being 93% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000895665_2022_Clearday_Inc.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "28.2",
"Liabilities": "36.8",
"Stockholders Equity": "42.3",
"ECR before LimitedLiability": "-30.9",
"Assets, Current": "43.9",
"Intangible Assets": "-25.3",
"Long Term Liabilities": "35.7",
"Liabilities, Current": "24.9",
"Expenses": "-69.0",
"Revenues": "-14.6",
"Net Income": "-110",
"Research And Development Expense": "-52.8",
"Other Expenses": "-18.2",
"Operating Costs and Expenses": "10.7",
"Labor Expense": "17.1",
"General and Administrative Expense": "-43.0",
"Cost of Goods and Services Sold": "10.7",
"Other Revenues": "-14.6",
"Other Net Income": "-35.3",
"Comprehensive Net Income": "-110",
"Economic Capital Ratio": "-37.5"
},
"2012": {
"Property Plant and Equipment": "53.6",
"Assets": "27.1",
"Liabilities": "52.2",
"Stockholders Equity": "55.2",
"ECR before LimitedLiability": "-9.88",
"Intangible Assets": "-22.4",
"Liabilities, Current": "25.7",
"Long Term Liabilities": "29.0",
"Research And Development Expense": "-49.6",
"Expenses": "-57.3",
"Revenues": "-10.1",
"Net Income": "-93.3",
"Other Expenses": "-10.1",
"General and Administrative Expense": "-36.1",
"Operating Costs and Expenses": "7.49",
"Cost of Goods and Services Sold": "9.76",
"Labor Expense": "15.9",
"Other Revenues": "-10.1",
"Other Net Income": "-31.2",
"Comprehensive Net Income": "-93.0",
"Economic Capital Ratio": "-24.1"
},
"2013": {
"Assets": "3.08",
"Liabilities": "-1.53",
"Stockholders Equity": "0.746",
"Property Plant and Equipment": "4.76",
"Assets, Current": "3.87",
"Intangible Assets": "-13.2",
"Other Liabilities": "-60.8",
"Liabilities, Current": "2.18",
"Long Term Liabilities": "1.92",
"Expenses": "-1.93",
"Revenues": "-19.7",
"Net Income": "-64.2",
"General and Administrative Expense": "-7.48",
"Labor Expense": "1.08",
"Other Expenses": "1.81",
"Research And Development Expense": "-33.5",
"Other Revenues": "-19.7",
"ECR before LimitedLiability": "-65.9",
"Comprehensive Net Income": "-63.9",
"Other Net Income": "-22.6",
"Economic Capital Ratio": "-75.0"
},
"2014": {
"Other Liabilities": "-44.7",
"Liabilities": "-1.04",
"Stockholders Equity": "-1.38",
"ECR before LimitedLiability": "-55.8",
"Liabilities, Current": "1.55",
"Long Term Liabilities": "4.18",
"Expenses": "-8.58",
"Net Income": "-39.1",
"Labor Expense": "2.34",
"Research And Development Expense": "-33.3",
"Other Expenses": "1.91",
"Cost of Goods and Services Sold": "1.28",
"General and Administrative Expense": "-8.31",
"Other Revenues": "-18.1",
"Revenues": "-18.1",
"Intangible Assets": "-5.26",
"Property Plant and Equipment": "31.4",
"Assets, Current": "-14.0",
"Comprehensive Net Income": "-38.9",
"Other Net Income": "1.39",
"Economic Capital Ratio": "-69.0"
},
"2015": {
"Assets, Current": "29.2",
"Assets": "29.4",
"Liabilities": "66.2",
"Stockholders Equity": "107",
"ECR before LimitedLiability": "47.0",
"Intangible Assets": "-15.0",
"Property Plant and Equipment": "22.9",
"Long Term Liabilities": "19.0",
"Other Liabilities": "12.9",
"Liabilities, Current": "38.8",
"Expenses": "-33.5",
"Revenues": "-41.4",
"Net Income": "-52.7",
"General and Administrative Expense": "-30.2",
"Other Expenses": "-16.5",
"Labor Expense": "11.9",
"Cost of Goods and Services Sold": "-15.3",
"Other Revenues": "-41.4",
"Comprehensive Net Income": "-52.3",
"Other Net Income": "23.3",
"Economic Capital Ratio": "34.6"
},
"2016": {
"Property Plant and Equipment": "11.4",
"Assets": "93.6",
"Liabilities": "56.9",
"Stockholders Equity": "102",
"ECR before LimitedLiability": "58.2",
"Intangible Assets": "-13.0",
"Assets, Current": "94.4",
"Liabilities, Current": "34.9",
"Other Liabilities": "11.2",
"Long Term Liabilities": "13.7",
"Expenses": "-27.4",
"Revenues": "-35.0",
"Net Income": "-73.8",
"Selling and Marketing Expense": "4.79",
"General and Administrative Expense": "-25.4",
"Labor Expense": "5.04",
"Cost of Goods and Services Sold": "-16.9",
"Other Revenues": "-35.0",
"Other Net Income": "-10.7",
"Comprehensive Net Income": "-73.3",
"Economic Capital Ratio": "30.5"
},
"2017": {
"Other Assets": "5.17",
"Assets": "4.05",
"Liabilities": "14.3",
"Stockholders Equity": "30.6",
"ECR before LimitedLiability": "-43.3",
"Intangible Assets": "-6.59",
"Assets, Current": "13.1",
"Property Plant and Equipment": "8.67",
"Liabilities, Current": "7.10",
"Long Term Liabilities": "5.93",
"General and Administrative Expense": "-23.9",
"Expenses": "-80.3",
"Revenues": "-6.54",
"Net Income": "-140",
"Research And Development Expense": "2.62",
"Other Expenses": "-66.0",
"Cost of Goods and Services Sold": "4.80",
"Other Revenues": "-6.54",
"Other Net Income": "-5.20",
"Comprehensive Net Income": "-140",
"Economic Capital Ratio": "-67.4"
},
"2018": {
"Assets": "35.4",
"Liabilities": "37.6",
"Stockholders Equity": "45.4",
"ECR before LimitedLiability": "-14.9",
"Intangible Assets": "-26.9",
"Assets, Non-Current": "-11.5",
"Assets, Current": "47.8",
"Other Liabilities": "8.23",
"Liabilities, Current": "32.2",
"Long Term Liabilities": "29.2",
"Expenses": "-70.1",
"Revenues": "-45.2",
"Net Income": "-107",
"Other Expenses": "-77.4",
"General and Administrative Expense": "-47.1",
"Research And Development Expense": "8.10",
"Cost of Goods and Services Sold": "31.5",
"Labor Expense": "11.7",
"Other Revenues": "-45.2",
"Comprehensive Net Income": "-106",
"Economic Capital Ratio": "-35.6"
},
"2019": {
"Property Plant and Equipment": "-7.67",
"Assets": "-58.4",
"Liabilities": "-1.83",
"Stockholders Equity": "-7.35",
"ECR before LimitedLiability": "-149",
"Assets, Non-Current": "-6.95",
"Other Assets": "2.26",
"Intangible Assets": "-21.2",
"Assets, Current": "-12.1",
"Long Term Liabilities": "-1.38",
"Other Expenses": "-68.2",
"Expenses": "-78.5",
"Revenues": "-15.2",
"Net Income": "-147",
"General and Administrative Expense": "-26.3",
"Cost of Goods and Services Sold": "1.92",
"Research And Development Expense": "0.794",
"Labor Expense": "0.772",
"Other Revenues": "-15.2",
"Comprehensive Net Income": "-147",
"Economic Capital Ratio": "-159"
},
"2020": {
"Property Plant and Equipment": "-14.4",
"Assets": "52.0",
"Liabilities": "52.1",
"Stockholders Equity": "60.2",
"ECR before LimitedLiability": "-8.12",
"Other Assets": "75.1",
"Intangible Assets": "-22.7",
"Assets, Current": "18.0",
"Assets, Non-Current": "-14.3",
"Liabilities, Current": "17.9",
"Other Liabilities": "7.25",
"Long Term Liabilities": "38.5",
"Labor Expense": "7.06",
"Expenses": "-60.8",
"Revenues": "-47.7",
"Net Income": "-104",
"General and Administrative Expense": "-92.1",
"Cost of Goods and Services Sold": "23.2",
"Other Revenues": "-47.7",
"Comprehensive Net Income": "-104",
"Economic Capital Ratio": "-20.2"
},
"2021": {
"Assets": "-10.0",
"Liabilities": "-33.0",
"Stockholders Equity": "-64.4",
"ECR before LimitedLiability": "-86.5",
"Intangible Assets": "-10.0",
"Assets, Non-Current": "36.6",
"Assets, Current": "-12.1",
"Liabilities, Current": "-5.42",
"Long Term Liabilities": "2.97",
"Other Liabilities": "-14.2",
"General and Administrative Expense": "2.29",
"Expenses": "2.09",
"Revenues": "-7.19",
"Net Income": "-3.02",
"Operating Costs and Expenses": "-7.62",
"Cost of Goods and Services Sold": "4.96",
"Research And Development Expense": "1.47",
"Other Revenues": "-7.19",
"Comprehensive Net Income": "-2.99",
"Other Net Income": "3.33",
"Economic Capital Ratio": "-92.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000895665_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "8,307",
"Assets, Non-Current": "362",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,322",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,409",
"Labor Expense": "0",
"Liabilities, Current": "1,146",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "5,526",
"Other Liabilities": "628",
"Other Net Income": "22",
"Other Revenues": "3,768",
"Property Plant and Equipment": "2,871",
"Research And Development Expense": "5,325",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "12,949",
"Liabilities": "1,774",
"Expenses": "17,173",
"Revenues": "3,768",
"Stockholders Equity": "11,175",
"Net Income": "-13,383",
"Comprehensive Net Income": "-13,383",
"BaseVar": "17,843",
"ECR before LimitedLiability": "38%",
"Economic Capital Ratio": "123%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "4,122",
"Assets, Non-Current": "776",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,440",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "889",
"Labor Expense": "0",
"Liabilities, Current": "1,063",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4,015",
"Other Liabilities": "674",
"Other Net Income": "6.0",
"Other Revenues": "3,551",
"Property Plant and Equipment": "6,242",
"Research And Development Expense": "5,030",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "12,029",
"Liabilities": "1,737",
"Expenses": "14,485",
"Revenues": "3,551",
"Stockholders Equity": "10,292",
"Net Income": "-10,928",
"Comprehensive Net Income": "-10,928",
"BaseVar": "15,904",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "140%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "7,978",
"Assets, Non-Current": "501",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,068",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "888",
"Labor Expense": "0",
"Liabilities, Current": "1,340",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,093",
"Other Liabilities": "6,194",
"Other Net Income": "-1,789",
"Other Revenues": "1,850",
"Property Plant and Equipment": "5,473",
"Research And Development Expense": "6,073",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "14,840",
"Liabilities": "7,534",
"Expenses": "12,234",
"Revenues": "1,850",
"Stockholders Equity": "7,306",
"Net Income": "-12,173",
"Comprehensive Net Income": "-12,173",
"BaseVar": "19,124",
"ECR before LimitedLiability": "-14%",
"Economic Capital Ratio": "87%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "1,756",
"Assets, Non-Current": "255",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,389",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "886",
"Labor Expense": "0",
"Liabilities, Current": "2,163",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,558",
"Other Liabilities": "4,634",
"Other Net Income": "3,622",
"Other Revenues": "1,066",
"Property Plant and Equipment": "7,902",
"Research And Development Expense": "5,992",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "10,799",
"Liabilities": "6,797",
"Expenses": "12,939",
"Revenues": "1,066",
"Stockholders Equity": "4,002",
"Net Income": "-8,251",
"Comprehensive Net Income": "-8,251",
"BaseVar": "17,612",
"ECR before LimitedLiability": "-28%",
"Economic Capital Ratio": "86%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "7,750",
"Assets, Non-Current": "126",
"Cost of Goods and Services Sold": "3,004",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,838",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "850",
"Long Term Liabilities": "393",
"Operating Costs and Expenses": "0",
"Other Assets": "938",
"Other Compr. Net Income": "0",
"Other Expenses": "4,869",
"Other Liabilities": "0",
"Other Net Income": "4,852",
"Other Revenues": "257",
"Property Plant and Equipment": "5,551",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "14,365",
"Liabilities": "1,243",
"Expenses": "13,711",
"Revenues": "257",
"Stockholders Equity": "13,122",
"Net Income": "-8,602",
"Comprehensive Net Income": "-8,602",
"BaseVar": "17,214",
"ECR before LimitedLiability": "134%",
"Economic Capital Ratio": "194%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "10,637",
"Assets, Non-Current": "96",
"Cost of Goods and Services Sold": "3,444",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "5,146",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "944",
"Long Term Liabilities": "172",
"Operating Costs and Expenses": "0",
"Other Assets": "990",
"Other Compr. Net Income": "0",
"Other Expenses": "2,850",
"Other Liabilities": "0",
"Other Net Income": "183",
"Other Revenues": "141",
"Property Plant and Equipment": "3,491",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "15,214",
"Liabilities": "1,116",
"Expenses": "11,440",
"Revenues": "141",
"Stockholders Equity": "14,098",
"Net Income": "-11,116",
"Comprehensive Net Income": "-11,116",
"BaseVar": "14,047",
"ECR before LimitedLiability": "114%",
"Economic Capital Ratio": "181%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "3,392",
"Assets, Non-Current": "69",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "4,062",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "830",
"Long Term Liabilities": "54",
"Operating Costs and Expenses": "0",
"Other Assets": "742",
"Other Compr. Net Income": "0",
"Other Expenses": "6,047",
"Other Liabilities": "0",
"Other Net Income": "99",
"Other Revenues": "483",
"Property Plant and Equipment": "1,793",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,996",
"Liabilities": "884",
"Expenses": "10,109",
"Revenues": "483",
"Stockholders Equity": "5,112",
"Net Income": "-9,527",
"Comprehensive Net Income": "-9,527",
"BaseVar": "8,786",
"ECR before LimitedLiability": "-61%",
"Economic Capital Ratio": "81%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "5,850",
"Assets, Non-Current": "69",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,972",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "852",
"Long Term Liabilities": "17",
"Operating Costs and Expenses": "0",
"Other Assets": "686",
"Other Compr. Net Income": "0",
"Other Expenses": "5,831",
"Other Liabilities": "0",
"Other Net Income": "52",
"Other Revenues": "1,620",
"Property Plant and Equipment": "1,009",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,614",
"Liabilities": "869",
"Expenses": "9,803",
"Revenues": "1,620",
"Stockholders Equity": "6,745",
"Net Income": "-8,131",
"Comprehensive Net Income": "-8,131",
"BaseVar": "9,979",
"ECR before LimitedLiability": "39%",
"Economic Capital Ratio": "124%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,396",
"Assets, Non-Current": "212",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,918",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "967",
"Long Term Liabilities": "12",
"Operating Costs and Expenses": "0",
"Other Assets": "641",
"Other Compr. Net Income": "0",
"Other Expenses": "5,915",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "604",
"Property Plant and Equipment": "233",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,482",
"Liabilities": "979",
"Expenses": "9,833",
"Revenues": "604",
"Stockholders Equity": "1,503",
"Net Income": "-9,229",
"Comprehensive Net Income": "-9,229",
"BaseVar": "6,949",
"ECR before LimitedLiability": "-407%",
"Economic Capital Ratio": "2.8%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "1,420",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,704",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "315",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "1,600",
"Other Compr. Net Income": "0",
"Other Expenses": "261",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "186",
"Property Plant and Equipment": "0",
"Research And Development Expense": "178",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,020",
"Liabilities": "315",
"Expenses": "3,143",
"Revenues": "186",
"Stockholders Equity": "2,705",
"Net Income": "-2,957",
"Comprehensive Net Income": "-2,957",
"BaseVar": "3,332",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,923",
"Assets, Non-Current": "33,106",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "530",
"General and Administrative Expense": "7,394",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "23,550",
"Long Term Liabilities": "5,572",
"Operating Costs and Expenses": "22,488",
"Other Assets": "2,095",
"Other Compr. Net Income": "0",
"Other Expenses": "7,455",
"Other Liabilities": "37,356",
"Other Net Income": "5,478",
"Other Revenues": "12,882",
"Property Plant and Equipment": "7,419",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "46,543",
"Liabilities": "66,479",
"Expenses": "37,866",
"Revenues": "12,882",
"Stockholders Equity": "-19,936",
"Net Income": "-19,507",
"Comprehensive Net Income": "-19,507",
"BaseVar": "84,624",
"ECR before LimitedLiability": "-86%",
"Economic Capital Ratio": "75%"
}
}
},
"top_rated": false,
"trend": -43.0,
"value": 0.7506183055238059,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000895665.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000895665.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000895665.svg"
},
{
"company_id": "0001505497",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001505497.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001505497.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001505497.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001505497_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001505497_main_keyfigs.svg",
"name": "Biorestorative Therapies Inc",
"rank": 90,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001505497.svg",
"report_text": "The relative strengths and weaknesses of Biorestorative Therapies Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biorestorative Therapies Inc compared to the market average is the variable Assets, Current, increasing the Economic Capital Ratio by 62% points.The greatest weakness of Biorestorative Therapies Inc is the variable Net Income, reducing the Economic Capital Ratio by 188% points.
The company's Economic Capital Ratio, given in the ranking table, is 68%, being 100% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001505497_2022_Biorestorative_Therapies_Inc.pdf",
"shrinked_graph_json": {
"2012": {
"Property Plant and Equipment": "-10.7",
"Assets": "-44.3",
"Liabilities": "4.38",
"Stockholders Equity": "-72.0",
"ECR before LimitedLiability": "-144",
"Intangible Assets": "-0.831",
"Assets, Current": "-21.7",
"Assets, Non-Current": "-2.23",
"Liabilities, Current": "-0.801",
"Other Liabilities": "5.48",
"Expenses": "-4.37",
"Revenues": "-5.86",
"Net Income": "-28.3",
"Other Expenses": "-1.01",
"General and Administrative Expense": "-0.651",
"Cost of Goods and Services Sold": "0.752",
"Labor Expense": "-3.78",
"Other Revenues": "-5.86",
"Other Net Income": "-6.96",
"Comprehensive Net Income": "-28.2",
"Economic Capital Ratio": "-158"
},
"2013": {
"Other Assets": "-1.81",
"Assets": "-44.4",
"Liabilities": "5.07",
"Stockholders Equity": "-74.7",
"ECR before LimitedLiability": "-143",
"Property Plant and Equipment": "-11.5",
"Assets, Current": "-23.0",
"Intangible Assets": "-1.06",
"Assets, Non-Current": "-2.34",
"Liabilities, Current": "6.08",
"Expenses": "-1.71",
"Revenues": "-7.80",
"Net Income": "-20.9",
"General and Administrative Expense": "-3.72",
"Labor Expense": "1.60",
"Other Expenses": "1.46",
"Research And Development Expense": "-4.38",
"Other Revenues": "-7.80",
"Comprehensive Net Income": "-20.8",
"Other Net Income": "-6.54",
"Economic Capital Ratio": "-153"
},
"2014": {
"Other Assets": "-3.01",
"Assets": "-43.5",
"Liabilities": "2.56",
"Stockholders Equity": "-72.4",
"ECR before LimitedLiability": "-129",
"Intangible Assets": "-3.03",
"Assets, Non-Current": "-2.37",
"Property Plant and Equipment": "-9.95",
"Assets, Current": "-22.4",
"Liabilities, Current": "4.15",
"Expenses": "-2.26",
"Revenues": "-7.38",
"Net Income": "-20.5",
"Labor Expense": "2.22",
"Research And Development Expense": "-4.11",
"Cost of Goods and Services Sold": "1.37",
"General and Administrative Expense": "-4.06",
"Other Revenues": "-7.38",
"Comprehensive Net Income": "-20.5",
"Other Net Income": "-7.08",
"Economic Capital Ratio": "-142"
},
"2015": {
"Assets, Current": "-24.4",
"Assets": "-47.0",
"Liabilities": "3.16",
"Stockholders Equity": "-63.9",
"ECR before LimitedLiability": "-139",
"Assets, Non-Current": "-1.96",
"Intangible Assets": "-2.63",
"Other Assets": "-3.04",
"Property Plant and Equipment": "-7.91",
"Liabilities, Current": "4.28",
"Expenses": "-12.0",
"Revenues": "-6.85",
"Net Income": "-39.1",
"Research And Development Expense": "-6.59",
"General and Administrative Expense": "-10.9",
"Labor Expense": "1.71",
"Cost of Goods and Services Sold": "1.50",
"Other Revenues": "-6.85",
"Comprehensive Net Income": "-38.9",
"Other Net Income": "-6.49",
"Economic Capital Ratio": "-152"
},
"2016": {
"Property Plant and Equipment": "-5.10",
"Assets": "-38.9",
"Liabilities": "2.86",
"Stockholders Equity": "-56.2",
"ECR before LimitedLiability": "-119",
"Assets, Non-Current": "-1.61",
"Intangible Assets": "-1.36",
"Other Assets": "-1.05",
"Assets, Current": "-18.9",
"Liabilities, Current": "3.04",
"Expenses": "-7.17",
"Revenues": "-5.99",
"Net Income": "-31.4",
"General and Administrative Expense": "-4.21",
"Labor Expense": "0.501",
"Cost of Goods and Services Sold": "1.08",
"Research And Development Expense": "-5.83",
"Other Revenues": "-5.99",
"Other Net Income": "-3.41",
"Comprehensive Net Income": "-31.1",
"Economic Capital Ratio": "-147"
},
"2017": {
"Other Assets": "-1.92",
"Assets": "-44.1",
"Liabilities": "3.68",
"Stockholders Equity": "-67.2",
"ECR before LimitedLiability": "-119",
"Intangible Assets": "-3.69",
"Assets, Non-Current": "-1.52",
"Assets, Current": "-19.0",
"Property Plant and Equipment": "-6.33",
"Liabilities, Current": "4.31",
"General and Administrative Expense": "-4.58",
"Expenses": "-5.49",
"Revenues": "-5.17",
"Net Income": "-26.5",
"Research And Development Expense": "-2.99",
"Other Expenses": "-0.754",
"Cost of Goods and Services Sold": "1.04",
"Other Revenues": "-5.17",
"Other Net Income": "-4.84",
"Comprehensive Net Income": "-26.5",
"Economic Capital Ratio": "-144"
},
"2018": {
"Other Assets": "-1.20",
"Assets": "-44.3",
"Liabilities": "1.18",
"Stockholders Equity": "-64.1",
"ECR before LimitedLiability": "-137",
"Property Plant and Equipment": "-2.57",
"Intangible Assets": "-1.52",
"Assets, Non-Current": "-1.36",
"Assets, Current": "-16.8",
"Liabilities, Current": "1.19",
"Expenses": "-0.398",
"Revenues": "-4.01",
"Net Income": "-18.9",
"General and Administrative Expense": "-1.38",
"Research And Development Expense": "-0.502",
"Cost of Goods and Services Sold": "0.546",
"Labor Expense": "0.246",
"Other Revenues": "-4.01",
"Comprehensive Net Income": "-18.8",
"Other Net Income": "-4.07",
"Economic Capital Ratio": "-158"
},
"2020": {
"Property Plant and Equipment": "-12.1",
"Assets": "-41.3",
"Liabilities": "-1.66",
"Stockholders Equity": "-47.7",
"ECR before LimitedLiability": "-127",
"Other Assets": "-6.14",
"Intangible Assets": "-12.2",
"Assets, Current": "-6.13",
"Assets, Non-Current": "-5.86",
"Long Term Liabilities": "-2.78",
"Labor Expense": "2.02",
"Expenses": "9.91",
"Revenues": "-23.0",
"Net Income": "-58.7",
"Research And Development Expense": "-2.60",
"Other Expenses": "3.61",
"Cost of Goods and Services Sold": "5.95",
"Other Revenues": "-23.0",
"Other Net Income": "-51.9",
"Comprehensive Net Income": "-58.7",
"Economic Capital Ratio": "-139"
},
"2021": {
"Other Assets": "-4.66",
"Assets": "-12.4",
"Liabilities": "18.2",
"Stockholders Equity": "29.8",
"ECR before LimitedLiability": "-94.1",
"Intangible Assets": "-18.6",
"Property Plant and Equipment": "-10.8",
"Assets, Non-Current": "-10.6",
"Assets, Current": "62.3",
"Liabilities, Current": "9.62",
"Long Term Liabilities": "9.33",
"General and Administrative Expense": "-78.5",
"Expenses": "-18.3",
"Revenues": "-19.8",
"Net Income": "-188",
"Cost of Goods and Services Sold": "11.1",
"Other Expenses": "7.80",
"Other Revenues": "-19.8",
"Comprehensive Net Income": "-188",
"Other Net Income": "-55.9",
"Economic Capital Ratio": "-100"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001505497_strength_weakness.svg",
"table_records": {
"2012": {
"input_variables": {
"Assets, Current": "31",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,225",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,177",
"Labor Expense": "1,980",
"Liabilities, Current": "0",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,835",
"Other Liabilities": "6,410",
"Other Net Income": "-964",
"Other Revenues": "16",
"Property Plant and Equipment": "59",
"Research And Development Expense": "416",
"Selling and Marketing Expense": "132"
},
"output_variables": {
"Assets": "1,268",
"Liabilities": "6,410",
"Expenses": "5,588",
"Revenues": "16",
"Stockholders Equity": "-5,142",
"Net Income": "-6,537",
"Comprehensive Net Income": "-6,537",
"BaseVar": "7,123",
"ECR before LimitedLiability": "-364%",
"Economic Capital Ratio": "5.5%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "240",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,265",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,108",
"Labor Expense": "0",
"Liabilities, Current": "7,503",
"Long Term Liabilities": "524",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "780",
"Other Liabilities": "41",
"Other Net Income": "-999",
"Other Revenues": "1.7",
"Property Plant and Equipment": "36",
"Research And Development Expense": "1,594",
"Selling and Marketing Expense": "115"
},
"output_variables": {
"Assets": "1,383",
"Liabilities": "8,068",
"Expenses": "4,754",
"Revenues": "1.7",
"Stockholders Equity": "-6,685",
"Net Income": "-5,751",
"Comprehensive Net Income": "-5,751",
"BaseVar": "7,603",
"ECR before LimitedLiability": "-327%",
"Economic Capital Ratio": "9.5%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "114",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,258",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,038",
"Labor Expense": "0",
"Liabilities, Current": "8,525",
"Long Term Liabilities": "50",
"Operating Costs and Expenses": "0",
"Other Assets": "46",
"Other Compr. Net Income": "0",
"Other Expenses": "1,524",
"Other Liabilities": "5.2",
"Other Net Income": "-665",
"Other Revenues": "416",
"Property Plant and Equipment": "494",
"Research And Development Expense": "1,431",
"Selling and Marketing Expense": "126"
},
"output_variables": {
"Assets": "1,692",
"Liabilities": "8,580",
"Expenses": "5,339",
"Revenues": "416",
"Stockholders Equity": "-6,888",
"Net Income": "-5,588",
"Comprehensive Net Income": "-5,588",
"BaseVar": "8,346",
"ECR before LimitedLiability": "-303%",
"Economic Capital Ratio": "13%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "289",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,870",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,039",
"Labor Expense": "0",
"Liabilities, Current": "5,612",
"Long Term Liabilities": "302",
"Operating Costs and Expenses": "0",
"Other Assets": "46",
"Other Compr. Net Income": "0",
"Other Expenses": "1,656",
"Other Liabilities": "11",
"Other Net Income": "-753",
"Other Revenues": "629",
"Property Plant and Equipment": "643",
"Research And Development Expense": "2,105",
"Selling and Marketing Expense": "168"
},
"output_variables": {
"Assets": "2,017",
"Liabilities": "5,925",
"Expenses": "7,799",
"Revenues": "629",
"Stockholders Equity": "-3,908",
"Net Income": "-7,923",
"Comprehensive Net Income": "-7,923",
"BaseVar": "8,562",
"ECR before LimitedLiability": "-342%",
"Economic Capital Ratio": "7.6%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "62",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,258",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "964",
"Labor Expense": "0",
"Liabilities, Current": "5,845",
"Long Term Liabilities": "298",
"Operating Costs and Expenses": "0",
"Other Assets": "46",
"Other Compr. Net Income": "0",
"Other Expenses": "1,606",
"Other Liabilities": "438",
"Other Net Income": "-839",
"Other Revenues": "36",
"Property Plant and Equipment": "509",
"Research And Development Expense": "2,884",
"Selling and Marketing Expense": "86"
},
"output_variables": {
"Assets": "1,580",
"Liabilities": "6,580",
"Expenses": "7,834",
"Revenues": "36",
"Stockholders Equity": "-5,000",
"Net Income": "-8,636",
"Comprehensive Net Income": "-8,636",
"BaseVar": "8,435",
"ECR before LimitedLiability": "-389%",
"Economic Capital Ratio": "3.7%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "520",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,903",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "889",
"Labor Expense": "0",
"Liabilities, Current": "8,353",
"Long Term Liabilities": "194",
"Operating Costs and Expenses": "0",
"Other Assets": "22",
"Other Compr. Net Income": "0",
"Other Expenses": "2,334",
"Other Liabilities": "48",
"Other Net Income": "-1,070",
"Other Revenues": "81",
"Property Plant and Equipment": "328",
"Research And Development Expense": "2,152",
"Selling and Marketing Expense": "65"
},
"output_variables": {
"Assets": "1,759",
"Liabilities": "8,595",
"Expenses": "8,455",
"Revenues": "81",
"Stockholders Equity": "-6,837",
"Net Income": "-9,445",
"Comprehensive Net Income": "-9,445",
"BaseVar": "9,980",
"ECR before LimitedLiability": "-374%",
"Economic Capital Ratio": "4.8%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "181",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "4,022",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "814",
"Labor Expense": "0",
"Liabilities, Current": "9,255",
"Long Term Liabilities": "524",
"Operating Costs and Expenses": "0",
"Other Assets": "22",
"Other Compr. Net Income": "0",
"Other Expenses": "1,871",
"Other Liabilities": "55",
"Other Net Income": "-4,870",
"Other Revenues": "111",
"Property Plant and Equipment": "175",
"Research And Development Expense": "1,513",
"Selling and Marketing Expense": "352"
},
"output_variables": {
"Assets": "1,192",
"Liabilities": "9,833",
"Expenses": "7,759",
"Revenues": "111",
"Stockholders Equity": "-8,641",
"Net Income": "-12,518",
"Comprehensive Net Income": "-12,518",
"BaseVar": "11,883",
"ECR before LimitedLiability": "-454%",
"Economic Capital Ratio": "1.2%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "3,187",
"Assets, Non-Current": "474",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,787",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "664",
"Labor Expense": "0",
"Liabilities, Current": "1,045",
"Long Term Liabilities": "4,634",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "137",
"Other Liabilities": "0",
"Other Net Income": "-8,521",
"Other Revenues": "77",
"Property Plant and Equipment": "22",
"Research And Development Expense": "877",
"Selling and Marketing Expense": "28"
},
"output_variables": {
"Assets": "4,347",
"Liabilities": "5,679",
"Expenses": "2,829",
"Revenues": "77",
"Stockholders Equity": "-1,331",
"Net Income": "-11,273",
"Comprehensive Net Income": "-11,273",
"BaseVar": "10,726",
"ECR before LimitedLiability": "-263%",
"Economic Capital Ratio": "21%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "21,468",
"Assets, Non-Current": "358",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "25,538",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "590",
"Labor Expense": "0",
"Liabilities, Current": "364",
"Long Term Liabilities": "302",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "75",
"Other Liabilities": "191",
"Other Net Income": "-17,995",
"Other Revenues": "46",
"Property Plant and Equipment": "38",
"Research And Development Expense": "729",
"Selling and Marketing Expense": "12"
},
"output_variables": {
"Assets": "22,453",
"Liabilities": "856",
"Expenses": "26,354",
"Revenues": "46",
"Stockholders Equity": "21,597",
"Net Income": "-44,303",
"Comprehensive Net Income": "-44,303",
"BaseVar": "33,853",
"ECR before LimitedLiability": "-111%",
"Economic Capital Ratio": "68%"
}
}
},
"top_rated": false,
"trend": -17.0,
"value": 0.6753365059225939,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001505497.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001505497.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001505497.svg"
},
{
"company_id": "0000792935",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0000792935.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0000792935.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000792935.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000792935_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000792935_main_keyfigs.svg",
"name": "Ethema Health Corp",
"rank": 91,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0000792935.svg",
"report_text": "The relative strengths and weaknesses of Ethema Health Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Ethema Health Corp compared to the market average is the variable Assets, Non-Current, increasing the Economic Capital Ratio by 38% points.The greatest weakness of Ethema Health Corp is the variable Stockholders Equity, reducing the Economic Capital Ratio by 88% points.
The company's Economic Capital Ratio, given in the ranking table, is 60%, being 108% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0000792935_2022_Ethema_Health_Corp.pdf",
"shrinked_graph_json": {
"2016": {
"Property Plant and Equipment": "-15.6",
"Assets": "-41.1",
"Liabilities": "-31.5",
"Stockholders Equity": "-100",
"ECR before LimitedLiability": "-94.9",
"Assets, Non-Current": "2.92",
"Intangible Assets": "-14.9",
"Other Assets": "-2.92",
"Assets, Current": "-16.0",
"Liabilities, Current": "-46.6",
"Expenses": "9.60",
"Revenues": "-12.6",
"Net Income": "4.78",
"General and Administrative Expense": "3.63",
"Labor Expense": "1.64",
"Other Expenses": "-3.01",
"Cost of Goods and Services Sold": "3.73",
"Other Revenues": "-12.6",
"Other Net Income": "5.29",
"Comprehensive Net Income": "3.42",
"Economic Capital Ratio": "-123"
},
"2019": {
"Property Plant and Equipment": "-7.55",
"Assets": "-47.1",
"Liabilities": "5.75",
"Stockholders Equity": "-77.2",
"ECR before LimitedLiability": "-143",
"Assets, Non-Current": "2.37",
"Other Assets": "-2.28",
"Intangible Assets": "-11.0",
"Assets, Current": "-24.4",
"Liabilities, Current": "5.14",
"Other Expenses": "-16.0",
"Expenses": "-2.83",
"Revenues": "-10.7",
"Net Income": "-17.4",
"General and Administrative Expense": "1.45",
"Cost of Goods and Services Sold": "2.72",
"Research And Development Expense": "0.907",
"Other Revenues": "-10.7",
"Comprehensive Net Income": "-17.2",
"Other Net Income": "-0.931",
"Economic Capital Ratio": "-153"
},
"2020": {
"Property Plant and Equipment": "-12.4",
"Assets": "-36.6",
"Liabilities": "-34.3",
"Stockholders Equity": "-147",
"ECR before LimitedLiability": "-96.8",
"Other Assets": "-6.59",
"Intangible Assets": "-19.3",
"Assets, Current": "-31.0",
"Assets, Non-Current": "6.74",
"Liabilities, Current": "-31.9",
"Labor Expense": "2.98",
"Expenses": "5.62",
"Revenues": "-23.9",
"Net Income": "18.1",
"General and Administrative Expense": "9.89",
"Other Expenses": "-22.0",
"Cost of Goods and Services Sold": "9.34",
"Other Revenues": "-23.9",
"Other Net Income": "32.8",
"Comprehensive Net Income": "18.5",
"Economic Capital Ratio": "-109"
},
"2021": {
"Other Assets": "-17.1",
"Assets": "-21.5",
"Liabilities": "-39.7",
"Stockholders Equity": "-88.3",
"ECR before LimitedLiability": "-102",
"Intangible Assets": "-15.7",
"Property Plant and Equipment": "13.2",
"Assets, Non-Current": "37.7",
"Assets, Current": "-22.6",
"Liabilities, Current": "-45.9",
"General and Administrative Expense": "4.93",
"Expenses": "8.80",
"Revenues": "-10.1",
"Net Income": "2.16",
"Operating Costs and Expenses": "1.82",
"Cost of Goods and Services Sold": "5.31",
"Other Expenses": "-7.28",
"Other Revenues": "-10.1",
"Comprehensive Net Income": "2.01",
"Other Net Income": "4.07",
"Economic Capital Ratio": "-108"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0000792935_strength_weakness.svg",
"table_records": {
"2016": {
"input_variables": {
"Assets, Current": "276",
"Assets, Non-Current": "184",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "145",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,637",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "-126",
"Other Expenses": "738",
"Other Liabilities": "0",
"Other Net Income": "736",
"Other Revenues": "73",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "460",
"Liabilities": "3,637",
"Expenses": "883",
"Revenues": "73",
"Stockholders Equity": "-3,177",
"Net Income": "-74",
"Comprehensive Net Income": "-200",
"BaseVar": "2,957",
"ECR before LimitedLiability": "-235%",
"Economic Capital Ratio": "28%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "255",
"Assets, Non-Current": "2,956",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "217",
"General and Administrative Expense": "910",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "18,576",
"Long Term Liabilities": "4,656",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "98",
"Other Expenses": "13,200",
"Other Liabilities": "0",
"Other Net Income": "-1,003",
"Other Revenues": "367",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,211",
"Liabilities": "23,232",
"Expenses": "14,327",
"Revenues": "367",
"Stockholders Equity": "-20,021",
"Net Income": "-14,963",
"Comprehensive Net Income": "-14,865",
"BaseVar": "21,118",
"ECR before LimitedLiability": "-332%",
"Economic Capital Ratio": "8.8%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "935",
"Assets, Non-Current": "2,887",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "121",
"General and Administrative Expense": "56",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "13,865",
"Long Term Liabilities": "4,584",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "132",
"Other Expenses": "9,621",
"Other Liabilities": "0",
"Other Net Income": "12,543",
"Other Revenues": "340",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,822",
"Liabilities": "18,449",
"Expenses": "9,798",
"Revenues": "340",
"Stockholders Equity": "-14,626",
"Net Income": "3,085",
"Comprehensive Net Income": "3,217",
"BaseVar": "22,542",
"ECR before LimitedLiability": "-162%",
"Economic Capital Ratio": "51%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "272",
"Assets, Non-Current": "6,283",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "325",
"General and Administrative Expense": "531",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "13,517",
"Long Term Liabilities": "2,493",
"Operating Costs and Expenses": "0",
"Other Assets": "-3,013",
"Other Compr. Net Income": "-60",
"Other Expenses": "3,786",
"Other Liabilities": "0",
"Other Net Income": "1,127",
"Other Revenues": "1,943",
"Property Plant and Equipment": "3,013",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,554",
"Liabilities": "16,010",
"Expenses": "4,643",
"Revenues": "1,943",
"Stockholders Equity": "-9,455",
"Net Income": "-1,573",
"Comprehensive Net Income": "-1,634",
"BaseVar": "15,168",
"ECR before LimitedLiability": "-136%",
"Economic Capital Ratio": "60%"
}
}
},
"top_rated": false,
"trend": -20.0,
"value": 0.5950750937629063,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0000792935.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0000792935.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0000792935.svg"
},
{
"company_id": "0001468679",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001468679.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001468679.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001468679.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001468679_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001468679_main_keyfigs.svg",
"name": "American Cryostem Corp",
"rank": 92,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001468679.svg",
"report_text": "The relative strengths and weaknesses of American Cryostem Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of American Cryostem Corp compared to the market average is the variable Other Assets, increasing the Economic Capital Ratio by 15% points.The greatest weakness of American Cryostem Corp is the variable Stockholders Equity, reducing the Economic Capital Ratio by 68% points.
The company's Economic Capital Ratio, given in the ranking table, is 18%, being 150% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001468679_2022_American_Cryostem_Corp.pdf",
"shrinked_graph_json": {
"2011": {
"Other Assets": "19.0",
"Assets": "-16.6",
"Liabilities": "5.28",
"Stockholders Equity": "8.97",
"ECR before LimitedLiability": "-114",
"Property Plant and Equipment": "31.3",
"Assets, Current": "-19.5",
"Assets, Non-Current": "-7.34",
"Intangible Assets": "-34.3",
"Expenses": "-55.4",
"Revenues": "-26.6",
"Net Income": "-157",
"Research And Development Expense": "-15.4",
"Other Expenses": "27.3",
"Operating Costs and Expenses": "4.49",
"Labor Expense": "6.97",
"General and Administrative Expense": "-155",
"Other Revenues": "-26.6",
"Other Net Income": "-17.2",
"Comprehensive Net Income": "-157",
"Economic Capital Ratio": "-121"
},
"2012": {
"Property Plant and Equipment": "0.0800",
"Assets": "-38.8",
"Liabilities": "-0.294",
"Stockholders Equity": "-1.57",
"ECR before LimitedLiability": "-149",
"Intangible Assets": "-8.74",
"Assets, Current": "-21.0",
"Other Assets": "0.0866",
"Assets, Non-Current": "-0.321",
"Long Term Liabilities": "-0.177",
"Other Liabilities": "-0.101",
"Research And Development Expense": "-0.389",
"Expenses": "-51.6",
"Revenues": "-0.961",
"Net Income": "-120",
"Other Expenses": "0.0863",
"General and Administrative Expense": "-112",
"Other Revenues": "-0.961",
"Other Net Income": "-0.414",
"Comprehensive Net Income": "-119",
"Economic Capital Ratio": "-164"
},
"2013": {
"Other Assets": "0.892",
"Assets": "-45.0",
"Liabilities": "-1.11",
"Stockholders Equity": "-3.70",
"ECR before LimitedLiability": "-152",
"Property Plant and Equipment": "0.446",
"Assets, Current": "-26.1",
"Intangible Assets": "-14.9",
"Assets, Non-Current": "-1.31",
"Long Term Liabilities": "-0.664",
"Expenses": "-67.1",
"Revenues": "-5.41",
"Net Income": "-132",
"General and Administrative Expense": "-85.8",
"Labor Expense": "0.447",
"Other Expenses": "0.692",
"Research And Development Expense": "-1.42",
"Other Revenues": "-5.41",
"Comprehensive Net Income": "-131",
"Other Net Income": "-1.34",
"Economic Capital Ratio": "-161"
},
"2014": {
"Other Assets": "7.02",
"Assets": "-46.6",
"Liabilities": "2.83",
"Stockholders Equity": "-60.9",
"ECR before LimitedLiability": "-134",
"Intangible Assets": "-16.5",
"Assets, Non-Current": "-2.33",
"Property Plant and Equipment": "-17.7",
"Assets, Current": "-22.6",
"Liabilities, Current": "4.79",
"Expenses": "-17.5",
"Revenues": "-7.09",
"Net Income": "-42.5",
"Labor Expense": "1.90",
"Research And Development Expense": "-4.28",
"Other Expenses": "4.42",
"General and Administrative Expense": "-39.5",
"Other Revenues": "-7.09",
"Comprehensive Net Income": "-42.4",
"Other Net Income": "-4.14",
"Economic Capital Ratio": "-147"
},
"2015": {
"Assets, Current": "-26.5",
"Assets": "-45.8",
"Liabilities": "-2.89",
"Stockholders Equity": "-68.6",
"ECR before LimitedLiability": "-129",
"Assets, Non-Current": "-2.67",
"Intangible Assets": "-18.0",
"Other Assets": "12.8",
"Property Plant and Equipment": "-19.0",
"Liabilities, Current": "-4.83",
"Expenses": "-7.67",
"Revenues": "-6.16",
"Net Income": "-22.4",
"Research And Development Expense": "-3.75",
"General and Administrative Expense": "-23.4",
"Other Expenses": "6.24",
"Labor Expense": "2.81",
"Other Revenues": "-6.16",
"Comprehensive Net Income": "-22.2",
"Other Net Income": "-5.13",
"Economic Capital Ratio": "-142"
},
"2016": {
"Property Plant and Equipment": "-23.2",
"Assets": "-54.9",
"Liabilities, Current": "1.63",
"Stockholders Equity": "-58.1",
"ECR before LimitedLiability": "-111",
"Assets, Non-Current": "-4.51",
"Intangible Assets": "-22.1",
"Other Assets": "11.3",
"Assets, Current": "-30.9",
"Expenses": "-27.9",
"Revenues": "-3.19",
"Net Income": "-43.6",
"Operating Costs and Expenses": "1.01",
"Selling and Marketing Expense": "1.60",
"General and Administrative Expense": "-33.9",
"Labor Expense": "1.68",
"Other Expenses": "-0.949",
"Other Revenues": "-3.19",
"Other Net Income": "-4.99",
"Comprehensive Net Income": "-43.2",
"Economic Capital Ratio": "-138"
},
"2017": {
"Other Assets": "11.2",
"Assets": "-41.6",
"Liabilities": "-11.0",
"Stockholders Equity": "-76.4",
"ECR before LimitedLiability": "-78.9",
"Intangible Assets": "-26.0",
"Assets, Non-Current": "-5.88",
"Assets, Current": "-22.7",
"Property Plant and Equipment": "-23.4",
"Liabilities, Current": "-21.0",
"Long Term Liabilities": "4.36",
"General and Administrative Expense": "-34.9",
"Expenses": "-17.8",
"Revenues": "16.1",
"Net Income": "-13.1",
"Other Expenses": "12.9",
"Cost of Goods and Services Sold": "-5.20",
"Other Revenues": "16.1",
"Other Net Income": "-12.8",
"Comprehensive Net Income": "-13.0",
"Economic Capital Ratio": "-103"
},
"2018": {
"Other Assets": "36.2",
"Assets": "-29.9",
"Liabilities": "-17.4",
"Stockholders Equity": "-49.6",
"ECR before LimitedLiability": "-85.5",
"Property Plant and Equipment": "-14.9",
"Intangible Assets": "-17.8",
"Assets, Non-Current": "-8.52",
"Assets, Current": "-24.6",
"Other Liabilities": "-13.5",
"Liabilities, Current": "-7.73",
"Expenses": "-11.7",
"Revenues": "-6.59",
"Net Income": "-17.6",
"Other Expenses": "-14.9",
"Research And Development Expense": "-4.34",
"Cost of Goods and Services Sold": "4.37",
"Labor Expense": "4.11",
"Other Revenues": "-6.59",
"Comprehensive Net Income": "-17.5",
"Economic Capital Ratio": "-106"
},
"2019": {
"Property Plant and Equipment": "-10.5",
"Assets": "-19.2",
"Liabilities": "-29.2",
"Stockholders Equity": "-51.9",
"ECR before LimitedLiability": "-97.1",
"Assets, Non-Current": "-9.75",
"Other Assets": "35.4",
"Intangible Assets": "-13.9",
"Assets, Current": "-15.3",
"Other Liabilities": "-17.0",
"Long Term Liabilities": "3.15",
"Liabilities, Current": "-13.5",
"Other Revenues": "-14.3",
"Revenues": "-14.3",
"Net Income": "-12.3",
"Other Expenses": "-4.74",
"Comprehensive Net Income": "-12.2",
"General and Administrative Expense": "-4.59",
"Cost of Goods and Services Sold": "7.39",
"Labor Expense": "2.33",
"Economic Capital Ratio": "-107"
},
"2020": {
"Property Plant and Equipment": "-7.67",
"Assets": "-13.8",
"Liabilities": "-16.1",
"Stockholders Equity": "-40.1",
"ECR before LimitedLiability": "-78.4",
"Other Assets": "37.9",
"Intangible Assets": "-11.6",
"Assets, Current": "-11.4",
"Assets, Non-Current": "-7.16",
"Liabilities, Current": "-10.4",
"Other Liabilities": "-13.6",
"Long Term Liabilities": "6.45",
"Labor Expense": "2.29",
"Expenses": "-5.06",
"Revenues": "-8.87",
"Net Income": "-12.0",
"Other Expenses": "-14.2",
"Cost of Goods and Services Sold": "6.65",
"Other Revenues": "-8.87",
"Comprehensive Net Income": "-12.0",
"Economic Capital Ratio": "-90.5"
},
"2021": {
"Other Assets": "15.0",
"Assets": "-47.4",
"Liabilities": "-2.08",
"Stockholders Equity": "-67.7",
"ECR before LimitedLiability": "-144",
"Intangible Assets": "-22.7",
"Property Plant and Equipment": "-7.92",
"Assets, Non-Current": "-8.86",
"Assets, Current": "-34.5",
"Liabilities, Current": "-0.993",
"Expenses": "-14.6",
"Revenues": "-15.6",
"Net Income": "-33.3",
"Operating Costs and Expenses": "1.37",
"Labor Expense": "1.19",
"Cost of Goods and Services Sold": "3.65",
"Research And Development Expense": "-2.69",
"Other Expenses": "-22.8",
"Other Revenues": "-15.6",
"Comprehensive Net Income": "-33.2",
"Economic Capital Ratio": "-150"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001468679_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "125",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "1.4",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,294",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "145",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "102",
"Other Compr. Net Income": "0",
"Other Expenses": "-172",
"Other Liabilities": "0",
"Other Net Income": "5.1",
"Other Revenues": "5.0",
"Property Plant and Equipment": "334",
"Research And Development Expense": "177",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "561",
"Liabilities": "145",
"Expenses": "1,301",
"Revenues": "5.0",
"Stockholders Equity": "416",
"Net Income": "-1,290",
"Comprehensive Net Income": "-1,290",
"BaseVar": "1,009",
"ECR before LimitedLiability": "-195%",
"Economic Capital Ratio": "40%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "4.0",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0.66",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,374",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "261",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "137",
"Other Compr. Net Income": "0",
"Other Expenses": "-294",
"Other Liabilities": "0",
"Other Net Income": "0.0020",
"Other Revenues": "21",
"Property Plant and Equipment": "319",
"Research And Development Expense": "304",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "460",
"Liabilities": "261",
"Expenses": "2,386",
"Revenues": "21",
"Stockholders Equity": "199",
"Net Income": "-2,364",
"Comprehensive Net Income": "-2,364",
"BaseVar": "1,564",
"ECR before LimitedLiability": "-576%",
"Economic Capital Ratio": "0.087%"
}
},
"2013": {
"input_variables": {
"Assets, Current": "118",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "5.1",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,128",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "280",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "170",
"Other Compr. Net Income": "0",
"Other Expenses": "20",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "12",
"Property Plant and Equipment": "281",
"Research And Development Expense": "258",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "569",
"Liabilities": "280",
"Expenses": "2,411",
"Revenues": "12",
"Stockholders Equity": "289",
"Net Income": "-2,400",
"Comprehensive Net Income": "-2,400",
"BaseVar": "1,636",
"ECR before LimitedLiability": "-466%",
"Economic Capital Ratio": "0.94%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "82",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,011",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,496",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "458",
"Other Compr. Net Income": "0",
"Other Expenses": "-202",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "121",
"Property Plant and Equipment": "0",
"Research And Development Expense": "400",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "540",
"Liabilities": "1,496",
"Expenses": "2,209",
"Revenues": "121",
"Stockholders Equity": "-956",
"Net Income": "-2,088",
"Comprehensive Net Income": "-2,088",
"BaseVar": "2,183",
"ECR before LimitedLiability": "-341%",
"Economic Capital Ratio": "7.7%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "73",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "99",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,394",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,997",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "460",
"Other Compr. Net Income": "0",
"Other Expenses": "-58",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "339",
"Property Plant and Equipment": "0",
"Research And Development Expense": "283",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "534",
"Liabilities": "1,997",
"Expenses": "1,718",
"Revenues": "339",
"Stockholders Equity": "-1,463",
"Net Income": "-1,379",
"Comprehensive Net Income": "-1,379",
"BaseVar": "2,294",
"ECR before LimitedLiability": "-277%",
"Economic Capital Ratio": "18%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "127",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "294",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,594",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,273",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "465",
"Other Compr. Net Income": "0",
"Other Expenses": "489",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "611",
"Property Plant and Equipment": "0",
"Research And Development Expense": "115",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "592",
"Liabilities": "1,273",
"Expenses": "2,492",
"Revenues": "611",
"Stockholders Equity": "-681",
"Net Income": "-1,881",
"Comprehensive Net Income": "-1,881",
"BaseVar": "2,484",
"ECR before LimitedLiability": "-308%",
"Economic Capital Ratio": "12%"
}
},
"2017": {
"input_variables": {
"Assets, Current": "643",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "555",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "2,331",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,922",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "366",
"Other Compr. Net Income": "0",
"Other Expenses": "117",
"Other Liabilities": "109",
"Other Net Income": "0",
"Other Revenues": "1,867",
"Property Plant and Equipment": "0",
"Research And Development Expense": "87",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,009",
"Liabilities": "2,031",
"Expenses": "3,089",
"Revenues": "1,867",
"Stockholders Equity": "-1,022",
"Net Income": "-1,222",
"Comprehensive Net Income": "-1,222",
"BaseVar": "3,998",
"ECR before LimitedLiability": "-178%",
"Economic Capital Ratio": "45%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "369",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "297",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "670",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,112",
"Long Term Liabilities": "25",
"Operating Costs and Expenses": "0",
"Other Assets": "897",
"Other Compr. Net Income": "0",
"Other Expenses": "1,197",
"Other Liabilities": "830",
"Other Net Income": "-18",
"Other Revenues": "1,103",
"Property Plant and Equipment": "0",
"Research And Development Expense": "342",
"Selling and Marketing Expense": "71"
},
"output_variables": {
"Assets": "1,266",
"Liabilities": "1,967",
"Expenses": "2,576",
"Revenues": "1,103",
"Stockholders Equity": "-700",
"Net Income": "-1,491",
"Comprehensive Net Income": "-1,491",
"BaseVar": "3,465",
"ECR before LimitedLiability": "-155%",
"Economic Capital Ratio": "53%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "380",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "32",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "599",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,292",
"Long Term Liabilities": "102",
"Operating Costs and Expenses": "0",
"Other Assets": "914",
"Other Compr. Net Income": "0",
"Other Expenses": "506",
"Other Liabilities": "1,137",
"Other Net Income": "-9.1",
"Other Revenues": "322",
"Property Plant and Equipment": "0",
"Research And Development Expense": "225",
"Selling and Marketing Expense": "34"
},
"output_variables": {
"Assets": "1,294",
"Liabilities": "2,532",
"Expenses": "1,395",
"Revenues": "322",
"Stockholders Equity": "-1,238",
"Net Income": "-1,082",
"Comprehensive Net Income": "-1,082",
"BaseVar": "2,776",
"ECR before LimitedLiability": "-150%",
"Economic Capital Ratio": "55%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "567",
"Assets, Non-Current": "18",
"Cost of Goods and Services Sold": "44",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "440",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,050",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "892",
"Other Compr. Net Income": "0",
"Other Expenses": "1,253",
"Other Liabilities": "848",
"Other Net Income": "41",
"Other Revenues": "562",
"Property Plant and Equipment": "0",
"Research And Development Expense": "19",
"Selling and Marketing Expense": "26"
},
"output_variables": {
"Assets": "1,477",
"Liabilities": "1,898",
"Expenses": "1,782",
"Revenues": "562",
"Stockholders Equity": "-421",
"Net Income": "-1,179",
"Comprehensive Net Income": "-1,179",
"BaseVar": "2,880",
"ECR before LimitedLiability": "-106%",
"Economic Capital Ratio": "69%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "197",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "14",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "500",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,631",
"Long Term Liabilities": "133",
"Operating Costs and Expenses": "0",
"Other Assets": "859",
"Other Compr. Net Income": "0",
"Other Expenses": "1,978",
"Other Liabilities": "1,140",
"Other Net Income": "27",
"Other Revenues": "21",
"Property Plant and Equipment": "0",
"Research And Development Expense": "374",
"Selling and Marketing Expense": "6.1"
},
"output_variables": {
"Assets": "1,056",
"Liabilities": "2,904",
"Expenses": "2,872",
"Revenues": "21",
"Stockholders Equity": "-1,848",
"Net Income": "-2,825",
"Comprehensive Net Income": "-2,825",
"BaseVar": "3,440",
"ECR before LimitedLiability": "-278%",
"Economic Capital Ratio": "18%"
}
}
},
"top_rated": false,
"trend": -23.0,
"value": 0.17518477563978158,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001468679.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001468679.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001468679.svg"
},
{
"company_id": "0001652958",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001652958.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001652958.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001652958.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001652958_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001652958_main_keyfigs.svg",
"name": "Edgemode Inc",
"rank": 93,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001652958.svg",
"report_text": "The relative strengths and weaknesses of Edgemode Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Edgemode Inc compared to the market average is the variable Expenses, increasing the Economic Capital Ratio by 7.9% points.The greatest weakness of Edgemode Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 72% points.
The company's Economic Capital Ratio, given in the ranking table, is 14%, being 154% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001652958_2022_Edgemode_Inc.pdf",
"shrinked_graph_json": {
"2020": {
"Property Plant and Equipment": "-0.316",
"Assets": "-44.6",
"Liabilities": "0.0281",
"Stockholders Equity": "-26.3",
"ECR before LimitedLiability": "-148",
"Other Assets": "-0.0667",
"Intangible Assets": "-1.13",
"Assets, Current": "-5.76",
"Assets, Non-Current": "-0.312",
"Liabilities, Current": "0.0282",
"Other Liabilities": "-0.0108",
"Long Term Liabilities": "-0.0940",
"Expenses": "-4.78",
"Revenues": "-0.400",
"Net Income": "-21.5",
"General and Administrative Expense": "-12.0",
"Other Expenses": "-0.0177",
"Cost of Goods and Services Sold": "0.0189",
"Other Revenues": "-0.400",
"Comprehensive Net Income": "-21.5",
"Economic Capital Ratio": "-160"
},
"2021": {
"Other Assets": "-2.38",
"Assets": "-48.7",
"Liabilities": "1.38",
"Stockholders Equity": "-72.1",
"ECR before LimitedLiability": "-148",
"Intangible Assets": "-20.0",
"Property Plant and Equipment": "-6.75",
"Assets, Non-Current": "-7.57",
"Assets, Current": "-10.2",
"Liabilities, Current": "2.49",
"Expenses": "7.89",
"Revenues": "-13.2",
"Net Income": "-27.1",
"Operating Costs and Expenses": "1.11",
"Cost of Goods and Services Sold": "3.02",
"Research And Development Expense": "0.995",
"Other Expenses": "2.25",
"Other Revenues": "-13.2",
"Comprehensive Net Income": "-27.1",
"Other Net Income": "-27.7",
"Economic Capital Ratio": "-154"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001652958_strength_weakness.svg",
"table_records": {
"2020": {
"input_variables": {
"Assets, Current": "290",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "4,494",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,200",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "25",
"Other Compr. Net Income": "0",
"Other Expenses": "590",
"Other Liabilities": "0",
"Other Net Income": "0",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "315",
"Liabilities": "2,200",
"Expenses": "5,084",
"Revenues": "0",
"Stockholders Equity": "-1,884",
"Net Income": "-5,084",
"Comprehensive Net Income": "-5,084",
"BaseVar": "3,800",
"ECR before LimitedLiability": "-622%",
"Economic Capital Ratio": "0.028%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "3,808",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,847",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "13,996",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-9,899",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "3,808",
"Liabilities": "13,996",
"Expenses": "1,847",
"Revenues": "0",
"Stockholders Equity": "-10,188",
"Net Income": "-11,745",
"Comprehensive Net Income": "-11,745",
"BaseVar": "14,775",
"ECR before LimitedLiability": "-298%",
"Economic Capital Ratio": "14%"
}
}
},
"top_rated": false,
"trend": -17.0,
"value": 0.13795619815029364,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001652958.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001652958.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001652958.svg"
},
{
"company_id": "0001443863",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001443863.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001443863.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001443863.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001443863_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001443863_main_keyfigs.svg",
"name": "Biocorrx Inc",
"rank": 94,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001443863.svg",
"report_text": "The relative strengths and weaknesses of Biocorrx Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Biocorrx Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 5.3% points.The greatest weakness of Biocorrx Inc is the variable Stockholders Equity, reducing the Economic Capital Ratio by 81% points.
The company's Economic Capital Ratio, given in the ranking table, is 6.3%, being 162% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001443863_2022_Biocorrx_Inc.pdf",
"shrinked_graph_json": {
"2013": {
"Other Assets": "70.0",
"Assets": "1.57",
"Liabilities": "-30.5",
"Stockholders Equity": "-17.8",
"ECR before LimitedLiability": "-70.0",
"Property Plant and Equipment": "-3.99",
"Assets, Current": "-4.47",
"Intangible Assets": "-4.13",
"Assets, Non-Current": "-1.09",
"Other Liabilities": "-21.1",
"Liabilities, Current": "-1.10",
"Other Revenues": "-3.48",
"Revenues": "-3.48",
"Net Income": "-4.30",
"Comprehensive Net Income": "-4.28",
"General and Administrative Expense": "-4.50",
"Cost of Goods and Services Sold": "1.29",
"Other Net Income": "-2.63",
"Labor Expense": "2.32",
"Other Expenses": "4.58",
"Economic Capital Ratio": "-79.2"
},
"2014": {
"Other Assets": "74.0",
"Assets": "-3.68",
"Liabilities": "-7.47",
"Stockholders Equity": "-8.73",
"ECR before LimitedLiability": "-62.5",
"Intangible Assets": "-7.07",
"Property Plant and Equipment": "-7.25",
"Assets, Current": "-7.87",
"Other Liabilities": "-6.25",
"Liabilities, Current": "-4.39",
"Long Term Liabilities": "2.53",
"Expenses": "-3.54",
"Revenues": "-4.05",
"Net Income": "-7.87",
"Labor Expense": "3.90",
"Other Expenses": "5.03",
"General and Administrative Expense": "-14.8",
"Other Revenues": "-4.05",
"Comprehensive Net Income": "-7.86",
"Other Net Income": "-3.77",
"Economic Capital Ratio": "-75.6"
},
"2015": {
"Assets, Current": "-27.4",
"Assets": "-54.4",
"Liabilities": "2.00",
"Stockholders Equity": "-71.2",
"ECR before LimitedLiability": "-135",
"Assets, Non-Current": "-2.65",
"Intangible Assets": "-19.4",
"Other Assets": "8.81",
"Property Plant and Equipment": "-20.5",
"Liabilities, Current": "1.94",
"Expenses": "-15.3",
"Revenues": "-6.45",
"Net Income": "-30.0",
"General and Administrative Expense": "-7.52",
"Other Expenses": "-17.8",
"Labor Expense": "2.51",
"Cost of Goods and Services Sold": "1.52",
"Other Revenues": "-6.45",
"Comprehensive Net Income": "-29.8",
"Other Net Income": "-2.17",
"Economic Capital Ratio": "-147"
},
"2016": {
"Property Plant and Equipment": "-8.09",
"Assets": "-45.5",
"Liabilities": "3.57",
"Stockholders Equity": "-76.9",
"ECR before LimitedLiability": "-119",
"Assets, Non-Current": "-1.38",
"Intangible Assets": "-7.80",
"Other Assets": "0.497",
"Assets, Current": "-15.2",
"Other Liabilities": "3.35",
"Expenses": "1.83",
"Revenues": "-3.30",
"Net Income": "-11.9",
"General and Administrative Expense": "-2.19",
"Labor Expense": "0.437",
"Other Expenses": "1.41",
"Cost of Goods and Services Sold": "0.762",
"Other Revenues": "-3.30",
"Other Net Income": "-11.7",
"Comprehensive Net Income": "-11.8",
"Economic Capital Ratio": "-147"
},
"2018": {
"Other Assets": "-0.430",
"Assets": "-47.9",
"Liabilities": "1.95",
"Stockholders Equity": "-73.1",
"ECR before LimitedLiability": "-137",
"Property Plant and Equipment": "-3.82",
"Intangible Assets": "-5.62",
"Assets, Non-Current": "-1.84",
"Assets, Current": "-16.4",
"Liabilities, Current": "1.97",
"Long Term Liabilities": "-0.458",
"Expenses": "-1.03",
"Revenues": "-4.50",
"Net Income": "-16.3",
"Other Expenses": "0.620",
"General and Administrative Expense": "-7.28",
"Cost of Goods and Services Sold": "0.723",
"Other Revenues": "-4.50",
"Comprehensive Net Income": "-16.2",
"Other Net Income": "-2.94",
"Economic Capital Ratio": "-157"
},
"2020": {
"Property Plant and Equipment": "-13.0",
"Assets": "-60.1",
"Liabilities": "-6.92",
"Stockholders Equity": "-105",
"ECR before LimitedLiability": "-122",
"Other Assets": "-3.49",
"Intangible Assets": "-25.6",
"Assets, Current": "-39.3",
"Assets, Non-Current": "-6.34",
"Other Liabilities": "-6.65",
"Expenses": "-19.5",
"Revenues": "-28.9",
"Net Income": "-16.1",
"General and Administrative Expense": "-12.6",
"Research And Development Expense": "-31.8",
"Other Expenses": "5.47",
"Cost of Goods and Services Sold": "7.35",
"Other Revenues": "-28.9",
"Other Net Income": "18.1",
"Comprehensive Net Income": "-16.1",
"Economic Capital Ratio": "-134"
},
"2021": {
"Assets": "-55.3",
"Liabilities": "5.35",
"Stockholders Equity": "-80.7",
"ECR before LimitedLiability": "-155",
"Intangible Assets": "-14.7",
"Property Plant and Equipment": "-4.41",
"Assets, Non-Current": "-1.59",
"Assets, Current": "-27.5",
"Liabilities, Current": "3.00",
"Other Liabilities": "2.75",
"General and Administrative Expense": "-8.39",
"Expenses": "-5.47",
"Revenues": "-7.86",
"Net Income": "-15.1",
"Cost of Goods and Services Sold": "1.61",
"Research And Development Expense": "-3.49",
"Other Expenses": "0.953",
"Other Revenues": "-7.86",
"Comprehensive Net Income": "-15.1",
"Other Net Income": "0.829",
"Economic Capital Ratio": "-162"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001443863_strength_weakness.svg",
"table_records": {
"2013": {
"input_variables": {
"Assets, Current": "529",
"Assets, Non-Current": "44",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "136",
"General and Administrative Expense": "2,920",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,362",
"Long Term Liabilities": "601",
"Operating Costs and Expenses": "0",
"Other Assets": "3,844",
"Other Compr. Net Income": "0",
"Other Expenses": "160",
"Other Liabilities": "2,239",
"Other Net Income": "0",
"Other Revenues": "715",
"Property Plant and Equipment": "8.8",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,426",
"Liabilities": "4,203",
"Expenses": "3,215",
"Revenues": "715",
"Stockholders Equity": "223",
"Net Income": "-2,500",
"Comprehensive Net Income": "-2,500",
"BaseVar": "6,280",
"ECR before LimitedLiability": "-50%",
"Economic Capital Ratio": "83%"
}
},
"2014": {
"input_variables": {
"Assets, Current": "213",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "221",
"Depreciation, Depletion, Amortization": "135",
"General and Administrative Expense": "3,867",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "1,938",
"Long Term Liabilities": "449",
"Operating Costs and Expenses": "0",
"Other Assets": "3,864",
"Other Compr. Net Income": "0",
"Other Expenses": "353",
"Other Liabilities": "1,390",
"Other Net Income": "278",
"Other Revenues": "1,171",
"Property Plant and Equipment": "6.2",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,083",
"Liabilities": "3,777",
"Expenses": "4,576",
"Revenues": "1,171",
"Stockholders Equity": "306",
"Net Income": "-3,128",
"Comprehensive Net Income": "-3,128",
"BaseVar": "6,942",
"ECR before LimitedLiability": "-68%",
"Economic Capital Ratio": "79%"
}
},
"2015": {
"input_variables": {
"Assets, Current": "312",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "152",
"Depreciation, Depletion, Amortization": "125",
"General and Administrative Expense": "2,126",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,755",
"Long Term Liabilities": "5.5",
"Operating Costs and Expenses": "0",
"Other Assets": "1,089",
"Other Compr. Net Income": "0",
"Other Expenses": "3,640",
"Other Liabilities": "927",
"Other Net Income": "452",
"Other Revenues": "925",
"Property Plant and Equipment": "3.9",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,405",
"Liabilities": "4,688",
"Expenses": "6,043",
"Revenues": "925",
"Stockholders Equity": "-3,283",
"Net Income": "-4,666",
"Comprehensive Net Income": "-4,666",
"BaseVar": "6,756",
"ECR before LimitedLiability": "-309%",
"Economic Capital Ratio": "12%"
}
},
"2016": {
"input_variables": {
"Assets, Current": "101",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "175",
"Depreciation, Depletion, Amortization": "30",
"General and Administrative Expense": "2,545",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "2,451",
"Long Term Liabilities": "689",
"Operating Costs and Expenses": "0",
"Other Assets": "347",
"Other Compr. Net Income": "0",
"Other Expenses": "133",
"Other Liabilities": "5,461",
"Other Net Income": "-3,722",
"Other Revenues": "702",
"Property Plant and Equipment": "22",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "470",
"Liabilities": "8,601",
"Expenses": "2,884",
"Revenues": "702",
"Stockholders Equity": "-8,130",
"Net Income": "-5,904",
"Comprehensive Net Income": "-5,904",
"BaseVar": "8,189",
"ECR before LimitedLiability": "-390%",
"Economic Capital Ratio": "3.7%"
}
},
"2018": {
"input_variables": {
"Assets, Current": "319",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "171",
"Depreciation, Depletion, Amortization": "7.4",
"General and Administrative Expense": "4,423",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "6,127",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "265",
"Other Compr. Net Income": "0",
"Other Expenses": "250",
"Other Liabilities": "208",
"Other Net Income": "-1,958",
"Other Revenues": "377",
"Property Plant and Equipment": "44",
"Research And Development Expense": "152",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "628",
"Liabilities": "6,335",
"Expenses": "5,003",
"Revenues": "377",
"Stockholders Equity": "-5,706",
"Net Income": "-6,584",
"Comprehensive Net Income": "-6,584",
"BaseVar": "7,150",
"ECR before LimitedLiability": "-427%",
"Economic Capital Ratio": "2.0%"
}
},
"2020": {
"input_variables": {
"Assets, Current": "975",
"Assets, Non-Current": "490",
"Cost of Goods and Services Sold": "96",
"Depreciation, Depletion, Amortization": "77",
"General and Administrative Expense": "3,168",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,052",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "234",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "2,985",
"Other Net Income": "3,985",
"Other Revenues": "123",
"Property Plant and Equipment": "129",
"Research And Development Expense": "4,274",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,827",
"Liabilities": "6,037",
"Expenses": "7,615",
"Revenues": "123",
"Stockholders Equity": "-4,210",
"Net Income": "-3,507",
"Comprehensive Net Income": "-3,507",
"BaseVar": "9,794",
"ECR before LimitedLiability": "-244%",
"Economic Capital Ratio": "25%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "228",
"Assets, Non-Current": "385",
"Cost of Goods and Services Sold": "5.9",
"Depreciation, Depletion, Amortization": "64",
"General and Administrative Expense": "3,741",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "4,386",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "207",
"Other Compr. Net Income": "0",
"Other Expenses": "141",
"Other Liabilities": "3,395",
"Other Net Income": "299",
"Other Revenues": "48",
"Property Plant and Equipment": "0",
"Research And Development Expense": "1,606",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "820",
"Liabilities": "7,781",
"Expenses": "5,558",
"Revenues": "48",
"Stockholders Equity": "-6,961",
"Net Income": "-5,211",
"Comprehensive Net Income": "-5,211",
"BaseVar": "7,254",
"ECR before LimitedLiability": "-356%",
"Economic Capital Ratio": "6.3%"
}
}
},
"top_rated": false,
"trend": -22.0,
"value": 0.06268007745545706,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001443863.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001443863.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001443863.svg"
},
{
"company_id": "0001300524",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution_0001300524.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2021/graphs/IME_0001300524.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001300524.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001300524_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001300524_main_keyfigs.svg",
"name": "American International Holdings CORP",
"rank": 95,
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_0001300524.svg",
"report_text": "The relative strengths and weaknesses of American International Holdings CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of American International Holdings CORP compared to the market average is the variable Liabilities, Current, increasing the Economic Capital Ratio by 0.56% points.The greatest weakness of American International Holdings CORP is the variable Assets, reducing the Economic Capital Ratio by 54% points.
The company's Economic Capital Ratio, given in the ranking table, is 0.56%, being 167% points below the market average of 168%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2021/report/0001300524_2022_American_International_Holdings_CORP.pdf",
"shrinked_graph_json": {
"2011": {
"Assets": "-67.2",
"Stockholders Equity": "-94.5",
"ECR before LimitedLiability": "-33.7",
"Property Plant and Equipment": "-22.5",
"Intangible Assets": "-50.5",
"Other Liabilities": "17.5",
"Liabilities": "23.9",
"Long Term Liabilities": "33.5",
"Liabilities, Current": "-54.7",
"Expenses": "-39.4",
"Revenues": "52.7",
"Net Income": "29.9",
"Other Expenses": "-342",
"Operating Costs and Expenses": "15.8",
"Labor Expense": "25.4",
"General and Administrative Expense": "64.1",
"Cost of Goods and Services Sold": "48.3",
"Other Revenues": "52.7",
"Other Net Income": "-50.7",
"Comprehensive Net Income": "30.4",
"Economic Capital Ratio": "-40.4"
},
"2012": {
"Assets": "-3.13",
"Stockholders Equity": "160",
"ECR before LimitedLiability": "158",
"Assets, Current": "-10.2",
"Liabilities, Current": "33.0",
"Liabilities": "62.9",
"Long Term Liabilities": "24.0",
"Other Liabilities": "15.9",
"Research And Development Expense": "1.91",
"Expenses": "41.4",
"Revenues": "-27.5",
"Net Income": "16.3",
"Other Expenses": "18.4",
"General and Administrative Expense": "2.16",
"Goodwill Impairment Loss": "1.38",
"Operating Costs and Expenses": "3.78",
"Cost of Goods and Services Sold": "4.90",
"Labor Expense": "7.86",
"Other Revenues": "-27.5",
"Comprehensive Net Income": "16.5",
"Economic Capital Ratio": "144"
},
"2019": {
"Property Plant and Equipment": "-13.3",
"Assets": "-37.4",
"Liabilities": "-12.0",
"Stockholders Equity": "-44.5",
"ECR before LimitedLiability": "-106",
"Assets, Non-Current": "-5.08",
"Other Assets": "-7.71",
"Intangible Assets": "-21.6",
"Assets, Current": "-6.60",
"Liabilities, Current": "-18.5",
"Other Expenses": "6.47",
"Expenses": "-17.4",
"Revenues": "-8.48",
"Net Income": "-28.0",
"General and Administrative Expense": "-28.9",
"Cost of Goods and Services Sold": "-7.68",
"Research And Development Expense": "3.69",
"Labor Expense": "3.57",
"Other Revenues": "-8.48",
"Comprehensive Net Income": "-27.9",
"Economic Capital Ratio": "-116"
},
"2021": {
"Other Assets": "-0.399",
"Assets": "-54.0",
"Liabilities": "0.532",
"Stockholders Equity": "-52.2",
"ECR before LimitedLiability": "-161",
"Intangible Assets": "-8.41",
"Property Plant and Equipment": "-1.51",
"Assets, Non-Current": "-1.71",
"Assets, Current": "-9.70",
"Liabilities, Current": "0.562",
"Long Term Liabilities": "-0.475",
"General and Administrative Expense": "-11.4",
"Expenses": "-2.59",
"Revenues": "-2.59",
"Net Income": "-32.5",
"Cost of Goods and Services Sold": "0.256",
"Other Expenses": "0.206",
"Other Revenues": "-2.59",
"Comprehensive Net Income": "-32.4",
"Other Net Income": "-2.47",
"Economic Capital Ratio": "-167"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2021/plot_over_time/0001300524_strength_weakness.svg",
"table_records": {
"2011": {
"input_variables": {
"Assets, Current": "3,577",
"Assets, Non-Current": "6.5",
"Cost of Goods and Services Sold": "-5,276",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "-6,270",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "3,880",
"Long Term Liabilities": "50",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "23,150",
"Other Liabilities": "0",
"Other Net Income": "-41",
"Other Revenues": "11,293",
"Property Plant and Equipment": "1,701",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "5,285",
"Liabilities": "3,929",
"Expenses": "11,603",
"Revenues": "11,293",
"Stockholders Equity": "1,356",
"Net Income": "-351",
"Comprehensive Net Income": "-351",
"BaseVar": "16,076",
"ECR before LimitedLiability": "35%",
"Economic Capital Ratio": "120%"
}
},
"2012": {
"input_variables": {
"Assets, Current": "2,513",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "162",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "24",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "263",
"Other Revenues": "0",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,513",
"Liabilities": "24",
"Expenses": "162",
"Revenues": "0",
"Stockholders Equity": "2,489",
"Net Income": "101",
"Comprehensive Net Income": "101",
"BaseVar": "1,481",
"ECR before LimitedLiability": "292%",
"Economic Capital Ratio": "307%"
}
},
"2019": {
"input_variables": {
"Assets, Current": "1,641",
"Assets, Non-Current": "427",
"Cost of Goods and Services Sold": "1,627",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "3,223",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "30",
"Labor Expense": "0",
"Liabilities, Current": "2,738",
"Long Term Liabilities": "563",
"Operating Costs and Expenses": "0",
"Other Assets": "-60",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-276",
"Other Revenues": "1,914",
"Property Plant and Equipment": "155",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,192",
"Liabilities": "3,301",
"Expenses": "4,850",
"Revenues": "1,914",
"Stockholders Equity": "-1,109",
"Net Income": "-3,212",
"Comprehensive Net Income": "-3,212",
"BaseVar": "6,267",
"ECR before LimitedLiability": "-175%",
"Economic Capital Ratio": "46%"
}
},
"2021": {
"input_variables": {
"Assets, Current": "1,214",
"Assets, Non-Current": "18",
"Cost of Goods and Services Sold": "40",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "6,976",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "0",
"Labor Expense": "0",
"Liabilities, Current": "5,101",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "0",
"Other Liabilities": "0",
"Other Net Income": "-2,986",
"Other Revenues": "20",
"Property Plant and Equipment": "0",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,231",
"Liabilities": "5,101",
"Expenses": "7,015",
"Revenues": "20",
"Stockholders Equity": "-3,869",
"Net Income": "-9,981",
"Comprehensive Net Income": "-9,981",
"BaseVar": "8,177",
"ECR before LimitedLiability": "-492%",
"Economic Capital Ratio": "0.56%"
}
}
},
"top_rated": false,
"trend": null,
"value": 0.005621369073318843,
"company_index": "https://www.realrate-archive.com/us_health_services/2021/industry_indexes/0001300524.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2021/analytics/equity/0001300524.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2021/analytics/profit_loss/0001300524.svg"
}
],
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2021/feature_distribution/feature_distribution.svg",
"final_var_label": "Economic Capital Ratio",
"industry_box": [
[
"Revenues",
"202 B"
],
[
"Assets",
"276 B"
],
[
"Expenses",
"191 B"
],
[
"Stockholders Equity",
"145 B"
]
],
"industry_id": "us_health_services",
"industry_label": "Health Services",
"num_companies": 95,
"num_top_companies": 23,
"ecr_records": {
"2009": {
"0001022079": {
"rank": 1,
"ecr": "268"
},
"0000896262": {
"rank": 2,
"ecr": "205"
},
"0001014739": {
"rank": 3,
"ecr": "194"
},
"0000920148": {
"rank": 4,
"ecr": "168"
},
"0000927066": {
"rank": 5,
"ecr": "146"
}
},
"2010": {
"0000895930": {
"rank": 1,
"ecr": "295"
},
"0000352915": {
"rank": 2,
"ecr": "266"
},
"0000731012": {
"rank": 3,
"ecr": "265"
},
"0001022079": {
"rank": 4,
"ecr": "261"
},
"0000893949": {
"rank": 5,
"ecr": "221"
},
"0000896262": {
"rank": 6,
"ecr": "212"
},
"0000019411": {
"rank": 7,
"ecr": "211"
},
"0000019584": {
"rank": 8,
"ecr": "188"
},
"0000882235": {
"rank": 9,
"ecr": "175"
},
"0001301611": {
"rank": 10,
"ecr": "165"
},
"0000920148": {
"rank": 11,
"ecr": "160"
},
"0000785161": {
"rank": 12,
"ecr": "147"
},
"0000927066": {
"rank": 13,
"ecr": "139"
},
"0001332349": {
"rank": 14,
"ecr": "122"
},
"0001108109": {
"rank": 15,
"ecr": "117"
},
"0001001604": {
"rank": 16,
"ecr": "105"
}
},
"2011": {
"0000895930": {
"rank": 1,
"ecr": "292"
},
"0001091312": {
"rank": 2,
"ecr": "275"
},
"0001043000": {
"rank": 3,
"ecr": "270"
},
"0000352915": {
"rank": 4,
"ecr": "269"
},
"0000731012": {
"rank": 5,
"ecr": "262"
},
"0001522138": {
"rank": 6,
"ecr": "259"
},
"0001367832": {
"rank": 7,
"ecr": "258"
},
"0000744825": {
"rank": 8,
"ecr": "256"
},
"0001294632": {
"rank": 9,
"ecr": "252"
},
"0001125376": {
"rank": 10,
"ecr": "252"
},
"0001022079": {
"rank": 11,
"ecr": "249"
},
"0001131324": {
"rank": 12,
"ecr": "245"
},
"0000860730": {
"rank": 13,
"ecr": "244"
},
"0001138476": {
"rank": 14,
"ecr": "241"
},
"0000885978": {
"rank": 15,
"ecr": "239"
},
"0000893949": {
"rank": 16,
"ecr": "234"
},
"0001124140": {
"rank": 17,
"ecr": "232"
},
"0001060009": {
"rank": 18,
"ecr": "231"
},
"0001047335": {
"rank": 19,
"ecr": "229"
},
"0001410471": {
"rank": 20,
"ecr": "218"
},
"0000704415": {
"rank": 21,
"ecr": "217"
},
"0000792641": {
"rank": 22,
"ecr": "215"
},
"0000931059": {
"rank": 23,
"ecr": "212"
},
"0000929994": {
"rank": 24,
"ecr": "206"
},
"0000019411": {
"rank": 25,
"ecr": "203"
},
"0000019584": {
"rank": 26,
"ecr": "182"
},
"0001003130": {
"rank": 27,
"ecr": "181"
},
"0001316645": {
"rank": 28,
"ecr": "179"
},
"0001468328": {
"rank": 29,
"ecr": "178"
},
"0001159281": {
"rank": 30,
"ecr": "176"
},
"0001301611": {
"rank": 31,
"ecr": "164"
},
"0000882235": {
"rank": 32,
"ecr": "162"
},
"0000920148": {
"rank": 33,
"ecr": "161"
},
"0001383183": {
"rank": 34,
"ecr": "155"
},
"0000722723": {
"rank": 35,
"ecr": "152"
},
"0000948072": {
"rank": 36,
"ecr": "151"
},
"0000862692": {
"rank": 37,
"ecr": "151"
},
"0001101723": {
"rank": 38,
"ecr": "146"
},
"0001498021": {
"rank": 39,
"ecr": "146"
},
"0000896262": {
"rank": 40,
"ecr": "143"
},
"0000927066": {
"rank": 41,
"ecr": "142"
},
"0000320017": {
"rank": 42,
"ecr": "140"
},
"0000776325": {
"rank": 43,
"ecr": "139"
},
"0001035688": {
"rank": 44,
"ecr": "139"
},
"0001320414": {
"rank": 44,
"ecr": "139"
},
"0001014739": {
"rank": 46,
"ecr": "138"
},
"0000785161": {
"rank": 47,
"ecr": "136"
},
"0001360474": {
"rank": 48,
"ecr": "127"
},
"0000919956": {
"rank": 49,
"ecr": "124"
},
"0000895665": {
"rank": 50,
"ecr": "123"
},
"0001332349": {
"rank": 51,
"ecr": "122"
},
"0001300524": {
"rank": 52,
"ecr": "120"
},
"0001108109": {
"rank": 53,
"ecr": "118"
},
"0001520697": {
"rank": 54,
"ecr": "115"
},
"0000096793": {
"rank": 55,
"ecr": "113"
},
"0001001604": {
"rank": 56,
"ecr": "100"
},
"0001272597": {
"rank": 57,
"ecr": "91"
},
"0001383960": {
"rank": 58,
"ecr": "87"
},
"0001051488": {
"rank": 59,
"ecr": "87"
},
"0001503518": {
"rank": 60,
"ecr": "87"
},
"0001351051": {
"rank": 61,
"ecr": "87"
},
"0000817135": {
"rank": 62,
"ecr": "84"
},
"0000882289": {
"rank": 63,
"ecr": "82"
},
"0001289496": {
"rank": 64,
"ecr": "73"
},
"0001416876": {
"rank": 65,
"ecr": "68"
},
"0001449934": {
"rank": 66,
"ecr": "53"
},
"0000022872": {
"rank": 67,
"ecr": "51"
},
"0000941020": {
"rank": 68,
"ecr": "48"
},
"0001294157": {
"rank": 69,
"ecr": "46"
},
"0001507881": {
"rank": 70,
"ecr": "40"
},
"0001468679": {
"rank": 71,
"ecr": "40"
},
"0001136174": {
"rank": 72,
"ecr": "24"
}
},
"2012": {
"0001300524": {
"rank": 1,
"ecr": "307"
},
"0000895930": {
"rank": 2,
"ecr": "291"
},
"0000352915": {
"rank": 3,
"ecr": "269"
},
"0001022079": {
"rank": 4,
"ecr": "268"
},
"0001043000": {
"rank": 5,
"ecr": "265"
},
"0001091312": {
"rank": 6,
"ecr": "261"
},
"0000806517": {
"rank": 7,
"ecr": "256"
},
"0001294632": {
"rank": 8,
"ecr": "255"
},
"0000744825": {
"rank": 9,
"ecr": "255"
},
"0001138476": {
"rank": 10,
"ecr": "255"
},
"0000931059": {
"rank": 11,
"ecr": "254"
},
"0001522138": {
"rank": 12,
"ecr": "253"
},
"0001131324": {
"rank": 13,
"ecr": "250"
},
"0000731012": {
"rank": 14,
"ecr": "247"
},
"0000885978": {
"rank": 15,
"ecr": "246"
},
"0000704415": {
"rank": 16,
"ecr": "243"
},
"0000860730": {
"rank": 17,
"ecr": "234"
},
"0001060009": {
"rank": 18,
"ecr": "233"
},
"0001047335": {
"rank": 19,
"ecr": "230"
},
"0000792641": {
"rank": 20,
"ecr": "229"
},
"0000893949": {
"rank": 21,
"ecr": "227"
},
"0000019411": {
"rank": 22,
"ecr": "213"
},
"0001410471": {
"rank": 23,
"ecr": "208"
},
"0001367832": {
"rank": 24,
"ecr": "208"
},
"0001539778": {
"rank": 25,
"ecr": "207"
},
"0001124140": {
"rank": 26,
"ecr": "206"
},
"0001507881": {
"rank": 27,
"ecr": "205"
},
"0001468328": {
"rank": 28,
"ecr": "199"
},
"0001552845": {
"rank": 29,
"ecr": "196"
},
"0001316645": {
"rank": 30,
"ecr": "194"
},
"0000019584": {
"rank": 31,
"ecr": "183"
},
"0000896262": {
"rank": 32,
"ecr": "181"
},
"0001159281": {
"rank": 33,
"ecr": "180"
},
"0000890908": {
"rank": 34,
"ecr": "175"
},
"0000929994": {
"rank": 35,
"ecr": "171"
},
"0001003130": {
"rank": 36,
"ecr": "169"
},
"0001089815": {
"rank": 37,
"ecr": "162"
},
"0001301611": {
"rank": 38,
"ecr": "162"
},
"0001520697": {
"rank": 39,
"ecr": "160"
},
"0000920148": {
"rank": 40,
"ecr": "160"
},
"0000722723": {
"rank": 41,
"ecr": "157"
},
"0000316253": {
"rank": 42,
"ecr": "154"
},
"0000776325": {
"rank": 43,
"ecr": "142"
},
"0000895665": {
"rank": 44,
"ecr": "140"
},
"0001498021": {
"rank": 45,
"ecr": "138"
},
"0000948072": {
"rank": 46,
"ecr": "137"
},
"0001035688": {
"rank": 47,
"ecr": "135"
},
"0001320414": {
"rank": 47,
"ecr": "135"
},
"0000927066": {
"rank": 49,
"ecr": "134"
},
"0001360474": {
"rank": 50,
"ecr": "128"
},
"0001332349": {
"rank": 51,
"ecr": "119"
},
"0001101723": {
"rank": 52,
"ecr": "119"
},
"0000919956": {
"rank": 53,
"ecr": "116"
},
"0001351051": {
"rank": 54,
"ecr": "113"
},
"0001383960": {
"rank": 55,
"ecr": "96"
},
"0000790526": {
"rank": 56,
"ecr": "96"
},
"0001001604": {
"rank": 57,
"ecr": "93"
},
"0000885074": {
"rank": 58,
"ecr": "92"
},
"0001051488": {
"rank": 59,
"ecr": "87"
},
"0000817135": {
"rank": 60,
"ecr": "86"
},
"0000862692": {
"rank": 61,
"ecr": "85"
},
"0000882289": {
"rank": 62,
"ecr": "82"
},
"0001449934": {
"rank": 63,
"ecr": "77"
},
"0001550020": {
"rank": 64,
"ecr": "69"
},
"0001294157": {
"rank": 65,
"ecr": "53"
},
"0001383183": {
"rank": 66,
"ecr": "41"
},
"0000022872": {
"rank": 67,
"ecr": "29"
},
"0000941020": {
"rank": 68,
"ecr": "24"
},
"0001136174": {
"rank": 69,
"ecr": "20"
},
"0001272597": {
"rank": 70,
"ecr": "13"
},
"0001505497": {
"rank": 71,
"ecr": "5.5"
},
"0001468679": {
"rank": 72,
"ecr": "0.087"
}
},
"2013": {
"0001138476": {
"rank": 1,
"ecr": "324"
},
"0000895930": {
"rank": 2,
"ecr": "292"
},
"0001043000": {
"rank": 3,
"ecr": "269"
},
"0001022079": {
"rank": 4,
"ecr": "267"
},
"0000352915": {
"rank": 5,
"ecr": "263"
},
"0001539778": {
"rank": 6,
"ecr": "254"
},
"0000860730": {
"rank": 7,
"ecr": "241"
},
"0001124140": {
"rank": 8,
"ecr": "239"
},
"0001294632": {
"rank": 9,
"ecr": "238"
},
"0000731012": {
"rank": 10,
"ecr": "237"
},
"0000893949": {
"rank": 11,
"ecr": "235"
},
"0001131324": {
"rank": 12,
"ecr": "234"
},
"0001522138": {
"rank": 13,
"ecr": "231"
},
"0001488613": {
"rank": 14,
"ecr": "230"
},
"0001060009": {
"rank": 15,
"ecr": "229"
},
"0001047335": {
"rank": 16,
"ecr": "226"
},
"0001367832": {
"rank": 17,
"ecr": "225"
},
"0001303313": {
"rank": 18,
"ecr": "222"
},
"0001468328": {
"rank": 19,
"ecr": "219"
},
"0000885978": {
"rank": 20,
"ecr": "216"
},
"0001574774": {
"rank": 21,
"ecr": "215"
},
"0001349929": {
"rank": 22,
"ecr": "215"
},
"0001383183": {
"rank": 23,
"ecr": "209"
},
"0000019411": {
"rank": 24,
"ecr": "208"
},
"0000792641": {
"rank": 25,
"ecr": "207"
},
"0000890908": {
"rank": 26,
"ecr": "200"
},
"0000927066": {
"rank": 27,
"ecr": "196"
},
"0001003130": {
"rank": 28,
"ecr": "195"
},
"0001507881": {
"rank": 29,
"ecr": "194"
},
"0001316645": {
"rank": 30,
"ecr": "181"
},
"0001384101": {
"rank": 31,
"ecr": "181"
},
"0001552845": {
"rank": 32,
"ecr": "180"
},
"0000019584": {
"rank": 33,
"ecr": "177"
},
"0000931059": {
"rank": 34,
"ecr": "175"
},
"0001159281": {
"rank": 35,
"ecr": "173"
},
"0001089815": {
"rank": 36,
"ecr": "170"
},
"0001125376": {
"rank": 37,
"ecr": "166"
},
"0000722723": {
"rank": 38,
"ecr": "166"
},
"0000896262": {
"rank": 39,
"ecr": "158"
},
"0001301611": {
"rank": 40,
"ecr": "157"
},
"0000316253": {
"rank": 41,
"ecr": "153"
},
"0001520697": {
"rank": 42,
"ecr": "153"
},
"0000920148": {
"rank": 43,
"ecr": "152"
},
"0001498021": {
"rank": 44,
"ecr": "144"
},
"0001411574": {
"rank": 45,
"ecr": "132"
},
"0001449934": {
"rank": 46,
"ecr": "130"
},
"0000948072": {
"rank": 47,
"ecr": "125"
},
"0001101723": {
"rank": 48,
"ecr": "123"
},
"0001332349": {
"rank": 49,
"ecr": "120"
},
"0000862692": {
"rank": 50,
"ecr": "110"
},
"0001351051": {
"rank": 51,
"ecr": "107"
},
"0000885074": {
"rank": 52,
"ecr": "101"
},
"0000919956": {
"rank": 53,
"ecr": "97"
},
"0000948320": {
"rank": 54,
"ecr": "91"
},
"0001550020": {
"rank": 55,
"ecr": "89"
},
"0000790526": {
"rank": 56,
"ecr": "88"
},
"0001001604": {
"rank": 57,
"ecr": "88"
},
"0000895665": {
"rank": 58,
"ecr": "87"
},
"0001503518": {
"rank": 59,
"ecr": "87"
},
"0001383960": {
"rank": 60,
"ecr": "87"
},
"0000817135": {
"rank": 61,
"ecr": "85"
},
"0001272597": {
"rank": 62,
"ecr": "84"
},
"0001443863": {
"rank": 63,
"ecr": "83"
},
"0001416876": {
"rank": 64,
"ecr": "82"
},
"0001418115": {
"rank": 65,
"ecr": "38"
},
"0001294157": {
"rank": 66,
"ecr": "36"
},
"0000802257": {
"rank": 67,
"ecr": "34"
},
"0001136174": {
"rank": 68,
"ecr": "20"
},
"0001505497": {
"rank": 69,
"ecr": "9.5"
},
"0001468679": {
"rank": 70,
"ecr": "0.94"
}
},
"2014": {
"0001138476": {
"rank": 1,
"ecr": "317"
},
"0000895930": {
"rank": 2,
"ecr": "289"
},
"0000352915": {
"rank": 3,
"ecr": "261"
},
"0001043000": {
"rank": 4,
"ecr": "257"
},
"0001047335": {
"rank": 5,
"ecr": "250"
},
"0001294632": {
"rank": 6,
"ecr": "249"
},
"0001522138": {
"rank": 7,
"ecr": "249"
},
"0001022079": {
"rank": 8,
"ecr": "248"
},
"0000860730": {
"rank": 9,
"ecr": "247"
},
"0001060009": {
"rank": 10,
"ecr": "246"
},
"0001367832": {
"rank": 11,
"ecr": "233"
},
"0001124140": {
"rank": 12,
"ecr": "232"
},
"0000731012": {
"rank": 13,
"ecr": "225"
},
"0000885978": {
"rank": 14,
"ecr": "225"
},
"0000744825": {
"rank": 15,
"ecr": "222"
},
"0001468328": {
"rank": 16,
"ecr": "217"
},
"0001131324": {
"rank": 17,
"ecr": "217"
},
"0001606180": {
"rank": 18,
"ecr": "215"
},
"0000792641": {
"rank": 19,
"ecr": "211"
},
"0001303313": {
"rank": 20,
"ecr": "210"
},
"0001217234": {
"rank": 21,
"ecr": "205"
},
"0000893949": {
"rank": 22,
"ecr": "202"
},
"0001539778": {
"rank": 23,
"ecr": "197"
},
"0001488613": {
"rank": 24,
"ecr": "194"
},
"0000896262": {
"rank": 25,
"ecr": "188"
},
"0000806517": {
"rank": 26,
"ecr": "187"
},
"0000890908": {
"rank": 27,
"ecr": "185"
},
"0000019584": {
"rank": 28,
"ecr": "184"
},
"0000019411": {
"rank": 29,
"ecr": "180"
},
"0001125376": {
"rank": 30,
"ecr": "180"
},
"0001349929": {
"rank": 31,
"ecr": "179"
},
"0001507881": {
"rank": 32,
"ecr": "172"
},
"0000316253": {
"rank": 33,
"ecr": "167"
},
"0001574774": {
"rank": 34,
"ecr": "163"
},
"0001301611": {
"rank": 35,
"ecr": "156"
},
"0000920148": {
"rank": 36,
"ecr": "155"
},
"0001520697": {
"rank": 37,
"ecr": "151"
},
"0001384101": {
"rank": 38,
"ecr": "148"
},
"0001498021": {
"rank": 39,
"ecr": "146"
},
"0000927066": {
"rank": 40,
"ecr": "145"
},
"0001411574": {
"rank": 41,
"ecr": "145"
},
"0001602367": {
"rank": 42,
"ecr": "142"
},
"0001159281": {
"rank": 43,
"ecr": "139"
},
"0001089815": {
"rank": 44,
"ecr": "135"
},
"0001332349": {
"rank": 45,
"ecr": "128"
},
"0001101723": {
"rank": 46,
"ecr": "127"
},
"0001597892": {
"rank": 47,
"ecr": "122"
},
"0000931059": {
"rank": 48,
"ecr": "118"
},
"0001383183": {
"rank": 49,
"ecr": "118"
},
"0001351051": {
"rank": 50,
"ecr": "109"
},
"0000862692": {
"rank": 51,
"ecr": "109"
},
"0000948072": {
"rank": 52,
"ecr": "107"
},
"0000919956": {
"rank": 53,
"ecr": "105"
},
"0000885074": {
"rank": 54,
"ecr": "95"
},
"0000790526": {
"rank": 55,
"ecr": "89"
},
"0001370804": {
"rank": 56,
"ecr": "87"
},
"0001272597": {
"rank": 57,
"ecr": "87"
},
"0000817135": {
"rank": 58,
"ecr": "86"
},
"0000895665": {
"rank": 59,
"ecr": "86"
},
"0001503518": {
"rank": 60,
"ecr": "85"
},
"0001416876": {
"rank": 61,
"ecr": "82"
},
"0001443863": {
"rank": 62,
"ecr": "79"
},
"0001552845": {
"rank": 63,
"ecr": "58"
},
"0001044378": {
"rank": 64,
"ecr": "26"
},
"0001449934": {
"rank": 65,
"ecr": "21"
},
"0000948320": {
"rank": 66,
"ecr": "19"
},
"0001294157": {
"rank": 67,
"ecr": "15"
},
"0001505497": {
"rank": 68,
"ecr": "13"
},
"0000802257": {
"rank": 69,
"ecr": "8.4"
},
"0001468679": {
"rank": 70,
"ecr": "7.7"
}
},
"2015": {
"0001138476": {
"rank": 1,
"ecr": "321"
},
"0000895930": {
"rank": 2,
"ecr": "287"
},
"0001043000": {
"rank": 3,
"ecr": "274"
},
"0001638833": {
"rank": 4,
"ecr": "269"
},
"0000352915": {
"rank": 5,
"ecr": "269"
},
"0001022079": {
"rank": 6,
"ecr": "267"
},
"0001047335": {
"rank": 7,
"ecr": "255"
},
"0000860730": {
"rank": 8,
"ecr": "250"
},
"0001608638": {
"rank": 9,
"ecr": "248"
},
"0000731012": {
"rank": 10,
"ecr": "248"
},
"0001351051": {
"rank": 11,
"ecr": "245"
},
"0000744825": {
"rank": 12,
"ecr": "241"
},
"0001060009": {
"rank": 13,
"ecr": "241"
},
"0001477449": {
"rank": 14,
"ecr": "239"
},
"0001488613": {
"rank": 15,
"ecr": "226"
},
"0000885978": {
"rank": 16,
"ecr": "225"
},
"0001468328": {
"rank": 17,
"ecr": "223"
},
"0001124140": {
"rank": 18,
"ecr": "210"
},
"0001131324": {
"rank": 19,
"ecr": "208"
},
"0001303313": {
"rank": 20,
"ecr": "206"
},
"0001367832": {
"rank": 21,
"ecr": "205"
},
"0000019584": {
"rank": 22,
"ecr": "200"
},
"0000862692": {
"rank": 23,
"ecr": "200"
},
"0001574774": {
"rank": 24,
"ecr": "196"
},
"0000895665": {
"rank": 25,
"ecr": "194"
},
"0001501134": {
"rank": 26,
"ecr": "189"
},
"0000316253": {
"rank": 27,
"ecr": "189"
},
"0001125376": {
"rank": 28,
"ecr": "189"
},
"0000896262": {
"rank": 29,
"ecr": "187"
},
"0001451929": {
"rank": 30,
"ecr": "187"
},
"0001539778": {
"rank": 31,
"ecr": "186"
},
"0000096793": {
"rank": 32,
"ecr": "186"
},
"0000893949": {
"rank": 33,
"ecr": "182"
},
"0001604821": {
"rank": 34,
"ecr": "180"
},
"0001507881": {
"rank": 35,
"ecr": "179"
},
"0000806517": {
"rank": 36,
"ecr": "179"
},
"0000019411": {
"rank": 37,
"ecr": "173"
},
"0001349929": {
"rank": 38,
"ecr": "161"
},
"0001606180": {
"rank": 39,
"ecr": "159"
},
"0001384101": {
"rank": 40,
"ecr": "158"
},
"0001411574": {
"rank": 41,
"ecr": "157"
},
"0001301611": {
"rank": 42,
"ecr": "154"
},
"0001520697": {
"rank": 43,
"ecr": "152"
},
"0001217234": {
"rank": 44,
"ecr": "150"
},
"0000890908": {
"rank": 45,
"ecr": "147"
},
"0000920148": {
"rank": 46,
"ecr": "143"
},
"0001089815": {
"rank": 47,
"ecr": "142"
},
"0001498021": {
"rank": 48,
"ecr": "140"
},
"0000927066": {
"rank": 49,
"ecr": "139"
},
"0001590750": {
"rank": 50,
"ecr": "134"
},
"0001602367": {
"rank": 51,
"ecr": "134"
},
"0001597892": {
"rank": 52,
"ecr": "134"
},
"0001159281": {
"rank": 53,
"ecr": "134"
},
"0001383183": {
"rank": 54,
"ecr": "123"
},
"0001332349": {
"rank": 55,
"ecr": "120"
},
"0000948320": {
"rank": 56,
"ecr": "115"
},
"0000919956": {
"rank": 57,
"ecr": "103"
},
"0001272597": {
"rank": 58,
"ecr": "98"
},
"0000948072": {
"rank": 59,
"ecr": "95"
},
"0000790526": {
"rank": 60,
"ecr": "95"
},
"0001416876": {
"rank": 61,
"ecr": "93"
},
"0001658432": {
"rank": 62,
"ecr": "87"
},
"0000817135": {
"rank": 63,
"ecr": "87"
},
"0001503518": {
"rank": 64,
"ecr": "84"
},
"0001370804": {
"rank": 65,
"ecr": "81"
},
"0001293818": {
"rank": 66,
"ecr": "80"
},
"0001552845": {
"rank": 67,
"ecr": "79"
},
"0001316645": {
"rank": 68,
"ecr": "78"
},
"0000931059": {
"rank": 69,
"ecr": "62"
},
"0001044378": {
"rank": 70,
"ecr": "61"
},
"0001136174": {
"rank": 71,
"ecr": "18"
},
"0001468679": {
"rank": 72,
"ecr": "18"
},
"0001443863": {
"rank": 73,
"ecr": "12"
},
"0000811222": {
"rank": 74,
"ecr": "11"
},
"0001505497": {
"rank": 75,
"ecr": "7.6"
},
"0000802257": {
"rank": 76,
"ecr": "5.0"
}
},
"2016": {
"0001138476": {
"rank": 1,
"ecr": "284"
},
"0000316253": {
"rank": 2,
"ecr": "283"
},
"0001022079": {
"rank": 3,
"ecr": "274"
},
"0001638833": {
"rank": 4,
"ecr": "272"
},
"0001043000": {
"rank": 5,
"ecr": "272"
},
"0001674930": {
"rank": 6,
"ecr": "265"
},
"0000352915": {
"rank": 7,
"ecr": "264"
},
"0001047335": {
"rank": 8,
"ecr": "259"
},
"0001409916": {
"rank": 9,
"ecr": "255"
},
"0000731012": {
"rank": 10,
"ecr": "253"
},
"0000744825": {
"rank": 11,
"ecr": "252"
},
"0000860730": {
"rank": 12,
"ecr": "251"
},
"0001608638": {
"rank": 13,
"ecr": "247"
},
"0001477449": {
"rank": 14,
"ecr": "243"
},
"0001574774": {
"rank": 15,
"ecr": "236"
},
"0001131324": {
"rank": 16,
"ecr": "224"
},
"0000806517": {
"rank": 17,
"ecr": "218"
},
"0001539778": {
"rank": 18,
"ecr": "212"
},
"0001468328": {
"rank": 19,
"ecr": "211"
},
"0001303313": {
"rank": 20,
"ecr": "211"
},
"0001124140": {
"rank": 21,
"ecr": "206"
},
"0000019584": {
"rank": 22,
"ecr": "199"
},
"0000896262": {
"rank": 23,
"ecr": "198"
},
"0000885978": {
"rank": 24,
"ecr": "183"
},
"0000895665": {
"rank": 25,
"ecr": "181"
},
"0000893949": {
"rank": 26,
"ecr": "178"
},
"0001488613": {
"rank": 27,
"ecr": "177"
},
"0001383183": {
"rank": 28,
"ecr": "172"
},
"0001125376": {
"rank": 29,
"ecr": "166"
},
"0001411574": {
"rank": 30,
"ecr": "166"
},
"0000019411": {
"rank": 31,
"ecr": "163"
},
"0001384101": {
"rank": 32,
"ecr": "154"
},
"0001597892": {
"rank": 33,
"ecr": "154"
},
"0000920148": {
"rank": 34,
"ecr": "152"
},
"0001349929": {
"rank": 35,
"ecr": "151"
},
"0001089815": {
"rank": 36,
"ecr": "149"
},
"0001301611": {
"rank": 37,
"ecr": "148"
},
"0000927066": {
"rank": 38,
"ecr": "140"
},
"0001501134": {
"rank": 39,
"ecr": "136"
},
"0001159281": {
"rank": 40,
"ecr": "134"
},
"0001498068": {
"rank": 41,
"ecr": "131"
},
"0000096793": {
"rank": 42,
"ecr": "126"
},
"0001604821": {
"rank": 43,
"ecr": "123"
},
"0001289496": {
"rank": 44,
"ecr": "119"
},
"0001332349": {
"rank": 45,
"ecr": "118"
},
"0000790526": {
"rank": 46,
"ecr": "97"
},
"0000919956": {
"rank": 47,
"ecr": "97"
},
"0000948072": {
"rank": 48,
"ecr": "87"
},
"0001367832": {
"rank": 49,
"ecr": "87"
},
"0001217234": {
"rank": 50,
"ecr": "87"
},
"0001658432": {
"rank": 51,
"ecr": "81"
},
"0001370804": {
"rank": 52,
"ecr": "76"
},
"0000862692": {
"rank": 53,
"ecr": "75"
},
"0000741815": {
"rank": 54,
"ecr": "74"
},
"0001552845": {
"rank": 55,
"ecr": "64"
},
"0000811222": {
"rank": 56,
"ecr": "58"
},
"0001293818": {
"rank": 57,
"ecr": "39"
},
"0000792935": {
"rank": 58,
"ecr": "28"
},
"0001044378": {
"rank": 59,
"ecr": "26"
},
"0001590750": {
"rank": 60,
"ecr": "14"
},
"0001468679": {
"rank": 61,
"ecr": "12"
},
"0001136174": {
"rank": 62,
"ecr": "7.2"
},
"0000931059": {
"rank": 63,
"ecr": "3.7"
},
"0001505497": {
"rank": 64,
"ecr": "3.7"
},
"0001443863": {
"rank": 65,
"ecr": "3.7"
},
"0001550020": {
"rank": 66,
"ecr": "0.91"
}
},
"2017": {
"0001138476": {
"rank": 1,
"ecr": "293"
},
"0001674930": {
"rank": 2,
"ecr": "276"
},
"0001022079": {
"rank": 3,
"ecr": "274"
},
"0000320017": {
"rank": 4,
"ecr": "274"
},
"0001043000": {
"rank": 5,
"ecr": "269"
},
"0001603454": {
"rank": 6,
"ecr": "267"
},
"0001477449": {
"rank": 7,
"ecr": "266"
},
"0000096793": {
"rank": 8,
"ecr": "261"
},
"0000352915": {
"rank": 9,
"ecr": "250"
},
"0000860730": {
"rank": 10,
"ecr": "250"
},
"0001608638": {
"rank": 11,
"ecr": "248"
},
"0001131324": {
"rank": 12,
"ecr": "239"
},
"0000316253": {
"rank": 13,
"ecr": "238"
},
"0000806517": {
"rank": 14,
"ecr": "232"
},
"0001124140": {
"rank": 15,
"ecr": "231"
},
"0000731012": {
"rank": 16,
"ecr": "229"
},
"0001409916": {
"rank": 17,
"ecr": "228"
},
"0000885978": {
"rank": 18,
"ecr": "224"
},
"0001303313": {
"rank": 19,
"ecr": "206"
},
"0001468328": {
"rank": 20,
"ecr": "204"
},
"0000896262": {
"rank": 21,
"ecr": "198"
},
"0000019584": {
"rank": 22,
"ecr": "195"
},
"0000893949": {
"rank": 23,
"ecr": "178"
},
"0001597892": {
"rank": 24,
"ecr": "164"
},
"0001125376": {
"rank": 25,
"ecr": "164"
},
"0001089815": {
"rank": 26,
"ecr": "163"
},
"0001590750": {
"rank": 27,
"ecr": "163"
},
"0000920148": {
"rank": 28,
"ecr": "162"
},
"0001574774": {
"rank": 29,
"ecr": "161"
},
"0000019411": {
"rank": 30,
"ecr": "160"
},
"0001520697": {
"rank": 31,
"ecr": "157"
},
"0001301611": {
"rank": 32,
"ecr": "150"
},
"0000927066": {
"rank": 33,
"ecr": "140"
},
"0001606180": {
"rank": 34,
"ecr": "131"
},
"0001159281": {
"rank": 35,
"ecr": "131"
},
"0001349929": {
"rank": 36,
"ecr": "130"
},
"0001498068": {
"rank": 37,
"ecr": "129"
},
"0001384101": {
"rank": 38,
"ecr": "123"
},
"0001501134": {
"rank": 39,
"ecr": "121"
},
"0001332349": {
"rank": 40,
"ecr": "110"
},
"0000790526": {
"rank": 41,
"ecr": "99"
},
"0000919956": {
"rank": 42,
"ecr": "91"
},
"0001289496": {
"rank": 43,
"ecr": "87"
},
"0001488613": {
"rank": 44,
"ecr": "87"
},
"0000948072": {
"rank": 45,
"ecr": "86"
},
"0000862692": {
"rank": 46,
"ecr": "83"
},
"0000741815": {
"rank": 47,
"ecr": "81"
},
"0000895665": {
"rank": 48,
"ecr": "81"
},
"0001217234": {
"rank": 49,
"ecr": "78"
},
"0001604821": {
"rank": 50,
"ecr": "76"
},
"0001370804": {
"rank": 51,
"ecr": "53"
},
"0000885074": {
"rank": 52,
"ecr": "51"
},
"0001451929": {
"rank": 53,
"ecr": "47"
},
"0001552845": {
"rank": 54,
"ecr": "46"
},
"0001468679": {
"rank": 55,
"ecr": "45"
},
"0001136174": {
"rank": 56,
"ecr": "38"
},
"0001293818": {
"rank": 57,
"ecr": "30"
},
"0001044378": {
"rank": 58,
"ecr": "15"
},
"0001550020": {
"rank": 59,
"ecr": "12"
},
"0000811222": {
"rank": 60,
"ecr": "9.2"
},
"0001505497": {
"rank": 61,
"ecr": "4.8"
},
"0001680139": {
"rank": 62,
"ecr": "4.4"
}
},
"2018": {
"0001138476": {
"rank": 1,
"ecr": "308"
},
"0001713210": {
"rank": 2,
"ecr": "298"
},
"0001651944": {
"rank": 3,
"ecr": "291"
},
"0001477449": {
"rank": 4,
"ecr": "276"
},
"0001674930": {
"rank": 5,
"ecr": "268"
},
"0000704415": {
"rank": 6,
"ecr": "268"
},
"0001043000": {
"rank": 7,
"ecr": "267"
},
"0001638833": {
"rank": 8,
"ecr": "267"
},
"0000352915": {
"rank": 9,
"ecr": "264"
},
"0001022079": {
"rank": 10,
"ecr": "261"
},
"0001603454": {
"rank": 11,
"ecr": "251"
},
"0001608638": {
"rank": 12,
"ecr": "249"
},
"0001131324": {
"rank": 13,
"ecr": "248"
},
"0000860730": {
"rank": 14,
"ecr": "247"
},
"0000885978": {
"rank": 15,
"ecr": "244"
},
"0001576280": {
"rank": 16,
"ecr": "244"
},
"0001289496": {
"rank": 17,
"ecr": "242"
},
"0000731012": {
"rank": 18,
"ecr": "237"
},
"0000806517": {
"rank": 19,
"ecr": "235"
},
"0001468328": {
"rank": 20,
"ecr": "232"
},
"0001303313": {
"rank": 21,
"ecr": "224"
},
"0001351051": {
"rank": 22,
"ecr": "224"
},
"0000316253": {
"rank": 23,
"ecr": "222"
},
"0000896262": {
"rank": 24,
"ecr": "219"
},
"0001047335": {
"rank": 25,
"ecr": "209"
},
"0000019584": {
"rank": 26,
"ecr": "209"
},
"0000320017": {
"rank": 27,
"ecr": "203"
},
"0000096793": {
"rank": 28,
"ecr": "202"
},
"0001461119": {
"rank": 29,
"ecr": "199"
},
"0001384101": {
"rank": 30,
"ecr": "181"
},
"0001125376": {
"rank": 31,
"ecr": "178"
},
"0001217234": {
"rank": 32,
"ecr": "177"
},
"0000893949": {
"rank": 33,
"ecr": "177"
},
"0001590750": {
"rank": 34,
"ecr": "173"
},
"0000920148": {
"rank": 35,
"ecr": "161"
},
"0001089815": {
"rank": 36,
"ecr": "159"
},
"0000019411": {
"rank": 37,
"ecr": "157"
},
"0001597892": {
"rank": 38,
"ecr": "156"
},
"0001124140": {
"rank": 39,
"ecr": "148"
},
"0001520697": {
"rank": 40,
"ecr": "144"
},
"0001501134": {
"rank": 41,
"ecr": "135"
},
"0000927066": {
"rank": 42,
"ecr": "129"
},
"0000895665": {
"rank": 43,
"ecr": "124"
},
"0001498068": {
"rank": 44,
"ecr": "122"
},
"0001451929": {
"rank": 45,
"ecr": "104"
},
"0000070318": {
"rank": 46,
"ecr": "103"
},
"0001332349": {
"rank": 47,
"ecr": "103"
},
"0001159281": {
"rank": 48,
"ecr": "95"
},
"0001606180": {
"rank": 49,
"ecr": "87"
},
"0000722723": {
"rank": 50,
"ecr": "87"
},
"0001719435": {
"rank": 51,
"ecr": "87"
},
"0000919956": {
"rank": 52,
"ecr": "87"
},
"0000948320": {
"rank": 53,
"ecr": "87"
},
"0001108109": {
"rank": 54,
"ecr": "87"
},
"0001014739": {
"rank": 55,
"ecr": "87"
},
"0000862692": {
"rank": 56,
"ecr": "86"
},
"0001604821": {
"rank": 57,
"ecr": "86"
},
"0001349929": {
"rank": 58,
"ecr": "86"
},
"0000885074": {
"rank": 59,
"ecr": "79"
},
"0001293818": {
"rank": 60,
"ecr": "66"
},
"0001468679": {
"rank": 61,
"ecr": "53"
},
"0000811222": {
"rank": 62,
"ecr": "29"
},
"0001136174": {
"rank": 63,
"ecr": "23"
},
"0001044378": {
"rank": 64,
"ecr": "17"
},
"0001552845": {
"rank": 65,
"ecr": "13"
},
"0001550020": {
"rank": 66,
"ecr": "2.7"
},
"0001443863": {
"rank": 67,
"ecr": "2.0"
},
"0001505497": {
"rank": 68,
"ecr": "1.2"
},
"0001680139": {
"rank": 69,
"ecr": "0.25"
}
},
"2019": {
"0001289496": {
"rank": 1,
"ecr": "282"
},
"0001674930": {
"rank": 2,
"ecr": "276"
},
"0001477449": {
"rank": 3,
"ecr": "272"
},
"0000096793": {
"rank": 4,
"ecr": "270"
},
"0001638833": {
"rank": 5,
"ecr": "269"
},
"0000352915": {
"rank": 6,
"ecr": "262"
},
"0001043000": {
"rank": 7,
"ecr": "260"
},
"0001022079": {
"rank": 8,
"ecr": "255"
},
"0000860730": {
"rank": 9,
"ecr": "250"
},
"0000744825": {
"rank": 10,
"ecr": "250"
},
"0001384101": {
"rank": 11,
"ecr": "249"
},
"0001576280": {
"rank": 12,
"ecr": "248"
},
"0000704415": {
"rank": 13,
"ecr": "244"
},
"0000731012": {
"rank": 14,
"ecr": "243"
},
"0000316253": {
"rank": 15,
"ecr": "239"
},
"0001603454": {
"rank": 16,
"ecr": "234"
},
"0001351051": {
"rank": 17,
"ecr": "226"
},
"0001468328": {
"rank": 18,
"ecr": "224"
},
"0001551306": {
"rank": 19,
"ecr": "217"
},
"0001303313": {
"rank": 20,
"ecr": "217"
},
"0001447362": {
"rank": 21,
"ecr": "216"
},
"0000885978": {
"rank": 22,
"ecr": "214"
},
"0000019584": {
"rank": 23,
"ecr": "199"
},
"0001089815": {
"rank": 24,
"ecr": "197"
},
"0001124140": {
"rank": 25,
"ecr": "196"
},
"0000806517": {
"rank": 26,
"ecr": "194"
},
"0001047335": {
"rank": 27,
"ecr": "194"
},
"0001461119": {
"rank": 28,
"ecr": "194"
},
"0001527753": {
"rank": 29,
"ecr": "188"
},
"0001729149": {
"rank": 30,
"ecr": "184"
},
"0001217234": {
"rank": 31,
"ecr": "183"
},
"0001274737": {
"rank": 32,
"ecr": "180"
},
"0000896262": {
"rank": 33,
"ecr": "180"
},
"0001574774": {
"rank": 34,
"ecr": "179"
},
"0000019411": {
"rank": 35,
"ecr": "162"
},
"0001597892": {
"rank": 36,
"ecr": "160"
},
"0000920148": {
"rank": 37,
"ecr": "159"
},
"0001404123": {
"rank": 38,
"ecr": "159"
},
"0001520697": {
"rank": 39,
"ecr": "148"
},
"0001604821": {
"rank": 40,
"ecr": "144"
},
"0000320017": {
"rank": 41,
"ecr": "143"
},
"0001014739": {
"rank": 42,
"ecr": "139"
},
"0001159281": {
"rank": 43,
"ecr": "136"
},
"0001501134": {
"rank": 44,
"ecr": "135"
},
"0001320414": {
"rank": 45,
"ecr": "130"
},
"0000927066": {
"rank": 46,
"ecr": "123"
},
"0001349929": {
"rank": 47,
"ecr": "121"
},
"0001498068": {
"rank": 48,
"ecr": "115"
},
"0001729944": {
"rank": 49,
"ecr": "114"
},
"0001766400": {
"rank": 50,
"ecr": "112"
},
"0000070318": {
"rank": 51,
"ecr": "101"
},
"0001332349": {
"rank": 52,
"ecr": "98"
},
"0000722723": {
"rank": 53,
"ecr": "91"
},
"0001725255": {
"rank": 54,
"ecr": "87"
},
"0001651944": {
"rank": 55,
"ecr": "87"
},
"0000862692": {
"rank": 56,
"ecr": "87"
},
"0001108109": {
"rank": 57,
"ecr": "87"
},
"0000919956": {
"rank": 58,
"ecr": "87"
},
"0001044378": {
"rank": 59,
"ecr": "78"
},
"0001293818": {
"rank": 60,
"ecr": "78"
},
"0001590750": {
"rank": 61,
"ecr": "75"
},
"0001780097": {
"rank": 62,
"ecr": "74"
},
"0000948320": {
"rank": 63,
"ecr": "62"
},
"0001468679": {
"rank": 64,
"ecr": "55"
},
"0001136174": {
"rank": 65,
"ecr": "48"
},
"0001300524": {
"rank": 66,
"ecr": "46"
},
"0001680139": {
"rank": 67,
"ecr": "26"
},
"0000792935": {
"rank": 68,
"ecr": "8.8"
},
"0000895665": {
"rank": 69,
"ecr": "2.8"
}
},
"2020": {
"0001477449": {
"rank": 1,
"ecr": "293"
},
"0001447362": {
"rank": 2,
"ecr": "278"
},
"0001089815": {
"rank": 3,
"ecr": "276"
},
"0001674930": {
"rank": 4,
"ecr": "274"
},
"0001022079": {
"rank": 5,
"ecr": "269"
},
"0001138476": {
"rank": 6,
"ecr": "266"
},
"0001384101": {
"rank": 7,
"ecr": "262"
},
"0001638833": {
"rank": 8,
"ecr": "260"
},
"0001799191": {
"rank": 9,
"ecr": "256"
},
"0001713210": {
"rank": 10,
"ecr": "248"
},
"0000860730": {
"rank": 11,
"ecr": "247"
},
"0000731012": {
"rank": 12,
"ecr": "246"
},
"0000352915": {
"rank": 13,
"ecr": "246"
},
"0001729149": {
"rank": 14,
"ecr": "244"
},
"0000320017": {
"rank": 15,
"ecr": "234"
},
"0000096793": {
"rank": 16,
"ecr": "233"
},
"0001551306": {
"rank": 17,
"ecr": "217"
},
"0001217234": {
"rank": 18,
"ecr": "217"
},
"0000885978": {
"rank": 19,
"ecr": "215"
},
"0000019584": {
"rank": 20,
"ecr": "215"
},
"0001527753": {
"rank": 21,
"ecr": "214"
},
"0001737523": {
"rank": 22,
"ecr": "212"
},
"0001303313": {
"rank": 23,
"ecr": "205"
},
"0001651944": {
"rank": 24,
"ecr": "204"
},
"0000704415": {
"rank": 25,
"ecr": "204"
},
"0000744825": {
"rank": 26,
"ecr": "194"
},
"0000019411": {
"rank": 27,
"ecr": "192"
},
"0001047335": {
"rank": 28,
"ecr": "188"
},
"0001468328": {
"rank": 29,
"ecr": "188"
},
"0000896262": {
"rank": 30,
"ecr": "183"
},
"0001576280": {
"rank": 31,
"ecr": "176"
},
"0001597892": {
"rank": 32,
"ecr": "173"
},
"0001461119": {
"rank": 33,
"ecr": "167"
},
"0001501134": {
"rank": 34,
"ecr": "166"
},
"0001124140": {
"rank": 35,
"ecr": "166"
},
"0001590750": {
"rank": 36,
"ecr": "163"
},
"0001404123": {
"rank": 37,
"ecr": "163"
},
"0001159281": {
"rank": 38,
"ecr": "161"
},
"0000806517": {
"rank": 39,
"ecr": "157"
},
"0001274737": {
"rank": 40,
"ecr": "154"
},
"0001604821": {
"rank": 41,
"ecr": "149"
},
"0001014739": {
"rank": 42,
"ecr": "148"
},
"0000316253": {
"rank": 43,
"ecr": "146"
},
"0001125376": {
"rank": 44,
"ecr": "144"
},
"0000785161": {
"rank": 45,
"ecr": "140"
},
"0000895665": {
"rank": 46,
"ecr": "139"
},
"0001136174": {
"rank": 47,
"ecr": "139"
},
"0001791091": {
"rank": 48,
"ecr": "135"
},
"0001044378": {
"rank": 49,
"ecr": "130"
},
"0001520697": {
"rank": 50,
"ecr": "125"
},
"0001320414": {
"rank": 51,
"ecr": "124"
},
"0001729944": {
"rank": 52,
"ecr": "122"
},
"0001766400": {
"rank": 53,
"ecr": "121"
},
"0001043000": {
"rank": 54,
"ecr": "119"
},
"0000927066": {
"rank": 55,
"ecr": "118"
},
"0001725255": {
"rank": 56,
"ecr": "117"
},
"0001439725": {
"rank": 57,
"ecr": "114"
},
"0000070318": {
"rank": 58,
"ecr": "106"
},
"0001332349": {
"rank": 59,
"ecr": "106"
},
"0001293818": {
"rank": 60,
"ecr": "105"
},
"0000722723": {
"rank": 61,
"ecr": "99"
},
"0000893949": {
"rank": 62,
"ecr": "97"
},
"0001351051": {
"rank": 63,
"ecr": "94"
},
"0001719435": {
"rank": 64,
"ecr": "88"
},
"0000862692": {
"rank": 65,
"ecr": "87"
},
"0001108109": {
"rank": 66,
"ecr": "87"
},
"0000919956": {
"rank": 67,
"ecr": "87"
},
"0001349929": {
"rank": 68,
"ecr": "85"
},
"0001468679": {
"rank": 69,
"ecr": "69"
},
"0001780097": {
"rank": 70,
"ecr": "62"
},
"0000792935": {
"rank": 71,
"ecr": "51"
},
"0001443863": {
"rank": 72,
"ecr": "25"
},
"0001505497": {
"rank": 73,
"ecr": "21"
},
"0000802257": {
"rank": 74,
"ecr": "11"
},
"0000948320": {
"rank": 75,
"ecr": "1.1"
},
"0001652958": {
"rank": 76,
"ecr": "0.028"
}
},
"2021": {
"0001674930": {
"rank": 1,
"ecr": "327"
},
"0001138476": {
"rank": 2,
"ecr": "299"
},
"0001477449": {
"rank": 3,
"ecr": "293"
},
"0000096793": {
"rank": 4,
"ecr": "283"
},
"0001022079": {
"rank": 5,
"ecr": "274"
},
"0000704415": {
"rank": 6,
"ecr": "273"
},
"0001638833": {
"rank": 7,
"ecr": "268"
},
"0001384101": {
"rank": 8,
"ecr": "264"
},
"0000352915": {
"rank": 9,
"ecr": "257"
},
"0000744825": {
"rank": 10,
"ecr": "256"
},
"0000860730": {
"rank": 11,
"ecr": "253"
},
"0001447362": {
"rank": 12,
"ecr": "252"
},
"0001534969": {
"rank": 13,
"ecr": "247"
},
"0001729149": {
"rank": 14,
"ecr": "244"
},
"0000320017": {
"rank": 15,
"ecr": "243"
},
"0001418115": {
"rank": 16,
"ecr": "243"
},
"0001089815": {
"rank": 17,
"ecr": "241"
},
"0001217234": {
"rank": 18,
"ecr": "233"
},
"0001651944": {
"rank": 19,
"ecr": "232"
},
"0001551306": {
"rank": 20,
"ecr": "228"
},
"0000731012": {
"rank": 21,
"ecr": "228"
},
"0001816233": {
"rank": 22,
"ecr": "227"
},
"0001737523": {
"rank": 23,
"ecr": "226"
},
"0001822359": {
"rank": 24,
"ecr": "225"
},
"0001590750": {
"rank": 25,
"ecr": "221"
},
"0001803901": {
"rank": 26,
"ecr": "218"
},
"0001527753": {
"rank": 27,
"ecr": "211"
},
"0001828182": {
"rank": 28,
"ecr": "210"
},
"0001047335": {
"rank": 29,
"ecr": "207"
},
"0001773751": {
"rank": 30,
"ecr": "204"
},
"0001787640": {
"rank": 31,
"ecr": "196"
},
"0000885978": {
"rank": 32,
"ecr": "196"
},
"0001603454": {
"rank": 33,
"ecr": "195"
},
"0001834376": {
"rank": 34,
"ecr": "194"
},
"0001468328": {
"rank": 35,
"ecr": "193"
},
"0001404123": {
"rank": 36,
"ecr": "190"
},
"0001303313": {
"rank": 37,
"ecr": "188"
},
"0001520697": {
"rank": 38,
"ecr": "187"
},
"0001044378": {
"rank": 39,
"ecr": "187"
},
"0001274737": {
"rank": 40,
"ecr": "184"
},
"0000896262": {
"rank": 41,
"ecr": "184"
},
"0001501134": {
"rank": 42,
"ecr": "181"
},
"0000019584": {
"rank": 43,
"ecr": "181"
},
"0000920148": {
"rank": 44,
"ecr": "180"
},
"0001831097": {
"rank": 45,
"ecr": "180"
},
"0000806517": {
"rank": 46,
"ecr": "178"
},
"0001791091": {
"rank": 47,
"ecr": "171"
},
"0001759655": {
"rank": 48,
"ecr": "171"
},
"0001799191": {
"rank": 49,
"ecr": "166"
},
"0001844392": {
"rank": 50,
"ecr": "166"
},
"0001818331": {
"rank": 51,
"ecr": "163"
},
"0001124140": {
"rank": 52,
"ecr": "161"
},
"0001729944": {
"rank": 53,
"ecr": "160"
},
"0001014739": {
"rank": 54,
"ecr": "160"
},
"0001870940": {
"rank": 55,
"ecr": "159"
},
"0001159281": {
"rank": 56,
"ecr": "158"
},
"0001725255": {
"rank": 57,
"ecr": "153"
},
"0001125376": {
"rank": 58,
"ecr": "150"
},
"0001713210": {
"rank": 59,
"ecr": "150"
},
"0000785161": {
"rank": 60,
"ecr": "148"
},
"0000893949": {
"rank": 61,
"ecr": "143"
},
"0001800682": {
"rank": 62,
"ecr": "141"
},
"0001604821": {
"rank": 63,
"ecr": "134"
},
"0001293818": {
"rank": 64,
"ecr": "129"
},
"0001835567": {
"rank": 65,
"ecr": "128"
},
"0001136174": {
"rank": 66,
"ecr": "125"
},
"0001822479": {
"rank": 67,
"ecr": "124"
},
"0001320414": {
"rank": 68,
"ecr": "121"
},
"0001832415": {
"rank": 69,
"ecr": "121"
},
"0001766400": {
"rank": 70,
"ecr": "121"
},
"0001770141": {
"rank": 71,
"ecr": "120"
},
"0000070318": {
"rank": 72,
"ecr": "116"
},
"0001576280": {
"rank": 73,
"ecr": "114"
},
"0000927066": {
"rank": 74,
"ecr": "113"
},
"0001776197": {
"rank": 75,
"ecr": "110"
},
"0000722723": {
"rank": 76,
"ecr": "109"
},
"0001349929": {
"rank": 77,
"ecr": "107"
},
"0001735803": {
"rank": 78,
"ecr": "103"
},
"0001043000": {
"rank": 79,
"ecr": "103"
},
"0001332349": {
"rank": 80,
"ecr": "102"
},
"0000862692": {
"rank": 81,
"ecr": "101"
},
"0001680139": {
"rank": 82,
"ecr": "88"
},
"0001780097": {
"rank": 83,
"ecr": "87"
},
"0001815849": {
"rank": 84,
"ecr": "87"
},
"0001108109": {
"rank": 85,
"ecr": "87"
},
"0001439725": {
"rank": 86,
"ecr": "87"
},
"0000802257": {
"rank": 87,
"ecr": "81"
},
"0000948320": {
"rank": 88,
"ecr": "80"
},
"0000895665": {
"rank": 89,
"ecr": "75"
},
"0001505497": {
"rank": 90,
"ecr": "68"
},
"0000792935": {
"rank": 91,
"ecr": "60"
},
"0001468679": {
"rank": 92,
"ecr": "18"
},
"0001652958": {
"rank": 93,
"ecr": "14"
},
"0001443863": {
"rank": 94,
"ecr": "6.3"
},
"0001300524": {
"rank": 95,
"ecr": "0.56"
}
}
},
"rating_box": [
[
"Top rated",
"23 of 95"
],
[
"Best, worst rating",
"327 %, 0.562 %"
],
[
"New companies",
"26"
]
],
"regression_plot": "https://www.realrate-archive.com/us_health_services/2021/backtesting_correlation/regression_2021.svg",
"scentences": [
"Tivity Health INC climbed 19 positions from 25 to 6 due to its excellent Liabilities.",
"Agape ATP Corp lost 49 positions from 10 to 59 due to its bad Comprehensive Net Income.",
"SERA Prognostics INC entered the 2022 ranking at rank 13, making it the best newcomer."
],
"url_segment": "2022-us-health-services",
"year": 2022,
"feature_importance": "https://www.realrate-archive.com/us_health_services/2021/feature_importance/feature_importance.svg",
"obs_ecr": {
"0000920148": {
"2011": {
"obs_EconomicCapitalRatio": 1.663923414286983
},
"2012": {
"obs_EconomicCapitalRatio": 1.4407170672094647
},
"2013": {
"obs_EconomicCapitalRatio": 1.323792718489346
},
"2014": {
"obs_EconomicCapitalRatio": 1.470242712096841
},
"2015": {
"obs_EconomicCapitalRatio": 1.0214010482206495
},
"2016": {
"obs_EconomicCapitalRatio": 1.0954224043543792
},
"2017": {
"obs_EconomicCapitalRatio": 1.1879221981344004
},
"2018": {
"obs_EconomicCapitalRatio": 0.9477895219666614
},
"2019": {
"obs_EconomicCapitalRatio": 1.0949627880974482
},
"2021": {
"obs_EconomicCapitalRatio": 1.8399468745460335
},
"2022": {
"obs_EconomicCapitalRatio": 1.3068086669177197
},
"2023": {
"obs_EconomicCapitalRatio": 1.4492522183616858
},
"2024": {
"obs_EconomicCapitalRatio": 1.3176610991160915
},
"2025": {
"obs_EconomicCapitalRatio": 1.487123295160136
}
},
"0001022079": {
"2011": {
"obs_EconomicCapitalRatio": 1.267911138352765
},
"2012": {
"obs_EconomicCapitalRatio": 1.3862017229025643
},
"2013": {
"obs_EconomicCapitalRatio": 1.2031665213960887
},
"2014": {
"obs_EconomicCapitalRatio": 1.3396669994127473
},
"2015": {
"obs_EconomicCapitalRatio": 1.4903768348790714
},
"2016": {
"obs_EconomicCapitalRatio": 1.9095314518428617
},
"2017": {
"obs_EconomicCapitalRatio": 1.9713217210734026
},
"2018": {
"obs_EconomicCapitalRatio": 1.542844211769263
},
"2019": {
"obs_EconomicCapitalRatio": 1.7072037694942166
},
"2020": {
"obs_EconomicCapitalRatio": 1.8434784506594455
},
"2021": {
"obs_EconomicCapitalRatio": 2.4801222638557205
},
"2022": {
"obs_EconomicCapitalRatio": 2.303864240107965
},
"2023": {
"obs_EconomicCapitalRatio": 1.846925205369018
},
"2024": {
"obs_EconomicCapitalRatio": 1.810747224018149
},
"2025": {
"obs_EconomicCapitalRatio": 2.0966621477837926
}
},
"0001014739": {
"2011": {
"obs_EconomicCapitalRatio": 0.5455058467503717
},
"2018": {
"obs_EconomicCapitalRatio": 0.754424645512964
},
"2019": {
"obs_EconomicCapitalRatio": 1.1945159127889264
},
"2020": {
"obs_EconomicCapitalRatio": 1.3372488526870943
},
"2021": {
"obs_EconomicCapitalRatio": 2.287045484201052
},
"2022": {
"obs_EconomicCapitalRatio": 2.2629706450273175
},
"2023": {
"obs_EconomicCapitalRatio": 2.369798550093667
},
"2024": {
"obs_EconomicCapitalRatio": 1.431722453146353
},
"2025": {
"obs_EconomicCapitalRatio": 1.840512605157507
}
},
"0000927066": {
"2011": {
"obs_EconomicCapitalRatio": 0.9398495018958859
},
"2012": {
"obs_EconomicCapitalRatio": 0.7666044539176664
},
"2013": {
"obs_EconomicCapitalRatio": 0.9312599987060045
},
"2014": {
"obs_EconomicCapitalRatio": 1.0994201795059793
},
"2015": {
"obs_EconomicCapitalRatio": 0.9688014559679293
},
"2016": {
"obs_EconomicCapitalRatio": 0.8477409793726618
},
"2017": {
"obs_EconomicCapitalRatio": 0.824189439126132
},
"2018": {
"obs_EconomicCapitalRatio": 0.5103927085716712
},
"2019": {
"obs_EconomicCapitalRatio": 0.6180542558126978
},
"2020": {
"obs_EconomicCapitalRatio": 0.8322454933184945
},
"2021": {
"obs_EconomicCapitalRatio": 0.7116567354875124
},
"2022": {
"obs_EconomicCapitalRatio": 0.41763359468294975
},
"2023": {
"obs_EconomicCapitalRatio": 0.6154642053257157
},
"2024": {
"obs_EconomicCapitalRatio": 0.7615486641660242
},
"2025": {
"obs_EconomicCapitalRatio": 0.4785719594527293
}
},
"0000731012": {
"2011": {
"obs_EconomicCapitalRatio": 5.269267575857689
},
"2012": {
"obs_EconomicCapitalRatio": 5.962718744523781
},
"2013": {
"obs_EconomicCapitalRatio": 5.857390336910617
},
"2014": {
"obs_EconomicCapitalRatio": 6.010654031230302
},
"2015": {
"obs_EconomicCapitalRatio": 7.220294551700417
},
"2016": {
"obs_EconomicCapitalRatio": 7.592293402247349
},
"2017": {
"obs_EconomicCapitalRatio": 7.648779377528277
},
"2018": {
"obs_EconomicCapitalRatio": 5.948743829553438
},
"2019": {
"obs_EconomicCapitalRatio": 3.6760348928352986
},
"2020": {
"obs_EconomicCapitalRatio": 3.9099437641971453
},
"2021": {
"obs_EconomicCapitalRatio": 2.5108136581327076
},
"2022": {
"obs_EconomicCapitalRatio": 2.0121273406342404
},
"2023": {
"obs_EconomicCapitalRatio": 1.503981335283937
},
"2024": {
"obs_EconomicCapitalRatio": 1.6965676535663106
},
"2025": {
"obs_EconomicCapitalRatio": 2.8638609322827606
}
},
"0001332349": {
"2011": {
"obs_EconomicCapitalRatio": 0.5097293760371813
},
"2012": {
"obs_EconomicCapitalRatio": 0.7321295047182582
},
"2013": {
"obs_EconomicCapitalRatio": 0.7994065409175654
},
"2014": {
"obs_EconomicCapitalRatio": 0.7310943113449674
},
"2015": {
"obs_EconomicCapitalRatio": 0.3861457207385632
},
"2016": {
"obs_EconomicCapitalRatio": 0.29096091336542823
},
"2017": {
"obs_EconomicCapitalRatio": 0.26366034864469273
},
"2018": {
"obs_EconomicCapitalRatio": 0.21789711902103157
},
"2019": {
"obs_EconomicCapitalRatio": 0.1903375612099341
},
"2020": {
"obs_EconomicCapitalRatio": 0.12286042900676535
},
"2021": {
"obs_EconomicCapitalRatio": 0.15643986114831185
},
"2022": {
"obs_EconomicCapitalRatio": 0.09034196093382922
},
"2023": {
"obs_EconomicCapitalRatio": 0.20082534077007566
},
"2024": {
"obs_EconomicCapitalRatio": 0.16215618529739215
},
"2025": {
"obs_EconomicCapitalRatio": 0.42924858957859935
}
},
"0000785161": {
"2011": {
"obs_EconomicCapitalRatio": 0.6799239972910698
},
"2020": {
"obs_EconomicCapitalRatio": 1.4182305505026696
},
"2021": {
"obs_EconomicCapitalRatio": 1.0814619308963784
},
"2022": {
"obs_EconomicCapitalRatio": 1.2168672567310501
},
"2023": {
"obs_EconomicCapitalRatio": 1.3276977177956595
},
"2024": {
"obs_EconomicCapitalRatio": 1.8380528311696858
},
"2025": {
"obs_EconomicCapitalRatio": 1.9742320708117875
}
},
"0000893949": {
"2011": {
"obs_EconomicCapitalRatio": 2.4472442147004276
},
"2012": {
"obs_EconomicCapitalRatio": 2.324430027116807
},
"2013": {
"obs_EconomicCapitalRatio": 1.4153980642767163
},
"2014": {
"obs_EconomicCapitalRatio": 2.705255141805469
},
"2015": {
"obs_EconomicCapitalRatio": 2.0403070361793634
},
"2016": {
"obs_EconomicCapitalRatio": 1.5757900099368114
},
"2017": {
"obs_EconomicCapitalRatio": 1.1407480403624084
},
"2018": {
"obs_EconomicCapitalRatio": 0.6705050146055793
},
"2020": {
"obs_EconomicCapitalRatio": 0.6921913773195393
},
"2021": {
"obs_EconomicCapitalRatio": 1.0300015663795175
},
"2022": {
"obs_EconomicCapitalRatio": 0.6489855323488252
}
},
"0000352915": {
"2011": {
"obs_EconomicCapitalRatio": 0.0553602404895168
},
"2012": {
"obs_EconomicCapitalRatio": 0.0667388364815138
},
"2013": {
"obs_EconomicCapitalRatio": 0.10746186223320742
},
"2014": {
"obs_EconomicCapitalRatio": 0.1377020365266119
},
"2015": {
"obs_EconomicCapitalRatio": 0.14053215356654963
},
"2016": {
"obs_EconomicCapitalRatio": 0.11621934942230021
},
"2017": {
"obs_EconomicCapitalRatio": 0.114780744950106
},
"2018": {
"obs_EconomicCapitalRatio": 0.11647085422878821
},
"2019": {
"obs_EconomicCapitalRatio": 0.13844490306808155
},
"2020": {
"obs_EconomicCapitalRatio": 0.10967403520573908
},
"2021": {
"obs_EconomicCapitalRatio": 0.10964465033831926
},
"2022": {
"obs_EconomicCapitalRatio": 0.11838136871728291
}
},
"0001108109": {
"2011": {
"obs_EconomicCapitalRatio": 0.11115589636411495
},
"2018": {
"obs_EconomicCapitalRatio": 0.020711060055743875
},
"2019": {
"obs_EconomicCapitalRatio": 0.02087391002128378
},
"2020": {
"obs_EconomicCapitalRatio": 0.055024335706864366
},
"2021": {
"obs_EconomicCapitalRatio": 0.11238728706954826
},
"2022": {
"obs_EconomicCapitalRatio": 0.03480717712086575
}
},
"0000019584": {
"2011": {
"obs_EconomicCapitalRatio": 1.6007792741509022
},
"2012": {
"obs_EconomicCapitalRatio": 1.9490756925806219
},
"2013": {
"obs_EconomicCapitalRatio": 1.914488847567999
},
"2014": {
"obs_EconomicCapitalRatio": 2.7276355806390216
},
"2015": {
"obs_EconomicCapitalRatio": 4.108866362531992
},
"2016": {
"obs_EconomicCapitalRatio": 4.056449959720801
},
"2017": {
"obs_EconomicCapitalRatio": 5.771321991229426
},
"2018": {
"obs_EconomicCapitalRatio": 6.4038316847246515
},
"2019": {
"obs_EconomicCapitalRatio": 7.58709219872699
},
"2020": {
"obs_EconomicCapitalRatio": 8.473284302050429
},
"2021": {
"obs_EconomicCapitalRatio": 7.75419875738273
},
"2022": {
"obs_EconomicCapitalRatio": 7.217090228251971
},
"2023": {
"obs_EconomicCapitalRatio": 7.848784782008866
},
"2024": {
"obs_EconomicCapitalRatio": 7.020418240239263
},
"2025": {
"obs_EconomicCapitalRatio": 5.834267895037539
}
},
"0000885978": {
"2011": {
"obs_EconomicCapitalRatio": 1.8249280503248755
},
"2012": {
"obs_EconomicCapitalRatio": 2.5724402670747026
},
"2013": {
"obs_EconomicCapitalRatio": 2.440280256916831
},
"2014": {
"obs_EconomicCapitalRatio": 2.7841283878931624
},
"2015": {
"obs_EconomicCapitalRatio": 3.1734064882953517
},
"2016": {
"obs_EconomicCapitalRatio": 3.0246117738545863
},
"2017": {
"obs_EconomicCapitalRatio": 3.0139939481056994
},
"2018": {
"obs_EconomicCapitalRatio": 4.338573763941583
},
"2019": {
"obs_EconomicCapitalRatio": 3.5619391851687783
},
"2020": {
"obs_EconomicCapitalRatio": 3.608060136945878
},
"2021": {
"obs_EconomicCapitalRatio": 2.2035870209619968
},
"2022": {
"obs_EconomicCapitalRatio": 1.6051840413020122
},
"2023": {
"obs_EconomicCapitalRatio": 1.9917917705186083
}
},
"0001043000": {
"2011": {
"obs_EconomicCapitalRatio": 0.8293232149926116
},
"2012": {
"obs_EconomicCapitalRatio": 1.4742528917925262
},
"2013": {
"obs_EconomicCapitalRatio": 1.7089349147012525
},
"2014": {
"obs_EconomicCapitalRatio": 1.4658517655187218
},
"2015": {
"obs_EconomicCapitalRatio": 1.1163300237064913
},
"2016": {
"obs_EconomicCapitalRatio": 0.8011463796423269
},
"2017": {
"obs_EconomicCapitalRatio": 0.6657619630661099
},
"2018": {
"obs_EconomicCapitalRatio": 0.3499332196919161
},
"2019": {
"obs_EconomicCapitalRatio": 0.1435327336460731
},
"2020": {
"obs_EconomicCapitalRatio": 0.7691184527453718
},
"2021": {
"obs_EconomicCapitalRatio": 0.2472761050128782
},
"2022": {
"obs_EconomicCapitalRatio": 0.11342826064079066
},
"2023": {
"obs_EconomicCapitalRatio": 0.12215537075834612
},
"2024": {
"obs_EconomicCapitalRatio": 0.5680879390824175
},
"2025": {
"obs_EconomicCapitalRatio": 0.7440503530902668
}
},
"0001047335": {
"2011": {
"obs_EconomicCapitalRatio": 0.7030648064303432
},
"2012": {
"obs_EconomicCapitalRatio": 0.7986366131163368
},
"2013": {
"obs_EconomicCapitalRatio": 0.8810375321554819
},
"2014": {
"obs_EconomicCapitalRatio": 1.0391703058215966
},
"2015": {
"obs_EconomicCapitalRatio": 1.1792883497574127
},
"2016": {
"obs_EconomicCapitalRatio": 1.4494970214093919
},
"2018": {
"obs_EconomicCapitalRatio": 1.3317026977764668
},
"2019": {
"obs_EconomicCapitalRatio": 1.2199733107599542
},
"2020": {
"obs_EconomicCapitalRatio": 0.9159128240235758
},
"2021": {
"obs_EconomicCapitalRatio": 0.974181561146432
},
"2022": {
"obs_EconomicCapitalRatio": 1.0185115295379144
},
"2023": {
"obs_EconomicCapitalRatio": 1.6164670839378312
},
"2024": {
"obs_EconomicCapitalRatio": 1.6149386864581519
},
"2025": {
"obs_EconomicCapitalRatio": 2.1616166738307125
}
},
"0001125376": {
"2011": {
"obs_EconomicCapitalRatio": 1399.2430658223911
},
"2013": {
"obs_EconomicCapitalRatio": 1.5989526445598863
},
"2014": {
"obs_EconomicCapitalRatio": 2.650540849834678
},
"2015": {
"obs_EconomicCapitalRatio": 1.0482953396008179
},
"2016": {
"obs_EconomicCapitalRatio": 1.43190595552074
},
"2017": {
"obs_EconomicCapitalRatio": 1.298859391390505
},
"2018": {
"obs_EconomicCapitalRatio": 2.258510853301959
},
"2020": {
"obs_EconomicCapitalRatio": 1.8301794320010123
},
"2021": {
"obs_EconomicCapitalRatio": 1.9403448034625244
},
"2022": {
"obs_EconomicCapitalRatio": 1.8563425494032437
},
"2023": {
"obs_EconomicCapitalRatio": 1.8496058389879095
},
"2024": {
"obs_EconomicCapitalRatio": 2.05284060578683
},
"2025": {
"obs_EconomicCapitalRatio": 2.3535867345733354
}
},
"0001320414": {
"2011": {
"obs_EconomicCapitalRatio": 0.4096752742860925
},
"2012": {
"obs_EconomicCapitalRatio": 0.4783822969318578
},
"2019": {
"obs_EconomicCapitalRatio": 0.44294593397271526
},
"2020": {
"obs_EconomicCapitalRatio": 0.4886895190465231
},
"2021": {
"obs_EconomicCapitalRatio": 0.5402804679327372
},
"2022": {
"obs_EconomicCapitalRatio": 0.4248829592184213
},
"2023": {
"obs_EconomicCapitalRatio": 0.42798358473497655
},
"2024": {
"obs_EconomicCapitalRatio": 0.5226074625086464
},
"2025": {
"obs_EconomicCapitalRatio": 0.37980794355505854
}
},
"0000860730": {
"2011": {
"obs_EconomicCapitalRatio": 0.4286902706847537
},
"2012": {
"obs_EconomicCapitalRatio": 0.7436572689093711
},
"2013": {
"obs_EconomicCapitalRatio": 1.1206263058489003
},
"2014": {
"obs_EconomicCapitalRatio": 1.6352993886568388
},
"2015": {
"obs_EconomicCapitalRatio": 1.3417604658415376
},
"2016": {
"obs_EconomicCapitalRatio": 1.2987056545778823
},
"2017": {
"obs_EconomicCapitalRatio": 1.3588133779185207
},
"2018": {
"obs_EconomicCapitalRatio": 1.690582150801402
},
"2019": {
"obs_EconomicCapitalRatio": 1.8037161509724668
},
"2020": {
"obs_EconomicCapitalRatio": 1.8890537469679993
},
"2021": {
"obs_EconomicCapitalRatio": 2.5241883533491696
},
"2022": {
"obs_EconomicCapitalRatio": 2.1212350019474413
}
},
"0000744825": {
"2011": {
"obs_EconomicCapitalRatio": 0.3013270885313684
},
"2012": {
"obs_EconomicCapitalRatio": 0.2786524695351668
},
"2014": {
"obs_EconomicCapitalRatio": 0.32061093649804834
},
"2015": {
"obs_EconomicCapitalRatio": 0.27328011615268516
},
"2016": {
"obs_EconomicCapitalRatio": 0.507485494797134
},
"2019": {
"obs_EconomicCapitalRatio": 0.47749793539701463
},
"2020": {
"obs_EconomicCapitalRatio": 0.4205109400804776
},
"2021": {
"obs_EconomicCapitalRatio": 0.5408241989221371
},
"2022": {
"obs_EconomicCapitalRatio": 0.551218384744222
},
"2023": {
"obs_EconomicCapitalRatio": 0.43442074411285875
},
"2024": {
"obs_EconomicCapitalRatio": 0.4546792591572024
},
"2025": {
"obs_EconomicCapitalRatio": 0.33160145828748444
}
},
"0001124140": {
"2011": {
"obs_EconomicCapitalRatio": 8.166711011815341
},
"2012": {
"obs_EconomicCapitalRatio": 10.92431895435195
},
"2013": {
"obs_EconomicCapitalRatio": 11.153573080374903
},
"2014": {
"obs_EconomicCapitalRatio": 13.87272928515707
},
"2015": {
"obs_EconomicCapitalRatio": 4.498727547879557
},
"2016": {
"obs_EconomicCapitalRatio": 7.186191888088503
},
"2017": {
"obs_EconomicCapitalRatio": 18.744201313894912
},
"2018": {
"obs_EconomicCapitalRatio": 6.328551540717717
},
"2019": {
"obs_EconomicCapitalRatio": 5.219972902769483
},
"2020": {
"obs_EconomicCapitalRatio": 5.8461764979525555
},
"2021": {
"obs_EconomicCapitalRatio": 2.693158098121996
},
"2022": {
"obs_EconomicCapitalRatio": 1.8966263786723718
},
"2023": {
"obs_EconomicCapitalRatio": 2.675453724118233
},
"2024": {
"obs_EconomicCapitalRatio": 2.2518786178746426
},
"2025": {
"obs_EconomicCapitalRatio": 4.130870838625185
}
},
"0001416876": {
"2011": {
"obs_EconomicCapitalRatio": 6.005379679717644
}
},
"0001468328": {
"2011": {
"obs_EconomicCapitalRatio": 0.3339618789772089
},
"2012": {
"obs_EconomicCapitalRatio": 0.7361666670249098
},
"2013": {
"obs_EconomicCapitalRatio": 2.4221362236697006
},
"2014": {
"obs_EconomicCapitalRatio": 2.247833539524948
},
"2015": {
"obs_EconomicCapitalRatio": 2.1765194287839145
},
"2016": {
"obs_EconomicCapitalRatio": 2.669870396751533
},
"2017": {
"obs_EconomicCapitalRatio": 2.225023618015959
},
"2018": {
"obs_EconomicCapitalRatio": 3.999238099074307
},
"2019": {
"obs_EconomicCapitalRatio": 3.6416558946940984
},
"2020": {
"obs_EconomicCapitalRatio": 2.8759264575125654
},
"2021": {
"obs_EconomicCapitalRatio": 2.2511133868811335
},
"2022": {
"obs_EconomicCapitalRatio": 2.6282063462550895
},
"2025": {
"obs_EconomicCapitalRatio": 2.289809915160802
}
},
"0000320017": {
"2011": {
"obs_EconomicCapitalRatio": 0.7845651461442082
},
"2017": {
"obs_EconomicCapitalRatio": 0.8441397867838771
},
"2018": {
"obs_EconomicCapitalRatio": 1.450029837906473
},
"2019": {
"obs_EconomicCapitalRatio": 1.3779837923295708
},
"2020": {
"obs_EconomicCapitalRatio": 1.4413081267952197
},
"2021": {
"obs_EconomicCapitalRatio": 1.0188229702380915
},
"2022": {
"obs_EconomicCapitalRatio": 0.4977353007777521
},
"2023": {
"obs_EconomicCapitalRatio": 0.7478434592910281
},
"2024": {
"obs_EconomicCapitalRatio": 1.2214669648900207
},
"2025": {
"obs_EconomicCapitalRatio": 1.697675419723171
}
},
"0000862692": {
"2012": {
"obs_EconomicCapitalRatio": 1.6030934401757337
},
"2013": {
"obs_EconomicCapitalRatio": 1.4904801656352977
},
"2014": {
"obs_EconomicCapitalRatio": 2.29460235161725
},
"2015": {
"obs_EconomicCapitalRatio": 1.5555905563042072
},
"2016": {
"obs_EconomicCapitalRatio": 0.8703509764233575
},
"2017": {
"obs_EconomicCapitalRatio": 1.745275561455659
},
"2018": {
"obs_EconomicCapitalRatio": 1.0071098975322699
},
"2019": {
"obs_EconomicCapitalRatio": 0.9780748861936736
},
"2020": {
"obs_EconomicCapitalRatio": 0.9549593957112342
},
"2021": {
"obs_EconomicCapitalRatio": 1.392951720347594
},
"2022": {
"obs_EconomicCapitalRatio": 0.49974368258860846
}
},
"0001138476": {
"2011": {
"obs_EconomicCapitalRatio": 1.0159968197446956
},
"2012": {
"obs_EconomicCapitalRatio": 2.6993579909368757
},
"2013": {
"obs_EconomicCapitalRatio": 13.336168649980072
},
"2014": {
"obs_EconomicCapitalRatio": 9.494406793998118
},
"2015": {
"obs_EconomicCapitalRatio": 1.9380748685240585
},
"2016": {
"obs_EconomicCapitalRatio": 2.7272575024723023
},
"2017": {
"obs_EconomicCapitalRatio": 3.028696524958903
},
"2018": {
"obs_EconomicCapitalRatio": 2.885688962134937
},
"2020": {
"obs_EconomicCapitalRatio": 1.8494446405798506
},
"2021": {
"obs_EconomicCapitalRatio": 1.8473038660504764
},
"2022": {
"obs_EconomicCapitalRatio": 1.3523816738275818
},
"2023": {
"obs_EconomicCapitalRatio": 1.4350490259676654
}
},
"0001520697": {
"2011": {
"obs_EconomicCapitalRatio": 0.6081713564397228
},
"2012": {
"obs_EconomicCapitalRatio": 1.2349126249303797
},
"2013": {
"obs_EconomicCapitalRatio": 2.431136189781226
},
"2014": {
"obs_EconomicCapitalRatio": 2.1113051231339535
},
"2015": {
"obs_EconomicCapitalRatio": 1.3038377293511394
},
"2017": {
"obs_EconomicCapitalRatio": 0.5522060999716568
},
"2018": {
"obs_EconomicCapitalRatio": 0.4571543250579229
},
"2019": {
"obs_EconomicCapitalRatio": 0.5212458993293995
},
"2020": {
"obs_EconomicCapitalRatio": 0.7890311768704694
},
"2021": {
"obs_EconomicCapitalRatio": 1.5307713118327542
},
"2022": {
"obs_EconomicCapitalRatio": 2.1315460187424224
}
},
"0000790526": {
"2012": {
"obs_EconomicCapitalRatio": 0.13358036301597942
},
"2013": {
"obs_EconomicCapitalRatio": 0.09085026990368239
},
"2014": {
"obs_EconomicCapitalRatio": 0.5431310806294178
},
"2015": {
"obs_EconomicCapitalRatio": 0.3505983920433856
},
"2016": {
"obs_EconomicCapitalRatio": 0.3682069337967622
},
"2017": {
"obs_EconomicCapitalRatio": 0.5710188707297758
},
"2024": {
"obs_EconomicCapitalRatio": 1.973558336079889
},
"2025": {
"obs_EconomicCapitalRatio": 1.822716365763516
}
},
"0000806517": {
"2012": {
"obs_EconomicCapitalRatio": 4.60715791025414
},
"2014": {
"obs_EconomicCapitalRatio": 3.3264549819016556
},
"2015": {
"obs_EconomicCapitalRatio": 2.6996817675995533
},
"2016": {
"obs_EconomicCapitalRatio": 5.952072258353605
},
"2017": {
"obs_EconomicCapitalRatio": 5.394572797693456
},
"2018": {
"obs_EconomicCapitalRatio": 4.474632330961844
},
"2019": {
"obs_EconomicCapitalRatio": 2.3961219464673005
},
"2020": {
"obs_EconomicCapitalRatio": 1.3262727318756238
},
"2021": {
"obs_EconomicCapitalRatio": 2.3750491230099042
},
"2022": {
"obs_EconomicCapitalRatio": 2.026772375492911
},
"2023": {
"obs_EconomicCapitalRatio": 1.8485765440798285
},
"2024": {
"obs_EconomicCapitalRatio": 1.9825798798980514
}
},
"0001505497": {
"2012": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2021": {
"obs_EconomicCapitalRatio": 1.3561386622109721
},
"2022": {
"obs_EconomicCapitalRatio": 1.2272159903361468
},
"2024": {
"obs_EconomicCapitalRatio": 1.3211056224972826
},
"2025": {
"obs_EconomicCapitalRatio": 2.6392582155377524
}
},
"0001089815": {
"2012": {
"obs_EconomicCapitalRatio": 0.27461324171750273
},
"2013": {
"obs_EconomicCapitalRatio": 0.5652182034205951
},
"2014": {
"obs_EconomicCapitalRatio": 0.5784619345201361
},
"2015": {
"obs_EconomicCapitalRatio": 0.1633049803157926
},
"2016": {
"obs_EconomicCapitalRatio": 0.2753162215937384
},
"2017": {
"obs_EconomicCapitalRatio": 0.4022421591008146
},
"2018": {
"obs_EconomicCapitalRatio": 0.3316176238371148
},
"2019": {
"obs_EconomicCapitalRatio": 0.4783975439001473
},
"2020": {
"obs_EconomicCapitalRatio": 0.919678507057958
},
"2021": {
"obs_EconomicCapitalRatio": 0.9237462870829648
},
"2022": {
"obs_EconomicCapitalRatio": 1.539192368372456
},
"2023": {
"obs_EconomicCapitalRatio": 3.7939396247631856
},
"2024": {
"obs_EconomicCapitalRatio": 6.231155648407009
},
"2025": {
"obs_EconomicCapitalRatio": 7.171877525786021
}
},
"0000802257": {
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2020": {
"obs_EconomicCapitalRatio": 1.9744005113966216
},
"2021": {
"obs_EconomicCapitalRatio": 3.6904748791510964
},
"2022": {
"obs_EconomicCapitalRatio": 18.356104790380286
}
},
"0000948320": {
"2013": {
"obs_EconomicCapitalRatio": 19.122408312536397
},
"2014": {
"obs_EconomicCapitalRatio": 12.544382169245214
},
"2015": {
"obs_EconomicCapitalRatio": 10.709507411111359
},
"2018": {
"obs_EconomicCapitalRatio": 3.298409579098017
},
"2019": {
"obs_EconomicCapitalRatio": 1.7309580285301396
},
"2020": {
"obs_EconomicCapitalRatio": 10.40786666630324
},
"2021": {
"obs_EconomicCapitalRatio": 3.3516170514357024
},
"2022": {
"obs_EconomicCapitalRatio": 2.1668311020786786
},
"2023": {
"obs_EconomicCapitalRatio": 5.666378657404718
},
"2024": {
"obs_EconomicCapitalRatio": 2.9540486786201483
},
"2025": {
"obs_EconomicCapitalRatio": 2.8022594173750055
}
},
"0001384101": {
"2013": {
"obs_EconomicCapitalRatio": 5.726396731332951
},
"2014": {
"obs_EconomicCapitalRatio": 4.2258505750915285
},
"2015": {
"obs_EconomicCapitalRatio": 4.002792419943674
},
"2016": {
"obs_EconomicCapitalRatio": 2.907069930522243
},
"2017": {
"obs_EconomicCapitalRatio": 3.6955164524484863
},
"2018": {
"obs_EconomicCapitalRatio": 5.903084432595021
},
"2019": {
"obs_EconomicCapitalRatio": 9.17221087672525
},
"2020": {
"obs_EconomicCapitalRatio": 12.009349418296129
},
"2021": {
"obs_EconomicCapitalRatio": 4.569266085280168
},
"2022": {
"obs_EconomicCapitalRatio": 2.957324756862987
},
"2023": {
"obs_EconomicCapitalRatio": 3.476700938886737
},
"2024": {
"obs_EconomicCapitalRatio": 4.4085578126382945
},
"2025": {
"obs_EconomicCapitalRatio": 4.485792425264168
}
},
"0001443863": {
"2013": {
"obs_EconomicCapitalRatio": 3.48321910388931
},
"2014": {
"obs_EconomicCapitalRatio": 3.4046294626511577
},
"2015": {
"obs_EconomicCapitalRatio": 1.5631269234101999
},
"2016": {
"obs_EconomicCapitalRatio": 1.1237533540614515
},
"2018": {
"obs_EconomicCapitalRatio": 4.838143851132696
},
"2020": {
"obs_EconomicCapitalRatio": 1.516717809911702
},
"2021": {
"obs_EconomicCapitalRatio": 6.736268258202685
},
"2022": {
"obs_EconomicCapitalRatio": 1.547614374795819
},
"2025": {
"obs_EconomicCapitalRatio": 0.9131965951472314
}
},
"0001597892": {
"2016": {
"obs_EconomicCapitalRatio": 0.4573910404286819
},
"2017": {
"obs_EconomicCapitalRatio": 0.7307048923124139
},
"2018": {
"obs_EconomicCapitalRatio": 1.0765984359761611
},
"2019": {
"obs_EconomicCapitalRatio": 2.9112556811490666
},
"2020": {
"obs_EconomicCapitalRatio": 0.0805492763350369
},
"2023": {
"obs_EconomicCapitalRatio": 2.308586009655766
}
},
"0001217234": {
"2014": {
"obs_EconomicCapitalRatio": 2.106099248600515
},
"2015": {
"obs_EconomicCapitalRatio": 1.8606992876041615
},
"2016": {
"obs_EconomicCapitalRatio": 0.8991741565472338
},
"2017": {
"obs_EconomicCapitalRatio": 2.3625185935969757
},
"2018": {
"obs_EconomicCapitalRatio": 10.988768401944188
},
"2019": {
"obs_EconomicCapitalRatio": 9.295696048608347
},
"2020": {
"obs_EconomicCapitalRatio": 15.894232884028792
},
"2021": {
"obs_EconomicCapitalRatio": 7.107376945609629
},
"2022": {
"obs_EconomicCapitalRatio": 1.868289639503857
},
"2023": {
"obs_EconomicCapitalRatio": 1.9021864798831671
},
"2024": {
"obs_EconomicCapitalRatio": 3.75555356135359
},
"2025": {
"obs_EconomicCapitalRatio": 3.8258403033619546
}
},
"0000811222": {
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 2.313895027277619
},
"2025": {
"obs_EconomicCapitalRatio": 1.2879555622882315
}
},
"0001477449": {
"2015": {
"obs_EconomicCapitalRatio": 5.544764703239246
},
"2016": {
"obs_EconomicCapitalRatio": 4.7132034470335
},
"2017": {
"obs_EconomicCapitalRatio": 4.690116935020641
},
"2018": {
"obs_EconomicCapitalRatio": 4.243448916525309
},
"2019": {
"obs_EconomicCapitalRatio": 7.066330202032505
},
"2020": {
"obs_EconomicCapitalRatio": 3.2033660875692913
},
"2021": {
"obs_EconomicCapitalRatio": 1.6724116401293925
},
"2022": {
"obs_EconomicCapitalRatio": 1.6400447522007024
},
"2023": {
"obs_EconomicCapitalRatio": 1.4808360827926537
},
"2024": {
"obs_EconomicCapitalRatio": 0.5824872091940608
},
"2025": {
"obs_EconomicCapitalRatio": 0.5880410245147577
}
},
"0001638833": {
"2015": {
"obs_EconomicCapitalRatio": 0.8690576081521365
},
"2016": {
"obs_EconomicCapitalRatio": 0.5809479181547815
},
"2018": {
"obs_EconomicCapitalRatio": 0.19992190836322066
},
"2019": {
"obs_EconomicCapitalRatio": 0.28413337094038393
},
"2020": {
"obs_EconomicCapitalRatio": 0.47610580888076925
},
"2021": {
"obs_EconomicCapitalRatio": 1.3205930250979123
},
"2022": {
"obs_EconomicCapitalRatio": 0.6666538559780858
},
"2023": {
"obs_EconomicCapitalRatio": 1.1049807370417983
},
"2024": {
"obs_EconomicCapitalRatio": 0.6276252284290024
},
"2025": {
"obs_EconomicCapitalRatio": 0.46493861746268283
}
},
"0001590750": {
"2015": {
"obs_EconomicCapitalRatio": 0.932903006677119
},
"2016": {
"obs_EconomicCapitalRatio": 13.0711249565521
},
"2017": {
"obs_EconomicCapitalRatio": 6.356633171990735
},
"2018": {
"obs_EconomicCapitalRatio": 2.0254040755220735
},
"2019": {
"obs_EconomicCapitalRatio": 0.6907471032007421
},
"2020": {
"obs_EconomicCapitalRatio": 14.802536994480796
},
"2021": {
"obs_EconomicCapitalRatio": 4.033972483760562
},
"2023": {
"obs_EconomicCapitalRatio": 4.295100066488977
},
"2024": {
"obs_EconomicCapitalRatio": 3.7757140806874343
},
"2025": {
"obs_EconomicCapitalRatio": 5.655591493377748
}
},
"0001604821": {
"2015": {
"obs_EconomicCapitalRatio": 3.240855334715597
},
"2016": {
"obs_EconomicCapitalRatio": 3.9343020841567653
},
"2017": {
"obs_EconomicCapitalRatio": 2.797164141426769
},
"2018": {
"obs_EconomicCapitalRatio": 3.2298690908277656
},
"2019": {
"obs_EconomicCapitalRatio": 5.987358295647832
},
"2020": {
"obs_EconomicCapitalRatio": 12.840764363166384
},
"2021": {
"obs_EconomicCapitalRatio": 9.697207220674155
},
"2022": {
"obs_EconomicCapitalRatio": 3.8690619189941047
},
"2023": {
"obs_EconomicCapitalRatio": 6.871334386701791
},
"2024": {
"obs_EconomicCapitalRatio": 19.864753055012294
}
},
"0000792935": {
"2016": {
"obs_EconomicCapitalRatio": 0.47107162549473863
},
"2019": {
"obs_EconomicCapitalRatio": 0.06465501080251583
},
"2020": {
"obs_EconomicCapitalRatio": 0.5290719268064846
},
"2021": {
"obs_EconomicCapitalRatio": 0.2676343291130003
},
"2022": {
"obs_EconomicCapitalRatio": 0.13585432723348395
},
"2024": {
"obs_EconomicCapitalRatio": 0.2432404069211452
}
},
"0001674930": {
"2016": {
"obs_EconomicCapitalRatio": 5.977117435291776
},
"2017": {
"obs_EconomicCapitalRatio": 2.4695749151172817
},
"2018": {
"obs_EconomicCapitalRatio": 2.079409314730264
},
"2019": {
"obs_EconomicCapitalRatio": 5.306880144073147
},
"2020": {
"obs_EconomicCapitalRatio": 2.8216283049254067
},
"2021": {
"obs_EconomicCapitalRatio": 4.339147344390559
},
"2022": {
"obs_EconomicCapitalRatio": 1.1938018387890712
}
},
"0001680139": {
"2017": {
"obs_EconomicCapitalRatio": 3.9395693520833825
},
"2018": {
"obs_EconomicCapitalRatio": 6.2256973384254515
},
"2019": {
"obs_EconomicCapitalRatio": 3.533160492046391
},
"2021": {
"obs_EconomicCapitalRatio": 15.437613384223065
},
"2022": {
"obs_EconomicCapitalRatio": 3.5079397431580226
},
"2023": {
"obs_EconomicCapitalRatio": 4.4482071080504575
}
},
"0001603454": {
"2018": {
"obs_EconomicCapitalRatio": 17.66433991837258
},
"2019": {
"obs_EconomicCapitalRatio": 9.527163233702987
},
"2021": {
"obs_EconomicCapitalRatio": 3.7696196477965644
},
"2022": {
"obs_EconomicCapitalRatio": 1.8690407255909658
},
"2023": {
"obs_EconomicCapitalRatio": 2.9173109469879184
},
"2024": {
"obs_EconomicCapitalRatio": 2.485696746340044
},
"2025": {
"obs_EconomicCapitalRatio": 11.243231230995297
}
},
"0001713210": {
"2023": {
"obs_EconomicCapitalRatio": 14.39400262713444
},
"2024": {
"obs_EconomicCapitalRatio": 2.0773963940030575
},
"2025": {
"obs_EconomicCapitalRatio": 0.44125322995284166
}
},
"0000070318": {
"2018": {
"obs_EconomicCapitalRatio": 0.08552924410432898
},
"2019": {
"obs_EconomicCapitalRatio": 0.17754638364786196
},
"2020": {
"obs_EconomicCapitalRatio": 0.16463973728908057
},
"2021": {
"obs_EconomicCapitalRatio": 0.33521955077878823
},
"2022": {
"obs_EconomicCapitalRatio": 0.20317691382837733
},
"2023": {
"obs_EconomicCapitalRatio": 0.30062697803053423
},
"2024": {
"obs_EconomicCapitalRatio": 0.4934054549593957
},
"2025": {
"obs_EconomicCapitalRatio": 0.6933671309524378
}
},
"0001576280": {
"2018": {
"obs_EconomicCapitalRatio": 9.409998338204176
},
"2019": {
"obs_EconomicCapitalRatio": 14.015133034824808
},
"2020": {
"obs_EconomicCapitalRatio": 8.033623509502428
},
"2021": {
"obs_EconomicCapitalRatio": 5.378829839582666
},
"2022": {
"obs_EconomicCapitalRatio": 1.8770406090353164
},
"2023": {
"obs_EconomicCapitalRatio": 1.9270482881595639
},
"2024": {
"obs_EconomicCapitalRatio": 2.4823202710500136
},
"2025": {
"obs_EconomicCapitalRatio": 6.1920599604917745
}
},
"0001766400": {
"2019": {
"obs_EconomicCapitalRatio": 2.2358107646248047
},
"2020": {
"obs_EconomicCapitalRatio": 3.7377872544961175
},
"2021": {
"obs_EconomicCapitalRatio": 1.317407127445334
},
"2022": {
"obs_EconomicCapitalRatio": 0.7196383548705427
},
"2023": {
"obs_EconomicCapitalRatio": 0.8927955560969081
},
"2024": {
"obs_EconomicCapitalRatio": 1.7720749372810554
},
"2025": {
"obs_EconomicCapitalRatio": 1.2970657367956044
}
},
"0001274737": {
"2019": {
"obs_EconomicCapitalRatio": 5.3105465475101905
},
"2020": {
"obs_EconomicCapitalRatio": 2.660107841280965
},
"2021": {
"obs_EconomicCapitalRatio": 2.2167256957939694
},
"2022": {
"obs_EconomicCapitalRatio": 0.6076712499435017
},
"2023": {
"obs_EconomicCapitalRatio": 0.654214032721451
},
"2024": {
"obs_EconomicCapitalRatio": 2.2025057987368397
},
"2025": {
"obs_EconomicCapitalRatio": 2.875555288576213
}
},
"0001447362": {
"2019": {
"obs_EconomicCapitalRatio": 6.498753866445175
},
"2020": {
"obs_EconomicCapitalRatio": 6.026288703848502
},
"2021": {
"obs_EconomicCapitalRatio": 4.175460360278498
},
"2022": {
"obs_EconomicCapitalRatio": 2.4739768633055252
},
"2023": {
"obs_EconomicCapitalRatio": 2.256072832055694
},
"2024": {
"obs_EconomicCapitalRatio": 2.501859695117348
},
"2025": {
"obs_EconomicCapitalRatio": 3.3619067449345166
}
},
"0001527753": {
"2019": {
"obs_EconomicCapitalRatio": 2.953743430117927
},
"2020": {
"obs_EconomicCapitalRatio": 10.527770127762217
},
"2021": {
"obs_EconomicCapitalRatio": 2.645722439374889
},
"2022": {
"obs_EconomicCapitalRatio": 0.47315593157114144
}
},
"0001725255": {
"2019": {
"obs_EconomicCapitalRatio": 0.5857155046057619
},
"2020": {
"obs_EconomicCapitalRatio": 1.4955681062795707
},
"2021": {
"obs_EconomicCapitalRatio": 0.7234441813573314
},
"2022": {
"obs_EconomicCapitalRatio": 0.6234341278934857
},
"2023": {
"obs_EconomicCapitalRatio": 0.26119597375409453
},
"2024": {
"obs_EconomicCapitalRatio": 0.35440894588014293
},
"2025": {
"obs_EconomicCapitalRatio": 0.3887325800588612
}
},
"0001551306": {
"2019": {
"obs_EconomicCapitalRatio": 23.128888643767834
},
"2020": {
"obs_EconomicCapitalRatio": 21.25263485685163
},
"2021": {
"obs_EconomicCapitalRatio": 19.928211362808444
},
"2022": {
"obs_EconomicCapitalRatio": 8.182587418805609
},
"2023": {
"obs_EconomicCapitalRatio": 7.48169024244033
},
"2024": {
"obs_EconomicCapitalRatio": 3.143226224073416
},
"2025": {
"obs_EconomicCapitalRatio": 4.595221185166977
}
},
"0001729149": {
"2019": {
"obs_EconomicCapitalRatio": 3.9141912518645925
},
"2020": {
"obs_EconomicCapitalRatio": 4.377758147257698
},
"2021": {
"obs_EconomicCapitalRatio": 3.1175442632229804
},
"2022": {
"obs_EconomicCapitalRatio": 4.165808200790573
},
"2023": {
"obs_EconomicCapitalRatio": 3.0905943820113806
},
"2024": {
"obs_EconomicCapitalRatio": 2.8280699797927302
},
"2025": {
"obs_EconomicCapitalRatio": 2.208374174708051
}
},
"0001729944": {
"2019": {
"obs_EconomicCapitalRatio": 0.80033022263604
},
"2020": {
"obs_EconomicCapitalRatio": 0.8939501524991209
},
"2021": {
"obs_EconomicCapitalRatio": 1.670257709676602
},
"2022": {
"obs_EconomicCapitalRatio": 0.7555010825436428
},
"2023": {
"obs_EconomicCapitalRatio": 1.486124730980496
},
"2024": {
"obs_EconomicCapitalRatio": 0.5100288861637816
}
},
"0001799191": {
"2020": {
"obs_EconomicCapitalRatio": 1.9354663360497144
},
"2021": {
"obs_EconomicCapitalRatio": 1.4314265160413502
},
"2022": {
"obs_EconomicCapitalRatio": 0.5369289711729511
},
"2024": {
"obs_EconomicCapitalRatio": 0.09570735084291766
},
"2025": {
"obs_EconomicCapitalRatio": 2.001660729797598
}
},
"0001439725": {
"2020": {
"obs_EconomicCapitalRatio": 4.899553478061839
},
"2021": {
"obs_EconomicCapitalRatio": 1.7991006973357486
},
"2022": {
"obs_EconomicCapitalRatio": 0.9045190531820879
}
},
"0001737523": {
"2021": {
"obs_EconomicCapitalRatio": 671.1968392005622
},
"2022": {
"obs_EconomicCapitalRatio": 385.49382888758356
},
"2023": {
"obs_EconomicCapitalRatio": 1.5191647865482536
},
"2024": {
"obs_EconomicCapitalRatio": 0.7490768181400523
},
"2025": {
"obs_EconomicCapitalRatio": 2.0065585272756072
}
},
"0001759655": {
"2021": {
"obs_EconomicCapitalRatio": 5.9854315421959114
},
"2022": {
"obs_EconomicCapitalRatio": 4.9874077872328435
},
"2023": {
"obs_EconomicCapitalRatio": 3.9996069884808416
},
"2024": {
"obs_EconomicCapitalRatio": 3.0209663872592287
},
"2025": {
"obs_EconomicCapitalRatio": 3.0134479613948315
}
},
"0001803901": {
"2021": {
"obs_EconomicCapitalRatio": 2.3239919326101237
},
"2022": {
"obs_EconomicCapitalRatio": 1.1649813946676386
}
},
"0001818331": {
"2021": {
"obs_EconomicCapitalRatio": 3.031702783280354
},
"2022": {
"obs_EconomicCapitalRatio": 0.2650382635460216
},
"2023": {
"obs_EconomicCapitalRatio": 0.2340008975350877
},
"2024": {
"obs_EconomicCapitalRatio": 7.1433325795924105
},
"2025": {
"obs_EconomicCapitalRatio": 10.607580330133818
}
},
"0001822359": {
"2021": {
"obs_EconomicCapitalRatio": 4.529492069938443
},
"2022": {
"obs_EconomicCapitalRatio": 2.771063189488642
},
"2023": {
"obs_EconomicCapitalRatio": 1.6728383727412641
},
"2024": {
"obs_EconomicCapitalRatio": 1.4843694887626384
},
"2025": {
"obs_EconomicCapitalRatio": 0.5634025375829321
}
},
"0001834376": {
"2021": {
"obs_EconomicCapitalRatio": 1.9802948402224156
},
"2022": {
"obs_EconomicCapitalRatio": 2.439532779220166
},
"2023": {
"obs_EconomicCapitalRatio": 1.8744085157804056
},
"2024": {
"obs_EconomicCapitalRatio": 1.3621909662118414
}
},
"0001773751": {
"2021": {
"obs_EconomicCapitalRatio": 4.971853684184344
},
"2022": {
"obs_EconomicCapitalRatio": 6.128488895753875
},
"2023": {
"obs_EconomicCapitalRatio": 6.554674754785222
},
"2024": {
"obs_EconomicCapitalRatio": 12.126553207078992
},
"2025": {
"obs_EconomicCapitalRatio": 4.04039885819204
}
},
"0001870940": {
"2021": {
"obs_EconomicCapitalRatio": 5.033081838177257
},
"2022": {
"obs_EconomicCapitalRatio": 1.132782907988652
},
"2023": {
"obs_EconomicCapitalRatio": 2.5947989753230587
},
"2024": {
"obs_EconomicCapitalRatio": 1.8671046483783382
}
},
"0001534969": {
"2021": {
"obs_EconomicCapitalRatio": 2.8842820361801325
},
"2022": {
"obs_EconomicCapitalRatio": 0.5713512984391965
},
"2023": {
"obs_EconomicCapitalRatio": 3.1922358214415856
}
},
"0001822479": {
"2021": {
"obs_EconomicCapitalRatio": 2.6314647506130555
},
"2022": {
"obs_EconomicCapitalRatio": 0.7794445581652086
},
"2023": {
"obs_EconomicCapitalRatio": 1.6169003077959527
},
"2024": {
"obs_EconomicCapitalRatio": 1.317382776714733
},
"2025": {
"obs_EconomicCapitalRatio": 1.6819107661299355
}
},
"0001831097": {
"2021": {
"obs_EconomicCapitalRatio": 10.135987542140258
},
"2022": {
"obs_EconomicCapitalRatio": 5.716884020987739
},
"2023": {
"obs_EconomicCapitalRatio": 3.6117017245510086
},
"2024": {
"obs_EconomicCapitalRatio": 0.5237840028274809
},
"2025": {
"obs_EconomicCapitalRatio": 0.2429987445135107
}
},
"0001844392": {
"2021": {
"obs_EconomicCapitalRatio": 3.102693963604072
},
"2022": {
"obs_EconomicCapitalRatio": 0.36018627065159414
},
"2024": {
"obs_EconomicCapitalRatio": 0.5451364493905979
},
"2025": {
"obs_EconomicCapitalRatio": 0.3728897696807099
}
},
"0001832511": {
"2022": {
"obs_EconomicCapitalRatio": 0.14225887468579412
},
"2023": {
"obs_EconomicCapitalRatio": 0.21200771759380008
},
"2024": {
"obs_EconomicCapitalRatio": 0.045389475358619244
}
},
"0001892316": {
"2023": {
"obs_EconomicCapitalRatio": 110.39054612853406
},
"2024": {
"obs_EconomicCapitalRatio": 94.60058336986788
}
},
"0001635077": {
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 0.0
},
"2025": {
"obs_EconomicCapitalRatio": 0.5450667778424255
}
},
"0001803737": {
"2022": {
"obs_EconomicCapitalRatio": 0.5721263204730309
},
"2023": {
"obs_EconomicCapitalRatio": 0.4928465005438502
},
"2024": {
"obs_EconomicCapitalRatio": 0.4077090775440418
},
"2025": {
"obs_EconomicCapitalRatio": 0.5377770193692863
}
},
"0001826667": {
"2023": {
"obs_EconomicCapitalRatio": 5.747039577983446
},
"2024": {
"obs_EconomicCapitalRatio": 3.6673040258093965
},
"2025": {
"obs_EconomicCapitalRatio": 6.744892845411586
}
},
"0001965040": {
"2023": {
"obs_EconomicCapitalRatio": 0.8853775922144298
},
"2024": {
"obs_EconomicCapitalRatio": 0.5806666737511045
},
"2025": {
"obs_EconomicCapitalRatio": 0.6601762335313033
}
},
"0001938046": {
"2023": {
"obs_EconomicCapitalRatio": 7.485743735641145
},
"2024": {
"obs_EconomicCapitalRatio": 0.7342890394360521
},
"2025": {
"obs_EconomicCapitalRatio": 1.2366752765702367
}
},
"0001699031": {
"2024": {
"obs_EconomicCapitalRatio": 0.36247445601460876
},
"2025": {
"obs_EconomicCapitalRatio": 2.141226559604184
}
},
"0001960262": {
"2024": {
"obs_EconomicCapitalRatio": 20.758484759101325
}
}
}
}